Convert any text to a graph of knowledge. This can be used for Graph Augmented Generation or Knowledge Graph based QnA
HTML
first commit
Nayak42c8904faa4f
diff --git a/.gitignore b/.gitignorenew file mode 100644index 0000000..652953f--- /dev/null+++ b/.gitignore@@ -0,0 +1,3 @@+*/__pycache__+*/.DS_Store+.DS_Store\ No newline at end of filediff --git a/.python-version b/.python-versionnew file mode 100644index 0000000..a0edbea--- /dev/null+++ b/.python-version@@ -0,0 +1 @@+OpenAI@3111diff --git a/concept_graph.ipynb b/concept_graph.ipynbnew file mode 100644index 0000000..f7b85fb--- /dev/null+++ b/concept_graph.ipynb@@ -0,0 +1,715 @@+{+ "cells": [+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "# Create Network Graph"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Basic setup"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 24,+ "metadata": {},+ "outputs": [],+ "source": [+ "import pandas as pd\n",+ "import numpy as np\n",+ "from pyvis.network import Network\n",+ "import networkx as nx\n",+ "import seaborn as sns\n"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Loading previously calculated dataframes"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 25,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>text</th>\n",+ " <th>source</th>\n",+ " <th>page</th>\n",+ " <th>chunk_id</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>147\\n147Mental Health as a \\nPathway to Health...</td>\n",+ " <td>data/MedicalDocuments/OrfPathHealth/MentalHeal...</td>\n",+ " <td>0</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>sense, mental health encompasses promotive and...</td>\n",+ " <td>data/MedicalDocuments/OrfPathHealth/MentalHeal...</td>\n",+ " <td>0</td>\n",+ " <td>80ab9a7c29b44098961576ccd53fb7f6</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>148Accelerating Global Health: Pathways to Hea...</td>\n",+ " <td>data/MedicalDocuments/OrfPathHealth/MentalHeal...</td>\n",+ " <td>1</td>\n",+ " <td>1d5cc8cbbb074190b824e1fbc0d644aa</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>adversity is a recognised risk factor in condi...</td>\n",+ " <td>data/MedicalDocuments/OrfPathHealth/MentalHeal...</td>\n",+ " <td>1</td>\n",+ " <td>1f02a81a02054efaacb0ace0c5eadd14</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>both in healthcare service delivery.\\nThe chal...</td>\n",+ " <td>data/MedicalDocuments/OrfPathHealth/MentalHeal...</td>\n",+ " <td>1</td>\n",+ " <td>33e4526e998e4865bd5b0dde036c2a20</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " text \\\n",+ "0 147\\n147Mental Health as a \\nPathway to Health... \n",+ "1 sense, mental health encompasses promotive and... \n",+ "2 148Accelerating Global Health: Pathways to Hea... \n",+ "3 adversity is a recognised risk factor in condi... \n",+ "4 both in healthcare service delivery.\\nThe chal... \n",+ "\n",+ " source page \\\n",+ "0 data/MedicalDocuments/OrfPathHealth/MentalHeal... 0 \n",+ "1 data/MedicalDocuments/OrfPathHealth/MentalHeal... 0 \n",+ "2 data/MedicalDocuments/OrfPathHealth/MentalHeal... 1 \n",+ "3 data/MedicalDocuments/OrfPathHealth/MentalHeal... 1 \n",+ "4 data/MedicalDocuments/OrfPathHealth/MentalHeal... 1 \n",+ "\n",+ " chunk_id \n",+ "0 83d4d0367bb0467e811782a4ada3bbb9 \n",+ "1 80ab9a7c29b44098961576ccd53fb7f6 \n",+ "2 1d5cc8cbbb074190b824e1fbc0d644aa \n",+ "3 1f02a81a02054efaacb0ace0c5eadd14 \n",+ "4 33e4526e998e4865bd5b0dde036c2a20 "+ ]+ },+ "execution_count": 25,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "dataframe_dir = 'OrfPathHealth'\n",+ "df = pd.read_csv(f\"./data_output/{dataframe_dir}/chunks.csv\", sep=\"|\")\n",+ "df_concepts = pd.read_csv(f\"./data_output/{dataframe_dir}/concepts.csv\", sep=\"|\")\n",+ "df.head()\n"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Calculate Graphy Dataframe"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Graph dataframe is a dataframe where every row is a connection between two nodes. \n",+ "\n",+ "It is basically an inner self join of the nodes dataframe"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 26,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "Total number of nodes = 16370\n"+ ]+ }+ ],+ "source": [+ "dfne_join = pd.merge(df_concepts, df_concepts, how='inner', on='chunk_id', suffixes=('_L', '_R'))\n",+ "print(\"Total number of nodes = \", dfne_join.shape[0])"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "#### Clean the graph dataframe"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Cleaning the graph to make it smaller for visualisation purpose\n",+ "\n",+ "- Calculate self loops\n",+ "- remove the less important nodes (for performance)"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 27,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "Self Loops 1536\n",+ "less important edges 13577\n",+ "Total Removable Edges = 13748\n",+ "Final Number of Edges = 2622\n"+ ]+ },+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>index</th>\n",+ " <th>entity_L</th>\n",+ " <th>importance_L</th>\n",+ " <th>category_L</th>\n",+ " <th>chunk_id</th>\n",+ " <th>type_L</th>\n",+ " <th>entity_R</th>\n",+ " <th>importance_R</th>\n",+ " <th>category_R</th>\n",+ " <th>type_R</th>\n",+ " <th>weight</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>1</td>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " <td>Health Equity</td>\n",+ " <td>4</td>\n",+ " <td>concept</td>\n",+ " <td>concept</td>\n",+ " <td>4.5</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>2</td>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " <td>World Health Organization (WHO)</td>\n",+ " <td>3</td>\n",+ " <td>organisation</td>\n",+ " <td>concept</td>\n",+ " <td>4.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>3</td>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " <td>United Nations (UN)</td>\n",+ " <td>3</td>\n",+ " <td>organisation</td>\n",+ " <td>concept</td>\n",+ " <td>4.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>4</td>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " <td>Sustainable Development Goals (SDGs)</td>\n",+ " <td>4</td>\n",+ " <td>document</td>\n",+ " <td>concept</td>\n",+ " <td>4.5</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>5</td>\n",+ " <td>Health Equity</td>\n",+ " <td>4</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>concept</td>\n",+ " <td>4.5</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " index entity_L importance_L category_L \\\n",+ "0 1 Mental Health 5 concept \n",+ "1 2 Mental Health 5 concept \n",+ "2 3 Mental Health 5 concept \n",+ "3 4 Mental Health 5 concept \n",+ "4 5 Health Equity 4 concept \n",+ "\n",+ " chunk_id type_L \\\n",+ "0 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "1 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "2 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "3 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "4 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "\n",+ " entity_R importance_R category_R type_R \\\n",+ "0 Health Equity 4 concept concept \n",+ "1 World Health Organization (WHO) 3 organisation concept \n",+ "2 United Nations (UN) 3 organisation concept \n",+ "3 Sustainable Development Goals (SDGs) 4 document concept \n",+ "4 Mental Health 5 concept concept \n",+ "\n",+ " weight \n",+ "0 4.5 \n",+ "1 4.0 \n",+ "2 4.0 \n",+ "3 4.5 \n",+ "4 4.5 "+ ]+ },+ "execution_count": 27,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "df_join_selfloops = dfne_join[dfne_join['entity_L'] == dfne_join['entity_R']]\n",+ "df_low_importance = dfne_join[(dfne_join['importance_L']< 5) & (dfne_join['importance_R'] < 5)]\n",+ "drops = df_join_selfloops.index.union(df_low_importance.index)\n",+ "print(\"Self Loops\", df_join_selfloops.index.shape[0])\n",+ "print(\"less important edges\", df_low_importance.index.shape[0])\n",+ "print(\"Total Removable Edges = \", drops.shape[0])\n",+ "\n",+ "## Remove these rows from the graph dataframe\n",+ "df_graph = dfne_join.drop(index=drops).reset_index()\n",+ "df_graph['weight'] = df_graph.apply(lambda x: (x.importance_L + x.importance_R)/2, axis=1)\n",+ "print(\"Final Number of Edges = \", df_graph.shape[0])\n",+ "df_graph.head()"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": []+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Creating a NetworkX Graph"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Calculate nodes\n",+ "\n",+ "Here I am grouping the graph dataframe by left node and calculating the mean importance. This way we will end up with only the unique nodes from the graph dataframe along with their weights. "+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 36,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>entity_L</th>\n",+ " <th>importance_L</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>Member states</td>\n",+ " <td>4.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>10 million deaths</td>\n",+ " <td>3.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>100 Days Mission</td>\n",+ " <td>3.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>150,000 Health and Wellness Centres (HWC)</td>\n",+ " <td>3.0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>191 countries</td>\n",+ " <td>2.0</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " entity_L importance_L\n",+ "0 Member states 4.0\n",+ "1 10 million deaths 3.0\n",+ "2 100 Days Mission 3.0\n",+ "3 150,000 Health and Wellness Centres (HWC) 3.0\n",+ "4 191 countries 2.0"+ ]+ },+ "execution_count": 36,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "# nodes = df_graph[\"entity_L\"].unique()\n",+ "nodes = df_graph.groupby(['entity_L']).agg({'importance_L': 'mean'}).reset_index()\n",+ "nodes.head()"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Build a NetworkX object with nodes and edges"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 37,+ "metadata": {},+ "outputs": [],+ "source": [+ "G = nx.Graph()\n",+ "for index, row in nodes.iterrows():\n",+ " G.add_node(row['entity_L'])\n",+ " \n",+ "for index, row in df_graph.iterrows():\n",+ " G.add_weighted_edges_from(\n",+ " [(str(row[\"entity_L\"]), str(row[\"entity_R\"]), row[\"weight\"])]\n",+ " )"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "### Community Detection"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Detect communities using the Girvan Newman algorithm "+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 38,+ "metadata": {},+ "outputs": [],+ "source": [+ "communities_generator = nx.community.girvan_newman(G)\n",+ "top_level_communities = next(communities_generator)\n",+ "next_level_communities = next(communities_generator)\n",+ "communities = sorted(map(sorted, next_level_communities))\n",+ "\n"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Add colors to nodes based on community"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 74,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>entity_L</th>\n",+ " <th>importance_L</th>\n",+ " <th>color</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>Member states</td>\n",+ " <td>4.0</td>\n",+ " <td>#db5769</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>10 million deaths</td>\n",+ " <td>3.0</td>\n",+ " <td>#db5784</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>100 Days Mission</td>\n",+ " <td>3.0</td>\n",+ " <td>#db5784</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>150,000 Health and Wellness Centres (HWC)</td>\n",+ " <td>3.0</td>\n",+ " <td>#db5784</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>191 countries</td>\n",+ " <td>2.0</td>\n",+ " <td>#db579e</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " entity_L importance_L color\n",+ "0 Member states 4.0 #db5769\n",+ "1 10 million deaths 3.0 #db5784\n",+ "2 100 Days Mission 3.0 #db5784\n",+ "3 150,000 Health and Wellness Centres (HWC) 3.0 #db5784\n",+ "4 191 countries 2.0 #db579e"+ ]+ },+ "execution_count": 74,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "\n",+ "## Now add these colors to communities and make another dataframe\n",+ "def colors2Community(communities) -> pd.DataFrame:\n",+ " ## Define a color palette\n",+ " p = sns.color_palette(\"hls\", len(communities)).as_hex()\n",+ " rows = []\n",+ " for community in communities:\n",+ " color = p.pop()\n",+ " for node in community:\n",+ " rows += [{'entity_L': node, 'color':color}]\n",+ " df_colors = pd.DataFrame(rows)\n",+ " return df_colors\n",+ "\n",+ "colors = colors2Community(communities)\n",+ "\n",+ "df_nodes_colors = pd.merge(nodes, colors, how='left', on='entity_L', suffixes=('_N', '_C'))\n",+ "# nodes.head()\n",+ "df_nodes_colors.head()"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "So now we have a nodes dataframe with colors and sizes of each node. \n",+ "\n",+ "lets recreate our graph."+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 75,+ "metadata": {},+ "outputs": [],+ "source": [+ "G = nx.Graph()\n",+ "for index, row in df_nodes_colors.iterrows():\n",+ " G.add_node(row['entity_L'], size=row['importance_L']*8, title=row['entity_L'], color=row['color'])\n",+ " \n",+ "for index, row in df_graph.iterrows():\n",+ " G.add_weighted_edges_from(\n",+ " [(str(row[\"entity_L\"]), str(row[\"entity_R\"]), row[\"weight\"])]\n",+ " )"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Visualisation"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 76,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "./graph/nodes.html\n"+ ]+ }+ ],+ "source": [+ "graph_output_directory = './graph/nodes.html'\n",+ "\n",+ "net = Network(\n",+ " notebook=False,\n",+ " cdn_resources=\"remote\",\n",+ " bgcolor=\"#111212\",\n",+ " height=\"900px\",\n",+ " width=\"100%\",\n",+ " select_menu=True,\n",+ " font_color='#dbdbdb',\n",+ " # filter_menu=True,\n",+ ")\n",+ "net.from_nx(G)\n",+ "net.repulsion(node_distance=150, spring_length=400)\n",+ "# net.barnes_hut(gravity=-18100, central_gravity=5.05, spring_length=380)\n",+ "net.show_buttons(filter_='physics')\n",+ "net.show(graph_output_directory, notebook=False)\n"+ ]+ }+ ],+ "metadata": {+ "kernelspec": {+ "display_name": "OpenAI@3111",+ "language": "python",+ "name": "python3"+ },+ "language_info": {+ "codemirror_mode": {+ "name": "ipython",+ "version": 3+ },+ "file_extension": ".py",+ "mimetype": "text/x-python",+ "name": "python",+ "nbconvert_exporter": "python",+ "pygments_lexer": "ipython3",+ "version": "3.11.1"+ }+ },+ "nbformat": 4,+ "nbformat_minor": 2+}diff --git a/data_input/AI in Health and Medicine.pdf b/data_input/AI in Health and Medicine.pdfnew file mode 100644index 0000000..3079a0eBinary files /dev/null and b/data_input/AI in Health and Medicine.pdf differdiff --git a/data_input/GlobalPublicHealth2022.pdf b/data_input/GlobalPublicHealth2022.pdfnew file mode 100644index 0000000..dc15629Binary files /dev/null and b/data_input/GlobalPublicHealth2022.pdf differdiff --git a/data_input/GuideToHealthReform_FULL_18August2023.pdf b/data_input/GuideToHealthReform_FULL_18August2023.pdfnew file mode 100644index 0000000..ec235e2Binary files /dev/null and b/data_input/GuideToHealthReform_FULL_18August2023.pdf differdiff --git a/data_input/OrfPathHealth/BridgingTheDivide.pdf b/data_input/OrfPathHealth/BridgingTheDivide.pdfnew file mode 100644index 0000000..466f069Binary files /dev/null and b/data_input/OrfPathHealth/BridgingTheDivide.pdf differdiff --git a/data_input/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf b/data_input/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdfnew file mode 100644index 0000000..d3cfa3bBinary files /dev/null and b/data_input/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf differdiff --git a/data_input/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf b/data_input/OrfPathHealth/EnsuringAccessToAffordableHealth.pdfnew file mode 100644index 0000000..2d0fe60Binary files /dev/null and b/data_input/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf differdiff --git a/data_input/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf b/data_input/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdfnew file mode 100644index 0000000..390e8dbBinary files /dev/null and b/data_input/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf differdiff --git a/data_input/OrfPathHealth/GlobalVaccineLibrary.pdf b/data_input/OrfPathHealth/GlobalVaccineLibrary.pdfnew file mode 100644index 0000000..4bbfcfdBinary files /dev/null and b/data_input/OrfPathHealth/GlobalVaccineLibrary.pdf differdiff --git a/data_input/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf b/data_input/OrfPathHealth/InvestingInPublicHealthWorkforce.pdfnew file mode 100644index 0000000..c0a68b6Binary files /dev/null and b/data_input/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf differdiff --git a/data_input/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf b/data_input/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdfnew file mode 100644index 0000000..9333786Binary files /dev/null and b/data_input/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf differdiff --git a/data_input/OrfPathHealth/MentalHealthPathwayToEquity.pdf b/data_input/OrfPathHealth/MentalHealthPathwayToEquity.pdfnew file mode 100644index 0000000..73d62f7Binary files /dev/null and b/data_input/OrfPathHealth/MentalHealthPathwayToEquity.pdf differdiff --git a/data_input/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf b/data_input/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdfnew file mode 100644index 0000000..a7445b6Binary files /dev/null and b/data_input/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf differdiff --git a/data_input/OrfPathHealth/UrgentNeedForPandemicAccors.pdf b/data_input/OrfPathHealth/UrgentNeedForPandemicAccors.pdfnew file mode 100644index 0000000..0194fbcBinary files /dev/null and b/data_input/OrfPathHealth/UrgentNeedForPandemicAccors.pdf differdiff --git a/data_input/WHO-HIS-SDS-2018.15-eng.pdf b/data_input/WHO-HIS-SDS-2018.15-eng.pdfnew file mode 100644index 0000000..72654c8Binary files /dev/null and b/data_input/WHO-HIS-SDS-2018.15-eng.pdf differdiff --git a/data_input/orf-path_health-ttemp.pdf b/data_input/orf-path_health-ttemp.pdfnew file mode 100644index 0000000..8539864Binary files /dev/null and b/data_input/orf-path_health-ttemp.pdf differdiff --git a/data_output/OrfPathHealth/chunks.csv b/data_output/OrfPathHealth/chunks.csvnew file mode 100644index 0000000..e97556e--- /dev/null+++ b/data_output/OrfPathHealth/chunks.csv@@ -0,0 +1,2650 @@+text|source|page|chunk_id+"147+147Mental Health as a+Pathway to Health+Equity+ Pratima Murthy, Krishna Prasad Muliyala, and+Channaveerachari Naveen Kumar+Equity, diversity, and inclusiveness are the basic tenets of distributive+justice and are essential goals for development. The World Health+Organization (WHO) envisages that health equity can be achieved when+everyone attains their full potential for health and well-being. This includes+mental health. According to WHO’s definition, ‘mental health’ is a state of+mental well-being that enables people to cope with the stresses of life,+realise their abilities, learn well and work well, and contribute to their+community.1+Mental health is closely linked with many of the United Nations (UN)+Sustainable Development Goals (SDGs).2 It comprises people’s individual+and collective abilities to make decisions, build relationships, and shape the+world, and is more than the mere absence of mental illness. In its broadest"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|0|83d4d0367bb0467e811782a4ada3bbb9+"sense, mental health encompasses promotive and preventive aspects, while+mental disorders or illnesses (used interchangeably in this article) are more+focused on treatment and rehabilitative aspects. However, mental health+and well-being is equally important for persons with mental disorders, as+much as it is for those without such disorders."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|0|80ab9a7c29b44098961576ccd53fb7f6+"148Accelerating Global Health: Pathways to Health Equity for the G20+149Integrating Mental Health into General Healthcare+The complex interaction of biological, psychological, and social determinants+shapes an individual’s mental health. There is evidence that poverty and+other adverse social circumstances are risk factors for poor mental health,+and for mental disorders. Biological vulnerability as well as psychosocial+distress predispose an individual to common mental disorders like+depression, substance use disorders, and behavioural addictions.3 They can+also be reasons for relapse for episodes of severe mental illness (SMI)+such as schizophrenia or bipolar mood disorder.+The relationship between social adversity, mental distress, mental and+physical illness is both interactive and complex. The presence of mental+illness, particularly SMI, can drive people to poverty and worsen mental+distress for both the individual and their family. Similarly, psychosocial"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|1d5cc8cbbb074190b824e1fbc0d644aa+"adversity is a recognised risk factor in conditions like diabetes and+tuberculosis and influences health outcomes.4,5 Socioeconomic, political,+cultural and place-based conditions all determine health outcomes, including+on mental health.+Multimorbidity—defined as the co-occurrence of more than one chronic+condition in an individual—can occur a decade earlier in those who are+experiencing socioeconomic vulnerabilities.6 When two or more conditions+cluster together (both contributing and resulting in socioeconomic+inequalities), medical specialists use the term ‘syndemic’ to describe such+a situation. Therefore, the contextual determinants of health and disease+are paramount in the conceptual framework of syndemics. Moreover, the+two or more chronic conditions can interact and lead to adverse mutual+outcomes for the conditions. The imperative, therefore, is to shed a+dichotomous approach to mental and physical health and integrate them+both in healthcare service delivery."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|1f02a81a02054efaacb0ace0c5eadd14+"both in healthcare service delivery.+The challenge is how to efficiently distribute healthcare resources to those+who most need them. In many regions of the world, while disadvantaged+populations need greater healthcare, they receive less.7 Some sections+of society (for example, those with mental illness) may warrant greater+allocations of resources, as much as equal treatment is required for similar+needs. Health economists and the World Health Organization (WHO) have"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|33e4526e998e4865bd5b0dde036c2a20+"149Mental Health as a Pathway to Health Equityargued that investing in mental health is important from the point of view+of improving population health and reducing social inequality, promoting+human rights, and improving economic efficiency.8 The economic implications+of mental and substance disorders can be enormous: for example, the+global economic loss due to common mental disorders is an estimated US$+1 trillion per year.9 Given the increasing prevalence of mental illness, the+costs are likely to only further mount. Investment in treatment of mental+illness can result in large economic productivity gains.10+The Burden of Mental Health, Substance Use Disorders and+Multimorbidity+Mental and substance-abuse disorders are leading contributors to premature+morbidity and mortality globally. In India, for example, the National Mental+Health Survey (NMHS), 2015-16, has reported a 13.6-percent lifetime+prevalence of any mental/substance-abuse disorder morbidity.11 The overall"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|b9359fe26659413da22ea47729356210+"number of Disability-Adjusted-Life-Years (DALYs) for mental disorders has+increased by more than 50 percent between 1990 and 2019.12 This growth+pattern is expected to continue, necessitating a proportionate response from+the health systems. Most of the mental and substance abuse disorders+are chronic and disabling conditions. The treatment gap for mental and+substance abuse disorders (defined as proportions of those needing care+but not receiving) remains high (about 75 percent), contributing to the+high burden at various levels (individual, family and community). A vast+majority of the population cannot afford out-of-pocket (OOP) spending+for the treatment of mental and substance abuse disorders and psychiatric+rehabilitation.+Such out-of-pocket expenditure, in India, is dominated by medicines.13 In+more than half of the population, non-medical costs such as expenses+on travel and accommodation contribute to more than one-third of OOP"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|acf42504124f4b29b4f551d0365821b0+"spending. The share of doctors’ fees and diagnostic charges in OOP+expenditure is high in private healthcare settings.14 Discrimination in the+coverage by health insurance toward mental illness significantly raises+the chances of catastrophic spending in such circumstances. Despite the+Insurance Regulatory and Development Authority of India (IRDAI) having+directed Indian insurance companies to cover mental illnesses as per the"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|5b6399f5e510497481764cd1009caa5c+"150Accelerating Global Health: Pathways to Health Equity for the G20+151Mental Health Care Act, 2017, there have been many reported violations of+the provision of the Act.15 The violations have included rejections of claims+for mental illness by insurance companies and discriminatory ceilings on+the sum of reimbursement for mental illness.+Worldwide, people with SMI have shortened life expectancy by 10-20+years, which is explained by the high rates of multimorbidity.16 Yet the+interventions to address the multimorbidity, primarily non-communicable+diseases (NCDs) and the associated risk factors such as tobacco and alcohol+use, physical inactivity, and poor diets—are insufficient for this group.+The existing national programs to address these chronic conditions seem+oriented vertically with poor horizontal integration across the programmes.+Homeless persons, women, persons with developmental disorders, and"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|b123ca85f1a04a5294b943d121e5c61b+"elderly with mental illness experience even further inequities among the+unequal.+The living conditions of persons in India with SMI chronically and who+reside in psychiatric hospitals have been highlighted through public interest+litigations and addressed by the active intervention of the judiciary. The+National Human Rights Commission (NHRC), with the technical support+of the National Institute of Mental Health & Neuro Sciences (NIMHANS),+Bengaluru, has reviewed the rights violations of persons with SMI in these+hospitals and monitored the required systemic changes.17,18+Over the last two decades, there have been consistent efforts toward+developing a better systemic response in the care of persons with mental+illness.+Key Efforts in Improving Mental Healthcare in India+The NMHS, 2015-16, India, reported the current prevalence of any mental+morbidity to be 10.56 percent.19 Those with low education and lower"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|fbc1612e79c946e0bb9c62472a5e49ca+"income, and are middle-aged were at the highest risk for mental illness.20+Only two out of every 10 individuals with mental illness received mental+healthcare.21 Lack of mental health resources (e.g., shortage of mental health+professionals), poor mental health literacy, stigma and discrimination,"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|072bf535acba49bb8a7059ff890dfd7a+"151Mental Health as a Pathway to Health Equitysocial inequality, gender issues and lack of community participation may+be among the various factors that impede mental health equity in India.+To be sure, India has made strides toward improving mental healthcare+(summarised in Box 1). India was one of the first Asian countries to have+a National Program for Mental Health (NMHP; as early as 1982). The+District Mental Health Program (DMHP) today covers 700 districts across+the country. The DMHP is the implementation arm of the NMHP tasked+to ensure the availability and accessibility of minimum mental healthcare,+integration of mental health in general healthcare, and to promote+community participation in mental health development.+Box 1. Initiatives in India to Ensure Equitable Mental Healthcare+Programmes:+• Expansion of the National Mental Health Programme – District+Mental Health Programme (>700 districts) and Taluk Mental Health+programme (e.g., Karnataka)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|4|0fd5e7c372a842cc9368e25bf0cb57b4+"programme (e.g., Karnataka)+• Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY) –+Universal Health Coverage, Health and Wellness Centres+• National Tele Mental Health Programme (Tele Mental Health Assistance+and Networking Across States: Tele-MANAS)+• Generic medicines – Jan Aushadhi Kendras+Policies:+• National Mental Health Policy (2014)+• National Health Policy (2017)+Legislations:+• Rights of Persons with Disability Act, 2016+• Mental Health Care Act, 2017"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|4|d1159f0aacce4add93913834766d4b45+"152Accelerating Global Health: Pathways to Health Equity for the G20+153Moreover, the availability of psychotropic medications in primary healthcare+has also improved. Screening and basic management of mental illness have+been incorporated into the services offered at Health and Wellness Centres+(HWC). India has a progressive Mental Health Policy (2014) based on equity,+justice, integrated and evidence-based care in a rights-based approach.22+The use of digital technology is being leveraged for training and expanding+human resources for mental health care in the country through digital+academies at NIMHANS as well as other institutions. The National Tobacco+Control Program has employed a mobile-based strategy called m-Cessation+and tobacco quit-lines to support those who wish to quit tobacco.23,24 The+Government of India launched the National Tele Mental Health Program+(Tele Mental Health Assistance and Networking Across States: Tele-MANAS)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|0e19e6305c0049768cd3d005956a6c24+"initiative on World Mental Health Day, 2022, to provide 24/7 comprehensive+tele-mental health services that cater to remote and underserved areas.25+The Tele-MANAS initiative—a phone-based, counsellor-led service—aims to+address mental distress, identify mental illnesses and behaviours that need+specialist mental health referrals, and improve service networking in each+State/Union Territory. The examples of digital technology-based initiatives+in India for mental health are summarised in Box 2.+Box 2. Technological Initiatives in India for Mental Health+◊ Telephone/mobile based: Quitline, m-cessation (tobacco), Nikshay Sampark+(TB helpline), Tele-MANAS (National Tele-mental health programme),+Kiran (mental health rehabilitation), COVID-19 psychosocial helpline, sui -+cide helplines, crisis helplines for elderly, women, children, farmers+◊ E-healthcare: eSanjeevani (National Telemedicine Service of India),+e-Manas Karnataka (Mental Healthcare Management System)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|3fc32cb84c4d4da6b29abc6c19d6eb76+"◊ Training: NIMHANS digital academy, Telemedicine Centre, NIMHANS, CIP+Digital Academy, LGBRIMH Digital Academy+◊ Telepsychiatry: NIMHANS ECHO model, PGIMER “Tele-enabling model”+◊ Potential uses: chatbots, telerehabilitation, self-help"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|14b35b1d32d540e9b9815a325f95911e+"153Mental Health as a Pathway to Health EquityThe Government of India’s flagship insurance scheme, Ayushman Bharat-+Pradhan Mantri Jan Arogya Yojna (PM-JAY), aims to achieve Universal+Health Care (UHC) in India.26 The scheme will cover most secondary and+tertiary hospitalisations for nearly 40 percent of the population. The annual+coverage of INR 500,000 per family is irrespective of family size. The+scheme does not, however, cover outpatient expenses. Generic medicines+have been made available in Jan Aushadhi Kendras.27 The availability of+generic medicines at cheaper rates than branded drugs will likely reduce+the economic burden for all sections of society, especially the poor and+marginalised. The second pillar of the PM-JAY is the provision of universal,+comprehensive healthcare in primary care through the 150,000 Health and+Wellness Centres (HWC). The HWC will act as the first point of contact+for comprehensive services, including screening and essential mental health"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|5bbe6986777c47ee854e432f79982bc2+"conditions management.+Two progressive legislations were enacted by the Government of India in+the backdrop of the United Nations Convention on the Rights of Persons+with Disability to address critical concerns of inequality and inequity in+mental healthcare. The Rights of Persons with Disability Act (RPWD),+2016 has provided a reservation of 1 percent for mental illness-related+disabilities in recruitment to government jobs or aided organisations.28+The Act guarantees reasonable accommodation in education and work in+government institutions for persons with disability. The Mental Health+Care Act (MHCA) 2017 provides the right to access mental healthcare and+treatment from mental health services run or funded by the appropriate+Government.29 The provision under the Act encompasses a range of services+for persons with mental illness, including psychiatric rehabilitation and+community reintegration. The Act also underscores the need for integrating"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|250599129c69496098a9f054d3e8f273+"mental health services with general health services at all levels. The MHCA+2017 also directs parity for mental illness in health insurance as is available+for physical conditions. Appointing persons with mental illness, their family+members and NGOs in the Central and State Mental Health Authorities and+the Mental Health Review Boards is an affirmative step towards ensuring+checks and balances in the delivery of mental healthcare in an equitable+manner."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|2e92547f635f4574ad69394da1fa736d+"154Accelerating Global Health: Pathways to Health Equity for the G20+155Thus, there have been improvements in curative and preventive care domains+for mental and substance use disorders in the last decade. However, these+need to be translated on the ground. There is also still a lack of adequate+focus on rehabilitative care, which remains restricted to select tertiary care+mental health institutions.+The Way Forward+If the vision of the National Mental Health Policy 2014 must be truly+realised, its strategic directions and recommendations for action will need to+be implemented. The distinct mental health needs of vulnerable populations+such as children, the elderly, the homeless, require to be addressed. Macro-+environmental issues such as poverty, unemployment, displacement, and+emerging concerns such as the mental health impact of climate change+require particular focus. Leadership and governance at various levels must"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|4cd87763e8f84bdc8f0067b2b4dec451+"be strengthened. Mental health systems should be strengthened at various+levels to provide decentralised care in smaller administrative units such as+the taluks /blocks.+Preventive and promotive aspects of mental health provide an opportunity+to integrate existing mainstream/biomedical as well as alternative/traditional+systems of care, including Yoga. Mental health should be effectively+addressed at the workplace. The mental health of children and adolescents+should take primacy and can be addressed in educational settings.+However, given that there may be a substantial group of out-of-school+children and adolescents, as well as a large proportion of the population+that works in the unorganised sector, there is a need to expand the reach+of access to mental healthcare. A life-span approach to mental healthcare,+extending from perinatal care to elderly care is recommended. Research in+public mental health aspects is another priority. Mental health indicators"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|aabe35a0a6ee404f8b52f740eef53457+"need to be standardised and incorporated in governance regularly. The+comprehensive set of interrelated services has been deemed necessary+in the World Mental Health Report, 2022 – these cover the life cycle, from+maternal and child mental health, to the elderly.30"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|25ad6848459145afa5072490e52d8550+"155Mental Health as a Pathway to Health EquityInequity in mental healthcare needs to be systematically measured and+monitored in LMICs to identify gaps and to inform policies and programmes.+WHO has developed the Health Equity Assessment Toolkit (HEAT and HEAT+Plus) software to explore and compare within-country health inequalities+and across settings using disaggregated datasets.31 Simultaneously, there is+a need to learn from successful models developed in High-Income Countries+(HICs). For example, in the United Kingdom (UK), the National Health+Service (NHS) through the Five-Year Forward View for Mental Health has+prioritised addressing inequity.32 There have been debates in the public+health domain for “disparity interventions” that are specifically designed+for populations that face inequality.33 Most of the existing inequality+interventions in the mental health field from the HICs have focused on"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|e7ce4dbfa7e046b6aba50e75ac56ef07+"racial disparities, age-related factors, and socioeconomic issues. While+developing, testing, and implementing the interventions, at each stage, all+stakeholders including the service users will have to get involved.+To ensure universal health coverage for mental health, specific efforts have+been conducted by WHO in six early adopter countries. Inadequate human+resource and inequitable distribution of specialists were reported to be the+crucial issues in the situational analysis.34 In India, for the PM-JAY to+meet the goal of universal health coverage, service delivery needs to be+strengthened at all levels and systems to maintain continuity of care must+be created, an area that is particularly relevant for mental health.35 The+coverage for non-PM-JAY patients, specifically non-below poverty line but+belonging to lower/middle socioeconomic classes will have to be addressed+to reduce catastrophic spending.36 Mechanisms of surveillance and health"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|5638dcc7ccf74e4d9d46edc619192c2b+"information must be further strengthened to encompass private healthcare+providers.+The national programmes for non-communicable diseases and chronic+communicable diseases such as Tuberculosis need to consider that+most patients with these conditions have multimorbidity and align the+programmes with the NMHP at various levels. Integration of care at the+primary care level and the HWC will have to be implemented as envisioned+in the PM-JAY, with an emphasis to improve patient reported outcomes,+besides clinical outcomes. There is sufficient evidence for self-management+and peer-based interventions for chronic conditions that have emerged+and have been successfully implemented in HICs.37,38 They must be adapted"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|d7a98a5523a14a81b33b3cadbeef1397+"156Accelerating Global Health: Pathways to Health Equity for the G20+157to the cultural settings of LMICs. The effectiveness of brief psychological+interventions delivered by lay counsellors for moderate to severe depressive+disorders and harmful drinking in primary care has been demonstrated in+India.39,40+These low-cost interventions may have important lessons for HIC as the+health systems in HICs are overwhelmed with long waiting periods for+psychological intervention. Low-intensity interventions such as WHO’s+Problem Management plus (PM+) can be used in low-human resource+settings for adults in distress due to exposure to adversity.41 Families+are an important resource for care provision in LMICs, specifically in the+context of mental health and the role and concerns of family caregivers+must be formally addressed. Indigenous interventions such as Yoga as well+as alternative forms of medicine have potential benefits for multimorbidity."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|644bde3f851d4926ba9d1fa8b25b904b+"An evidence-based integration into the public health system may enhance+outcomes as they are culturally acceptable and may have a broad spectrum+of action.+Technology has been harnessed in healthcare in India as exemplified+by the Tele-MANAS programme. However, the metrics to monitor the+implementation of the programme should encompass inequities in the+delivery of virtual care. Methods to enhance digital literacy and adaptation+of the care so that even those with low digital literacy can comfortably+use the portals of care, need to be considered during implementation. As+primary healthcare is the locus of UHC, addressing the referral pathways+with monitoring of the referrals, robust information systems and integration+of mental and physical care are central to improving outcomes. The+successful translation of policies and programmes on the ground requires+governmental engagement as well as that of all stakeholders to ensure+equitable and quality healthcare."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|78487c391631417992f97fcd77f0ba19+"equitable and quality healthcare.+Dr. Pratima Murthy, Director and Senior Professor of Psychiatry, NIMHANS, Bengaluru+Dr. Krishna Prasad Muliyala, A d d i t i o n a l P r o f e s s o r o f P s y c h i a t r y , N I M H A N S , B e n g a l u r u+Dr. Channaveerachari Naveen Kumar, Professor of Psychiatry and Head of Community+Psychiatry, NIMHANS, Bengaluru"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|996585f3b2fe4afe9aad026a32d48fe9+"39+39The COVID-19 pandemic took the world by surprise. In early 2020, no+one would have thought that in months to come, millions of people+would be in ‘lockdown’, trillions of dollars would be lost to the global+economy, and over 7 million people would die from the disease caused by+the novel coronavirus. For many years before 2020, scientists and medical+experts had been warning that the world was simply not ready for disease+‘X’; such a pandemic was almost inevitable, however, coming as it did+from a zoonotic virus for which no vaccines or drugs had been developed.+Although it has been declared that the Public Health Emergency of+International Concern relating to COVID-19 is over, many countries,+especially low-income ones, still have a substantial number of COVID-19+cases and are without access to the vaccines and drugs they need. There is+the risk of becoming complacent again. There are hundreds of thousands"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|0|8bf2b50e94df47b392aa512dbb2e74c1+"of bird and animal viruses that could get transmitted to humans, and+potentially onwards from human to human. A new infectious disease can+almost certainly strike. The question is when.+While not all disease outbreaks can be prevented, they can be arrested so+that they do not escalate into an epidemic or pandemic. Social inequalities Barbara StockingThe Urgent Need for+a Pandemic Accord"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|0|03a06fd2936d41afa48ec291c8bcbda8+"40Accelerating Global Health: Pathways to Health Equity for the G20+41can be reduced, and health systems strengthened, to better protect+populations against such outbreaks. The imperative is to understand what+went wrong, and what it would take to make things right.+Critical Failures+To prevent history from repeating itself, the global community would do+well to learn the lessons of COVID-19.+a. Countries were insufficiently prepared. Even those with strong healthcare+systems geared to tackle pandemics had not tested them through,+for instance, simulation exercises. Poorer countries did not have the+resources to run a fully functioning public health system. In almost+all countries, there was little understanding of the implications of a+lockdown—for livelihoods and the economy, trade, and social services+such as education .+b. Aside from public health experts, others had no understanding of how+fast an outbreak can develop into a pandemic. Initially, governments"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|1|40998ca4b2594430b3f1f64aadfec89b+"took a ‘wait and see’ approach rather than precautionary action. February+2020 was a critical month when the opportunity to take control of the+virus was lost.+c. Countries did not comply with the International Health Regulations+(IHR) which have been in place since 2005, and often did not accept+evidence-based advice from the World Health Organization (WHO).+d. The wide inequities between countries and population groups were+exacerbated, and the consequences were dire in determining who had+access to vaccines and drugs and who did not.+A New Pandemic Treaty and Amendments to the IHR+Early on in the pandemic, calls were made for action including developing+a ‘pandemic treaty’ that would set out what countries need to do, and hold+them to account. At a special session of the World Health Assembly (WHA)"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|1|546a91dcc37740dfb8597967e1999249+"41The Urgent Need for a Pandemic Accordin 2021, WHO’s 194 member states agreed to negotiate a new ‘Convention+Accord or other International Instrument’ on pandemic preparedness and+response (PPR) (referred to as the WHO CA+ or the Pandemic Accord).1+The work began with an Intergovernmental Negotiating Body (INB) being+established with a final proposal to be delivered to the WHA in May 2024.+In May 2022, it was also agreed that a Working Group on amendments to+the IHR should be established (WGIHR).2 Its report is due at the end of+2023. All member states are engaged in both negotiations.+From the beginning, the scope of the changes to the IHR has been+contentious. The resolution of the WHA was to keep it to a small number+of amendments, but some countries argued for a much wider scope. They+sought, for example, for ‘One Health’a prevention measures, and equity in+access to drugs and vaccines. It has led to 300 amendments to the IHR"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|2|8a0b9edbbadd44c4babe8192a73bc83d+"being submitted to the WGIHR. Countries which might have preferred a+more limited approach also jumped in when it was clear that the scope+was to be broader. As a result, many proposed changes are similar to those+suggested in the Pandemic Accord.+Ultimately, there has to be coherence and compatibility between the Accord+and the IHR. It is likely that the Accord will have more of the overarching+principles and wider issues, with the IHR defining the technical requirements+to deliver them. There is a long way to go but the member states guiding+the negotiations are meeting regularly to try to ensure coherence and avoid+conflicting recommendations.+Guiding Principles+The following are the key principles that should be at the heart of the+Pandemic Accord and the IHR:+a ‘One Health’ is a collaborative, multi-sectoral approach to health, which recognises the+interconnection between people, animals, plants and their shared environment."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|2|b666ff6d8d3445a98869212995fcb597+"42Accelerating Global Health: Pathways to Health Equity for the G20+43• Solidarity.+Preventing outbreaks from turning into pandemics is a collective+responsibility and is in every country’s self-interest. Unhelpful campaigning+on social media and elsewhere has suggested that a new treaty could+challenge the sovereignty of a country. That is not the case; countries will+continue to take their own decisions. The Charter of the United Nations+affirms the sovereignty of States Parties in addressing their own public+health matters.3 However, it also sets out the obligation to ensure that+“activities within their own jurisdiction or control do not cause damage to+their peoples, other States Parties, and areas beyond the limits of national+jurisdiction”.+• Equity.+Morality and national self-interest demand equitable access to all tools,+including vaccines, diagnostics and treatments, and financing for these+resources. Equity includes a change of attitude in governance. There"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|3|6e54c98b3b944682acb35e1bfe531831+"needs to be equity in governance systems, for example, in financing for+preparedness and response to pandemics. It should not be just controlled+by donors.+Equity also means fairness in the assessment of what countries are capable+of. There are significant differences in each country’s ability to deliver+preparedness and response. Poorer countries simply do not have the same+level of resources as the developed ones.+• Transparency.+Transparency of data and genomic sequencing are vital to responding+quickly and effectively to the pandemic, and required for the development+of new drugs and vaccines. Transparency is what builds trust within and+between countries.+• Accountability.+The new Accord must set out greater accountability requirements than were+in place in the past. This is one of the key reasons for the Accord. Many"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|3|9ccb6cad21444a27b7970917ba7e6c8b+"43The Urgent Need for a Pandemic Accordcivil society organisations have been sceptical about whether a new treaty+would make a difference, pointing out that compliance with the IHR is still+lacking. That challenge must be met.+Accountability should be to the people of each country through parliamentary+systems and civil society. It is also needed for mutual assurance between+countries. When governments require extraordinary actions from their+populations—for example, lockdowns and mask mandates—they need to be+confident that other countries are also taking appropriate action.+Building Consensus+Early in 2023 the ‘zero draft’ of the Accord was made available and+the real negotiations began. Taking into account all the discussions and+proposed texts from member states, a revised draft—the ‘first draft’—is+to be produced in the summer of 2023. The negotiations are undoubtedly+complex, but it is worth noting that a surprising amount seems to be+commonly agreed upon."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|50ba14851d3f4a95ac0e459eb61a0f50+"commonly agreed upon.+The purpose of the Accord and its principles seem widely accepted, including+the protection of the human rights of all people wherever and whoever they+may be. There is particular concern that the needs of the most vulnerable+people are taken into account in pandemics. There is commitment to the+development of public health and healthcare systems and to protect staff,+who are most at risk in epidemics and pandemics. There is a need to+communicate well with the public and deal with misinformation. There is+commitment to a ‘whole-of-society’ approach for all plans and actions,+and recognition of the need for global coordination.+There appears to be conceptual agreement that preparedness plans should+involve all of government, and that there should be regular simulation+exercises. A ‘Universal Health and Preparedness Review’ is suggested as+a mechanism for review of each country’s preparedness. Both peer review"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|bc526127448645b3837dcc3b45668a83+"of the plans as well as independent assessment are being discussed.+Surprisingly, remarkably little is being said about public health response,+presumably because so much of it falls within the IHR."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|5e2a17a4edaa487290ad2532cd863fd8+"44Accelerating Global Health: Pathways to Health Equity for the G20+45An area of work making encouraging process is prevention. This brings+together human and animal health, now often described as ‘one health’.+Because zoonosesb a r e t h e g r e a t e s t r i s k , a c t i o n s t o r e d u c e t r a n s m i s s i o n —+such as closure of wet markets or banning of exotic animal trade—are+being considered alongside work on the habitats of humans and animals.+However, it seems unlikely that a fully considered plan will be ready for the+Accord; a new protocol might be more appropriate. The Joint Plan of Action+is being developed by WHO, the Food and Agriculture Organization, the+World Organisation for Animal Health, and the United Nations Environment+Programme,4 m a k i n g u p t h e s o - c a l l e d ‘ q u a d r i p a r t i t e ’ .+Areas of Contention+The contentious issues are around equity, especially related to countries’"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|83977ec929b94ecc86a6c51a35fa39cf+"access to vaccines, drugs, and other medical equipment. Member states+might sign up to the principle, but there are great differences among them+on how this should be achieved. Developing countries are pressing for a+wider spread of manufacturing, particularly for vaccines, but not only for+them. Success in getting mRNA vaccine manufacturing underway in South+Africa is a good start, although manufacturing for the whole continent and+globally will require both financial investment and technology transfer. The+extent to which the pharmaceutical industry would be prepared to engage+with technology transfer and the associated question of intellectual property+rights is unclear.+Various models have been proposed to achieve access. When wealthier+governments fund the research and development (R&D) of companies, for+example, they could persuade industry players to earmark a percentage of+vaccines for the poorer countries, or to sell these to them at cost. However,"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|c4ed77f811a94b6b8d85279085b53df5+"that would still leave the poorest countries at their mercy. Meanwhile, the+pharmaceutical industry argues that without commercial pricing of new+drugs and vaccines, there is no incentive for innovation.+b These are infectious diseases which can be transferred from animals to humans, or vice+versa."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|1a4820465fa844f8901275aa62a66e82+"45The Urgent Need for a Pandemic AccordSuch debates are not new. The World Trade Organization struggled to reach+an agreement on a Trade Related Aspects of Intellectual Property Rights+(TRIPS) waiver throughout the pandemic, with limited success.5 This was+despite an early agreement on TRIPS waivers for drugs in a public health+emergency, reached many years ago in 2001 during the Doha Trade Round.6+It is difficult to see how there can be a breakthrough, but developing+countries have made it clear they will not support a new Accord which+does not deal with equity of access.+Crucial Gaps+The Pandemic Accord and the IHR will fail if two areas are not attended+to: financing and accountability.+Financing : The G20 Independent High-Level Panel estimated that the+annual financing need for future preparedness and response to pandemics+was US$ 31 billion.7 Even considering domestic and international financing,+US$ 10 billion a year is required for PPR, which includes upgrading public"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|abe8dec679a3446db21c31d36bcd3b12+"health systems, R&D, and overall preparedness. If the amount seems high,+it must be remembered that it is a tiny amount compared to the cost of+a pandemic.+The G20 report and another from the World Bank and WHO8 led to the+establishing of the Pandemic Fund at the World Bank. However, the+promised funding in the first year has been only US$ 1.6 billion, and there+are concerns about how funds can be raised in the longer term. This is+the moment for the G20 to deliberate on how the necessary financing can+be found.+Accountability: For the Accord and the IHR to succeed, countries must+deliver on the obligations they have committed to. External accountability+mechanisms are also needed as safeguards to ensure that all parties are+answerable for these obligations. The Panel, which this author chairs,+firmly believes that there should be independent assessment of countries—+their preparedness plans, response, and other matters which might be"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|c410a5c9df2e4df2998153d58af3836c+agreed upon in the Accord. WHO is a friend and supporter of countries,|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|c134e5a2812f44f9803c15d7591765a0+"46Accelerating Global Health: Pathways to Health Equity for the G20+47which makes it difficult for it to challenge them in the public space. The+Panel believes that the way forward is a small independent body for the+Accord and perhaps the IHR, too. The Accord will be hosted by WHO but+will have its own secretariat. An arms-length independent assessment body+could be housed within the Accord’s treaty structure. The International+Atomic Energy Agency (IAEA) is one model being proposed, but because+WHO already has much of the monitoring information, the independent+assessment body need not be as large as the IAEA.+Assessments do not have to be about blaming and shaming. They need+to be public but supportive, especially of countries that do not have the+resources and are in need of financial and technical help. Pandemics create+huge risks to individuals and nations. The public has a right to know what+their governments and other governments are doing to protect them, and"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|7|42c1df8501c946858051c31ad52c5ec5+"that includes ensuring countries across the world have the resources to+deliver.+Dame Barbara Stocking, Chair, Panel for a Global Public Health Convention, is+responsible for opinions expressed in this article though they are informed by the+Panel’s discussions."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|7|d4d6f26b296047fabb3e74cec31ebc41+"19+1819There is an enormous sense of relief that the world has already+suffered the most acute stage of the COVID-19 pandemic—with+its heartbreaking death toll, devastating illness, and crushing social and+economic fallout. The job of hardening the world’s defences against future+disease outbreaks, however, has only begun. Indeed, COVID-19 is still with+us and will continue to smoulder for years to come, assuming it does+not flare up again. Moreover, the prospect of future, and potentially more+menacing, global infectious disease outbreaks remains in the horizon—+made more likely by factors like climate change, unabated encroachment+on the habitats of wild animals that carry dangerous pathogens, population+growth, and urbanisation.+Now is the time to take stock of the many lessons of COVID-19 and, more+importantly, to act on them. The emotional, physical, economic and social+scars that millions suffered are still fresh enough to feed the political will"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|0|6c5e141d752f40efbbd485a82f2926ff+"as leaders need to make big, tough choices about investments in future Ensuring Equitable+Supply and Access+to Critical Vaccines+During Pandemics:+The Lessons of COV AX+Aurélia Nguyen"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|0|f21a0cbf122d44f599f9b52ccec5f521+"19The Lessons of COVAX+19pandemic preparedness and response. If they fail to do so, the global+community will once again pay dearly—in lives lost and damaged and in+profound economic and social shocks.+The overarching and perhaps most obvious lesson of the pandemic was+that most countries, and the world collectively, were unprepared to defend+themselves against SARS-CoV-2, the virus that causes COVID-19.1 Nearly all+countries—even those whose health systems were presumed to be strong—+struggled not just to arrest the spread and blunt the devastating impacts+of the virus but also to continue delivering other vital health services.2+This was no surprise to the many global health experts who had long+warned about the world’s vulnerability to a crisis of such magnitude.+Yet, even those experts could not have fully anticipated exactly the ways+COVID-19 ultimately exploited the gaps in health security systems globally."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|bb43ca5f9f4c4e648f73d21bc059925f+"If there is anything meaningful that emerged from the pandemic, it is+the knowledge of where and how health systems struggled, where they+performed well, and what must be done to prepare for future pandemics.+This author speaks from experience as managing director of the Office of+the COVAX Facility from the fall of 2020 through mid-2022. The Access to+COVID-19 Tools Accelerator (or ACT-A) was a global collaboration focused+on accelerating the development, production, and access to vaccines. COVAX,+the vaccines pillar of ACT-A, had the remit of facilitating access to potential+COVID-19 vaccines to the most vulnerable everywhere, regardless of their+income;3 to date, it has delivered nearly 2 billion doses of COVID-19+vaccines to 146 countries across the world.4 It is a collaborative work of+the Coalition for Epidemic Preparedness Innovations (CEPI), the World+Health Organization (WHO), the United Nations Children’s Fund (UNICEF)"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|7aa69007cfd442f9822d3663a6c4c65a+"and Gavi, the Vaccine Alliance which co-managed COVAX.+COVAX accomplished a great deal, and according to estimates from Imperial+College London, the impact of COVID-19 vaccinations on COVAX AMC+participants included the prevention of an estimated 2.7 million deaths+worldwide.5 It could have made even greater impact had certain conditions+been met even before it was launched in 2020. To that end, one must heed+three categories of lessons that emerged while dealing with the pandemic"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|3c76d07238434794b3a491927cbf70e4+"20Accelerating Global Health: Pathways to Health Equity for the G20+21puzzle—the procurement, distribution, and administration of COVID-19+vaccines across countries.+First, the world must be willing to take risks and make contingent+financing available to ramp up rapidly as health crises emerge. Before+the COVID-19 pandemic broke out, there was nothing in the world like+COVAX. It began without any funding and with virtually no personnel.+Unlike sovereign governments with sizeable spending power, global health+organisations and other international development agencies could not take+on the risk of paying billions of dollars in purchase orders for vaccines.6+It thus took COVAX several months to raise sufficient funds to secure+early-purchase agreements with vaccine makers. Meanwhile, vaccine+manufacturers gave priority to bilateral customers—typically, well-resourced+sovereign governments—even months before it was clear which, if any"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|80889f7b0eaa4090934f8879b238d535+"of the vaccine candidates would earn regulatory approval.7 That, in turn,+left relatively few doses available early on for COVAX to procure. More+importantly, some countries imposed export bans on vaccines or vaccine+ingredients manufactured on their shores to ensure they would have enough+supply for their citizens.8+It is understandable that countries will do everything they can to place+the health needs of their citizens first in a crisis such as COVID-19. This+dynamic will not change. The question, therefore, is how the world can+navigate this geopolitical reality.+One way is to put in place now contingent funding that will be immediately+deployable as soon as another crisis strikes. That will help global health+agencies—like a future version of the COVAX Facility—mount an even more+effective global response.+Such funding must be flexible and agile. It will require mechanisms to+constantly update working assumptions regarding epidemiology, policy"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|4d3ad7c8415c4169b650d2f3754e263d+"recommendations, supply, demand, R&D, manufacturing, country-level+challenges, and other factors, and for making at-risk investments for+multiple scenarios. This funding should also include a proportion that could+be used with a high-risk appetite to secure vaccines that are at any R&D+stage, even with the risk of vaccine failure.9"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|895f9a65a28c496595bb295596c4fdd1+"21The Lessons of COVAXAnother lesson is related to the value of an innovative financing mechanism+that COVAX created, called the pandemic vaccine pool (PVP), which ensures+that there will be cash on hand to make rapid procurement of vaccines+available, especially to lower-income countries—even in a scenario such as+the one in 2020 where it was uncertain which of the vaccine candidates+would get approval. Likewise, COVAX pioneered other new innovations out+of the crisis—such as indemnification and liability agreements and a ‘no-+fault compensation scheme’ that would lower the risks for manufacturers—+which were also critical to removing bottlenecks and speeding up the+response-time during COVID-19. Mechanisms that allow fast response and+sharing of risk during an emergency are important features of any future+responses.+Moreover, multinational trade-facilitation measures must be strengthened+to allow for the free flow of vaccines, manufacturing supplies, and other"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|19c06e9b16344d5f98aae0410d469d9c+"life-saving equipment during health emergencies. There should be in place,+for example, exemptions and waivers that allow agencies involved in the+global health response to ship life-saving medical countermeasures and+materials to low- and middle-income countries as well as into humanitarian+situations exempt from any trade barriers.10+Second, it is now known that turning vaccines i n t o vaccinations depends+upon strong, reliable health systems. That is, getting shots in people’s+arms requires complete end-to-end solutions at the country level, backed+by investments—from early R&D; scaling-up manufacturing; securing deals;+consistent policy guidance; and setting up operational, logistical, regulatory,+and legal frameworks further along the value chain. This applies not just+to the vaccines themselves but also ancillary supplies, such as cold chain+and safe injection equipment, international freight and logistics as well as"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|f85f8a3779d1458a97ac8d5f13f782d0+"in-country delivery requirements, including personal protective equipment+for healthcare workers.11+Many countries that lacked this infrastructure strained to get doses+to the people who needed them. To be sure, the challenge was less+pronounced—though still serious—in many countries where organisations+like Gavi and WHO had already provided significant resources over many+years to help strengthen health systems (particularly primary health care),"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|7b0a4ad9437f45829cb41258f4f78a71+"22Accelerating Global Health: Pathways to Health Equity for the G20+23build cold chains that facilitated the widespread delivery of vaccines, and+establish relations with all the many stakeholders who make immunisation+programmes work.+At Gavi, which has supported the improvement of lower-income countries’+routine immunisation programmes since 2000, the concern was that+those efforts to vaccinate mostly children would flag significantly under+the extra burden of delivering COVID-19 vaccines to other populations. It+was unexpected, therefore, when many showed relatively little decline in+routine immunisation. To be sure, their systems were pushed to the limit.+Vaccinators, doctors and nurses were burned out. However, considering that+while responding to the pandemic and having to deliver three times the+number of vaccines compared with previous years, immunisation in Gavi-+implementing countries suffered declines of only 4 percent in 2020 and"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|4b38bb5b7e7343dc87ddf380cad54595+"1 percent in 2021 and a near return to pre-COVID levels by the end of+2022—there was a lot more resilience than expected.12+Those many years of health system strengthening investments apparently+paid off. But these countries will need more, especially when it comes to+building out primary healthcare services, cold chain, vaccine track-and-+trace, human resources and data monitoring systems13 that reach all their+citizens, especially those with the least access to healthcare.+One step in that direction, for example, is the COVID-19 vaccine Delivery+Support (CDS) which was time-sensitive funding based on country’s+requirements across various areas, including service delivery, data and+monitoring, and supply chain systems that Gavi helped put in place+to deal with funding gaps for delivery and improve countries’ capacity+to rapidly scale up COVID-19 vaccinations. In addition to that goal, in+many countries the programme has also contributed to health system"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|c34ec7b0256847df9acfe84b02149252+"strengthening, including upscaled cold chain infrastructure, digitisation of+health data, improved outreach capabilities, combined COVID-19 and routine+immunisation deliveries, and expanded vaccine supply chain capacity.+Somalia, for example, where targeted CDS investment saw the digitisation+of its health systems, strengthening of the country’s cold chain capacity,+and the training of health workers at the front of community engagement+and support of risk communications for both COVID-19 vaccination and"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|fbff8d3c7a8444c588467b08b54c26d1+"23The Lessons of COVAXroutine immunisation helped increase primary COVID-19 vaccine coverage+from 5 percent at the beginning of 2022 to 41 percent by the end of the+year.14 Gavi invested approximately US$1.3 billion in health systems in+Gavi-implementing countries from 2021 to 2022.15+Moreover, it must be ensured that every country puts in place regulatory+readiness, harmonisation, and policy development for pandemic preparedness.+They must build access for the most vulnerable people—especially those+who are chronically hard to reach—into the pandemic architecture. This+should acknowledge that, despite best efforts, there will be disparities in+countries’ readiness levels, infrastructure, and capacity in the event of+another pandemic.16 The global community cannot shirk from the challenge+of closing those gaps, as much as possible.+Third, it is important to lower barriers to the equitable supply of vaccines—"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|0e304bf478d4428e929abad5c796e272+"such as vaccine nationalism, hoarding, and export bans. The very idea of+the COVAX Facility emerged from a desire to prevent a replay of what took+place in 2009 during the H1N1 pandemic when better-resourced countries+dominated nearly all the global supply of vaccines.17 Countries with little+financial resources and without their own vaccine production capacity were+left largely empty-handed.18+To solve that problem, COVAX sought to pool demand for COVID-19 vaccines+from lower-income economies as well as from wealthier nations. With+pooled demand and funding, COVAX would ideally be in a better position+to make large-scale investments. It could build a diverse portfolio of what+was eventually 11 vaccine-candidates across four technology platforms (10 of+which received regulatory approval for use). This was the largest portfolio+secured by any buyer, making more than 4 billion doses available to 191+countries that were part of COVAX.19"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|27df9e2ca46243ad8d81ff5a54a1fb00+"countries that were part of COVAX.19+In other words, COVAX would be able to compete with better-resourced+countries for what would surely be a finite supply of vaccine doses. Dose+domination by relatively few countries would not follow the pattern of the+H1N1 vaccine."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|55b09ec3abaf48e98355f0d359b46caf+"24Accelerating Global Health: Pathways to Health Equity for the G20+25The experience during COVID-19 and previous pandemics cries out for+increased and geographically diversified vaccine manufacturing, particularly+across the African continent. Africa has an eighth of the world’s population+but only about 0.1 percent of the vaccine manufacturing capacity.20 There is+much work that must and can be done to help those regions establish this+essential infrastructure, not just for emergencies but for the production of+routine vaccines during non-crisis times. To help regional production take+root and grow, there must be support for technology transfer as well as+demand-side financing to promote a sustainable diversified manufacturing+base.21+With this goal in mind, Gavi and the African Union Commission entered+into a Memorandum of Understanding in May 2023 (with the cooperation+of the Africa Center for Disease Control)22 to work together to stimulate,"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d4a21a81d74e413ba4d349be59d06804+"among other health advances, sustainable regional vaccine manufacturing in+the continent. The endeavour includes 10 commitments to increase political,+financial, and technical investments in immunisation programmes.23+Another one of the biggest lessons was that critical to an effective global+response is putting models in place that can ensure, long before the+occurrence of a pandemic, that lower-income countries receive volumes of+vaccine doses at the same time and in the same levels that high-income+countries do to stop the spread of variants. This will require increased+standards for manufacturers’ transparency about their order books so+that it is possible to determine—and correct— the supply inequities among+countries. This will also require that contingent financing continues to be+readily available to allow response to unexpected trends in the trajectory+of the pandemic. Discussions on the use of available COVAX AMC funding"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d07c2d94246f4df795c7be6170d78db1+"is currently ongoing, with consideration on using part of the available PVP+funding channelled to the procurement of new products, including variant-+containing vaccine boosters, based on country requirements.+Discussions also focus on the implementation of the 2024–25 COVID-19+programme approved by the Gavi board in June 2023.24 Equally important+considerations include using these funds to prepare for other health+emergencies, catching up from the effects of the pandemic, accelerating+diversified manufacturing—all of which will be discussed further at the+December board meeting of Gavi."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d7a7913899f445febee6bff8c39924bc+"25The Lessons of COVAXThe global community is relieved to have moved past the worst of the+biggest and most devastating global health crisis in more than a century.+However, such sense of relief—and perhaps the understandable weariness+after three years of searing crisis—must not turn into complacency or+neglect. The future depends on learning from what the world lived through+and to make the big, smart changes that are required.+Aurélia Nguyen is the chief programme strategy officer at Gavi, the Vaccine Alliance.+She served as managing director of the Office of the COVAX Facility for the first two and+a half years of the pandemic and, previously, as Gavi’s managing director for vaccines+and sustainability."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|7|54d16e33cfb44174b61da49448891293+"13Among the most important lessons the world should learn from+the COVID-19 pandemic is that being prepared—being ready to act+urgently with the right technology, know-how and resources—can give the+world a crucial head start in tackling a newly-emerging infectious disease+outbreak.+With COVID-19, many countries and regions of the world were seriously+deficient on many important epidemic and pandemic preparedness measures,+putting them way behind the line. However, in one key aspect of the race+against the novel viral threat—vaccine development—the world had put+itself a few critical steps ahead by the time the SARS-CoV-2 coronavirus+emerged in 2020.+This was in large part a result of many years of studying other similar+viruses, whereby scientists had the chance to develop and hone techniques+to facilitate new vaccine designs. Research initially on respiratory syncytial+virus (RSV)—a virus first identified in 1956 that can cause respiratory"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|0|4a54fe47a5c242909e36b598566cee82+"tract infections—and subsequently on the SARS coronavirus that emerged+in China in 2003, then on the MERS coronavirus that was first reported a+12Richard Hatchett and Kate KellandA Global Vaccine+Library:+Giving Humanity a Head Start Against+Pandemic Threats"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|0|33dce39a3c574625aebc87a71f0c4e63+"13A Global Vaccine Librarydecade later in Saudi Arabia, meant scientists had well-developed insights+into these types of viruses and knew how to go about designing effective+vaccines against them.+Those decades of work allowed scientists to understand, for example, the+importance of the spike protein of the coronavirus for the production of+neutralising antibodies. They had also developed and refined techniques+for manipulating the spike protein to make it more visible to the immune+system and therefore more able to illicit a potent immune response.+In early 2020 when the novel coronavirus SARS-CoV-2 emerged, drug+developers were able to create new candidate vaccines at record speed.+They pulled off the shelf previous research, data and knowledge on RSV,+SARS and MERS virology, vaccinology and immunology, and tweaked it to+figure out how to best tackle the novel threat. Therefore, despite never+before having seen the COVID-19-causing virus, they were not reinventing"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|0cd02fb084694bbca463dd2b114f1d48+"the wheel in developing COVID-19 vaccines. Humanity had a head start.+Consider also the case of Mpox. Formerly known as monkeypox, Mpox+is a contagious disease caused by a virus from a family called the+orthopoxviruses—a viral family that also counts smallpox, cowpox and+many other pox viruses among its members. When Mpox began to spread+in 2022 in a far larger outbreak that reached more geographies, humanity+had again put itself a few critical steps ahead. It was in the late 1800s+when vaccines against the highly deadly smallpox were developed, before+being refined and ultimately deployed to greatest effect in the 1970s and+1980s when smallpox became the first—and so far only—human disease+to be eradicated. After this success, however, many governments remained+highly concerned about the potential for the smallpox virus to be used one+day as a weapon of bioterrorism. This led national and international health"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|a490246e3c3a4465988ec32641696a00+"security bodies to decide to maintain stockpiles of smallpox vaccines.+Fortunately, those smallpox vaccines also offer broad protection against+other viruses in the orthopoxvirus family, including Mpox. When Mpox case+numbers ballooned into an epidemic of international emergency proportions+in 2022, the bank of knowledge, data and vaccines that could help public+health authorities curb the outbreak was significant. Again, humanity had+a head start."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|d7a7df237a9b4336b1e40e727ecdd5c9+"14Accelerating Global Health: Pathways to Health Equity for the G20+15What if humanity could get itself a similar head start against any viral+threat—known or unknown, novel or re-emerging? What if we could get+ahead of any infectious pathogen with the potential to cause a serious+and deadly epidemic? Doing that would give us a far better chance of+winning the containment race against an emerging virus and of controlling+a nascent pandemic before it is able to spread across the world.+A Proposed ‘One World Vaccine Library’+At the Coalition for Epidemic Preparedness Innovations (CEPI), of which+the authors of this essay are part, we have a concept for how the world+could do just this—by creating and stocking a library of knowledge, data+and prototype vaccines against every one of the viral families we already+know have the potential to cause human disease outbreaks. CEPI calls this+the ‘One World Vaccine Library’—a vaccine library for the whole world that"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|7a57613761f64fe58fbc8709d4670828+"will help the global community achieve greater health security by being+better prepared to beat the next pandemic threat, wherever it emerges, and+whatever form it takes.+Vaccines are among the most potent tools against pandemic threats and+will be critical to any future response to dangerous and deadly outbreaks+of infectious disease. The faster an effective vaccine can be developed and+deployed, the faster it can be used to mitigate and potentially contain an+incipient pandemic. This is why we need to work on getting those head+starts against as many as possible of our potential opponents.+Getting ahead of any potential viral threat, known or unknown, can at first+sound like an impossible task. There are between 250 and 300 viruses+from around 25 viral families that are already known to have the ability+to infect people, and the world’s scientists cannot create new vaccines+against every one of them, just on a chance that they might one day pose+a deadly threat."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|58efa624d5c4493eb9e220aab122325c+"a deadly threat.+Yet the beauty of a One World Vaccine Library is that we do not need to.+As those several hundred viruses all come from just 25 families, scientists+can take a viral-family-based prototype vaccine approach to preparing+the world’s defences against them. They can gather knowledge, scientific"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|dc468156950d4a4d8a8878e75499afa3+"15A Global Vaccine Libraryinsights and research data on a selection of representative viruses from+each family and create vaccines that target their most common threatening+features. That way, the world will have a bank of detailed fundamental+knowledge about the threats posed by these virus families.+As things currently stand, scientists have already made meaningful+progress—proven safe and effective vaccines are available against scores of+viruses that come from and represent at least 15 of the 25 virus families.+For the One World Vaccine Library to be able to help the world respond+at speed to a newly emerging threat, however, those vaccines will need to+be transferred onto so-called rapid response platforms—technologies like+mRNA platforms or viral vector platforms that can be rapidly scaled up to+allow for hundreds of millions of doses to be produced within months if+needed.+Beyond that, the library will need to be stocked with data and research and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|4cc81b46b20b4a85ba51e82ad1ce6219+"potential vaccine candidates against viruses that represent all the remaining+families, and its sections on the most threatening virus families must be+filled with as much preparatory work as possible. That way, new vaccine+development will be faster and more efficient, saving precious time, and+potentially lives, that would otherwise be at risk if new vaccines had to be+started from scratch each time a pandemic threat looms.+Take the paramyxoviruses, for example. The paramyxovirus family includes+a number of well-known human disease threats, including measles and+mumps, as well as several less well-known ones, such as Hendra and+Nipah.+If the aim is to make similarly fast—indeed, ideally, faster—progress+against a future emerging novel paramyxovirus threat as was made in 2020+with the novel coronavirus, the One World Vaccine Library’s paramyxovirus+section should be stocked with as much research, data and technical"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|25b3c3dadaa34134a00f9af146a4c02d+"knowledge about how to design and make effective vaccines against the+known and closely related viruses in that family.+In other words, the library will collate scientific knowledge and prototype+rapid-response vaccine candidates for measles, mumps, Nipah, Hendra and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|e470b9a71a9a40a3adb706bb55c19258+"16Accelerating Global Health: Pathways to Health Equity for the G20+17other known paramyxoviruses. If and when a novel paramyxovirus emerges+and begins to infect people in a fast-spreading outbreak, the library can+be accessed for knowledge that can help rapidly create vaccines or other+medical countermeasures to prevent that spread as much and as soon as+possible.+An Ambitious Yet Achievable Global Endeavour+Building a One World Vaccine Library and stocking it to its fullest possible+capacity is a substantial task and will require sustained investment of time,+effort and money. Such a Library, however, will mean the fruits of human+ingenuity—the benefits of scientific progress—can potentially be made+available to all, whenever and wherever they are needed. It will mean that+when the next viral pandemic threat emerges—whether it is a known virus+or a novel one—humanity will have the knowledge and the technology to"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|0b579a5b26e9407a902cb29529089cee+"develop vaccines and other medical defences far more swiftly than it has+ever done before.+Researchers assessing a new outbreak and the virus causing it, wherever+and whenever it occurs, will be able within days and weeks to sequence+its genome, match it against related viruses and select prototype vaccines+from the library to develop and deploy new vaccines against the epidemic+or pandemic threat.+CEPI’s current work includes prioritising the development and stocking+of sections of the One World Vaccine Library for the virus families that+pose the greatest and most urgent threats to global health security. CEPI+is engaging virus experts to systematically rank each family to assess+its potential to spawn the next Disease X. For each family selected,+the aim is to create vaccine candidates for at least one and potentially+several different viruses, depending on the family’s complexity and genetic+diversity. Vaccines in the library will be taken through preclinical and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|cc987a2a91d846c5a1d952ecc309cc62+"early-stage clinical testing to build vital knowledge about the safety and+immunogenicity of both the platform and the antigens they target. The+larger goal is to establish clinical proof of concept for the lead candidates+in multiple families over the next five years."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|f82e8abf722e423ba48ded1798296b13+"17A Global Vaccine LibraryThe ‘100 Days Mission’ and the Need for Speed+Creating and stocking a One World Vaccine Library is a critical enabler of+CEPI’s 100 Days Mission, embraced by the G7 and the G20, to compress+the development timeline for new vaccines against emerging disease threats+to 100 days. Coupled with improved surveillance providing earlier detection+and warning of potential viral disease threats, and with swift and effective+use of non-pharmaceutical interventions such as testing, contact tracing+and social distancing to suppress disease transmission, delivering an+effective new vaccine within 100 days would give the world a real chance+to extinguish the existential threat posed by a future Disease X pandemic+virus.+The head starts in these viral races—and there are sure to be ever more+frequent ones in this era of novel epidemic threats—will come from having+a One World Vaccine Library that is comprehensive and extensive and,"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|8cb3bc020aed4d0a86a05c1f658e2708+"crucially, immediately accessible to all nations and regions whenever they+need it. As the bank of knowledge builds up in the library, so too, does+the potential for scientists to significantly accelerate vaccine development+against a wide and growing range of virus families over time.+Like the 100 Days Mission, the ambition of creating a One World Vaccine+Library is a bold one. It is also an essentially equitable one that seeks+to help people across the world bolster their defences against the ever-+increasing risk of viral infectious diseases.+Building and stocking the library will take the combined resources, will,+and ingenuity of the world’s best scientific minds, political leaders and+health security experts. In return, the library’s evolving knowledge and+increasingly sophisticated contents will be a living gift from generation+to generation: the prospect of a future free from the deadly threat of+pandemics."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|f5b55f34587246179c6c6d2bc0801141+"pandemics.+Dr. Richard Hatchett is Chief Executive Officer of the Coalition for Epidemic+Preparedness Innovations (CEPI).+Kate Kelland is CEPI’s Chief Scientific Writer."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|4160fb9924f24b5eb68e493cd9361060+"161+160161Investing in the Public+Health Workforce:+Reflections for the G20+ Wenzhen Zuo, Huan Xu, Lizzie Tecson, Bettina Borisch, Sadaf Lynnes,+Laura Magaña, Priscilla Robinson, Duncan Selbie, and Jim Campbell+Public health workers are the backbone of the public health system+and a determining factor in the capacity for emergency preparedness+and response. The COVID-19 pandemic tested and exposed the weaknesses+in core public health capacities around the world,1,2 which are often the+result of decades of underfunding and lack of political commitment to+public health.3,4 Alongside the number of confirmed deaths from COVID-19,+there was increased mortality and morbidity due to the severe disruptions+in essential health services, including preventive care such as routine+immunisation.5,6 The inadequate preparedness of many health systems to+respond to disease outbreaks partly explains these outcomes.7 However, the"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|0|732fe967002642599669103e63f2f22a+"limited availability of the health workforce was the critical bottleneck.8,9+This was largely due to longstanding workforce shortages that were+exacerbated by COVID-19 infections and deaths among health workers; the+burden placed upon them, which resulted in mental health issues, including+burnout; and poor working conditions.10,11+The world is also burdened with other public health emergencies,+including protracted conflicts and a global increase in climate-related and+humanitarian disasters. These have collectively contributed to a public health+crisis, with reversals in life expectancy and Sustainable Development Goals"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|0|3dcdf4837b764370bb2cf1e2776825cc+"161Investing in the Public Health Workforce+161targets.12,13 These reversals and the increasing likelihood of multi-hazards+and future emergencies stress the imperative for strengthening national+health systems through investment in the 12 Essential Public Health+Functiona (EPHF) through an all-hazards emergency risk management+approach.14 Strengthening the quantity and quality of the national public+health workforce capacity to deliver these EPHFs is essential15 and requires+political leadership as well as global investment+There was the emergence of a global consensus to strengthen public health+during the pandemic, as evident in the political and technical consensus+within the G7 and G20 intergovernmental processes from 2021 to 2023.16+This contributed to an iterative process coordinated by the World Health+Organization (WHO) along with a global partnership of associations,+institutions, and schools of public health (as represented by their national,"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|c9d7fdd45c4e4061ac050c6a21b2f583+"regional, and global bodies)b to jointly develop and endorse a WHO Roadmap+to strengthen national public health and emergency workforces.17+The G20’s and G7’s Role in Strengthening Public Health+and Emergency Workforces+Both the G20 and the G7 processes have historically incorporated public+health within their intergovernmental deliberations, aiming to address+pressing global health challenges and foster international cooperation+amongst member and partner countries. This was reinforced during the+COVID-19 pandemic, where both the G20 and the G7 platforms tabled+agenda items on public health for consideration in the Health Ministers+and Heads of State meetings.+a The EPHFs are a set of interconnected activities both within and beyond the health sector+that are required to ensure effective public health action to prevent disease and promote and+protect health and well-being.+b Including the World Federation of Public Health Associations (WFPHA), International"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|525f8e57fb164f289fed4c4155309473+"Association of National Public Health Institutions (IANPHI) and Global Network Academic+Schools of Public Health (GNASPH)."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|99d0ffec664a4147b99327b232eec755+"162Accelerating Global Health: Pathways to Health Equity for the G20+163G20 and G7 Deliberations on Public Health (2021–2023)+G20 Italy, 2021+In May 2021, the G20 and invited leaders, heads of international and+regional organisations, and representatives of global health bodies gathered+in Rome for the Global Health Summit that culminated in the Rome+Declaration.18 This political declaration recognised the impacts of the+pandemic, the reversal of public health gains, and the sacrifices from+the health and care workforce. The Rome Declaration set out a global+consensus which subsequently informed the G20 Italia Declaration of+Health Ministers in September 2021,19 where investment in health systems+and public health workforce strengthening was identified as a prerequisite+for countries to improve future pandemic preparedness and response. The+declaration affirmed the role of political consensus in strengthening the"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|2106f61eb09845f7855d15da890e67ae+"health workforce. It highlighted the need to protect workers and invest+in their education, employment, and retention, including to strengthen+multidisciplinary teams to better respond to future emergencies and deliver+the essential functions in “health care system and preventive care”.20+G7 United Kingdom, 2021+In June 2021, the Carbis Bay Health Declaration21 was signed at the G7+Summit in Cornwall, United Kingdom. The primary objective of the G7+Summit 2021 was to bring the world’s leading democracies together to fight+COVID-19 and build a greener, more prosperous future. The G7 summit+recognised the contributions and commitment of health and care workers+and highlighted the importance of maintaining a health workforce that+can adapt to changing circumstances. Training, supporting, and protecting+health and care workers were important aspects of the discussion.+G7 Germany, 2022+Germany’s presidency of the G7 built upon Italy’s legacy on essential public"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|5837ba13e7f942cf8b17ebfcaef29429+"health functions by diving deeper into pandemic preparedness and response.+On 19 May 2022, the G7 ministers met in Berlin and launched the G7 Pact+for Pandemic Readiness,22,23 which focuses on strengthening collaborative+surveillance in low- and lower-middle income countries (LMICs) and"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|1ef5b0e99e864a539d6ef6e41039de13+"163Investing in the Public Health Workforcepredictable rapid “regional and global surge readiness groups”.24 This focus+on pandemic preparedness and response demonstrated alignment with+similar deliberations among WHO member states in Strengthening the Global+Architecture for Health Emergency Preparedness and Response (HEPR).25 The+HEPR structures a new global health architecture around health emergency+governance,c systems, and financing, applying the principles of EPHFs at a+global level. Supporting the global health architecture, the G7’s Roadmap+for Practical Cooperation to Advance the G7 Pact26 committed to help 100+countries strengthen their International Health Regulation (IHR 2005) core+capacities.d+G20 Indonesia, 2022+G20 in Indonesia continued to advance the global health architecture for+emergency preparedness and response by launching the Pandemic Fund.27+The fund aims to strengthen countries’ pandemic prevention, preparedness,"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|58263ccaef7b48289de7a0d400d6d13d+"and response (PPR) capacities by addressing capacity and capability gaps.+The Pandemic Fund further aims to catalyse investment in critical health+workforce capacities and in health systems to strengthen synergies between+the health system and pandemic PPR capacity at country and local levels+in core domains of the IHR 2005 and the World Organisation for Animal+Health’s (WOAH) international standards. It is estimated that there is+a need for US$10 billion per year of international funding to cover the+catalytic funding for systemic preparedness required in LMICs.e+c Under the governance part of HEPR, it contains the ongoing Intergovernmental Negotiating+Body on new WHO convention, agreement, or other international instrument on PPR (WHO+CA+) and International Health Regulation amendments.+d IHR core capacities: described in IHR 2005’s Annex 1, the core capacities for surveillance and+responses require public health capacities ranging from the local community and primary"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|887e07843c974acab105fad93d11ba9f+"public health level all up until the national public health leadership level. In the voluntary+Joint External Evaluation tool to assess the IHR 2005 capacities, the highest scores for IHR+capacities as human resources are given to countries who have a national multisectoral+skilled and competent health personnel for sustainable and functional public health+surveillance and response at all levels of the health system.+e Worth noting that the Pandemic Fund, as of May 2023, had received a pledge of just 10% of+the annual amount needed from donors and foreign aid from the main G20 countries."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|31bccb036af346ad98a2832f1bf09068+"164Accelerating Global Health: Pathways to Health Equity for the G20+165G7 Japan, 2023+The G7 in Japan further reaffirmed the prevailing health consensus to+strengthen the national Public Health and Emergency Workforce in the+G7 Global Plan for UHC Action Agenda.28 Action area 8 of the UHC Action+Agenda specifically addresses UHC and health security by strengthening all+EPHFs and to “support well-trained workforce to deliver the EPHF in line+with WHO Roadmap”.29 The Action Agenda also advocates for investing,+protecting, educating, and employing the entire health and care workforce+while also recognising the importance of strengthening the public health+workforce.+The G7 leaders supported the development of global network of experts,+including their trainings, and committed to work together to implement IHR+core capacities in 100 LMICs until 2027, echoing the 2022 commitment at+G7 Germany. To achieve UHC and health security, G7 Japan also announced"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|f9437db5dfe14a128a621dee423b0855+"the launch of the Impact Investment Initiative for Global Health,30 in+time for the United Nations’ three High-Level Meetings (HLM) on UHC,+tuberculosis, and pandemic preparedness and response. This initiative+prioritises investment in impactful initiatives and capacity building in the+Global South for non-communicable and communicable diseases, PPR, and+to “restore of essential health services to better than pre-pandemic level”.31+Emerging Consensus for WHO and Partners’ Roadmap for+Public Health Workforce+The public health momentum from the G20 and the G7 processes enabled+renewed dialogue on public health, the 12 essential public health functions+that are typically prevalent across all countries, and the public health+workforce required to deliver these functions. Building on the political call+for action during Italy’s G20 presidency and resolutions adopted in the+World Health Assembly,32,33,34,35 WHO convened and worked with its partners"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|7cb2165fcdc945c6ae0860e59f189275+"to jointly develop and launch a roadmap and an action plan36 on national+public health workforce capacity to deliver all EPHFs, including emergency+preparedness and response. The public health workforce encompasses core+public health personnel and professionals, health and care workers who+perform at least one of the essential public health functions, and all"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|c758753adaf94ea9a1978600c51ad623+"165Investing in the Public Health Workforceoccupations outside of the health sector that contribute to public health+(e.g., water, sanitation, social determinants).37,38+Global partners on the roadmap and action plan have jointly developed+reference documents and tools for countries of all income classifications to+assess their public health workforce against the standard EPHF and their+individual public health priorities.39 T h e a s s e s s m e n t i s u n d e r p i n n e d b y a+whole-of-government and whole-of-society approach that involves national+stakeholders and existing national and global networks of partners of the+roadmap, including associations, institutions, and schools of public health.+This country-based assessment will ultimately guide policy improvement+and address gaps in national public health workforce planning, delivery,+and competency-based education curricula in order to bolster national"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|b5e8fd8bf09244c9a74995e5e618f489+"workforce capacity and readiness for all current and future public health+needs.+The above tools are timely additions to support national assessments and+benchmarking. The G20 support to invest in preparedness and national+capacity contributed to the launch of the World Bank’s Pandemic Fund in+November 2022. In its first call for submissions, strengthening human+resources to help countries prevent, prepare for, and respond to health+emergencies was highlighted as a priority.40 This indicates an opportunity+to prioritise sustainable public health workforce capacity in LMICs.+The roadmap also assists in alignment with the ongoing governance+processes of IHR 2005 amendments and negotiations on a global pandemic+accord, the Intergovernmental Negotiating Body (INB) on a new WHO+convention, agreement, or other international instruments on PPR (WHO+CA+).f+f Under the governance part of HEPR, it contains the ongoing Intergovernmental Negotiating"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|0cb51c16f7fe42cb9f4ad07e5e6ab337+"Body on new WHO convention, agreement, or other international instrument on PPR (WHO+CA+) and International Health Regulation amendments."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|503ecc2f98c64e4ba8733349b9834adc+"166Accelerating Global Health: Pathways to Health Equity for the G20+167The Role of India’s G20 Presidency+The intergovernmental consensus and commitment for public health+strengthening has evolved over the last three years, and in mid-2023,+there was a window of opportunity to convert consensus into national+actions that address public health workforce needs. The G20 in India has+signalled the development cooperation for SDGs and the global health+architecture for PPR as important priorities for the Indian presidency.41,42 It+also presents an opportunity for India to amplify public health workforce+strengthening from the perspective of developing countries, ensuring that+multilateral investment is leveraged to strengthen public health workforce+across LMICs. This might present an attractive legacy agenda in 2024 when+Brazil assumes the G20 and would likely resonate with Italy’s G7.+Elements for reflection might therefore include the role of G20 stakeholders"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|0ed58dcdb4a043718b2c6e0652992e78+"and partners to:+• Expand domestic financing to strengthen national health system capacity+and the respective public health workforce to deliver all essential+health services and public health functions, including health emergency+preparedness and response.+• Expand international financing to support the LMICs in national public+health and health system strengthening, as committed by the G7+Germany in the Roadmap to PPR in 2022 and G7 Japan.+• Capitalise and leverage the proposed Impact Investment Initiative for+Global Health and the Pandemic Fund to meet demand.+• Strengthen and position the G20 consensus language on protecting and+investing in the public health workforce, consistent with the Italy G20+language and recommendations from the 5th Global Forum on Human+Resources for Health.+• Strengthen and position the G20 consensus language in the preparations+and outcomes for the UN HLM for PPR in New York and the member"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|2054b41edbe54badb7d32a4c36da2d1f+state deliberations on the IHR amendments and WHO CA+ in Geneva.|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|84f7c3515e664f558f550a928bdde5b8+"167Investing in the Public Health Workforce• Strengthen and position gender inequality as a systemic issue to+contribute to an enabling environment for women’s economic and social+rights by gender-equitable policy for the health sector and beyond.43+Wenzhen (Jen) Zuo , Family Physician - Hospitalist / Glob al Health Consultant, World+Health Organization.+Huan Xu, Technical Officer, Health Workforce Department, World Health Organization;+Lead, General coordination of the Public health and emergency workforce roadmap.+Lizzie Tecson, Programme Officer at the Health Workforce Department, World Health+Organization; Co-lead, General coordination of Public health and emergency workforce+roadmap.+Bettina Borisch, Professor at the University of Geneva and Executive Director of the+World Federation of Public Health Associations(WFPHA).+Sadaf Lynes, Director of Collaborative Surveillance workforce and health"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|7|9788f3475aa54d1db48ff648f860e453+"emergencies, International Association of National Public Health Institutes (IANPHI).+Laura Magaña, President & CEO of the Association of Schools and Programs of Public+Health (ASPPH); co-chair, Competency b ased education, Public health and emergency+workforce roadmap.+Priscilla Robinson, Adjunct Associate Professor at LaT robe University; co-chair,+Competency based education, Public health and emergency workforce roadmap.+Duncan Selbie, President, International Association of National Public Health Institutes+(IANPHI).+Jim Campbell, Director, Health Workforce Department, World Health Organization."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|7|9e0d4b33f8d34f858eb42aa765c93415+"49+4849Soumya Swaminathan and Priyadarshini RajamaniBridging the Divide:+Advancing ‘One Health’ for a+Better World+Human health is interconnected with the ecosystem that consists+of animals, plants, and the environment. As such, any health+intervention should be integrative of these connecting factors. ‘One Health’+(OH) is a holistic approach that considers all the determinants of health,+designed for disease prevention and control. It is a transdisciplinary+approach that allows multisectoral collaboration and deals with antimicrobial+resistance and the prevention and control of zoonoses and vector-, food-+and water-borne diseases.+Since 2022, the Quadripartite collaboration between the World Health+Organization, Food and Agriculture Organization, United Nations Environment+Programme, and World Organisation for Animal Health has been responsible+for OH operations, guiding countries in planning and adapting strategies"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|0|c347385c32c941ca9500d586d9b9e88e+"for addressing global health challenges. Implementing OH will enhance+pandemic prevention, preparedness, and response, and will also enable the+strengthening of domestic health systems, including in India."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|0|2dd90976e41d4112a2f6e029eb90b1e3+"49Advancing ‘One Health’ for a Better World+49Deconstructing ‘One Health’+The World Health Organization (WHO) defines ‘One Health’ (OH) as+“an integrated, unifying approach that aims to sustainably balance and+optimize the health of people, animals, and ecosystems.”1 In addition to an+individual’s characteristics and behavioural patterns, social, economic and+physical environments are important determinants of health, and include+a variety of factors such as water, air, animals, plants, housing, and+jobs. Animal trade, agriculture, livestock farming, urbanisation, extractive+industries, climate change, habitat fragmentation, and encroachment into+wild areas are some of the factors that can impact human health. It is+essential to consider the possible interactions of these factors with an+individual’s health to achieve optimal health outcomes. Therefore, no health+intervention can be designed and implemented with the consideration of the"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|dce5126b1d5b4331b4d3aca658636be8+"health sector alone. There should be multisectoral inclusivity in addressing+any health-related issues. For example, antimicrobial resistance (AMR)+cannot be addressed only through medical intervention and also requires+the checking of antibacterial content in food and water.+The OH concept encourages a collaborative, multisectoral, and+transdisciplinary approach at the local, regional, national, and global levels.+It recognises the interconnection between people, animals, plants, and their+shared environment to achieve optimal health outcomes, and it encourages+experts from multiple sectors to work together. Under the OH concept,+policy, advocacy, financing, organisational development, data, evidence, and+knowledge are focused on providing sustainable and long-lasting results at+all levels.+The OH concept identifies a range of priority health issues that need the+world’s urgent attention:+Antimicrobial Resistance (AMR)"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|e2379daababe407ba77deb9138fedacf+"Antimicrobial Resistance (AMR)+AMR is one of the greatest threats to human health, food security, and+development. WHO has declared AMR as one of the top 10 global public+health threats that need coordinated and concerted global action.2 By 2050,+there could be nearly 10 million deaths due to AMR each year, and it could+cost the global economy between US$11–444 million.3"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|d33d167928ec4c02a898302812a56a09+"50Accelerating Global Health: Pathways to Health Equity for the G20+51Medicines become ineffective when pathogens undergo structural changes+as a result of increased drug exposure. Misuse or overuse of antimicrobials,+multiplication of pathogens due to unhygienic water and poor sanitation+processes, and inadequate infection prevention and control measures in+hospitals and healthcare settings are some of the other factors that cause+AMR. It also arises due to the use of antibiotics in the farming, livestock,+and fisheries sectors, which enables pathogens infecting these animals to+develop resistance. Close contact with these animals and the contamination+of soil and water with these microbes exposes humans to these bugs.+AMR makes treating infections difficult, leaving patients with limited+treatment options, if at all. In such cases, managing serious infections in+children and adults alongside any surgical intervention becomes a challenge."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|8315c966561a4451868cb4e134e0519f+"Indeed, the global health system is already exposed to drug-resistant+Tuberculosis, HIV infections, and specific AMRs such as artemisinin-based+combination therapy-resistance in malaria treatment, and antileprotic drug+resistance.+Zoonotic diseases+Over the past three decades, around 30 pathogens have been detected, with+75 percent of them originating from animals, causing zoonotic diseases and+contributing to about 60 percent of emerging infectious diseases globally.4+These diseases can be spread directly through the saliva, blood, urine,+mucous, faeces, or body fluids of infected animals, or indirectly through+contact with areas where animals live and roam as well as through+contaminated objects or surfaces.+Urbanisation and the destruction of the natural habitats of animals, illegal+trade in wildlife, and wet markets increase the chances of interaction+between animals, animal products and humans, thereby increasing the risk"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|f5f198d153604bd3a98fa4917c114a0e+"of zoonotic disease and contributing to zoonotic spillover. Recent disease+outbreaks such as SARS, MERS, Ebola, Nipah, and avian influenza are+examples of zoonotic infections being established in humans. It is important+to ensure the hygienic and appropriate care of animals in the agriculture+sector, and the safe handling of meat, eggs, dairy, and vegetables to avoid+contamination to prevent outbreaks of food-borne zoonotic diseases."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|764f6457770c4826aadcd6d83adba840+"51Advancing ‘One Health’ for a Better WorldAddressing zoonotic infectious diseases through an OH approach includes+multiple actions:+• Raising awareness at all levels of society on prevention and risk-+reduction strategies.+• Investing in interdisciplinary approaches including OH perspectives.+• Initiating research to explore the complex social, economic, and ecological+dimensions of diseases; to assess risks and effective interventions; and+to conduct cost-benefit analyses.+• Regularly monitoring food systems, from farm to fork, and improving+sanitary measures.+• Implementing biosecurity and zoonoses-control measures for both+industrial and disadvantaged smallholder farmers and herders.+• Supporting agricultural and wildlife habitats by managing landscapes+and seascapes collectively.+• Promoting agro-ecological methods of food production, mitigating waste+and pollution, reducing further destruction of wildlife and habitat loss,+and maintaining ecological connectivity."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|3|245fa44631ca4515978c91ab18d97bbe+"and maintaining ecological connectivity.+• Being mindful of biodiversity during government and private-sector+planning, decision-making, and capacity building.5+WHO, the Food and Agriculture Organization (FAO), and the World+Organisation for Animal Health (WOAH) have already established the+Global Early Warning and Response System for Major Animal Diseases to+combat zoonoses to coordinate risk assessment and assist in early warning,+prevention, and control of disease threats.6+Vector-borne diseases+The determining demographic, environmental, and social factors of the+distribution of vector-borne diseases are often complex, such as global+travel, trade, and unplanned urbanisation. WHO’s Global Vector Control+Response (GVCR) 2017–2030 provides strategic guidance to countries for+strengthening vector-control programmes.7"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|3|ceced3fafd4146ab93a56d8df2c7991f+"52Accelerating Global Health: Pathways to Health Equity for the G20+53Water-borne diseases+Drinking or coming in contact with contaminated water causes water-borne+diseases. Faecal-contaminated water is consumed by two billion people+globally, which causes diseases such as cholera, dysentery, typhoid and+polio. These diseases are responsible for around 485,000 deaths every year.8+Food-borne diseases+Over 200 diseases, ranging from diarrhoea to cancers, are caused by+eating or drinking food contaminated with animal or human faecal matter,+chemical substances such as unpasteurised (raw) milk, undercooked meat+or eggs, and raw fruits and vegetables. Globally, 600 million people are+affected by food-borne diseases, in which 420,000 die each year, resulting+in 33 million healthy life years lost. Access to adequate safe and nutritious+food is key to sustaining life and promoting good health.9+Operationalising ‘One Health’"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|c0439552464a4e14b6ef0c4b597c1409+"Operationalising ‘One Health’+In April 2022, WHO, FAO, United Nations Environment Programme (UNEP),+and WOAH signed a memorandum of understanding for joint work on OH,+forming the ‘Quadripartite Collaboration for One Health’. The Quadripartite+is a strategic coordination mechanism that aims to work towards “a world+capable of preventing, detecting, containing, eliminating, and responding to animal+and public health risks attributable to zoonoses and animal diseases with an impact+on food security through multi-sectoral cooperation and strong partnerships”.10 The+One Health High-Level Expert Panel comprising 26 key international experts+serves as the advisory group to the Quadripartite. In late 2022, the group+launched the first One Health Joint Plan of Action (2022-2026) to combat+health risks at the human–animal–environment interface.11+The Quadripartite has urged all countries to translate the OH approach"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|502eb4a32dcc478381748da0c9bd7614+"into policy actions by promoting and increasing investment in intersectoral+health governance. Countries are encouraged to adopt national OH policies,+and create and exchange research on OH. Research institutions can be+encouraged to work on improved genomic surveillance and data-sharing+practices. Academic courses on OH can help train and equip a workforce."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|46f7a03700434a8497df7279c7a66991+"53Advancing ‘One Health’ for a Better WorldSince the OH approach is similar to pandemic prevention and preparedness,+resources allocated for the latter can also be utilised for operationalising+OH. For instance, the World Bank’s US$10-billion fund for pandemic+prevention can be used to implement the OH approach. Additionally,+the UN’s high-level meeting on pandemic prevention, preparedness, and+response (scheduled for September 2023) is an opportunity to integrate the+OH agenda into the pandemic action plan.+According to the World Bank, between US$10.3-11.5 billion is needed+annually to implement OH at a global scale.12 But the lack of centralised+OH funding is a challenge, leaving relevant ministries in each country to+assume the responsibility for implementing necessary actions and activities.+This hinders the development of effective global OH strategies.+WHO has identified several other existing gaps in the implementation of"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|5|51906241584640d99e39f60f1f346d60+"the OH approach.13 These gaps are evident in the following areas:+• Databases and knowledge-sharing resources for effective information+exchange.+• Showcasing best practice examples to encourage successful OH initiatives.+• Mapping and generating an OH workforce to strengthen capacity.+• Developing a model for an integrated OH surveillance system.+• Establishing routine and emergency coordination mechanisms with+stakeholders.+• Creating a standardised framework for addressing zoonotic spillover+risks related to animal trade, agriculture, and livestock farming.+• Addressing issues related to urbanisation and habitat fragmentation.+• Identifying spillover risks and disease spread in ways that minimise+trade-offs and maximise co-benefits.+‘One Health’ in the G20 countries14+The G20 countries can play a key role in improving global health, for+various reasons—the member countries are among the world’s largest+economies, they are home to roughly two-thirds of the global population"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|5|fc1d9effc3a4494daf5a1c78a36bf77f+"54Accelerating Global Health: Pathways to Health Equity for the G20+55(including the majority of the ageing population), they house 78 percent+of the world’s pharmaceutical companies, see a high prevalence of non-+communicable diseases (and account for nearly 70 percent of proportional+mortality from such diseases), and contribute 72 percent of all CO2+emissions.15 T h e G 2 0 c o u n t r i e s a g r e e d t o a d o p t O H a t t h e 2 0 2 2 S u m m i t .16+India has already made headway on this front.+One Health approach in India17+The Indian government initiated the OH approach under the office of+the Principal Scientific Adviser (PSA) with the aim to increase pandemic+preparedness and integrated disease control against priority diseases in+both human and animal sectors. A supplementary goal includes establishing+an early warning system built on an integrated surveillance system and+response-readiness for endemic and emerging epidemic or pandemic threats."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|e3ed493f83654c1a87d1f5bc648a8325+"The country has also sought to implement integrated disease surveillance,+build environmental surveillance systems, and develop robust outbreak+investigation mechanisms. The OH mission will also focus on:+ •Targeted R&D to develop critical tools such as vaccines, diagnostics,+therapeutics, and other prevention tools, and to invest in developing+novel disease surveillance and control methodologies.+ •Data and database integration for better information sharing across+different departments, and investing in analytics for better tracking of+national-level progress and implementation at the local level.+ •Streamlining regulatory and approval processes for enabling OH research+and for rapid decision-making.+ •Building a governance model for integrating OH into existing+programmes for system strengthening, sustainability and resource+allocation for maximising outcomes.+India has also established a One Health Centre at the National Institute"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|3abe5438d6c9449f81cb2cb913a89f17+"of Animal Biotechnology, Hyderabad, for intersectoral collaboration among+veterinary, medical, agriculture, environmental, forestry, meteorological and"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|0e0bd75ae62745a9b1657abbda56fea9+"55Advancing ‘One Health’ for a Better Worldother areas to detect, prevent and control zoonoses and transboundary+animal diseases.18+In 2008, an attempt to operationalise the OH approach for zoonotic+disease control and prevention identified the barriers preventing effective+cross-sectoral collaboration on disease control.19 These included a lack+of supportive policies, conflicting departmental priorities and limited+institutional capacities. A review of zoonotic policy documents revealed+there is a lack of specific mechanisms or strategies to safeguard livestock+health, and a lack of guidelines for promoting cross-sectoral action. It also+revealed a lack of clarity and inadequate information regarding engagement+in the animal and forest sectors. This study found that implementing the+OH approach in India requires contextual adaptation based on the underlying+sociopolitical, institutional, and cultural contexts.20"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|c1f9626d266a4b3d820e6980b6dacc08+"Given India’s diverse context, the way forward involves developing strategies+that focus on fostering existing informal interpersonal relationships and+collaborations between different sectors to successfully adopt the OH+approach. It also requires intersectoral coordination at all levels, including+the veterinary workforce, academic institutions, and the local or grassroots+population. For instance, to conduct the SARS-CoV2 vaccine trial, the Tamil+Nadu Veterinary and Animal Sciences University signed a pact with the+Tamil Nadu Dr MGR Medical University for conducting joint academic and+research activities. Similarly, during an outbreak investigation in Punjab,+community health workers, non-government organisations, auxiliary nursing+midwives, accredited social health activists (or ASHAs) and village leaders+actively participated in efforts to address vaccine hesitancy.21+Conclusion+Implementing the OH approach will enhance pandemic prevention,"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|a23f8844edf54ac7a6711c6983787cb1+"preparedness, and response. It will also strengthen systems and cross-+sectoral capacities, allowing for the co-design and implementation of+inclusive and equitable multi-level workplans and strategies in line with+OH principles. It is essential to develop, disseminate, and utilise improved+and harmonised OH tools, technologies, and practices that integrate data+and knowledge to prevention of future pandemics, reduce the spread"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|36dd1d845a3147dba0c7891d5d6fb924+"56Accelerating Global Health: Pathways to Health Equity for the G20+57of infectious diseases through better surveillance systems, and boost+collaboration between different organisations.+India’s G20 theme of ‘One Earth, One Family, One Future’ highlights that+global collaboration and solidarity is needed to live harmoniously with+nature and to ensure health and well-being for all people, everywhere.+Dr Soumya Swaminathan is Chairperson, MS Swaminathan Research Foundation and+Former Chief Scientist, World Health Organization.+Dr Priyadarshini Rajamani is a consultant with the MS Swaminathan Research+Foundation."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|8|baf822f00df24576a51d07fdc84491e6+"82Accelerating Global Health: Pathways to Health Equity for the G20+83Building a Resilient+Digital Health+Ecosystem in India+Lav Agarwal+Technology now permeates every facet of human existence. From+communication and transportation to healthcare and entertainment,+technology has redefined how we live, work, and interact. Its omnipresence+is reshaping societal norms, revolutionising various sectors, and propelling+us into the future.+Through improvements in diagnostics, treatment, and patient care,+technological advancements have had a profound impact on healthcare.+Medical devices, telemedicine, electronic health records, and artificial+intelligence (AI)-driven diagnostics have transformed healthcare delivery by+making it more precise, efficient, and accessible. Wearable devices and health+apps have empowered individuals to monitor and manage their well-being+proactively. Technology has also played a crucial role in advancing medical"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|0|c0a97f842ce84d1399bb35fcc9ca17a8+"research, discovering new treatments, and improving overall healthcare+outcomes. In response to the COVID-19 pandemic, the world witnessed the+exponential growth of digital health."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|0|00596c043eb84a829a663e034eb52bde+"83Building a Resilient Digital Health Ecosystem in India Digital Health Landscape in India+Given India’s massive population, providing equitable access to healthcare+services to all is an important agenda. By harnessing the power of+technology, digital health can effectively address these challenges and+ensure that healthcare services are accessible even in the remote regions.+Patients can use digital platforms for convenient access to care. Digital+platforms therefore bridge gaps and improve healthcare delivery across the+nation.+In line with the ‘Digital India’ initiative and the vision to create+interoperable and standardised electronic health records across the country,+the Indian government notified the Electronic Health Record1 standards in+2016. The National Health Policy2 (2017) envisages the creation of a digital+health technology ecosystem that serves the needs of all stakeholders and+improves efficiency, transparency, and citizens’ experiences across public"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|a57747eedbc94f27aeaa023ebf800e32+"and private healthcare.+Over the recent years, India has made progress in digital healthcare+delivery, as demonstrated in national health programmes such as the+Hospital Management Information System, Online Registration System, the+national tuberculosis elimination (Ni-kshay) programme, Mother and Child+Tracking System, Mera Aspataal (My Hospital, a patient feedback system), the+Health Management Information System, the Integrated Health Information+Platform, and Non-Communicable Diseases screening application—which+have benefitted patients through the timely delivery of services and by+making government healthcare more affordable and accessible.3+The need for a future-ready digital health system has become even more+urgent with the announcement of the Ayushman Bharat Pradhan Mantri Jan+Arogya Yojana (AB-PMJAY)4 in 2018, India’s flagship programme that would+herald an infrastructural transformation of the nation’s health system. This+mission envisions the following:"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|1c7917baa4ae4cee997ec26107908884+"mission envisions the following:+I. Operationalising 1.5 lakh health and wellness centres that offer preventive+and primary care, including telemedicine consultation services; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|eba3bd7af89a46a586d2786a9549f23b+"84Accelerating Global Health: Pathways to Health Equity for the G20+85II. Providing financial protection of up to INR 500,000 per family annually+for secondary and tertiary care hospitalisation to the over 120 million+crore poor and vulnerable families that comprise the bottom 40 percent+of the Indian population.+These initiatives aim to scale up a wellness-oriented approach instead+of an illness-focused one—a key step towards achieving universal health+coverage (UHC) through patient data portability across primary, secondary,+and tertiary levels. This essentially translates into an environment where+all people can obtain health services anywhere in the country without+suffering financial hardship or excessive indirect costs.+Achieving such scale requires us to rethink the core technology backbone+of our system and leverage cutting-edge digital solutions to tackle the+challenge. However, it is also felt that all these efforts need to converge into"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|ec1766626938432892c24b9acb2ca6ca+"a single framework to achieve interoperability of data, which would benefit+both policymakers for decision-making and patients with effective services+at the time of need. In response, the government developed the National+Digital Health Blueprint as a framework for the efficient implementation of+digital health treatments.+The Ayushman Bharat Digital Mission5+To implement the principles of the blueprint, the National Digital Health+Mission, now known as the Ayushman Bharat Digital Mission (ABDM), was+launched in six union territories in August 2020. It was proposed to be+carried out via six key components—i.e, the digital health ID card, Digi-+Doctor, Health Facility Registry, Personal Health Records, e-pharmacy, and+telemedicine. India launched the nationwide implementation the ABDM in+September 2021 . The ABDM intends to create the framework needed to+enable an integrated digital health infrastructure in India. Additionally, it"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|65393c34cb53464a960c0e7f6ebd4d68+"will bridge the existing gap amongst different stakeholders of the healthcare+ecosystem through digital highways.+Under the ABDM, every citizen will be provided a 14-digit Ayushman+Bharat Account (ABHA) number, which is a unique health identifier. With+the patient’s informed consent, the ABHAs will be used to identify and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|2aa329278e3f4383831bc6efa5942993+"85Building a Resilient Digital Health Ecosystem in India authenticate people’s health records across various systems and stakeholders.+As of July 2023, over 435 million ABHAa numbers have been created, and+214,396 health facilities and 207,274 doctors have been registered under+the ABDM ecosystem.+ABDM has accelerated the participation of various stakeholders of the+healthcare ecosystem and ensured deployment of patient-centric policies—+resulting in cashless care with improved access to ensure protection+for the poor. Given its federal and complex healthcare structure, India+demands agility, flexibility and evidence-based smart policymaking for+implementation of healthcare initiatives, driving all stakeholders towards+health-seeking behaviours with renewed energy.+Digital Health in COVID-19 Management+The COVID-19 pandemic has challenged health systems across the globe.+The India government not only focused on the management of the pandemic"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|784ecfb5b0fa4e41a0d142cf69671e30+"through various activities but also formulated innovative solutions to ensure+the continuity of health services across the spectrum. It has followed a+‘whole of government, whole of society’ approach to battle the pandemic+by engaging subnational and local governments, civil society organisations,+the private sector, and local communities in mitigation efforts.+Amid the pandemic, India recognised the need to ease access to digital+consultations, and issued the Telemedicine Practice Guidelines in March+2020. India also launched eSanjeevaniOPD,6 a first of its kind and the+world’s largest national telemedicine service to facilitate online health+facilities to patients in the confines of their home at no cost to ensure+continuum of care. The eSanjeevani initiative has been instrumental in+bridging the digital divide in India, particularly in rural areas where access+to healthcare is often limited. This initiative has completed 142 million"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|c3bf84643ff44d68bf38a16e96fd9e86+"consultationsb in record time and is currently serving around 400,000+patients every day as of 27 July 2023.+a https://dashboard.abdm.gov.in/abdm/+b https://esanjeevani.mohfw.gov.in/#/"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|00c023acbd1649be8e5673413309c140+"86Accelerating Global Health: Pathways to Health Equity for the G20+87India developed another state-of-the-art digital health system, CoWIN,7 a+digital platform that helped more than a billion beneficiaries book COVID-19+vaccinations in less than three months. In less than 18 months, CoWIN+had helped administer two billion COVID-19 vaccination doses, immunising+over 90 percent of all eligible adults.+The establishment of digitally-enabled COVID-19 ‘war rooms’ at the central+and state levels allowed key stakeholders to undertake data-driven decisions+towards infrastructure gap analysis, case projection and management, and+to identify problem areas that required specific state-centre coordination.+Various other digital health initiatives that have enhanced India’s efforts+against the COVID-19 crisis are outlined in the following points:+i. the COVID-19 India Portal developed for disease tracking by geography,"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|96c919e1d14e4ba9870d0f5015e90f1f+"inventory tracking of essential items, and predicting demands at the+national, state, and district levels based on case-loads;+ii. the Aarogya Setu, a mobile tracking app which uses the smartphone's+GPS and Bluetooth features to track the coronavirus infection through+contact tracing, syndromic mapping, and self-assessment in addition to+essential risk communication for our citizens;+iii. the RT-PCR app, a hand-held tool for country-wide sample collection;+and+iv. a COVID-19 facility app which allows health system stakeholders up to+the district level to track the state and management of patients.+Institutionalising Pandemic Learnings: National Public Health+Observatory (NPHO)+India has established the National Public Health Observatory (NPHO) and+the Health Emergency Operations Centre (HEOC) for real-time monitoring+and analysis of various data points for informed decision-making. The+NPHO will ensure comprehensive monitoring of health systems, including"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|a29a332cd2de4594a574bb57c7d10fd2+"overall healthcare service delivery, integration of healthcare programmes,+and transformation of the healthcare situation in the country."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|c53fa240102b418d96669de0302129ff+"87Building a Resilient Digital Health Ecosystem in India Leveraging AI for Improved Healthcare+Across the world, AI is being used in healthcare to support doctors and+healthcare workers, improve customer service and patient management, and+monitor diseases. The Indian government has established three centres of+excellence for AI—at the All India Institutes of Medical Sciences in Delhi+and Rishikesh, and at the Post Graduate Institute of Medical Education &+Research in Chandigarh—to leverage and identify potential areas for the+use of AI in the health sector. The centres are already working on several+solutions for healthcare which leverage generative AI, including:+i. a clinical decision support system, a multilingual solution to provide+diagnostic and triaging support to doctors;+ii. event-based disease surveillance to scan large volumes of digital media+in English as well as 10 Indian languages to monitor events that signal+an impending disease outbreak; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|8368e5f419c943b89a7a33939b57aa87+"an impending disease outbreak; and+iii. an AI assistant for frontline workers in 11 Indian languages to enable+and empower healthcare workers to ask questions and receive responses+to enhance their work.+Stimulating Advanced Knowledge for Sustainable Health+Management (SAKSHAM) Portal+The inclusive capacity building of health professionals is an important+component to ensure the efficient delivery of healthcare services across+the country. Tele-education has benefitted all fields of education including+medical education, especially for students in remote areas with limited access+to schools and qualified teachers. Online platforms, video conferencing,+and pre-recorded lectures have facilitated learning for students who were+previously deprived of quality education due to their geographical location.+Keeping this vision in mind, the government has developed a unified and+dedicated online learning and training platform, SAKSHAM,8 to enable"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|8ef6462971234fea8ca5b9c897badcc4+"health professionals to receive advanced training without any disruption in+their regular jobs. The portal hosts more than 200 courses on public health+and 150 on clinical practices."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|9b1e7fd4829c450b8cc36fbd9453d186+"88Accelerating Global Health: Pathways to Health Equity for the G20+89With such developments in digital health, India has leapfrogged in terms+of the adoption of digital health in the public sector. This will arguably+lead to the creation of a national digital health ecosystem through wide-+scale adoption of digital tools across the continuum of care, both in the+private and public sectors.+Promoting the Digital Health Agenda Globally+India has emerged as a frontrunner in championing digital health and+in positioning it as a critical agenda at the global level. Recognising+the transformative potential of technology in healthcare, India has+taken proactive steps to harness digital innovations, promote healthcare+accessibility, and drive advancements in the field globally.+India tabled the Digital Health Resolution in the 71st World Health+Assembly in May 2018 at Geneva, which was unanimously adopted by all"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|a4cd493a8ff94f7b9f31d65bd15833b2+"the member states of the World Health Organization (WHO). The resolution+highlighted global attention to the potential challenges and opportunities+related to digital health technology and need for close collaboration on the+issue globally. As a follow-up action, WHO has prioritised digital health+agenda by establishing the Department for Digital Health and Innovation in+April 2019 and published the Global Strategy on Digital Health 2020-2025 to+promote healthy lives and well-being for all.+India served as Chair of the Global Digital Health Partnership (GDHP,+between 2019 and 2021), which is the world’s largest intergovernmental+and multilateral forum on the issue of digital health. Under India’s+leadership, the GDHP’s membership grew from 14 to 33, including three+international organisations (WHO, Organisation for Economic Co-operation+and Development, and the International Digital Health and AI Research+Collaborative)."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|71de2efb72064d318b9e0bee887f6879+"Collaborative).+India’s G20 Leadership Catalysing Global Health Initiatives+India’s G20 presidency set ambitious goals to address the 21st century’s+greatest challenges such as climate change, food insecurity, the threat of"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|eb215b2863164d6ba5e98fcffff46cba+"89Building a Resilient Digital Health Ecosystem in India future pandemics, and other health emergencies by building international+co-operation and strengthening global systems. The pandemic experience+has taught us that preventing and preparing for a health emergency must+always be a top priority at a global level, because when it comes to health,+“no one is safe until everyone is safe.”+Drawing from the lessons from the pandemic, the G20 Health Working+Group set out to catalyse and enervate global health initiatives. Through+four meetings, culminating in the health ministers’ meeting, three main+priorities were discussed:+i. prevention, preparedness, and response to health emergencies with+focus on anti-microbial resistance and ‘One Health’;+ii. strengthening cooperation in the pharmaceutical sector with focus on+availability and access to safe, effective, quality, and affordable medical+countermeasures, namely vaccines, therapeutics, and diagnostics; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|1a76e52834584b208c08bddb9a1f0b62+"iii. digital health innovations and solutions to aid universal health coverage+and improve healthcare services delivery.+Digital health, the third priority under India’s G20 presidency aims to+leverage the country’s acumen and achievements along with other global+initiatives in the digital health space, and develop innovative digital health+solutions that can be applied across the world. A number of programmes+and projects seeking to develop digital health products are being initiated+independently. These projects are cumulatively spending billions of dollars+while working on similar aspects.+India’s G20 presidency has aimed to bring them all under the umbrella+of the Global Initiative on Digital Health (GIDH), a network managed by+WHO. The GIDH is an opportunity to create a globally connected digital+health ecosystem, converging worldwide efforts in scaling up commitments+and investments of relevant stakeholders and promotion of digital health"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|998d8f77c3c949cd8843d7bdf421b78d+"solutions as digital public goods. This will be achieved through coordinated+engagements and implementation aligned with WHO norms, standards, and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|73e23711e0a54a8dafa05eb4e0949f6b+"90Accelerating Global Health: Pathways to Health Equity for the G20+91guidelines, while increasing transparency of resources being allocated to+digital transformation and identifying important gaps in support.+Conclusion+Adopting digital health is no longer a choice. The pandemic has undoubtedly+paved the way for the quick adoption of digital health. Digital health is+propelling the world towards more integrated health systems that are+focused on delivering patient-centred care, improving health outcomes, and+making the best use of healthcare resources. India’s digital health initiatives+such as the ABDM, CoWIN, and eSanjeevani have provided a stimulus to+act in conformity with a globally progressive commitment to health equity.+They have also enabled the country to work towards creating a movement+to enable integration of technology-informed models for universal health+coverage."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|8|97cddb2fd5c54f7f91c34ca00913ee2e+"coverage.+Lav Agarwal i s A d d i t i o n a l S e c r e t a r y f o r eHealth, International Health & Collaboration,+Public Health, and G20 at the Ministry of Health and Family Welfare, Government of+India."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|8|ebc08425c0f94baaad5796ba621470b9+"93+9293Lessons from+India’s Digital Public+Infrastructure+Transformation+Sameer Kanwar and Varun Kumar+In today's rapidly evolving digital landscape, many countries are+striving to establish and strengthen digital public infrastructure (DPI)+to harness the transformative power of technology to benefit citizens. India+has emerged as a noteworthy example by successfully using technological+advancements to create robust DPI. It has implemented various initiatives+that mobilise technology for inclusive growth, economic development, and+improved governance. Countries around the world can learn from India’s+experience and achievements to initiate similar digital transformations.+Through the Digital India programme, India is seeking to digitally equip+citizens with access to all government services by improving internet+connectivity and developing online infrastructure. This encompasses three+key areas: (a) establishing a secure digital infrastructure; (b) successfully"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|0|9b7a9f8531134be2b16e734bda64a349+"delivering digital services; and (c) ensuring that every citizen has access+to the internet. India has also seen an increase in the number of digital+technology users, with an estimated 750 million smartphone users, and a+projected one billion users by 2025.1 This increase has generated demand+for a centralised digital architecture that functions as a single enterprise."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|0|a7321ba158184f8b86aac4988ef5ec62+"93Lessons from India’s Digital Public Infrastructure Transformation+93In 2018, the Ministry of Electronics and Information Technology (MeitY)+created the India Enterprise Architecture (IndEA) framework1 for the adoption+of a whole-of-government enterprise architecture by central ministries,+state departments, and public sector enterprises. Built with a focus on+performance, IndEA offers open standards to promote interoperability+and supports decentralisation. At the same time, it supports both new+(greenfield) and legacy (brownfield) e-governance initiatives. The emphasis+of the IndEA initiative is to enable “One Government – a government+that is least visible but is effective” by implementing the concept of+“virtualisation of departments” to activate synergy.2+Growing digitalisation will lead to the increased generation of data,+and consequently, data protection and ownership must be addressed at+the outset. The Data Empowerment and Protection Architecture (DEPA)"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|508c60a74e3c4391a8d4136d0a90ffeb+"framework, introduced in 2020, seeks to ensure user control over data.+DEPA suggests measures for consent-governed and secure data-sharing+with third-party institutions. Controlled by consent managers, only relevant+user data is plugged in to any private ecosystem and there is no need+to set up bilateral databases.3 This empowers citizens with ownership and+control over their own data and how it is shared.+While DEPA has been flexibly applied in multiple sectors, it has been+particularly well-used as a techno-legal solution in the finance sector.+Since DEPA empowers individuals to securely share their financial data+with banks, insurers, investors, and other stakeholders, its first immediate+benefit has been to encourage competition among private players.+Individuals and small businesses are now able to get loans, insurance, and+other financial products at competitive rates, just by using their digital"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|b7f8f25fdd3c482cb13517142b7c0117+"footprint. In practice, DEPA works closely with the many layers of India+Stack4—Aadhaar-based e-KYC, Unified Payments Interface (UPI) for cashless+payments, and Aadhaar-based eSign) and uses the Open Credit Enablement+Network to facilitate lending. India Stack has enabled the country to build+its digital infrastructure, especially in establishing a design to improve+private sector service delivery, and has served as India’s digital library,+housing several digital global goods and offering learnings to the world.+Over the last decade, India has taken landmark steps to set in motion its+vision of becoming an inclusive digital economy. This includes establishing"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|be5f478737c04472bffaf880bf0be06b+"94Accelerating Global Health: Pathways to Health Equity for the G20+95robust DPI and the facilitation of digital governance by streamlining+roles, accountability, and change management. This encompasses various+components, including digital identification systems, digital payments+systems, and digital service delivery platforms.+Pillars of Digital Public Infrastructure in India+The foundation: Aadhaar5+India's Aadhaar programme, a biometric and face authentication-based+digital identification system, has revolutionised identity verification+and service delivery in the country. Aadhaar has provided a unique+identification number to over 1.3 billion residents of India, enabling access+to essential services such as government subsidies, bank accounts, and+mobile connections. It has enabled the government to streamline service+delivery and eliminate duplication by providing a single digital identity+across multiple sectors. The world can learn from India's approach in"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|d407fea54dd0419d993eea72ba0ffc30+"implementing a centralised, secure, and inclusive identification system, that+has facilitated interoperability across service delivery platforms, both public+and private.+Driving financial inclusion: Unified Payments Interface6+India's push to digitise payments has transformed the way financial+transactions are conducted in the country. The implementation of UPI has+created a platform that enables instant money transfers between bank+accounts. It offers a smartphone-based interface to support seamless,+interoperable, and real-time payments, available on the go. UPI has not only+transformed the way individuals transact but has also provided a significant+boost to the growth of the digital economy. Countries can gather important+lessons from India's experience in fostering a competitive and interoperable+payment ecosystem, which has led to increased financial inclusion, reduced+reliance on cash, and enhanced transparency in transactions."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|72e89e28e10a42a6a177299e73a70265+"The number of digital transactions increased by more than three times+from 3 billion in November 2019 to 10 billion by January 2023.7 A 2019"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|6c3a8512b9a140c983b92ad7f3e5ac41+"95Lessons from India’s Digital Public Infrastructure Transformation MeitY study noted that under a ‘business as usual’ scenario, India’s+digital economy will grow to US$500 billion by 2025, with the potential+to increase to US$1 trillion.8 In 2021, India had 48.6 billion real-time+payments, as compared to 18.5 billion in China and 8.7 billion in Brazil.9+This is indicative of the ease with which the Indian population has adopted+digital platforms for making payments even if the average value of such+payments may be rather low.+Efficient welfare delivery: Direct Benefit Transfer10+India's Direct Benefit Transfer (DBT) programme is aimed at eliminating+potential leakages in the physical delivery of financial benefits and ensuring+an efficient transfer of welfare to the right beneficiaries. By leveraging+digital payment systems, benefits are directly credited to the beneficiaries’+bank accounts, reducing corruption, eliminating middlemen, and improving"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|26dcc67d7f7c43b4a92343aa220232c4+"transparency in the transfer of subsidies.11 The enablers for DBT in India+are the Pradhan Mantri Jan-Dhan Yojana, the Jan Dhan-Aadhaar-Mobile+Yojana, and nearly 312 other schemes from 53 ministries across all states+and union territories. More than INR 24,800 billion has been transferred+through the DBT programme since 2013, with INR 6,300 billion transferred+in FY 2021-22 alone. On average, more than 9 million DBT payments were+processed daily in FY 2021-22.12+Citizen-centric services: E-governance13+India has leveraged technology to enhance governance and service delivery+through initiatives like Digital India and other e-governance platforms. The+use of digital platforms (or information and communication technologies)+has facilitated efficient and transparent administration, improved the+accessibility of government services, and reduced bureaucratic inefficiencies."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|5e5cf5cf4f2f42189004a55fd0fbe71f+"The MyGov platform14 h a s b e e n a c r u c i a l c o n t r i b u t o r t o t r a n s f o r m i n g c i t i z e n -+government interactions. India's approach to digital governance emphasises+citizen-centricity, where technology acts as an enabler to bridge the gap+between the government and its citizens. By adopting similar approaches,+countries can enhance government services, promote transparency, and+strengthen democratic participation."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|89d34f6b4a1149da8434c3dc7e361947+"96Accelerating Global Health: Pathways to Health Equity for the G20+97Creating a digital ecosystem: Technology access and innovation+India has created a vibrant digital ecosystem that fosters innovation+and entrepreneurship. Initiatives like Startup India15 a n d M a k e i n I n d i a16+have encouraged the growth of technology start-ups and attracted global+investments. India has nurtured a conducive environment for technology+and innovation through policy reforms, access to funding, and incubation+support. Managed by the Department for Promotion of Industry and Internal+Trade under the commerce ministry, the Startup India initiative has helped+introduce various programmes that support entrepreneurs and create a+healthy start-up ecosystem. Similarly, the ‘Make in India’ initiative has+incentivised the development, manufacture, and assembly of products in the+country, and has thus boosted partnerships, investments, and innovations."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|79c55fbf94dd417284553421cb291e12+"Growing digital literacy and inclusion in harnessing the benefits of+technology has also been crucial achievements for the country. India's+experience underscores the importance of widespread access to affordable+internet connectivity, digital skills training, and tailored initiatives for+marginalised communities. Initiatives like BharatNet,17 which aims to+connect over 250,000 local rural bodies with high-speed internet, and the+Common Service Centers,18 which provide access to government services in+remote areas, have been instrumental in extending the benefits of India’s+digital infrastructure to rural communities. In addition to the digital+training programmes offered through government-supported bodies like+the National Skills Development Centre19 and the National Institute for+Entrepreneurship and Small Business Development,20 other private training+institutes and online platforms have significantly contributed to digital skill"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|b5cc53eec04d4b72976b76bac99600d1+"building among citizens, both in urban and rural settings. By prioritising+digital literacy and inclusion, countries can bridge the digital divide and+empower their citizens to participate fully in the digital age.+Key Drivers of India’s Digital Transformation+India’s achievements in implementing DPI demonstrate the transformative+power of technology when combined with inclusivity, scalability, regulation,+and collaboration. The key factors that equipped the country to achieve this+digital revolution include:"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|e5168689a0894a83821de56e5646e40c+"97Lessons from India’s Digital Public Infrastructure Transformation Ecosystem collaboration+India's success in digital service delivery can be attributed to strong+collaboration between government agencies, industry leaders, startups,+academia, and civil society organisations. This collaborative approach+has fostered innovation, shared expertise, and effective implementation.+India’s G20 presidency has further drawn attention to the importance+of collaboration, with initiatives like the Global DPI Summit21 allowing+a close agreement between partners (and non-partners alike) on the+common principles and design aspects of DPIs. By bringing together all the+stakeholders, the Indian government has created a collaborative environment+for developing and implementing digital public infrastructure projects.+Industry players have contributed their expertise, resources, and technological+innovations to build and maintain the required infrastructure. Similarly,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|ded53e412e15418db0ce8e093a0b0bb7+"collaborations with academic institutions and research organisations have+aided innovation and helped address technical and policy challenges. Public-+private partnerships and international collaborations have further supported+knowledge exchange, best practice sharing, and access to resources and+funding.+The Indian government has been able to promote such an ecosystem+collaboration by establishing platforms (such as, India Stack), forums (for+example, India Stack Knowledge Exchange Forum, 202222), and regulatory+frameworks (IndEA and DEPA) that encourage active participation,+information sharing, and coordination between different stakeholders.+These collaborations prioritise interoperability, data privacy, security, and+scalability to build a robust and sustainable DPI in the country.+Scalability and inclusion+India's experience in scaling up its DPI demonstrates the significance+of inclusivity, with the most successful case being that of its digital"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|92aa0e11195f43fab4ecaf8c6b4db87c+"identification system. MeitY, in response to an unstarred question in the+upper house of Parliament (in July 2022), said that out of the approximate+projected population of 1.37 billion, around 1.27 billion held a live Aadhaar+number.23 By ensuring accessibility and ease of enrollment for all citizens,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|695d9199ed71476d91d5a642cd5901a7+"98Accelerating Global Health: Pathways to Health Equity for the G20+99including marginalised communities, India has achieved a notable level of+inclusivity. While there are gaps in digital inclusion across demographic+locations (55 percent share of urban telephone subscribers, as of December+202224) and gender (11 percent gender gap in mobile ownership, 202325),+the country is consistently invested in closing this difference.+India’s digital infrastructure has been created keeping in mind future+needs and potential growth. With a quantum increase in users connected+to the internet, the emergence of multiple types of intermediaries (digital+media, e-commerce, and others), and the possible use of connectivity to+cause harm or commit crimes cannot be ignored. Comprehensive measures+need to be taken to prepare for the future. To check a potential DPI’s+scalability even before introduction, significant emphasis has been placed"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|c1ec1f16dbb64a0d8dbd9b266609afae+"on considerations like robust technology frameworks, interoperability, open+Application Programming Interfaces, data management, and addressing+infrastructure gaps.+India’s journey is an example of how scalability and inclusion work+together in building a resilient and equitable digital public infrastructure.+Key strategies that have helped the country’s efforts to establish its+infrastructure at scale are ensuring accessibility, promoting digital literacy+and skill development, focus on last-mile connectivity, multilingual support+in technological solutions, participatory implementation, and regulations to+ensure affordability.+Balancing regulation and innovation+India's digital payments ecosystem demonstrates the need to strike a+balance between regulation and innovation. While fostering competition and+innovation, the country has implemented robust regulatory measures to+ensure the security and integrity of transactions."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|554377b8bd544ea0b0e343c02cb822bc+"Putting in place provisions like regulatory sandboxes, which provide a+controlled environment for testing innovative technologies and business+models, has allowed experimentation and innovation, while ensuring+consumer protection and risk mitigation. At the same time, taking a"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|717cc8137f1e405aa98adda0a4d527db+"99Lessons from India’s Digital Public Infrastructure Transformation collaborative approach by establishing forums and platforms for stakeholders+to engage in policy discussions and regulatory consultations has helped+in understanding their needs and concerns, thus informing the adoption+of balanced regulatory policies. Recognising the fast-paced nature of the+digital landscape, Indian regulators have also shown agility in updating and+adapting regulations. Recent policy measures like the introduction of the+Digital Personal Data Protection Bill 2022,26 which restricts the processing+of personal data until after the individual’s consent has been recorded, and+the presentation of the Digital India Act 2023,27 to set up global standard+cyber laws, have demonstrated a willingness to understand and respond to+consumer needs, emerging technologies, and market trends.+While India has made strides in regulation and innovation, challenges"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|3dea693354c2490488cf797844863da1+"remain. Striking the right balance between the two requires continuous+monitoring, assessment, and adaptation of regulatory frameworks to keep+pace with evolving technologies and market dynamics. Employing these+efforts at the desired scale in the country would require infrastructure,+investment, and a strong commitment. Ongoing collaboration between+regulators, industry players, and other stakeholders will be crucial to+maintaining an innovation-friendly environment while upholding consumer+protection and addressing emerging risks.+Conclusion+India's DPI provides valuable lessons on the advantages of harnessing+technology for inclusive growth, economic development, and improved+governance. Through initiatives like Aadhaar, UPI, digital health+infrastructure, DBT, e-governance, regulatory frameworks, and creating an+enabling digital ecosystem, India has been able to unlock the transformative+potential of DPI. By focusing on the key lessons from India's experience,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|2d915595100243ee97337357adfbd5a8+"other countries can implement similar DPIs to address their unique+challenges and leverage the potential of technology for the benefit of their+citizens."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|00184cc144484362ba8613f06f0aadec+"100Accelerating Global Health: Pathways to Health Equity for the G20+101These countries must consider their contextual differences based on+population size, level of technological development, political priorities, and+policy outlooks to customise their learnings to suit their specific needs and+challenges. As the world embraces the digital era, India's DPI experience+can serve as inspiration and guide for building robust digital systems that+could foster inclusive societies and drive sustainable development in the+21st century.+Sameer Kanwar is Director, Digital Health, India and South Asia Hub, PATH .+Varun Kumar is Senior Program Officer, PATH."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|8|613d6988832246eaaf57f6d9192e54d0+"29+2829Antibiotics have revolutionised modern medicine by reducing+morbidity and mortality caused by bacterial infections. However,+the overuse and misuse of antibiotics has accelerated the development of+antibiotic resistance, making once-treatable infections increasingly difficult+to manage.1 Antimicrobial resistance (AMR) is a grave global health crisis,+posing significant challenges to achieving health equity on a global scale.+In 2019 alone, bacterial AMR was directly responsible for 1.27 million+deaths worldwide.2 If left unchecked, this is predicted to cause a staggering+10 million deaths by 2050,3,4,5 u n d e r l i n i n g t h e u r g e n t n e e d f o r a c t i o n .+An increase in AMR will significantly impact the global economy and is+expected to push an additional 24 million people into extreme poverty by+2030.6 Although reliable estimates from developing nations remain limited,+perhaps due to inadequate surveillance, the burden of AMR is suspected"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|0|a2e40d44ac8b4bc1b87b168a9a450207+"to be highest in low-income countries. Unless suitable interventions are+implemented, certain susceptible bacterial pathogens will eventually become+resistant to antimicrobials, thereby rendering treatments ineffective.7 This+essay explores the multifaceted nature of AMR and its impact on healthcare+systems and patient outcomes. The focus is on accelerating efforts to+combat AMR, with the recognition that addressing this issue is crucial for+ensuring health equity for all. Ranga Reddy Burri, Robert Skov, Bulagonda Eswarappa Pradeep,+and Ralf SudbrakThe Battle Against+Antimicrobial+Resistance"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|0|845384860a874fc8b18ed38b165d91fb+"29The Battle Against Antimicrobial Resistance+29Understanding Antimicrobial Resistance+The emergence of AMR impedes the prevention and/or treatment of+persistent infectious diseases. Although a number of measures have been+initiated at the global, national, and regional levels, AMR persists.8 To+effectively combat AMR, it is essential to comprehend its fundamental+aspects. AMR refers to the ability of microorganisms, such as bacteria,+viruses, fungi, and parasites, to withstand the effects of antimicrobial drugs.+The development of resistance is part of the natural biological evolution as+this is part of the defence system of microorganisms. Resistance can be+inherent (i.e. no target for the antibiotic) or it can arise through various+mechanisms, including genetic mutations, horizontal transfer of resistance+genes between microorganisms, target modification, membrane permeability+alteration, drug modification, and antibiotic efflux. Exposure to antimicrobials"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|1|f1e59f2d24db4d059c8bc8fdc7a5193c+"accelerates the generation of resistance by increasing rates of mutation+and exchange of genetic resistance mechanisms as well as the killing of+susceptible microorganisms (including many bacteria of the normal flora),+thereby giving resistant microorganisms a competitive advantage (also+known as ‘selection’). Resistance affects all types of antimicrobial agents,+including antibiotics, antivirals, antifungals, and antiparasitic drugs. There+are five key factors that contribute to the rise of AMR (see Figure 1).+Figure 1: Factors Contributing to the Rise of AMR+Source: Authors’ ownInadequate+infection+prevention+and controlPoor+diagnostic+capacityDrying+antimicrobial+development and+production+pipelineAbuse/+Inappropriate+use of+antibiotics"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|1|5f12a23a8cd14c22a6ce2a6851934d50+"30Accelerating Global Health: Pathways to Health Equity for the G20+31a) Inadequate infection prevention and control: The spread of AMR is+closely linked to the ability of bacteria and other microorganisms to+rapidly multiply and spread their population through various vectors/hosts.+Poor hand hygiene, improper disinfection and sterilisation practices, and+inadequate sanitation can lead to the rapid spread of these drug-resistant+pathogens. Strict adherence to infection control measures can lower the+occurrence of hospital-acquired infections.9 Therefore, appropriate measures+need to be taken to enhance the existing infection prevention framework and+reduce the risk of the spread of AMR. A significant hurdle in implementing+infection prevention and control (IPC) practices, especially in low- and+middle-income countries (LMICs), is the presence of adequately-trained+human resources. To address this, institutions such as the World Health"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|66c6d834348b4a62b864b5a39bb15fe1+"Organization (WHO) and US Centers for Disease Control and Prevention+have developed training modules, while the Infection Control Academy+of India (IFCAI) has developed a diploma course to build the capacity of+infection preventionists.+b) Abuse/inappropriate use of antibiotics : In addition to the selection+pressure on microbes due to the use of antimicrobial drugs, social and+administrative factors also contribute to, and exacerbate the emergence of+AMR. One of the contributing factors is the availability, in many countries,+of antimicrobials through over-the-counter (OTC) sales without requiring+prescriptions. Furthermore, the inappropriate prescription of antibiotics by+physicians contribute to the overuse of antibiotics. A study conducted by+WHO highlighted that a significant proportion of antimicrobials prescribed+in outpatient departments of various hospitals were unnecessary or+inappropriate.10 Rampant use of antibiotics in the livestock sector, pressure"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|814076eb4141455baa4afe3bddce0dd9+"from patients to be prescribed an antibiotic for immediate relief from+symptoms, self-medication, and the discontinuation of antibiotic course+after relief from symptoms—all worsen drug resistance in pathogens.11,12+New legislation and the enforcement of existing regulations to prevent the+OTC sale of antimicrobials is crucial, as are stricter antibiotic prescription+and consumption measures.+c) Drying antimicrobial development and production pipeline: The complete+antimicrobial drug development process, from discovery to market entry, takes+an average of eight to 12 years. Although advancements in computational"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|0aef0d4620f242e996cf1d0b2d84b4cc+"31The Battle Against Antimicrobial Resistancechemistry and artificial intelligence (AI) have aided in drastically cutting+down the timelines for the discovery of new antimicrobials, the in vitro+and in vivo trials take time. Even after such laborious efforts, bacteria+swiftly develop resistance to these antibiotics. Quicker and more efficient+antibiotic testing and approval pipelines need to be established to combat+AMR.13+Recent advances in antimicrobial discovery—including the repurposing+of existing drugs, exploration of natural products, employing alternate+treatment strategies, the use of computational approaches for drug design,+interdisciplinary collaborations, and the integration of new technologies may+help in accelerating the discovery process14 a n d i n t h e m i t i g a t i o n o f A M R .+Despite the recent advantages, investment in antibiotic research and+development remains limited, resulting in a clinical antibacterial pipeline"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|7fb1b39b4037448eaf3eb30e1898fc7e+"that is insufficient to address the emergence and spread of AMR infections.+In 2021,15 there were only 77 antibacterials in the clinical pipeline that target+WHO priority pathogens (Enterobacteriaceae, Acinetobacter and P s e u d o m o n a s )+including tuberculosis.16 Of these, 45 are traditional antibacterial agents and+32 are non-traditional. Of the 45 traditional antibiotics, 27 are reported+to be active against the WHO bacterial priority pathogens, 13 against+Mycobacterium tuberculosis, and five exclusively against Clostridium difficile.+Only six of the 27 antibacterials targeting the priority pathogens fulfil at+least one of WHO’s four innovation criteria (i.e., absence of known cross-+resistance, new class of drug, new target site, and new mode of action).17+However, a robust pipeline of novel antibiotics is critical to tackling the+increasing emergence and spread of AMR. The Global AMR R&D Hub+and WHO18 reported on the progress and challenges for incentivising the"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|c00efcf689b046e79324603ecf4f180e+"development of new antibacterial treatments to tackle the emerging threat+of AMR. The return on investment for new antibiotics fails to cover the+costs of their development, manufacturing, and distribution.19 As a result, big+pharmaceutical companies have exited the antibiotic market, and companies+remaining in the space (often small or micro biotech firms) face challenges+to sustain their operations given the cost and time for drugs to reach the+market. Novel reimbursement models addressing the market failures are+needed to make antibiotic development more economically sustainable."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|676eaa0f093b4fbc80687cb2f30c6f16+"32Accelerating Global Health: Pathways to Health Equity for the G20+33Innovative financing mechanisms play a crucial role in addressing the+lack of financial incentives for the private sector to develop, test, and roll+out new antimicrobials. One potential solution is the implementation of+advance market commitment–type investments, such as those undertaken+by organisations like DNDi (Drugs for Neglected Diseases Initiative), CEPI+(Coalition for Epidemic Preparedness Innovations), and Gavi (Global Alliance+for Vaccines and Immunization).+Under this model, governments pool funding to support manufacturers+and the private sector in creating antibiotics, thereby reducing innovation+risks and ensuring equitable pricing and access. This approach incentivises+private-sector investment, overcomes financial barriers, and contributes to+the fight against AMR, securing effective treatments for all.+d) Poor diagnostic capacity: Accurate and timely diagnostics are critical for"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|29773bc63cdc4fa680e82c66e6629eed+"identifying and managing infectious diseases effectively. Poor diagnostic+capacity can lead to delayed or inappropriate treatment, increased morbidity,+mortality, and spread of infectious diseases, including outbreaks. Poor+diagnostics encompass several aspects, including limited access to diagnostic+technologies, inadequate laboratory supplies and equipment, poor quality of+chemicals and equipment, absence of reliable quality assurance systems,+limited access to reference laboratories, inadequate infrastructure, lack of+trained personnel, and delays in obtaining test results.20 Poor diagnostic+capacity is one of the biggest challenges of the health sector in developing+countries.21 Lack of timely diagnostics is also a challenge in vulnerable+populations in high-income countries (HIC). Therefore, improving diagnostic+capacity is essential, especially in LMICs, as is ensuring equitable access to+diagnostics for vulnerable populations to enhance the quality and efficiency"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|7745a8bcb0d44d66ad78c6d2c0971a61+"of healthcare delivery and for achieving the global health goals of reducing+the burden of communicable and non-communicable diseases.22+Innovations Related to AMR+a) Exploration of alternative therapies: Alternate ways of treatment+like “bacteriophages,23 a n t i m i c r o b i a l p e p t i d e s ( A M P s ) o r b a c t e r i o c i n s ,24+antimicrobial adjuvants, faecal microbiota transplant (FMT) and competitive+exclusion of pathogens through genetically modified probiotics and"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|705bfb5bc30d4ce9a762f127476a6352+"33The Battle Against Antimicrobial Resistancepostbiotics”25 rather than antibacterial agents alone, could be an alternate+way to reduce the use of antimicrobials.+b) Streamlined approval of new antimicrobials: Efficient and streamlined+clinical trial processes are crucial for expediting the development timeline+of new antimicrobials, including regulatory processes and innovative+trial designs, such as adaptive dose-ranging studies and seamless phase+transitions. This calls for better collaboration between regulatory agencies,+researchers, and industry stakeholders to establish harmonised protocols,+reduce administrative burden, and expedite patient recruitment, leading to+faster completion of clinical trials.26+c) Repurposing of existing drugs: Drug repurposing, or identifying new+therapeutic applications for existing drugs offers another strategy to+expedite antibacterial production. By leveraging the extensive knowledge"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|573672aab4184bd0a0d749d328280bc8+"and safety profiles of approved drugs, researchers could bypass certain+preclinical and early clinical development stages, significantly reducing the+overall timeline. Repurposing can be achieved through in-silico analyses,+high-throughput screening, and exploring drug libraries, aiming to identify+existing drugs with potential antibacterial activity.27+d) Harnessing the power of AI: Machine learning (ML) and AI offer+possibilities to accelerate drug repurposing in several ways, including the+detection of the relationships among various biological components (such as+genes, proteins, diseases, and drugs) and through the analysis of molecular+fingerprints of compounds. Furthermore, neural network-based approaches+can be trained to learn the patterns and properties of fingerprints, enabling+prediction of drug activities and identifying potential drug candidates.28+AI can also be harnessed to streamline the diagnostic process. An academic–"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|a2dff2067d5543578a60182bfd8845c5+"industry collaboration in India (between Sri Sathya Sai Institute of Higher+Learning, IFCAI and SCIINV Biosciences Private Limited) has developed+AMRx™ , an AI/ML-based culture-free prediction system in the context of+urinary tract infections. It is a clinical decision support system to improve+empirical antibiotic prescriptions and to reduce unnecessary laboratory+testing of samples."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|21cf6462eb7f41de8afc3c403e296587+"34Accelerating Global Health: Pathways to Health Equity for the G20+35e) Collaborative research and funding initiatives: Global efforts are urgently+needed to address the complex elements of AMR. These include coordinated+leadership at the global, regional, and national level, involving diverse+government agencies, academia, practitioners, and industry.29,30 Recognising+the spread of AMR, WHO, the Food and Agriculture Organization, the United+Nations Environment Programme, and the World Organisation for Animal+Health have formed the Quadripartite to promote a ‘One Health’ approach31+that aims to align actions across the human, animal, and environmental+sectors. Several initiatives are ongoing, and 170 countries have developed+national action plans (NAPs). However, only 10 percent of these plans are+fully costed. Converting the NAPs to concrete AMR mitigation actions has+proved to be difficult, including in the LMICs."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|0cac054347174785b04ddef8537bee36+"proved to be difficult, including in the LMICs.+In response, Denmark initiated the establishment of the International Centre+for Antimicrobial Resistance Solutions (ICARS) to support these countries+with funding and expertise to develop evidence-based, context-specific+and cost-effective solutions that can be scaled to establish sustainable+AMR mitigation. The AMR Multi-Partner Trust Fund (MPTF) was launched+in 2019 by the Quadripartite members to catalyse the implementation of+One Health NAPs and to provide effective leadership and coordination of+multisectoral One Health response to AMR. Additionally, the Global AMR+R&D Hub in Berlin is promoting collaboration and coordination of research+and development on AMR, and is cataloguing the present funding in AMR+R&D to provide the landscape of present funding for future prioritisation.+Organisations such as CARB-X, Global Antibiotic Research & Development+Partnership (GARDP), and the AMR Action Fund work to stimulate drug"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|eb9b28d8481946eb8748c0029240feb7+"discovery and equitable access. To solve the market failure for antimicrobials,+new models for financing the development of novel antimicrobials, where+countries pay for the accessibility of drugs, are currently being explored.32+f) Rapid Diagnostic Tests and Point-of-Care Technologies in AMR: Absolute,+concrete, and timely diagnosis detection, and management of infection-+causing pathogens will significantly decline morbidity, mortality, and the+cost burden. Rapid diagnostic tests (RDTs)33 and point-of-care technologies+(POC) are tools that can be employed in achieving timely diagnostics.+The integration of RDTs and POC technologies, such as polymerase chain+reaction-based tests, genotypic assays, and phenotypic assays, in AMR"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|6fa033fa9795403f88f1b4cea6fa05f4+"35The Battle Against Antimicrobial Resistancemanagement can potentially transform clinical practice and public health+interventions.34+Accelerating Efforts to Combat AMR+Combating AMR requires a multipronged approach the comprises all critical+components—from policy to implementation. Development of new antibiotics and alternative treatments in the era+of Antimicrobial ResistanceOvercoming difficulties in finding new drugsAntibiotic repurposingDevelopment of alternate therapies like BacteriophagesImproving infection prevention and control practicesOptimising antimicrobial useStrengthening surveillance and data collectionIntegrated One Health approach to unify and integrate multiple+sectorsIncorporating AMR into national and global health plansEngaging stakeholders and raising awareness about AMRMobilising political will and fostering multi-sectoral collaboration"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|7|132097da86644b35b8147fcb94ab68d8+"36Accelerating Global Health: Pathways to Health Equity for the G20+37Conclusion+AMR is an ongoing and evolving pandemic that impacts LMICs and+vulnerable populations in HICs the hardest. This is aggravated by a drying+pipeline of antimicrobials and the industry leaving the field of antimicrobial+drug discovery due to lack of economic sustainability. The consequences of+the AMR pandemic are already severe, but will become even more dire if+not reversed. There is an urgent need for increased and focused action. Due+to the complex nature of AMR, this effort needs to be multifaceted, both+in reducing the circulation and spread of existing resistant microorganisms+and in slowing the increase of novel resistance mechanisms. Key to this+is lowering the overall use of antimicrobials (i.e. infection prevention),+antimicrobial stewardship (including accessibility of affordable and timely+diagnostics), and strengthening IPC and biosecurity procedures, all of which"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|83a561974e644530b643bd7b78aaca7a+"need to be carried out through the ‘One Health’ approach. This needs+involvement at all levels and of all stakeholders, including civil society.+Exploring alternative therapies such as bacteriophage therapy, repurposing+existing drugs, harnessing the power of AI, and fostering collaborative+research initiatives are key strategies in tackling AMR. These innovative+approaches provide hope for the future, where a robust antibacterial+pipeline can meet the challenges posed by evolving bacterial infections and+ensure effective treatment options for patients worldwide.+Dr. Ranga Reddy Burri is President, Infection Control Academy of India and Honorary+Professor, at the University of Hyderabad, India.+Dr. Robert Skov is Scientific Director at the International Centre for Antimicrobial+Resistance Solutions (ICARS, Copenhagen, Denmark); President-Elect & Secretary General,+European Society of Clinical Microbiology and Infectious Diseases (ESCMID)."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|79badcad1dbd487888b1764e9c892c46+"Dr. Bulagonda Eswarappa Pradeep is Associate Professor, Department of Biosciences,+Sri Sathya Sai Institute of Higher Learning, India.+Dr. Ralf Sudbrak i s D e p u t y D i r e c t o r a t t h e G l o b a l A M R R & D H u b , B e r l i n , G e r m a n y ."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|6c480a85100e4e80adba9687a25de868+"59+59Janice Tan and Jeremy LimEnsuring Access+to Affordable+Healthcare for All:+The Role of Health Finance in G20+Countries+The G20 countries, individually and collectively, have made strides+in improving human health since the group's inception in 1999.+Average life expectancy across the member states has shown remarkable+progress, increasing from 73 years to 78 years over the past two decades,+well above the global average of 67 years.1+Figure 1: Average Life Expectancy in G20 Countries+Source: WHO dataAverage life expectancy (yrs)+100+50+0+ARG FRA JPN ZAF AUS DEU KOR TUR BRA IND MEX UK CAN IDN RUS US CHI ITA KSA74+79+70+79+71+79+78+62+66+79+81+75+73+66+72+59+71+77+7777+83+75+82+78+83+81+71+71+84+84+83+74+73+77+66+78+81+79+1999 2019"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|0|47b323d77856431b8d67d73bf0cde810+"60Accelerating Global Health: Pathways to Health Equity for the G20+61This achievement demonstrates the potential of the G20’s collective+commitment towards enhancing public health outcomes and underscores+the importance of continued efforts to prioritise health equity between+countries. There is still much to be done: within the group, there is an+18.2-year difference in life expectancy between the highest and lowest+achieving members. Imagine the life and health gains if all G20 countries+levelled up.+The improvements in human health have been accompanied by an increase+in healthcare spending in absolute terms. With the exception of India and+Turkey, G20 nations saw a rise in the average healthcare expenditure as+percent of GDP, from 6.8 percent to 8.5 percent between 2000 and 2019,+or just above US$3,000 per capita.+Figure 2: Healthcare Expenditure as % of GDP for G20 countries+Source: WHO data2Healthcare Expenditure (% of GDP)+20+15+10+5"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|1|ec5c38d181dd4fe98b66c735aac3841b+"20+15+10+5+0ARG FRA JPN ZAF AUS DEU KOR TUR BRA IND MEX UK CAN IDN RUS US CHI ITA8.2+7.6+8.3+8.3+4.5+9.6+9.9+4.0+1.9+7.6+7.0+3.9+8.1+5.5+7.3+4.6+7.2+12.59.5+10.2+9.6+11.0+5.4+11.1+11.7+2.9+2.9+8.7+10.8+4.5+5.0+5.7+8.2+4.4+9.9+16.7+2000 2019"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|1|7f17a419c6ec4be294b6a2008c0a73c7+"61The Role of Health Finance in G20 Countries Figure 3: Higher % GDP Spending in Healthcare and Increase in+UHC Coverage+Source: WHO Data3+There is recognition that investments in healthcare, overall, runs parallel+to expansion in coverage of Universal Health Care (see Fig. 3). However,+this coupling between healthcare spending and health outcomes is a topic+of intense interest when discussing health finance in G20 countries. While+increased healthcare expenditure often leads to improved health outcomes,+this is not always the case and it is crucial to ensure that investments+are directed effectively and efficiently. By adopting innovative financing+mechanisms, G20 countries can optimise the impact of healthcare spending+and achieve desired health outcomes for their populations.+Persisting Out-of-Pocket Expenses+Despite progress, the issue of high out-of-pocket (OOP) expenses remains+a significant concern in many G20 countries. OOP expenses often place"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|2|67bf46897ef2443ea58021ade0df45a0+"a disproportionate burden on vulnerable populations, leading to financial+hardships and limited access to healthcare.4 Embedded in the advocacy for+health equity is the recognition that health disparities exist among different+populations due to various factors such as socioeconomic status, race,+ethnicity, gender, geographic location and access to healthcare services.5+Thus, achieving health equity requires interventions and policies targeted+towards those who are most disadvantaged and have the greatest needs.+This may involve redistributing resources, implementing targeted healthcare+programs, improving access to quality healthcare services, addressing social+and economic inequalities, and promoting health education and prevention UHC+Global average : 67+India+IndonesiaTurkiyeChinaSingapore South KoreaNetherlands+UKCanada+United StatesGermany+FranceJapan+Spain+Brazil+ArgentinaSouth AfricaRussiaAustralia+Mexico+% GDP100+80+60+40+20+0+0 5 10 15 20Italy"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|2|cee9405d7f9345ac9beb4b3fbf485aec+"62Accelerating Global Health: Pathways to Health Equity for the G20+63initiatives. As the COVID-19 pandemic has illustrated, no one is safe until+everyone is, and even if primarily motivated by self-interest, there is an+economic case (if not for reasons of equity) for uplifting the most vulnerable+populations.+The efficiency of healthcare systems also varies greatly among G20 countries.+While some economies have successfully implemented efficient and effective+healthcare models, others continue to face challenges in delivering equitable+care. The authors of this article examine the relationship between universal+healthcare service coverage (UHC) and Out-Of-Pocket Expenses (OOPE) as a+proportion of Current Health Expenditure for G20 countries (Fig. 4), reflecting+targets 3.8.1 and 3.8.2 of the UN Sustainable Development Goals for Universal+Health Care.+UHC measures coverage of essential health services that include reproductive,"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|b3125524cd434526969844ef534e60b7+"maternal, newborn and child health, infectious diseases, non-communicable+diseases and service capacity and access among the general and the most+disadvantaged populations. Meanwhile, 3.8.2 highlights catastrophic OOP+healthcare spending, usually defined as populations with household expenditure+on health >10 percent or 25 percent of total household expenditure. The+authors used data from previous decade to sift out which countries of the+G20 had shown the most recent improvements, and also included Spain and+Singapore to the analysis as both these countries are permanent or recurring+guest nations to the G20 dialogues and could offer lessons to emulate.+Figure 4: Changes in UHC Service Coverage with OOPE in the+Past Decade for G20 Countries+Source: WHO data6UHC+AUS+90+80+70+60+50+40More health service coverage is betterIdeal+Situation"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|9cfbef4b83674b20b627a9af06d3ae12+"Situation+Lower Out of Pocket Expenditure as a% of Current Health Expenditure is betterOOPE70 60 50 40 30 20 10Global average : 67Global average : 312019+2009+ZAFTURTUR+KSA KSAFRA+FRA+USAUSAJPN+JPNDEU+AUSSPN+SPNITA+ITA+BRABRAKOR+CHI+CHIRUS+RUSMEX+MEX+IDN+IDNIND+INDKOR+SGP+SGPCAN+CAN+UKUK+DEU+ARG ARG+ZAF"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|8557a7dfb0ce4db8a2b165aedc19d757+"63The Role of Health Finance in G20 Countries From the chart, directional movement to the upper left quadrant or+North-West direction would be ideal as it highlights increased UHC+with lower OOPE, i.e. better coverage at greater affordability. The most+significant improvements are highlighted in green (China, India, Indonesia,+Singapore). This article discusses efforts in Indonesia and Singapore that+have contributed to these remarkable achievements. By examining diverse+strategies, readers can gain insights into potential pathways towards+achieving health equity within different national contexts, be they in+developing or developed nations.+Best Practices+Indonesia+Indonesia’s journey to UHC is a textbook case of adherence to expanding+health insurance coverage and implementing social protection mechanisms.+The landmark JKN National Health Insurance was implemented in 2014+to provide access to healthcare for its population and today covers"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|2637f57224b34d4895cf7ade5482c61c+"approximately 250M people.7 The JKN program covers all Indonesian+citizens, including formal and informal sector workers, and those+categorised as poor and near-poor, ensuring that everyone has access to+essential healthcare services. It consolidates more than 300 risk pools and+operates under a single-payer system, managed by the Social Security+Agency for Health ( Badan Penyelenggara Jaminan Sosial Kesehatan o r B P J S ) .+BPJS collects contributions, manages the insurance fund, and coordinates+with healthcare providers. Participation for all eligible individuals is+mandatory, and contributions are based on income and employment status,+with the government subsidising the premium for the poor and near-+poor. The insurance scheme entitles every Indonesian to the same medical+benefit package, decreasing OOPE from 47 percent to 34 percent in just+four years.8+Within this OOP spending, in LMICs (low- and medium-income countries)"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|f2ee990cbb1942db85479fce8ded4160+"such as Indonesia, medicines typically account for 20-60 percent of total+healthcare expenditure with nearly 90 percent of the population purchasing+medicines through OOP payments.9 Managing drug pricing and procurement+is thus a key lever for further managing costs and affordability. Indonesia"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|36832b98f50e46df903ea924ff5e55c5+"64Accelerating Global Health: Pathways to Health Equity for the G20+65has implemented a generic medicine pricing policy where the retail price+of generics cannot exceed the maximum retail price set by the MOH.+A 2010 study across nine public hospitals, 64 private pharmacies, and nine+NGO hospitals in four provinces in Indonesia, showed that the prices of+Lowest Price Generic (LPG) and Innovator Brand (IB) medicines was lower+in 2010 than in 2004, with declines ranging from 40 percent to 2200+percent.10 This showed that generic medicine pricing policies have succeeded+in lowering the price of medicines. Despite this success, however, there+is wide variation in implementation as exemplified by the excess paid by+patients compared to MOH set prices varying widely from 2 percent to+600 percent. Even within countries, there is substantial opportunity to+narrow the differences. More recently, the government has also embarked"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|86eac922752743339f35699cfccec378+"on working through state-owned enterprises (SOEs) to centralise drug+procurement and leverage purchasing power, negotiating lower prices to+further ensure availability of medications across facilities.+On the demand side, Indonesia has promoted the use of generics with+public awareness campaigns to educate the public about their benefits.+These campaigns aim to dispel misconceptions and increase confidence+in the quality and efficacy of generic medications. Additionally, the+government has provided incentives for healthcare professionals to prescribe+and dispense generic medications. These incentives may include financial+incentives or recognition for healthcare providers who prioritise generic+prescribing. Again, implementation has been varied. In an observational+study at Kalisat District Hospital, doctor’s compliance in prescribing generic+drugs reached 68 percent while the national standard in April 2013 reached+90 percent.11"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|e66fc805e2f748178c0c1270b907aec8+"90 percent.11+Overall, in Indonesia, BPJS and various national policies have forged+significant steps in achieving UHC. However, as highlighted above, uniform+and consistent implementation remains a challenge. Beyond these, there+are also additional efforts that Indonesia can undertake to improve UHC+further. Whilst JKN has an extensive network of healthcare providers,+including public and private hospitals, clinics and facilities, challenges+exist due to disparities in healthcare infrastructure across the vast island+archipelago, and despite co-payments by beneficiaries, the JKN also faces a"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|e663f199a53b4d5094921d1e38169663+"65The Role of Health Finance in G20 Countries significant deficit. To raise funds, Indonesia has room to raise Public Health+Expenditure and contribution compliance. At the same time, Indonesia can+also improve primary care and manage spending and governance.12+Singapore+Whilst Indonesia is rightly lauded as having the fastest growing insurance+program in the world (with BPJS covering close to 91 percent of its+population in less than 10 years),13 Singapore has had its 3M approach+(Medisave - a compulsory health savings account, Medishield – catastrophic+illness insurance and MediFund – a social security net for the indigent)+initiated 30 years prior, in 1984. What has Singapore done in the past+decade to continue to move the needle in improving UHC and affordability?+Expanding capacity has been a priority. In 2009, there were approximately+8,000 acute hospital and 9,000 nursing home beds in Singapore. Today,"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|9cd4784114ac446782aa0d71f1e7dc21+"those numbers have grown to 12,000 and 17,000 beds, respectively, or+a combined 70-percent increase in institutional places. With healthy+economic and GDP growth, the Singapore government has been assiduously+increasing healthcare infrastructure, particularly in the eldercare sector as+it prepares to become the 2nd fastest aging economy in Asia outside of+Japan. By 2030, one in every four Singaporeans will be above 65, and along+with changing societal and family patterns, will require massive capacity+to cater to the elderly who mostly live independently and require support+with their daily activities. Singapore has tried to keep costs manageable for+the eldercare sector by footing high land and building costs of residential+nursing homes and then offering concessions through competitive bids for+operators. Eligible seniors are means tested and substantial subsidies of up+to 80 percent of monthly fees are extended."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|5655410587404d1a8412a9fc74acd655+"to 80 percent of monthly fees are extended.+Widening coverage to become truly universal has been a highlight of+the last decade. In 2015, MediShield was replaced by MediShield Life, a+more comprehensive and universal health insurance scheme that extended+coverage to all Singaporeans, including those with pre-existing conditions+and older individuals who were previously excluded or had difficulty+obtaining coverage. All citizens and permanent residents were automatically+enrolled in the scheme with lifetime coverage. Whilst MediShield Life helps"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|47a256fcc0844063998f9a4ffb3f1c94+"66Accelerating Global Health: Pathways to Health Equity for the G20+67to pay for large hospital bills and selected costly outpatient treatments such+as dialysis and chemotherapy, Singaporeans also have access to CareShield+Life, which is a long-term insurance targeted at severe disability, providing+cash payouts for long-term care costs for life (and applicable towards+nursing home fees). Both MediShield and CareShield premiums can be paid+using Medisave, with needier beneficiaries able to benefit from top-ups by+family members or occasionally, one-off government disbursements.+Prudent and rational use of limited funds is a priority in Singapore,+especially with increased investment. The visible, frontline expansion of+services aside, the Ministry of Health has also been actively shoring up+decision-making and support services for better health economics. The+Agency for Care Effectiveness (ACE) was set up in 2015—subsuming the"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|bab2aa6e0ee048878763f123e2e739d0+"prior Pharmacoeconomic and Drug Utilization Unit (PEDU)—as an expanded+health technology assessment (HTA) unit to support the MOH’s Drug+Advisory Committee in making evidence-based recommendations for the+public funding of drugs. Standardised HTA methods and processes have+been developed in line with international best practices and since ACE’s+establishment, subsidised medications are provided earlier within a drug’s+life cycle and value-based pricing has led to more cost-effective prices+being negotiated with pharma.14 However, bandwidth limitations and lack of+skilled HTA practitioners impact ACE’s capacity to achieve greater impact.+The cost positioning for Singapore was further improved when the public+healthcare clusters banded together in 2018 to centralise procurement+through the setting up of ALPS Healthcare. Touted as a supply chain+partner, ALPS consolidates, negotiates and manages logistics for supplies"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|325c82ae1f6d45ca8776fccb347158ae+"for all public healthcare players—from primary to quarternary care and+including the eldercare sector. ALPS’s coverage goes beyond pharmaceuticals+to include consumables and even support services such as housekeeping+and laundry. This is especially important given the small size of the+domestic Singapore market and consolidation improves efficiency and more+cost-effective procurement.+Despite these cost-saving measures, Singapore has not escaped the+worldwide dilemma of rising healthcare costs. ‘Healthier SG’, set to+go live in July 2023, advocates the signing up of every citizen with"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|33c4a060e2b843fcb72a5289bfa5d04a+"67The Role of Health Finance in G20 Countries a dedicated GP/family physician. The GP then serves as continuing and+continuous partner in managing each individual’s healthcare needs more+holistically—from simple needs to acute referrals to chronic diseases. The+focus will progressively shift from a hospital-centric healthcare system+to a preventive model and right-siting care to the most appropriate (and+cost-effective) modalities, which translates to more care within community+settings and providing care that is most appropriate for the individual and+not necessarily just what is most advanced medically.+As this article highlights the examples of Indonesia and Singapore, broad+themes emerge in the approaches used in achieving universal health+care. Expanding financial coverage is critical and with this, widening+service accessibility, especially in primary care and judicious purchasing+and effective procurement. Implementation is paramount and there is"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|a4172b8d44d642dd8993e93089d0e52f+"opportunity here for countries to learn and work better together.+Particularly in Southeast Asia, where government procurement is+significant and yet not entirely efficient, the region lacks cross-country+learning opportunities. In the vein of RESYST (Resilient and Responsive+Health Systems) and SPARC (Strategic Purchasing for Africa Resource+Centre), international consortia focused on strategic purchasing, the+South East Asia Regional Collaborative for Health (SEARCH)15 hosted+by the National University of Singapore aims to review existing health+purchasing mechanisms of all ASEAN countries and provide national and+regional-level policy recommendations. This will be a meaningful step to+educate policymakers and help countries overcome roadblocks to strategic+purchasing.+Beyond risk pooling, pricing and procurement, more efforts can be poured+into strengthening primary care provision; there are additional opportunities"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|1324e2bb4f5742cab74473e14d467926+"from technology and digital modalities. Telehealth and insurtech, if devised+and regulated appropriately, could allow the next step-change in improving+access to healthcare, both within a dense urban city state like Singapore+or a dispersed island nation such as Indonesia. The COVID-19 pandemic+has shown the need and case for such services, and particularly for a+developing nation like Indonesia, the vast proliferation of mobile services+could pave the way for micro-insurance and insurtech to further improve+affordability of healthcare services."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|76280917c6254c15b067914f14125841+"68Accelerating Global Health: Pathways to Health Equity for the G20+69The journey to UHC and improving health equity is an ongoing endeavour.+While G20 countries have made remarkable progress in improving human+health and increasing healthcare spending, more can be done to ensure+access to affordable healthcare for all. By prioritising health equity and+implementing innovative approaches to health finance, G20 countries can+accelerate progress in transforming public health systems. It is hoped that+some of the learnings shared in this chapter may inform and support+continued commitment to addressing the complex and interconnected public+health challenges faced by societies worldwide.+Associate Professor J e r e m y L i m , MBBS, MPH, is director of global health at the National+University of Singapore’s Saw Swee Hock School of Public Health.+Janice Tan is an experienced healthcare management executive who holds a wealth"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|9|4dbae5e4a3ee45bdbf9d55dec8921c2c+"of experience spanning diverse landscapes, including both public and private sector+hospitals as well as nursing homes, across both Singapore and Malaysia."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|9|2f3c4ce941c14624bfbd3da82ff8def7diff --git a/data_output/OrfPathHealth/concepts.csv b/data_output/OrfPathHealth/concepts.csvnew file mode 100644index 0000000..30a6c7b--- /dev/null+++ b/data_output/OrfPathHealth/concepts.csv@@ -0,0 +1,1537 @@+entity|importance|category|chunk_id|type+Mental Health|5|concept|83d4d0367bb0467e811782a4ada3bbb9|concept+Health Equity|4|concept|83d4d0367bb0467e811782a4ada3bbb9|concept+World Health Organization (WHO)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept+United Nations (UN)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept+Sustainable Development Goals (SDGs)|4|document|83d4d0367bb0467e811782a4ada3bbb9|concept+Accelerating Global Health|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Pathways to Health Equity for the G20|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Integrating Mental Health into General Healthcare|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Poverty|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Mental Health|5|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Biological Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Psychological Determinants|4|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Social Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Depression|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Substance Use Disorders|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Behavioural Addictions|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Severe Mental Illness (SMI)|3|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Schizophrenia|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Bipolar Mood Disorder|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+adversity|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+diabetes|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+tuberculosis|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+socioeconomic vulnerability|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+multimorbidity|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+syndemic|4|concept|1f02a81a02054efaacb0ace0c5eadd14|concept+mental health|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+healthcare service delivery|5|event|33e4526e998e4865bd5b0dde036c2a20|concept+healthcare resources|4|object|33e4526e998e4865bd5b0dde036c2a20|concept+disadvantaged populations|3|organisation|33e4526e998e4865bd5b0dde036c2a20|concept+mental illness|4|concept|33e4526e998e4865bd5b0dde036c2a20|concept+World Health Organization (WHO)|4|organisation|33e4526e998e4865bd5b0dde036c2a20|concept+Mental Health as a Pathway to Health Equity|5|concept|b9359fe26659413da22ea47729356210|concept+Investing in mental health|4|event|b9359fe26659413da22ea47729356210|concept+Improving population health|3|concept|b9359fe26659413da22ea47729356210|concept+Social inequality|3|condition|b9359fe26659413da22ea47729356210|concept+Human rights|2|concept|b9359fe26659413da22ea47729356210|concept+Economic efficiency|3|concept|b9359fe26659413da22ea47729356210|concept+Global economic loss due to mental disorders|2|misc|b9359fe26659413da22ea47729356210|concept+Investment in treatment of mental illness|3|event|b9359fe26659413da22ea47729356210|concept+Economic productivity gains|2|concept|b9359fe26659413da22ea47729356210|concept+The Burden of Mental Health, Substance Use Disorders and Multimorbidity|3|event|b9359fe26659413da22ea47729356210|concept+Mental and substance-abuse disorders|2|misc|b9359fe26659413da22ea47729356210|concept+Premature morbidity and mortality globally|1|condition|b9359fe26659413da22ea47729356210|concept+National Mental Health Survey (NMHS), 2015-16|1|document|b9359fe26659413da22ea47729356210|concept+India|2|place|b9359fe26659413da22ea47729356210|concept+Disability-Adjusted-Life-Years (DALYs)|5|condition|acf42504124f4b29b4f551d0365821b0|concept+mental disorders|4|concept|acf42504124f4b29b4f551d0365821b0|concept+treatment gap for mental and substance abuse disorders|3|condition|acf42504124f4b29b4f551d0365821b0|concept+out-of-pocket (OOP) spending|2|concept|acf42504124f4b29b4f551d0365821b0|concept+medicines|3|object|acf42504124f4b29b4f551d0365821b0|concept+spending|3|event|5b6399f5e510497481764cd1009caa5c|concept+doctors’ fees and diagnostic charges in OOP expenditure|4|object|5b6399f5e510497481764cd1009caa5c|concept+private healthcare settings|3|place|5b6399f5e510497481764cd1009caa5c|concept+discrimination in the coverage by health insurance toward mental illness|4|misc|5b6399f5e510497481764cd1009caa5c|concept+chances of catastrophic spending|3|event|5b6399f5e510497481764cd1009caa5c|concept+Insurance Regulatory and Development Authority of India (IRDAI)|2|organisation|5b6399f5e510497481764cd1009caa5c|concept+mental illnesses|3|misc|5b6399f5e510497481764cd1009caa5c|concept+Accelerating Global Health|5|event|b123ca85f1a04a5294b943d121e5c61b|concept+Pathways to Health Equity for the G20|4|event|b123ca85f1a04a5294b943d121e5c61b|concept+Mental Health Care Act, 2017|3|document|b123ca85f1a04a5294b943d121e5c61b|concept+reported violations|2|event|b123ca85f1a04a5294b943d121e5c61b|concept+rejections of claims for mental illness by insurance companies|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+discriminatory ceilings on the sum of reimbursement for mental illness|2|event|b123ca85f1a04a5294b943d121e5c61b|concept+people with serious mental illness (SMI)|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept+shortened life expectancy|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+multimorbidity|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept+non-communicable diseases (NCDs)|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+tobacco and alcohol use|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+physical inactivity|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+poor diets|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+national programs to address chronic conditions|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+chronic conditions|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+poor horizontal integration across the programmes|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+homeless persons|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+women|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+persons with developmental disorders|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+mental health equity|5|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+social inequality|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+gender issues|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+community participation|3|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+National Program for Mental Health (NMHP)|5|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+District Mental Health Program (DMHP)|4|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+India|5|place|0fd5e7c372a842cc9368e25bf0cb57b4|concept+Asian countries|3|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+National Mental Health Programme – District Mental Health Programme (>700 districts)|4|document|0fd5e7c372a842cc9368e25bf0cb57b4|concept+Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|programme|d1159f0aacce4add93913834766d4b45|concept+Universal Health Coverage|4|concept|d1159f0aacce4add93913834766d4b45|concept+Health and Wellness Centres|4|programme|d1159f0aacce4add93913834766d4b45|concept+National Tele Mental Health Programme (Tele MANAS)|3|programme|d1159f0aacce4add93913834766d4b45|concept+Jan Aushadhi Kendras|4|programme|d1159f0aacce4add93913834766d4b45|concept+National Mental Health Policy (2014)|3|policy|d1159f0aacce4add93913834766d4b45|concept+National Health Policy (2017)|3|policy|d1159f0aacce4add93913834766d4b45|concept+Rights of Persons with Disability Act, 2016|4|legislation|d1159f0aacce4add93913834766d4b45|concept+Mental Health Care Act, 2017|3|legislation|d1159f0aacce4add93913834766d4b45|concept+Accelerating Global Health|5|event|0e19e6305c0049768cd3d005956a6c24|concept+Pathways to Health Equity for the G20|5|event|0e19e6305c0049768cd3d005956a6c24|concept+Psychotropic medications|3|object|0e19e6305c0049768cd3d005956a6c24|concept+Mental Health Policy (2014)|4|document|0e19e6305c0049768cd3d005956a6c24|concept+digital academies at NIMHANS|3|organization|0e19e6305c0049768cd3d005956a6c24|concept+m-Cessation|2|object|0e19e6305c0049768cd3d005956a6c24|concept+tobacco quit-lines|2|organization|0e19e6305c0049768cd3d005956a6c24|concept+National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)|4|event|0e19e6305c0049768cd3d005956a6c24|concept+Tele-MANAS initiative|5|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+World Mental Health Day|3|event|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+tele-mental health services|4|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+remote and underserved areas|3|location|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+Box 2. Technological Initiatives in India for Mental Health|4|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+Telephone/mobile based initiatives|3|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+eSanjeevani|4|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+e-Manas Karnataka|3|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+NIMHANS digital academy|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept+Telemedicine Centre|3|place|14b35b1d32d540e9b9815a325f95911e|concept+NIMHANS|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept+CIP|2|misc|14b35b1d32d540e9b9815a325f95911e|concept+Digital Academy|3|organisation|14b35b1d32d540e9b9815a325f95911e|concept+LGBRIMH Digital Academy|2|misc|14b35b1d32d540e9b9815a325f95911e|concept+NIMHANS ECHO model|3|concept|14b35b1d32d540e9b9815a325f95911e|concept+PGIMER “Tele-enabling model”|3|concept|14b35b1d32d540e9b9815a325f95911e|concept+Chatbots|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Telerehabilitation|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Self-help|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|organisation|5bbe6986777c47ee854e432f79982bc2|concept+Universal Health Care (UHC) in India|4|concept|5bbe6986777c47ee854e432f79982bc2|concept+Secondary and tertiary hospitalisations|3|event|5bbe6986777c47ee854e432f79982bc2|concept+Annual coverage of INR 500,000 per family|2|document|5bbe6986777c47ee854e432f79982bc2|concept+Generic medicines|3|object|5bbe6986777c47ee854e432f79982bc2|concept+Jan Aushadhi Kendras|2|place|5bbe6986777c47ee854e432f79982bc2|concept+Economic burden|3|concept|5bbe6986777c47ee854e432f79982bc2|concept+Poor and marginalised|2|condition|5bbe6986777c47ee854e432f79982bc2|concept+150,000 Health and Wellness Centres (HWC)|3|organisation|5bbe6986777c47ee854e432f79982bc2|concept+Comprehensive services|2|event|5bbe6986777c47ee854e432f79982bc2|concept+Screening and essential mental health|2|event|5bbe6986777c47ee854e432f79982bc2|concept+mental health services|5|concept|2e92547f635f4574ad69394da1fa736d|concept+general health services|3|concept|2e92547f635f4574ad69394da1fa736d|concept+MHCA 2017|4|document|2e92547f635f4574ad69394da1fa736d|concept+parity for mental illness|3|concept|2e92547f635f4574ad69394da1fa736d|concept+physical conditions|3|concept|2e92547f635f4574ad69394da1fa736d|concept+Central and State Mental Health Authorities|4|organisation|2e92547f635f4574ad69394da1fa736d|concept+Mental Health Review Boards|3|organisation|2e92547f635f4574ad69394da1fa736d|concept+persons with mental illness|4|concept|2e92547f635f4574ad69394da1fa736d|concept+family members|3|concept|2e92547f635f4574ad69394da1fa736d|concept+NGOs|4|organisation|2e92547f635f4574ad69394da1fa736d|concept+checks and balances|3|concept|2e92547f635f4574ad69394da1fa736d|concept+delivery of mental healthcare|4|concept|2e92547f635f4574ad69394da1fa736d|concept+mental illness|5|concept|2e92547f635f4574ad69394da1fa736d|concept+health insurance|4|document|2e92547f635f4574ad69394da1fa736d|concept+Accelerating Global Health|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept+Pathways to Health Equity for the G20|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept+Improvements in curative and preventive care domains|4|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Rehabilitative care|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+National Mental Health Policy 2014|4|document|4cd87763e8f84bdc8f0067b2b4dec451|concept+Vulnerable populations|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Children|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Elderly|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Homeless|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Macro-environmental issues|4|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Poverty|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Unemployment|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Displacement|2|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Mental health impact of climate change|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Leadership and governance|3|organisation|4cd87763e8f84bdc8f0067b2b4dec451|concept+World Mental Health Report, 2022|5|document|25ad6848459145afa5072490e52d8550|concept+interrelated services|4|concept|25ad6848459145afa5072490e52d8550|concept+life cycle|3|misc|25ad6848459145afa5072490e52d8550|concept+maternal and child mental health|2|concept|25ad6848459145afa5072490e52d8550|concept+elderly|2|condition|25ad6848459145afa5072490e52d8550|concept+Mental Health|5|concept|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+LMICs|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Health Equity Assessment Toolkit (HEAT and HEAT Plus)|3|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+High-Income Countries|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+United Kingdom (UK)|3|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+National Health Service (NHS)|2|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Five-Year Forward View for Mental Health|3|document|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Public Health Domain|3|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Disparity Interventions|2|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Inequality|4|condition|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+private healthcare providers|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+non-communicable diseases|4|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+chronic communicable diseases|3|condition|d7a98a5523a14a81b33b3cadbeef1397|concept+Tuberculosis|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+multimorbidity|4|condition|d7a98a5523a14a81b33b3cadbeef1397|concept+National Programmes|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+non-communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+chronic communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+National Mission for Health and Family Welfare (NMHP)|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+primary care level|3|object|d7a98a5523a14a81b33b3cadbeef1397|concept+HWC (Health and Wellness Centers)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+PM-JAY (Prime Minister's Jan Arogya Yojana)|4|object|d7a98a5523a14a81b33b3cadbeef1397|concept+patient reported outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+clinical outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+self-management interventions|2|object|d7a98a5523a14a81b33b3cadbeef1397|concept+peer-based interventions|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+HICs (High Income Countries)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+Accelerating Global Health: Pathways to Health Equity for the G20|5|event|644bde3f851d4926ba9d1fa8b25b904b|concept+cultural settings of LMICs|4|place|644bde3f851d4926ba9d1fa8b25b904b|concept+brief psychological interventions|3|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+lay counsellors|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+moderate to severe depressive disorders and harmful drinking|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+health systems in HICs|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+long waiting periods for psychological intervention|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+low-intensity interventions|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+Problem Management plus (PM+)|3|document|644bde3f851d4926ba9d1fa8b25b904b|concept+adults in distress due to exposure to adversity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+family caregivers|3|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+mental health|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+indigenous interventions|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept+Yoga|4|object|644bde3f851d4926ba9d1fa8b25b904b|concept+alternative forms of medicine|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept+multimorbidity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+evidence-based integration|5|concept|78487c391631417992f97fcd77f0ba19|concept+public health system|4|place|78487c391631417992f97fcd77f0ba19|concept+cultural acceptance|3|condition|78487c391631417992f97fcd77f0ba19|concept+Tele-MANAS programme|4|organisation|78487c391631417992f97fcd77f0ba19|concept+digital literacy|3|condition|78487c391631417992f97fcd77f0ba19|concept+primary healthcare|4|place|78487c391631417992f97fcd77f0ba19|concept+Universal Health Coverage (UHC)|3|concept|78487c391631417992f97fcd77f0ba19|concept+referral pathways|2|misc|78487c391631417992f97fcd77f0ba19|concept+mental care|3|concept|78487c391631417992f97fcd77f0ba19|concept+physical care|2|misc|78487c391631417992f97fcd77f0ba19|concept+robust information systems|3|condition|78487c391631417992f97fcd77f0ba19|concept+mental and physical care integration|2|misc|78487c391631417992f97fcd77f0ba19|concept+equitable and quality healthcare|4|concept|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Pratima Murthy|3|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Director and Senior Professor of Psychiatry|2|position|996585f3b2fe4afe9aad026a32d48fe9|concept+NIMHANS, Bengaluru|3|organisation|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Krishna Prasad Muliyala|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Additional Professor of Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Channaveerachari Naveen Kumar|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Professor of Psychiatry and Head of Community Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept+COVID-19 pandemic|5|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+lockdown|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+global economy|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+novel coronavirus|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+disease|3|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+zoonotic virus|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+Public Health Emergency of International Concern|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+low-income countries|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+vaccines and drugs|3|object|8bf2b50e94df47b392aa512dbb2e74c1|concept+bird and animal viruses|5|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+infectious disease|4|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+epidemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept+pandemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept+prevent|2|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+Barbara Stocking|1|person|03a06fd2936d41afa48ec291c8bcbda8|concept+The Urgent Need for a Pandemic Accord|2|document|03a06fd2936d41afa48ec291c8bcbda8|concept+Accelerating Global Health: Pathways to Health Equity for the G20|4|event|40998ca4b2594430b3f1f64aadfec89b|concept+COVID-19|5|event|40998ca4b2594430b3f1f64aadfec89b|concept+Healthcare systems|3|object|40998ca4b2594430b3f1f64aadfec89b|concept+Simulation exercises|2|event|40998ca4b2594430b3f1f64aadfec89b|concept+Public health system|3|object|40998ca4b2594430b3f1f64aadfec89b|concept+Lockdown|4|event|40998ca4b2594430b3f1f64aadfec89b|concept+Livelihoods and economy|3|condition|40998ca4b2594430b3f1f64aadfec89b|concept+Trade|2|event|40998ca4b2594430b3f1f64aadfec89b|concept+Social services (education)|2|object|40998ca4b2594430b3f1f64aadfec89b|concept+wait and see approach|2|concept|546a91dcc37740dfb8597967e1999249|concept+February 2020|3|event|546a91dcc37740dfb8597967e1999249|concept+International Health Regulations (IHR)|4|document|546a91dcc37740dfb8597967e1999249|concept+World Health Organization (WHO)|3|organisation|546a91dcc37740dfb8597967e1999249|concept+inequities between countries and population groups|4|concept|546a91dcc37740dfb8597967e1999249|concept+access to vaccines and drugs|3|concept|546a91dcc37740dfb8597967e1999249|concept+pandemic treaty|4|concept|546a91dcc37740dfb8597967e1999249|concept+World Health Assembly (WHA)|3|organisation|546a91dcc37740dfb8597967e1999249|concept+Pandemic Accord|5|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept+WHO's 194 member states|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+Intergovernmental Negotiating Body (INB)|2|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+World Health Assembly (WHA)|4|event|8a0b9edbbadd44c4babe8192a73bc83d|concept+Working Group on amendments to the IHR (WGIHR)|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+International Health Regulations (IHR)|4|document|8a0b9edbbadd44c4babe8192a73bc83d|concept+One Health|2|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept+Equity in access to drugs and vaccines|3|condition|8a0b9edbbadd44c4babe8192a73bc83d|concept+WGIHR|4|organisation|b666ff6d8d3445a98869212995fcb597|concept+Pandemic Accord|4|document|b666ff6d8d3445a98869212995fcb597|concept+IHR|5|organisation|b666ff6d8d3445a98869212995fcb597|concept+One Health|3|concept|b666ff6d8d3445a98869212995fcb597|concept+Accelerating Global Health: Pathways to Health Equity for the G20|4|event|6e54c98b3b944682acb35e1bfe531831|concept+Solidarity|3|concept|6e54c98b3b944682acb35e1bfe531831|concept+United Nations Charter|2|document|6e54c98b3b944682acb35e1bfe531831|concept+vaccines, diagnostics and treatments|3|object|6e54c98b3b944682acb35e1bfe531831|concept+financing for these resources|2|condition|6e54c98b3b944682acb35e1bfe531831|concept+equity in governance systems|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+financing for preparedness and response to pandemics|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+donors|2|organisation|9ccb6cad21444a27b7970917ba7e6c8b|concept+equity|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+fairness|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+capabilities of countries|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+poorer countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+developed ones|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+transparency of data and genomic sequencing|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+quickly and effectively responding to the pandemic|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+development of new drugs and vaccines|2|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+trust within and between countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+accountability requirements|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+past Accord|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+Pandemic Accord|4|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept+IHR|3|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept+civil society organisations|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept+parliamentary systems|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept+zero draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept+first draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept+Accord|5|event|bc526127448645b3837dcc3b45668a83|concept+Human Rights Protection|4|concept|bc526127448645b3837dcc3b45668a83|concept+Public Health and Healthcare Systems|3|object|bc526127448645b3837dcc3b45668a83|concept+Staff Protection|4|misc|bc526127448645b3837dcc3b45668a83|concept+Misinformation Management|3|event|bc526127448645b3837dcc3b45668a83|concept+Whole-of-Society Approach|4|concept|bc526127448645b3837dcc3b45668a83|concept+Global Coordination|3|event|bc526127448645b3837dcc3b45668a83|concept+Preparedness Plans|4|event|bc526127448645b3837dcc3b45668a83|concept+Simulation Exercises|3|event|bc526127448645b3837dcc3b45668a83|concept+Universal Health and Preparedness Review|4|document|bc526127448645b3837dcc3b45668a83|concept+plans|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+independent assessment|2|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+public health response|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+IHR|2|organisation|5e2a17a4edaa487290ad2532cd863fd8|concept+Accelerating Global Health|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept+Pathways to Health Equity for the G20|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept+one health|4|concept|83977ec929b94ecc86a6c51a35fa39cf|concept+zoonoses|3|condition|83977ec929b94ecc86a6c51a35fa39cf|concept+wet markets|2|place|83977ec929b94ecc86a6c51a35fa39cf|concept+Joint Plan of Action|3|document|83977ec929b94ecc86a6c51a35fa39cf|concept+equity|4|condition|83977ec929b94ecc86a6c51a35fa39cf|concept+access to vaccines, drugs, and other medical equipment|5|event|c4ed77f811a94b6b8d85279085b53df5|concept+ Member states|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept+differences among them|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept+Developing countries|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept+wider spread of manufacturing|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+Success in getting mRNA vaccine manufacturing underway in South Africa|4|event|c4ed77f811a94b6b8d85279085b53df5|concept+manufacturing for the whole continent and globally|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+financial investment|4|condition|c4ed77f811a94b6b8d85279085b53df5|concept+technology transfer|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+pharmaceutical industry|4|organisation|c4ed77f811a94b6b8d85279085b53df5|concept+technology transfer and the associated question of intellectual property rights|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept+wealthier governments funding R&D|4|event|c4ed77f811a94b6b8d85279085b53df5|concept+companies earmark a percentage of vaccines for the poorer countries or sell to them at cost|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+pharmaceutical industry|4|organisation|1a4820465fa844f8901275aa62a66e82|concept+infectious diseases|3|condition|1a4820465fa844f8901275aa62a66e82|concept+Pandemic Accord|5|concept|abe8dec679a3446db21c31d36bcd3b12|concept+World Trade Organization|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+TRIPS waiver|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+Doha Trade Round|3|event|abe8dec679a3446db21c31d36bcd3b12|concept+equity of access|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+Pandemic Accord and the IHR|3|misc|abe8dec679a3446db21c31d36bcd3b12|concept+financing|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+G20 Independent High-Level Panel|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+annual financing need for future preparedness and response to pandemics|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+PPR|2|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+health systems|4|concept|c410a5c9df2e4df2998153d58af3836c|concept+R&D|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+overall preparedness|4|concept|c410a5c9df2e4df2998153d58af3836c|concept+G20 report|3|document|c410a5c9df2e4df2998153d58af3836c|concept+Pandemic Fund at the World Bank|4|organisation|c410a5c9df2e4df2998153d58af3836c|concept+IHR|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+Accountability|4|misc|c410a5c9df2e4df2998153d58af3836c|concept+Accord|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+external accountability mechanisms|4|misc|c410a5c9df2e4df2998153d58af3836c|concept+independent assessment of countries|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+Accord|4|event|c134e5a2812f44f9803c15d7591765a0|concept+WHO|3|organisation|c134e5a2812f44f9803c15d7591765a0|concept+Accord|4|event|42c1df8501c946858051c31ad52c5ec5|concept+IHR|3|concept|42c1df8501c946858051c31ad52c5ec5|concept+WHO|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept+International Atomic Energy Agency (IAEA)|3|organisation|42c1df8501c946858051c31ad52c5ec5|concept+public space|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+independent assessment body|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept+monitoring information|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+pandemics|4|event|42c1df8501c946858051c31ad52c5ec5|concept+governments|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+Global Public Health Convention|5|event|d4d6f26b296047fabb3e74cec31ebc41|concept+countries across the world|4|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept+resources to deliver|3|condition|d4d6f26b296047fabb3e74cec31ebc41|concept+Dame Barbara Stocking|4|person|d4d6f26b296047fabb3e74cec31ebc41|concept+Panel for a Global Public Health Convention|3|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept+investments in future|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Ensuring Equitable Supply and Access|2|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Critical Vaccines|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Pandemics|4|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+COV AX Aurélia Nguyen|2|misc|f21a0cbf122d44f599f9b52ccec5f521|concept+pandemic|5|event|7aa69007cfd442f9822d3663a6c4c65a|concept+health systems|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept+COVAX Facility|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Access to COVID-19 Tools Accelerator (ACT-A)|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept+COVAX|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|2|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+World Health Organization (WHO)|4|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+United Nations Children’s Fund (UNICEF)|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Gavi, the Vaccine Alliance|5|organisation|3c76d07238434794b3a491927cbf70e4|concept+COVAX AMC|4|organisation|3c76d07238434794b3a491927cbf70e4|concept+Imperial College London|3|organisation|3c76d07238434794b3a491927cbf70e4|concept+COVID-19 vaccinations|4|concept|3c76d07238434794b3a491927cbf70e4|concept+conditions|3|condition|3c76d07238434794b3a491927cbf70e4|concept+pandemic|4|concept|3c76d07238434794b3a491927cbf70e4|concept+Accelerating Global Health|3|event|80889f7b0eaa4090934f8879b238d535|concept+Pathways to Health Equity for the G20|4|concept|80889f7b0eaa4090934f8879b238d535|concept+procurement, distribution, administration of COVID-19 vaccines|5|misc|80889f7b0eaa4090934f8879b238d535|concept+COVID-19|4|event|80889f7b0eaa4090934f8879b238d535|concept+COVAX|3|organisation|80889f7b0eaa4090934f8879b238d535|concept+vaccine makers|4|organisation|80889f7b0eaa4090934f8879b238d535|concept+bilateral customers|3|misc|80889f7b0eaa4090934f8879b238d535|concept+vaccine candidates|5|concept|4d3ad7c8415c4169b650d2f3754e263d|concept+COVAX|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+export bans|3|misc|4d3ad7c8415c4169b650d2f3754e263d|concept+global health agencies|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+COVAX Facility|3|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+recommendations|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+supply|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+demand|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+R&D|5|concept|895f9a65a28c496595bb295596c4fdd1|concept+manufacturing|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+country-level challenges|5|misc|895f9a65a28c496595bb295596c4fdd1|concept+other factors|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+at-risk investments|5|misc|895f9a65a28c496595bb295596c4fdd1|concept+funding|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+vaccines|5|object|895f9a65a28c496595bb295596c4fdd1|concept+R&D stage|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+COVAX|4|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+pandemic vaccine pool (PVP)|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+lower-income countries|2|place|19c06e9b16344d5f98aae0410d469d9c|concept+vaccine candidates|3|misc|19c06e9b16344d5f98aae0410d469d9c|concept+COVID-19|4|event|19c06e9b16344d5f98aae0410d469d9c|concept+multinational trade-facilitation measures|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+life-saving equipment|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+health emergencies|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept+exemptions and waivers|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+trade barriers|3|condition|f85f8a3779d1458a97ac8d5f13f782d0|concept+life-saving medical countermeasures and materials|4|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+low- and middle-income countries|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept+humanitarian situations|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept+vaccines|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+vaccinations|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+strong, reliable health systems|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+early R&D|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+scaling-up manufacturing|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+securing deals|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+consistent policy guidance|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+operational, logistical, regulatory, and legal frameworks|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+ancillary supplies|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+cold chain|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+safe injection equipment|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+international freight and logistics|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept+in-country delivery requirements|5|event|7b0a4ad9437f45829cb41258f4f78a71|concept+personal protective equipment for healthcare workers|4|object|7b0a4ad9437f45829cb41258f4f78a71|concept+countries lacking infrastructure|3|condition|7b0a4ad9437f45829cb41258f4f78a71|concept+Gavi and WHO|4|organisation|7b0a4ad9437f45829cb41258f4f78a71|concept+Accelerating Global Health|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept+Pathways to Health Equity for the G20|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept+cold chains|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept+immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept+Gavi|3|organisation|4b38bb5b7e7343dc87ddf380cad54595|concept+lower-income countries' routine immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept+COVID-19 vaccines|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept+extra burden of delivering COVID-19 vaccines to other populations|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+efforts to vaccinate mostly children|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+relatively little decline in routine immunisation|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+vaccinators, doctors and nurses were burned out|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+immunisation in Gavi-implementing countries|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+COVID-19|5|event|c34ec7b0256847df9acfe84b02149252|concept+Health system strengthening investments|4|concept|c34ec7b0256847df9acfe84b02149252|concept+Primary healthcare services|3|concept|c34ec7b0256847df9acfe84b02149252|concept+Cold chain|2|object|c34ec7b0256847df9acfe84b02149252|concept+Vaccine track-and-trace|3|concept|c34ec7b0256847df9acfe84b02149252|concept+Human resources|2|object|c34ec7b0256847df9acfe84b02149252|concept+Data monitoring systems|3|concept|c34ec7b0256847df9acfe84b02149252|concept+COVID-19 vaccine Delivery Support (CDS)|4|organisation|c34ec7b0256847df9acfe84b02149252|concept+Gavi|3|organisation|c34ec7b0256847df9acfe84b02149252|concept+COVAX|5|organisation|0e304bf478d4428e929abad5c796e272|concept+Gavi-implementing countries|4|place|0e304bf478d4428e929abad5c796e272|concept+routine immunisation|3|concept|0e304bf478d4428e929abad5c796e272|concept+COVID-19 vaccine coverage|4|condition|0e304bf478d4428e929abad5c796e272|concept+pandemic preparedness|3|concept|0e304bf478d4428e929abad5c796e272|concept+most vulnerable people|4|misc|0e304bf478d4428e929abad5c796e272|concept+equitable supply of vaccines|3|concept|0e304bf478d4428e929abad5c796e272|concept+vaccine nationalism|5|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+hoarding|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+export bans|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX Facility|5|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept+H1N1 pandemic|4|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept+vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept+lower-income economies|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+wealthier nations|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVID-19 vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept+vaccine-candidates|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+technology platforms|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+regulatory approval|3|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept+large-scale investments|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX portfolio|4|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept+191 countries|2|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX|5|organisation|55b09ec3abaf48e98355f0d359b46caf|concept+finite supply of vaccine doses|3|condition|55b09ec3abaf48e98355f0d359b46caf|concept+H1N1 vaccine|2|concept|55b09ec3abaf48e98355f0d359b46caf|concept+Accelerating Global Health|4|event|d4a21a81d74e413ba4d349be59d06804|concept+Pathways to Health Equity for the G20|3|event|d4a21a81d74e413ba4d349be59d06804|concept+COVID-19 pandemic|5|event|d4a21a81d74e413ba4d349be59d06804|concept+vaccine manufacturing|4|object|d4a21a81d74e413ba4d349be59d06804|concept+African continent|2|place|d4a21a81d74e413ba4d349be59d06804|concept+Africa Center for Disease Control|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+Memorandum of Understanding|3|event|d4a21a81d74e413ba4d349be59d06804|concept+Gavi|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+African Union Commission|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+sustainable regional vaccine manufacturing|4|event|d07c2d94246f4df795c7be6170d78db1|concept+commitments to increase political, financial, and technical investments in immunisation programmes|4|event|d07c2d94246f4df795c7be6170d78db1|concept+models for ensuring lower-income countries receive vaccine doses|3|event|d07c2d94246f4df795c7be6170d78db1|concept+manufacturers' transparency about their order books|4|event|d07c2d94246f4df795c7be6170d78db1|concept+supply inequities among countries|3|condition|d07c2d94246f4df795c7be6170d78db1|concept+contingent financing for pandemic response|4|event|d07c2d94246f4df795c7be6170d78db1|concept+COVAX AMC funding|3|document|d07c2d94246f4df795c7be6170d78db1|concept+PVP funding|3|organisation|d7a7913899f445febee6bff8c39924bc|concept+variant-containing vaccine boosters|4|object|d7a7913899f445febee6bff8c39924bc|concept+2024–25 COVID-19 programme|4|event|d7a7913899f445febee6bff8c39924bc|concept+Gavi board|3|organisation|d7a7913899f445febee6bff8c39924bc|concept+COVAX|5|organisation|54d16e33cfb44174b61da49448891293|concept+Gavi, the Vaccine Alliance|4|organisation|54d16e33cfb44174b61da49448891293|concept+Aurélia Nguyen|3|person|54d16e33cfb44174b61da49448891293|concept+Global Vaccine Library|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept+coronavirus|5|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+spike protein|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept+neutralising antibodies|3|concept|0cd02fb084694bbca463dd2b114f1d48|concept+RSV|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+SARS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+MERS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+security bodies|3|organisation|d7a7df237a9b4336b1e40e727ecdd5c9|concept+smallpox vaccines|4|object|d7a7df237a9b4336b1e40e727ecdd5c9|concept+Mpox|3|concept|d7a7df237a9b4336b1e40e727ecdd5c9|concept+2022 Mpox epidemic|4|event|d7a7df237a9b4336b1e40e727ecdd5c9|concept+Accelerating Global Health|3|event|7a57613761f64fe58fbc8709d4670828|concept+Pathways to Health Equity for the G20|3|event|7a57613761f64fe58fbc8709d4670828|concept+Viral Threats|3|concept|7a57613761f64fe58fbc8709d4670828|concept+Infectious Pathogens|4|concept|7a57613761f64fe58fbc8709d4670828|concept+Containment Race|3|event|7a57613761f64fe58fbc8709d4670828|concept+Pandemic Control|4|concept|7a57613761f64fe58fbc8709d4670828|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|3|organisation|7a57613761f64fe58fbc8709d4670828|concept+One World Vaccine Library|4|document|7a57613761f64fe58fbc8709d4670828|concept+global community|5|organisation|58efa624d5c4493eb9e220aab122325c|concept+health security|4|concept|58efa624d5c4493eb9e220aab122325c|concept+pandemic threats|3|event|58efa624d5c4493eb9e220aab122325c|concept+vaccines|4|object|58efa624d5c4493eb9e220aab122325c|concept+dangerous and deadly outbreaks|2|event|58efa624d5c4493eb9e220aab122325c|concept+incipient pandemic|3|event|58efa624d5c4493eb9e220aab122325c|concept+potential opponents|2|concept|58efa624d5c4493eb9e220aab122325c|concept+viruses from around 25 viral families|3|organisation|58efa624d5c4493eb9e220aab122325c|concept+One World Vaccine Library|3|misc|dc468156950d4a4d8a8878e75499afa3|concept+viral-family-based prototype vaccine approach|4|concept|dc468156950d4a4d8a8878e75499afa3|concept+Accelerating Global Health|5|event|0b579a5b26e9407a902cb29529089cee|concept+Pathways to Health Equity for the G20|4|event|0b579a5b26e9407a902cb29529089cee|concept+novel paramyxovirus|3|concept|0b579a5b26e9407a902cb29529089cee|concept+One World Vaccine Library|5|object|0b579a5b26e9407a902cb29529089cee|concept+Develop vaccines|3|event|cc987a2a91d846c5a1d952ecc309cc62|concept+Researchers|2|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept+New outbreak and virus|2|event|cc987a2a91d846c5a1d952ecc309cc62|concept+Genome sequencing|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+One World Vaccine Library|4|object|cc987a2a91d846c5a1d952ecc309cc62|concept+CEPI|3|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept+Virus families|2|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+Disease X|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+Vaccine library candidates|3|object|cc987a2a91d846c5a1d952ecc309cc62|concept+clinical testing|4|event|f82e8abf722e423ba48ded1798296b13|concept+safety|3|condition|f82e8abf722e423ba48ded1798296b13|concept+immunogenicity|4|concept|f82e8abf722e423ba48ded1798296b13|concept+platform|3|object|f82e8abf722e423ba48ded1798296b13|concept+antigens|2|object|f82e8abf722e423ba48ded1798296b13|concept+lead candidates|4|organisation|f82e8abf722e423ba48ded1798296b13|concept+families|3|misc|f82e8abf722e423ba48ded1798296b13|concept+clinical proof of concept|4|concept|f82e8abf722e423ba48ded1798296b13|concept+One World Vaccine Library|5|object|8cb3bc020aed4d0a86a05c1f658e2708|concept+100 Days Mission|4|event|8cb3bc020aed4d0a86a05c1f658e2708|concept+CEPI's 100 Days Mission|3|concept|8cb3bc020aed4d0a86a05c1f658e2708|concept+G7 and the G20|3|organisation|8cb3bc020aed4d0a86a05c1f658e2708|concept+Disease X pandemic virus|4|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept+new vaccines|3|object|8cb3bc020aed4d0a86a05c1f658e2708|concept+improved surveillance|2|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept+non-pharmaceutical interventions|3|misc|8cb3bc020aed4d0a86a05c1f658e2708|concept+One World Vaccine Library|5|concept|f5b55f34587246179c6c6d2bc0801141|concept+virus families|4|concept|f5b55f34587246179c6c6d2bc0801141|concept+pandemics|3|concept|f5b55f34587246179c6c6d2bc0801141|concept+100 Days Mission|2|event|f5b55f34587246179c6c6d2bc0801141|concept+pandemics|5|event|4160fb9924f24b5eb68e493cd9361060|concept+Dr. Richard Hatchett|4|person|4160fb9924f24b5eb68e493cd9361060|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|5|organisation|4160fb9924f24b5eb68e493cd9361060|concept+Kate Kelland|3|person|4160fb9924f24b5eb68e493cd9361060|concept+Public Health Workforce|5|concept|732fe967002642599669103e63f2f22a|concept+COVID-19 pandemic|4|event|732fe967002642599669103e63f2f22a|concept+Public Health System|3|object|732fe967002642599669103e63f2f22a|concept+Essential health services|2|object|732fe967002642599669103e63f2f22a|concept+Routine immunisation|1|object|732fe967002642599669103e63f2f22a|concept+Disease outbreaks|2|event|732fe967002642599669103e63f2f22a|concept+limited availability of the health workforce|5|event|3dcdf4837b764370bb2cf1e2776825cc|concept+COVID-19 infections and deaths among health workers|4|event|3dcdf4837b764370bb2cf1e2776825cc|concept+mental health issues, including burnout|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+poor working conditions|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+protracted conflicts|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept+global increase in climate-related and humanitarian disasters|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept+public health crisis|3|event|3dcdf4837b764370bb2cf1e2776825cc|concept+reversals in life expectancy and Sustainable Development Goals|2|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+Investing in the Public Health Workforce|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept+Essential Public Health Functiona (EPHF)|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept+Global investment|5|misc|c9d7fdd45c4e4061ac050c6a21b2f583|concept+G7 and G20 intergovernmental processes|4|event|c9d7fdd45c4e4061ac050c6a21b2f583|concept+World Health Organization (WHO)|5|organization|c9d7fdd45c4e4061ac050c6a21b2f583|concept+regional, and global bodies|5|organisation|525f8e57fb164f289fed4c4155309473|concept+G20|4|organisation|525f8e57fb164f289fed4c4155309473|concept+G7|4|organisation|525f8e57fb164f289fed4c4155309473|concept+COVID-19 pandemic|3|event|525f8e57fb164f289fed4c4155309473|concept+EPHFs (Emergency Public Health Functions)|2|concept|525f8e57fb164f289fed4c4155309473|concept+World Federation of Public Health Associations (WFPHA), International|2|organisation|525f8e57fb164f289fed4c4155309473|concept+Association of National Public Health Institutions (IANPHI)|4|organisation|99d0ffec664a4147b99327b232eec755|concept+Global Network Academic Schools of Public Health (GNASPH).|3|organisation|99d0ffec664a4147b99327b232eec755|concept+Global Health Summit|5|event|2106f61eb09845f7855d15da890e67ae|concept+Rome Declaration|4|document|2106f61eb09845f7855d15da890e67ae|concept+G20 Italia Declaration of Health Ministers|3|document|2106f61eb09845f7855d15da890e67ae|concept+health workforce|5|misc|5837ba13e7f942cf8b17ebfcaef29429|concept+COVID-19|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept+G7 Summit|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept+Carbis Bay Health Declaration|3|document|5837ba13e7f942cf8b17ebfcaef29429|concept+G7 Germany|2|event|5837ba13e7f942cf8b17ebfcaef29429|concept+pandemic preparedness and response|4|concept|1ef5b0e99e864a539d6ef6e41039de13|concept+G7 Pact for Pandemic Readiness|3|organisation|1ef5b0e99e864a539d6ef6e41039de13|concept+Berlin|2|place|1ef5b0e99e864a539d6ef6e41039de13|concept+low- and lower-middle income countries (LMICs)|3|concept|1ef5b0e99e864a539d6ef6e41039de13|concept+Public Health Workforce|4|concept|58263ccaef7b48289de7a0d400d6d13d|concept+pandemic preparedness and response|3|concept|58263ccaef7b48289de7a0d400d6d13d|concept+WHO|4|organisation|58263ccaef7b48289de7a0d400d6d13d|concept+Strengthening the Global Architecture for Health Emergency Preparedness and Response (HEPR)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept+G7 Roadmap|2|document|58263ccaef7b48289de7a0d400d6d13d|concept+International Health Regulation (IHR 2005)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept+G7 Pact|2|misc|58263ccaef7b48289de7a0d400d6d13d|concept+Pandemic Fund|3|object|58263ccaef7b48289de7a0d400d6d13d|concept+Impact Investment Initiative for Global Health|3|event|7cb2165fcdc945c6ae0860e59f189275|concept+United Nations' three High-Level Meetings|4|event|7cb2165fcdc945c6ae0860e59f189275|concept+Global South|3|place|7cb2165fcdc945c6ae0860e59f189275|concept+non-communicable and communicable diseases|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept+PPR|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept+Essential health services|3|object|7cb2165fcdc945c6ae0860e59f189275|concept+Public health workforce|4|organisation|7cb2165fcdc945c6ae0860e59f189275|concept+G20 and the G7 processes|3|event|7cb2165fcdc945c6ae0860e59f189275|concept+12 essential public health functions|2|concept|7cb2165fcdc945c6ae0860e59f189275|concept+roadmap|4|plan|c758753adaf94ea9a1978600c51ad623|concept+national public health workforce capacity|5|concept|c758753adaf94ea9a1978600c51ad623|concept+EPHFs|4|event|c758753adaf94ea9a1978600c51ad623|concept+emergency preparedness and response|3|concept|c758753adaf94ea9a1978600c51ad623|concept+public health workforce|4|organisation|c758753adaf94ea9a1978600c51ad623|concept+Public Health Workforce|5|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+occupations outside of the health sector|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+Global partners|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept+roadmap and action plan|4|document|b5e8fd8bf09244c9a74995e5e618f489|concept+standard EPHF|3|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+whole-of-government and whole-of-society approach|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+national stakeholders|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept+existing national and global networks of partners|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+country-based assessment|3|event|b5e8fd8bf09244c9a74995e5e618f489|concept+policy improvement|4|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+workforce capacity and readiness|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+national assessments and benchmarking|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+G20 support to invest in preparedness and national capacity|5|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+World Bank’s Pandemic Fund|4|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+strengthening human resources|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+countries prevent, prepare for, and respond to health emergencies|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+sustainable public health workforce capacity in LMICs|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)|3|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+WHO|3|organisation|503ecc2f98c64e4ba8733349b9834adc|concept+convention, agreement, international instrument|4|event|503ecc2f98c64e4ba8733349b9834adc|concept+PPR (WHO CA+)|3|condition|503ecc2f98c64e4ba8733349b9834adc|concept+International Health Regulation|2|document|503ecc2f98c64e4ba8733349b9834adc|concept+amendments|3|event|503ecc2f98c64e4ba8733349b9834adc|concept+Accelerating Global Health|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Pathways to Health Equity for the G20|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Role of India's G20 Presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+intergovernmental consensus and commitment for public health strengthening|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+public health workforce needs|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+G20 in India|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+SDGs and global health architecture for PPR|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Indian presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+multilateral investment|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+LMICs|3|acronym|0ed58dcdb4a043718b2c6e0652992e78|concept+G20 stakeholders|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+IHR amendments|4|concept|84f7c3515e664f558f550a928bdde5b8|concept+WHO CA+|3|organisation|84f7c3515e664f558f550a928bdde5b8|concept+Geneva|2|place|84f7c3515e664f558f550a928bdde5b8|concept+Public Health Workforce|5|concept|9788f3475aa54d1db48ff648f860e453|concept+Gender Inequality|4|concept|9788f3475aa54d1db48ff648f860e453|concept+Health Sector|3|organisation|9788f3475aa54d1db48ff648f860e453|concept+World Health Organization|4|organisation|9788f3475aa54d1db48ff648f860e453|concept+Public health and emergency workforce roadmap|3|document|9788f3475aa54d1db48ff648f860e453|concept+International Association of National Public Health Institutes (IANPHI)|3|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept+ASPPH|2|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept+Competency based education, Public health and emergency workforce roadmap|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept+emergencies|2|event|9e0d4b33f8d34f858eb42aa765c93415|concept+Public health|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept+One Health|5|concept|c347385c32c941ca9500d586d9b9e88e|concept+World Health Organization|3|organisation|c347385c32c941ca9500d586d9b9e88e|concept+Food and Agriculture Organization|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+United Nations Environment Programme|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+World Organisation for Animal Health|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+One Health|5|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept+pandemic prevention, preparedness, and response|4|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept+domestic health systems|3|object|2dd90976e41d4112a2f6e029eb90b1e3|concept+India|4|place|2dd90976e41d4112a2f6e029eb90b1e3|concept+Multisectoral inclusivity|3|concept|e2379daababe407ba77deb9138fedacf|concept+OH concept|4|concept|e2379daababe407ba77deb9138fedacf|concept+Antimicrobial Resistance (AMR)|5|condition|e2379daababe407ba77deb9138fedacf|concept+Antimicrobial Resistance (AMR)|5|concept|d33d167928ec4c02a898302812a56a09|concept+WHO|4|organisation|d33d167928ec4c02a898302812a56a09|concept+Global Public Health Threats|3|concept|d33d167928ec4c02a898302812a56a09|concept+2050|4|event|d33d167928ec4c02a898302812a56a09|concept+10 million deaths|3|condition|d33d167928ec4c02a898302812a56a09|concept+Global Economy|2|concept|d33d167928ec4c02a898302812a56a09|concept+US$11-444 million|3|misc|d33d167928ec4c02a898302812a56a09|concept+global health system|5|organisation|f5f198d153604bd3a98fa4917c114a0e|concept+drug-resistant Tuberculosis|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept+HIV infections|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept+artemisinin-based combination therapy-resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+antileprotic drug resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+zoonotic diseases|4|event|f5f198d153604bd3a98fa4917c114a0e|concept+pathogens|3|object|f5f198d153604bd3a98fa4917c114a0e|concept+animals|4|misc|f5f198d153604bd3a98fa4917c114a0e|concept+urbanisation|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+destruction of natural habitats|3|event|f5f198d153604bd3a98fa4917c114a0e|concept+illegal trade in wildlife|3|organisation|f5f198d153604bd3a98fa4917c114a0e|concept+wet markets|3|object|f5f198d153604bd3a98fa4917c114a0e|concept+zoonotic disease|5|concept|764f6457770c4826aadcd6d83adba840|concept+SARS|3|event|764f6457770c4826aadcd6d83adba840|concept+MERS|3|event|764f6457770c4826aadcd6d83adba840|concept+Ebola|3|event|764f6457770c4826aadcd6d83adba840|concept+Nipah|3|event|764f6457770c4826aadcd6d83adba840|concept+avian influenza|3|event|764f6457770c4826aadcd6d83adba840|concept+agriculture sector|4|concept|764f6457770c4826aadcd6d83adba840|concept+meat handling|3|event|764f6457770c4826aadcd6d83adba840|concept+eggs|2|object|764f6457770c4826aadcd6d83adba840|concept+dairy products|2|object|764f6457770c4826aadcd6d83adba840|concept+vegetables|2|object|764f6457770c4826aadcd6d83adba840|concept+ecological connectivity|5|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+biodiversity|4|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Global Early Warning and Response System for Major Animal Diseases|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept+zoonoses|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Global Vector Control Response (GVCR) 2017–2030|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept+vector-borne diseases|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Accelerating Global Health|5|event|c0439552464a4e14b6ef0c4b597c1409|concept+Pathways to Health Equity for the G20|5|event|c0439552464a4e14b6ef0c4b597c1409|concept+Water-borne diseases|3|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Drinking or coming in contact with contaminated water|2|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Faecal-contaminated water|2|object|c0439552464a4e14b6ef0c4b597c1409|concept+Two billion people globally|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Cholera, dysentery, typhoid and polio|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Around 485,000 deaths every year|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Food-borne diseases|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Over 200 diseases|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Chemical substances such as unpasteurised (raw) milk|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Undercooked meat or eggs|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Raw fruits and vegetables|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+600 million people are affected by food-borne diseases|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+420,000 die each year|2|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Healthy life years lost|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Access to adequate safe and nutritious food|2|object|c0439552464a4e14b6ef0c4b597c1409|concept+One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept+Operationalising ‘One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept+One Health|5|concept|502eb4a32dcc478381748da0c9bd7614|concept+Memorandum of Understanding (MOU)|4|event|502eb4a32dcc478381748da0c9bd7614|concept+Quadripartite Collaboration for One Health|5|organisation|502eb4a32dcc478381748da0c9bd7614|concept+One Health High-Level Expert Panel|4|misc|502eb4a32dcc478381748da0c9bd7614|concept+One Health Joint Plan of Action (2022-2026)|3|document|502eb4a32dcc478381748da0c9bd7614|concept+World Health Organisation (WHO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept+Food and Agriculture Organisation (FAO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept+United Nations Environment Programme (UNEP)|3|organisation|502eb4a32dcc478381748da0c9bd7614|concept+World Organisation for Animal Health (OIE)|2|organisation|502eb4a32dcc478381748da0c9bd7614|concept+policy actions|3|event|46f7a03700434a8497df7279c7a66991|concept+investment in intersectoral health governance|4|concept|46f7a03700434a8497df7279c7a66991|concept+national OH policies|3|object|46f7a03700434a8497df7279c7a66991|concept+research on OH|4|event|46f7a03700434a8497df7279c7a66991|concept+genomic surveillance and data-sharing practices|3|object|46f7a03700434a8497df7279c7a66991|concept+academic courses on OH|2|event|46f7a03700434a8497df7279c7a66991|concept+One Health|5|concept|51906241584640d99e39f60f1f346d60|concept+pandemic prevention and preparedness|4|concept|51906241584640d99e39f60f1f346d60|concept+World Bank's US$10-billion fund|3|object|51906241584640d99e39f60f1f346d60|concept+UN’s high-level meeting on pandemic prevention, preparedness, and response (September 2023)|4|event|51906241584640d99e39f60f1f346d60|concept+WHO|4|organisation|51906241584640d99e39f60f1f346d60|concept+OH approach|5|concept|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Databases and knowledge-sharing resources|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Best practice examples|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+OH workforce|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Integrated OH surveillance system|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Routine and emergency coordination mechanisms|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Standardised framework for addressing zoonotic spillover risks|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Urbanisation and habitat fragmentation|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Spillover risks and disease spread|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+G20 countries|5|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+G20|5|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept+One Health approach in India|4|concept|e3ed493f83654c1a87d1f5bc648a8325|concept+Office of the Principal Scientific Adviser (PSA)|3|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept+integrated disease surveillance|4|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+environmental surveillance systems|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+robust outbreak investigation mechanisms|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+OH mission|4|event|3abe5438d6c9449f81cb2cb913a89f17|concept+Targeted R&D|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+vaccines, diagnostics, therapeutics, and other prevention tools|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept+data and database integration|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+analytics for better tracking of national-level progress and implementation at the local level|2|misc|3abe5438d6c9449f81cb2cb913a89f17|concept+streamlining regulatory and approval processes|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+One Health Centre|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept+One Health|5|concept|c1f9626d266a4b3d820e6980b6dacc08|concept+zoonoses and transboundary animal diseases|4|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+2008 attempt to operationalise the OH approach for zoonotic disease control and prevention|3|event|c1f9626d266a4b3d820e6980b6dacc08|concept+zonotic policy documents|4|document|c1f9626d266a4b3d820e6980b6dacc08|concept+lack of supportive policies|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+conflicting departmental priorities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+limited institutional capacities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+cross-sectoral collaboration on disease control|2|event|c1f9626d266a4b3d820e6980b6dacc08|concept+contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts|3|concept|c1f9626d266a4b3d820e6980b6dacc08|concept+OH approach|5|concept|a23f8844edf54ac7a6711c6983787cb1|concept+interpersonal relationships|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept+veterinary workforce|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+academic institutions|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+local population|3|misc|a23f8844edf54ac7a6711c6983787cb1|concept+Tamil Nadu Veterinary and Animal Sciences University|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+Tamil Nadu Dr MGR Medical University|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+Punjab|2|place|a23f8844edf54ac7a6711c6983787cb1|concept+SARS-CoV2 vaccine trial|4|event|a23f8844edf54ac7a6711c6983787cb1|concept+outbreak investigation|3|event|a23f8844edf54ac7a6711c6983787cb1|concept+vaccine hesitancy|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept+ASHAs|2|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+preparedness|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+response|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+systems and cross-sectoral capacities|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+inclusive and equitable multi-level workplans and strategies|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+OH principles|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+OH tools, technologies, and practices|3|object|36dd1d845a3147dba0c7891d5d6fb924|concept+data and knowledge|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+Global Health|5|concept|baf822f00df24576a51d07fdc84491e6|concept+Pathways to Health Equity|4|concept|baf822f00df24576a51d07fdc84491e6|concept+G20|3|organisation|baf822f00df24576a51d07fdc84491e6|concept+Infectious diseases|4|concept|baf822f00df24576a51d07fdc84491e6|concept+Surveillance systems|3|object|baf822f00df24576a51d07fdc84491e6|concept+Global collaboration and solidarity|4|concept|baf822f00df24576a51d07fdc84491e6|concept+Nature|2|object|baf822f00df24576a51d07fdc84491e6|concept+Health and well-being for all people everywhere|4|concept|baf822f00df24576a51d07fdc84491e6|concept+MS Swaminathan Research Foundation|2|organisation|baf822f00df24576a51d07fdc84491e6|concept+World Health Organization|3|organisation|baf822f00df24576a51d07fdc84491e6|concept+Dr Soumya Swaminathan|4|person|baf822f00df24576a51d07fdc84491e6|concept+Dr Priyadarshini Rajamani|2|person|baf822f00df24576a51d07fdc84491e6|concept+Accelerating Global Health|5|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Pathways to Health Equity for the G20|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Building a Resilient Digital Health Ecosystem in India|3|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Lav Agarwal|2|person|c0a97f842ce84d1399bb35fcc9ca17a8|concept+technology|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+communication|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+transportation|3|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+healthcare|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+electronic health records|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+artificial intelligence|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+wearable devices|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+health apps|2|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+research|3|concept|00596c043eb84a829a663e034eb52bde|concept+discovering new treatments|4|concept|00596c043eb84a829a663e034eb52bde|concept+improving overall healthcare outcomes|3|concept|00596c043eb84a829a663e034eb52bde|concept+COVID-19 pandemic|4|event|00596c043eb84a829a663e034eb52bde|concept+exponential growth of digital health|3|concept|00596c043eb84a829a663e034eb52bde|concept+India's massive population|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+Digital Health Landscape in India|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept+equitable access to healthcare services|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+technology|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept+digital platforms for care|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+interoperable and standardised electronic health records|3|object|a57747eedbc94f27aeaa023ebf800e32|concept+Electronic Health Record standards|2|document|a57747eedbc94f27aeaa023ebf800e32|concept+National Health Policy|3|document|a57747eedbc94f27aeaa023ebf800e32|concept+India|5|place|1c7917baa4ae4cee997ec26107908884|concept+Digital healthcare|4|concept|1c7917baa4ae4cee997ec26107908884|concept+Hospital Management Information System|3|organisation|1c7917baa4ae4cee997ec26107908884|concept+Online Registration System|2|object|1c7917baa4ae4cee997ec26107908884|concept+National tuberculosis elimination (Ni-kshay)|3|organisation|1c7917baa4ae4cee997ec26107908884|concept+Mother and Child Tracking System|2|object|1c7917baa4ae4cee997ec26107908884|concept+Mera Aspataal (My Hospital)|2|organisation|1c7917baa4ae4cee997ec26107908884|concept+Health Management Information System|3|object|1c7917baa4ae4cee997ec26107908884|concept+Integrated Health Information Platform|2|organisation|1c7917baa4ae4cee997ec26107908884|concept+Non-Communicable Diseases screening application|2|object|1c7917baa4ae4cee997ec26107908884|concept+Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)|4|event|1c7917baa4ae4cee997ec26107908884|concept+health and wellness centers|4|organisation|eba3bd7af89a46a586d2786a9549f23b|concept+preventive care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept+primary care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept+telemedicine consultation services|4|object|eba3bd7af89a46a586d2786a9549f23b|concept+Accelerating Global Health|4|event|ec1766626938432892c24b9acb2ca6ca|concept+Health Equity for the G20|4|event|ec1766626938432892c24b9acb2ca6ca|concept+financial protection of up to INR 500,000 per family annually|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+over 120 million crore poor and vulnerable families|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+Indian population|3|place|ec1766626938432892c24b9acb2ca6ca|concept+wellness-oriented approach|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+universal health coverage (UHC)|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+patient data portability|2|misc|ec1766626938432892c24b9acb2ca6ca|concept+environment where all people can obtain health services|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+rethink the core technology backbone of our system|2|misc|ec1766626938432892c24b9acb2ca6ca|concept+cutting-edge digital solutions|2|concept|ec1766626938432892c24b9acb2ca6ca|concept+converge into|1|misc|ec1766626938432892c24b9acb2ca6ca|concept+Resilient Digital Health Ecosystem|5|event|784ecfb5b0fa4e41a0d142cf69671e30|concept+ABHA numbers|4|document|784ecfb5b0fa4e41a0d142cf69671e30|concept+ABDM ecosystem|4|organisation|784ecfb5b0fa4e41a0d142cf69671e30|concept+healthcare structure|3|condition|784ecfb5b0fa4e41a0d142cf69671e30|concept+COVID-19 pandemic|4|event|784ecfb5b0fa4e41a0d142cf69671e30|concept+activities|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+innovative solutions|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept+continuity of health services|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept+whole of government, whole of society' approach|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+pandemic battle|4|event|c3bf84643ff44d68bf38a16e96fd9e86|concept+subnational and local governments|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+civil society organisations|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+private sector|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+local communities|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+Telemedicine Practice Guidelines|4|document|c3bf84643ff44d68bf38a16e96fd9e86|concept+eSanjeevaniOPD|4|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+world’s largest national telemedicine service|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+online health facilities|4|object|c3bf84643ff44d68bf38a16e96fd9e86|concept+eSanjeevani initiative|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+digital divide|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept+rural areas|2|place|c3bf84643ff44d68bf38a16e96fd9e86|concept+access to healthcare|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept+completed 142 million|2|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+consultations|5|event|00c023acbd1649be8e5673413309c140|concept+record time|4|condition|00c023acbd1649be8e5673413309c140|concept+patients|3|object|00c023acbd1649be8e5673413309c140|concept+27 July 2023|2|misc|00c023acbd1649be8e5673413309c140|concept+abdm.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept+esanjeevani.mohfw.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept+Accelerating Global Health|5|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept+CoWIN|4|organisation|96c919e1d14e4ba9870d0f5015e90f1f|concept+COVID-19 'war rooms'|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept+digital health initiatives|4|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept+COVID-19 India Portal|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept+inventory tracking|4|event|a29a332cd2de4594a574bb57c7d10fd2|concept+Aarogya Setu|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+RT-PCR app|2|object|a29a332cd2de4594a574bb57c7d10fd2|concept+COVID-19 facility app|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+National Public Health Observatory (NPHO)|4|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+Health Emergency Operations Centre (HEOC)|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+overall healthcare service delivery|5|event|c53fa240102b418d96669de0302129ff|concept+integration of healthcare programmes|4|concept|c53fa240102b418d96669de0302129ff|concept+transformation of the healthcare situation in the country|5|event|c53fa240102b418d96669de0302129ff|concept+Resilient Digital Health Ecosystem|5|concept|8368e5f419c943b89a7a33939b57aa87|concept+AI in healthcare|4|event|8368e5f419c943b89a7a33939b57aa87|concept+Centres of Excellence for AI|3|place|8368e5f419c943b89a7a33939b57aa87|concept+Clinical decision support system|2|object|8368e5f419c943b89a7a33939b57aa87|concept+Event-based disease surveillance|2|event|8368e5f419c943b89a7a33939b57aa87|concept+impending disease outbreak|5|event|8ef6462971234fea8ca5b9c897badcc4|concept+AI assistant for frontline workers in 11 Indian languages|4|object|8ef6462971234fea8ca5b9c897badcc4|concept+Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept+inclusive capacity building of health professionals|3|concept|8ef6462971234fea8ca5b9c897badcc4|concept+Tele-education in medical education for remote areas|4|event|8ef6462971234fea8ca5b9c897badcc4|concept+online platforms, video conferencing, pre-recorded lectures|3|object|8ef6462971234fea8ca5b9c897badcc4|concept+government unified and dedicated online learning and training platform SAKSHAM|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept+health professionals|4|organisation|9b1e7fd4829c450b8cc36fbd9453d186|concept+advanced training|3|event|9b1e7fd4829c450b8cc36fbd9453d186|concept+regular jobs|2|condition|9b1e7fd4829c450b8cc36fbd9453d186|concept+portal|3|object|9b1e7fd4829c450b8cc36fbd9453d186|concept+public health|2|concept|9b1e7fd4829c450b8cc36fbd9453d186|concept+clinical practices|2|event|9b1e7fd4829c450b8cc36fbd9453d186|concept+Accelerating Global Health|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Pathways to Health Equity for the G20|3|concept|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Digital health|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Public sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Private sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept+National digital health ecosystem|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Digital tools|3|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+World Health Assembly|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept+World Health Organization (WHO)|5|organisation|71de2efb72064d318b9e0bee887f6879|concept+Global Digital Health Partnership (GDHP)|4|organisation|71de2efb72064d318b9e0bee887f6879|concept+Department for Digital Health and Innovation|3|organisation|71de2efb72064d318b9e0bee887f6879|concept+Global Strategy on Digital Health 2020-2025|3|document|71de2efb72064d318b9e0bee887f6879|concept+India's G20 Leadership|5|event|eb215b2863164d6ba5e98fcffff46cba|concept+Global Health Initiatives|4|concept|eb215b2863164d6ba5e98fcffff46cba|concept+Climate Change|3|concept|eb215b2863164d6ba5e98fcffff46cba|concept+Food Insecurity|2|condition|eb215b2863164d6ba5e98fcffff46cba|concept+pandemic|5|event|1a76e52834584b208c08bddb9a1f0b62|concept+international cooperation|4|organisation|1a76e52834584b208c08bddb9a1f0b62|concept+health emergency|4|event|1a76e52834584b208c08bddb9a1f0b62|concept+One Health|3|concept|1a76e52834584b208c08bddb9a1f0b62|concept+antimicrobial resistance|3|condition|1a76e52834584b208c08bddb9a1f0b62|concept+pharmaceutical sector|3|organisation|1a76e52834584b208c08bddb9a1f0b62|concept+vaccines, therapeutics, diagnostics|2|object|1a76e52834584b208c08bddb9a1f0b62|concept+Digital Health|5|concept|998d8f77c3c949cd8843d7bdf421b78d|concept+India's G20 presidency|4|event|998d8f77c3c949cd8843d7bdf421b78d|concept+Global Initiative on Digital Health (GIDH)|3|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept+World Health Organization (WHO)|2|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept+digital public goods|5|concept|73e23711e0a54a8dafa05eb4e0949f6b|concept+WHO norms, standards, and|4|organisation|73e23711e0a54a8dafa05eb4e0949f6b|concept+Accelerating Global Health|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept+Pathways to Health Equity for the G20|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept+digital transformation|3|concept|97cddb2fd5c54f7f91c34ca00913ee2e|concept+ABDM|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept+CoWIN|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept+eSanjeevani|2|object|97cddb2fd5c54f7f91c34ca00913ee2e|concept+Lav Agarwal|4|person|ebc08425c0f94baaad5796ba621470b9|concept+eHealth|3|organisation|ebc08425c0f94baaad5796ba621470b9|concept+International Health & Collaboration|2|concept|ebc08425c0f94baaad5796ba621470b9|concept+Public Health|3|concept|ebc08425c0f94baaad5796ba621470b9|concept+G20|2|organisation|ebc08425c0f94baaad5796ba621470b9|concept+India's Digital Public Infrastructure Transformation|5|event|9b7a9f8531134be2b16e734bda64a349|concept+Digital India programme|4|document|9b7a9f8531134be2b16e734bda64a349|concept+India Enterprise Architecture|5|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept+Ministry of Electronics and Information Technology (MeitY)|4|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept+One Government|3|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept+Data Empowerment and Protection Architecture (DEPA)|2|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept+framework|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+DEPA|4|concept|b7f8f25fdd3c482cb13517142b7c0117|concept+consent-governed and secure data-sharing|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+controlled by consent managers|2|concept|b7f8f25fdd3c482cb13517142b7c0117|concept+private ecosystem|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+citizens|2|organisation|b7f8f25fdd3c482cb13517142b7c0117|concept+finance sector|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+loans, insurance, and other financial products|2|event|b7f8f25fdd3c482cb13517142b7c0117|concept+digital|1|misc|b7f8f25fdd3c482cb13517142b7c0117|concept+India Stack|5|organisation|be5f478737c04472bffaf880bf0be06b|concept+DEPA|4|organisation|be5f478737c04472bffaf880bf0be06b|concept+Aadhaar-based e-KYC|3|technology|be5f478737c04472bffaf880bf0be06b|concept+Unified Payments Interface (UPI)|4|technology|be5f478737c04472bffaf880bf0be06b|concept+Aadhaar-based eSign|3|technology|be5f478737c04472bffaf880bf0be06b|concept+Open Credit Enablement Network|2|technology|be5f478737c04472bffaf880bf0be06b|concept+Digital infrastructure|4|concept|be5f478737c04472bffaf880bf0be06b|concept+Private sector service delivery|3|concept|be5f478737c04472bffaf880bf0be06b|concept+digital transactions|4|event|6c3a8512b9a140c983b92ad7f3e5ac41|concept+November 2019|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept+January 2023|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept+India's Digital Public Infrastructure Transformation|5|event|26dcc67d7f7c43b4a92343aa220232c4|concept+MeitY study|4|document|26dcc67d7f7c43b4a92343aa220232c4|concept+US$500 billion by 2025|3|condition|26dcc67d7f7c43b4a92343aa220232c4|concept+India's digital economy potential to US$1 trillion|4|concept|26dcc67d7f7c43b4a92343aa220232c4|concept+business as usual scenario|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+real-time payments in India, China, Brazil|3|concept|26dcc67d7f7c43b4a92343aa220232c4|concept+Direct Benefit Transfer (DBT) programme|4|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept+physical delivery of financial benefits|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+digital payment systems|3|object|26dcc67d7f7c43b4a92343aa220232c4|concept+beneficiaries' bank accounts|2|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept+corruption, eliminating middlemen|3|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+transparency|5|concept|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+direct benefit transfer (DBT) in India|4|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Pradhan Mantri Jan-Dhan Yojana|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Jan Dhan-Aadhaar-Mobile Yojana|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Indian Rupees (INR)|2|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+FY 2021-22|3|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Digital India|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+e-governance platforms|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+MyGov platform|5|organisation|89d34f6b4a1149da8434c3dc7e361947|concept+digital governance|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept+citizen-centricity|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept+technology|4|object|89d34f6b4a1149da8434c3dc7e361947|concept+government interactions|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+citizen-government gap|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept+enhance government services|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+transparency|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept+democratic participation|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+digital literacy|5|concept|e5168689a0894a83821de56e5646e40c|concept+digital divide|4|condition|e5168689a0894a83821de56e5646e40c|concept+DPI|5|document|e5168689a0894a83821de56e5646e40c|concept+India's digital transformation|4|event|e5168689a0894a83821de56e5646e40c|concept+technology|3|concept|e5168689a0894a83821de56e5646e40c|concept+inclusivity|4|condition|e5168689a0894a83821de56e5646e40c|concept+scalability|3|condition|e5168689a0894a83821de56e5646e40c|concept+regulation|3|condition|e5168689a0894a83821de56e5646e40c|concept+collaboration|3|concept|e5168689a0894a83821de56e5646e40c|concept+India's Digital Public Infrastructure Transformation Ecosystem|5|event|ded53e412e15418db0ce8e093a0b0bb7|concept+government agencies|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+industry leaders|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+startups|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+academia|2|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+civil society organisations|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+India’s G20 presidency|4|event|ded53e412e15418db0ce8e093a0b0bb7|concept+Global DPI Summit21|3|event|ded53e412e15418db0ce8e093a0b0bb7|concept+Accelerating Global Health|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+Pathways to Health Equity for the G20|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+marginalised communities|4|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+India|5|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+digital inclusion|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+urban telephone subscribers|2|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+gender gap in mobile ownership|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+India's digital infrastructure|4|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+intermediaries (digital media, e-commerce)|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept+connectivity to cause harm or commit crimes|3|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+comprehensive measures|4|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+potential DPI’s scalability|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept+regulatory sandboxes|4|concept|717cc8137f1e405aa98adda0a4d527db|concept+innovative technologies|3|concept|717cc8137f1e405aa98adda0a4d527db|concept+consumer protection|4|condition|717cc8137f1e405aa98adda0a4d527db|concept+risk mitigation|3|condition|717cc8137f1e405aa98adda0a4d527db|concept+India's Digital Public Infrastructure Transformation|5|event|3dea693354c2490488cf797844863da1|concept+forums and platforms for stakeholders|4|object|3dea693354c2490488cf797844863da1|concept+policy discussions and regulatory consultations|4|event|3dea693354c2490488cf797844863da1|concept+balanced regulatory policies|3|concept|3dea693354c2490488cf797844863da1|concept+Indian regulators|4|organisation|3dea693354c2490488cf797844863da1|concept+Digital Personal Data Protection Bill 2022|3|document|3dea693354c2490488cf797844863da1|concept+presentation of the Digital India Act 2023|3|event|3dea693354c2490488cf797844863da1|concept+consumer needs, emerging technologies, and market trends|4|condition|3dea693354c2490488cf797844863da1|concept+challenges|2|misc|3dea693354c2490488cf797844863da1|concept+technology|5|concept|2d915595100243ee97337357adfbd5a8|concept+regulatory frameworks|4|concept|2d915595100243ee97337357adfbd5a8|concept+India's DPI|4|concept|2d915595100243ee97337357adfbd5a8|concept+Aadhaar|3|object|2d915595100243ee97337357adfbd5a8|concept+UPI|3|object|2d915595100243ee97337357adfbd5a8|concept+digital health infrastructure|3|object|2d915595100243ee97337357adfbd5a8|concept+DBT|3|object|2d915595100243ee97337357adfbd5a8|concept+e-governance|3|object|2d915595100243ee97337357adfbd5a8|concept+Accelerating Global Health|5|event|613d6988832246eaaf57f6d9192e54d0|concept+Pathways to Health Equity for the G20|4|concept|613d6988832246eaaf57f6d9192e54d0|concept+India's DPI experience|3|object|613d6988832246eaaf57f6d9192e54d0|concept+Digital systems|3|object|613d6988832246eaaf57f6d9192e54d0|concept+Inclusive societies|2|concept|613d6988832246eaaf57f6d9192e54d0|concept+Sustainable development in the 21st century|2|event|613d6988832246eaaf57f6d9192e54d0|concept+Sameer Kanwar|3|person|613d6988832246eaaf57f6d9192e54d0|concept+Varun Kumar|2|person|613d6988832246eaaf57f6d9192e54d0|concept+Antibiotics|5|object|a2e40d44ac8b4bc1b87b168a9a450207|concept+Antimicrobial Resistance (AMR)|5|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Global Health Crisis|4|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Health Equity|3|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Global Economy|2|object|a2e40d44ac8b4bc1b87b168a9a450207|concept+Extreme Poverty|1|condition|a2e40d44ac8b4bc1b87b168a9a450207|concept+Developing Nations|2|location|a2e40d44ac8b4bc1b87b168a9a450207|concept+AMR|5|concept|845384860a874fc8b18ed38b165d91fb|concept+Interventions|3|concept|845384860a874fc8b18ed38b165d91fb|concept+Antimicrobials|4|object|845384860a874fc8b18ed38b165d91fb|concept+Healthcare Systems|3|place|845384860a874fc8b18ed38b165d91fb|concept+Patient Outcomes|4|concept|845384860a874fc8b18ed38b165d91fb|concept+Health Equity|3|condition|845384860a874fc8b18ed38b165d91fb|concept+Essay|2|document|845384860a874fc8b18ed38b165d91fb|concept+Ranga Reddy Burri|1|person|845384860a874fc8b18ed38b165d91fb|concept+Robert Skov|1|person|845384860a874fc8b18ed38b165d91fb|concept+Bulagonda Eswarappa Pradeep|1|person|845384860a874fc8b18ed38b165d91fb|concept+Ralf Sudbrak|1|person|845384860a874fc8b18ed38b165d91fb|concept+Antimicrobial Resistance|5|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Persistent Infectious Diseases|4|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antimicrobial Drugs|3|object|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Biological Evolution|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Defense System of Microorganisms|3|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antibiotic Resistance Mechanisms|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antimicrobial Resistance (AMR)|5|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept+Resistance|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept+Antibiotics|3|object|5f12a23a8cd14c22a6ce2a6851934d50|concept+Microorganisms|2|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept+Selection|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept+Accelerating Global Health|5|event|66c6d834348b4a62b864b5a39bb15fe1|concept+Pathways to Health Equity for the G20|4|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Inadequate infection prevention and control|4|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+AMR|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Hand hygiene|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Improper disinfection and sterilisation practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Inadequate sanitation|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Hospital-acquired infections|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Infection prevention and control measures|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Infection control practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Low- and middle-income countries (LMICs)|3|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+World Health Organization|2|organisation|66c6d834348b4a62b864b5a39bb15fe1|concept+WHO|4|organisation|814076eb4141455baa4afe3bddce0dd9|concept+US Centers for Disease Control and Prevention|3|organisation|814076eb4141455baa4afe3bddce0dd9|concept+Infection Control Academy of India (IFCAI)|2|organisation|814076eb4141455baa4afe3bddce0dd9|concept+Abuse/inappropriate use of antibiotics|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Selection pressure on microbes due to the use of antimicrobial drugs|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Social and administrative factors|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+Availability of antimicrobials through over-the-counter (OTC) sales without requiring prescriptions|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Inappropriate prescription of antibiotics by physicians|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+Study conducted by WHO|2|event|814076eb4141455baa4afe3bddce0dd9|concept+Significant proportion of antimicrobials prescribed in outpatient departments were unnecessary or inappropriate|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Rampant use of antibiotics in the livestock sector|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+antibiotic|5|object|0aef0d4620f242e996cf1d0b2d84b4cc|concept+patients|3|organisation|0aef0d4620f242e996cf1d0b2d84b4cc|concept+OTC sale of antimicrobials|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+New legislation|3|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+stricter antibiotic prescription and consumption measures|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+antimicrobial drug development process|3|concept|0aef0d4620f242e996cf1d0b2d84b4cc|concept+advancements in computational|2|misc|0aef0d4620f242e996cf1d0b2d84b4cc|concept+Battle Against Antimicrobial Resistance|5|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+chemistry and artificial intelligence (AI)|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antimicrobials|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+in vitro and in vivo trials|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+bacteria|3|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antibiotics|4|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+quicker and more efficient antibiotic testing and approval pipelines|3|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antimicrobial discovery|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+existing drugs|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+natural products|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+alternate treatment strategies|2|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+computational approaches for drug design|3|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+interdisciplinary collaborations|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+new technologies|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+clinical antibacterial pipeline|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+AMR infections|4|condition|c00efcf689b046e79324603ecf4f180e|concept+antibacterials|4|object|c00efcf689b046e79324603ecf4f180e|concept+WHO priority pathogens|3|concept|c00efcf689b046e79324603ecf4f180e|concept+tuberculosis|2|condition|c00efcf689b046e79324603ecf4f180e|concept+Global AMR R&D Hub|3|organisation|c00efcf689b046e79324603ecf4f180e|concept+WHO|4|organisation|c00efcf689b046e79324603ecf4f180e|concept+development of new antibacterial treatments|5|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept+emerging threat of AMR|4|condition|676eaa0f093b4fbc80687cb2f30c6f16|concept+return on investment for new antibiotics|3|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept+big pharmaceutical companies|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept+antibiotic market|3|market|676eaa0f093b4fbc80687cb2f30c6f16|concept+small or micro biotech firms|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept+novel reimbursement models|3|misc|676eaa0f093b4fbc80687cb2f30c6f16|concept+Accelerating Global Health|4|event|29773bc63cdc4fa680e82c66e6629eed|concept+Pathways to Health Equity for the G20|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Innovative financing mechanisms|5|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Antimicrobials|4|object|29773bc63cdc4fa680e82c66e6629eed|concept+Advance market commitment–type investments|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+DNDi (Drugs for Neglected Diseases Initiative)|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+CEPI (Coalition for Epidemic Preparedness Innovations)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Gavi (Global Alliance for Vaccines and Immunization)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Antibiotics|4|object|29773bc63cdc4fa680e82c66e6629eed|concept+Governments pool funding|3|event|29773bc63cdc4fa680e82c66e6629eed|concept+Manufacturers and the private sector|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Financial incentives|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Equitable pricing and access|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Fight against AMR|3|event|29773bc63cdc4fa680e82c66e6629eed|concept+Effective treatments for all|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Poor diagnostic capacity|3|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Accurate and timely diagnostics|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+infectious diseases|5|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept+diagnostic capacity|4|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept+developing countries|3|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept+vulnerable populations|3|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept+high-income countries|2|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept+LMICs|3|organisation|7745a8bcb0d44d66ad78c6d2c0971a61|concept+quality and efficiency|2|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept+healthcare delivery|3|event|705bfb5bc30d4ce9a762f127476a6352|concept+global health goals|4|concept|705bfb5bc30d4ce9a762f127476a6352|concept+communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept+non-communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept+innovations related to AMR|4|event|705bfb5bc30d4ce9a762f127476a6352|concept+alternative therapies|2|concept|705bfb5bc30d4ce9a762f127476a6352|concept+bacteriophages|3|object|705bfb5bc30d4ce9a762f127476a6352|concept+antimicrobial peptides (AMPs) or bacteria|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept+antimicrobial adjuvants|3|object|705bfb5bc30d4ce9a762f127476a6352|concept+faecal microbiota transplant (FMT)|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept+competitive exclusion of pathogens|3|concept|705bfb5bc30d4ce9a762f127476a6352|concept+genetically modified probiotics|2|object|705bfb5bc30d4ce9a762f127476a6352|concept+Battle Against Antimicrobial Resistance|4|concept|573672aab4184bd0a0d749d328280bc8|concept+postbiotics|3|object|573672aab4184bd0a0d749d328280bc8|concept+antimicrobials|4|concept|573672aab4184bd0a0d749d328280bc8|concept+streamlined approval|3|misc|573672aab4184bd0a0d749d328280bc8|concept+regulatory agencies|2|organisation|573672aab4184bd0a0d749d328280bc8|concept+researchers|2|misc|573672aab4184bd0a0d749d328280bc8|concept+industry stakeholders|2|misc|573672aab4184bd0a0d749d328280bc8|concept+adaptive dose-ranging studies|3|document|573672aab4184bd0a0d749d328280bc8|concept+seamless phase transitions|2|misc|573672aab4184bd0a0d749d328280bc8|concept+drug repurposing|3|concept|573672aab4184bd0a0d749d328280bc8|concept+Approved drugs|3|object|a2dff2067d5543578a60182bfd8845c5|concept+Preclinical and early clinical development stages|2|event|a2dff2067d5543578a60182bfd8845c5|concept+Repurposing drugs|4|concept|a2dff2067d5543578a60182bfd8845c5|concept+In-silico analyses|3|event|a2dff2067d5543578a60182bfd8845c5|concept+High-throughput screening|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Drug libraries|2|object|a2dff2067d5543578a60182bfd8845c5|concept+Antibacterial activity|3|concept|a2dff2067d5543578a60182bfd8845c5|concept+Machine learning (ML)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept+Artificial intelligence (AI)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept+Neural network-based approaches|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Molecular fingerprints|2|object|a2dff2067d5543578a60182bfd8845c5|concept+Diagnostic process|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Industry Collaboration|4|event|21cf6462eb7f41de8afc3c403e296587|concept+Sri Sathya Sai Institute of Higher Learning|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+IFCAI|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+SCIINV Biosciences Private Limited|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+AMRx™|3|object|21cf6462eb7f41de8afc3c403e296587|concept+AI/ML-based culture-free prediction system|4|concept|21cf6462eb7f41de8afc3c403e296587|concept+Urinary Tract Infections|3|condition|21cf6462eb7f41de8afc3c403e296587|concept+Clinical Decision Support System|2|object|21cf6462eb7f41de8afc3c403e296587|concept+Empirical Antibiotic Prescriptions|3|concept|21cf6462eb7f41de8afc3c403e296587|concept+Unnecessary Laboratory Testing of Samples|2|condition|21cf6462eb7f41de8afc3c403e296587|concept+Accelerating Global Health|5|event|0cac054347174785b04ddef8537bee36|concept+Pathways to Health Equity for the G20|4|event|0cac054347174785b04ddef8537bee36|concept+AMR (Antimicrobial Resistance)|5|concept|0cac054347174785b04ddef8537bee36|concept+Quadripartite|3|organisation|0cac054347174785b04ddef8537bee36|concept+One Health approach|4|concept|0cac054347174785b04ddef8537bee36|concept+National Action Plans (NAPs)|3|document|0cac054347174785b04ddef8537bee36|concept+market failure for antimicrobials|4|condition|6fa033fa9795403f88f1b4cea6fa05f4|concept+financing development of novel antimicrobials|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept+Rapid Diagnostic Tests and Point-of-Care Technologies in AMR|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept+Absolute, concrete, and timely diagnosis detection|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept+infection-causing pathogens|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept+Rapid diagnostic tests (RDTs)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+Point-of-care technologies (POC)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+polymerase chain reaction-based tests|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+genotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+phenotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+Battle Against Antimicrobial Resistance|5|event|132097da86644b35b8147fcb94ab68d8|concept+Accelerating Efforts to Combat AMR|3|event|132097da86644b35b8147fcb94ab68d8|concept+Combating AMR|5|concept|132097da86644b35b8147fcb94ab68d8|concept+Policy|3|object|132097da86644b35b8147fcb94ab68d8|concept+Implementation|3|event|132097da86644b35b8147fcb94ab68d8|concept+New antibiotics|4|object|132097da86644b35b8147fcb94ab68d8|concept+Alternative treatments|3|object|132097da86644b35b8147fcb94ab68d8|concept+Bacteriophages|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+Infection prevention and control practices|3|object|132097da86644b35b8147fcb94ab68d8|concept+Antimicrobial use|2|condition|132097da86644b35b8147fcb94ab68d8|concept+Surveillance and data collection|3|event|132097da86644b35b8147fcb94ab68d8|concept+One Health approach|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+National and global health plans|3|document|132097da86644b35b8147fcb94ab68d8|concept+Stakeholders|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+Political will|2|event|132097da86644b35b8147fcb94ab68d8|concept+Accelerating Global Health|5|event|83a561974e644530b643bd7b78aaca7a|concept+Pathways to Health Equity for the G20|5|event|83a561974e644530b643bd7b78aaca7a|concept+AMR|5|concept|83a561974e644530b643bd7b78aaca7a|concept+LMICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept+vulnerable populations in HICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept+antimicrobials pipeline|3|concept|83a561974e644530b643bd7b78aaca7a|concept+industry leaving the field of antimicrobial drug discovery|4|event|83a561974e644530b643bd7b78aaca7a|concept+AMR pandemic|5|concept|83a561974e644530b643bd7b78aaca7a|concept+consequences of AMR|4|event|83a561974e644530b643bd7b78aaca7a|concept+need for increased action|5|event|83a561974e644530b643bd7b78aaca7a|concept+multifaceted effort|4|event|83a561974e644530b643bd7b78aaca7a|concept+reducing the circulation and spread of existing resistant microorganisms|3|event|83a561974e644530b643bd7b78aaca7a|concept+increase of novel resistance mechanisms|4|concept|83a561974e644530b643bd7b78aaca7a|concept+lowering the overall use of antimicrobials|3|event|83a561974e644530b643bd7b78aaca7a|concept+antimicrobial stewardship|4|concept|83a561974e644530b643bd7b78aaca7a|concept+accessibility of affordable and timely diagnostics|3|event|83a561974e644530b643bd7b78aaca7a|concept+strengthening IPC and biosecurity procedures|3|event|83a561974e644530b643bd7b78aaca7a|concept+Dr. Bulagonda Eswarappa Pradeep|2|person|6c480a85100e4e80adba9687a25de868|concept+Department of Biosciences|3|organisation|6c480a85100e4e80adba9687a25de868|concept+Sri Sathya Sai Institute of Higher Learning|2|organisation|6c480a85100e4e80adba9687a25de868|concept+India|3|place|6c480a85100e4e80adba9687a25de868|concept+Dr. Ralf Sudbrak|2|person|6c480a85100e4e80adba9687a25de868|concept+Deputy Director at the Global A M R R & D Hub|3|organisation|6c480a85100e4e80adba9687a25de868|concept+Berlin, Germany|2|place|6c480a85100e4e80adba9687a25de868|concept+G20 Countries|5|organisation|47b323d77856431b8d67d73bf0cde810|concept+Average Life Expectancy|4|condition|47b323d77856431b8d67d73bf0cde810|concept+Global Average of Life Expectancy|3|condition|47b323d77856431b8d67d73bf0cde810|concept+Accelerating Global Health|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+G20|5|organisation|ec5c38d181dd4fe98b66c735aac3841b|concept+Public Health Outcomes|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Health Equity|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Life Expectancy|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Healthcare Spending|5|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+GDP|3|object|ec5c38d181dd4fe98b66c735aac3841b|concept+Role of Health Finance in G20 Countries|5|concept|67bf46897ef2443ea58021ade0df45a0|concept+Higher % GDP Spending in Healthcare|3|event|67bf46897ef2443ea58021ade0df45a0|concept+Universal Health Care Coverage|4|concept|67bf46897ef2443ea58021ade0df45a0|concept+WHO Data|2|document|67bf46897ef2443ea58021ade0df45a0|concept+Healthcare Spending and Health Outcomes|4|event|67bf46897ef2443ea58021ade0df45a0|concept+Innovative Financing Mechanisms|3|object|67bf46897ef2443ea58021ade0df45a0|concept+G20 Countries|4|organization|67bf46897ef2443ea58021ade0df45a0|concept+Out-of-Pocket Expenses|3|concept|67bf46897ef2443ea58021ade0df45a0|concept+health equity|5|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+health disparities|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+socioeconomic status|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+race|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+ethnicity|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+gender|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+geographic location|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+access to healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+redistributing resources|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+targeted healthcare programs|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+improving access to quality healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+addressing social and economic inequalities|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+promoting health education and prevention|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+Universal Health Coverage (UHC)|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+Global|2|organisation|cee9405d7f9345ac9beb4b3fbf485aec|concept+India|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Indonesia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Turkiye|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+China|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Singapore|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+South Korea|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Netherlands|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+UK|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Canada|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+United States|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Germany|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+France|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Japan|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Spain|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Brazil|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Argentina|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+South Africa|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Russia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Australia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Mexico|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Accelerating Global Health|5|event|b3125524cd434526969844ef534e60b7|concept+Pathways to Health Equity for the G20|5|concept|b3125524cd434526969844ef534e60b7|concept+COVID-19 pandemic|4|event|b3125524cd434526969844ef534e60b7|concept+G20 countries|5|organisation|b3125524cd434526969844ef534e60b7|concept+Universal Health Coverage (UHC)|4|concept|b3125524cd434526969844ef534e60b7|concept+Out-Of-Pocket Expenses (OOPE)|3|concept|b3125524cd434526969844ef534e60b7|concept+maternal, newborn and child health|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+infectious diseases|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+non-communicable diseases|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+service capacity and access|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+general and most disadvantaged populations|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+catastrophic OOP healthcare spending|4|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+G20 countries|3|organisation|9cfbef4b83674b20b627a9af06d3ae12|concept+Spain and Singapore|2|place|9cfbef4b83674b20b627a9af06d3ae12|concept+WHO data6UHC|3|document|9cfbef4b83674b20b627a9af06d3ae12|concept+Figure 4|2|object|9cfbef4b83674b20b627a9af06d3ae12|concept+Past Decade for G20 Countries|3|event|9cfbef4b83674b20b627a9af06d3ae12|concept+Lower Out of Pocket Expenditure as a% of Current Health Expenditure|5|concept|8557a7dfb0ce4db8a2b165aedc19d757|concept+Global average|3|misc|8557a7dfb0ce4db8a2b165aedc19d757|concept+2009|1|event|8557a7dfb0ce4db8a2b165aedc19d757|concept+ZAFTURTUR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+KSA KSAFRA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+FRA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+USAUSAJPN|2|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+JPNDEU|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+AUSSPN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+SPNITA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+ITA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+BRABRAKOR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+CHI|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+CHIRUS|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+RUSMEX|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+MEX|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+IDN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+IDNIND|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+INDKOR|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+SGP|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+SGPCAN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+CAN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+UKUK|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+DEU|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+ARG ARG|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+ZAF|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+Health Finance|5|concept|2637f57224b34d4895cf7ade5482c61c|concept+G20 Countries|4|event|2637f57224b34d4895cf7ade5482c61c|concept+Universal Health Coverage (UHC)|5|concept|2637f57224b34d4895cf7ade5482c61c|concept+Out-of-Pocket Expenditure (OOPE)|4|concept|2637f57224b34d4895cf7ade5482c61c|concept+Green Highlighted Countries|3|event|2637f57224b34d4895cf7ade5482c61c|concept+Best Practices|4|concept|2637f57224b34d4895cf7ade5482c61c|concept+Indonesia|3|place|2637f57224b34d4895cf7ade5482c61c|concept+JKN National Health Insurance|2|document|2637f57224b34d4895cf7ade5482c61c|concept+JKN program|5|program|f2ee990cbb1942db85479fce8ded4160|concept+Indonesian citizens|4|concept|f2ee990cbb1942db85479fce8ded4160|concept+Social Security Agency for Health (B P J S)|3|organisation|f2ee990cbb1942db85479fce8ded4160|concept+Healthcare providers|2|object|f2ee990cbb1942db85479fce8ded4160|concept+medical benefit package|3|concept|f2ee990cbb1942db85479fce8ded4160|concept+Out-of-pocket expenditure (OOP)|2|condition|f2ee990cbb1942db85479fce8ded4160|concept+Low and medium-income countries (LMICs)|1|concept|f2ee990cbb1942db85479fce8ded4160|concept+Indonesia|5|place|36832b98f50e46df903ea924ff5e55c5|concept+medicines|4|object|36832b98f50e46df903ea924ff5e55c5|concept+healthcare expenditure|3|concept|36832b98f50e46df903ea924ff5e55c5|concept+OOP payments|2|misc|36832b98f50e46df903ea924ff5e55c5|concept+drug pricing and procurement|4|concept|36832b98f50e46df903ea924ff5e55c5|concept+Accelerating Global Health|5|event|86eac922752743339f35699cfccec378|concept+Pathways to Health Equity for the G20|4|concept|86eac922752743339f35699cfccec378|concept+generic medicine pricing policy|5|event|86eac922752743339f35699cfccec378|concept+Maximum Retail Price set by the MOH|3|document|86eac922752743339f35699cfccec378|concept+2010 study|4|event|86eac922752743339f35699cfccec378|concept+public hospitals|3|organisation|86eac922752743339f35699cfccec378|concept+private pharmacies|2|object|86eac922752743339f35699cfccec378|concept+NGO hospitals|3|organisation|86eac922752743339f35699cfccec378|concept+Lowest Price Generic (LPG) medicines|4|object|86eac922752743339f35699cfccec378|concept+Innovator Brand (IB) medicines|4|object|86eac922752743339f35699cfccec378|concept+2010 prices|3|document|86eac922752743339f35699cfccec378|concept+2004 prices|3|document|86eac922752743339f35699cfccec378|concept+declines ranging from 40 percent to 2200 percent|3|misc|86eac922752743339f35699cfccec378|concept+generic medicine pricing policies have succeeded in lowering the price of medicines|4|event|86eac922752743339f35699cfccec378|concept+variation in implementation|3|condition|86eac922752743339f35699cfccec378|concept+excess paid by patients compared to MOH set prices|4|misc|86eac922752743339f35699cfccec378|concept+narrow the differences|3|condition|86eac922752743339f35699cfccec378|concept+more recently|2|misc|86eac922752743339f35699cfccec378|concept+state-owned enterprises|5|organisation|e66fc805e2f748178c0c1270b907aec8|concept+drug procurement|4|event|e66fc805e2f748178c0c1270b907aec8|concept+generic medications|5|object|e66fc805e2f748178c0c1270b907aec8|concept+public awareness campaigns|4|event|e66fc805e2f748178c0c1270b907aec8|concept+financial incentives|3|misc|e66fc805e2f748178c0c1270b907aec8|concept+UHC|5|concept|e663f199a53b4d5094921d1e38169663|concept+BPJS|4|organisation|e663f199a53b4d5094921d1e38169663|concept+national policies|4|concept|e663f199a53b4d5094921d1e38169663|concept+JKN|3|organisation|e663f199a53b4d5094921d1e38169663|concept+healthcare providers|4|object|e663f199a53b4d5094921d1e38169663|concept+public and private hospitals|3|object|e663f199a53b4d5094921d1e38169663|concept+clinics and facilities|3|object|e663f199a53b4d5094921d1e38169663|concept+healthcare infrastructure|4|object|e663f199a53b4d5094921d1e38169663|concept+disparities in healthcare infrastructure|3|condition|e663f199a53b4d5094921d1e38169663|concept+eldercare sector|4|concept|5655410587404d1a8412a9fc74acd655|concept+GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept+12,000 and 17,000 beds|3|object|5655410587404d1a8412a9fc74acd655|concept+Singapore government|4|organisation|5655410587404d1a8412a9fc74acd655|concept+healthy economic and GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept+institutional places|3|object|5655410587404d1a8412a9fc74acd655|concept+2nd fastest aging economy in Asia|4|concept|5655410587404d1a8412a9fc74acd655|concept+Singaporeans above 65 by 2030|4|condition|5655410587404d1a8412a9fc74acd655|concept+land and building costs of residential nursing homes|3|object|5655410587404d1a8412a9fc74acd655|concept+competitive bids for operators|3|event|5655410587404d1a8412a9fc74acd655|concept+means tested seniors|3|condition|5655410587404d1a8412a9fc74acd655|concept+substantial subsidies of up to 80 percent of monthly fees|3|object|5655410587404d1a8412a9fc74acd655|concept+Widening coverage|4|concept|47a256fcc0844063998f9a4ffb3f1c94|concept+MediShield Life|5|organisation|47a256fcc0844063998f9a4ffb3f1c94|concept+pre-existing conditions|4|condition|47a256fcc0844063998f9a4ffb3f1c94|concept+older individuals|3|misc|47a256fcc0844063998f9a4ffb3f1c94|concept+Accelerating Global Health|4|event|bab2aa6e0ee048878763f123e2e739d0|concept+G20|3|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+hospital bills|4|concept|bab2aa6e0ee048878763f123e2e739d0|concept+large outpatient treatments|3|event|bab2aa6e0ee048878763f123e2e739d0|concept+dialysis|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+chemotherapy|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+CareShield Life|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+long-term insurance|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+severe disability|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+cash payouts|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+long-term care costs|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+nursing home fees|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+MediShield|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+CareShield premiums|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+Medisave|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+Ministry of Health|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+decision-making and support services|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+Agency for Care Effectiveness (ACE)|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+Pharmacoeconomic and Drug Utilization Unit (PEDU)|4|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Health Technology Assessment (HTA) unit|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Ministry of Health's (MOH) Drug Advisory Committee|3|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Standardised HTA methods and processes|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Advanced Clinical Evidence (ACE)|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Bandwidth limitations and lack of skilled HTA practitioners|3|condition|325c82ae1f6d45ca8776fccb347158ae|concept+Public healthcare clusters|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+ALPS Healthcare|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Supply chain partner|2|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Health Finance|5|concept|a4172b8d44d642dd8993e93089d0e52f|concept+G20 Countries|4|organisation|a4172b8d44d642dd8993e93089d0e52f|concept+GP/family physician|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+hospital-centric healthcare system|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+preventive model|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+universal health care|4|concept|a4172b8d44d642dd8993e93089d0e52f|concept+Indonesia|2|place|a4172b8d44d642dd8993e93089d0e52f|concept+Singapore|2|place|a4172b8d44d642dd8993e93089d0e52f|concept+primary care|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+judicious purchasing and effective procurement|2|misc|a4172b8d44d642dd8993e93089d0e52f|concept+Southeast Asia|4|place|1324e2bb4f5742cab74473e14d467926|concept+ASEAN countries|3|organisation|1324e2bb4f5742cab74473e14d467926|concept+RESYST|2|concept|1324e2bb4f5742cab74473e14d467926|concept+SPARC|2|concept|1324e2bb4f5742cab74473e14d467926|concept+SEARCH|3|organisation|1324e2bb4f5742cab74473e14d467926|concept+National University of Singapore|2|place|1324e2bb4f5742cab74473e14d467926|concept+Telehealth|4|concept|76280917c6254c15b067914f14125841|concept+insurtech|3|concept|76280917c6254c15b067914f14125841|concept+COVID-19 pandemic|2|event|76280917c6254c15b067914f14125841|concept+Singapore|3|place|76280917c6254c15b067914f14125841|concept+Indonesia|4|place|76280917c6254c15b067914f14125841|concept+mobile services|3|concept|76280917c6254c15b067914f14125841|concept+micro-insurance|2|concept|76280917c6254c15b067914f14125841|concept+Accelerating Global Health|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Pathways to Health Equity for the G20|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+UHC (Universal Health Coverage)|4|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+G20 countries|4|organisation|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+National University of Singapore's Saw Swee Hock School of Public Health|3|place|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Associate Professor Jeremy Lim|2|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Janice Tan|1|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+diverse landscapes|3|misc|2f3c4ce941c14624bfbd3da82ff8def7|concept+public and private sector hospitals|4|place|2f3c4ce941c14624bfbd3da82ff8def7|concept+nursing homes|3|place|2f3c4ce941c14624bfbd3da82ff8def7|concept+singapore and malaysia|4|location|2f3c4ce941c14624bfbd3da82ff8def7|conceptdiff --git a/data_output/OrfPathHealth/health_india_concepts.csv b/data_output/OrfPathHealth/health_india_concepts.csvnew file mode 100644index 0000000..30a6c7b--- /dev/null+++ b/data_output/OrfPathHealth/health_india_concepts.csv@@ -0,0 +1,1537 @@+entity|importance|category|chunk_id|type+Mental Health|5|concept|83d4d0367bb0467e811782a4ada3bbb9|concept+Health Equity|4|concept|83d4d0367bb0467e811782a4ada3bbb9|concept+World Health Organization (WHO)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept+United Nations (UN)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept+Sustainable Development Goals (SDGs)|4|document|83d4d0367bb0467e811782a4ada3bbb9|concept+Accelerating Global Health|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Pathways to Health Equity for the G20|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Integrating Mental Health into General Healthcare|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Poverty|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Mental Health|5|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Biological Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Psychological Determinants|4|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Social Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Depression|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Substance Use Disorders|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Behavioural Addictions|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Severe Mental Illness (SMI)|3|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Schizophrenia|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+Bipolar Mood Disorder|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept+adversity|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+diabetes|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+tuberculosis|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+socioeconomic vulnerability|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+multimorbidity|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+syndemic|4|concept|1f02a81a02054efaacb0ace0c5eadd14|concept+mental health|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept+healthcare service delivery|5|event|33e4526e998e4865bd5b0dde036c2a20|concept+healthcare resources|4|object|33e4526e998e4865bd5b0dde036c2a20|concept+disadvantaged populations|3|organisation|33e4526e998e4865bd5b0dde036c2a20|concept+mental illness|4|concept|33e4526e998e4865bd5b0dde036c2a20|concept+World Health Organization (WHO)|4|organisation|33e4526e998e4865bd5b0dde036c2a20|concept+Mental Health as a Pathway to Health Equity|5|concept|b9359fe26659413da22ea47729356210|concept+Investing in mental health|4|event|b9359fe26659413da22ea47729356210|concept+Improving population health|3|concept|b9359fe26659413da22ea47729356210|concept+Social inequality|3|condition|b9359fe26659413da22ea47729356210|concept+Human rights|2|concept|b9359fe26659413da22ea47729356210|concept+Economic efficiency|3|concept|b9359fe26659413da22ea47729356210|concept+Global economic loss due to mental disorders|2|misc|b9359fe26659413da22ea47729356210|concept+Investment in treatment of mental illness|3|event|b9359fe26659413da22ea47729356210|concept+Economic productivity gains|2|concept|b9359fe26659413da22ea47729356210|concept+The Burden of Mental Health, Substance Use Disorders and Multimorbidity|3|event|b9359fe26659413da22ea47729356210|concept+Mental and substance-abuse disorders|2|misc|b9359fe26659413da22ea47729356210|concept+Premature morbidity and mortality globally|1|condition|b9359fe26659413da22ea47729356210|concept+National Mental Health Survey (NMHS), 2015-16|1|document|b9359fe26659413da22ea47729356210|concept+India|2|place|b9359fe26659413da22ea47729356210|concept+Disability-Adjusted-Life-Years (DALYs)|5|condition|acf42504124f4b29b4f551d0365821b0|concept+mental disorders|4|concept|acf42504124f4b29b4f551d0365821b0|concept+treatment gap for mental and substance abuse disorders|3|condition|acf42504124f4b29b4f551d0365821b0|concept+out-of-pocket (OOP) spending|2|concept|acf42504124f4b29b4f551d0365821b0|concept+medicines|3|object|acf42504124f4b29b4f551d0365821b0|concept+spending|3|event|5b6399f5e510497481764cd1009caa5c|concept+doctors’ fees and diagnostic charges in OOP expenditure|4|object|5b6399f5e510497481764cd1009caa5c|concept+private healthcare settings|3|place|5b6399f5e510497481764cd1009caa5c|concept+discrimination in the coverage by health insurance toward mental illness|4|misc|5b6399f5e510497481764cd1009caa5c|concept+chances of catastrophic spending|3|event|5b6399f5e510497481764cd1009caa5c|concept+Insurance Regulatory and Development Authority of India (IRDAI)|2|organisation|5b6399f5e510497481764cd1009caa5c|concept+mental illnesses|3|misc|5b6399f5e510497481764cd1009caa5c|concept+Accelerating Global Health|5|event|b123ca85f1a04a5294b943d121e5c61b|concept+Pathways to Health Equity for the G20|4|event|b123ca85f1a04a5294b943d121e5c61b|concept+Mental Health Care Act, 2017|3|document|b123ca85f1a04a5294b943d121e5c61b|concept+reported violations|2|event|b123ca85f1a04a5294b943d121e5c61b|concept+rejections of claims for mental illness by insurance companies|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+discriminatory ceilings on the sum of reimbursement for mental illness|2|event|b123ca85f1a04a5294b943d121e5c61b|concept+people with serious mental illness (SMI)|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept+shortened life expectancy|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+multimorbidity|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept+non-communicable diseases (NCDs)|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+tobacco and alcohol use|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+physical inactivity|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+poor diets|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+national programs to address chronic conditions|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+chronic conditions|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+poor horizontal integration across the programmes|3|event|b123ca85f1a04a5294b943d121e5c61b|concept+homeless persons|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+women|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+persons with developmental disorders|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept+mental health equity|5|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+social inequality|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+gender issues|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+community participation|3|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept+National Program for Mental Health (NMHP)|5|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+District Mental Health Program (DMHP)|4|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+India|5|place|0fd5e7c372a842cc9368e25bf0cb57b4|concept+Asian countries|3|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept+National Mental Health Programme – District Mental Health Programme (>700 districts)|4|document|0fd5e7c372a842cc9368e25bf0cb57b4|concept+Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|programme|d1159f0aacce4add93913834766d4b45|concept+Universal Health Coverage|4|concept|d1159f0aacce4add93913834766d4b45|concept+Health and Wellness Centres|4|programme|d1159f0aacce4add93913834766d4b45|concept+National Tele Mental Health Programme (Tele MANAS)|3|programme|d1159f0aacce4add93913834766d4b45|concept+Jan Aushadhi Kendras|4|programme|d1159f0aacce4add93913834766d4b45|concept+National Mental Health Policy (2014)|3|policy|d1159f0aacce4add93913834766d4b45|concept+National Health Policy (2017)|3|policy|d1159f0aacce4add93913834766d4b45|concept+Rights of Persons with Disability Act, 2016|4|legislation|d1159f0aacce4add93913834766d4b45|concept+Mental Health Care Act, 2017|3|legislation|d1159f0aacce4add93913834766d4b45|concept+Accelerating Global Health|5|event|0e19e6305c0049768cd3d005956a6c24|concept+Pathways to Health Equity for the G20|5|event|0e19e6305c0049768cd3d005956a6c24|concept+Psychotropic medications|3|object|0e19e6305c0049768cd3d005956a6c24|concept+Mental Health Policy (2014)|4|document|0e19e6305c0049768cd3d005956a6c24|concept+digital academies at NIMHANS|3|organization|0e19e6305c0049768cd3d005956a6c24|concept+m-Cessation|2|object|0e19e6305c0049768cd3d005956a6c24|concept+tobacco quit-lines|2|organization|0e19e6305c0049768cd3d005956a6c24|concept+National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)|4|event|0e19e6305c0049768cd3d005956a6c24|concept+Tele-MANAS initiative|5|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+World Mental Health Day|3|event|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+tele-mental health services|4|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+remote and underserved areas|3|location|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+Box 2. Technological Initiatives in India for Mental Health|4|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+Telephone/mobile based initiatives|3|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+eSanjeevani|4|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+e-Manas Karnataka|3|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept+NIMHANS digital academy|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept+Telemedicine Centre|3|place|14b35b1d32d540e9b9815a325f95911e|concept+NIMHANS|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept+CIP|2|misc|14b35b1d32d540e9b9815a325f95911e|concept+Digital Academy|3|organisation|14b35b1d32d540e9b9815a325f95911e|concept+LGBRIMH Digital Academy|2|misc|14b35b1d32d540e9b9815a325f95911e|concept+NIMHANS ECHO model|3|concept|14b35b1d32d540e9b9815a325f95911e|concept+PGIMER “Tele-enabling model”|3|concept|14b35b1d32d540e9b9815a325f95911e|concept+Chatbots|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Telerehabilitation|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Self-help|2|technology|14b35b1d32d540e9b9815a325f95911e|concept+Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|organisation|5bbe6986777c47ee854e432f79982bc2|concept+Universal Health Care (UHC) in India|4|concept|5bbe6986777c47ee854e432f79982bc2|concept+Secondary and tertiary hospitalisations|3|event|5bbe6986777c47ee854e432f79982bc2|concept+Annual coverage of INR 500,000 per family|2|document|5bbe6986777c47ee854e432f79982bc2|concept+Generic medicines|3|object|5bbe6986777c47ee854e432f79982bc2|concept+Jan Aushadhi Kendras|2|place|5bbe6986777c47ee854e432f79982bc2|concept+Economic burden|3|concept|5bbe6986777c47ee854e432f79982bc2|concept+Poor and marginalised|2|condition|5bbe6986777c47ee854e432f79982bc2|concept+150,000 Health and Wellness Centres (HWC)|3|organisation|5bbe6986777c47ee854e432f79982bc2|concept+Comprehensive services|2|event|5bbe6986777c47ee854e432f79982bc2|concept+Screening and essential mental health|2|event|5bbe6986777c47ee854e432f79982bc2|concept+mental health services|5|concept|2e92547f635f4574ad69394da1fa736d|concept+general health services|3|concept|2e92547f635f4574ad69394da1fa736d|concept+MHCA 2017|4|document|2e92547f635f4574ad69394da1fa736d|concept+parity for mental illness|3|concept|2e92547f635f4574ad69394da1fa736d|concept+physical conditions|3|concept|2e92547f635f4574ad69394da1fa736d|concept+Central and State Mental Health Authorities|4|organisation|2e92547f635f4574ad69394da1fa736d|concept+Mental Health Review Boards|3|organisation|2e92547f635f4574ad69394da1fa736d|concept+persons with mental illness|4|concept|2e92547f635f4574ad69394da1fa736d|concept+family members|3|concept|2e92547f635f4574ad69394da1fa736d|concept+NGOs|4|organisation|2e92547f635f4574ad69394da1fa736d|concept+checks and balances|3|concept|2e92547f635f4574ad69394da1fa736d|concept+delivery of mental healthcare|4|concept|2e92547f635f4574ad69394da1fa736d|concept+mental illness|5|concept|2e92547f635f4574ad69394da1fa736d|concept+health insurance|4|document|2e92547f635f4574ad69394da1fa736d|concept+Accelerating Global Health|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept+Pathways to Health Equity for the G20|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept+Improvements in curative and preventive care domains|4|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Rehabilitative care|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+National Mental Health Policy 2014|4|document|4cd87763e8f84bdc8f0067b2b4dec451|concept+Vulnerable populations|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Children|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Elderly|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Homeless|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept+Macro-environmental issues|4|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Poverty|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Unemployment|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Displacement|2|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept+Mental health impact of climate change|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept+Leadership and governance|3|organisation|4cd87763e8f84bdc8f0067b2b4dec451|concept+World Mental Health Report, 2022|5|document|25ad6848459145afa5072490e52d8550|concept+interrelated services|4|concept|25ad6848459145afa5072490e52d8550|concept+life cycle|3|misc|25ad6848459145afa5072490e52d8550|concept+maternal and child mental health|2|concept|25ad6848459145afa5072490e52d8550|concept+elderly|2|condition|25ad6848459145afa5072490e52d8550|concept+Mental Health|5|concept|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+LMICs|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Health Equity Assessment Toolkit (HEAT and HEAT Plus)|3|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+High-Income Countries|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+United Kingdom (UK)|3|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+National Health Service (NHS)|2|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Five-Year Forward View for Mental Health|3|document|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Public Health Domain|3|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Disparity Interventions|2|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+Inequality|4|condition|e7ce4dbfa7e046b6aba50e75ac56ef07|concept+private healthcare providers|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+non-communicable diseases|4|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+chronic communicable diseases|3|condition|d7a98a5523a14a81b33b3cadbeef1397|concept+Tuberculosis|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+multimorbidity|4|condition|d7a98a5523a14a81b33b3cadbeef1397|concept+National Programmes|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+non-communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+chronic communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+National Mission for Health and Family Welfare (NMHP)|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+primary care level|3|object|d7a98a5523a14a81b33b3cadbeef1397|concept+HWC (Health and Wellness Centers)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+PM-JAY (Prime Minister's Jan Arogya Yojana)|4|object|d7a98a5523a14a81b33b3cadbeef1397|concept+patient reported outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+clinical outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+self-management interventions|2|object|d7a98a5523a14a81b33b3cadbeef1397|concept+peer-based interventions|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept+HICs (High Income Countries)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept+Accelerating Global Health: Pathways to Health Equity for the G20|5|event|644bde3f851d4926ba9d1fa8b25b904b|concept+cultural settings of LMICs|4|place|644bde3f851d4926ba9d1fa8b25b904b|concept+brief psychological interventions|3|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+lay counsellors|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+moderate to severe depressive disorders and harmful drinking|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+health systems in HICs|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+long waiting periods for psychological intervention|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+low-intensity interventions|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+Problem Management plus (PM+)|3|document|644bde3f851d4926ba9d1fa8b25b904b|concept+adults in distress due to exposure to adversity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+family caregivers|3|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept+mental health|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept+indigenous interventions|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept+Yoga|4|object|644bde3f851d4926ba9d1fa8b25b904b|concept+alternative forms of medicine|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept+multimorbidity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept+evidence-based integration|5|concept|78487c391631417992f97fcd77f0ba19|concept+public health system|4|place|78487c391631417992f97fcd77f0ba19|concept+cultural acceptance|3|condition|78487c391631417992f97fcd77f0ba19|concept+Tele-MANAS programme|4|organisation|78487c391631417992f97fcd77f0ba19|concept+digital literacy|3|condition|78487c391631417992f97fcd77f0ba19|concept+primary healthcare|4|place|78487c391631417992f97fcd77f0ba19|concept+Universal Health Coverage (UHC)|3|concept|78487c391631417992f97fcd77f0ba19|concept+referral pathways|2|misc|78487c391631417992f97fcd77f0ba19|concept+mental care|3|concept|78487c391631417992f97fcd77f0ba19|concept+physical care|2|misc|78487c391631417992f97fcd77f0ba19|concept+robust information systems|3|condition|78487c391631417992f97fcd77f0ba19|concept+mental and physical care integration|2|misc|78487c391631417992f97fcd77f0ba19|concept+equitable and quality healthcare|4|concept|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Pratima Murthy|3|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Director and Senior Professor of Psychiatry|2|position|996585f3b2fe4afe9aad026a32d48fe9|concept+NIMHANS, Bengaluru|3|organisation|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Krishna Prasad Muliyala|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Additional Professor of Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept+Dr. Channaveerachari Naveen Kumar|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept+Professor of Psychiatry and Head of Community Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept+COVID-19 pandemic|5|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+lockdown|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+global economy|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+novel coronavirus|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+disease|3|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+zoonotic virus|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+Public Health Emergency of International Concern|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept+low-income countries|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept+vaccines and drugs|3|object|8bf2b50e94df47b392aa512dbb2e74c1|concept+bird and animal viruses|5|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+infectious disease|4|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+epidemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept+pandemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept+prevent|2|concept|03a06fd2936d41afa48ec291c8bcbda8|concept+Barbara Stocking|1|person|03a06fd2936d41afa48ec291c8bcbda8|concept+The Urgent Need for a Pandemic Accord|2|document|03a06fd2936d41afa48ec291c8bcbda8|concept+Accelerating Global Health: Pathways to Health Equity for the G20|4|event|40998ca4b2594430b3f1f64aadfec89b|concept+COVID-19|5|event|40998ca4b2594430b3f1f64aadfec89b|concept+Healthcare systems|3|object|40998ca4b2594430b3f1f64aadfec89b|concept+Simulation exercises|2|event|40998ca4b2594430b3f1f64aadfec89b|concept+Public health system|3|object|40998ca4b2594430b3f1f64aadfec89b|concept+Lockdown|4|event|40998ca4b2594430b3f1f64aadfec89b|concept+Livelihoods and economy|3|condition|40998ca4b2594430b3f1f64aadfec89b|concept+Trade|2|event|40998ca4b2594430b3f1f64aadfec89b|concept+Social services (education)|2|object|40998ca4b2594430b3f1f64aadfec89b|concept+wait and see approach|2|concept|546a91dcc37740dfb8597967e1999249|concept+February 2020|3|event|546a91dcc37740dfb8597967e1999249|concept+International Health Regulations (IHR)|4|document|546a91dcc37740dfb8597967e1999249|concept+World Health Organization (WHO)|3|organisation|546a91dcc37740dfb8597967e1999249|concept+inequities between countries and population groups|4|concept|546a91dcc37740dfb8597967e1999249|concept+access to vaccines and drugs|3|concept|546a91dcc37740dfb8597967e1999249|concept+pandemic treaty|4|concept|546a91dcc37740dfb8597967e1999249|concept+World Health Assembly (WHA)|3|organisation|546a91dcc37740dfb8597967e1999249|concept+Pandemic Accord|5|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept+WHO's 194 member states|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+Intergovernmental Negotiating Body (INB)|2|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+World Health Assembly (WHA)|4|event|8a0b9edbbadd44c4babe8192a73bc83d|concept+Working Group on amendments to the IHR (WGIHR)|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept+International Health Regulations (IHR)|4|document|8a0b9edbbadd44c4babe8192a73bc83d|concept+One Health|2|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept+Equity in access to drugs and vaccines|3|condition|8a0b9edbbadd44c4babe8192a73bc83d|concept+WGIHR|4|organisation|b666ff6d8d3445a98869212995fcb597|concept+Pandemic Accord|4|document|b666ff6d8d3445a98869212995fcb597|concept+IHR|5|organisation|b666ff6d8d3445a98869212995fcb597|concept+One Health|3|concept|b666ff6d8d3445a98869212995fcb597|concept+Accelerating Global Health: Pathways to Health Equity for the G20|4|event|6e54c98b3b944682acb35e1bfe531831|concept+Solidarity|3|concept|6e54c98b3b944682acb35e1bfe531831|concept+United Nations Charter|2|document|6e54c98b3b944682acb35e1bfe531831|concept+vaccines, diagnostics and treatments|3|object|6e54c98b3b944682acb35e1bfe531831|concept+financing for these resources|2|condition|6e54c98b3b944682acb35e1bfe531831|concept+equity in governance systems|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+financing for preparedness and response to pandemics|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+donors|2|organisation|9ccb6cad21444a27b7970917ba7e6c8b|concept+equity|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+fairness|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+capabilities of countries|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+poorer countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+developed ones|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+transparency of data and genomic sequencing|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+quickly and effectively responding to the pandemic|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+development of new drugs and vaccines|2|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+trust within and between countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+accountability requirements|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept+past Accord|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept+Pandemic Accord|4|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept+IHR|3|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept+civil society organisations|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept+parliamentary systems|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept+zero draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept+first draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept+Accord|5|event|bc526127448645b3837dcc3b45668a83|concept+Human Rights Protection|4|concept|bc526127448645b3837dcc3b45668a83|concept+Public Health and Healthcare Systems|3|object|bc526127448645b3837dcc3b45668a83|concept+Staff Protection|4|misc|bc526127448645b3837dcc3b45668a83|concept+Misinformation Management|3|event|bc526127448645b3837dcc3b45668a83|concept+Whole-of-Society Approach|4|concept|bc526127448645b3837dcc3b45668a83|concept+Global Coordination|3|event|bc526127448645b3837dcc3b45668a83|concept+Preparedness Plans|4|event|bc526127448645b3837dcc3b45668a83|concept+Simulation Exercises|3|event|bc526127448645b3837dcc3b45668a83|concept+Universal Health and Preparedness Review|4|document|bc526127448645b3837dcc3b45668a83|concept+plans|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+independent assessment|2|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+public health response|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept+IHR|2|organisation|5e2a17a4edaa487290ad2532cd863fd8|concept+Accelerating Global Health|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept+Pathways to Health Equity for the G20|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept+one health|4|concept|83977ec929b94ecc86a6c51a35fa39cf|concept+zoonoses|3|condition|83977ec929b94ecc86a6c51a35fa39cf|concept+wet markets|2|place|83977ec929b94ecc86a6c51a35fa39cf|concept+Joint Plan of Action|3|document|83977ec929b94ecc86a6c51a35fa39cf|concept+equity|4|condition|83977ec929b94ecc86a6c51a35fa39cf|concept+access to vaccines, drugs, and other medical equipment|5|event|c4ed77f811a94b6b8d85279085b53df5|concept+ Member states|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept+differences among them|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept+Developing countries|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept+wider spread of manufacturing|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+Success in getting mRNA vaccine manufacturing underway in South Africa|4|event|c4ed77f811a94b6b8d85279085b53df5|concept+manufacturing for the whole continent and globally|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+financial investment|4|condition|c4ed77f811a94b6b8d85279085b53df5|concept+technology transfer|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+pharmaceutical industry|4|organisation|c4ed77f811a94b6b8d85279085b53df5|concept+technology transfer and the associated question of intellectual property rights|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept+wealthier governments funding R&D|4|event|c4ed77f811a94b6b8d85279085b53df5|concept+companies earmark a percentage of vaccines for the poorer countries or sell to them at cost|3|event|c4ed77f811a94b6b8d85279085b53df5|concept+pharmaceutical industry|4|organisation|1a4820465fa844f8901275aa62a66e82|concept+infectious diseases|3|condition|1a4820465fa844f8901275aa62a66e82|concept+Pandemic Accord|5|concept|abe8dec679a3446db21c31d36bcd3b12|concept+World Trade Organization|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+TRIPS waiver|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+Doha Trade Round|3|event|abe8dec679a3446db21c31d36bcd3b12|concept+equity of access|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+Pandemic Accord and the IHR|3|misc|abe8dec679a3446db21c31d36bcd3b12|concept+financing|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+G20 Independent High-Level Panel|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+annual financing need for future preparedness and response to pandemics|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept+PPR|2|organisation|abe8dec679a3446db21c31d36bcd3b12|concept+health systems|4|concept|c410a5c9df2e4df2998153d58af3836c|concept+R&D|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+overall preparedness|4|concept|c410a5c9df2e4df2998153d58af3836c|concept+G20 report|3|document|c410a5c9df2e4df2998153d58af3836c|concept+Pandemic Fund at the World Bank|4|organisation|c410a5c9df2e4df2998153d58af3836c|concept+IHR|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+Accountability|4|misc|c410a5c9df2e4df2998153d58af3836c|concept+Accord|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+external accountability mechanisms|4|misc|c410a5c9df2e4df2998153d58af3836c|concept+independent assessment of countries|3|concept|c410a5c9df2e4df2998153d58af3836c|concept+Accord|4|event|c134e5a2812f44f9803c15d7591765a0|concept+WHO|3|organisation|c134e5a2812f44f9803c15d7591765a0|concept+Accord|4|event|42c1df8501c946858051c31ad52c5ec5|concept+IHR|3|concept|42c1df8501c946858051c31ad52c5ec5|concept+WHO|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept+International Atomic Energy Agency (IAEA)|3|organisation|42c1df8501c946858051c31ad52c5ec5|concept+public space|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+independent assessment body|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept+monitoring information|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+pandemics|4|event|42c1df8501c946858051c31ad52c5ec5|concept+governments|3|misc|42c1df8501c946858051c31ad52c5ec5|concept+Global Public Health Convention|5|event|d4d6f26b296047fabb3e74cec31ebc41|concept+countries across the world|4|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept+resources to deliver|3|condition|d4d6f26b296047fabb3e74cec31ebc41|concept+Dame Barbara Stocking|4|person|d4d6f26b296047fabb3e74cec31ebc41|concept+Panel for a Global Public Health Convention|3|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept+investments in future|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Ensuring Equitable Supply and Access|2|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Critical Vaccines|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+Pandemics|4|concept|f21a0cbf122d44f599f9b52ccec5f521|concept+COV AX Aurélia Nguyen|2|misc|f21a0cbf122d44f599f9b52ccec5f521|concept+pandemic|5|event|7aa69007cfd442f9822d3663a6c4c65a|concept+health systems|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept+COVAX Facility|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Access to COVID-19 Tools Accelerator (ACT-A)|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept+COVAX|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|2|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+World Health Organization (WHO)|4|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+United Nations Children’s Fund (UNICEF)|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept+Gavi, the Vaccine Alliance|5|organisation|3c76d07238434794b3a491927cbf70e4|concept+COVAX AMC|4|organisation|3c76d07238434794b3a491927cbf70e4|concept+Imperial College London|3|organisation|3c76d07238434794b3a491927cbf70e4|concept+COVID-19 vaccinations|4|concept|3c76d07238434794b3a491927cbf70e4|concept+conditions|3|condition|3c76d07238434794b3a491927cbf70e4|concept+pandemic|4|concept|3c76d07238434794b3a491927cbf70e4|concept+Accelerating Global Health|3|event|80889f7b0eaa4090934f8879b238d535|concept+Pathways to Health Equity for the G20|4|concept|80889f7b0eaa4090934f8879b238d535|concept+procurement, distribution, administration of COVID-19 vaccines|5|misc|80889f7b0eaa4090934f8879b238d535|concept+COVID-19|4|event|80889f7b0eaa4090934f8879b238d535|concept+COVAX|3|organisation|80889f7b0eaa4090934f8879b238d535|concept+vaccine makers|4|organisation|80889f7b0eaa4090934f8879b238d535|concept+bilateral customers|3|misc|80889f7b0eaa4090934f8879b238d535|concept+vaccine candidates|5|concept|4d3ad7c8415c4169b650d2f3754e263d|concept+COVAX|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+export bans|3|misc|4d3ad7c8415c4169b650d2f3754e263d|concept+global health agencies|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+COVAX Facility|3|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept+recommendations|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+supply|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+demand|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+R&D|5|concept|895f9a65a28c496595bb295596c4fdd1|concept+manufacturing|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+country-level challenges|5|misc|895f9a65a28c496595bb295596c4fdd1|concept+other factors|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+at-risk investments|5|misc|895f9a65a28c496595bb295596c4fdd1|concept+funding|4|concept|895f9a65a28c496595bb295596c4fdd1|concept+vaccines|5|object|895f9a65a28c496595bb295596c4fdd1|concept+R&D stage|4|misc|895f9a65a28c496595bb295596c4fdd1|concept+COVAX|4|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+pandemic vaccine pool (PVP)|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+lower-income countries|2|place|19c06e9b16344d5f98aae0410d469d9c|concept+vaccine candidates|3|misc|19c06e9b16344d5f98aae0410d469d9c|concept+COVID-19|4|event|19c06e9b16344d5f98aae0410d469d9c|concept+multinational trade-facilitation measures|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept+life-saving equipment|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+health emergencies|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept+exemptions and waivers|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+trade barriers|3|condition|f85f8a3779d1458a97ac8d5f13f782d0|concept+life-saving medical countermeasures and materials|4|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+low- and middle-income countries|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept+humanitarian situations|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept+vaccines|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+vaccinations|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+strong, reliable health systems|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+early R&D|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+scaling-up manufacturing|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+securing deals|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+consistent policy guidance|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+operational, logistical, regulatory, and legal frameworks|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept+ancillary supplies|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+cold chain|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+safe injection equipment|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept+international freight and logistics|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept+in-country delivery requirements|5|event|7b0a4ad9437f45829cb41258f4f78a71|concept+personal protective equipment for healthcare workers|4|object|7b0a4ad9437f45829cb41258f4f78a71|concept+countries lacking infrastructure|3|condition|7b0a4ad9437f45829cb41258f4f78a71|concept+Gavi and WHO|4|organisation|7b0a4ad9437f45829cb41258f4f78a71|concept+Accelerating Global Health|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept+Pathways to Health Equity for the G20|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept+cold chains|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept+immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept+Gavi|3|organisation|4b38bb5b7e7343dc87ddf380cad54595|concept+lower-income countries' routine immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept+COVID-19 vaccines|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept+extra burden of delivering COVID-19 vaccines to other populations|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+efforts to vaccinate mostly children|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+relatively little decline in routine immunisation|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+vaccinators, doctors and nurses were burned out|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+immunisation in Gavi-implementing countries|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept+COVID-19|5|event|c34ec7b0256847df9acfe84b02149252|concept+Health system strengthening investments|4|concept|c34ec7b0256847df9acfe84b02149252|concept+Primary healthcare services|3|concept|c34ec7b0256847df9acfe84b02149252|concept+Cold chain|2|object|c34ec7b0256847df9acfe84b02149252|concept+Vaccine track-and-trace|3|concept|c34ec7b0256847df9acfe84b02149252|concept+Human resources|2|object|c34ec7b0256847df9acfe84b02149252|concept+Data monitoring systems|3|concept|c34ec7b0256847df9acfe84b02149252|concept+COVID-19 vaccine Delivery Support (CDS)|4|organisation|c34ec7b0256847df9acfe84b02149252|concept+Gavi|3|organisation|c34ec7b0256847df9acfe84b02149252|concept+COVAX|5|organisation|0e304bf478d4428e929abad5c796e272|concept+Gavi-implementing countries|4|place|0e304bf478d4428e929abad5c796e272|concept+routine immunisation|3|concept|0e304bf478d4428e929abad5c796e272|concept+COVID-19 vaccine coverage|4|condition|0e304bf478d4428e929abad5c796e272|concept+pandemic preparedness|3|concept|0e304bf478d4428e929abad5c796e272|concept+most vulnerable people|4|misc|0e304bf478d4428e929abad5c796e272|concept+equitable supply of vaccines|3|concept|0e304bf478d4428e929abad5c796e272|concept+vaccine nationalism|5|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+hoarding|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+export bans|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX Facility|5|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept+H1N1 pandemic|4|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept+vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept+lower-income economies|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+wealthier nations|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVID-19 vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept+vaccine-candidates|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+technology platforms|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+regulatory approval|3|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept+large-scale investments|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX portfolio|4|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept+191 countries|2|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept+COVAX|5|organisation|55b09ec3abaf48e98355f0d359b46caf|concept+finite supply of vaccine doses|3|condition|55b09ec3abaf48e98355f0d359b46caf|concept+H1N1 vaccine|2|concept|55b09ec3abaf48e98355f0d359b46caf|concept+Accelerating Global Health|4|event|d4a21a81d74e413ba4d349be59d06804|concept+Pathways to Health Equity for the G20|3|event|d4a21a81d74e413ba4d349be59d06804|concept+COVID-19 pandemic|5|event|d4a21a81d74e413ba4d349be59d06804|concept+vaccine manufacturing|4|object|d4a21a81d74e413ba4d349be59d06804|concept+African continent|2|place|d4a21a81d74e413ba4d349be59d06804|concept+Africa Center for Disease Control|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+Memorandum of Understanding|3|event|d4a21a81d74e413ba4d349be59d06804|concept+Gavi|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+African Union Commission|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept+sustainable regional vaccine manufacturing|4|event|d07c2d94246f4df795c7be6170d78db1|concept+commitments to increase political, financial, and technical investments in immunisation programmes|4|event|d07c2d94246f4df795c7be6170d78db1|concept+models for ensuring lower-income countries receive vaccine doses|3|event|d07c2d94246f4df795c7be6170d78db1|concept+manufacturers' transparency about their order books|4|event|d07c2d94246f4df795c7be6170d78db1|concept+supply inequities among countries|3|condition|d07c2d94246f4df795c7be6170d78db1|concept+contingent financing for pandemic response|4|event|d07c2d94246f4df795c7be6170d78db1|concept+COVAX AMC funding|3|document|d07c2d94246f4df795c7be6170d78db1|concept+PVP funding|3|organisation|d7a7913899f445febee6bff8c39924bc|concept+variant-containing vaccine boosters|4|object|d7a7913899f445febee6bff8c39924bc|concept+2024–25 COVID-19 programme|4|event|d7a7913899f445febee6bff8c39924bc|concept+Gavi board|3|organisation|d7a7913899f445febee6bff8c39924bc|concept+COVAX|5|organisation|54d16e33cfb44174b61da49448891293|concept+Gavi, the Vaccine Alliance|4|organisation|54d16e33cfb44174b61da49448891293|concept+Aurélia Nguyen|3|person|54d16e33cfb44174b61da49448891293|concept+Global Vaccine Library|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept+coronavirus|5|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+spike protein|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept+neutralising antibodies|3|concept|0cd02fb084694bbca463dd2b114f1d48|concept+RSV|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+SARS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+MERS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept+security bodies|3|organisation|d7a7df237a9b4336b1e40e727ecdd5c9|concept+smallpox vaccines|4|object|d7a7df237a9b4336b1e40e727ecdd5c9|concept+Mpox|3|concept|d7a7df237a9b4336b1e40e727ecdd5c9|concept+2022 Mpox epidemic|4|event|d7a7df237a9b4336b1e40e727ecdd5c9|concept+Accelerating Global Health|3|event|7a57613761f64fe58fbc8709d4670828|concept+Pathways to Health Equity for the G20|3|event|7a57613761f64fe58fbc8709d4670828|concept+Viral Threats|3|concept|7a57613761f64fe58fbc8709d4670828|concept+Infectious Pathogens|4|concept|7a57613761f64fe58fbc8709d4670828|concept+Containment Race|3|event|7a57613761f64fe58fbc8709d4670828|concept+Pandemic Control|4|concept|7a57613761f64fe58fbc8709d4670828|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|3|organisation|7a57613761f64fe58fbc8709d4670828|concept+One World Vaccine Library|4|document|7a57613761f64fe58fbc8709d4670828|concept+global community|5|organisation|58efa624d5c4493eb9e220aab122325c|concept+health security|4|concept|58efa624d5c4493eb9e220aab122325c|concept+pandemic threats|3|event|58efa624d5c4493eb9e220aab122325c|concept+vaccines|4|object|58efa624d5c4493eb9e220aab122325c|concept+dangerous and deadly outbreaks|2|event|58efa624d5c4493eb9e220aab122325c|concept+incipient pandemic|3|event|58efa624d5c4493eb9e220aab122325c|concept+potential opponents|2|concept|58efa624d5c4493eb9e220aab122325c|concept+viruses from around 25 viral families|3|organisation|58efa624d5c4493eb9e220aab122325c|concept+One World Vaccine Library|3|misc|dc468156950d4a4d8a8878e75499afa3|concept+viral-family-based prototype vaccine approach|4|concept|dc468156950d4a4d8a8878e75499afa3|concept+Accelerating Global Health|5|event|0b579a5b26e9407a902cb29529089cee|concept+Pathways to Health Equity for the G20|4|event|0b579a5b26e9407a902cb29529089cee|concept+novel paramyxovirus|3|concept|0b579a5b26e9407a902cb29529089cee|concept+One World Vaccine Library|5|object|0b579a5b26e9407a902cb29529089cee|concept+Develop vaccines|3|event|cc987a2a91d846c5a1d952ecc309cc62|concept+Researchers|2|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept+New outbreak and virus|2|event|cc987a2a91d846c5a1d952ecc309cc62|concept+Genome sequencing|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+One World Vaccine Library|4|object|cc987a2a91d846c5a1d952ecc309cc62|concept+CEPI|3|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept+Virus families|2|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+Disease X|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept+Vaccine library candidates|3|object|cc987a2a91d846c5a1d952ecc309cc62|concept+clinical testing|4|event|f82e8abf722e423ba48ded1798296b13|concept+safety|3|condition|f82e8abf722e423ba48ded1798296b13|concept+immunogenicity|4|concept|f82e8abf722e423ba48ded1798296b13|concept+platform|3|object|f82e8abf722e423ba48ded1798296b13|concept+antigens|2|object|f82e8abf722e423ba48ded1798296b13|concept+lead candidates|4|organisation|f82e8abf722e423ba48ded1798296b13|concept+families|3|misc|f82e8abf722e423ba48ded1798296b13|concept+clinical proof of concept|4|concept|f82e8abf722e423ba48ded1798296b13|concept+One World Vaccine Library|5|object|8cb3bc020aed4d0a86a05c1f658e2708|concept+100 Days Mission|4|event|8cb3bc020aed4d0a86a05c1f658e2708|concept+CEPI's 100 Days Mission|3|concept|8cb3bc020aed4d0a86a05c1f658e2708|concept+G7 and the G20|3|organisation|8cb3bc020aed4d0a86a05c1f658e2708|concept+Disease X pandemic virus|4|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept+new vaccines|3|object|8cb3bc020aed4d0a86a05c1f658e2708|concept+improved surveillance|2|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept+non-pharmaceutical interventions|3|misc|8cb3bc020aed4d0a86a05c1f658e2708|concept+One World Vaccine Library|5|concept|f5b55f34587246179c6c6d2bc0801141|concept+virus families|4|concept|f5b55f34587246179c6c6d2bc0801141|concept+pandemics|3|concept|f5b55f34587246179c6c6d2bc0801141|concept+100 Days Mission|2|event|f5b55f34587246179c6c6d2bc0801141|concept+pandemics|5|event|4160fb9924f24b5eb68e493cd9361060|concept+Dr. Richard Hatchett|4|person|4160fb9924f24b5eb68e493cd9361060|concept+Coalition for Epidemic Preparedness Innovations (CEPI)|5|organisation|4160fb9924f24b5eb68e493cd9361060|concept+Kate Kelland|3|person|4160fb9924f24b5eb68e493cd9361060|concept+Public Health Workforce|5|concept|732fe967002642599669103e63f2f22a|concept+COVID-19 pandemic|4|event|732fe967002642599669103e63f2f22a|concept+Public Health System|3|object|732fe967002642599669103e63f2f22a|concept+Essential health services|2|object|732fe967002642599669103e63f2f22a|concept+Routine immunisation|1|object|732fe967002642599669103e63f2f22a|concept+Disease outbreaks|2|event|732fe967002642599669103e63f2f22a|concept+limited availability of the health workforce|5|event|3dcdf4837b764370bb2cf1e2776825cc|concept+COVID-19 infections and deaths among health workers|4|event|3dcdf4837b764370bb2cf1e2776825cc|concept+mental health issues, including burnout|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+poor working conditions|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+protracted conflicts|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept+global increase in climate-related and humanitarian disasters|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept+public health crisis|3|event|3dcdf4837b764370bb2cf1e2776825cc|concept+reversals in life expectancy and Sustainable Development Goals|2|condition|3dcdf4837b764370bb2cf1e2776825cc|concept+Investing in the Public Health Workforce|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept+Essential Public Health Functiona (EPHF)|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept+Global investment|5|misc|c9d7fdd45c4e4061ac050c6a21b2f583|concept+G7 and G20 intergovernmental processes|4|event|c9d7fdd45c4e4061ac050c6a21b2f583|concept+World Health Organization (WHO)|5|organization|c9d7fdd45c4e4061ac050c6a21b2f583|concept+regional, and global bodies|5|organisation|525f8e57fb164f289fed4c4155309473|concept+G20|4|organisation|525f8e57fb164f289fed4c4155309473|concept+G7|4|organisation|525f8e57fb164f289fed4c4155309473|concept+COVID-19 pandemic|3|event|525f8e57fb164f289fed4c4155309473|concept+EPHFs (Emergency Public Health Functions)|2|concept|525f8e57fb164f289fed4c4155309473|concept+World Federation of Public Health Associations (WFPHA), International|2|organisation|525f8e57fb164f289fed4c4155309473|concept+Association of National Public Health Institutions (IANPHI)|4|organisation|99d0ffec664a4147b99327b232eec755|concept+Global Network Academic Schools of Public Health (GNASPH).|3|organisation|99d0ffec664a4147b99327b232eec755|concept+Global Health Summit|5|event|2106f61eb09845f7855d15da890e67ae|concept+Rome Declaration|4|document|2106f61eb09845f7855d15da890e67ae|concept+G20 Italia Declaration of Health Ministers|3|document|2106f61eb09845f7855d15da890e67ae|concept+health workforce|5|misc|5837ba13e7f942cf8b17ebfcaef29429|concept+COVID-19|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept+G7 Summit|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept+Carbis Bay Health Declaration|3|document|5837ba13e7f942cf8b17ebfcaef29429|concept+G7 Germany|2|event|5837ba13e7f942cf8b17ebfcaef29429|concept+pandemic preparedness and response|4|concept|1ef5b0e99e864a539d6ef6e41039de13|concept+G7 Pact for Pandemic Readiness|3|organisation|1ef5b0e99e864a539d6ef6e41039de13|concept+Berlin|2|place|1ef5b0e99e864a539d6ef6e41039de13|concept+low- and lower-middle income countries (LMICs)|3|concept|1ef5b0e99e864a539d6ef6e41039de13|concept+Public Health Workforce|4|concept|58263ccaef7b48289de7a0d400d6d13d|concept+pandemic preparedness and response|3|concept|58263ccaef7b48289de7a0d400d6d13d|concept+WHO|4|organisation|58263ccaef7b48289de7a0d400d6d13d|concept+Strengthening the Global Architecture for Health Emergency Preparedness and Response (HEPR)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept+G7 Roadmap|2|document|58263ccaef7b48289de7a0d400d6d13d|concept+International Health Regulation (IHR 2005)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept+G7 Pact|2|misc|58263ccaef7b48289de7a0d400d6d13d|concept+Pandemic Fund|3|object|58263ccaef7b48289de7a0d400d6d13d|concept+Impact Investment Initiative for Global Health|3|event|7cb2165fcdc945c6ae0860e59f189275|concept+United Nations' three High-Level Meetings|4|event|7cb2165fcdc945c6ae0860e59f189275|concept+Global South|3|place|7cb2165fcdc945c6ae0860e59f189275|concept+non-communicable and communicable diseases|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept+PPR|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept+Essential health services|3|object|7cb2165fcdc945c6ae0860e59f189275|concept+Public health workforce|4|organisation|7cb2165fcdc945c6ae0860e59f189275|concept+G20 and the G7 processes|3|event|7cb2165fcdc945c6ae0860e59f189275|concept+12 essential public health functions|2|concept|7cb2165fcdc945c6ae0860e59f189275|concept+roadmap|4|plan|c758753adaf94ea9a1978600c51ad623|concept+national public health workforce capacity|5|concept|c758753adaf94ea9a1978600c51ad623|concept+EPHFs|4|event|c758753adaf94ea9a1978600c51ad623|concept+emergency preparedness and response|3|concept|c758753adaf94ea9a1978600c51ad623|concept+public health workforce|4|organisation|c758753adaf94ea9a1978600c51ad623|concept+Public Health Workforce|5|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+occupations outside of the health sector|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+Global partners|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept+roadmap and action plan|4|document|b5e8fd8bf09244c9a74995e5e618f489|concept+standard EPHF|3|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+whole-of-government and whole-of-society approach|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+national stakeholders|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept+existing national and global networks of partners|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept+country-based assessment|3|event|b5e8fd8bf09244c9a74995e5e618f489|concept+policy improvement|4|concept|b5e8fd8bf09244c9a74995e5e618f489|concept+workforce capacity and readiness|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+national assessments and benchmarking|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+G20 support to invest in preparedness and national capacity|5|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+World Bank’s Pandemic Fund|4|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+strengthening human resources|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+countries prevent, prepare for, and respond to health emergencies|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+sustainable public health workforce capacity in LMICs|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)|3|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept+WHO|3|organisation|503ecc2f98c64e4ba8733349b9834adc|concept+convention, agreement, international instrument|4|event|503ecc2f98c64e4ba8733349b9834adc|concept+PPR (WHO CA+)|3|condition|503ecc2f98c64e4ba8733349b9834adc|concept+International Health Regulation|2|document|503ecc2f98c64e4ba8733349b9834adc|concept+amendments|3|event|503ecc2f98c64e4ba8733349b9834adc|concept+Accelerating Global Health|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Pathways to Health Equity for the G20|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Role of India's G20 Presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+intergovernmental consensus and commitment for public health strengthening|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+public health workforce needs|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+G20 in India|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+SDGs and global health architecture for PPR|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+Indian presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept+multilateral investment|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+LMICs|3|acronym|0ed58dcdb4a043718b2c6e0652992e78|concept+G20 stakeholders|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept+IHR amendments|4|concept|84f7c3515e664f558f550a928bdde5b8|concept+WHO CA+|3|organisation|84f7c3515e664f558f550a928bdde5b8|concept+Geneva|2|place|84f7c3515e664f558f550a928bdde5b8|concept+Public Health Workforce|5|concept|9788f3475aa54d1db48ff648f860e453|concept+Gender Inequality|4|concept|9788f3475aa54d1db48ff648f860e453|concept+Health Sector|3|organisation|9788f3475aa54d1db48ff648f860e453|concept+World Health Organization|4|organisation|9788f3475aa54d1db48ff648f860e453|concept+Public health and emergency workforce roadmap|3|document|9788f3475aa54d1db48ff648f860e453|concept+International Association of National Public Health Institutes (IANPHI)|3|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept+ASPPH|2|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept+Competency based education, Public health and emergency workforce roadmap|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept+emergencies|2|event|9e0d4b33f8d34f858eb42aa765c93415|concept+Public health|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept+One Health|5|concept|c347385c32c941ca9500d586d9b9e88e|concept+World Health Organization|3|organisation|c347385c32c941ca9500d586d9b9e88e|concept+Food and Agriculture Organization|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+United Nations Environment Programme|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+World Organisation for Animal Health|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept+One Health|5|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept+pandemic prevention, preparedness, and response|4|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept+domestic health systems|3|object|2dd90976e41d4112a2f6e029eb90b1e3|concept+India|4|place|2dd90976e41d4112a2f6e029eb90b1e3|concept+Multisectoral inclusivity|3|concept|e2379daababe407ba77deb9138fedacf|concept+OH concept|4|concept|e2379daababe407ba77deb9138fedacf|concept+Antimicrobial Resistance (AMR)|5|condition|e2379daababe407ba77deb9138fedacf|concept+Antimicrobial Resistance (AMR)|5|concept|d33d167928ec4c02a898302812a56a09|concept+WHO|4|organisation|d33d167928ec4c02a898302812a56a09|concept+Global Public Health Threats|3|concept|d33d167928ec4c02a898302812a56a09|concept+2050|4|event|d33d167928ec4c02a898302812a56a09|concept+10 million deaths|3|condition|d33d167928ec4c02a898302812a56a09|concept+Global Economy|2|concept|d33d167928ec4c02a898302812a56a09|concept+US$11-444 million|3|misc|d33d167928ec4c02a898302812a56a09|concept+global health system|5|organisation|f5f198d153604bd3a98fa4917c114a0e|concept+drug-resistant Tuberculosis|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept+HIV infections|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept+artemisinin-based combination therapy-resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+antileprotic drug resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+zoonotic diseases|4|event|f5f198d153604bd3a98fa4917c114a0e|concept+pathogens|3|object|f5f198d153604bd3a98fa4917c114a0e|concept+animals|4|misc|f5f198d153604bd3a98fa4917c114a0e|concept+urbanisation|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept+destruction of natural habitats|3|event|f5f198d153604bd3a98fa4917c114a0e|concept+illegal trade in wildlife|3|organisation|f5f198d153604bd3a98fa4917c114a0e|concept+wet markets|3|object|f5f198d153604bd3a98fa4917c114a0e|concept+zoonotic disease|5|concept|764f6457770c4826aadcd6d83adba840|concept+SARS|3|event|764f6457770c4826aadcd6d83adba840|concept+MERS|3|event|764f6457770c4826aadcd6d83adba840|concept+Ebola|3|event|764f6457770c4826aadcd6d83adba840|concept+Nipah|3|event|764f6457770c4826aadcd6d83adba840|concept+avian influenza|3|event|764f6457770c4826aadcd6d83adba840|concept+agriculture sector|4|concept|764f6457770c4826aadcd6d83adba840|concept+meat handling|3|event|764f6457770c4826aadcd6d83adba840|concept+eggs|2|object|764f6457770c4826aadcd6d83adba840|concept+dairy products|2|object|764f6457770c4826aadcd6d83adba840|concept+vegetables|2|object|764f6457770c4826aadcd6d83adba840|concept+ecological connectivity|5|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+biodiversity|4|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Global Early Warning and Response System for Major Animal Diseases|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept+zoonoses|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Global Vector Control Response (GVCR) 2017–2030|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept+vector-borne diseases|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept+Accelerating Global Health|5|event|c0439552464a4e14b6ef0c4b597c1409|concept+Pathways to Health Equity for the G20|5|event|c0439552464a4e14b6ef0c4b597c1409|concept+Water-borne diseases|3|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Drinking or coming in contact with contaminated water|2|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Faecal-contaminated water|2|object|c0439552464a4e14b6ef0c4b597c1409|concept+Two billion people globally|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Cholera, dysentery, typhoid and polio|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Around 485,000 deaths every year|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Food-borne diseases|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept+Over 200 diseases|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Chemical substances such as unpasteurised (raw) milk|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Undercooked meat or eggs|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Raw fruits and vegetables|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+600 million people are affected by food-borne diseases|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept+420,000 die each year|2|condition|c0439552464a4e14b6ef0c4b597c1409|concept+Healthy life years lost|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept+Access to adequate safe and nutritious food|2|object|c0439552464a4e14b6ef0c4b597c1409|concept+One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept+Operationalising ‘One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept+One Health|5|concept|502eb4a32dcc478381748da0c9bd7614|concept+Memorandum of Understanding (MOU)|4|event|502eb4a32dcc478381748da0c9bd7614|concept+Quadripartite Collaboration for One Health|5|organisation|502eb4a32dcc478381748da0c9bd7614|concept+One Health High-Level Expert Panel|4|misc|502eb4a32dcc478381748da0c9bd7614|concept+One Health Joint Plan of Action (2022-2026)|3|document|502eb4a32dcc478381748da0c9bd7614|concept+World Health Organisation (WHO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept+Food and Agriculture Organisation (FAO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept+United Nations Environment Programme (UNEP)|3|organisation|502eb4a32dcc478381748da0c9bd7614|concept+World Organisation for Animal Health (OIE)|2|organisation|502eb4a32dcc478381748da0c9bd7614|concept+policy actions|3|event|46f7a03700434a8497df7279c7a66991|concept+investment in intersectoral health governance|4|concept|46f7a03700434a8497df7279c7a66991|concept+national OH policies|3|object|46f7a03700434a8497df7279c7a66991|concept+research on OH|4|event|46f7a03700434a8497df7279c7a66991|concept+genomic surveillance and data-sharing practices|3|object|46f7a03700434a8497df7279c7a66991|concept+academic courses on OH|2|event|46f7a03700434a8497df7279c7a66991|concept+One Health|5|concept|51906241584640d99e39f60f1f346d60|concept+pandemic prevention and preparedness|4|concept|51906241584640d99e39f60f1f346d60|concept+World Bank's US$10-billion fund|3|object|51906241584640d99e39f60f1f346d60|concept+UN’s high-level meeting on pandemic prevention, preparedness, and response (September 2023)|4|event|51906241584640d99e39f60f1f346d60|concept+WHO|4|organisation|51906241584640d99e39f60f1f346d60|concept+OH approach|5|concept|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Databases and knowledge-sharing resources|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Best practice examples|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+OH workforce|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Integrated OH surveillance system|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Routine and emergency coordination mechanisms|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Standardised framework for addressing zoonotic spillover risks|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Urbanisation and habitat fragmentation|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+Spillover risks and disease spread|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept+G20 countries|5|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept+G20|5|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept+One Health approach in India|4|concept|e3ed493f83654c1a87d1f5bc648a8325|concept+Office of the Principal Scientific Adviser (PSA)|3|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept+integrated disease surveillance|4|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+environmental surveillance systems|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+robust outbreak investigation mechanisms|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+OH mission|4|event|3abe5438d6c9449f81cb2cb913a89f17|concept+Targeted R&D|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+vaccines, diagnostics, therapeutics, and other prevention tools|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept+data and database integration|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+analytics for better tracking of national-level progress and implementation at the local level|2|misc|3abe5438d6c9449f81cb2cb913a89f17|concept+streamlining regulatory and approval processes|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept+One Health Centre|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept+One Health|5|concept|c1f9626d266a4b3d820e6980b6dacc08|concept+zoonoses and transboundary animal diseases|4|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+2008 attempt to operationalise the OH approach for zoonotic disease control and prevention|3|event|c1f9626d266a4b3d820e6980b6dacc08|concept+zonotic policy documents|4|document|c1f9626d266a4b3d820e6980b6dacc08|concept+lack of supportive policies|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+conflicting departmental priorities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+limited institutional capacities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept+cross-sectoral collaboration on disease control|2|event|c1f9626d266a4b3d820e6980b6dacc08|concept+contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts|3|concept|c1f9626d266a4b3d820e6980b6dacc08|concept+OH approach|5|concept|a23f8844edf54ac7a6711c6983787cb1|concept+interpersonal relationships|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept+veterinary workforce|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+academic institutions|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+local population|3|misc|a23f8844edf54ac7a6711c6983787cb1|concept+Tamil Nadu Veterinary and Animal Sciences University|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+Tamil Nadu Dr MGR Medical University|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+Punjab|2|place|a23f8844edf54ac7a6711c6983787cb1|concept+SARS-CoV2 vaccine trial|4|event|a23f8844edf54ac7a6711c6983787cb1|concept+outbreak investigation|3|event|a23f8844edf54ac7a6711c6983787cb1|concept+vaccine hesitancy|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept+ASHAs|2|organisation|a23f8844edf54ac7a6711c6983787cb1|concept+preparedness|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+response|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+systems and cross-sectoral capacities|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+inclusive and equitable multi-level workplans and strategies|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+OH principles|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+OH tools, technologies, and practices|3|object|36dd1d845a3147dba0c7891d5d6fb924|concept+data and knowledge|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept+Global Health|5|concept|baf822f00df24576a51d07fdc84491e6|concept+Pathways to Health Equity|4|concept|baf822f00df24576a51d07fdc84491e6|concept+G20|3|organisation|baf822f00df24576a51d07fdc84491e6|concept+Infectious diseases|4|concept|baf822f00df24576a51d07fdc84491e6|concept+Surveillance systems|3|object|baf822f00df24576a51d07fdc84491e6|concept+Global collaboration and solidarity|4|concept|baf822f00df24576a51d07fdc84491e6|concept+Nature|2|object|baf822f00df24576a51d07fdc84491e6|concept+Health and well-being for all people everywhere|4|concept|baf822f00df24576a51d07fdc84491e6|concept+MS Swaminathan Research Foundation|2|organisation|baf822f00df24576a51d07fdc84491e6|concept+World Health Organization|3|organisation|baf822f00df24576a51d07fdc84491e6|concept+Dr Soumya Swaminathan|4|person|baf822f00df24576a51d07fdc84491e6|concept+Dr Priyadarshini Rajamani|2|person|baf822f00df24576a51d07fdc84491e6|concept+Accelerating Global Health|5|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Pathways to Health Equity for the G20|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Building a Resilient Digital Health Ecosystem in India|3|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept+Lav Agarwal|2|person|c0a97f842ce84d1399bb35fcc9ca17a8|concept+technology|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+communication|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+transportation|3|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+healthcare|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+electronic health records|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+artificial intelligence|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept+wearable devices|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+health apps|2|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept+research|3|concept|00596c043eb84a829a663e034eb52bde|concept+discovering new treatments|4|concept|00596c043eb84a829a663e034eb52bde|concept+improving overall healthcare outcomes|3|concept|00596c043eb84a829a663e034eb52bde|concept+COVID-19 pandemic|4|event|00596c043eb84a829a663e034eb52bde|concept+exponential growth of digital health|3|concept|00596c043eb84a829a663e034eb52bde|concept+India's massive population|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+Digital Health Landscape in India|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept+equitable access to healthcare services|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+technology|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept+digital platforms for care|4|event|a57747eedbc94f27aeaa023ebf800e32|concept+interoperable and standardised electronic health records|3|object|a57747eedbc94f27aeaa023ebf800e32|concept+Electronic Health Record standards|2|document|a57747eedbc94f27aeaa023ebf800e32|concept+National Health Policy|3|document|a57747eedbc94f27aeaa023ebf800e32|concept+India|5|place|1c7917baa4ae4cee997ec26107908884|concept+Digital healthcare|4|concept|1c7917baa4ae4cee997ec26107908884|concept+Hospital Management Information System|3|organisation|1c7917baa4ae4cee997ec26107908884|concept+Online Registration System|2|object|1c7917baa4ae4cee997ec26107908884|concept+National tuberculosis elimination (Ni-kshay)|3|organisation|1c7917baa4ae4cee997ec26107908884|concept+Mother and Child Tracking System|2|object|1c7917baa4ae4cee997ec26107908884|concept+Mera Aspataal (My Hospital)|2|organisation|1c7917baa4ae4cee997ec26107908884|concept+Health Management Information System|3|object|1c7917baa4ae4cee997ec26107908884|concept+Integrated Health Information Platform|2|organisation|1c7917baa4ae4cee997ec26107908884|concept+Non-Communicable Diseases screening application|2|object|1c7917baa4ae4cee997ec26107908884|concept+Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)|4|event|1c7917baa4ae4cee997ec26107908884|concept+health and wellness centers|4|organisation|eba3bd7af89a46a586d2786a9549f23b|concept+preventive care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept+primary care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept+telemedicine consultation services|4|object|eba3bd7af89a46a586d2786a9549f23b|concept+Accelerating Global Health|4|event|ec1766626938432892c24b9acb2ca6ca|concept+Health Equity for the G20|4|event|ec1766626938432892c24b9acb2ca6ca|concept+financial protection of up to INR 500,000 per family annually|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+over 120 million crore poor and vulnerable families|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+Indian population|3|place|ec1766626938432892c24b9acb2ca6ca|concept+wellness-oriented approach|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+universal health coverage (UHC)|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+patient data portability|2|misc|ec1766626938432892c24b9acb2ca6ca|concept+environment where all people can obtain health services|3|concept|ec1766626938432892c24b9acb2ca6ca|concept+rethink the core technology backbone of our system|2|misc|ec1766626938432892c24b9acb2ca6ca|concept+cutting-edge digital solutions|2|concept|ec1766626938432892c24b9acb2ca6ca|concept+converge into|1|misc|ec1766626938432892c24b9acb2ca6ca|concept+Resilient Digital Health Ecosystem|5|event|784ecfb5b0fa4e41a0d142cf69671e30|concept+ABHA numbers|4|document|784ecfb5b0fa4e41a0d142cf69671e30|concept+ABDM ecosystem|4|organisation|784ecfb5b0fa4e41a0d142cf69671e30|concept+healthcare structure|3|condition|784ecfb5b0fa4e41a0d142cf69671e30|concept+COVID-19 pandemic|4|event|784ecfb5b0fa4e41a0d142cf69671e30|concept+activities|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+innovative solutions|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept+continuity of health services|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept+whole of government, whole of society' approach|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+pandemic battle|4|event|c3bf84643ff44d68bf38a16e96fd9e86|concept+subnational and local governments|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+civil society organisations|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+private sector|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+local communities|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+Telemedicine Practice Guidelines|4|document|c3bf84643ff44d68bf38a16e96fd9e86|concept+eSanjeevaniOPD|4|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+world’s largest national telemedicine service|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+online health facilities|4|object|c3bf84643ff44d68bf38a16e96fd9e86|concept+eSanjeevani initiative|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept+digital divide|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept+rural areas|2|place|c3bf84643ff44d68bf38a16e96fd9e86|concept+access to healthcare|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept+completed 142 million|2|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept+consultations|5|event|00c023acbd1649be8e5673413309c140|concept+record time|4|condition|00c023acbd1649be8e5673413309c140|concept+patients|3|object|00c023acbd1649be8e5673413309c140|concept+27 July 2023|2|misc|00c023acbd1649be8e5673413309c140|concept+abdm.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept+esanjeevani.mohfw.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept+Accelerating Global Health|5|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept+CoWIN|4|organisation|96c919e1d14e4ba9870d0f5015e90f1f|concept+COVID-19 'war rooms'|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept+digital health initiatives|4|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept+COVID-19 India Portal|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept+inventory tracking|4|event|a29a332cd2de4594a574bb57c7d10fd2|concept+Aarogya Setu|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+RT-PCR app|2|object|a29a332cd2de4594a574bb57c7d10fd2|concept+COVID-19 facility app|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+National Public Health Observatory (NPHO)|4|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+Health Emergency Operations Centre (HEOC)|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept+overall healthcare service delivery|5|event|c53fa240102b418d96669de0302129ff|concept+integration of healthcare programmes|4|concept|c53fa240102b418d96669de0302129ff|concept+transformation of the healthcare situation in the country|5|event|c53fa240102b418d96669de0302129ff|concept+Resilient Digital Health Ecosystem|5|concept|8368e5f419c943b89a7a33939b57aa87|concept+AI in healthcare|4|event|8368e5f419c943b89a7a33939b57aa87|concept+Centres of Excellence for AI|3|place|8368e5f419c943b89a7a33939b57aa87|concept+Clinical decision support system|2|object|8368e5f419c943b89a7a33939b57aa87|concept+Event-based disease surveillance|2|event|8368e5f419c943b89a7a33939b57aa87|concept+impending disease outbreak|5|event|8ef6462971234fea8ca5b9c897badcc4|concept+AI assistant for frontline workers in 11 Indian languages|4|object|8ef6462971234fea8ca5b9c897badcc4|concept+Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept+inclusive capacity building of health professionals|3|concept|8ef6462971234fea8ca5b9c897badcc4|concept+Tele-education in medical education for remote areas|4|event|8ef6462971234fea8ca5b9c897badcc4|concept+online platforms, video conferencing, pre-recorded lectures|3|object|8ef6462971234fea8ca5b9c897badcc4|concept+government unified and dedicated online learning and training platform SAKSHAM|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept+health professionals|4|organisation|9b1e7fd4829c450b8cc36fbd9453d186|concept+advanced training|3|event|9b1e7fd4829c450b8cc36fbd9453d186|concept+regular jobs|2|condition|9b1e7fd4829c450b8cc36fbd9453d186|concept+portal|3|object|9b1e7fd4829c450b8cc36fbd9453d186|concept+public health|2|concept|9b1e7fd4829c450b8cc36fbd9453d186|concept+clinical practices|2|event|9b1e7fd4829c450b8cc36fbd9453d186|concept+Accelerating Global Health|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Pathways to Health Equity for the G20|3|concept|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Digital health|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Public sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Private sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept+National digital health ecosystem|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+Digital tools|3|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept+World Health Assembly|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept+World Health Organization (WHO)|5|organisation|71de2efb72064d318b9e0bee887f6879|concept+Global Digital Health Partnership (GDHP)|4|organisation|71de2efb72064d318b9e0bee887f6879|concept+Department for Digital Health and Innovation|3|organisation|71de2efb72064d318b9e0bee887f6879|concept+Global Strategy on Digital Health 2020-2025|3|document|71de2efb72064d318b9e0bee887f6879|concept+India's G20 Leadership|5|event|eb215b2863164d6ba5e98fcffff46cba|concept+Global Health Initiatives|4|concept|eb215b2863164d6ba5e98fcffff46cba|concept+Climate Change|3|concept|eb215b2863164d6ba5e98fcffff46cba|concept+Food Insecurity|2|condition|eb215b2863164d6ba5e98fcffff46cba|concept+pandemic|5|event|1a76e52834584b208c08bddb9a1f0b62|concept+international cooperation|4|organisation|1a76e52834584b208c08bddb9a1f0b62|concept+health emergency|4|event|1a76e52834584b208c08bddb9a1f0b62|concept+One Health|3|concept|1a76e52834584b208c08bddb9a1f0b62|concept+antimicrobial resistance|3|condition|1a76e52834584b208c08bddb9a1f0b62|concept+pharmaceutical sector|3|organisation|1a76e52834584b208c08bddb9a1f0b62|concept+vaccines, therapeutics, diagnostics|2|object|1a76e52834584b208c08bddb9a1f0b62|concept+Digital Health|5|concept|998d8f77c3c949cd8843d7bdf421b78d|concept+India's G20 presidency|4|event|998d8f77c3c949cd8843d7bdf421b78d|concept+Global Initiative on Digital Health (GIDH)|3|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept+World Health Organization (WHO)|2|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept+digital public goods|5|concept|73e23711e0a54a8dafa05eb4e0949f6b|concept+WHO norms, standards, and|4|organisation|73e23711e0a54a8dafa05eb4e0949f6b|concept+Accelerating Global Health|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept+Pathways to Health Equity for the G20|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept+digital transformation|3|concept|97cddb2fd5c54f7f91c34ca00913ee2e|concept+ABDM|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept+CoWIN|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept+eSanjeevani|2|object|97cddb2fd5c54f7f91c34ca00913ee2e|concept+Lav Agarwal|4|person|ebc08425c0f94baaad5796ba621470b9|concept+eHealth|3|organisation|ebc08425c0f94baaad5796ba621470b9|concept+International Health & Collaboration|2|concept|ebc08425c0f94baaad5796ba621470b9|concept+Public Health|3|concept|ebc08425c0f94baaad5796ba621470b9|concept+G20|2|organisation|ebc08425c0f94baaad5796ba621470b9|concept+India's Digital Public Infrastructure Transformation|5|event|9b7a9f8531134be2b16e734bda64a349|concept+Digital India programme|4|document|9b7a9f8531134be2b16e734bda64a349|concept+India Enterprise Architecture|5|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept+Ministry of Electronics and Information Technology (MeitY)|4|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept+One Government|3|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept+Data Empowerment and Protection Architecture (DEPA)|2|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept+framework|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+DEPA|4|concept|b7f8f25fdd3c482cb13517142b7c0117|concept+consent-governed and secure data-sharing|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+controlled by consent managers|2|concept|b7f8f25fdd3c482cb13517142b7c0117|concept+private ecosystem|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+citizens|2|organisation|b7f8f25fdd3c482cb13517142b7c0117|concept+finance sector|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept+loans, insurance, and other financial products|2|event|b7f8f25fdd3c482cb13517142b7c0117|concept+digital|1|misc|b7f8f25fdd3c482cb13517142b7c0117|concept+India Stack|5|organisation|be5f478737c04472bffaf880bf0be06b|concept+DEPA|4|organisation|be5f478737c04472bffaf880bf0be06b|concept+Aadhaar-based e-KYC|3|technology|be5f478737c04472bffaf880bf0be06b|concept+Unified Payments Interface (UPI)|4|technology|be5f478737c04472bffaf880bf0be06b|concept+Aadhaar-based eSign|3|technology|be5f478737c04472bffaf880bf0be06b|concept+Open Credit Enablement Network|2|technology|be5f478737c04472bffaf880bf0be06b|concept+Digital infrastructure|4|concept|be5f478737c04472bffaf880bf0be06b|concept+Private sector service delivery|3|concept|be5f478737c04472bffaf880bf0be06b|concept+digital transactions|4|event|6c3a8512b9a140c983b92ad7f3e5ac41|concept+November 2019|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept+January 2023|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept+India's Digital Public Infrastructure Transformation|5|event|26dcc67d7f7c43b4a92343aa220232c4|concept+MeitY study|4|document|26dcc67d7f7c43b4a92343aa220232c4|concept+US$500 billion by 2025|3|condition|26dcc67d7f7c43b4a92343aa220232c4|concept+India's digital economy potential to US$1 trillion|4|concept|26dcc67d7f7c43b4a92343aa220232c4|concept+business as usual scenario|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+real-time payments in India, China, Brazil|3|concept|26dcc67d7f7c43b4a92343aa220232c4|concept+Direct Benefit Transfer (DBT) programme|4|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept+physical delivery of financial benefits|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+digital payment systems|3|object|26dcc67d7f7c43b4a92343aa220232c4|concept+beneficiaries' bank accounts|2|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept+corruption, eliminating middlemen|3|misc|26dcc67d7f7c43b4a92343aa220232c4|concept+transparency|5|concept|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+direct benefit transfer (DBT) in India|4|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Pradhan Mantri Jan-Dhan Yojana|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Jan Dhan-Aadhaar-Mobile Yojana|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Indian Rupees (INR)|2|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+FY 2021-22|3|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+Digital India|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+e-governance platforms|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept+MyGov platform|5|organisation|89d34f6b4a1149da8434c3dc7e361947|concept+digital governance|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept+citizen-centricity|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept+technology|4|object|89d34f6b4a1149da8434c3dc7e361947|concept+government interactions|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+citizen-government gap|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept+enhance government services|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+transparency|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept+democratic participation|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept+digital literacy|5|concept|e5168689a0894a83821de56e5646e40c|concept+digital divide|4|condition|e5168689a0894a83821de56e5646e40c|concept+DPI|5|document|e5168689a0894a83821de56e5646e40c|concept+India's digital transformation|4|event|e5168689a0894a83821de56e5646e40c|concept+technology|3|concept|e5168689a0894a83821de56e5646e40c|concept+inclusivity|4|condition|e5168689a0894a83821de56e5646e40c|concept+scalability|3|condition|e5168689a0894a83821de56e5646e40c|concept+regulation|3|condition|e5168689a0894a83821de56e5646e40c|concept+collaboration|3|concept|e5168689a0894a83821de56e5646e40c|concept+India's Digital Public Infrastructure Transformation Ecosystem|5|event|ded53e412e15418db0ce8e093a0b0bb7|concept+government agencies|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+industry leaders|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+startups|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+academia|2|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+civil society organisations|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept+India’s G20 presidency|4|event|ded53e412e15418db0ce8e093a0b0bb7|concept+Global DPI Summit21|3|event|ded53e412e15418db0ce8e093a0b0bb7|concept+Accelerating Global Health|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+Pathways to Health Equity for the G20|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+marginalised communities|4|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+India|5|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+digital inclusion|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+urban telephone subscribers|2|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+gender gap in mobile ownership|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept+India's digital infrastructure|4|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept+intermediaries (digital media, e-commerce)|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept+connectivity to cause harm or commit crimes|3|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+comprehensive measures|4|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept+potential DPI’s scalability|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept+regulatory sandboxes|4|concept|717cc8137f1e405aa98adda0a4d527db|concept+innovative technologies|3|concept|717cc8137f1e405aa98adda0a4d527db|concept+consumer protection|4|condition|717cc8137f1e405aa98adda0a4d527db|concept+risk mitigation|3|condition|717cc8137f1e405aa98adda0a4d527db|concept+India's Digital Public Infrastructure Transformation|5|event|3dea693354c2490488cf797844863da1|concept+forums and platforms for stakeholders|4|object|3dea693354c2490488cf797844863da1|concept+policy discussions and regulatory consultations|4|event|3dea693354c2490488cf797844863da1|concept+balanced regulatory policies|3|concept|3dea693354c2490488cf797844863da1|concept+Indian regulators|4|organisation|3dea693354c2490488cf797844863da1|concept+Digital Personal Data Protection Bill 2022|3|document|3dea693354c2490488cf797844863da1|concept+presentation of the Digital India Act 2023|3|event|3dea693354c2490488cf797844863da1|concept+consumer needs, emerging technologies, and market trends|4|condition|3dea693354c2490488cf797844863da1|concept+challenges|2|misc|3dea693354c2490488cf797844863da1|concept+technology|5|concept|2d915595100243ee97337357adfbd5a8|concept+regulatory frameworks|4|concept|2d915595100243ee97337357adfbd5a8|concept+India's DPI|4|concept|2d915595100243ee97337357adfbd5a8|concept+Aadhaar|3|object|2d915595100243ee97337357adfbd5a8|concept+UPI|3|object|2d915595100243ee97337357adfbd5a8|concept+digital health infrastructure|3|object|2d915595100243ee97337357adfbd5a8|concept+DBT|3|object|2d915595100243ee97337357adfbd5a8|concept+e-governance|3|object|2d915595100243ee97337357adfbd5a8|concept+Accelerating Global Health|5|event|613d6988832246eaaf57f6d9192e54d0|concept+Pathways to Health Equity for the G20|4|concept|613d6988832246eaaf57f6d9192e54d0|concept+India's DPI experience|3|object|613d6988832246eaaf57f6d9192e54d0|concept+Digital systems|3|object|613d6988832246eaaf57f6d9192e54d0|concept+Inclusive societies|2|concept|613d6988832246eaaf57f6d9192e54d0|concept+Sustainable development in the 21st century|2|event|613d6988832246eaaf57f6d9192e54d0|concept+Sameer Kanwar|3|person|613d6988832246eaaf57f6d9192e54d0|concept+Varun Kumar|2|person|613d6988832246eaaf57f6d9192e54d0|concept+Antibiotics|5|object|a2e40d44ac8b4bc1b87b168a9a450207|concept+Antimicrobial Resistance (AMR)|5|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Global Health Crisis|4|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Health Equity|3|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept+Global Economy|2|object|a2e40d44ac8b4bc1b87b168a9a450207|concept+Extreme Poverty|1|condition|a2e40d44ac8b4bc1b87b168a9a450207|concept+Developing Nations|2|location|a2e40d44ac8b4bc1b87b168a9a450207|concept+AMR|5|concept|845384860a874fc8b18ed38b165d91fb|concept+Interventions|3|concept|845384860a874fc8b18ed38b165d91fb|concept+Antimicrobials|4|object|845384860a874fc8b18ed38b165d91fb|concept+Healthcare Systems|3|place|845384860a874fc8b18ed38b165d91fb|concept+Patient Outcomes|4|concept|845384860a874fc8b18ed38b165d91fb|concept+Health Equity|3|condition|845384860a874fc8b18ed38b165d91fb|concept+Essay|2|document|845384860a874fc8b18ed38b165d91fb|concept+Ranga Reddy Burri|1|person|845384860a874fc8b18ed38b165d91fb|concept+Robert Skov|1|person|845384860a874fc8b18ed38b165d91fb|concept+Bulagonda Eswarappa Pradeep|1|person|845384860a874fc8b18ed38b165d91fb|concept+Ralf Sudbrak|1|person|845384860a874fc8b18ed38b165d91fb|concept+Antimicrobial Resistance|5|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Persistent Infectious Diseases|4|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antimicrobial Drugs|3|object|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Biological Evolution|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Defense System of Microorganisms|3|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antibiotic Resistance Mechanisms|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept+Antimicrobial Resistance (AMR)|5|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept+Resistance|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept+Antibiotics|3|object|5f12a23a8cd14c22a6ce2a6851934d50|concept+Microorganisms|2|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept+Selection|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept+Accelerating Global Health|5|event|66c6d834348b4a62b864b5a39bb15fe1|concept+Pathways to Health Equity for the G20|4|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Inadequate infection prevention and control|4|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+AMR|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Hand hygiene|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Improper disinfection and sterilisation practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Inadequate sanitation|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Hospital-acquired infections|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Infection prevention and control measures|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept+Infection control practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+Low- and middle-income countries (LMICs)|3|condition|66c6d834348b4a62b864b5a39bb15fe1|concept+World Health Organization|2|organisation|66c6d834348b4a62b864b5a39bb15fe1|concept+WHO|4|organisation|814076eb4141455baa4afe3bddce0dd9|concept+US Centers for Disease Control and Prevention|3|organisation|814076eb4141455baa4afe3bddce0dd9|concept+Infection Control Academy of India (IFCAI)|2|organisation|814076eb4141455baa4afe3bddce0dd9|concept+Abuse/inappropriate use of antibiotics|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Selection pressure on microbes due to the use of antimicrobial drugs|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Social and administrative factors|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+Availability of antimicrobials through over-the-counter (OTC) sales without requiring prescriptions|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Inappropriate prescription of antibiotics by physicians|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+Study conducted by WHO|2|event|814076eb4141455baa4afe3bddce0dd9|concept+Significant proportion of antimicrobials prescribed in outpatient departments were unnecessary or inappropriate|3|condition|814076eb4141455baa4afe3bddce0dd9|concept+Rampant use of antibiotics in the livestock sector|2|condition|814076eb4141455baa4afe3bddce0dd9|concept+antibiotic|5|object|0aef0d4620f242e996cf1d0b2d84b4cc|concept+patients|3|organisation|0aef0d4620f242e996cf1d0b2d84b4cc|concept+OTC sale of antimicrobials|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+New legislation|3|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+stricter antibiotic prescription and consumption measures|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept+antimicrobial drug development process|3|concept|0aef0d4620f242e996cf1d0b2d84b4cc|concept+advancements in computational|2|misc|0aef0d4620f242e996cf1d0b2d84b4cc|concept+Battle Against Antimicrobial Resistance|5|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+chemistry and artificial intelligence (AI)|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antimicrobials|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+in vitro and in vivo trials|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+bacteria|3|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antibiotics|4|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+quicker and more efficient antibiotic testing and approval pipelines|3|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+antimicrobial discovery|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+existing drugs|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+natural products|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+alternate treatment strategies|2|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+computational approaches for drug design|3|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept+interdisciplinary collaborations|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept+new technologies|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept+clinical antibacterial pipeline|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept+AMR infections|4|condition|c00efcf689b046e79324603ecf4f180e|concept+antibacterials|4|object|c00efcf689b046e79324603ecf4f180e|concept+WHO priority pathogens|3|concept|c00efcf689b046e79324603ecf4f180e|concept+tuberculosis|2|condition|c00efcf689b046e79324603ecf4f180e|concept+Global AMR R&D Hub|3|organisation|c00efcf689b046e79324603ecf4f180e|concept+WHO|4|organisation|c00efcf689b046e79324603ecf4f180e|concept+development of new antibacterial treatments|5|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept+emerging threat of AMR|4|condition|676eaa0f093b4fbc80687cb2f30c6f16|concept+return on investment for new antibiotics|3|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept+big pharmaceutical companies|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept+antibiotic market|3|market|676eaa0f093b4fbc80687cb2f30c6f16|concept+small or micro biotech firms|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept+novel reimbursement models|3|misc|676eaa0f093b4fbc80687cb2f30c6f16|concept+Accelerating Global Health|4|event|29773bc63cdc4fa680e82c66e6629eed|concept+Pathways to Health Equity for the G20|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Innovative financing mechanisms|5|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Antimicrobials|4|object|29773bc63cdc4fa680e82c66e6629eed|concept+Advance market commitment–type investments|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+DNDi (Drugs for Neglected Diseases Initiative)|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+CEPI (Coalition for Epidemic Preparedness Innovations)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Gavi (Global Alliance for Vaccines and Immunization)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Antibiotics|4|object|29773bc63cdc4fa680e82c66e6629eed|concept+Governments pool funding|3|event|29773bc63cdc4fa680e82c66e6629eed|concept+Manufacturers and the private sector|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept+Financial incentives|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept+Equitable pricing and access|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Fight against AMR|3|event|29773bc63cdc4fa680e82c66e6629eed|concept+Effective treatments for all|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Poor diagnostic capacity|3|condition|29773bc63cdc4fa680e82c66e6629eed|concept+Accurate and timely diagnostics|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept+infectious diseases|5|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept+diagnostic capacity|4|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept+developing countries|3|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept+vulnerable populations|3|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept+high-income countries|2|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept+LMICs|3|organisation|7745a8bcb0d44d66ad78c6d2c0971a61|concept+quality and efficiency|2|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept+healthcare delivery|3|event|705bfb5bc30d4ce9a762f127476a6352|concept+global health goals|4|concept|705bfb5bc30d4ce9a762f127476a6352|concept+communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept+non-communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept+innovations related to AMR|4|event|705bfb5bc30d4ce9a762f127476a6352|concept+alternative therapies|2|concept|705bfb5bc30d4ce9a762f127476a6352|concept+bacteriophages|3|object|705bfb5bc30d4ce9a762f127476a6352|concept+antimicrobial peptides (AMPs) or bacteria|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept+antimicrobial adjuvants|3|object|705bfb5bc30d4ce9a762f127476a6352|concept+faecal microbiota transplant (FMT)|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept+competitive exclusion of pathogens|3|concept|705bfb5bc30d4ce9a762f127476a6352|concept+genetically modified probiotics|2|object|705bfb5bc30d4ce9a762f127476a6352|concept+Battle Against Antimicrobial Resistance|4|concept|573672aab4184bd0a0d749d328280bc8|concept+postbiotics|3|object|573672aab4184bd0a0d749d328280bc8|concept+antimicrobials|4|concept|573672aab4184bd0a0d749d328280bc8|concept+streamlined approval|3|misc|573672aab4184bd0a0d749d328280bc8|concept+regulatory agencies|2|organisation|573672aab4184bd0a0d749d328280bc8|concept+researchers|2|misc|573672aab4184bd0a0d749d328280bc8|concept+industry stakeholders|2|misc|573672aab4184bd0a0d749d328280bc8|concept+adaptive dose-ranging studies|3|document|573672aab4184bd0a0d749d328280bc8|concept+seamless phase transitions|2|misc|573672aab4184bd0a0d749d328280bc8|concept+drug repurposing|3|concept|573672aab4184bd0a0d749d328280bc8|concept+Approved drugs|3|object|a2dff2067d5543578a60182bfd8845c5|concept+Preclinical and early clinical development stages|2|event|a2dff2067d5543578a60182bfd8845c5|concept+Repurposing drugs|4|concept|a2dff2067d5543578a60182bfd8845c5|concept+In-silico analyses|3|event|a2dff2067d5543578a60182bfd8845c5|concept+High-throughput screening|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Drug libraries|2|object|a2dff2067d5543578a60182bfd8845c5|concept+Antibacterial activity|3|concept|a2dff2067d5543578a60182bfd8845c5|concept+Machine learning (ML)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept+Artificial intelligence (AI)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept+Neural network-based approaches|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Molecular fingerprints|2|object|a2dff2067d5543578a60182bfd8845c5|concept+Diagnostic process|3|event|a2dff2067d5543578a60182bfd8845c5|concept+Industry Collaboration|4|event|21cf6462eb7f41de8afc3c403e296587|concept+Sri Sathya Sai Institute of Higher Learning|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+IFCAI|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+SCIINV Biosciences Private Limited|2|organization|21cf6462eb7f41de8afc3c403e296587|concept+AMRx™|3|object|21cf6462eb7f41de8afc3c403e296587|concept+AI/ML-based culture-free prediction system|4|concept|21cf6462eb7f41de8afc3c403e296587|concept+Urinary Tract Infections|3|condition|21cf6462eb7f41de8afc3c403e296587|concept+Clinical Decision Support System|2|object|21cf6462eb7f41de8afc3c403e296587|concept+Empirical Antibiotic Prescriptions|3|concept|21cf6462eb7f41de8afc3c403e296587|concept+Unnecessary Laboratory Testing of Samples|2|condition|21cf6462eb7f41de8afc3c403e296587|concept+Accelerating Global Health|5|event|0cac054347174785b04ddef8537bee36|concept+Pathways to Health Equity for the G20|4|event|0cac054347174785b04ddef8537bee36|concept+AMR (Antimicrobial Resistance)|5|concept|0cac054347174785b04ddef8537bee36|concept+Quadripartite|3|organisation|0cac054347174785b04ddef8537bee36|concept+One Health approach|4|concept|0cac054347174785b04ddef8537bee36|concept+National Action Plans (NAPs)|3|document|0cac054347174785b04ddef8537bee36|concept+market failure for antimicrobials|4|condition|6fa033fa9795403f88f1b4cea6fa05f4|concept+financing development of novel antimicrobials|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept+Rapid Diagnostic Tests and Point-of-Care Technologies in AMR|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept+Absolute, concrete, and timely diagnosis detection|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept+infection-causing pathogens|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept+Rapid diagnostic tests (RDTs)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+Point-of-care technologies (POC)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+polymerase chain reaction-based tests|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+genotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+phenotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept+Battle Against Antimicrobial Resistance|5|event|132097da86644b35b8147fcb94ab68d8|concept+Accelerating Efforts to Combat AMR|3|event|132097da86644b35b8147fcb94ab68d8|concept+Combating AMR|5|concept|132097da86644b35b8147fcb94ab68d8|concept+Policy|3|object|132097da86644b35b8147fcb94ab68d8|concept+Implementation|3|event|132097da86644b35b8147fcb94ab68d8|concept+New antibiotics|4|object|132097da86644b35b8147fcb94ab68d8|concept+Alternative treatments|3|object|132097da86644b35b8147fcb94ab68d8|concept+Bacteriophages|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+Infection prevention and control practices|3|object|132097da86644b35b8147fcb94ab68d8|concept+Antimicrobial use|2|condition|132097da86644b35b8147fcb94ab68d8|concept+Surveillance and data collection|3|event|132097da86644b35b8147fcb94ab68d8|concept+One Health approach|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+National and global health plans|3|document|132097da86644b35b8147fcb94ab68d8|concept+Stakeholders|2|organisation|132097da86644b35b8147fcb94ab68d8|concept+Political will|2|event|132097da86644b35b8147fcb94ab68d8|concept+Accelerating Global Health|5|event|83a561974e644530b643bd7b78aaca7a|concept+Pathways to Health Equity for the G20|5|event|83a561974e644530b643bd7b78aaca7a|concept+AMR|5|concept|83a561974e644530b643bd7b78aaca7a|concept+LMICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept+vulnerable populations in HICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept+antimicrobials pipeline|3|concept|83a561974e644530b643bd7b78aaca7a|concept+industry leaving the field of antimicrobial drug discovery|4|event|83a561974e644530b643bd7b78aaca7a|concept+AMR pandemic|5|concept|83a561974e644530b643bd7b78aaca7a|concept+consequences of AMR|4|event|83a561974e644530b643bd7b78aaca7a|concept+need for increased action|5|event|83a561974e644530b643bd7b78aaca7a|concept+multifaceted effort|4|event|83a561974e644530b643bd7b78aaca7a|concept+reducing the circulation and spread of existing resistant microorganisms|3|event|83a561974e644530b643bd7b78aaca7a|concept+increase of novel resistance mechanisms|4|concept|83a561974e644530b643bd7b78aaca7a|concept+lowering the overall use of antimicrobials|3|event|83a561974e644530b643bd7b78aaca7a|concept+antimicrobial stewardship|4|concept|83a561974e644530b643bd7b78aaca7a|concept+accessibility of affordable and timely diagnostics|3|event|83a561974e644530b643bd7b78aaca7a|concept+strengthening IPC and biosecurity procedures|3|event|83a561974e644530b643bd7b78aaca7a|concept+Dr. Bulagonda Eswarappa Pradeep|2|person|6c480a85100e4e80adba9687a25de868|concept+Department of Biosciences|3|organisation|6c480a85100e4e80adba9687a25de868|concept+Sri Sathya Sai Institute of Higher Learning|2|organisation|6c480a85100e4e80adba9687a25de868|concept+India|3|place|6c480a85100e4e80adba9687a25de868|concept+Dr. Ralf Sudbrak|2|person|6c480a85100e4e80adba9687a25de868|concept+Deputy Director at the Global A M R R & D Hub|3|organisation|6c480a85100e4e80adba9687a25de868|concept+Berlin, Germany|2|place|6c480a85100e4e80adba9687a25de868|concept+G20 Countries|5|organisation|47b323d77856431b8d67d73bf0cde810|concept+Average Life Expectancy|4|condition|47b323d77856431b8d67d73bf0cde810|concept+Global Average of Life Expectancy|3|condition|47b323d77856431b8d67d73bf0cde810|concept+Accelerating Global Health|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+G20|5|organisation|ec5c38d181dd4fe98b66c735aac3841b|concept+Public Health Outcomes|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Health Equity|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Life Expectancy|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+Healthcare Spending|5|concept|ec5c38d181dd4fe98b66c735aac3841b|concept+GDP|3|object|ec5c38d181dd4fe98b66c735aac3841b|concept+Role of Health Finance in G20 Countries|5|concept|67bf46897ef2443ea58021ade0df45a0|concept+Higher % GDP Spending in Healthcare|3|event|67bf46897ef2443ea58021ade0df45a0|concept+Universal Health Care Coverage|4|concept|67bf46897ef2443ea58021ade0df45a0|concept+WHO Data|2|document|67bf46897ef2443ea58021ade0df45a0|concept+Healthcare Spending and Health Outcomes|4|event|67bf46897ef2443ea58021ade0df45a0|concept+Innovative Financing Mechanisms|3|object|67bf46897ef2443ea58021ade0df45a0|concept+G20 Countries|4|organization|67bf46897ef2443ea58021ade0df45a0|concept+Out-of-Pocket Expenses|3|concept|67bf46897ef2443ea58021ade0df45a0|concept+health equity|5|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+health disparities|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+socioeconomic status|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+race|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+ethnicity|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+gender|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+geographic location|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+access to healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+redistributing resources|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+targeted healthcare programs|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+improving access to quality healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+addressing social and economic inequalities|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+promoting health education and prevention|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+Universal Health Coverage (UHC)|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept+Global|2|organisation|cee9405d7f9345ac9beb4b3fbf485aec|concept+India|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Indonesia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Turkiye|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+China|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Singapore|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+South Korea|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Netherlands|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+UK|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Canada|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+United States|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Germany|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+France|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Japan|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Spain|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Brazil|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Argentina|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+South Africa|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Russia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Australia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Mexico|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept+Accelerating Global Health|5|event|b3125524cd434526969844ef534e60b7|concept+Pathways to Health Equity for the G20|5|concept|b3125524cd434526969844ef534e60b7|concept+COVID-19 pandemic|4|event|b3125524cd434526969844ef534e60b7|concept+G20 countries|5|organisation|b3125524cd434526969844ef534e60b7|concept+Universal Health Coverage (UHC)|4|concept|b3125524cd434526969844ef534e60b7|concept+Out-Of-Pocket Expenses (OOPE)|3|concept|b3125524cd434526969844ef534e60b7|concept+maternal, newborn and child health|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+infectious diseases|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+non-communicable diseases|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+service capacity and access|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+general and most disadvantaged populations|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+catastrophic OOP healthcare spending|4|concept|9cfbef4b83674b20b627a9af06d3ae12|concept+G20 countries|3|organisation|9cfbef4b83674b20b627a9af06d3ae12|concept+Spain and Singapore|2|place|9cfbef4b83674b20b627a9af06d3ae12|concept+WHO data6UHC|3|document|9cfbef4b83674b20b627a9af06d3ae12|concept+Figure 4|2|object|9cfbef4b83674b20b627a9af06d3ae12|concept+Past Decade for G20 Countries|3|event|9cfbef4b83674b20b627a9af06d3ae12|concept+Lower Out of Pocket Expenditure as a% of Current Health Expenditure|5|concept|8557a7dfb0ce4db8a2b165aedc19d757|concept+Global average|3|misc|8557a7dfb0ce4db8a2b165aedc19d757|concept+2009|1|event|8557a7dfb0ce4db8a2b165aedc19d757|concept+ZAFTURTUR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+KSA KSAFRA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+FRA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+USAUSAJPN|2|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+JPNDEU|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+AUSSPN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+SPNITA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+ITA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+BRABRAKOR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+CHI|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+CHIRUS|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+RUSMEX|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+MEX|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+IDN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+IDNIND|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept+INDKOR|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+SGP|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+SGPCAN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+CAN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+UKUK|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+DEU|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+ARG ARG|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept+ZAF|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept+Health Finance|5|concept|2637f57224b34d4895cf7ade5482c61c|concept+G20 Countries|4|event|2637f57224b34d4895cf7ade5482c61c|concept+Universal Health Coverage (UHC)|5|concept|2637f57224b34d4895cf7ade5482c61c|concept+Out-of-Pocket Expenditure (OOPE)|4|concept|2637f57224b34d4895cf7ade5482c61c|concept+Green Highlighted Countries|3|event|2637f57224b34d4895cf7ade5482c61c|concept+Best Practices|4|concept|2637f57224b34d4895cf7ade5482c61c|concept+Indonesia|3|place|2637f57224b34d4895cf7ade5482c61c|concept+JKN National Health Insurance|2|document|2637f57224b34d4895cf7ade5482c61c|concept+JKN program|5|program|f2ee990cbb1942db85479fce8ded4160|concept+Indonesian citizens|4|concept|f2ee990cbb1942db85479fce8ded4160|concept+Social Security Agency for Health (B P J S)|3|organisation|f2ee990cbb1942db85479fce8ded4160|concept+Healthcare providers|2|object|f2ee990cbb1942db85479fce8ded4160|concept+medical benefit package|3|concept|f2ee990cbb1942db85479fce8ded4160|concept+Out-of-pocket expenditure (OOP)|2|condition|f2ee990cbb1942db85479fce8ded4160|concept+Low and medium-income countries (LMICs)|1|concept|f2ee990cbb1942db85479fce8ded4160|concept+Indonesia|5|place|36832b98f50e46df903ea924ff5e55c5|concept+medicines|4|object|36832b98f50e46df903ea924ff5e55c5|concept+healthcare expenditure|3|concept|36832b98f50e46df903ea924ff5e55c5|concept+OOP payments|2|misc|36832b98f50e46df903ea924ff5e55c5|concept+drug pricing and procurement|4|concept|36832b98f50e46df903ea924ff5e55c5|concept+Accelerating Global Health|5|event|86eac922752743339f35699cfccec378|concept+Pathways to Health Equity for the G20|4|concept|86eac922752743339f35699cfccec378|concept+generic medicine pricing policy|5|event|86eac922752743339f35699cfccec378|concept+Maximum Retail Price set by the MOH|3|document|86eac922752743339f35699cfccec378|concept+2010 study|4|event|86eac922752743339f35699cfccec378|concept+public hospitals|3|organisation|86eac922752743339f35699cfccec378|concept+private pharmacies|2|object|86eac922752743339f35699cfccec378|concept+NGO hospitals|3|organisation|86eac922752743339f35699cfccec378|concept+Lowest Price Generic (LPG) medicines|4|object|86eac922752743339f35699cfccec378|concept+Innovator Brand (IB) medicines|4|object|86eac922752743339f35699cfccec378|concept+2010 prices|3|document|86eac922752743339f35699cfccec378|concept+2004 prices|3|document|86eac922752743339f35699cfccec378|concept+declines ranging from 40 percent to 2200 percent|3|misc|86eac922752743339f35699cfccec378|concept+generic medicine pricing policies have succeeded in lowering the price of medicines|4|event|86eac922752743339f35699cfccec378|concept+variation in implementation|3|condition|86eac922752743339f35699cfccec378|concept+excess paid by patients compared to MOH set prices|4|misc|86eac922752743339f35699cfccec378|concept+narrow the differences|3|condition|86eac922752743339f35699cfccec378|concept+more recently|2|misc|86eac922752743339f35699cfccec378|concept+state-owned enterprises|5|organisation|e66fc805e2f748178c0c1270b907aec8|concept+drug procurement|4|event|e66fc805e2f748178c0c1270b907aec8|concept+generic medications|5|object|e66fc805e2f748178c0c1270b907aec8|concept+public awareness campaigns|4|event|e66fc805e2f748178c0c1270b907aec8|concept+financial incentives|3|misc|e66fc805e2f748178c0c1270b907aec8|concept+UHC|5|concept|e663f199a53b4d5094921d1e38169663|concept+BPJS|4|organisation|e663f199a53b4d5094921d1e38169663|concept+national policies|4|concept|e663f199a53b4d5094921d1e38169663|concept+JKN|3|organisation|e663f199a53b4d5094921d1e38169663|concept+healthcare providers|4|object|e663f199a53b4d5094921d1e38169663|concept+public and private hospitals|3|object|e663f199a53b4d5094921d1e38169663|concept+clinics and facilities|3|object|e663f199a53b4d5094921d1e38169663|concept+healthcare infrastructure|4|object|e663f199a53b4d5094921d1e38169663|concept+disparities in healthcare infrastructure|3|condition|e663f199a53b4d5094921d1e38169663|concept+eldercare sector|4|concept|5655410587404d1a8412a9fc74acd655|concept+GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept+12,000 and 17,000 beds|3|object|5655410587404d1a8412a9fc74acd655|concept+Singapore government|4|organisation|5655410587404d1a8412a9fc74acd655|concept+healthy economic and GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept+institutional places|3|object|5655410587404d1a8412a9fc74acd655|concept+2nd fastest aging economy in Asia|4|concept|5655410587404d1a8412a9fc74acd655|concept+Singaporeans above 65 by 2030|4|condition|5655410587404d1a8412a9fc74acd655|concept+land and building costs of residential nursing homes|3|object|5655410587404d1a8412a9fc74acd655|concept+competitive bids for operators|3|event|5655410587404d1a8412a9fc74acd655|concept+means tested seniors|3|condition|5655410587404d1a8412a9fc74acd655|concept+substantial subsidies of up to 80 percent of monthly fees|3|object|5655410587404d1a8412a9fc74acd655|concept+Widening coverage|4|concept|47a256fcc0844063998f9a4ffb3f1c94|concept+MediShield Life|5|organisation|47a256fcc0844063998f9a4ffb3f1c94|concept+pre-existing conditions|4|condition|47a256fcc0844063998f9a4ffb3f1c94|concept+older individuals|3|misc|47a256fcc0844063998f9a4ffb3f1c94|concept+Accelerating Global Health|4|event|bab2aa6e0ee048878763f123e2e739d0|concept+G20|3|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+hospital bills|4|concept|bab2aa6e0ee048878763f123e2e739d0|concept+large outpatient treatments|3|event|bab2aa6e0ee048878763f123e2e739d0|concept+dialysis|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+chemotherapy|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+CareShield Life|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+long-term insurance|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+severe disability|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+cash payouts|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+long-term care costs|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+nursing home fees|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+MediShield|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+CareShield premiums|2|object|bab2aa6e0ee048878763f123e2e739d0|concept+Medisave|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+Ministry of Health|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+decision-making and support services|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept+Agency for Care Effectiveness (ACE)|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept+Pharmacoeconomic and Drug Utilization Unit (PEDU)|4|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Health Technology Assessment (HTA) unit|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Ministry of Health's (MOH) Drug Advisory Committee|3|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Standardised HTA methods and processes|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Advanced Clinical Evidence (ACE)|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Bandwidth limitations and lack of skilled HTA practitioners|3|condition|325c82ae1f6d45ca8776fccb347158ae|concept+Public healthcare clusters|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+ALPS Healthcare|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept+Supply chain partner|2|concept|325c82ae1f6d45ca8776fccb347158ae|concept+Health Finance|5|concept|a4172b8d44d642dd8993e93089d0e52f|concept+G20 Countries|4|organisation|a4172b8d44d642dd8993e93089d0e52f|concept+GP/family physician|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+hospital-centric healthcare system|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+preventive model|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+universal health care|4|concept|a4172b8d44d642dd8993e93089d0e52f|concept+Indonesia|2|place|a4172b8d44d642dd8993e93089d0e52f|concept+Singapore|2|place|a4172b8d44d642dd8993e93089d0e52f|concept+primary care|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept+judicious purchasing and effective procurement|2|misc|a4172b8d44d642dd8993e93089d0e52f|concept+Southeast Asia|4|place|1324e2bb4f5742cab74473e14d467926|concept+ASEAN countries|3|organisation|1324e2bb4f5742cab74473e14d467926|concept+RESYST|2|concept|1324e2bb4f5742cab74473e14d467926|concept+SPARC|2|concept|1324e2bb4f5742cab74473e14d467926|concept+SEARCH|3|organisation|1324e2bb4f5742cab74473e14d467926|concept+National University of Singapore|2|place|1324e2bb4f5742cab74473e14d467926|concept+Telehealth|4|concept|76280917c6254c15b067914f14125841|concept+insurtech|3|concept|76280917c6254c15b067914f14125841|concept+COVID-19 pandemic|2|event|76280917c6254c15b067914f14125841|concept+Singapore|3|place|76280917c6254c15b067914f14125841|concept+Indonesia|4|place|76280917c6254c15b067914f14125841|concept+mobile services|3|concept|76280917c6254c15b067914f14125841|concept+micro-insurance|2|concept|76280917c6254c15b067914f14125841|concept+Accelerating Global Health|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Pathways to Health Equity for the G20|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+UHC (Universal Health Coverage)|4|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+G20 countries|4|organisation|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+National University of Singapore's Saw Swee Hock School of Public Health|3|place|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Associate Professor Jeremy Lim|2|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+Janice Tan|1|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept+diverse landscapes|3|misc|2f3c4ce941c14624bfbd3da82ff8def7|concept+public and private sector hospitals|4|place|2f3c4ce941c14624bfbd3da82ff8def7|concept+nursing homes|3|place|2f3c4ce941c14624bfbd3da82ff8def7|concept+singapore and malaysia|4|location|2f3c4ce941c14624bfbd3da82ff8def7|conceptdiff --git a/data_output/OrfPathHealth/health_india_data.csv b/data_output/OrfPathHealth/health_india_data.csvnew file mode 100644index 0000000..e97556e--- /dev/null+++ b/data_output/OrfPathHealth/health_india_data.csv@@ -0,0 +1,2650 @@+text|source|page|chunk_id+"147+147Mental Health as a+Pathway to Health+Equity+ Pratima Murthy, Krishna Prasad Muliyala, and+Channaveerachari Naveen Kumar+Equity, diversity, and inclusiveness are the basic tenets of distributive+justice and are essential goals for development. The World Health+Organization (WHO) envisages that health equity can be achieved when+everyone attains their full potential for health and well-being. This includes+mental health. According to WHO’s definition, ‘mental health’ is a state of+mental well-being that enables people to cope with the stresses of life,+realise their abilities, learn well and work well, and contribute to their+community.1+Mental health is closely linked with many of the United Nations (UN)+Sustainable Development Goals (SDGs).2 It comprises people’s individual+and collective abilities to make decisions, build relationships, and shape the+world, and is more than the mere absence of mental illness. In its broadest"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|0|83d4d0367bb0467e811782a4ada3bbb9+"sense, mental health encompasses promotive and preventive aspects, while+mental disorders or illnesses (used interchangeably in this article) are more+focused on treatment and rehabilitative aspects. However, mental health+and well-being is equally important for persons with mental disorders, as+much as it is for those without such disorders."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|0|80ab9a7c29b44098961576ccd53fb7f6+"148Accelerating Global Health: Pathways to Health Equity for the G20+149Integrating Mental Health into General Healthcare+The complex interaction of biological, psychological, and social determinants+shapes an individual’s mental health. There is evidence that poverty and+other adverse social circumstances are risk factors for poor mental health,+and for mental disorders. Biological vulnerability as well as psychosocial+distress predispose an individual to common mental disorders like+depression, substance use disorders, and behavioural addictions.3 They can+also be reasons for relapse for episodes of severe mental illness (SMI)+such as schizophrenia or bipolar mood disorder.+The relationship between social adversity, mental distress, mental and+physical illness is both interactive and complex. The presence of mental+illness, particularly SMI, can drive people to poverty and worsen mental+distress for both the individual and their family. Similarly, psychosocial"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|1d5cc8cbbb074190b824e1fbc0d644aa+"adversity is a recognised risk factor in conditions like diabetes and+tuberculosis and influences health outcomes.4,5 Socioeconomic, political,+cultural and place-based conditions all determine health outcomes, including+on mental health.+Multimorbidity—defined as the co-occurrence of more than one chronic+condition in an individual—can occur a decade earlier in those who are+experiencing socioeconomic vulnerabilities.6 When two or more conditions+cluster together (both contributing and resulting in socioeconomic+inequalities), medical specialists use the term ‘syndemic’ to describe such+a situation. Therefore, the contextual determinants of health and disease+are paramount in the conceptual framework of syndemics. Moreover, the+two or more chronic conditions can interact and lead to adverse mutual+outcomes for the conditions. The imperative, therefore, is to shed a+dichotomous approach to mental and physical health and integrate them+both in healthcare service delivery."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|1f02a81a02054efaacb0ace0c5eadd14+"both in healthcare service delivery.+The challenge is how to efficiently distribute healthcare resources to those+who most need them. In many regions of the world, while disadvantaged+populations need greater healthcare, they receive less.7 Some sections+of society (for example, those with mental illness) may warrant greater+allocations of resources, as much as equal treatment is required for similar+needs. Health economists and the World Health Organization (WHO) have"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|1|33e4526e998e4865bd5b0dde036c2a20+"149Mental Health as a Pathway to Health Equityargued that investing in mental health is important from the point of view+of improving population health and reducing social inequality, promoting+human rights, and improving economic efficiency.8 The economic implications+of mental and substance disorders can be enormous: for example, the+global economic loss due to common mental disorders is an estimated US$+1 trillion per year.9 Given the increasing prevalence of mental illness, the+costs are likely to only further mount. Investment in treatment of mental+illness can result in large economic productivity gains.10+The Burden of Mental Health, Substance Use Disorders and+Multimorbidity+Mental and substance-abuse disorders are leading contributors to premature+morbidity and mortality globally. In India, for example, the National Mental+Health Survey (NMHS), 2015-16, has reported a 13.6-percent lifetime+prevalence of any mental/substance-abuse disorder morbidity.11 The overall"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|b9359fe26659413da22ea47729356210+"number of Disability-Adjusted-Life-Years (DALYs) for mental disorders has+increased by more than 50 percent between 1990 and 2019.12 This growth+pattern is expected to continue, necessitating a proportionate response from+the health systems. Most of the mental and substance abuse disorders+are chronic and disabling conditions. The treatment gap for mental and+substance abuse disorders (defined as proportions of those needing care+but not receiving) remains high (about 75 percent), contributing to the+high burden at various levels (individual, family and community). A vast+majority of the population cannot afford out-of-pocket (OOP) spending+for the treatment of mental and substance abuse disorders and psychiatric+rehabilitation.+Such out-of-pocket expenditure, in India, is dominated by medicines.13 In+more than half of the population, non-medical costs such as expenses+on travel and accommodation contribute to more than one-third of OOP"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|acf42504124f4b29b4f551d0365821b0+"spending. The share of doctors’ fees and diagnostic charges in OOP+expenditure is high in private healthcare settings.14 Discrimination in the+coverage by health insurance toward mental illness significantly raises+the chances of catastrophic spending in such circumstances. Despite the+Insurance Regulatory and Development Authority of India (IRDAI) having+directed Indian insurance companies to cover mental illnesses as per the"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|2|5b6399f5e510497481764cd1009caa5c+"150Accelerating Global Health: Pathways to Health Equity for the G20+151Mental Health Care Act, 2017, there have been many reported violations of+the provision of the Act.15 The violations have included rejections of claims+for mental illness by insurance companies and discriminatory ceilings on+the sum of reimbursement for mental illness.+Worldwide, people with SMI have shortened life expectancy by 10-20+years, which is explained by the high rates of multimorbidity.16 Yet the+interventions to address the multimorbidity, primarily non-communicable+diseases (NCDs) and the associated risk factors such as tobacco and alcohol+use, physical inactivity, and poor diets—are insufficient for this group.+The existing national programs to address these chronic conditions seem+oriented vertically with poor horizontal integration across the programmes.+Homeless persons, women, persons with developmental disorders, and"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|b123ca85f1a04a5294b943d121e5c61b+"elderly with mental illness experience even further inequities among the+unequal.+The living conditions of persons in India with SMI chronically and who+reside in psychiatric hospitals have been highlighted through public interest+litigations and addressed by the active intervention of the judiciary. The+National Human Rights Commission (NHRC), with the technical support+of the National Institute of Mental Health & Neuro Sciences (NIMHANS),+Bengaluru, has reviewed the rights violations of persons with SMI in these+hospitals and monitored the required systemic changes.17,18+Over the last two decades, there have been consistent efforts toward+developing a better systemic response in the care of persons with mental+illness.+Key Efforts in Improving Mental Healthcare in India+The NMHS, 2015-16, India, reported the current prevalence of any mental+morbidity to be 10.56 percent.19 Those with low education and lower"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|fbc1612e79c946e0bb9c62472a5e49ca+"income, and are middle-aged were at the highest risk for mental illness.20+Only two out of every 10 individuals with mental illness received mental+healthcare.21 Lack of mental health resources (e.g., shortage of mental health+professionals), poor mental health literacy, stigma and discrimination,"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|3|072bf535acba49bb8a7059ff890dfd7a+"151Mental Health as a Pathway to Health Equitysocial inequality, gender issues and lack of community participation may+be among the various factors that impede mental health equity in India.+To be sure, India has made strides toward improving mental healthcare+(summarised in Box 1). India was one of the first Asian countries to have+a National Program for Mental Health (NMHP; as early as 1982). The+District Mental Health Program (DMHP) today covers 700 districts across+the country. The DMHP is the implementation arm of the NMHP tasked+to ensure the availability and accessibility of minimum mental healthcare,+integration of mental health in general healthcare, and to promote+community participation in mental health development.+Box 1. Initiatives in India to Ensure Equitable Mental Healthcare+Programmes:+• Expansion of the National Mental Health Programme – District+Mental Health Programme (>700 districts) and Taluk Mental Health+programme (e.g., Karnataka)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|4|0fd5e7c372a842cc9368e25bf0cb57b4+"programme (e.g., Karnataka)+• Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY) –+Universal Health Coverage, Health and Wellness Centres+• National Tele Mental Health Programme (Tele Mental Health Assistance+and Networking Across States: Tele-MANAS)+• Generic medicines – Jan Aushadhi Kendras+Policies:+• National Mental Health Policy (2014)+• National Health Policy (2017)+Legislations:+• Rights of Persons with Disability Act, 2016+• Mental Health Care Act, 2017"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|4|d1159f0aacce4add93913834766d4b45+"152Accelerating Global Health: Pathways to Health Equity for the G20+153Moreover, the availability of psychotropic medications in primary healthcare+has also improved. Screening and basic management of mental illness have+been incorporated into the services offered at Health and Wellness Centres+(HWC). India has a progressive Mental Health Policy (2014) based on equity,+justice, integrated and evidence-based care in a rights-based approach.22+The use of digital technology is being leveraged for training and expanding+human resources for mental health care in the country through digital+academies at NIMHANS as well as other institutions. The National Tobacco+Control Program has employed a mobile-based strategy called m-Cessation+and tobacco quit-lines to support those who wish to quit tobacco.23,24 The+Government of India launched the National Tele Mental Health Program+(Tele Mental Health Assistance and Networking Across States: Tele-MANAS)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|0e19e6305c0049768cd3d005956a6c24+"initiative on World Mental Health Day, 2022, to provide 24/7 comprehensive+tele-mental health services that cater to remote and underserved areas.25+The Tele-MANAS initiative—a phone-based, counsellor-led service—aims to+address mental distress, identify mental illnesses and behaviours that need+specialist mental health referrals, and improve service networking in each+State/Union Territory. The examples of digital technology-based initiatives+in India for mental health are summarised in Box 2.+Box 2. Technological Initiatives in India for Mental Health+◊ Telephone/mobile based: Quitline, m-cessation (tobacco), Nikshay Sampark+(TB helpline), Tele-MANAS (National Tele-mental health programme),+Kiran (mental health rehabilitation), COVID-19 psychosocial helpline, sui -+cide helplines, crisis helplines for elderly, women, children, farmers+◊ E-healthcare: eSanjeevani (National Telemedicine Service of India),+e-Manas Karnataka (Mental Healthcare Management System)"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|3fc32cb84c4d4da6b29abc6c19d6eb76+"◊ Training: NIMHANS digital academy, Telemedicine Centre, NIMHANS, CIP+Digital Academy, LGBRIMH Digital Academy+◊ Telepsychiatry: NIMHANS ECHO model, PGIMER “Tele-enabling model”+◊ Potential uses: chatbots, telerehabilitation, self-help"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|5|14b35b1d32d540e9b9815a325f95911e+"153Mental Health as a Pathway to Health EquityThe Government of India’s flagship insurance scheme, Ayushman Bharat-+Pradhan Mantri Jan Arogya Yojna (PM-JAY), aims to achieve Universal+Health Care (UHC) in India.26 The scheme will cover most secondary and+tertiary hospitalisations for nearly 40 percent of the population. The annual+coverage of INR 500,000 per family is irrespective of family size. The+scheme does not, however, cover outpatient expenses. Generic medicines+have been made available in Jan Aushadhi Kendras.27 The availability of+generic medicines at cheaper rates than branded drugs will likely reduce+the economic burden for all sections of society, especially the poor and+marginalised. The second pillar of the PM-JAY is the provision of universal,+comprehensive healthcare in primary care through the 150,000 Health and+Wellness Centres (HWC). The HWC will act as the first point of contact+for comprehensive services, including screening and essential mental health"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|5bbe6986777c47ee854e432f79982bc2+"conditions management.+Two progressive legislations were enacted by the Government of India in+the backdrop of the United Nations Convention on the Rights of Persons+with Disability to address critical concerns of inequality and inequity in+mental healthcare. The Rights of Persons with Disability Act (RPWD),+2016 has provided a reservation of 1 percent for mental illness-related+disabilities in recruitment to government jobs or aided organisations.28+The Act guarantees reasonable accommodation in education and work in+government institutions for persons with disability. The Mental Health+Care Act (MHCA) 2017 provides the right to access mental healthcare and+treatment from mental health services run or funded by the appropriate+Government.29 The provision under the Act encompasses a range of services+for persons with mental illness, including psychiatric rehabilitation and+community reintegration. The Act also underscores the need for integrating"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|250599129c69496098a9f054d3e8f273+"mental health services with general health services at all levels. The MHCA+2017 also directs parity for mental illness in health insurance as is available+for physical conditions. Appointing persons with mental illness, their family+members and NGOs in the Central and State Mental Health Authorities and+the Mental Health Review Boards is an affirmative step towards ensuring+checks and balances in the delivery of mental healthcare in an equitable+manner."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|6|2e92547f635f4574ad69394da1fa736d+"154Accelerating Global Health: Pathways to Health Equity for the G20+155Thus, there have been improvements in curative and preventive care domains+for mental and substance use disorders in the last decade. However, these+need to be translated on the ground. There is also still a lack of adequate+focus on rehabilitative care, which remains restricted to select tertiary care+mental health institutions.+The Way Forward+If the vision of the National Mental Health Policy 2014 must be truly+realised, its strategic directions and recommendations for action will need to+be implemented. The distinct mental health needs of vulnerable populations+such as children, the elderly, the homeless, require to be addressed. Macro-+environmental issues such as poverty, unemployment, displacement, and+emerging concerns such as the mental health impact of climate change+require particular focus. Leadership and governance at various levels must"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|4cd87763e8f84bdc8f0067b2b4dec451+"be strengthened. Mental health systems should be strengthened at various+levels to provide decentralised care in smaller administrative units such as+the taluks /blocks.+Preventive and promotive aspects of mental health provide an opportunity+to integrate existing mainstream/biomedical as well as alternative/traditional+systems of care, including Yoga. Mental health should be effectively+addressed at the workplace. The mental health of children and adolescents+should take primacy and can be addressed in educational settings.+However, given that there may be a substantial group of out-of-school+children and adolescents, as well as a large proportion of the population+that works in the unorganised sector, there is a need to expand the reach+of access to mental healthcare. A life-span approach to mental healthcare,+extending from perinatal care to elderly care is recommended. Research in+public mental health aspects is another priority. Mental health indicators"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|aabe35a0a6ee404f8b52f740eef53457+"need to be standardised and incorporated in governance regularly. The+comprehensive set of interrelated services has been deemed necessary+in the World Mental Health Report, 2022 – these cover the life cycle, from+maternal and child mental health, to the elderly.30"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|7|25ad6848459145afa5072490e52d8550+"155Mental Health as a Pathway to Health EquityInequity in mental healthcare needs to be systematically measured and+monitored in LMICs to identify gaps and to inform policies and programmes.+WHO has developed the Health Equity Assessment Toolkit (HEAT and HEAT+Plus) software to explore and compare within-country health inequalities+and across settings using disaggregated datasets.31 Simultaneously, there is+a need to learn from successful models developed in High-Income Countries+(HICs). For example, in the United Kingdom (UK), the National Health+Service (NHS) through the Five-Year Forward View for Mental Health has+prioritised addressing inequity.32 There have been debates in the public+health domain for “disparity interventions” that are specifically designed+for populations that face inequality.33 Most of the existing inequality+interventions in the mental health field from the HICs have focused on"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|e7ce4dbfa7e046b6aba50e75ac56ef07+"racial disparities, age-related factors, and socioeconomic issues. While+developing, testing, and implementing the interventions, at each stage, all+stakeholders including the service users will have to get involved.+To ensure universal health coverage for mental health, specific efforts have+been conducted by WHO in six early adopter countries. Inadequate human+resource and inequitable distribution of specialists were reported to be the+crucial issues in the situational analysis.34 In India, for the PM-JAY to+meet the goal of universal health coverage, service delivery needs to be+strengthened at all levels and systems to maintain continuity of care must+be created, an area that is particularly relevant for mental health.35 The+coverage for non-PM-JAY patients, specifically non-below poverty line but+belonging to lower/middle socioeconomic classes will have to be addressed+to reduce catastrophic spending.36 Mechanisms of surveillance and health"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|5638dcc7ccf74e4d9d46edc619192c2b+"information must be further strengthened to encompass private healthcare+providers.+The national programmes for non-communicable diseases and chronic+communicable diseases such as Tuberculosis need to consider that+most patients with these conditions have multimorbidity and align the+programmes with the NMHP at various levels. Integration of care at the+primary care level and the HWC will have to be implemented as envisioned+in the PM-JAY, with an emphasis to improve patient reported outcomes,+besides clinical outcomes. There is sufficient evidence for self-management+and peer-based interventions for chronic conditions that have emerged+and have been successfully implemented in HICs.37,38 They must be adapted"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|8|d7a98a5523a14a81b33b3cadbeef1397+"156Accelerating Global Health: Pathways to Health Equity for the G20+157to the cultural settings of LMICs. The effectiveness of brief psychological+interventions delivered by lay counsellors for moderate to severe depressive+disorders and harmful drinking in primary care has been demonstrated in+India.39,40+These low-cost interventions may have important lessons for HIC as the+health systems in HICs are overwhelmed with long waiting periods for+psychological intervention. Low-intensity interventions such as WHO’s+Problem Management plus (PM+) can be used in low-human resource+settings for adults in distress due to exposure to adversity.41 Families+are an important resource for care provision in LMICs, specifically in the+context of mental health and the role and concerns of family caregivers+must be formally addressed. Indigenous interventions such as Yoga as well+as alternative forms of medicine have potential benefits for multimorbidity."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|644bde3f851d4926ba9d1fa8b25b904b+"An evidence-based integration into the public health system may enhance+outcomes as they are culturally acceptable and may have a broad spectrum+of action.+Technology has been harnessed in healthcare in India as exemplified+by the Tele-MANAS programme. However, the metrics to monitor the+implementation of the programme should encompass inequities in the+delivery of virtual care. Methods to enhance digital literacy and adaptation+of the care so that even those with low digital literacy can comfortably+use the portals of care, need to be considered during implementation. As+primary healthcare is the locus of UHC, addressing the referral pathways+with monitoring of the referrals, robust information systems and integration+of mental and physical care are central to improving outcomes. The+successful translation of policies and programmes on the ground requires+governmental engagement as well as that of all stakeholders to ensure+equitable and quality healthcare."|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|78487c391631417992f97fcd77f0ba19+"equitable and quality healthcare.+Dr. Pratima Murthy, Director and Senior Professor of Psychiatry, NIMHANS, Bengaluru+Dr. Krishna Prasad Muliyala, A d d i t i o n a l P r o f e s s o r o f P s y c h i a t r y , N I M H A N S , B e n g a l u r u+Dr. Channaveerachari Naveen Kumar, Professor of Psychiatry and Head of Community+Psychiatry, NIMHANS, Bengaluru"|data/MedicalDocuments/OrfPathHealth/MentalHealthPathwayToEquity.pdf|9|996585f3b2fe4afe9aad026a32d48fe9+"39+39The COVID-19 pandemic took the world by surprise. In early 2020, no+one would have thought that in months to come, millions of people+would be in ‘lockdown’, trillions of dollars would be lost to the global+economy, and over 7 million people would die from the disease caused by+the novel coronavirus. For many years before 2020, scientists and medical+experts had been warning that the world was simply not ready for disease+‘X’; such a pandemic was almost inevitable, however, coming as it did+from a zoonotic virus for which no vaccines or drugs had been developed.+Although it has been declared that the Public Health Emergency of+International Concern relating to COVID-19 is over, many countries,+especially low-income ones, still have a substantial number of COVID-19+cases and are without access to the vaccines and drugs they need. There is+the risk of becoming complacent again. There are hundreds of thousands"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|0|8bf2b50e94df47b392aa512dbb2e74c1+"of bird and animal viruses that could get transmitted to humans, and+potentially onwards from human to human. A new infectious disease can+almost certainly strike. The question is when.+While not all disease outbreaks can be prevented, they can be arrested so+that they do not escalate into an epidemic or pandemic. Social inequalities Barbara StockingThe Urgent Need for+a Pandemic Accord"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|0|03a06fd2936d41afa48ec291c8bcbda8+"40Accelerating Global Health: Pathways to Health Equity for the G20+41can be reduced, and health systems strengthened, to better protect+populations against such outbreaks. The imperative is to understand what+went wrong, and what it would take to make things right.+Critical Failures+To prevent history from repeating itself, the global community would do+well to learn the lessons of COVID-19.+a. Countries were insufficiently prepared. Even those with strong healthcare+systems geared to tackle pandemics had not tested them through,+for instance, simulation exercises. Poorer countries did not have the+resources to run a fully functioning public health system. In almost+all countries, there was little understanding of the implications of a+lockdown—for livelihoods and the economy, trade, and social services+such as education .+b. Aside from public health experts, others had no understanding of how+fast an outbreak can develop into a pandemic. Initially, governments"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|1|40998ca4b2594430b3f1f64aadfec89b+"took a ‘wait and see’ approach rather than precautionary action. February+2020 was a critical month when the opportunity to take control of the+virus was lost.+c. Countries did not comply with the International Health Regulations+(IHR) which have been in place since 2005, and often did not accept+evidence-based advice from the World Health Organization (WHO).+d. The wide inequities between countries and population groups were+exacerbated, and the consequences were dire in determining who had+access to vaccines and drugs and who did not.+A New Pandemic Treaty and Amendments to the IHR+Early on in the pandemic, calls were made for action including developing+a ‘pandemic treaty’ that would set out what countries need to do, and hold+them to account. At a special session of the World Health Assembly (WHA)"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|1|546a91dcc37740dfb8597967e1999249+"41The Urgent Need for a Pandemic Accordin 2021, WHO’s 194 member states agreed to negotiate a new ‘Convention+Accord or other International Instrument’ on pandemic preparedness and+response (PPR) (referred to as the WHO CA+ or the Pandemic Accord).1+The work began with an Intergovernmental Negotiating Body (INB) being+established with a final proposal to be delivered to the WHA in May 2024.+In May 2022, it was also agreed that a Working Group on amendments to+the IHR should be established (WGIHR).2 Its report is due at the end of+2023. All member states are engaged in both negotiations.+From the beginning, the scope of the changes to the IHR has been+contentious. The resolution of the WHA was to keep it to a small number+of amendments, but some countries argued for a much wider scope. They+sought, for example, for ‘One Health’a prevention measures, and equity in+access to drugs and vaccines. It has led to 300 amendments to the IHR"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|2|8a0b9edbbadd44c4babe8192a73bc83d+"being submitted to the WGIHR. Countries which might have preferred a+more limited approach also jumped in when it was clear that the scope+was to be broader. As a result, many proposed changes are similar to those+suggested in the Pandemic Accord.+Ultimately, there has to be coherence and compatibility between the Accord+and the IHR. It is likely that the Accord will have more of the overarching+principles and wider issues, with the IHR defining the technical requirements+to deliver them. There is a long way to go but the member states guiding+the negotiations are meeting regularly to try to ensure coherence and avoid+conflicting recommendations.+Guiding Principles+The following are the key principles that should be at the heart of the+Pandemic Accord and the IHR:+a ‘One Health’ is a collaborative, multi-sectoral approach to health, which recognises the+interconnection between people, animals, plants and their shared environment."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|2|b666ff6d8d3445a98869212995fcb597+"42Accelerating Global Health: Pathways to Health Equity for the G20+43• Solidarity.+Preventing outbreaks from turning into pandemics is a collective+responsibility and is in every country’s self-interest. Unhelpful campaigning+on social media and elsewhere has suggested that a new treaty could+challenge the sovereignty of a country. That is not the case; countries will+continue to take their own decisions. The Charter of the United Nations+affirms the sovereignty of States Parties in addressing their own public+health matters.3 However, it also sets out the obligation to ensure that+“activities within their own jurisdiction or control do not cause damage to+their peoples, other States Parties, and areas beyond the limits of national+jurisdiction”.+• Equity.+Morality and national self-interest demand equitable access to all tools,+including vaccines, diagnostics and treatments, and financing for these+resources. Equity includes a change of attitude in governance. There"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|3|6e54c98b3b944682acb35e1bfe531831+"needs to be equity in governance systems, for example, in financing for+preparedness and response to pandemics. It should not be just controlled+by donors.+Equity also means fairness in the assessment of what countries are capable+of. There are significant differences in each country’s ability to deliver+preparedness and response. Poorer countries simply do not have the same+level of resources as the developed ones.+• Transparency.+Transparency of data and genomic sequencing are vital to responding+quickly and effectively to the pandemic, and required for the development+of new drugs and vaccines. Transparency is what builds trust within and+between countries.+• Accountability.+The new Accord must set out greater accountability requirements than were+in place in the past. This is one of the key reasons for the Accord. Many"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|3|9ccb6cad21444a27b7970917ba7e6c8b+"43The Urgent Need for a Pandemic Accordcivil society organisations have been sceptical about whether a new treaty+would make a difference, pointing out that compliance with the IHR is still+lacking. That challenge must be met.+Accountability should be to the people of each country through parliamentary+systems and civil society. It is also needed for mutual assurance between+countries. When governments require extraordinary actions from their+populations—for example, lockdowns and mask mandates—they need to be+confident that other countries are also taking appropriate action.+Building Consensus+Early in 2023 the ‘zero draft’ of the Accord was made available and+the real negotiations began. Taking into account all the discussions and+proposed texts from member states, a revised draft—the ‘first draft’—is+to be produced in the summer of 2023. The negotiations are undoubtedly+complex, but it is worth noting that a surprising amount seems to be+commonly agreed upon."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|50ba14851d3f4a95ac0e459eb61a0f50+"commonly agreed upon.+The purpose of the Accord and its principles seem widely accepted, including+the protection of the human rights of all people wherever and whoever they+may be. There is particular concern that the needs of the most vulnerable+people are taken into account in pandemics. There is commitment to the+development of public health and healthcare systems and to protect staff,+who are most at risk in epidemics and pandemics. There is a need to+communicate well with the public and deal with misinformation. There is+commitment to a ‘whole-of-society’ approach for all plans and actions,+and recognition of the need for global coordination.+There appears to be conceptual agreement that preparedness plans should+involve all of government, and that there should be regular simulation+exercises. A ‘Universal Health and Preparedness Review’ is suggested as+a mechanism for review of each country’s preparedness. Both peer review"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|bc526127448645b3837dcc3b45668a83+"of the plans as well as independent assessment are being discussed.+Surprisingly, remarkably little is being said about public health response,+presumably because so much of it falls within the IHR."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|4|5e2a17a4edaa487290ad2532cd863fd8+"44Accelerating Global Health: Pathways to Health Equity for the G20+45An area of work making encouraging process is prevention. This brings+together human and animal health, now often described as ‘one health’.+Because zoonosesb a r e t h e g r e a t e s t r i s k , a c t i o n s t o r e d u c e t r a n s m i s s i o n —+such as closure of wet markets or banning of exotic animal trade—are+being considered alongside work on the habitats of humans and animals.+However, it seems unlikely that a fully considered plan will be ready for the+Accord; a new protocol might be more appropriate. The Joint Plan of Action+is being developed by WHO, the Food and Agriculture Organization, the+World Organisation for Animal Health, and the United Nations Environment+Programme,4 m a k i n g u p t h e s o - c a l l e d ‘ q u a d r i p a r t i t e ’ .+Areas of Contention+The contentious issues are around equity, especially related to countries’"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|83977ec929b94ecc86a6c51a35fa39cf+"access to vaccines, drugs, and other medical equipment. Member states+might sign up to the principle, but there are great differences among them+on how this should be achieved. Developing countries are pressing for a+wider spread of manufacturing, particularly for vaccines, but not only for+them. Success in getting mRNA vaccine manufacturing underway in South+Africa is a good start, although manufacturing for the whole continent and+globally will require both financial investment and technology transfer. The+extent to which the pharmaceutical industry would be prepared to engage+with technology transfer and the associated question of intellectual property+rights is unclear.+Various models have been proposed to achieve access. When wealthier+governments fund the research and development (R&D) of companies, for+example, they could persuade industry players to earmark a percentage of+vaccines for the poorer countries, or to sell these to them at cost. However,"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|c4ed77f811a94b6b8d85279085b53df5+"that would still leave the poorest countries at their mercy. Meanwhile, the+pharmaceutical industry argues that without commercial pricing of new+drugs and vaccines, there is no incentive for innovation.+b These are infectious diseases which can be transferred from animals to humans, or vice+versa."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|5|1a4820465fa844f8901275aa62a66e82+"45The Urgent Need for a Pandemic AccordSuch debates are not new. The World Trade Organization struggled to reach+an agreement on a Trade Related Aspects of Intellectual Property Rights+(TRIPS) waiver throughout the pandemic, with limited success.5 This was+despite an early agreement on TRIPS waivers for drugs in a public health+emergency, reached many years ago in 2001 during the Doha Trade Round.6+It is difficult to see how there can be a breakthrough, but developing+countries have made it clear they will not support a new Accord which+does not deal with equity of access.+Crucial Gaps+The Pandemic Accord and the IHR will fail if two areas are not attended+to: financing and accountability.+Financing : The G20 Independent High-Level Panel estimated that the+annual financing need for future preparedness and response to pandemics+was US$ 31 billion.7 Even considering domestic and international financing,+US$ 10 billion a year is required for PPR, which includes upgrading public"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|abe8dec679a3446db21c31d36bcd3b12+"health systems, R&D, and overall preparedness. If the amount seems high,+it must be remembered that it is a tiny amount compared to the cost of+a pandemic.+The G20 report and another from the World Bank and WHO8 led to the+establishing of the Pandemic Fund at the World Bank. However, the+promised funding in the first year has been only US$ 1.6 billion, and there+are concerns about how funds can be raised in the longer term. This is+the moment for the G20 to deliberate on how the necessary financing can+be found.+Accountability: For the Accord and the IHR to succeed, countries must+deliver on the obligations they have committed to. External accountability+mechanisms are also needed as safeguards to ensure that all parties are+answerable for these obligations. The Panel, which this author chairs,+firmly believes that there should be independent assessment of countries—+their preparedness plans, response, and other matters which might be"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|c410a5c9df2e4df2998153d58af3836c+agreed upon in the Accord. WHO is a friend and supporter of countries,|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|6|c134e5a2812f44f9803c15d7591765a0+"46Accelerating Global Health: Pathways to Health Equity for the G20+47which makes it difficult for it to challenge them in the public space. The+Panel believes that the way forward is a small independent body for the+Accord and perhaps the IHR, too. The Accord will be hosted by WHO but+will have its own secretariat. An arms-length independent assessment body+could be housed within the Accord’s treaty structure. The International+Atomic Energy Agency (IAEA) is one model being proposed, but because+WHO already has much of the monitoring information, the independent+assessment body need not be as large as the IAEA.+Assessments do not have to be about blaming and shaming. They need+to be public but supportive, especially of countries that do not have the+resources and are in need of financial and technical help. Pandemics create+huge risks to individuals and nations. The public has a right to know what+their governments and other governments are doing to protect them, and"|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|7|42c1df8501c946858051c31ad52c5ec5+"that includes ensuring countries across the world have the resources to+deliver.+Dame Barbara Stocking, Chair, Panel for a Global Public Health Convention, is+responsible for opinions expressed in this article though they are informed by the+Panel’s discussions."|data/MedicalDocuments/OrfPathHealth/UrgentNeedForPandemicAccors.pdf|7|d4d6f26b296047fabb3e74cec31ebc41+"19+1819There is an enormous sense of relief that the world has already+suffered the most acute stage of the COVID-19 pandemic—with+its heartbreaking death toll, devastating illness, and crushing social and+economic fallout. The job of hardening the world’s defences against future+disease outbreaks, however, has only begun. Indeed, COVID-19 is still with+us and will continue to smoulder for years to come, assuming it does+not flare up again. Moreover, the prospect of future, and potentially more+menacing, global infectious disease outbreaks remains in the horizon—+made more likely by factors like climate change, unabated encroachment+on the habitats of wild animals that carry dangerous pathogens, population+growth, and urbanisation.+Now is the time to take stock of the many lessons of COVID-19 and, more+importantly, to act on them. The emotional, physical, economic and social+scars that millions suffered are still fresh enough to feed the political will"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|0|6c5e141d752f40efbbd485a82f2926ff+"as leaders need to make big, tough choices about investments in future Ensuring Equitable+Supply and Access+to Critical Vaccines+During Pandemics:+The Lessons of COV AX+Aurélia Nguyen"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|0|f21a0cbf122d44f599f9b52ccec5f521+"19The Lessons of COVAX+19pandemic preparedness and response. If they fail to do so, the global+community will once again pay dearly—in lives lost and damaged and in+profound economic and social shocks.+The overarching and perhaps most obvious lesson of the pandemic was+that most countries, and the world collectively, were unprepared to defend+themselves against SARS-CoV-2, the virus that causes COVID-19.1 Nearly all+countries—even those whose health systems were presumed to be strong—+struggled not just to arrest the spread and blunt the devastating impacts+of the virus but also to continue delivering other vital health services.2+This was no surprise to the many global health experts who had long+warned about the world’s vulnerability to a crisis of such magnitude.+Yet, even those experts could not have fully anticipated exactly the ways+COVID-19 ultimately exploited the gaps in health security systems globally."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|bb43ca5f9f4c4e648f73d21bc059925f+"If there is anything meaningful that emerged from the pandemic, it is+the knowledge of where and how health systems struggled, where they+performed well, and what must be done to prepare for future pandemics.+This author speaks from experience as managing director of the Office of+the COVAX Facility from the fall of 2020 through mid-2022. The Access to+COVID-19 Tools Accelerator (or ACT-A) was a global collaboration focused+on accelerating the development, production, and access to vaccines. COVAX,+the vaccines pillar of ACT-A, had the remit of facilitating access to potential+COVID-19 vaccines to the most vulnerable everywhere, regardless of their+income;3 to date, it has delivered nearly 2 billion doses of COVID-19+vaccines to 146 countries across the world.4 It is a collaborative work of+the Coalition for Epidemic Preparedness Innovations (CEPI), the World+Health Organization (WHO), the United Nations Children’s Fund (UNICEF)"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|7aa69007cfd442f9822d3663a6c4c65a+"and Gavi, the Vaccine Alliance which co-managed COVAX.+COVAX accomplished a great deal, and according to estimates from Imperial+College London, the impact of COVID-19 vaccinations on COVAX AMC+participants included the prevention of an estimated 2.7 million deaths+worldwide.5 It could have made even greater impact had certain conditions+been met even before it was launched in 2020. To that end, one must heed+three categories of lessons that emerged while dealing with the pandemic"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|1|3c76d07238434794b3a491927cbf70e4+"20Accelerating Global Health: Pathways to Health Equity for the G20+21puzzle—the procurement, distribution, and administration of COVID-19+vaccines across countries.+First, the world must be willing to take risks and make contingent+financing available to ramp up rapidly as health crises emerge. Before+the COVID-19 pandemic broke out, there was nothing in the world like+COVAX. It began without any funding and with virtually no personnel.+Unlike sovereign governments with sizeable spending power, global health+organisations and other international development agencies could not take+on the risk of paying billions of dollars in purchase orders for vaccines.6+It thus took COVAX several months to raise sufficient funds to secure+early-purchase agreements with vaccine makers. Meanwhile, vaccine+manufacturers gave priority to bilateral customers—typically, well-resourced+sovereign governments—even months before it was clear which, if any"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|80889f7b0eaa4090934f8879b238d535+"of the vaccine candidates would earn regulatory approval.7 That, in turn,+left relatively few doses available early on for COVAX to procure. More+importantly, some countries imposed export bans on vaccines or vaccine+ingredients manufactured on their shores to ensure they would have enough+supply for their citizens.8+It is understandable that countries will do everything they can to place+the health needs of their citizens first in a crisis such as COVID-19. This+dynamic will not change. The question, therefore, is how the world can+navigate this geopolitical reality.+One way is to put in place now contingent funding that will be immediately+deployable as soon as another crisis strikes. That will help global health+agencies—like a future version of the COVAX Facility—mount an even more+effective global response.+Such funding must be flexible and agile. It will require mechanisms to+constantly update working assumptions regarding epidemiology, policy"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|4d3ad7c8415c4169b650d2f3754e263d+"recommendations, supply, demand, R&D, manufacturing, country-level+challenges, and other factors, and for making at-risk investments for+multiple scenarios. This funding should also include a proportion that could+be used with a high-risk appetite to secure vaccines that are at any R&D+stage, even with the risk of vaccine failure.9"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|2|895f9a65a28c496595bb295596c4fdd1+"21The Lessons of COVAXAnother lesson is related to the value of an innovative financing mechanism+that COVAX created, called the pandemic vaccine pool (PVP), which ensures+that there will be cash on hand to make rapid procurement of vaccines+available, especially to lower-income countries—even in a scenario such as+the one in 2020 where it was uncertain which of the vaccine candidates+would get approval. Likewise, COVAX pioneered other new innovations out+of the crisis—such as indemnification and liability agreements and a ‘no-+fault compensation scheme’ that would lower the risks for manufacturers—+which were also critical to removing bottlenecks and speeding up the+response-time during COVID-19. Mechanisms that allow fast response and+sharing of risk during an emergency are important features of any future+responses.+Moreover, multinational trade-facilitation measures must be strengthened+to allow for the free flow of vaccines, manufacturing supplies, and other"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|19c06e9b16344d5f98aae0410d469d9c+"life-saving equipment during health emergencies. There should be in place,+for example, exemptions and waivers that allow agencies involved in the+global health response to ship life-saving medical countermeasures and+materials to low- and middle-income countries as well as into humanitarian+situations exempt from any trade barriers.10+Second, it is now known that turning vaccines i n t o vaccinations depends+upon strong, reliable health systems. That is, getting shots in people’s+arms requires complete end-to-end solutions at the country level, backed+by investments—from early R&D; scaling-up manufacturing; securing deals;+consistent policy guidance; and setting up operational, logistical, regulatory,+and legal frameworks further along the value chain. This applies not just+to the vaccines themselves but also ancillary supplies, such as cold chain+and safe injection equipment, international freight and logistics as well as"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|f85f8a3779d1458a97ac8d5f13f782d0+"in-country delivery requirements, including personal protective equipment+for healthcare workers.11+Many countries that lacked this infrastructure strained to get doses+to the people who needed them. To be sure, the challenge was less+pronounced—though still serious—in many countries where organisations+like Gavi and WHO had already provided significant resources over many+years to help strengthen health systems (particularly primary health care),"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|3|7b0a4ad9437f45829cb41258f4f78a71+"22Accelerating Global Health: Pathways to Health Equity for the G20+23build cold chains that facilitated the widespread delivery of vaccines, and+establish relations with all the many stakeholders who make immunisation+programmes work.+At Gavi, which has supported the improvement of lower-income countries’+routine immunisation programmes since 2000, the concern was that+those efforts to vaccinate mostly children would flag significantly under+the extra burden of delivering COVID-19 vaccines to other populations. It+was unexpected, therefore, when many showed relatively little decline in+routine immunisation. To be sure, their systems were pushed to the limit.+Vaccinators, doctors and nurses were burned out. However, considering that+while responding to the pandemic and having to deliver three times the+number of vaccines compared with previous years, immunisation in Gavi-+implementing countries suffered declines of only 4 percent in 2020 and"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|4b38bb5b7e7343dc87ddf380cad54595+"1 percent in 2021 and a near return to pre-COVID levels by the end of+2022—there was a lot more resilience than expected.12+Those many years of health system strengthening investments apparently+paid off. But these countries will need more, especially when it comes to+building out primary healthcare services, cold chain, vaccine track-and-+trace, human resources and data monitoring systems13 that reach all their+citizens, especially those with the least access to healthcare.+One step in that direction, for example, is the COVID-19 vaccine Delivery+Support (CDS) which was time-sensitive funding based on country’s+requirements across various areas, including service delivery, data and+monitoring, and supply chain systems that Gavi helped put in place+to deal with funding gaps for delivery and improve countries’ capacity+to rapidly scale up COVID-19 vaccinations. In addition to that goal, in+many countries the programme has also contributed to health system"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|c34ec7b0256847df9acfe84b02149252+"strengthening, including upscaled cold chain infrastructure, digitisation of+health data, improved outreach capabilities, combined COVID-19 and routine+immunisation deliveries, and expanded vaccine supply chain capacity.+Somalia, for example, where targeted CDS investment saw the digitisation+of its health systems, strengthening of the country’s cold chain capacity,+and the training of health workers at the front of community engagement+and support of risk communications for both COVID-19 vaccination and"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|4|fbff8d3c7a8444c588467b08b54c26d1+"23The Lessons of COVAXroutine immunisation helped increase primary COVID-19 vaccine coverage+from 5 percent at the beginning of 2022 to 41 percent by the end of the+year.14 Gavi invested approximately US$1.3 billion in health systems in+Gavi-implementing countries from 2021 to 2022.15+Moreover, it must be ensured that every country puts in place regulatory+readiness, harmonisation, and policy development for pandemic preparedness.+They must build access for the most vulnerable people—especially those+who are chronically hard to reach—into the pandemic architecture. This+should acknowledge that, despite best efforts, there will be disparities in+countries’ readiness levels, infrastructure, and capacity in the event of+another pandemic.16 The global community cannot shirk from the challenge+of closing those gaps, as much as possible.+Third, it is important to lower barriers to the equitable supply of vaccines—"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|0e304bf478d4428e929abad5c796e272+"such as vaccine nationalism, hoarding, and export bans. The very idea of+the COVAX Facility emerged from a desire to prevent a replay of what took+place in 2009 during the H1N1 pandemic when better-resourced countries+dominated nearly all the global supply of vaccines.17 Countries with little+financial resources and without their own vaccine production capacity were+left largely empty-handed.18+To solve that problem, COVAX sought to pool demand for COVID-19 vaccines+from lower-income economies as well as from wealthier nations. With+pooled demand and funding, COVAX would ideally be in a better position+to make large-scale investments. It could build a diverse portfolio of what+was eventually 11 vaccine-candidates across four technology platforms (10 of+which received regulatory approval for use). This was the largest portfolio+secured by any buyer, making more than 4 billion doses available to 191+countries that were part of COVAX.19"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|27df9e2ca46243ad8d81ff5a54a1fb00+"countries that were part of COVAX.19+In other words, COVAX would be able to compete with better-resourced+countries for what would surely be a finite supply of vaccine doses. Dose+domination by relatively few countries would not follow the pattern of the+H1N1 vaccine."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|5|55b09ec3abaf48e98355f0d359b46caf+"24Accelerating Global Health: Pathways to Health Equity for the G20+25The experience during COVID-19 and previous pandemics cries out for+increased and geographically diversified vaccine manufacturing, particularly+across the African continent. Africa has an eighth of the world’s population+but only about 0.1 percent of the vaccine manufacturing capacity.20 There is+much work that must and can be done to help those regions establish this+essential infrastructure, not just for emergencies but for the production of+routine vaccines during non-crisis times. To help regional production take+root and grow, there must be support for technology transfer as well as+demand-side financing to promote a sustainable diversified manufacturing+base.21+With this goal in mind, Gavi and the African Union Commission entered+into a Memorandum of Understanding in May 2023 (with the cooperation+of the Africa Center for Disease Control)22 to work together to stimulate,"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d4a21a81d74e413ba4d349be59d06804+"among other health advances, sustainable regional vaccine manufacturing in+the continent. The endeavour includes 10 commitments to increase political,+financial, and technical investments in immunisation programmes.23+Another one of the biggest lessons was that critical to an effective global+response is putting models in place that can ensure, long before the+occurrence of a pandemic, that lower-income countries receive volumes of+vaccine doses at the same time and in the same levels that high-income+countries do to stop the spread of variants. This will require increased+standards for manufacturers’ transparency about their order books so+that it is possible to determine—and correct— the supply inequities among+countries. This will also require that contingent financing continues to be+readily available to allow response to unexpected trends in the trajectory+of the pandemic. Discussions on the use of available COVAX AMC funding"|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d07c2d94246f4df795c7be6170d78db1+"is currently ongoing, with consideration on using part of the available PVP+funding channelled to the procurement of new products, including variant-+containing vaccine boosters, based on country requirements.+Discussions also focus on the implementation of the 2024–25 COVID-19+programme approved by the Gavi board in June 2023.24 Equally important+considerations include using these funds to prepare for other health+emergencies, catching up from the effects of the pandemic, accelerating+diversified manufacturing—all of which will be discussed further at the+December board meeting of Gavi."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|6|d7a7913899f445febee6bff8c39924bc+"25The Lessons of COVAXThe global community is relieved to have moved past the worst of the+biggest and most devastating global health crisis in more than a century.+However, such sense of relief—and perhaps the understandable weariness+after three years of searing crisis—must not turn into complacency or+neglect. The future depends on learning from what the world lived through+and to make the big, smart changes that are required.+Aurélia Nguyen is the chief programme strategy officer at Gavi, the Vaccine Alliance.+She served as managing director of the Office of the COVAX Facility for the first two and+a half years of the pandemic and, previously, as Gavi’s managing director for vaccines+and sustainability."|data/MedicalDocuments/OrfPathHealth/EnsuringEquitableSupplyOfVaccines.pdf|7|54d16e33cfb44174b61da49448891293+"13Among the most important lessons the world should learn from+the COVID-19 pandemic is that being prepared—being ready to act+urgently with the right technology, know-how and resources—can give the+world a crucial head start in tackling a newly-emerging infectious disease+outbreak.+With COVID-19, many countries and regions of the world were seriously+deficient on many important epidemic and pandemic preparedness measures,+putting them way behind the line. However, in one key aspect of the race+against the novel viral threat—vaccine development—the world had put+itself a few critical steps ahead by the time the SARS-CoV-2 coronavirus+emerged in 2020.+This was in large part a result of many years of studying other similar+viruses, whereby scientists had the chance to develop and hone techniques+to facilitate new vaccine designs. Research initially on respiratory syncytial+virus (RSV)—a virus first identified in 1956 that can cause respiratory"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|0|4a54fe47a5c242909e36b598566cee82+"tract infections—and subsequently on the SARS coronavirus that emerged+in China in 2003, then on the MERS coronavirus that was first reported a+12Richard Hatchett and Kate KellandA Global Vaccine+Library:+Giving Humanity a Head Start Against+Pandemic Threats"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|0|33dce39a3c574625aebc87a71f0c4e63+"13A Global Vaccine Librarydecade later in Saudi Arabia, meant scientists had well-developed insights+into these types of viruses and knew how to go about designing effective+vaccines against them.+Those decades of work allowed scientists to understand, for example, the+importance of the spike protein of the coronavirus for the production of+neutralising antibodies. They had also developed and refined techniques+for manipulating the spike protein to make it more visible to the immune+system and therefore more able to illicit a potent immune response.+In early 2020 when the novel coronavirus SARS-CoV-2 emerged, drug+developers were able to create new candidate vaccines at record speed.+They pulled off the shelf previous research, data and knowledge on RSV,+SARS and MERS virology, vaccinology and immunology, and tweaked it to+figure out how to best tackle the novel threat. Therefore, despite never+before having seen the COVID-19-causing virus, they were not reinventing"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|0cd02fb084694bbca463dd2b114f1d48+"the wheel in developing COVID-19 vaccines. Humanity had a head start.+Consider also the case of Mpox. Formerly known as monkeypox, Mpox+is a contagious disease caused by a virus from a family called the+orthopoxviruses—a viral family that also counts smallpox, cowpox and+many other pox viruses among its members. When Mpox began to spread+in 2022 in a far larger outbreak that reached more geographies, humanity+had again put itself a few critical steps ahead. It was in the late 1800s+when vaccines against the highly deadly smallpox were developed, before+being refined and ultimately deployed to greatest effect in the 1970s and+1980s when smallpox became the first—and so far only—human disease+to be eradicated. After this success, however, many governments remained+highly concerned about the potential for the smallpox virus to be used one+day as a weapon of bioterrorism. This led national and international health"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|a490246e3c3a4465988ec32641696a00+"security bodies to decide to maintain stockpiles of smallpox vaccines.+Fortunately, those smallpox vaccines also offer broad protection against+other viruses in the orthopoxvirus family, including Mpox. When Mpox case+numbers ballooned into an epidemic of international emergency proportions+in 2022, the bank of knowledge, data and vaccines that could help public+health authorities curb the outbreak was significant. Again, humanity had+a head start."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|1|d7a7df237a9b4336b1e40e727ecdd5c9+"14Accelerating Global Health: Pathways to Health Equity for the G20+15What if humanity could get itself a similar head start against any viral+threat—known or unknown, novel or re-emerging? What if we could get+ahead of any infectious pathogen with the potential to cause a serious+and deadly epidemic? Doing that would give us a far better chance of+winning the containment race against an emerging virus and of controlling+a nascent pandemic before it is able to spread across the world.+A Proposed ‘One World Vaccine Library’+At the Coalition for Epidemic Preparedness Innovations (CEPI), of which+the authors of this essay are part, we have a concept for how the world+could do just this—by creating and stocking a library of knowledge, data+and prototype vaccines against every one of the viral families we already+know have the potential to cause human disease outbreaks. CEPI calls this+the ‘One World Vaccine Library’—a vaccine library for the whole world that"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|7a57613761f64fe58fbc8709d4670828+"will help the global community achieve greater health security by being+better prepared to beat the next pandemic threat, wherever it emerges, and+whatever form it takes.+Vaccines are among the most potent tools against pandemic threats and+will be critical to any future response to dangerous and deadly outbreaks+of infectious disease. The faster an effective vaccine can be developed and+deployed, the faster it can be used to mitigate and potentially contain an+incipient pandemic. This is why we need to work on getting those head+starts against as many as possible of our potential opponents.+Getting ahead of any potential viral threat, known or unknown, can at first+sound like an impossible task. There are between 250 and 300 viruses+from around 25 viral families that are already known to have the ability+to infect people, and the world’s scientists cannot create new vaccines+against every one of them, just on a chance that they might one day pose+a deadly threat."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|58efa624d5c4493eb9e220aab122325c+"a deadly threat.+Yet the beauty of a One World Vaccine Library is that we do not need to.+As those several hundred viruses all come from just 25 families, scientists+can take a viral-family-based prototype vaccine approach to preparing+the world’s defences against them. They can gather knowledge, scientific"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|2|dc468156950d4a4d8a8878e75499afa3+"15A Global Vaccine Libraryinsights and research data on a selection of representative viruses from+each family and create vaccines that target their most common threatening+features. That way, the world will have a bank of detailed fundamental+knowledge about the threats posed by these virus families.+As things currently stand, scientists have already made meaningful+progress—proven safe and effective vaccines are available against scores of+viruses that come from and represent at least 15 of the 25 virus families.+For the One World Vaccine Library to be able to help the world respond+at speed to a newly emerging threat, however, those vaccines will need to+be transferred onto so-called rapid response platforms—technologies like+mRNA platforms or viral vector platforms that can be rapidly scaled up to+allow for hundreds of millions of doses to be produced within months if+needed.+Beyond that, the library will need to be stocked with data and research and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|4cc81b46b20b4a85ba51e82ad1ce6219+"potential vaccine candidates against viruses that represent all the remaining+families, and its sections on the most threatening virus families must be+filled with as much preparatory work as possible. That way, new vaccine+development will be faster and more efficient, saving precious time, and+potentially lives, that would otherwise be at risk if new vaccines had to be+started from scratch each time a pandemic threat looms.+Take the paramyxoviruses, for example. The paramyxovirus family includes+a number of well-known human disease threats, including measles and+mumps, as well as several less well-known ones, such as Hendra and+Nipah.+If the aim is to make similarly fast—indeed, ideally, faster—progress+against a future emerging novel paramyxovirus threat as was made in 2020+with the novel coronavirus, the One World Vaccine Library’s paramyxovirus+section should be stocked with as much research, data and technical"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|25b3c3dadaa34134a00f9af146a4c02d+"knowledge about how to design and make effective vaccines against the+known and closely related viruses in that family.+In other words, the library will collate scientific knowledge and prototype+rapid-response vaccine candidates for measles, mumps, Nipah, Hendra and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|3|e470b9a71a9a40a3adb706bb55c19258+"16Accelerating Global Health: Pathways to Health Equity for the G20+17other known paramyxoviruses. If and when a novel paramyxovirus emerges+and begins to infect people in a fast-spreading outbreak, the library can+be accessed for knowledge that can help rapidly create vaccines or other+medical countermeasures to prevent that spread as much and as soon as+possible.+An Ambitious Yet Achievable Global Endeavour+Building a One World Vaccine Library and stocking it to its fullest possible+capacity is a substantial task and will require sustained investment of time,+effort and money. Such a Library, however, will mean the fruits of human+ingenuity—the benefits of scientific progress—can potentially be made+available to all, whenever and wherever they are needed. It will mean that+when the next viral pandemic threat emerges—whether it is a known virus+or a novel one—humanity will have the knowledge and the technology to"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|0b579a5b26e9407a902cb29529089cee+"develop vaccines and other medical defences far more swiftly than it has+ever done before.+Researchers assessing a new outbreak and the virus causing it, wherever+and whenever it occurs, will be able within days and weeks to sequence+its genome, match it against related viruses and select prototype vaccines+from the library to develop and deploy new vaccines against the epidemic+or pandemic threat.+CEPI’s current work includes prioritising the development and stocking+of sections of the One World Vaccine Library for the virus families that+pose the greatest and most urgent threats to global health security. CEPI+is engaging virus experts to systematically rank each family to assess+its potential to spawn the next Disease X. For each family selected,+the aim is to create vaccine candidates for at least one and potentially+several different viruses, depending on the family’s complexity and genetic+diversity. Vaccines in the library will be taken through preclinical and"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|cc987a2a91d846c5a1d952ecc309cc62+"early-stage clinical testing to build vital knowledge about the safety and+immunogenicity of both the platform and the antigens they target. The+larger goal is to establish clinical proof of concept for the lead candidates+in multiple families over the next five years."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|4|f82e8abf722e423ba48ded1798296b13+"17A Global Vaccine LibraryThe ‘100 Days Mission’ and the Need for Speed+Creating and stocking a One World Vaccine Library is a critical enabler of+CEPI’s 100 Days Mission, embraced by the G7 and the G20, to compress+the development timeline for new vaccines against emerging disease threats+to 100 days. Coupled with improved surveillance providing earlier detection+and warning of potential viral disease threats, and with swift and effective+use of non-pharmaceutical interventions such as testing, contact tracing+and social distancing to suppress disease transmission, delivering an+effective new vaccine within 100 days would give the world a real chance+to extinguish the existential threat posed by a future Disease X pandemic+virus.+The head starts in these viral races—and there are sure to be ever more+frequent ones in this era of novel epidemic threats—will come from having+a One World Vaccine Library that is comprehensive and extensive and,"|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|8cb3bc020aed4d0a86a05c1f658e2708+"crucially, immediately accessible to all nations and regions whenever they+need it. As the bank of knowledge builds up in the library, so too, does+the potential for scientists to significantly accelerate vaccine development+against a wide and growing range of virus families over time.+Like the 100 Days Mission, the ambition of creating a One World Vaccine+Library is a bold one. It is also an essentially equitable one that seeks+to help people across the world bolster their defences against the ever-+increasing risk of viral infectious diseases.+Building and stocking the library will take the combined resources, will,+and ingenuity of the world’s best scientific minds, political leaders and+health security experts. In return, the library’s evolving knowledge and+increasingly sophisticated contents will be a living gift from generation+to generation: the prospect of a future free from the deadly threat of+pandemics."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|f5b55f34587246179c6c6d2bc0801141+"pandemics.+Dr. Richard Hatchett is Chief Executive Officer of the Coalition for Epidemic+Preparedness Innovations (CEPI).+Kate Kelland is CEPI’s Chief Scientific Writer."|data/MedicalDocuments/OrfPathHealth/GlobalVaccineLibrary.pdf|5|4160fb9924f24b5eb68e493cd9361060+"161+160161Investing in the Public+Health Workforce:+Reflections for the G20+ Wenzhen Zuo, Huan Xu, Lizzie Tecson, Bettina Borisch, Sadaf Lynnes,+Laura Magaña, Priscilla Robinson, Duncan Selbie, and Jim Campbell+Public health workers are the backbone of the public health system+and a determining factor in the capacity for emergency preparedness+and response. The COVID-19 pandemic tested and exposed the weaknesses+in core public health capacities around the world,1,2 which are often the+result of decades of underfunding and lack of political commitment to+public health.3,4 Alongside the number of confirmed deaths from COVID-19,+there was increased mortality and morbidity due to the severe disruptions+in essential health services, including preventive care such as routine+immunisation.5,6 The inadequate preparedness of many health systems to+respond to disease outbreaks partly explains these outcomes.7 However, the"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|0|732fe967002642599669103e63f2f22a+"limited availability of the health workforce was the critical bottleneck.8,9+This was largely due to longstanding workforce shortages that were+exacerbated by COVID-19 infections and deaths among health workers; the+burden placed upon them, which resulted in mental health issues, including+burnout; and poor working conditions.10,11+The world is also burdened with other public health emergencies,+including protracted conflicts and a global increase in climate-related and+humanitarian disasters. These have collectively contributed to a public health+crisis, with reversals in life expectancy and Sustainable Development Goals"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|0|3dcdf4837b764370bb2cf1e2776825cc+"161Investing in the Public Health Workforce+161targets.12,13 These reversals and the increasing likelihood of multi-hazards+and future emergencies stress the imperative for strengthening national+health systems through investment in the 12 Essential Public Health+Functiona (EPHF) through an all-hazards emergency risk management+approach.14 Strengthening the quantity and quality of the national public+health workforce capacity to deliver these EPHFs is essential15 and requires+political leadership as well as global investment+There was the emergence of a global consensus to strengthen public health+during the pandemic, as evident in the political and technical consensus+within the G7 and G20 intergovernmental processes from 2021 to 2023.16+This contributed to an iterative process coordinated by the World Health+Organization (WHO) along with a global partnership of associations,+institutions, and schools of public health (as represented by their national,"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|c9d7fdd45c4e4061ac050c6a21b2f583+"regional, and global bodies)b to jointly develop and endorse a WHO Roadmap+to strengthen national public health and emergency workforces.17+The G20’s and G7’s Role in Strengthening Public Health+and Emergency Workforces+Both the G20 and the G7 processes have historically incorporated public+health within their intergovernmental deliberations, aiming to address+pressing global health challenges and foster international cooperation+amongst member and partner countries. This was reinforced during the+COVID-19 pandemic, where both the G20 and the G7 platforms tabled+agenda items on public health for consideration in the Health Ministers+and Heads of State meetings.+a The EPHFs are a set of interconnected activities both within and beyond the health sector+that are required to ensure effective public health action to prevent disease and promote and+protect health and well-being.+b Including the World Federation of Public Health Associations (WFPHA), International"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|525f8e57fb164f289fed4c4155309473+"Association of National Public Health Institutions (IANPHI) and Global Network Academic+Schools of Public Health (GNASPH)."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|1|99d0ffec664a4147b99327b232eec755+"162Accelerating Global Health: Pathways to Health Equity for the G20+163G20 and G7 Deliberations on Public Health (2021–2023)+G20 Italy, 2021+In May 2021, the G20 and invited leaders, heads of international and+regional organisations, and representatives of global health bodies gathered+in Rome for the Global Health Summit that culminated in the Rome+Declaration.18 This political declaration recognised the impacts of the+pandemic, the reversal of public health gains, and the sacrifices from+the health and care workforce. The Rome Declaration set out a global+consensus which subsequently informed the G20 Italia Declaration of+Health Ministers in September 2021,19 where investment in health systems+and public health workforce strengthening was identified as a prerequisite+for countries to improve future pandemic preparedness and response. The+declaration affirmed the role of political consensus in strengthening the"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|2106f61eb09845f7855d15da890e67ae+"health workforce. It highlighted the need to protect workers and invest+in their education, employment, and retention, including to strengthen+multidisciplinary teams to better respond to future emergencies and deliver+the essential functions in “health care system and preventive care”.20+G7 United Kingdom, 2021+In June 2021, the Carbis Bay Health Declaration21 was signed at the G7+Summit in Cornwall, United Kingdom. The primary objective of the G7+Summit 2021 was to bring the world’s leading democracies together to fight+COVID-19 and build a greener, more prosperous future. The G7 summit+recognised the contributions and commitment of health and care workers+and highlighted the importance of maintaining a health workforce that+can adapt to changing circumstances. Training, supporting, and protecting+health and care workers were important aspects of the discussion.+G7 Germany, 2022+Germany’s presidency of the G7 built upon Italy’s legacy on essential public"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|5837ba13e7f942cf8b17ebfcaef29429+"health functions by diving deeper into pandemic preparedness and response.+On 19 May 2022, the G7 ministers met in Berlin and launched the G7 Pact+for Pandemic Readiness,22,23 which focuses on strengthening collaborative+surveillance in low- and lower-middle income countries (LMICs) and"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|2|1ef5b0e99e864a539d6ef6e41039de13+"163Investing in the Public Health Workforcepredictable rapid “regional and global surge readiness groups”.24 This focus+on pandemic preparedness and response demonstrated alignment with+similar deliberations among WHO member states in Strengthening the Global+Architecture for Health Emergency Preparedness and Response (HEPR).25 The+HEPR structures a new global health architecture around health emergency+governance,c systems, and financing, applying the principles of EPHFs at a+global level. Supporting the global health architecture, the G7’s Roadmap+for Practical Cooperation to Advance the G7 Pact26 committed to help 100+countries strengthen their International Health Regulation (IHR 2005) core+capacities.d+G20 Indonesia, 2022+G20 in Indonesia continued to advance the global health architecture for+emergency preparedness and response by launching the Pandemic Fund.27+The fund aims to strengthen countries’ pandemic prevention, preparedness,"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|58263ccaef7b48289de7a0d400d6d13d+"and response (PPR) capacities by addressing capacity and capability gaps.+The Pandemic Fund further aims to catalyse investment in critical health+workforce capacities and in health systems to strengthen synergies between+the health system and pandemic PPR capacity at country and local levels+in core domains of the IHR 2005 and the World Organisation for Animal+Health’s (WOAH) international standards. It is estimated that there is+a need for US$10 billion per year of international funding to cover the+catalytic funding for systemic preparedness required in LMICs.e+c Under the governance part of HEPR, it contains the ongoing Intergovernmental Negotiating+Body on new WHO convention, agreement, or other international instrument on PPR (WHO+CA+) and International Health Regulation amendments.+d IHR core capacities: described in IHR 2005’s Annex 1, the core capacities for surveillance and+responses require public health capacities ranging from the local community and primary"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|887e07843c974acab105fad93d11ba9f+"public health level all up until the national public health leadership level. In the voluntary+Joint External Evaluation tool to assess the IHR 2005 capacities, the highest scores for IHR+capacities as human resources are given to countries who have a national multisectoral+skilled and competent health personnel for sustainable and functional public health+surveillance and response at all levels of the health system.+e Worth noting that the Pandemic Fund, as of May 2023, had received a pledge of just 10% of+the annual amount needed from donors and foreign aid from the main G20 countries."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|3|31bccb036af346ad98a2832f1bf09068+"164Accelerating Global Health: Pathways to Health Equity for the G20+165G7 Japan, 2023+The G7 in Japan further reaffirmed the prevailing health consensus to+strengthen the national Public Health and Emergency Workforce in the+G7 Global Plan for UHC Action Agenda.28 Action area 8 of the UHC Action+Agenda specifically addresses UHC and health security by strengthening all+EPHFs and to “support well-trained workforce to deliver the EPHF in line+with WHO Roadmap”.29 The Action Agenda also advocates for investing,+protecting, educating, and employing the entire health and care workforce+while also recognising the importance of strengthening the public health+workforce.+The G7 leaders supported the development of global network of experts,+including their trainings, and committed to work together to implement IHR+core capacities in 100 LMICs until 2027, echoing the 2022 commitment at+G7 Germany. To achieve UHC and health security, G7 Japan also announced"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|f9437db5dfe14a128a621dee423b0855+"the launch of the Impact Investment Initiative for Global Health,30 in+time for the United Nations’ three High-Level Meetings (HLM) on UHC,+tuberculosis, and pandemic preparedness and response. This initiative+prioritises investment in impactful initiatives and capacity building in the+Global South for non-communicable and communicable diseases, PPR, and+to “restore of essential health services to better than pre-pandemic level”.31+Emerging Consensus for WHO and Partners’ Roadmap for+Public Health Workforce+The public health momentum from the G20 and the G7 processes enabled+renewed dialogue on public health, the 12 essential public health functions+that are typically prevalent across all countries, and the public health+workforce required to deliver these functions. Building on the political call+for action during Italy’s G20 presidency and resolutions adopted in the+World Health Assembly,32,33,34,35 WHO convened and worked with its partners"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|7cb2165fcdc945c6ae0860e59f189275+"to jointly develop and launch a roadmap and an action plan36 on national+public health workforce capacity to deliver all EPHFs, including emergency+preparedness and response. The public health workforce encompasses core+public health personnel and professionals, health and care workers who+perform at least one of the essential public health functions, and all"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|4|c758753adaf94ea9a1978600c51ad623+"165Investing in the Public Health Workforceoccupations outside of the health sector that contribute to public health+(e.g., water, sanitation, social determinants).37,38+Global partners on the roadmap and action plan have jointly developed+reference documents and tools for countries of all income classifications to+assess their public health workforce against the standard EPHF and their+individual public health priorities.39 T h e a s s e s s m e n t i s u n d e r p i n n e d b y a+whole-of-government and whole-of-society approach that involves national+stakeholders and existing national and global networks of partners of the+roadmap, including associations, institutions, and schools of public health.+This country-based assessment will ultimately guide policy improvement+and address gaps in national public health workforce planning, delivery,+and competency-based education curricula in order to bolster national"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|b5e8fd8bf09244c9a74995e5e618f489+"workforce capacity and readiness for all current and future public health+needs.+The above tools are timely additions to support national assessments and+benchmarking. The G20 support to invest in preparedness and national+capacity contributed to the launch of the World Bank’s Pandemic Fund in+November 2022. In its first call for submissions, strengthening human+resources to help countries prevent, prepare for, and respond to health+emergencies was highlighted as a priority.40 This indicates an opportunity+to prioritise sustainable public health workforce capacity in LMICs.+The roadmap also assists in alignment with the ongoing governance+processes of IHR 2005 amendments and negotiations on a global pandemic+accord, the Intergovernmental Negotiating Body (INB) on a new WHO+convention, agreement, or other international instruments on PPR (WHO+CA+).f+f Under the governance part of HEPR, it contains the ongoing Intergovernmental Negotiating"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|0cb51c16f7fe42cb9f4ad07e5e6ab337+"Body on new WHO convention, agreement, or other international instrument on PPR (WHO+CA+) and International Health Regulation amendments."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|5|503ecc2f98c64e4ba8733349b9834adc+"166Accelerating Global Health: Pathways to Health Equity for the G20+167The Role of India’s G20 Presidency+The intergovernmental consensus and commitment for public health+strengthening has evolved over the last three years, and in mid-2023,+there was a window of opportunity to convert consensus into national+actions that address public health workforce needs. The G20 in India has+signalled the development cooperation for SDGs and the global health+architecture for PPR as important priorities for the Indian presidency.41,42 It+also presents an opportunity for India to amplify public health workforce+strengthening from the perspective of developing countries, ensuring that+multilateral investment is leveraged to strengthen public health workforce+across LMICs. This might present an attractive legacy agenda in 2024 when+Brazil assumes the G20 and would likely resonate with Italy’s G7.+Elements for reflection might therefore include the role of G20 stakeholders"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|0ed58dcdb4a043718b2c6e0652992e78+"and partners to:+• Expand domestic financing to strengthen national health system capacity+and the respective public health workforce to deliver all essential+health services and public health functions, including health emergency+preparedness and response.+• Expand international financing to support the LMICs in national public+health and health system strengthening, as committed by the G7+Germany in the Roadmap to PPR in 2022 and G7 Japan.+• Capitalise and leverage the proposed Impact Investment Initiative for+Global Health and the Pandemic Fund to meet demand.+• Strengthen and position the G20 consensus language on protecting and+investing in the public health workforce, consistent with the Italy G20+language and recommendations from the 5th Global Forum on Human+Resources for Health.+• Strengthen and position the G20 consensus language in the preparations+and outcomes for the UN HLM for PPR in New York and the member"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|2054b41edbe54badb7d32a4c36da2d1f+state deliberations on the IHR amendments and WHO CA+ in Geneva.|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|6|84f7c3515e664f558f550a928bdde5b8+"167Investing in the Public Health Workforce• Strengthen and position gender inequality as a systemic issue to+contribute to an enabling environment for women’s economic and social+rights by gender-equitable policy for the health sector and beyond.43+Wenzhen (Jen) Zuo , Family Physician - Hospitalist / Glob al Health Consultant, World+Health Organization.+Huan Xu, Technical Officer, Health Workforce Department, World Health Organization;+Lead, General coordination of the Public health and emergency workforce roadmap.+Lizzie Tecson, Programme Officer at the Health Workforce Department, World Health+Organization; Co-lead, General coordination of Public health and emergency workforce+roadmap.+Bettina Borisch, Professor at the University of Geneva and Executive Director of the+World Federation of Public Health Associations(WFPHA).+Sadaf Lynes, Director of Collaborative Surveillance workforce and health"|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|7|9788f3475aa54d1db48ff648f860e453+"emergencies, International Association of National Public Health Institutes (IANPHI).+Laura Magaña, President & CEO of the Association of Schools and Programs of Public+Health (ASPPH); co-chair, Competency b ased education, Public health and emergency+workforce roadmap.+Priscilla Robinson, Adjunct Associate Professor at LaT robe University; co-chair,+Competency based education, Public health and emergency workforce roadmap.+Duncan Selbie, President, International Association of National Public Health Institutes+(IANPHI).+Jim Campbell, Director, Health Workforce Department, World Health Organization."|data/MedicalDocuments/OrfPathHealth/InvestingInPublicHealthWorkforce.pdf|7|9e0d4b33f8d34f858eb42aa765c93415+"49+4849Soumya Swaminathan and Priyadarshini RajamaniBridging the Divide:+Advancing ‘One Health’ for a+Better World+Human health is interconnected with the ecosystem that consists+of animals, plants, and the environment. As such, any health+intervention should be integrative of these connecting factors. ‘One Health’+(OH) is a holistic approach that considers all the determinants of health,+designed for disease prevention and control. It is a transdisciplinary+approach that allows multisectoral collaboration and deals with antimicrobial+resistance and the prevention and control of zoonoses and vector-, food-+and water-borne diseases.+Since 2022, the Quadripartite collaboration between the World Health+Organization, Food and Agriculture Organization, United Nations Environment+Programme, and World Organisation for Animal Health has been responsible+for OH operations, guiding countries in planning and adapting strategies"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|0|c347385c32c941ca9500d586d9b9e88e+"for addressing global health challenges. Implementing OH will enhance+pandemic prevention, preparedness, and response, and will also enable the+strengthening of domestic health systems, including in India."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|0|2dd90976e41d4112a2f6e029eb90b1e3+"49Advancing ‘One Health’ for a Better World+49Deconstructing ‘One Health’+The World Health Organization (WHO) defines ‘One Health’ (OH) as+“an integrated, unifying approach that aims to sustainably balance and+optimize the health of people, animals, and ecosystems.”1 In addition to an+individual’s characteristics and behavioural patterns, social, economic and+physical environments are important determinants of health, and include+a variety of factors such as water, air, animals, plants, housing, and+jobs. Animal trade, agriculture, livestock farming, urbanisation, extractive+industries, climate change, habitat fragmentation, and encroachment into+wild areas are some of the factors that can impact human health. It is+essential to consider the possible interactions of these factors with an+individual’s health to achieve optimal health outcomes. Therefore, no health+intervention can be designed and implemented with the consideration of the"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|dce5126b1d5b4331b4d3aca658636be8+"health sector alone. There should be multisectoral inclusivity in addressing+any health-related issues. For example, antimicrobial resistance (AMR)+cannot be addressed only through medical intervention and also requires+the checking of antibacterial content in food and water.+The OH concept encourages a collaborative, multisectoral, and+transdisciplinary approach at the local, regional, national, and global levels.+It recognises the interconnection between people, animals, plants, and their+shared environment to achieve optimal health outcomes, and it encourages+experts from multiple sectors to work together. Under the OH concept,+policy, advocacy, financing, organisational development, data, evidence, and+knowledge are focused on providing sustainable and long-lasting results at+all levels.+The OH concept identifies a range of priority health issues that need the+world’s urgent attention:+Antimicrobial Resistance (AMR)"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|e2379daababe407ba77deb9138fedacf+"Antimicrobial Resistance (AMR)+AMR is one of the greatest threats to human health, food security, and+development. WHO has declared AMR as one of the top 10 global public+health threats that need coordinated and concerted global action.2 By 2050,+there could be nearly 10 million deaths due to AMR each year, and it could+cost the global economy between US$11–444 million.3"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|1|d33d167928ec4c02a898302812a56a09+"50Accelerating Global Health: Pathways to Health Equity for the G20+51Medicines become ineffective when pathogens undergo structural changes+as a result of increased drug exposure. Misuse or overuse of antimicrobials,+multiplication of pathogens due to unhygienic water and poor sanitation+processes, and inadequate infection prevention and control measures in+hospitals and healthcare settings are some of the other factors that cause+AMR. It also arises due to the use of antibiotics in the farming, livestock,+and fisheries sectors, which enables pathogens infecting these animals to+develop resistance. Close contact with these animals and the contamination+of soil and water with these microbes exposes humans to these bugs.+AMR makes treating infections difficult, leaving patients with limited+treatment options, if at all. In such cases, managing serious infections in+children and adults alongside any surgical intervention becomes a challenge."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|8315c966561a4451868cb4e134e0519f+"Indeed, the global health system is already exposed to drug-resistant+Tuberculosis, HIV infections, and specific AMRs such as artemisinin-based+combination therapy-resistance in malaria treatment, and antileprotic drug+resistance.+Zoonotic diseases+Over the past three decades, around 30 pathogens have been detected, with+75 percent of them originating from animals, causing zoonotic diseases and+contributing to about 60 percent of emerging infectious diseases globally.4+These diseases can be spread directly through the saliva, blood, urine,+mucous, faeces, or body fluids of infected animals, or indirectly through+contact with areas where animals live and roam as well as through+contaminated objects or surfaces.+Urbanisation and the destruction of the natural habitats of animals, illegal+trade in wildlife, and wet markets increase the chances of interaction+between animals, animal products and humans, thereby increasing the risk"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|f5f198d153604bd3a98fa4917c114a0e+"of zoonotic disease and contributing to zoonotic spillover. Recent disease+outbreaks such as SARS, MERS, Ebola, Nipah, and avian influenza are+examples of zoonotic infections being established in humans. It is important+to ensure the hygienic and appropriate care of animals in the agriculture+sector, and the safe handling of meat, eggs, dairy, and vegetables to avoid+contamination to prevent outbreaks of food-borne zoonotic diseases."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|2|764f6457770c4826aadcd6d83adba840+"51Advancing ‘One Health’ for a Better WorldAddressing zoonotic infectious diseases through an OH approach includes+multiple actions:+• Raising awareness at all levels of society on prevention and risk-+reduction strategies.+• Investing in interdisciplinary approaches including OH perspectives.+• Initiating research to explore the complex social, economic, and ecological+dimensions of diseases; to assess risks and effective interventions; and+to conduct cost-benefit analyses.+• Regularly monitoring food systems, from farm to fork, and improving+sanitary measures.+• Implementing biosecurity and zoonoses-control measures for both+industrial and disadvantaged smallholder farmers and herders.+• Supporting agricultural and wildlife habitats by managing landscapes+and seascapes collectively.+• Promoting agro-ecological methods of food production, mitigating waste+and pollution, reducing further destruction of wildlife and habitat loss,+and maintaining ecological connectivity."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|3|245fa44631ca4515978c91ab18d97bbe+"and maintaining ecological connectivity.+• Being mindful of biodiversity during government and private-sector+planning, decision-making, and capacity building.5+WHO, the Food and Agriculture Organization (FAO), and the World+Organisation for Animal Health (WOAH) have already established the+Global Early Warning and Response System for Major Animal Diseases to+combat zoonoses to coordinate risk assessment and assist in early warning,+prevention, and control of disease threats.6+Vector-borne diseases+The determining demographic, environmental, and social factors of the+distribution of vector-borne diseases are often complex, such as global+travel, trade, and unplanned urbanisation. WHO’s Global Vector Control+Response (GVCR) 2017–2030 provides strategic guidance to countries for+strengthening vector-control programmes.7"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|3|ceced3fafd4146ab93a56d8df2c7991f+"52Accelerating Global Health: Pathways to Health Equity for the G20+53Water-borne diseases+Drinking or coming in contact with contaminated water causes water-borne+diseases. Faecal-contaminated water is consumed by two billion people+globally, which causes diseases such as cholera, dysentery, typhoid and+polio. These diseases are responsible for around 485,000 deaths every year.8+Food-borne diseases+Over 200 diseases, ranging from diarrhoea to cancers, are caused by+eating or drinking food contaminated with animal or human faecal matter,+chemical substances such as unpasteurised (raw) milk, undercooked meat+or eggs, and raw fruits and vegetables. Globally, 600 million people are+affected by food-borne diseases, in which 420,000 die each year, resulting+in 33 million healthy life years lost. Access to adequate safe and nutritious+food is key to sustaining life and promoting good health.9+Operationalising ‘One Health’"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|c0439552464a4e14b6ef0c4b597c1409+"Operationalising ‘One Health’+In April 2022, WHO, FAO, United Nations Environment Programme (UNEP),+and WOAH signed a memorandum of understanding for joint work on OH,+forming the ‘Quadripartite Collaboration for One Health’. The Quadripartite+is a strategic coordination mechanism that aims to work towards “a world+capable of preventing, detecting, containing, eliminating, and responding to animal+and public health risks attributable to zoonoses and animal diseases with an impact+on food security through multi-sectoral cooperation and strong partnerships”.10 The+One Health High-Level Expert Panel comprising 26 key international experts+serves as the advisory group to the Quadripartite. In late 2022, the group+launched the first One Health Joint Plan of Action (2022-2026) to combat+health risks at the human–animal–environment interface.11+The Quadripartite has urged all countries to translate the OH approach"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|502eb4a32dcc478381748da0c9bd7614+"into policy actions by promoting and increasing investment in intersectoral+health governance. Countries are encouraged to adopt national OH policies,+and create and exchange research on OH. Research institutions can be+encouraged to work on improved genomic surveillance and data-sharing+practices. Academic courses on OH can help train and equip a workforce."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|4|46f7a03700434a8497df7279c7a66991+"53Advancing ‘One Health’ for a Better WorldSince the OH approach is similar to pandemic prevention and preparedness,+resources allocated for the latter can also be utilised for operationalising+OH. For instance, the World Bank’s US$10-billion fund for pandemic+prevention can be used to implement the OH approach. Additionally,+the UN’s high-level meeting on pandemic prevention, preparedness, and+response (scheduled for September 2023) is an opportunity to integrate the+OH agenda into the pandemic action plan.+According to the World Bank, between US$10.3-11.5 billion is needed+annually to implement OH at a global scale.12 But the lack of centralised+OH funding is a challenge, leaving relevant ministries in each country to+assume the responsibility for implementing necessary actions and activities.+This hinders the development of effective global OH strategies.+WHO has identified several other existing gaps in the implementation of"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|5|51906241584640d99e39f60f1f346d60+"the OH approach.13 These gaps are evident in the following areas:+• Databases and knowledge-sharing resources for effective information+exchange.+• Showcasing best practice examples to encourage successful OH initiatives.+• Mapping and generating an OH workforce to strengthen capacity.+• Developing a model for an integrated OH surveillance system.+• Establishing routine and emergency coordination mechanisms with+stakeholders.+• Creating a standardised framework for addressing zoonotic spillover+risks related to animal trade, agriculture, and livestock farming.+• Addressing issues related to urbanisation and habitat fragmentation.+• Identifying spillover risks and disease spread in ways that minimise+trade-offs and maximise co-benefits.+‘One Health’ in the G20 countries14+The G20 countries can play a key role in improving global health, for+various reasons—the member countries are among the world’s largest+economies, they are home to roughly two-thirds of the global population"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|5|fc1d9effc3a4494daf5a1c78a36bf77f+"54Accelerating Global Health: Pathways to Health Equity for the G20+55(including the majority of the ageing population), they house 78 percent+of the world’s pharmaceutical companies, see a high prevalence of non-+communicable diseases (and account for nearly 70 percent of proportional+mortality from such diseases), and contribute 72 percent of all CO2+emissions.15 T h e G 2 0 c o u n t r i e s a g r e e d t o a d o p t O H a t t h e 2 0 2 2 S u m m i t .16+India has already made headway on this front.+One Health approach in India17+The Indian government initiated the OH approach under the office of+the Principal Scientific Adviser (PSA) with the aim to increase pandemic+preparedness and integrated disease control against priority diseases in+both human and animal sectors. A supplementary goal includes establishing+an early warning system built on an integrated surveillance system and+response-readiness for endemic and emerging epidemic or pandemic threats."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|e3ed493f83654c1a87d1f5bc648a8325+"The country has also sought to implement integrated disease surveillance,+build environmental surveillance systems, and develop robust outbreak+investigation mechanisms. The OH mission will also focus on:+ •Targeted R&D to develop critical tools such as vaccines, diagnostics,+therapeutics, and other prevention tools, and to invest in developing+novel disease surveillance and control methodologies.+ •Data and database integration for better information sharing across+different departments, and investing in analytics for better tracking of+national-level progress and implementation at the local level.+ •Streamlining regulatory and approval processes for enabling OH research+and for rapid decision-making.+ •Building a governance model for integrating OH into existing+programmes for system strengthening, sustainability and resource+allocation for maximising outcomes.+India has also established a One Health Centre at the National Institute"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|3abe5438d6c9449f81cb2cb913a89f17+"of Animal Biotechnology, Hyderabad, for intersectoral collaboration among+veterinary, medical, agriculture, environmental, forestry, meteorological and"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|6|0e0bd75ae62745a9b1657abbda56fea9+"55Advancing ‘One Health’ for a Better Worldother areas to detect, prevent and control zoonoses and transboundary+animal diseases.18+In 2008, an attempt to operationalise the OH approach for zoonotic+disease control and prevention identified the barriers preventing effective+cross-sectoral collaboration on disease control.19 These included a lack+of supportive policies, conflicting departmental priorities and limited+institutional capacities. A review of zoonotic policy documents revealed+there is a lack of specific mechanisms or strategies to safeguard livestock+health, and a lack of guidelines for promoting cross-sectoral action. It also+revealed a lack of clarity and inadequate information regarding engagement+in the animal and forest sectors. This study found that implementing the+OH approach in India requires contextual adaptation based on the underlying+sociopolitical, institutional, and cultural contexts.20"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|c1f9626d266a4b3d820e6980b6dacc08+"Given India’s diverse context, the way forward involves developing strategies+that focus on fostering existing informal interpersonal relationships and+collaborations between different sectors to successfully adopt the OH+approach. It also requires intersectoral coordination at all levels, including+the veterinary workforce, academic institutions, and the local or grassroots+population. For instance, to conduct the SARS-CoV2 vaccine trial, the Tamil+Nadu Veterinary and Animal Sciences University signed a pact with the+Tamil Nadu Dr MGR Medical University for conducting joint academic and+research activities. Similarly, during an outbreak investigation in Punjab,+community health workers, non-government organisations, auxiliary nursing+midwives, accredited social health activists (or ASHAs) and village leaders+actively participated in efforts to address vaccine hesitancy.21+Conclusion+Implementing the OH approach will enhance pandemic prevention,"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|a23f8844edf54ac7a6711c6983787cb1+"preparedness, and response. It will also strengthen systems and cross-+sectoral capacities, allowing for the co-design and implementation of+inclusive and equitable multi-level workplans and strategies in line with+OH principles. It is essential to develop, disseminate, and utilise improved+and harmonised OH tools, technologies, and practices that integrate data+and knowledge to prevention of future pandemics, reduce the spread"|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|7|36dd1d845a3147dba0c7891d5d6fb924+"56Accelerating Global Health: Pathways to Health Equity for the G20+57of infectious diseases through better surveillance systems, and boost+collaboration between different organisations.+India’s G20 theme of ‘One Earth, One Family, One Future’ highlights that+global collaboration and solidarity is needed to live harmoniously with+nature and to ensure health and well-being for all people, everywhere.+Dr Soumya Swaminathan is Chairperson, MS Swaminathan Research Foundation and+Former Chief Scientist, World Health Organization.+Dr Priyadarshini Rajamani is a consultant with the MS Swaminathan Research+Foundation."|data/MedicalDocuments/OrfPathHealth/BridgingTheDivide.pdf|8|baf822f00df24576a51d07fdc84491e6+"82Accelerating Global Health: Pathways to Health Equity for the G20+83Building a Resilient+Digital Health+Ecosystem in India+Lav Agarwal+Technology now permeates every facet of human existence. From+communication and transportation to healthcare and entertainment,+technology has redefined how we live, work, and interact. Its omnipresence+is reshaping societal norms, revolutionising various sectors, and propelling+us into the future.+Through improvements in diagnostics, treatment, and patient care,+technological advancements have had a profound impact on healthcare.+Medical devices, telemedicine, electronic health records, and artificial+intelligence (AI)-driven diagnostics have transformed healthcare delivery by+making it more precise, efficient, and accessible. Wearable devices and health+apps have empowered individuals to monitor and manage their well-being+proactively. Technology has also played a crucial role in advancing medical"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|0|c0a97f842ce84d1399bb35fcc9ca17a8+"research, discovering new treatments, and improving overall healthcare+outcomes. In response to the COVID-19 pandemic, the world witnessed the+exponential growth of digital health."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|0|00596c043eb84a829a663e034eb52bde+"83Building a Resilient Digital Health Ecosystem in India Digital Health Landscape in India+Given India’s massive population, providing equitable access to healthcare+services to all is an important agenda. By harnessing the power of+technology, digital health can effectively address these challenges and+ensure that healthcare services are accessible even in the remote regions.+Patients can use digital platforms for convenient access to care. Digital+platforms therefore bridge gaps and improve healthcare delivery across the+nation.+In line with the ‘Digital India’ initiative and the vision to create+interoperable and standardised electronic health records across the country,+the Indian government notified the Electronic Health Record1 standards in+2016. The National Health Policy2 (2017) envisages the creation of a digital+health technology ecosystem that serves the needs of all stakeholders and+improves efficiency, transparency, and citizens’ experiences across public"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|a57747eedbc94f27aeaa023ebf800e32+"and private healthcare.+Over the recent years, India has made progress in digital healthcare+delivery, as demonstrated in national health programmes such as the+Hospital Management Information System, Online Registration System, the+national tuberculosis elimination (Ni-kshay) programme, Mother and Child+Tracking System, Mera Aspataal (My Hospital, a patient feedback system), the+Health Management Information System, the Integrated Health Information+Platform, and Non-Communicable Diseases screening application—which+have benefitted patients through the timely delivery of services and by+making government healthcare more affordable and accessible.3+The need for a future-ready digital health system has become even more+urgent with the announcement of the Ayushman Bharat Pradhan Mantri Jan+Arogya Yojana (AB-PMJAY)4 in 2018, India’s flagship programme that would+herald an infrastructural transformation of the nation’s health system. This+mission envisions the following:"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|1c7917baa4ae4cee997ec26107908884+"mission envisions the following:+I. Operationalising 1.5 lakh health and wellness centres that offer preventive+and primary care, including telemedicine consultation services; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|1|eba3bd7af89a46a586d2786a9549f23b+"84Accelerating Global Health: Pathways to Health Equity for the G20+85II. Providing financial protection of up to INR 500,000 per family annually+for secondary and tertiary care hospitalisation to the over 120 million+crore poor and vulnerable families that comprise the bottom 40 percent+of the Indian population.+These initiatives aim to scale up a wellness-oriented approach instead+of an illness-focused one—a key step towards achieving universal health+coverage (UHC) through patient data portability across primary, secondary,+and tertiary levels. This essentially translates into an environment where+all people can obtain health services anywhere in the country without+suffering financial hardship or excessive indirect costs.+Achieving such scale requires us to rethink the core technology backbone+of our system and leverage cutting-edge digital solutions to tackle the+challenge. However, it is also felt that all these efforts need to converge into"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|ec1766626938432892c24b9acb2ca6ca+"a single framework to achieve interoperability of data, which would benefit+both policymakers for decision-making and patients with effective services+at the time of need. In response, the government developed the National+Digital Health Blueprint as a framework for the efficient implementation of+digital health treatments.+The Ayushman Bharat Digital Mission5+To implement the principles of the blueprint, the National Digital Health+Mission, now known as the Ayushman Bharat Digital Mission (ABDM), was+launched in six union territories in August 2020. It was proposed to be+carried out via six key components—i.e, the digital health ID card, Digi-+Doctor, Health Facility Registry, Personal Health Records, e-pharmacy, and+telemedicine. India launched the nationwide implementation the ABDM in+September 2021 . The ABDM intends to create the framework needed to+enable an integrated digital health infrastructure in India. Additionally, it"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|65393c34cb53464a960c0e7f6ebd4d68+"will bridge the existing gap amongst different stakeholders of the healthcare+ecosystem through digital highways.+Under the ABDM, every citizen will be provided a 14-digit Ayushman+Bharat Account (ABHA) number, which is a unique health identifier. With+the patient’s informed consent, the ABHAs will be used to identify and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|2|2aa329278e3f4383831bc6efa5942993+"85Building a Resilient Digital Health Ecosystem in India authenticate people’s health records across various systems and stakeholders.+As of July 2023, over 435 million ABHAa numbers have been created, and+214,396 health facilities and 207,274 doctors have been registered under+the ABDM ecosystem.+ABDM has accelerated the participation of various stakeholders of the+healthcare ecosystem and ensured deployment of patient-centric policies—+resulting in cashless care with improved access to ensure protection+for the poor. Given its federal and complex healthcare structure, India+demands agility, flexibility and evidence-based smart policymaking for+implementation of healthcare initiatives, driving all stakeholders towards+health-seeking behaviours with renewed energy.+Digital Health in COVID-19 Management+The COVID-19 pandemic has challenged health systems across the globe.+The India government not only focused on the management of the pandemic"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|784ecfb5b0fa4e41a0d142cf69671e30+"through various activities but also formulated innovative solutions to ensure+the continuity of health services across the spectrum. It has followed a+‘whole of government, whole of society’ approach to battle the pandemic+by engaging subnational and local governments, civil society organisations,+the private sector, and local communities in mitigation efforts.+Amid the pandemic, India recognised the need to ease access to digital+consultations, and issued the Telemedicine Practice Guidelines in March+2020. India also launched eSanjeevaniOPD,6 a first of its kind and the+world’s largest national telemedicine service to facilitate online health+facilities to patients in the confines of their home at no cost to ensure+continuum of care. The eSanjeevani initiative has been instrumental in+bridging the digital divide in India, particularly in rural areas where access+to healthcare is often limited. This initiative has completed 142 million"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|c3bf84643ff44d68bf38a16e96fd9e86+"consultationsb in record time and is currently serving around 400,000+patients every day as of 27 July 2023.+a https://dashboard.abdm.gov.in/abdm/+b https://esanjeevani.mohfw.gov.in/#/"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|3|00c023acbd1649be8e5673413309c140+"86Accelerating Global Health: Pathways to Health Equity for the G20+87India developed another state-of-the-art digital health system, CoWIN,7 a+digital platform that helped more than a billion beneficiaries book COVID-19+vaccinations in less than three months. In less than 18 months, CoWIN+had helped administer two billion COVID-19 vaccination doses, immunising+over 90 percent of all eligible adults.+The establishment of digitally-enabled COVID-19 ‘war rooms’ at the central+and state levels allowed key stakeholders to undertake data-driven decisions+towards infrastructure gap analysis, case projection and management, and+to identify problem areas that required specific state-centre coordination.+Various other digital health initiatives that have enhanced India’s efforts+against the COVID-19 crisis are outlined in the following points:+i. the COVID-19 India Portal developed for disease tracking by geography,"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|96c919e1d14e4ba9870d0f5015e90f1f+"inventory tracking of essential items, and predicting demands at the+national, state, and district levels based on case-loads;+ii. the Aarogya Setu, a mobile tracking app which uses the smartphone's+GPS and Bluetooth features to track the coronavirus infection through+contact tracing, syndromic mapping, and self-assessment in addition to+essential risk communication for our citizens;+iii. the RT-PCR app, a hand-held tool for country-wide sample collection;+and+iv. a COVID-19 facility app which allows health system stakeholders up to+the district level to track the state and management of patients.+Institutionalising Pandemic Learnings: National Public Health+Observatory (NPHO)+India has established the National Public Health Observatory (NPHO) and+the Health Emergency Operations Centre (HEOC) for real-time monitoring+and analysis of various data points for informed decision-making. The+NPHO will ensure comprehensive monitoring of health systems, including"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|a29a332cd2de4594a574bb57c7d10fd2+"overall healthcare service delivery, integration of healthcare programmes,+and transformation of the healthcare situation in the country."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|4|c53fa240102b418d96669de0302129ff+"87Building a Resilient Digital Health Ecosystem in India Leveraging AI for Improved Healthcare+Across the world, AI is being used in healthcare to support doctors and+healthcare workers, improve customer service and patient management, and+monitor diseases. The Indian government has established three centres of+excellence for AI—at the All India Institutes of Medical Sciences in Delhi+and Rishikesh, and at the Post Graduate Institute of Medical Education &+Research in Chandigarh—to leverage and identify potential areas for the+use of AI in the health sector. The centres are already working on several+solutions for healthcare which leverage generative AI, including:+i. a clinical decision support system, a multilingual solution to provide+diagnostic and triaging support to doctors;+ii. event-based disease surveillance to scan large volumes of digital media+in English as well as 10 Indian languages to monitor events that signal+an impending disease outbreak; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|8368e5f419c943b89a7a33939b57aa87+"an impending disease outbreak; and+iii. an AI assistant for frontline workers in 11 Indian languages to enable+and empower healthcare workers to ask questions and receive responses+to enhance their work.+Stimulating Advanced Knowledge for Sustainable Health+Management (SAKSHAM) Portal+The inclusive capacity building of health professionals is an important+component to ensure the efficient delivery of healthcare services across+the country. Tele-education has benefitted all fields of education including+medical education, especially for students in remote areas with limited access+to schools and qualified teachers. Online platforms, video conferencing,+and pre-recorded lectures have facilitated learning for students who were+previously deprived of quality education due to their geographical location.+Keeping this vision in mind, the government has developed a unified and+dedicated online learning and training platform, SAKSHAM,8 to enable"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|8ef6462971234fea8ca5b9c897badcc4+"health professionals to receive advanced training without any disruption in+their regular jobs. The portal hosts more than 200 courses on public health+and 150 on clinical practices."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|5|9b1e7fd4829c450b8cc36fbd9453d186+"88Accelerating Global Health: Pathways to Health Equity for the G20+89With such developments in digital health, India has leapfrogged in terms+of the adoption of digital health in the public sector. This will arguably+lead to the creation of a national digital health ecosystem through wide-+scale adoption of digital tools across the continuum of care, both in the+private and public sectors.+Promoting the Digital Health Agenda Globally+India has emerged as a frontrunner in championing digital health and+in positioning it as a critical agenda at the global level. Recognising+the transformative potential of technology in healthcare, India has+taken proactive steps to harness digital innovations, promote healthcare+accessibility, and drive advancements in the field globally.+India tabled the Digital Health Resolution in the 71st World Health+Assembly in May 2018 at Geneva, which was unanimously adopted by all"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|a4cd493a8ff94f7b9f31d65bd15833b2+"the member states of the World Health Organization (WHO). The resolution+highlighted global attention to the potential challenges and opportunities+related to digital health technology and need for close collaboration on the+issue globally. As a follow-up action, WHO has prioritised digital health+agenda by establishing the Department for Digital Health and Innovation in+April 2019 and published the Global Strategy on Digital Health 2020-2025 to+promote healthy lives and well-being for all.+India served as Chair of the Global Digital Health Partnership (GDHP,+between 2019 and 2021), which is the world’s largest intergovernmental+and multilateral forum on the issue of digital health. Under India’s+leadership, the GDHP’s membership grew from 14 to 33, including three+international organisations (WHO, Organisation for Economic Co-operation+and Development, and the International Digital Health and AI Research+Collaborative)."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|71de2efb72064d318b9e0bee887f6879+"Collaborative).+India’s G20 Leadership Catalysing Global Health Initiatives+India’s G20 presidency set ambitious goals to address the 21st century’s+greatest challenges such as climate change, food insecurity, the threat of"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|6|eb215b2863164d6ba5e98fcffff46cba+"89Building a Resilient Digital Health Ecosystem in India future pandemics, and other health emergencies by building international+co-operation and strengthening global systems. The pandemic experience+has taught us that preventing and preparing for a health emergency must+always be a top priority at a global level, because when it comes to health,+“no one is safe until everyone is safe.”+Drawing from the lessons from the pandemic, the G20 Health Working+Group set out to catalyse and enervate global health initiatives. Through+four meetings, culminating in the health ministers’ meeting, three main+priorities were discussed:+i. prevention, preparedness, and response to health emergencies with+focus on anti-microbial resistance and ‘One Health’;+ii. strengthening cooperation in the pharmaceutical sector with focus on+availability and access to safe, effective, quality, and affordable medical+countermeasures, namely vaccines, therapeutics, and diagnostics; and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|1a76e52834584b208c08bddb9a1f0b62+"iii. digital health innovations and solutions to aid universal health coverage+and improve healthcare services delivery.+Digital health, the third priority under India’s G20 presidency aims to+leverage the country’s acumen and achievements along with other global+initiatives in the digital health space, and develop innovative digital health+solutions that can be applied across the world. A number of programmes+and projects seeking to develop digital health products are being initiated+independently. These projects are cumulatively spending billions of dollars+while working on similar aspects.+India’s G20 presidency has aimed to bring them all under the umbrella+of the Global Initiative on Digital Health (GIDH), a network managed by+WHO. The GIDH is an opportunity to create a globally connected digital+health ecosystem, converging worldwide efforts in scaling up commitments+and investments of relevant stakeholders and promotion of digital health"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|998d8f77c3c949cd8843d7bdf421b78d+"solutions as digital public goods. This will be achieved through coordinated+engagements and implementation aligned with WHO norms, standards, and"|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|7|73e23711e0a54a8dafa05eb4e0949f6b+"90Accelerating Global Health: Pathways to Health Equity for the G20+91guidelines, while increasing transparency of resources being allocated to+digital transformation and identifying important gaps in support.+Conclusion+Adopting digital health is no longer a choice. The pandemic has undoubtedly+paved the way for the quick adoption of digital health. Digital health is+propelling the world towards more integrated health systems that are+focused on delivering patient-centred care, improving health outcomes, and+making the best use of healthcare resources. India’s digital health initiatives+such as the ABDM, CoWIN, and eSanjeevani have provided a stimulus to+act in conformity with a globally progressive commitment to health equity.+They have also enabled the country to work towards creating a movement+to enable integration of technology-informed models for universal health+coverage."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|8|97cddb2fd5c54f7f91c34ca00913ee2e+"coverage.+Lav Agarwal i s A d d i t i o n a l S e c r e t a r y f o r eHealth, International Health & Collaboration,+Public Health, and G20 at the Ministry of Health and Family Welfare, Government of+India."|data/MedicalDocuments/OrfPathHealth/BuildingResilientDigitalHealthIndia.pdf|8|ebc08425c0f94baaad5796ba621470b9+"93+9293Lessons from+India’s Digital Public+Infrastructure+Transformation+Sameer Kanwar and Varun Kumar+In today's rapidly evolving digital landscape, many countries are+striving to establish and strengthen digital public infrastructure (DPI)+to harness the transformative power of technology to benefit citizens. India+has emerged as a noteworthy example by successfully using technological+advancements to create robust DPI. It has implemented various initiatives+that mobilise technology for inclusive growth, economic development, and+improved governance. Countries around the world can learn from India’s+experience and achievements to initiate similar digital transformations.+Through the Digital India programme, India is seeking to digitally equip+citizens with access to all government services by improving internet+connectivity and developing online infrastructure. This encompasses three+key areas: (a) establishing a secure digital infrastructure; (b) successfully"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|0|9b7a9f8531134be2b16e734bda64a349+"delivering digital services; and (c) ensuring that every citizen has access+to the internet. India has also seen an increase in the number of digital+technology users, with an estimated 750 million smartphone users, and a+projected one billion users by 2025.1 This increase has generated demand+for a centralised digital architecture that functions as a single enterprise."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|0|a7321ba158184f8b86aac4988ef5ec62+"93Lessons from India’s Digital Public Infrastructure Transformation+93In 2018, the Ministry of Electronics and Information Technology (MeitY)+created the India Enterprise Architecture (IndEA) framework1 for the adoption+of a whole-of-government enterprise architecture by central ministries,+state departments, and public sector enterprises. Built with a focus on+performance, IndEA offers open standards to promote interoperability+and supports decentralisation. At the same time, it supports both new+(greenfield) and legacy (brownfield) e-governance initiatives. The emphasis+of the IndEA initiative is to enable “One Government – a government+that is least visible but is effective” by implementing the concept of+“virtualisation of departments” to activate synergy.2+Growing digitalisation will lead to the increased generation of data,+and consequently, data protection and ownership must be addressed at+the outset. The Data Empowerment and Protection Architecture (DEPA)"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|508c60a74e3c4391a8d4136d0a90ffeb+"framework, introduced in 2020, seeks to ensure user control over data.+DEPA suggests measures for consent-governed and secure data-sharing+with third-party institutions. Controlled by consent managers, only relevant+user data is plugged in to any private ecosystem and there is no need+to set up bilateral databases.3 This empowers citizens with ownership and+control over their own data and how it is shared.+While DEPA has been flexibly applied in multiple sectors, it has been+particularly well-used as a techno-legal solution in the finance sector.+Since DEPA empowers individuals to securely share their financial data+with banks, insurers, investors, and other stakeholders, its first immediate+benefit has been to encourage competition among private players.+Individuals and small businesses are now able to get loans, insurance, and+other financial products at competitive rates, just by using their digital"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|b7f8f25fdd3c482cb13517142b7c0117+"footprint. In practice, DEPA works closely with the many layers of India+Stack4—Aadhaar-based e-KYC, Unified Payments Interface (UPI) for cashless+payments, and Aadhaar-based eSign) and uses the Open Credit Enablement+Network to facilitate lending. India Stack has enabled the country to build+its digital infrastructure, especially in establishing a design to improve+private sector service delivery, and has served as India’s digital library,+housing several digital global goods and offering learnings to the world.+Over the last decade, India has taken landmark steps to set in motion its+vision of becoming an inclusive digital economy. This includes establishing"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|1|be5f478737c04472bffaf880bf0be06b+"94Accelerating Global Health: Pathways to Health Equity for the G20+95robust DPI and the facilitation of digital governance by streamlining+roles, accountability, and change management. This encompasses various+components, including digital identification systems, digital payments+systems, and digital service delivery platforms.+Pillars of Digital Public Infrastructure in India+The foundation: Aadhaar5+India's Aadhaar programme, a biometric and face authentication-based+digital identification system, has revolutionised identity verification+and service delivery in the country. Aadhaar has provided a unique+identification number to over 1.3 billion residents of India, enabling access+to essential services such as government subsidies, bank accounts, and+mobile connections. It has enabled the government to streamline service+delivery and eliminate duplication by providing a single digital identity+across multiple sectors. The world can learn from India's approach in"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|d407fea54dd0419d993eea72ba0ffc30+"implementing a centralised, secure, and inclusive identification system, that+has facilitated interoperability across service delivery platforms, both public+and private.+Driving financial inclusion: Unified Payments Interface6+India's push to digitise payments has transformed the way financial+transactions are conducted in the country. The implementation of UPI has+created a platform that enables instant money transfers between bank+accounts. It offers a smartphone-based interface to support seamless,+interoperable, and real-time payments, available on the go. UPI has not only+transformed the way individuals transact but has also provided a significant+boost to the growth of the digital economy. Countries can gather important+lessons from India's experience in fostering a competitive and interoperable+payment ecosystem, which has led to increased financial inclusion, reduced+reliance on cash, and enhanced transparency in transactions."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|72e89e28e10a42a6a177299e73a70265+"The number of digital transactions increased by more than three times+from 3 billion in November 2019 to 10 billion by January 2023.7 A 2019"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|2|6c3a8512b9a140c983b92ad7f3e5ac41+"95Lessons from India’s Digital Public Infrastructure Transformation MeitY study noted that under a ‘business as usual’ scenario, India’s+digital economy will grow to US$500 billion by 2025, with the potential+to increase to US$1 trillion.8 In 2021, India had 48.6 billion real-time+payments, as compared to 18.5 billion in China and 8.7 billion in Brazil.9+This is indicative of the ease with which the Indian population has adopted+digital platforms for making payments even if the average value of such+payments may be rather low.+Efficient welfare delivery: Direct Benefit Transfer10+India's Direct Benefit Transfer (DBT) programme is aimed at eliminating+potential leakages in the physical delivery of financial benefits and ensuring+an efficient transfer of welfare to the right beneficiaries. By leveraging+digital payment systems, benefits are directly credited to the beneficiaries’+bank accounts, reducing corruption, eliminating middlemen, and improving"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|26dcc67d7f7c43b4a92343aa220232c4+"transparency in the transfer of subsidies.11 The enablers for DBT in India+are the Pradhan Mantri Jan-Dhan Yojana, the Jan Dhan-Aadhaar-Mobile+Yojana, and nearly 312 other schemes from 53 ministries across all states+and union territories. More than INR 24,800 billion has been transferred+through the DBT programme since 2013, with INR 6,300 billion transferred+in FY 2021-22 alone. On average, more than 9 million DBT payments were+processed daily in FY 2021-22.12+Citizen-centric services: E-governance13+India has leveraged technology to enhance governance and service delivery+through initiatives like Digital India and other e-governance platforms. The+use of digital platforms (or information and communication technologies)+has facilitated efficient and transparent administration, improved the+accessibility of government services, and reduced bureaucratic inefficiencies."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|5e5cf5cf4f2f42189004a55fd0fbe71f+"The MyGov platform14 h a s b e e n a c r u c i a l c o n t r i b u t o r t o t r a n s f o r m i n g c i t i z e n -+government interactions. India's approach to digital governance emphasises+citizen-centricity, where technology acts as an enabler to bridge the gap+between the government and its citizens. By adopting similar approaches,+countries can enhance government services, promote transparency, and+strengthen democratic participation."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|3|89d34f6b4a1149da8434c3dc7e361947+"96Accelerating Global Health: Pathways to Health Equity for the G20+97Creating a digital ecosystem: Technology access and innovation+India has created a vibrant digital ecosystem that fosters innovation+and entrepreneurship. Initiatives like Startup India15 a n d M a k e i n I n d i a16+have encouraged the growth of technology start-ups and attracted global+investments. India has nurtured a conducive environment for technology+and innovation through policy reforms, access to funding, and incubation+support. Managed by the Department for Promotion of Industry and Internal+Trade under the commerce ministry, the Startup India initiative has helped+introduce various programmes that support entrepreneurs and create a+healthy start-up ecosystem. Similarly, the ‘Make in India’ initiative has+incentivised the development, manufacture, and assembly of products in the+country, and has thus boosted partnerships, investments, and innovations."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|79c55fbf94dd417284553421cb291e12+"Growing digital literacy and inclusion in harnessing the benefits of+technology has also been crucial achievements for the country. India's+experience underscores the importance of widespread access to affordable+internet connectivity, digital skills training, and tailored initiatives for+marginalised communities. Initiatives like BharatNet,17 which aims to+connect over 250,000 local rural bodies with high-speed internet, and the+Common Service Centers,18 which provide access to government services in+remote areas, have been instrumental in extending the benefits of India’s+digital infrastructure to rural communities. In addition to the digital+training programmes offered through government-supported bodies like+the National Skills Development Centre19 and the National Institute for+Entrepreneurship and Small Business Development,20 other private training+institutes and online platforms have significantly contributed to digital skill"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|b5cc53eec04d4b72976b76bac99600d1+"building among citizens, both in urban and rural settings. By prioritising+digital literacy and inclusion, countries can bridge the digital divide and+empower their citizens to participate fully in the digital age.+Key Drivers of India’s Digital Transformation+India’s achievements in implementing DPI demonstrate the transformative+power of technology when combined with inclusivity, scalability, regulation,+and collaboration. The key factors that equipped the country to achieve this+digital revolution include:"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|4|e5168689a0894a83821de56e5646e40c+"97Lessons from India’s Digital Public Infrastructure Transformation Ecosystem collaboration+India's success in digital service delivery can be attributed to strong+collaboration between government agencies, industry leaders, startups,+academia, and civil society organisations. This collaborative approach+has fostered innovation, shared expertise, and effective implementation.+India’s G20 presidency has further drawn attention to the importance+of collaboration, with initiatives like the Global DPI Summit21 allowing+a close agreement between partners (and non-partners alike) on the+common principles and design aspects of DPIs. By bringing together all the+stakeholders, the Indian government has created a collaborative environment+for developing and implementing digital public infrastructure projects.+Industry players have contributed their expertise, resources, and technological+innovations to build and maintain the required infrastructure. Similarly,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|ded53e412e15418db0ce8e093a0b0bb7+"collaborations with academic institutions and research organisations have+aided innovation and helped address technical and policy challenges. Public-+private partnerships and international collaborations have further supported+knowledge exchange, best practice sharing, and access to resources and+funding.+The Indian government has been able to promote such an ecosystem+collaboration by establishing platforms (such as, India Stack), forums (for+example, India Stack Knowledge Exchange Forum, 202222), and regulatory+frameworks (IndEA and DEPA) that encourage active participation,+information sharing, and coordination between different stakeholders.+These collaborations prioritise interoperability, data privacy, security, and+scalability to build a robust and sustainable DPI in the country.+Scalability and inclusion+India's experience in scaling up its DPI demonstrates the significance+of inclusivity, with the most successful case being that of its digital"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|92aa0e11195f43fab4ecaf8c6b4db87c+"identification system. MeitY, in response to an unstarred question in the+upper house of Parliament (in July 2022), said that out of the approximate+projected population of 1.37 billion, around 1.27 billion held a live Aadhaar+number.23 By ensuring accessibility and ease of enrollment for all citizens,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|5|695d9199ed71476d91d5a642cd5901a7+"98Accelerating Global Health: Pathways to Health Equity for the G20+99including marginalised communities, India has achieved a notable level of+inclusivity. While there are gaps in digital inclusion across demographic+locations (55 percent share of urban telephone subscribers, as of December+202224) and gender (11 percent gender gap in mobile ownership, 202325),+the country is consistently invested in closing this difference.+India’s digital infrastructure has been created keeping in mind future+needs and potential growth. With a quantum increase in users connected+to the internet, the emergence of multiple types of intermediaries (digital+media, e-commerce, and others), and the possible use of connectivity to+cause harm or commit crimes cannot be ignored. Comprehensive measures+need to be taken to prepare for the future. To check a potential DPI’s+scalability even before introduction, significant emphasis has been placed"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|c1ec1f16dbb64a0d8dbd9b266609afae+"on considerations like robust technology frameworks, interoperability, open+Application Programming Interfaces, data management, and addressing+infrastructure gaps.+India’s journey is an example of how scalability and inclusion work+together in building a resilient and equitable digital public infrastructure.+Key strategies that have helped the country’s efforts to establish its+infrastructure at scale are ensuring accessibility, promoting digital literacy+and skill development, focus on last-mile connectivity, multilingual support+in technological solutions, participatory implementation, and regulations to+ensure affordability.+Balancing regulation and innovation+India's digital payments ecosystem demonstrates the need to strike a+balance between regulation and innovation. While fostering competition and+innovation, the country has implemented robust regulatory measures to+ensure the security and integrity of transactions."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|554377b8bd544ea0b0e343c02cb822bc+"Putting in place provisions like regulatory sandboxes, which provide a+controlled environment for testing innovative technologies and business+models, has allowed experimentation and innovation, while ensuring+consumer protection and risk mitigation. At the same time, taking a"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|6|717cc8137f1e405aa98adda0a4d527db+"99Lessons from India’s Digital Public Infrastructure Transformation collaborative approach by establishing forums and platforms for stakeholders+to engage in policy discussions and regulatory consultations has helped+in understanding their needs and concerns, thus informing the adoption+of balanced regulatory policies. Recognising the fast-paced nature of the+digital landscape, Indian regulators have also shown agility in updating and+adapting regulations. Recent policy measures like the introduction of the+Digital Personal Data Protection Bill 2022,26 which restricts the processing+of personal data until after the individual’s consent has been recorded, and+the presentation of the Digital India Act 2023,27 to set up global standard+cyber laws, have demonstrated a willingness to understand and respond to+consumer needs, emerging technologies, and market trends.+While India has made strides in regulation and innovation, challenges"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|3dea693354c2490488cf797844863da1+"remain. Striking the right balance between the two requires continuous+monitoring, assessment, and adaptation of regulatory frameworks to keep+pace with evolving technologies and market dynamics. Employing these+efforts at the desired scale in the country would require infrastructure,+investment, and a strong commitment. Ongoing collaboration between+regulators, industry players, and other stakeholders will be crucial to+maintaining an innovation-friendly environment while upholding consumer+protection and addressing emerging risks.+Conclusion+India's DPI provides valuable lessons on the advantages of harnessing+technology for inclusive growth, economic development, and improved+governance. Through initiatives like Aadhaar, UPI, digital health+infrastructure, DBT, e-governance, regulatory frameworks, and creating an+enabling digital ecosystem, India has been able to unlock the transformative+potential of DPI. By focusing on the key lessons from India's experience,"|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|2d915595100243ee97337357adfbd5a8+"other countries can implement similar DPIs to address their unique+challenges and leverage the potential of technology for the benefit of their+citizens."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|7|00184cc144484362ba8613f06f0aadec+"100Accelerating Global Health: Pathways to Health Equity for the G20+101These countries must consider their contextual differences based on+population size, level of technological development, political priorities, and+policy outlooks to customise their learnings to suit their specific needs and+challenges. As the world embraces the digital era, India's DPI experience+can serve as inspiration and guide for building robust digital systems that+could foster inclusive societies and drive sustainable development in the+21st century.+Sameer Kanwar is Director, Digital Health, India and South Asia Hub, PATH .+Varun Kumar is Senior Program Officer, PATH."|data/MedicalDocuments/OrfPathHealth/LessonsIndiaDigitalHealthTfn.pdf|8|613d6988832246eaaf57f6d9192e54d0+"29+2829Antibiotics have revolutionised modern medicine by reducing+morbidity and mortality caused by bacterial infections. However,+the overuse and misuse of antibiotics has accelerated the development of+antibiotic resistance, making once-treatable infections increasingly difficult+to manage.1 Antimicrobial resistance (AMR) is a grave global health crisis,+posing significant challenges to achieving health equity on a global scale.+In 2019 alone, bacterial AMR was directly responsible for 1.27 million+deaths worldwide.2 If left unchecked, this is predicted to cause a staggering+10 million deaths by 2050,3,4,5 u n d e r l i n i n g t h e u r g e n t n e e d f o r a c t i o n .+An increase in AMR will significantly impact the global economy and is+expected to push an additional 24 million people into extreme poverty by+2030.6 Although reliable estimates from developing nations remain limited,+perhaps due to inadequate surveillance, the burden of AMR is suspected"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|0|a2e40d44ac8b4bc1b87b168a9a450207+"to be highest in low-income countries. Unless suitable interventions are+implemented, certain susceptible bacterial pathogens will eventually become+resistant to antimicrobials, thereby rendering treatments ineffective.7 This+essay explores the multifaceted nature of AMR and its impact on healthcare+systems and patient outcomes. The focus is on accelerating efforts to+combat AMR, with the recognition that addressing this issue is crucial for+ensuring health equity for all. Ranga Reddy Burri, Robert Skov, Bulagonda Eswarappa Pradeep,+and Ralf SudbrakThe Battle Against+Antimicrobial+Resistance"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|0|845384860a874fc8b18ed38b165d91fb+"29The Battle Against Antimicrobial Resistance+29Understanding Antimicrobial Resistance+The emergence of AMR impedes the prevention and/or treatment of+persistent infectious diseases. Although a number of measures have been+initiated at the global, national, and regional levels, AMR persists.8 To+effectively combat AMR, it is essential to comprehend its fundamental+aspects. AMR refers to the ability of microorganisms, such as bacteria,+viruses, fungi, and parasites, to withstand the effects of antimicrobial drugs.+The development of resistance is part of the natural biological evolution as+this is part of the defence system of microorganisms. Resistance can be+inherent (i.e. no target for the antibiotic) or it can arise through various+mechanisms, including genetic mutations, horizontal transfer of resistance+genes between microorganisms, target modification, membrane permeability+alteration, drug modification, and antibiotic efflux. Exposure to antimicrobials"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|1|f1e59f2d24db4d059c8bc8fdc7a5193c+"accelerates the generation of resistance by increasing rates of mutation+and exchange of genetic resistance mechanisms as well as the killing of+susceptible microorganisms (including many bacteria of the normal flora),+thereby giving resistant microorganisms a competitive advantage (also+known as ‘selection’). Resistance affects all types of antimicrobial agents,+including antibiotics, antivirals, antifungals, and antiparasitic drugs. There+are five key factors that contribute to the rise of AMR (see Figure 1).+Figure 1: Factors Contributing to the Rise of AMR+Source: Authors’ ownInadequate+infection+prevention+and controlPoor+diagnostic+capacityDrying+antimicrobial+development and+production+pipelineAbuse/+Inappropriate+use of+antibiotics"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|1|5f12a23a8cd14c22a6ce2a6851934d50+"30Accelerating Global Health: Pathways to Health Equity for the G20+31a) Inadequate infection prevention and control: The spread of AMR is+closely linked to the ability of bacteria and other microorganisms to+rapidly multiply and spread their population through various vectors/hosts.+Poor hand hygiene, improper disinfection and sterilisation practices, and+inadequate sanitation can lead to the rapid spread of these drug-resistant+pathogens. Strict adherence to infection control measures can lower the+occurrence of hospital-acquired infections.9 Therefore, appropriate measures+need to be taken to enhance the existing infection prevention framework and+reduce the risk of the spread of AMR. A significant hurdle in implementing+infection prevention and control (IPC) practices, especially in low- and+middle-income countries (LMICs), is the presence of adequately-trained+human resources. To address this, institutions such as the World Health"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|66c6d834348b4a62b864b5a39bb15fe1+"Organization (WHO) and US Centers for Disease Control and Prevention+have developed training modules, while the Infection Control Academy+of India (IFCAI) has developed a diploma course to build the capacity of+infection preventionists.+b) Abuse/inappropriate use of antibiotics : In addition to the selection+pressure on microbes due to the use of antimicrobial drugs, social and+administrative factors also contribute to, and exacerbate the emergence of+AMR. One of the contributing factors is the availability, in many countries,+of antimicrobials through over-the-counter (OTC) sales without requiring+prescriptions. Furthermore, the inappropriate prescription of antibiotics by+physicians contribute to the overuse of antibiotics. A study conducted by+WHO highlighted that a significant proportion of antimicrobials prescribed+in outpatient departments of various hospitals were unnecessary or+inappropriate.10 Rampant use of antibiotics in the livestock sector, pressure"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|814076eb4141455baa4afe3bddce0dd9+"from patients to be prescribed an antibiotic for immediate relief from+symptoms, self-medication, and the discontinuation of antibiotic course+after relief from symptoms—all worsen drug resistance in pathogens.11,12+New legislation and the enforcement of existing regulations to prevent the+OTC sale of antimicrobials is crucial, as are stricter antibiotic prescription+and consumption measures.+c) Drying antimicrobial development and production pipeline: The complete+antimicrobial drug development process, from discovery to market entry, takes+an average of eight to 12 years. Although advancements in computational"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|2|0aef0d4620f242e996cf1d0b2d84b4cc+"31The Battle Against Antimicrobial Resistancechemistry and artificial intelligence (AI) have aided in drastically cutting+down the timelines for the discovery of new antimicrobials, the in vitro+and in vivo trials take time. Even after such laborious efforts, bacteria+swiftly develop resistance to these antibiotics. Quicker and more efficient+antibiotic testing and approval pipelines need to be established to combat+AMR.13+Recent advances in antimicrobial discovery—including the repurposing+of existing drugs, exploration of natural products, employing alternate+treatment strategies, the use of computational approaches for drug design,+interdisciplinary collaborations, and the integration of new technologies may+help in accelerating the discovery process14 a n d i n t h e m i t i g a t i o n o f A M R .+Despite the recent advantages, investment in antibiotic research and+development remains limited, resulting in a clinical antibacterial pipeline"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|7fb1b39b4037448eaf3eb30e1898fc7e+"that is insufficient to address the emergence and spread of AMR infections.+In 2021,15 there were only 77 antibacterials in the clinical pipeline that target+WHO priority pathogens (Enterobacteriaceae, Acinetobacter and P s e u d o m o n a s )+including tuberculosis.16 Of these, 45 are traditional antibacterial agents and+32 are non-traditional. Of the 45 traditional antibiotics, 27 are reported+to be active against the WHO bacterial priority pathogens, 13 against+Mycobacterium tuberculosis, and five exclusively against Clostridium difficile.+Only six of the 27 antibacterials targeting the priority pathogens fulfil at+least one of WHO’s four innovation criteria (i.e., absence of known cross-+resistance, new class of drug, new target site, and new mode of action).17+However, a robust pipeline of novel antibiotics is critical to tackling the+increasing emergence and spread of AMR. The Global AMR R&D Hub+and WHO18 reported on the progress and challenges for incentivising the"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|c00efcf689b046e79324603ecf4f180e+"development of new antibacterial treatments to tackle the emerging threat+of AMR. The return on investment for new antibiotics fails to cover the+costs of their development, manufacturing, and distribution.19 As a result, big+pharmaceutical companies have exited the antibiotic market, and companies+remaining in the space (often small or micro biotech firms) face challenges+to sustain their operations given the cost and time for drugs to reach the+market. Novel reimbursement models addressing the market failures are+needed to make antibiotic development more economically sustainable."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|3|676eaa0f093b4fbc80687cb2f30c6f16+"32Accelerating Global Health: Pathways to Health Equity for the G20+33Innovative financing mechanisms play a crucial role in addressing the+lack of financial incentives for the private sector to develop, test, and roll+out new antimicrobials. One potential solution is the implementation of+advance market commitment–type investments, such as those undertaken+by organisations like DNDi (Drugs for Neglected Diseases Initiative), CEPI+(Coalition for Epidemic Preparedness Innovations), and Gavi (Global Alliance+for Vaccines and Immunization).+Under this model, governments pool funding to support manufacturers+and the private sector in creating antibiotics, thereby reducing innovation+risks and ensuring equitable pricing and access. This approach incentivises+private-sector investment, overcomes financial barriers, and contributes to+the fight against AMR, securing effective treatments for all.+d) Poor diagnostic capacity: Accurate and timely diagnostics are critical for"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|29773bc63cdc4fa680e82c66e6629eed+"identifying and managing infectious diseases effectively. Poor diagnostic+capacity can lead to delayed or inappropriate treatment, increased morbidity,+mortality, and spread of infectious diseases, including outbreaks. Poor+diagnostics encompass several aspects, including limited access to diagnostic+technologies, inadequate laboratory supplies and equipment, poor quality of+chemicals and equipment, absence of reliable quality assurance systems,+limited access to reference laboratories, inadequate infrastructure, lack of+trained personnel, and delays in obtaining test results.20 Poor diagnostic+capacity is one of the biggest challenges of the health sector in developing+countries.21 Lack of timely diagnostics is also a challenge in vulnerable+populations in high-income countries (HIC). Therefore, improving diagnostic+capacity is essential, especially in LMICs, as is ensuring equitable access to+diagnostics for vulnerable populations to enhance the quality and efficiency"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|7745a8bcb0d44d66ad78c6d2c0971a61+"of healthcare delivery and for achieving the global health goals of reducing+the burden of communicable and non-communicable diseases.22+Innovations Related to AMR+a) Exploration of alternative therapies: Alternate ways of treatment+like “bacteriophages,23 a n t i m i c r o b i a l p e p t i d e s ( A M P s ) o r b a c t e r i o c i n s ,24+antimicrobial adjuvants, faecal microbiota transplant (FMT) and competitive+exclusion of pathogens through genetically modified probiotics and"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|4|705bfb5bc30d4ce9a762f127476a6352+"33The Battle Against Antimicrobial Resistancepostbiotics”25 rather than antibacterial agents alone, could be an alternate+way to reduce the use of antimicrobials.+b) Streamlined approval of new antimicrobials: Efficient and streamlined+clinical trial processes are crucial for expediting the development timeline+of new antimicrobials, including regulatory processes and innovative+trial designs, such as adaptive dose-ranging studies and seamless phase+transitions. This calls for better collaboration between regulatory agencies,+researchers, and industry stakeholders to establish harmonised protocols,+reduce administrative burden, and expedite patient recruitment, leading to+faster completion of clinical trials.26+c) Repurposing of existing drugs: Drug repurposing, or identifying new+therapeutic applications for existing drugs offers another strategy to+expedite antibacterial production. By leveraging the extensive knowledge"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|573672aab4184bd0a0d749d328280bc8+"and safety profiles of approved drugs, researchers could bypass certain+preclinical and early clinical development stages, significantly reducing the+overall timeline. Repurposing can be achieved through in-silico analyses,+high-throughput screening, and exploring drug libraries, aiming to identify+existing drugs with potential antibacterial activity.27+d) Harnessing the power of AI: Machine learning (ML) and AI offer+possibilities to accelerate drug repurposing in several ways, including the+detection of the relationships among various biological components (such as+genes, proteins, diseases, and drugs) and through the analysis of molecular+fingerprints of compounds. Furthermore, neural network-based approaches+can be trained to learn the patterns and properties of fingerprints, enabling+prediction of drug activities and identifying potential drug candidates.28+AI can also be harnessed to streamline the diagnostic process. An academic–"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|a2dff2067d5543578a60182bfd8845c5+"industry collaboration in India (between Sri Sathya Sai Institute of Higher+Learning, IFCAI and SCIINV Biosciences Private Limited) has developed+AMRx™ , an AI/ML-based culture-free prediction system in the context of+urinary tract infections. It is a clinical decision support system to improve+empirical antibiotic prescriptions and to reduce unnecessary laboratory+testing of samples."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|5|21cf6462eb7f41de8afc3c403e296587+"34Accelerating Global Health: Pathways to Health Equity for the G20+35e) Collaborative research and funding initiatives: Global efforts are urgently+needed to address the complex elements of AMR. These include coordinated+leadership at the global, regional, and national level, involving diverse+government agencies, academia, practitioners, and industry.29,30 Recognising+the spread of AMR, WHO, the Food and Agriculture Organization, the United+Nations Environment Programme, and the World Organisation for Animal+Health have formed the Quadripartite to promote a ‘One Health’ approach31+that aims to align actions across the human, animal, and environmental+sectors. Several initiatives are ongoing, and 170 countries have developed+national action plans (NAPs). However, only 10 percent of these plans are+fully costed. Converting the NAPs to concrete AMR mitigation actions has+proved to be difficult, including in the LMICs."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|0cac054347174785b04ddef8537bee36+"proved to be difficult, including in the LMICs.+In response, Denmark initiated the establishment of the International Centre+for Antimicrobial Resistance Solutions (ICARS) to support these countries+with funding and expertise to develop evidence-based, context-specific+and cost-effective solutions that can be scaled to establish sustainable+AMR mitigation. The AMR Multi-Partner Trust Fund (MPTF) was launched+in 2019 by the Quadripartite members to catalyse the implementation of+One Health NAPs and to provide effective leadership and coordination of+multisectoral One Health response to AMR. Additionally, the Global AMR+R&D Hub in Berlin is promoting collaboration and coordination of research+and development on AMR, and is cataloguing the present funding in AMR+R&D to provide the landscape of present funding for future prioritisation.+Organisations such as CARB-X, Global Antibiotic Research & Development+Partnership (GARDP), and the AMR Action Fund work to stimulate drug"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|eb9b28d8481946eb8748c0029240feb7+"discovery and equitable access. To solve the market failure for antimicrobials,+new models for financing the development of novel antimicrobials, where+countries pay for the accessibility of drugs, are currently being explored.32+f) Rapid Diagnostic Tests and Point-of-Care Technologies in AMR: Absolute,+concrete, and timely diagnosis detection, and management of infection-+causing pathogens will significantly decline morbidity, mortality, and the+cost burden. Rapid diagnostic tests (RDTs)33 and point-of-care technologies+(POC) are tools that can be employed in achieving timely diagnostics.+The integration of RDTs and POC technologies, such as polymerase chain+reaction-based tests, genotypic assays, and phenotypic assays, in AMR"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|6|6fa033fa9795403f88f1b4cea6fa05f4+"35The Battle Against Antimicrobial Resistancemanagement can potentially transform clinical practice and public health+interventions.34+Accelerating Efforts to Combat AMR+Combating AMR requires a multipronged approach the comprises all critical+components—from policy to implementation. Development of new antibiotics and alternative treatments in the era+of Antimicrobial ResistanceOvercoming difficulties in finding new drugsAntibiotic repurposingDevelopment of alternate therapies like BacteriophagesImproving infection prevention and control practicesOptimising antimicrobial useStrengthening surveillance and data collectionIntegrated One Health approach to unify and integrate multiple+sectorsIncorporating AMR into national and global health plansEngaging stakeholders and raising awareness about AMRMobilising political will and fostering multi-sectoral collaboration"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|7|132097da86644b35b8147fcb94ab68d8+"36Accelerating Global Health: Pathways to Health Equity for the G20+37Conclusion+AMR is an ongoing and evolving pandemic that impacts LMICs and+vulnerable populations in HICs the hardest. This is aggravated by a drying+pipeline of antimicrobials and the industry leaving the field of antimicrobial+drug discovery due to lack of economic sustainability. The consequences of+the AMR pandemic are already severe, but will become even more dire if+not reversed. There is an urgent need for increased and focused action. Due+to the complex nature of AMR, this effort needs to be multifaceted, both+in reducing the circulation and spread of existing resistant microorganisms+and in slowing the increase of novel resistance mechanisms. Key to this+is lowering the overall use of antimicrobials (i.e. infection prevention),+antimicrobial stewardship (including accessibility of affordable and timely+diagnostics), and strengthening IPC and biosecurity procedures, all of which"|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|83a561974e644530b643bd7b78aaca7a+"need to be carried out through the ‘One Health’ approach. This needs+involvement at all levels and of all stakeholders, including civil society.+Exploring alternative therapies such as bacteriophage therapy, repurposing+existing drugs, harnessing the power of AI, and fostering collaborative+research initiatives are key strategies in tackling AMR. These innovative+approaches provide hope for the future, where a robust antibacterial+pipeline can meet the challenges posed by evolving bacterial infections and+ensure effective treatment options for patients worldwide.+Dr. Ranga Reddy Burri is President, Infection Control Academy of India and Honorary+Professor, at the University of Hyderabad, India.+Dr. Robert Skov is Scientific Director at the International Centre for Antimicrobial+Resistance Solutions (ICARS, Copenhagen, Denmark); President-Elect & Secretary General,+European Society of Clinical Microbiology and Infectious Diseases (ESCMID)."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|79badcad1dbd487888b1764e9c892c46+"Dr. Bulagonda Eswarappa Pradeep is Associate Professor, Department of Biosciences,+Sri Sathya Sai Institute of Higher Learning, India.+Dr. Ralf Sudbrak i s D e p u t y D i r e c t o r a t t h e G l o b a l A M R R & D H u b , B e r l i n , G e r m a n y ."|data/MedicalDocuments/OrfPathHealth/TheBattleAgainstAntimicrobialResistance.pdf|8|6c480a85100e4e80adba9687a25de868+"59+59Janice Tan and Jeremy LimEnsuring Access+to Affordable+Healthcare for All:+The Role of Health Finance in G20+Countries+The G20 countries, individually and collectively, have made strides+in improving human health since the group's inception in 1999.+Average life expectancy across the member states has shown remarkable+progress, increasing from 73 years to 78 years over the past two decades,+well above the global average of 67 years.1+Figure 1: Average Life Expectancy in G20 Countries+Source: WHO dataAverage life expectancy (yrs)+100+50+0+ARG FRA JPN ZAF AUS DEU KOR TUR BRA IND MEX UK CAN IDN RUS US CHI ITA KSA74+79+70+79+71+79+78+62+66+79+81+75+73+66+72+59+71+77+7777+83+75+82+78+83+81+71+71+84+84+83+74+73+77+66+78+81+79+1999 2019"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|0|47b323d77856431b8d67d73bf0cde810+"60Accelerating Global Health: Pathways to Health Equity for the G20+61This achievement demonstrates the potential of the G20’s collective+commitment towards enhancing public health outcomes and underscores+the importance of continued efforts to prioritise health equity between+countries. There is still much to be done: within the group, there is an+18.2-year difference in life expectancy between the highest and lowest+achieving members. Imagine the life and health gains if all G20 countries+levelled up.+The improvements in human health have been accompanied by an increase+in healthcare spending in absolute terms. With the exception of India and+Turkey, G20 nations saw a rise in the average healthcare expenditure as+percent of GDP, from 6.8 percent to 8.5 percent between 2000 and 2019,+or just above US$3,000 per capita.+Figure 2: Healthcare Expenditure as % of GDP for G20 countries+Source: WHO data2Healthcare Expenditure (% of GDP)+20+15+10+5"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|1|ec5c38d181dd4fe98b66c735aac3841b+"20+15+10+5+0ARG FRA JPN ZAF AUS DEU KOR TUR BRA IND MEX UK CAN IDN RUS US CHI ITA8.2+7.6+8.3+8.3+4.5+9.6+9.9+4.0+1.9+7.6+7.0+3.9+8.1+5.5+7.3+4.6+7.2+12.59.5+10.2+9.6+11.0+5.4+11.1+11.7+2.9+2.9+8.7+10.8+4.5+5.0+5.7+8.2+4.4+9.9+16.7+2000 2019"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|1|7f17a419c6ec4be294b6a2008c0a73c7+"61The Role of Health Finance in G20 Countries Figure 3: Higher % GDP Spending in Healthcare and Increase in+UHC Coverage+Source: WHO Data3+There is recognition that investments in healthcare, overall, runs parallel+to expansion in coverage of Universal Health Care (see Fig. 3). However,+this coupling between healthcare spending and health outcomes is a topic+of intense interest when discussing health finance in G20 countries. While+increased healthcare expenditure often leads to improved health outcomes,+this is not always the case and it is crucial to ensure that investments+are directed effectively and efficiently. By adopting innovative financing+mechanisms, G20 countries can optimise the impact of healthcare spending+and achieve desired health outcomes for their populations.+Persisting Out-of-Pocket Expenses+Despite progress, the issue of high out-of-pocket (OOP) expenses remains+a significant concern in many G20 countries. OOP expenses often place"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|2|67bf46897ef2443ea58021ade0df45a0+"a disproportionate burden on vulnerable populations, leading to financial+hardships and limited access to healthcare.4 Embedded in the advocacy for+health equity is the recognition that health disparities exist among different+populations due to various factors such as socioeconomic status, race,+ethnicity, gender, geographic location and access to healthcare services.5+Thus, achieving health equity requires interventions and policies targeted+towards those who are most disadvantaged and have the greatest needs.+This may involve redistributing resources, implementing targeted healthcare+programs, improving access to quality healthcare services, addressing social+and economic inequalities, and promoting health education and prevention UHC+Global average : 67+India+IndonesiaTurkiyeChinaSingapore South KoreaNetherlands+UKCanada+United StatesGermany+FranceJapan+Spain+Brazil+ArgentinaSouth AfricaRussiaAustralia+Mexico+% GDP100+80+60+40+20+0+0 5 10 15 20Italy"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|2|cee9405d7f9345ac9beb4b3fbf485aec+"62Accelerating Global Health: Pathways to Health Equity for the G20+63initiatives. As the COVID-19 pandemic has illustrated, no one is safe until+everyone is, and even if primarily motivated by self-interest, there is an+economic case (if not for reasons of equity) for uplifting the most vulnerable+populations.+The efficiency of healthcare systems also varies greatly among G20 countries.+While some economies have successfully implemented efficient and effective+healthcare models, others continue to face challenges in delivering equitable+care. The authors of this article examine the relationship between universal+healthcare service coverage (UHC) and Out-Of-Pocket Expenses (OOPE) as a+proportion of Current Health Expenditure for G20 countries (Fig. 4), reflecting+targets 3.8.1 and 3.8.2 of the UN Sustainable Development Goals for Universal+Health Care.+UHC measures coverage of essential health services that include reproductive,"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|b3125524cd434526969844ef534e60b7+"maternal, newborn and child health, infectious diseases, non-communicable+diseases and service capacity and access among the general and the most+disadvantaged populations. Meanwhile, 3.8.2 highlights catastrophic OOP+healthcare spending, usually defined as populations with household expenditure+on health >10 percent or 25 percent of total household expenditure. The+authors used data from previous decade to sift out which countries of the+G20 had shown the most recent improvements, and also included Spain and+Singapore to the analysis as both these countries are permanent or recurring+guest nations to the G20 dialogues and could offer lessons to emulate.+Figure 4: Changes in UHC Service Coverage with OOPE in the+Past Decade for G20 Countries+Source: WHO data6UHC+AUS+90+80+70+60+50+40More health service coverage is betterIdeal+Situation"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|9cfbef4b83674b20b627a9af06d3ae12+"Situation+Lower Out of Pocket Expenditure as a% of Current Health Expenditure is betterOOPE70 60 50 40 30 20 10Global average : 67Global average : 312019+2009+ZAFTURTUR+KSA KSAFRA+FRA+USAUSAJPN+JPNDEU+AUSSPN+SPNITA+ITA+BRABRAKOR+CHI+CHIRUS+RUSMEX+MEX+IDN+IDNIND+INDKOR+SGP+SGPCAN+CAN+UKUK+DEU+ARG ARG+ZAF"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|3|8557a7dfb0ce4db8a2b165aedc19d757+"63The Role of Health Finance in G20 Countries From the chart, directional movement to the upper left quadrant or+North-West direction would be ideal as it highlights increased UHC+with lower OOPE, i.e. better coverage at greater affordability. The most+significant improvements are highlighted in green (China, India, Indonesia,+Singapore). This article discusses efforts in Indonesia and Singapore that+have contributed to these remarkable achievements. By examining diverse+strategies, readers can gain insights into potential pathways towards+achieving health equity within different national contexts, be they in+developing or developed nations.+Best Practices+Indonesia+Indonesia’s journey to UHC is a textbook case of adherence to expanding+health insurance coverage and implementing social protection mechanisms.+The landmark JKN National Health Insurance was implemented in 2014+to provide access to healthcare for its population and today covers"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|2637f57224b34d4895cf7ade5482c61c+"approximately 250M people.7 The JKN program covers all Indonesian+citizens, including formal and informal sector workers, and those+categorised as poor and near-poor, ensuring that everyone has access to+essential healthcare services. It consolidates more than 300 risk pools and+operates under a single-payer system, managed by the Social Security+Agency for Health ( Badan Penyelenggara Jaminan Sosial Kesehatan o r B P J S ) .+BPJS collects contributions, manages the insurance fund, and coordinates+with healthcare providers. Participation for all eligible individuals is+mandatory, and contributions are based on income and employment status,+with the government subsidising the premium for the poor and near-+poor. The insurance scheme entitles every Indonesian to the same medical+benefit package, decreasing OOPE from 47 percent to 34 percent in just+four years.8+Within this OOP spending, in LMICs (low- and medium-income countries)"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|f2ee990cbb1942db85479fce8ded4160+"such as Indonesia, medicines typically account for 20-60 percent of total+healthcare expenditure with nearly 90 percent of the population purchasing+medicines through OOP payments.9 Managing drug pricing and procurement+is thus a key lever for further managing costs and affordability. Indonesia"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|4|36832b98f50e46df903ea924ff5e55c5+"64Accelerating Global Health: Pathways to Health Equity for the G20+65has implemented a generic medicine pricing policy where the retail price+of generics cannot exceed the maximum retail price set by the MOH.+A 2010 study across nine public hospitals, 64 private pharmacies, and nine+NGO hospitals in four provinces in Indonesia, showed that the prices of+Lowest Price Generic (LPG) and Innovator Brand (IB) medicines was lower+in 2010 than in 2004, with declines ranging from 40 percent to 2200+percent.10 This showed that generic medicine pricing policies have succeeded+in lowering the price of medicines. Despite this success, however, there+is wide variation in implementation as exemplified by the excess paid by+patients compared to MOH set prices varying widely from 2 percent to+600 percent. Even within countries, there is substantial opportunity to+narrow the differences. More recently, the government has also embarked"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|86eac922752743339f35699cfccec378+"on working through state-owned enterprises (SOEs) to centralise drug+procurement and leverage purchasing power, negotiating lower prices to+further ensure availability of medications across facilities.+On the demand side, Indonesia has promoted the use of generics with+public awareness campaigns to educate the public about their benefits.+These campaigns aim to dispel misconceptions and increase confidence+in the quality and efficacy of generic medications. Additionally, the+government has provided incentives for healthcare professionals to prescribe+and dispense generic medications. These incentives may include financial+incentives or recognition for healthcare providers who prioritise generic+prescribing. Again, implementation has been varied. In an observational+study at Kalisat District Hospital, doctor’s compliance in prescribing generic+drugs reached 68 percent while the national standard in April 2013 reached+90 percent.11"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|e66fc805e2f748178c0c1270b907aec8+"90 percent.11+Overall, in Indonesia, BPJS and various national policies have forged+significant steps in achieving UHC. However, as highlighted above, uniform+and consistent implementation remains a challenge. Beyond these, there+are also additional efforts that Indonesia can undertake to improve UHC+further. Whilst JKN has an extensive network of healthcare providers,+including public and private hospitals, clinics and facilities, challenges+exist due to disparities in healthcare infrastructure across the vast island+archipelago, and despite co-payments by beneficiaries, the JKN also faces a"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|5|e663f199a53b4d5094921d1e38169663+"65The Role of Health Finance in G20 Countries significant deficit. To raise funds, Indonesia has room to raise Public Health+Expenditure and contribution compliance. At the same time, Indonesia can+also improve primary care and manage spending and governance.12+Singapore+Whilst Indonesia is rightly lauded as having the fastest growing insurance+program in the world (with BPJS covering close to 91 percent of its+population in less than 10 years),13 Singapore has had its 3M approach+(Medisave - a compulsory health savings account, Medishield – catastrophic+illness insurance and MediFund – a social security net for the indigent)+initiated 30 years prior, in 1984. What has Singapore done in the past+decade to continue to move the needle in improving UHC and affordability?+Expanding capacity has been a priority. In 2009, there were approximately+8,000 acute hospital and 9,000 nursing home beds in Singapore. Today,"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|9cd4784114ac446782aa0d71f1e7dc21+"those numbers have grown to 12,000 and 17,000 beds, respectively, or+a combined 70-percent increase in institutional places. With healthy+economic and GDP growth, the Singapore government has been assiduously+increasing healthcare infrastructure, particularly in the eldercare sector as+it prepares to become the 2nd fastest aging economy in Asia outside of+Japan. By 2030, one in every four Singaporeans will be above 65, and along+with changing societal and family patterns, will require massive capacity+to cater to the elderly who mostly live independently and require support+with their daily activities. Singapore has tried to keep costs manageable for+the eldercare sector by footing high land and building costs of residential+nursing homes and then offering concessions through competitive bids for+operators. Eligible seniors are means tested and substantial subsidies of up+to 80 percent of monthly fees are extended."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|5655410587404d1a8412a9fc74acd655+"to 80 percent of monthly fees are extended.+Widening coverage to become truly universal has been a highlight of+the last decade. In 2015, MediShield was replaced by MediShield Life, a+more comprehensive and universal health insurance scheme that extended+coverage to all Singaporeans, including those with pre-existing conditions+and older individuals who were previously excluded or had difficulty+obtaining coverage. All citizens and permanent residents were automatically+enrolled in the scheme with lifetime coverage. Whilst MediShield Life helps"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|6|47a256fcc0844063998f9a4ffb3f1c94+"66Accelerating Global Health: Pathways to Health Equity for the G20+67to pay for large hospital bills and selected costly outpatient treatments such+as dialysis and chemotherapy, Singaporeans also have access to CareShield+Life, which is a long-term insurance targeted at severe disability, providing+cash payouts for long-term care costs for life (and applicable towards+nursing home fees). Both MediShield and CareShield premiums can be paid+using Medisave, with needier beneficiaries able to benefit from top-ups by+family members or occasionally, one-off government disbursements.+Prudent and rational use of limited funds is a priority in Singapore,+especially with increased investment. The visible, frontline expansion of+services aside, the Ministry of Health has also been actively shoring up+decision-making and support services for better health economics. The+Agency for Care Effectiveness (ACE) was set up in 2015—subsuming the"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|bab2aa6e0ee048878763f123e2e739d0+"prior Pharmacoeconomic and Drug Utilization Unit (PEDU)—as an expanded+health technology assessment (HTA) unit to support the MOH’s Drug+Advisory Committee in making evidence-based recommendations for the+public funding of drugs. Standardised HTA methods and processes have+been developed in line with international best practices and since ACE’s+establishment, subsidised medications are provided earlier within a drug’s+life cycle and value-based pricing has led to more cost-effective prices+being negotiated with pharma.14 However, bandwidth limitations and lack of+skilled HTA practitioners impact ACE’s capacity to achieve greater impact.+The cost positioning for Singapore was further improved when the public+healthcare clusters banded together in 2018 to centralise procurement+through the setting up of ALPS Healthcare. Touted as a supply chain+partner, ALPS consolidates, negotiates and manages logistics for supplies"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|325c82ae1f6d45ca8776fccb347158ae+"for all public healthcare players—from primary to quarternary care and+including the eldercare sector. ALPS’s coverage goes beyond pharmaceuticals+to include consumables and even support services such as housekeeping+and laundry. This is especially important given the small size of the+domestic Singapore market and consolidation improves efficiency and more+cost-effective procurement.+Despite these cost-saving measures, Singapore has not escaped the+worldwide dilemma of rising healthcare costs. ‘Healthier SG’, set to+go live in July 2023, advocates the signing up of every citizen with"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|7|33c4a060e2b843fcb72a5289bfa5d04a+"67The Role of Health Finance in G20 Countries a dedicated GP/family physician. The GP then serves as continuing and+continuous partner in managing each individual’s healthcare needs more+holistically—from simple needs to acute referrals to chronic diseases. The+focus will progressively shift from a hospital-centric healthcare system+to a preventive model and right-siting care to the most appropriate (and+cost-effective) modalities, which translates to more care within community+settings and providing care that is most appropriate for the individual and+not necessarily just what is most advanced medically.+As this article highlights the examples of Indonesia and Singapore, broad+themes emerge in the approaches used in achieving universal health+care. Expanding financial coverage is critical and with this, widening+service accessibility, especially in primary care and judicious purchasing+and effective procurement. Implementation is paramount and there is"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|a4172b8d44d642dd8993e93089d0e52f+"opportunity here for countries to learn and work better together.+Particularly in Southeast Asia, where government procurement is+significant and yet not entirely efficient, the region lacks cross-country+learning opportunities. In the vein of RESYST (Resilient and Responsive+Health Systems) and SPARC (Strategic Purchasing for Africa Resource+Centre), international consortia focused on strategic purchasing, the+South East Asia Regional Collaborative for Health (SEARCH)15 hosted+by the National University of Singapore aims to review existing health+purchasing mechanisms of all ASEAN countries and provide national and+regional-level policy recommendations. This will be a meaningful step to+educate policymakers and help countries overcome roadblocks to strategic+purchasing.+Beyond risk pooling, pricing and procurement, more efforts can be poured+into strengthening primary care provision; there are additional opportunities"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|1324e2bb4f5742cab74473e14d467926+"from technology and digital modalities. Telehealth and insurtech, if devised+and regulated appropriately, could allow the next step-change in improving+access to healthcare, both within a dense urban city state like Singapore+or a dispersed island nation such as Indonesia. The COVID-19 pandemic+has shown the need and case for such services, and particularly for a+developing nation like Indonesia, the vast proliferation of mobile services+could pave the way for micro-insurance and insurtech to further improve+affordability of healthcare services."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|8|76280917c6254c15b067914f14125841+"68Accelerating Global Health: Pathways to Health Equity for the G20+69The journey to UHC and improving health equity is an ongoing endeavour.+While G20 countries have made remarkable progress in improving human+health and increasing healthcare spending, more can be done to ensure+access to affordable healthcare for all. By prioritising health equity and+implementing innovative approaches to health finance, G20 countries can+accelerate progress in transforming public health systems. It is hoped that+some of the learnings shared in this chapter may inform and support+continued commitment to addressing the complex and interconnected public+health challenges faced by societies worldwide.+Associate Professor J e r e m y L i m , MBBS, MPH, is director of global health at the National+University of Singapore’s Saw Swee Hock School of Public Health.+Janice Tan is an experienced healthcare management executive who holds a wealth"|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|9|4dbae5e4a3ee45bdbf9d55dec8921c2c+"of experience spanning diverse landscapes, including both public and private sector+hospitals as well as nursing homes, across both Singapore and Malaysia."|data/MedicalDocuments/OrfPathHealth/EnsuringAccessToAffordableHealth.pdf|9|2f3c4ce941c14624bfbd3da82ff8def7diff --git a/data_output/temp/health_india_concepts.csv b/data_output/temp/health_india_concepts.csvnew file mode 100644index 0000000..d06586e--- /dev/null+++ b/data_output/temp/health_india_concepts.csv@@ -0,0 +1,8 @@+entity|importance|category|chunk_id|type+consultations|5|event|a864c6a3aa9e4714b6773022853020df|concept+patients|4|misc|a864c6a3aa9e4714b6773022853020df|concept+abdm.gov.in|3|document|a864c6a3aa9e4714b6773022853020df|concept+esanjeevani.mohfw.gov.in|4|document|a864c6a3aa9e4714b6773022853020df|concept+Accelerating Global Health|5|concept|60df57d856f447b7950656fe9dbe5ae5|concept+CoWIN|4|object|60df57d856f447b7950656fe9dbe5ae5|concept+COVID-19 India Portal|3|object|60df57d856f447b7950656fe9dbe5ae5|conceptdiff --git a/data_output/temp/health_india_data.csv b/data_output/temp/health_india_data.csvnew file mode 100644index 0000000..a155ae1--- /dev/null+++ b/data_output/temp/health_india_data.csv@@ -0,0 +1,520 @@+text|source|page|chunk_id+"82Accelerating Global Health: Pathways to Health Equity for the G20+83Building a Resilient+Digital Health+Ecosystem in India+Lav Agarwal+Technology now permeates every facet of human existence. From+communication and transportation to healthcare and entertainment,+technology has redefined how we live, work, and interact. Its omnipresence+is reshaping societal norms, revolutionising various sectors, and propelling+us into the future.+Through improvements in diagnostics, treatment, and patient care,+technological advancements have had a profound impact on healthcare.+Medical devices, telemedicine, electronic health records, and artificial+intelligence (AI)-driven diagnostics have transformed healthcare delivery by+making it more precise, efficient, and accessible. Wearable devices and health+apps have empowered individuals to monitor and manage their well-being+proactively. Technology has also played a crucial role in advancing medical"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|0|13476c1867c9495c84d01303b9f5222a+"research, discovering new treatments, and improving overall healthcare+outcomes. In response to the COVID-19 pandemic, the world witnessed the+exponential growth of digital health."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|0|86113e13490f4002a68f873173662f9a+"83Building a Resilient Digital Health Ecosystem in India Digital Health Landscape in India+Given India’s massive population, providing equitable access to healthcare+services to all is an important agenda. By harnessing the power of+technology, digital health can effectively address these challenges and+ensure that healthcare services are accessible even in the remote regions.+Patients can use digital platforms for convenient access to care. Digital+platforms therefore bridge gaps and improve healthcare delivery across the+nation.+In line with the ‘Digital India’ initiative and the vision to create+interoperable and standardised electronic health records across the country,+the Indian government notified the Electronic Health Record1 standards in+2016. The National Health Policy2 (2017) envisages the creation of a digital+health technology ecosystem that serves the needs of all stakeholders and+improves efficiency, transparency, and citizens’ experiences across public"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|1|b179a090fb084d6ea17fee9439a110d1+"and private healthcare.+Over the recent years, India has made progress in digital healthcare+delivery, as demonstrated in national health programmes such as the+Hospital Management Information System, Online Registration System, the+national tuberculosis elimination (Ni-kshay) programme, Mother and Child+Tracking System, Mera Aspataal (My Hospital, a patient feedback system), the+Health Management Information System, the Integrated Health Information+Platform, and Non-Communicable Diseases screening application—which+have benefitted patients through the timely delivery of services and by+making government healthcare more affordable and accessible.3+The need for a future-ready digital health system has become even more+urgent with the announcement of the Ayushman Bharat Pradhan Mantri Jan+Arogya Yojana (AB-PMJAY)4 in 2018, India’s flagship programme that would+herald an infrastructural transformation of the nation’s health system. This+mission envisions the following:"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|1|bf384699b63a44e9a6429a506dfb961e+"mission envisions the following:+I. Operationalising 1.5 lakh health and wellness centres that offer preventive+and primary care, including telemedicine consultation services; and"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|1|2807f6f0a7dd43c0aff29de2279ae157+"84Accelerating Global Health: Pathways to Health Equity for the G20+85II. Providing financial protection of up to INR 500,000 per family annually+for secondary and tertiary care hospitalisation to the over 120 million+crore poor and vulnerable families that comprise the bottom 40 percent+of the Indian population.+These initiatives aim to scale up a wellness-oriented approach instead+of an illness-focused one—a key step towards achieving universal health+coverage (UHC) through patient data portability across primary, secondary,+and tertiary levels. This essentially translates into an environment where+all people can obtain health services anywhere in the country without+suffering financial hardship or excessive indirect costs.+Achieving such scale requires us to rethink the core technology backbone+of our system and leverage cutting-edge digital solutions to tackle the+challenge. However, it is also felt that all these efforts need to converge into"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|2|d75ac3dcfd744c7b963a9b4c90fbd9d9+"a single framework to achieve interoperability of data, which would benefit+both policymakers for decision-making and patients with effective services+at the time of need. In response, the government developed the National+Digital Health Blueprint as a framework for the efficient implementation of+digital health treatments.+The Ayushman Bharat Digital Mission5+To implement the principles of the blueprint, the National Digital Health+Mission, now known as the Ayushman Bharat Digital Mission (ABDM), was+launched in six union territories in August 2020. It was proposed to be+carried out via six key components—i.e, the digital health ID card, Digi-+Doctor, Health Facility Registry, Personal Health Records, e-pharmacy, and+telemedicine. India launched the nationwide implementation the ABDM in+September 2021 . The ABDM intends to create the framework needed to+enable an integrated digital health infrastructure in India. Additionally, it"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|2|31edc3e999ac4bc8a24b5aed3c81d49d+"will bridge the existing gap amongst different stakeholders of the healthcare+ecosystem through digital highways.+Under the ABDM, every citizen will be provided a 14-digit Ayushman+Bharat Account (ABHA) number, which is a unique health identifier. With+the patient’s informed consent, the ABHAs will be used to identify and"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|2|4077d77275bc45b98606bbe4e77387d1+"85Building a Resilient Digital Health Ecosystem in India authenticate people’s health records across various systems and stakeholders.+As of July 2023, over 435 million ABHAa numbers have been created, and+214,396 health facilities and 207,274 doctors have been registered under+the ABDM ecosystem.+ABDM has accelerated the participation of various stakeholders of the+healthcare ecosystem and ensured deployment of patient-centric policies—+resulting in cashless care with improved access to ensure protection+for the poor. Given its federal and complex healthcare structure, India+demands agility, flexibility and evidence-based smart policymaking for+implementation of healthcare initiatives, driving all stakeholders towards+health-seeking behaviours with renewed energy.+Digital Health in COVID-19 Management+The COVID-19 pandemic has challenged health systems across the globe.+The India government not only focused on the management of the pandemic"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|3|563b45ecd7d447c089670da47fd6f9ec+"through various activities but also formulated innovative solutions to ensure+the continuity of health services across the spectrum. It has followed a+‘whole of government, whole of society’ approach to battle the pandemic+by engaging subnational and local governments, civil society organisations,+the private sector, and local communities in mitigation efforts.+Amid the pandemic, India recognised the need to ease access to digital+consultations, and issued the Telemedicine Practice Guidelines in March+2020. India also launched eSanjeevaniOPD,6 a first of its kind and the+world’s largest national telemedicine service to facilitate online health+facilities to patients in the confines of their home at no cost to ensure+continuum of care. The eSanjeevani initiative has been instrumental in+bridging the digital divide in India, particularly in rural areas where access+to healthcare is often limited. This initiative has completed 142 million"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|3|8022fb132d55422fa241f9aebc537158+"consultationsb in record time and is currently serving around 400,000+patients every day as of 27 July 2023.+a https://dashboard.abdm.gov.in/abdm/+b https://esanjeevani.mohfw.gov.in/#/"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|3|a864c6a3aa9e4714b6773022853020df+"86Accelerating Global Health: Pathways to Health Equity for the G20+87India developed another state-of-the-art digital health system, CoWIN,7 a+digital platform that helped more than a billion beneficiaries book COVID-19+vaccinations in less than three months. In less than 18 months, CoWIN+had helped administer two billion COVID-19 vaccination doses, immunising+over 90 percent of all eligible adults.+The establishment of digitally-enabled COVID-19 ‘war rooms’ at the central+and state levels allowed key stakeholders to undertake data-driven decisions+towards infrastructure gap analysis, case projection and management, and+to identify problem areas that required specific state-centre coordination.+Various other digital health initiatives that have enhanced India’s efforts+against the COVID-19 crisis are outlined in the following points:+i. the COVID-19 India Portal developed for disease tracking by geography,"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|4|60df57d856f447b7950656fe9dbe5ae5+"inventory tracking of essential items, and predicting demands at the+national, state, and district levels based on case-loads;+ii. the Aarogya Setu, a mobile tracking app which uses the smartphone's+GPS and Bluetooth features to track the coronavirus infection through+contact tracing, syndromic mapping, and self-assessment in addition to+essential risk communication for our citizens;+iii. the RT-PCR app, a hand-held tool for country-wide sample collection;+and+iv. a COVID-19 facility app which allows health system stakeholders up to+the district level to track the state and management of patients.+Institutionalising Pandemic Learnings: National Public Health+Observatory (NPHO)+India has established the National Public Health Observatory (NPHO) and+the Health Emergency Operations Centre (HEOC) for real-time monitoring+and analysis of various data points for informed decision-making. The+NPHO will ensure comprehensive monitoring of health systems, including"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|4|506570cee97045fdbbd6f6fa40148423+"overall healthcare service delivery, integration of healthcare programmes,+and transformation of the healthcare situation in the country."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|4|3ace18959abf4e81a8cb3d616aa96327+"87Building a Resilient Digital Health Ecosystem in India Leveraging AI for Improved Healthcare+Across the world, AI is being used in healthcare to support doctors and+healthcare workers, improve customer service and patient management, and+monitor diseases. The Indian government has established three centres of+excellence for AI—at the All India Institutes of Medical Sciences in Delhi+and Rishikesh, and at the Post Graduate Institute of Medical Education &+Research in Chandigarh—to leverage and identify potential areas for the+use of AI in the health sector. The centres are already working on several+solutions for healthcare which leverage generative AI, including:+i. a clinical decision support system, a multilingual solution to provide+diagnostic and triaging support to doctors;+ii. event-based disease surveillance to scan large volumes of digital media+in English as well as 10 Indian languages to monitor events that signal+an impending disease outbreak; and"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|5|eaa37a93bd1b4a7a9713e4186e935786+"an impending disease outbreak; and+iii. an AI assistant for frontline workers in 11 Indian languages to enable+and empower healthcare workers to ask questions and receive responses+to enhance their work.+Stimulating Advanced Knowledge for Sustainable Health+Management (SAKSHAM) Portal+The inclusive capacity building of health professionals is an important+component to ensure the efficient delivery of healthcare services across+the country. Tele-education has benefitted all fields of education including+medical education, especially for students in remote areas with limited access+to schools and qualified teachers. Online platforms, video conferencing,+and pre-recorded lectures have facilitated learning for students who were+previously deprived of quality education due to their geographical location.+Keeping this vision in mind, the government has developed a unified and+dedicated online learning and training platform, SAKSHAM,8 to enable"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|5|aa8d6614bfc94397897f73b56ab9c6ca+"health professionals to receive advanced training without any disruption in+their regular jobs. The portal hosts more than 200 courses on public health+and 150 on clinical practices."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|5|f473348c6cf242d3aa0a855283ed2af7+"88Accelerating Global Health: Pathways to Health Equity for the G20+89With such developments in digital health, India has leapfrogged in terms+of the adoption of digital health in the public sector. This will arguably+lead to the creation of a national digital health ecosystem through wide-+scale adoption of digital tools across the continuum of care, both in the+private and public sectors.+Promoting the Digital Health Agenda Globally+India has emerged as a frontrunner in championing digital health and+in positioning it as a critical agenda at the global level. Recognising+the transformative potential of technology in healthcare, India has+taken proactive steps to harness digital innovations, promote healthcare+accessibility, and drive advancements in the field globally.+India tabled the Digital Health Resolution in the 71st World Health+Assembly in May 2018 at Geneva, which was unanimously adopted by all"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|6|8b7151d4c540461bbb6c6d1cc46ca27c+"the member states of the World Health Organization (WHO). The resolution+highlighted global attention to the potential challenges and opportunities+related to digital health technology and need for close collaboration on the+issue globally. As a follow-up action, WHO has prioritised digital health+agenda by establishing the Department for Digital Health and Innovation in+April 2019 and published the Global Strategy on Digital Health 2020-2025 to+promote healthy lives and well-being for all.+India served as Chair of the Global Digital Health Partnership (GDHP,+between 2019 and 2021), which is the world’s largest intergovernmental+and multilateral forum on the issue of digital health. Under India’s+leadership, the GDHP’s membership grew from 14 to 33, including three+international organisations (WHO, Organisation for Economic Co-operation+and Development, and the International Digital Health and AI Research+Collaborative)."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|6|c8b5be8cbd904b85993063c806f35357+"Collaborative).+India’s G20 Leadership Catalysing Global Health Initiatives+India’s G20 presidency set ambitious goals to address the 21st century’s+greatest challenges such as climate change, food insecurity, the threat of"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|6|1084281ae25042bcabd574e63cb93cf0+"89Building a Resilient Digital Health Ecosystem in India future pandemics, and other health emergencies by building international+co-operation and strengthening global systems. The pandemic experience+has taught us that preventing and preparing for a health emergency must+always be a top priority at a global level, because when it comes to health,+“no one is safe until everyone is safe.”+Drawing from the lessons from the pandemic, the G20 Health Working+Group set out to catalyse and enervate global health initiatives. Through+four meetings, culminating in the health ministers’ meeting, three main+priorities were discussed:+i. prevention, preparedness, and response to health emergencies with+focus on anti-microbial resistance and ‘One Health’;+ii. strengthening cooperation in the pharmaceutical sector with focus on+availability and access to safe, effective, quality, and affordable medical+countermeasures, namely vaccines, therapeutics, and diagnostics; and"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|7|3a2b7bba4b20447bba50b43246d52bb9+"iii. digital health innovations and solutions to aid universal health coverage+and improve healthcare services delivery.+Digital health, the third priority under India’s G20 presidency aims to+leverage the country’s acumen and achievements along with other global+initiatives in the digital health space, and develop innovative digital health+solutions that can be applied across the world. A number of programmes+and projects seeking to develop digital health products are being initiated+independently. These projects are cumulatively spending billions of dollars+while working on similar aspects.+India’s G20 presidency has aimed to bring them all under the umbrella+of the Global Initiative on Digital Health (GIDH), a network managed by+WHO. The GIDH is an opportunity to create a globally connected digital+health ecosystem, converging worldwide efforts in scaling up commitments+and investments of relevant stakeholders and promotion of digital health"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|7|0409b3edab974d9abac6a39e22368ef3+"solutions as digital public goods. This will be achieved through coordinated+engagements and implementation aligned with WHO norms, standards, and"|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|7|ed875ee5493d4896b733fb1ae7b9af2a+"90Accelerating Global Health: Pathways to Health Equity for the G20+91guidelines, while increasing transparency of resources being allocated to+digital transformation and identifying important gaps in support.+Conclusion+Adopting digital health is no longer a choice. The pandemic has undoubtedly+paved the way for the quick adoption of digital health. Digital health is+propelling the world towards more integrated health systems that are+focused on delivering patient-centred care, improving health outcomes, and+making the best use of healthcare resources. India’s digital health initiatives+such as the ABDM, CoWIN, and eSanjeevani have provided a stimulus to+act in conformity with a globally progressive commitment to health equity.+They have also enabled the country to work towards creating a movement+to enable integration of technology-informed models for universal health+coverage."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|8|cefde7e5f720409c906b7a789099ba0c+"coverage.+Lav Agarwal i s A d d i t i o n a l S e c r e t a r y f o r eHealth, International Health & Collaboration,+Public Health, and G20 at the Ministry of Health and Family Welfare, Government of+India."|data/MedicalDocuments/India/BuildingResilientDigitalHealthIndia.pdf|8|c5acb60e6fe04d2485554b4c5362cfc4+"93+9293Lessons from+India’s Digital Public+Infrastructure+Transformation+Sameer Kanwar and Varun Kumar+In today's rapidly evolving digital landscape, many countries are+striving to establish and strengthen digital public infrastructure (DPI)+to harness the transformative power of technology to benefit citizens. India+has emerged as a noteworthy example by successfully using technological+advancements to create robust DPI. It has implemented various initiatives+that mobilise technology for inclusive growth, economic development, and+improved governance. Countries around the world can learn from India’s+experience and achievements to initiate similar digital transformations.+Through the Digital India programme, India is seeking to digitally equip+citizens with access to all government services by improving internet+connectivity and developing online infrastructure. This encompasses three+key areas: (a) establishing a secure digital infrastructure; (b) successfully"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|0|1b372b2c96bf4cf5be87c9ecf6535941+"delivering digital services; and (c) ensuring that every citizen has access+to the internet. India has also seen an increase in the number of digital+technology users, with an estimated 750 million smartphone users, and a+projected one billion users by 2025.1 This increase has generated demand+for a centralised digital architecture that functions as a single enterprise."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|0|6fc85b4fdeef43289abba22a98b48bd1+"93Lessons from India’s Digital Public Infrastructure Transformation+93In 2018, the Ministry of Electronics and Information Technology (MeitY)+created the India Enterprise Architecture (IndEA) framework1 for the adoption+of a whole-of-government enterprise architecture by central ministries,+state departments, and public sector enterprises. Built with a focus on+performance, IndEA offers open standards to promote interoperability+and supports decentralisation. At the same time, it supports both new+(greenfield) and legacy (brownfield) e-governance initiatives. The emphasis+of the IndEA initiative is to enable “One Government – a government+that is least visible but is effective” by implementing the concept of+“virtualisation of departments” to activate synergy.2+Growing digitalisation will lead to the increased generation of data,+and consequently, data protection and ownership must be addressed at+the outset. The Data Empowerment and Protection Architecture (DEPA)"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|1|bcba5a5d25d8471aafa6da4a13cbd5f0+"framework, introduced in 2020, seeks to ensure user control over data.+DEPA suggests measures for consent-governed and secure data-sharing+with third-party institutions. Controlled by consent managers, only relevant+user data is plugged in to any private ecosystem and there is no need+to set up bilateral databases.3 This empowers citizens with ownership and+control over their own data and how it is shared.+While DEPA has been flexibly applied in multiple sectors, it has been+particularly well-used as a techno-legal solution in the finance sector.+Since DEPA empowers individuals to securely share their financial data+with banks, insurers, investors, and other stakeholders, its first immediate+benefit has been to encourage competition among private players.+Individuals and small businesses are now able to get loans, insurance, and+other financial products at competitive rates, just by using their digital"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|1|ad7832db5516440d84c6cfd72e7cd917+"footprint. In practice, DEPA works closely with the many layers of India+Stack4—Aadhaar-based e-KYC, Unified Payments Interface (UPI) for cashless+payments, and Aadhaar-based eSign) and uses the Open Credit Enablement+Network to facilitate lending. India Stack has enabled the country to build+its digital infrastructure, especially in establishing a design to improve+private sector service delivery, and has served as India’s digital library,+housing several digital global goods and offering learnings to the world.+Over the last decade, India has taken landmark steps to set in motion its+vision of becoming an inclusive digital economy. This includes establishing"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|1|d5bb32aab9d64c40b61624e114470f5d+"94Accelerating Global Health: Pathways to Health Equity for the G20+95robust DPI and the facilitation of digital governance by streamlining+roles, accountability, and change management. This encompasses various+components, including digital identification systems, digital payments+systems, and digital service delivery platforms.+Pillars of Digital Public Infrastructure in India+The foundation: Aadhaar5+India's Aadhaar programme, a biometric and face authentication-based+digital identification system, has revolutionised identity verification+and service delivery in the country. Aadhaar has provided a unique+identification number to over 1.3 billion residents of India, enabling access+to essential services such as government subsidies, bank accounts, and+mobile connections. It has enabled the government to streamline service+delivery and eliminate duplication by providing a single digital identity+across multiple sectors. The world can learn from India's approach in"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|2|0ffd7ae1eed043cbb84efab7d4513c47+"implementing a centralised, secure, and inclusive identification system, that+has facilitated interoperability across service delivery platforms, both public+and private.+Driving financial inclusion: Unified Payments Interface6+India's push to digitise payments has transformed the way financial+transactions are conducted in the country. The implementation of UPI has+created a platform that enables instant money transfers between bank+accounts. It offers a smartphone-based interface to support seamless,+interoperable, and real-time payments, available on the go. UPI has not only+transformed the way individuals transact but has also provided a significant+boost to the growth of the digital economy. Countries can gather important+lessons from India's experience in fostering a competitive and interoperable+payment ecosystem, which has led to increased financial inclusion, reduced+reliance on cash, and enhanced transparency in transactions."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|2|323abf2e2dd640b68025a5e6b9346734+"The number of digital transactions increased by more than three times+from 3 billion in November 2019 to 10 billion by January 2023.7 A 2019"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|2|2ed578303b5e4434844b6472c6c1a2a2+"95Lessons from India’s Digital Public Infrastructure Transformation MeitY study noted that under a ‘business as usual’ scenario, India’s+digital economy will grow to US$500 billion by 2025, with the potential+to increase to US$1 trillion.8 In 2021, India had 48.6 billion real-time+payments, as compared to 18.5 billion in China and 8.7 billion in Brazil.9+This is indicative of the ease with which the Indian population has adopted+digital platforms for making payments even if the average value of such+payments may be rather low.+Efficient welfare delivery: Direct Benefit Transfer10+India's Direct Benefit Transfer (DBT) programme is aimed at eliminating+potential leakages in the physical delivery of financial benefits and ensuring+an efficient transfer of welfare to the right beneficiaries. By leveraging+digital payment systems, benefits are directly credited to the beneficiaries’+bank accounts, reducing corruption, eliminating middlemen, and improving"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|3|b9fc627dc58a4940915aefe392262ca3+"transparency in the transfer of subsidies.11 The enablers for DBT in India+are the Pradhan Mantri Jan-Dhan Yojana, the Jan Dhan-Aadhaar-Mobile+Yojana, and nearly 312 other schemes from 53 ministries across all states+and union territories. More than INR 24,800 billion has been transferred+through the DBT programme since 2013, with INR 6,300 billion transferred+in FY 2021-22 alone. On average, more than 9 million DBT payments were+processed daily in FY 2021-22.12+Citizen-centric services: E-governance13+India has leveraged technology to enhance governance and service delivery+through initiatives like Digital India and other e-governance platforms. The+use of digital platforms (or information and communication technologies)+has facilitated efficient and transparent administration, improved the+accessibility of government services, and reduced bureaucratic inefficiencies."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|3|8045b63702f14e20aeecdab5e9d55069+"The MyGov platform14 h a s b e e n a c r u c i a l c o n t r i b u t o r t o t r a n s f o r m i n g c i t i z e n -+government interactions. India's approach to digital governance emphasises+citizen-centricity, where technology acts as an enabler to bridge the gap+between the government and its citizens. By adopting similar approaches,+countries can enhance government services, promote transparency, and+strengthen democratic participation."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|3|5a6b176e0ea544508b33ab20d77ece86+"96Accelerating Global Health: Pathways to Health Equity for the G20+97Creating a digital ecosystem: Technology access and innovation+India has created a vibrant digital ecosystem that fosters innovation+and entrepreneurship. Initiatives like Startup India15 a n d M a k e i n I n d i a16+have encouraged the growth of technology start-ups and attracted global+investments. India has nurtured a conducive environment for technology+and innovation through policy reforms, access to funding, and incubation+support. Managed by the Department for Promotion of Industry and Internal+Trade under the commerce ministry, the Startup India initiative has helped+introduce various programmes that support entrepreneurs and create a+healthy start-up ecosystem. Similarly, the ‘Make in India’ initiative has+incentivised the development, manufacture, and assembly of products in the+country, and has thus boosted partnerships, investments, and innovations."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|4|11dbcb29edd24ce9bdc983d9f6ef4703+"Growing digital literacy and inclusion in harnessing the benefits of+technology has also been crucial achievements for the country. India's+experience underscores the importance of widespread access to affordable+internet connectivity, digital skills training, and tailored initiatives for+marginalised communities. Initiatives like BharatNet,17 which aims to+connect over 250,000 local rural bodies with high-speed internet, and the+Common Service Centers,18 which provide access to government services in+remote areas, have been instrumental in extending the benefits of India’s+digital infrastructure to rural communities. In addition to the digital+training programmes offered through government-supported bodies like+the National Skills Development Centre19 and the National Institute for+Entrepreneurship and Small Business Development,20 other private training+institutes and online platforms have significantly contributed to digital skill"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|4|b806fb3d2fe445c49eabb633e9c94715+"building among citizens, both in urban and rural settings. By prioritising+digital literacy and inclusion, countries can bridge the digital divide and+empower their citizens to participate fully in the digital age.+Key Drivers of India’s Digital Transformation+India’s achievements in implementing DPI demonstrate the transformative+power of technology when combined with inclusivity, scalability, regulation,+and collaboration. The key factors that equipped the country to achieve this+digital revolution include:"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|4|4346c415761a400bbd13738d2880dc1d+"97Lessons from India’s Digital Public Infrastructure Transformation Ecosystem collaboration+India's success in digital service delivery can be attributed to strong+collaboration between government agencies, industry leaders, startups,+academia, and civil society organisations. This collaborative approach+has fostered innovation, shared expertise, and effective implementation.+India’s G20 presidency has further drawn attention to the importance+of collaboration, with initiatives like the Global DPI Summit21 allowing+a close agreement between partners (and non-partners alike) on the+common principles and design aspects of DPIs. By bringing together all the+stakeholders, the Indian government has created a collaborative environment+for developing and implementing digital public infrastructure projects.+Industry players have contributed their expertise, resources, and technological+innovations to build and maintain the required infrastructure. Similarly,"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|5|72341765203b43498a676b032bedf44c+"collaborations with academic institutions and research organisations have+aided innovation and helped address technical and policy challenges. Public-+private partnerships and international collaborations have further supported+knowledge exchange, best practice sharing, and access to resources and+funding.+The Indian government has been able to promote such an ecosystem+collaboration by establishing platforms (such as, India Stack), forums (for+example, India Stack Knowledge Exchange Forum, 202222), and regulatory+frameworks (IndEA and DEPA) that encourage active participation,+information sharing, and coordination between different stakeholders.+These collaborations prioritise interoperability, data privacy, security, and+scalability to build a robust and sustainable DPI in the country.+Scalability and inclusion+India's experience in scaling up its DPI demonstrates the significance+of inclusivity, with the most successful case being that of its digital"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|5|53c1745ea8864bdcb280f11902de0be2+"identification system. MeitY, in response to an unstarred question in the+upper house of Parliament (in July 2022), said that out of the approximate+projected population of 1.37 billion, around 1.27 billion held a live Aadhaar+number.23 By ensuring accessibility and ease of enrollment for all citizens,"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|5|0c64ee48cf0246289234f29befd7b34e+"98Accelerating Global Health: Pathways to Health Equity for the G20+99including marginalised communities, India has achieved a notable level of+inclusivity. While there are gaps in digital inclusion across demographic+locations (55 percent share of urban telephone subscribers, as of December+202224) and gender (11 percent gender gap in mobile ownership, 202325),+the country is consistently invested in closing this difference.+India’s digital infrastructure has been created keeping in mind future+needs and potential growth. With a quantum increase in users connected+to the internet, the emergence of multiple types of intermediaries (digital+media, e-commerce, and others), and the possible use of connectivity to+cause harm or commit crimes cannot be ignored. Comprehensive measures+need to be taken to prepare for the future. To check a potential DPI’s+scalability even before introduction, significant emphasis has been placed"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|6|c4df77774a1644f7854fce36f38dd1c9+"on considerations like robust technology frameworks, interoperability, open+Application Programming Interfaces, data management, and addressing+infrastructure gaps.+India’s journey is an example of how scalability and inclusion work+together in building a resilient and equitable digital public infrastructure.+Key strategies that have helped the country’s efforts to establish its+infrastructure at scale are ensuring accessibility, promoting digital literacy+and skill development, focus on last-mile connectivity, multilingual support+in technological solutions, participatory implementation, and regulations to+ensure affordability.+Balancing regulation and innovation+India's digital payments ecosystem demonstrates the need to strike a+balance between regulation and innovation. While fostering competition and+innovation, the country has implemented robust regulatory measures to+ensure the security and integrity of transactions."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|6|8b202115529b413e805052339024fb38+"Putting in place provisions like regulatory sandboxes, which provide a+controlled environment for testing innovative technologies and business+models, has allowed experimentation and innovation, while ensuring+consumer protection and risk mitigation. At the same time, taking a"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|6|095821a0ae1b48d4bc4127dd272e8e30+"99Lessons from India’s Digital Public Infrastructure Transformation collaborative approach by establishing forums and platforms for stakeholders+to engage in policy discussions and regulatory consultations has helped+in understanding their needs and concerns, thus informing the adoption+of balanced regulatory policies. Recognising the fast-paced nature of the+digital landscape, Indian regulators have also shown agility in updating and+adapting regulations. Recent policy measures like the introduction of the+Digital Personal Data Protection Bill 2022,26 which restricts the processing+of personal data until after the individual’s consent has been recorded, and+the presentation of the Digital India Act 2023,27 to set up global standard+cyber laws, have demonstrated a willingness to understand and respond to+consumer needs, emerging technologies, and market trends.+While India has made strides in regulation and innovation, challenges"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|7|450a40f14b1e45e48521b712958e128a+"remain. Striking the right balance between the two requires continuous+monitoring, assessment, and adaptation of regulatory frameworks to keep+pace with evolving technologies and market dynamics. Employing these+efforts at the desired scale in the country would require infrastructure,+investment, and a strong commitment. Ongoing collaboration between+regulators, industry players, and other stakeholders will be crucial to+maintaining an innovation-friendly environment while upholding consumer+protection and addressing emerging risks.+Conclusion+India's DPI provides valuable lessons on the advantages of harnessing+technology for inclusive growth, economic development, and improved+governance. Through initiatives like Aadhaar, UPI, digital health+infrastructure, DBT, e-governance, regulatory frameworks, and creating an+enabling digital ecosystem, India has been able to unlock the transformative+potential of DPI. By focusing on the key lessons from India's experience,"|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|7|8efb3d0a66f64a69b8b91f270d852d52+"other countries can implement similar DPIs to address their unique+challenges and leverage the potential of technology for the benefit of their+citizens."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|7|9ea22e2775f04d79a52b48481a4704fb+"100Accelerating Global Health: Pathways to Health Equity for the G20+101These countries must consider their contextual differences based on+population size, level of technological development, political priorities, and+policy outlooks to customise their learnings to suit their specific needs and+challenges. As the world embraces the digital era, India's DPI experience+can serve as inspiration and guide for building robust digital systems that+could foster inclusive societies and drive sustainable development in the+21st century.+Sameer Kanwar is Director, Digital Health, India and South Asia Hub, PATH .+Varun Kumar is Senior Program Officer, PATH."|data/MedicalDocuments/India/LessonsIndiaDigitalHealthTfn.pdf|8|ee322f1af7c94acd8e538b65f908692ddiff --git a/extract_concepts.ipynb b/extract_concepts.ipynbnew file mode 100644index 0000000..c7f8291--- /dev/null+++ b/extract_concepts.ipynb@@ -0,0 +1,698 @@+{+ "cells": [+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Setup"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 1,+ "metadata": {},+ "outputs": [],+ "source": [+ "import pandas as pd\n",+ "import numpy as np\n",+ "import os\n",+ "from langchain.document_loaders import PyPDFLoader, UnstructuredPDFLoader, PyPDFium2Loader\n",+ "from langchain.document_loaders import PyPDFDirectoryLoader\n",+ "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",+ "from pathlib import Path\n",+ "\n",+ "## Input data directory\n",+ "data_dir = \"OrfPathHealth\"\n",+ "inputdirectory = Path(f\"./data_input/{data_dir}\")\n",+ "## This is where the output csv files will be written\n",+ "out_dir = data_dir\n",+ "outputdirectory = Path(f\"./data_output/{out_dir}\")"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Load Documents"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 2,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "Number of chunks = 226\n"+ ]+ }+ ],+ "source": [+ "## Dir Loader\n",+ "documents = PyPDFDirectoryLoader(inputdirectory).load()\n",+ "## File Loader\n",+ "# documents = PyPDFLoader(\"./data/MedicalDocuments/orf-path_health-n1.pdf\").load()\n",+ "\n",+ "splitter = RecursiveCharacterTextSplitter(\n",+ " chunk_size=1000,\n",+ " chunk_overlap=50,\n",+ " length_function=len,\n",+ " is_separator_regex=False,\n",+ ")\n",+ "\n",+ "pages = splitter.split_documents(documents)\n",+ "print(\"Number of chunks = \", len(pages))\n"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Create a dataframe of all the chunks"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 3,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "(226, 4)\n"+ ]+ },+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>text</th>\n",+ " <th>source</th>\n",+ " <th>page</th>\n",+ " <th>chunk_id</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>147\\n147Mental Health as a \\nPathway to Health...</td>\n",+ " <td>data_input/OrfPathHealth/MentalHealthPathwayTo...</td>\n",+ " <td>0</td>\n",+ " <td>6a13f1b883a641d698148be3652fae52</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>sense, mental health encompasses promotive and...</td>\n",+ " <td>data_input/OrfPathHealth/MentalHealthPathwayTo...</td>\n",+ " <td>0</td>\n",+ " <td>9867158fca1e4e2e9e6c9a70472fea37</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>148Accelerating Global Health: Pathways to Hea...</td>\n",+ " <td>data_input/OrfPathHealth/MentalHealthPathwayTo...</td>\n",+ " <td>1</td>\n",+ " <td>6c16b5fb1bdf4e7481a58a41f3935d01</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>adversity is a recognised risk factor in condi...</td>\n",+ " <td>data_input/OrfPathHealth/MentalHealthPathwayTo...</td>\n",+ " <td>1</td>\n",+ " <td>310128b7580441d99c7ac8466a60c4df</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>both in healthcare service delivery.\\nThe chal...</td>\n",+ " <td>data_input/OrfPathHealth/MentalHealthPathwayTo...</td>\n",+ " <td>1</td>\n",+ " <td>995ff2fe191a41a2ae6e99b87beb01fc</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " text \\\n",+ "0 147\\n147Mental Health as a \\nPathway to Health... \n",+ "1 sense, mental health encompasses promotive and... \n",+ "2 148Accelerating Global Health: Pathways to Hea... \n",+ "3 adversity is a recognised risk factor in condi... \n",+ "4 both in healthcare service delivery.\\nThe chal... \n",+ "\n",+ " source page \\\n",+ "0 data_input/OrfPathHealth/MentalHealthPathwayTo... 0 \n",+ "1 data_input/OrfPathHealth/MentalHealthPathwayTo... 0 \n",+ "2 data_input/OrfPathHealth/MentalHealthPathwayTo... 1 \n",+ "3 data_input/OrfPathHealth/MentalHealthPathwayTo... 1 \n",+ "4 data_input/OrfPathHealth/MentalHealthPathwayTo... 1 \n",+ "\n",+ " chunk_id \n",+ "0 6a13f1b883a641d698148be3652fae52 \n",+ "1 9867158fca1e4e2e9e6c9a70472fea37 \n",+ "2 6c16b5fb1bdf4e7481a58a41f3935d01 \n",+ "3 310128b7580441d99c7ac8466a60c4df \n",+ "4 995ff2fe191a41a2ae6e99b87beb01fc "+ ]+ },+ "execution_count": 3,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "from helpers.df_helpers import documents2Dataframe\n",+ "df = documents2Dataframe(pages)\n",+ "print(df.shape)\n",+ "df.head()"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Extract Concepts"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 4,+ "metadata": {},+ "outputs": [],+ "source": [+ "## This function uses the helpers/prompt function to extract concepts from text\n",+ "from helpers.df_helpers import df2ConceptsList\n",+ "from helpers.df_helpers import concepts2Df"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 9,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ " [\n",+ " {\n",+ " \"entity\": \"income\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"mental illness\",\n",+ " \"importance\": 5,\n",+ " \"category\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"middle-aged\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"mental healthcare\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"object\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"mental health professionals\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"organisation\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"mental health literacy\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"stigma and discrimination\",\n",+ " \"importance\": 2,\n",+ " \"category\": \"misc\"\n",+ " }\n",+ "] [\n",+ " {\n",+ " \"entity\": \"mental health equity\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"social inequality\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"gender issues\",\n",+ " \"importance\": 2,\n",+ " \"category\": \"misc\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"lack of community participation\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"India's National Program for Mental Health (NMHP)\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"organisation\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"District Mental Health Program (DMHP)\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"organisation\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"mental healthcare\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"integration of mental health in general healthcare\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"community participation in mental health development\",\n",+ " \"importance\": 3,\n",+ " \"category\": \"condition\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"National Mental Health Programme – District Mental Health Programme\",\n",+ " \"importance\": 4,\n",+ " \"category\": \"organisation\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"Taluk Mental Health programme (e.g., Karnataka)\",\n",+ " \"importance\": 2,\n",+ " \"category\": \"misc\"\n",+ " }\n",+ "]"+ ]+ }+ ],+ "source": [+ "concepts_list = df2ConceptsList(df[10:12])"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 26,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>entity</th>\n",+ " <th>importance</th>\n",+ " <th>category</th>\n",+ " <th>chunk_id</th>\n",+ " <th>type</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>Mental Health</td>\n",+ " <td>5</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>Health Equity</td>\n",+ " <td>4</td>\n",+ " <td>concept</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>World Health Organization (WHO)</td>\n",+ " <td>3</td>\n",+ " <td>organisation</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>United Nations (UN)</td>\n",+ " <td>3</td>\n",+ " <td>organisation</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>Sustainable Development Goals (SDGs)</td>\n",+ " <td>4</td>\n",+ " <td>document</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>concept</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "</div>"+ ],+ "text/plain": [+ " entity importance category \\\n",+ "0 Mental Health 5 concept \n",+ "1 Health Equity 4 concept \n",+ "2 World Health Organization (WHO) 3 organisation \n",+ "3 United Nations (UN) 3 organisation \n",+ "4 Sustainable Development Goals (SDGs) 4 document \n",+ "\n",+ " chunk_id type \n",+ "0 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "1 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "2 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "3 83d4d0367bb0467e811782a4ada3bbb9 concept \n",+ "4 83d4d0367bb0467e811782a4ada3bbb9 concept "+ ]+ },+ "execution_count": 26,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "dfne = concepts2Df(concepts_list)\n",+ "dfne.head()"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "### Write CSV to an output directory"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "Both the dataframes are written in the csv format so we dont have to calculate them again. \n",+ "\n",+ " dfne = dataframe of names entities\n",+ "\n",+ " df = dataframe of chunks"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 28,+ "metadata": {},+ "outputs": [],+ "source": [+ "if not os.path.exists(outputdirectory):\n",+ " os.makedirs(outputdirectory)\n",+ " \n",+ "dfne.to_csv(outputdirectory/\"concepts.csv\", sep=\"|\", index=False)\n",+ "df.to_csv(outputdirectory/\"chunks.csv\", sep=\"|\", index=False)"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "## Named Entities from Concepts"+ ]+ },+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "**Not using this right now**\n",+ "\n",+ "Extracting named entities our of concepts. \n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 3,+ "metadata": {},+ "outputs": [],+ "source": [+ "from transformers import pipeline\n",+ "\n",+ "ner = pipeline(\"token-classification\", model=\"2rtl3/mn-xlm-roberta-base-named-entity\", aggregation_strategy=\"simple\")\n",+ "# ner = pipeline(\"token-classification\", model=\"dslim/bert-large-NER\", aggregation_strategy=\"simple\")\n",+ "\n",+ "def row2NamedEntities(row):\n",+ " ner_results = ner(row['entity'])\n",+ " metadata = {'chunk_id': row['chunk_id'], 'type': 'entity'}\n",+ " entities = []\n",+ " for result in ner_results:\n",+ " entities = entities + [{'entity': result['word'], 'catetory': result['entity_group'], **metadata}]\n",+ " \n",+ " return entities\n",+ "\n",+ "\n",+ "\n",+ "def dfText2DfNE(dataframe: pd.DataFrame):\n",+ " ## Takes a dataframe from the parsed data and returns dataframe with named entities. \n",+ " ## The input dataframe must have a entity and a chunk_id column. \n",+ "\n",+ " ## 1. Calculate named entities for each row of the dataframe. \n",+ " results = dataframe.apply(row2NamedEntities, axis=1).reset_index(drop=True)\n",+ "\n",+ " ## Flatten the list of lists to one single list of entities. \n",+ " entities_list = np.concatenate(results).ravel().tolist()\n",+ "\n",+ " ## Remove all NaN entities\n",+ " entities_dataframe = pd.DataFrame(entities_list).replace(' ', np.nan)\n",+ " entities_dataframe = entities_dataframe.dropna(subset=['entity'])\n",+ "\n",+ " ## Count the number of occurances per chunk id\n",+ " # entities_dataframe = entities_dataframe.groupby(['entity', 'category', 'chunk_id']).size().reset_index(name='count')\n",+ "\n",+ " return entities_dataframe"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 5,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>entity</th>\n",+ " <th>catetory</th>\n",+ " <th>chunk_id</th>\n",+ " <th>type</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>Mental Health</td>\n",+ " <td>MISC</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>Health Equity</td>\n",+ " <td>ORG</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>World Health Organization (WHO)</td>\n",+ " <td>ORG</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>United Nations (UN)</td>\n",+ " <td>ORG</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>Sustainable Development Goals (SDGs)</td>\n",+ " <td>MISC</td>\n",+ " <td>83d4d0367bb0467e811782a4ada3bbb9</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>...</th>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>967</th>\n",+ " <td>National University of Singapore's Saw Swee Ho...</td>\n",+ " <td>ORG</td>\n",+ " <td>4dbae5e4a3ee45bdbf9d55dec8921c2c</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>968</th>\n",+ " <td>Associate Professor</td>\n",+ " <td>MISC</td>\n",+ " <td>4dbae5e4a3ee45bdbf9d55dec8921c2c</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>969</th>\n",+ " <td>Jeremy Lim</td>\n",+ " <td>PER</td>\n",+ " <td>4dbae5e4a3ee45bdbf9d55dec8921c2c</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>970</th>\n",+ " <td>Janice Tan</td>\n",+ " <td>PER</td>\n",+ " <td>4dbae5e4a3ee45bdbf9d55dec8921c2c</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>971</th>\n",+ " <td>singapore</td>\n",+ " <td>LOC</td>\n",+ " <td>2f3c4ce941c14624bfbd3da82ff8def7</td>\n",+ " <td>entity</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "<p>972 rows × 4 columns</p>\n",+ "</div>"+ ],+ "text/plain": [+ " entity catetory \\\n",+ "0 Mental Health MISC \n",+ "1 Health Equity ORG \n",+ "2 World Health Organization (WHO) ORG \n",+ "3 United Nations (UN) ORG \n",+ "4 Sustainable Development Goals (SDGs) MISC \n",+ ".. ... ... \n",+ "967 National University of Singapore's Saw Swee Ho... ORG \n",+ "968 Associate Professor MISC \n",+ "969 Jeremy Lim PER \n",+ "970 Janice Tan PER \n",+ "971 singapore LOC \n",+ "\n",+ " chunk_id type \n",+ "0 83d4d0367bb0467e811782a4ada3bbb9 entity \n",+ "1 83d4d0367bb0467e811782a4ada3bbb9 entity \n",+ "2 83d4d0367bb0467e811782a4ada3bbb9 entity \n",+ "3 83d4d0367bb0467e811782a4ada3bbb9 entity \n",+ "4 83d4d0367bb0467e811782a4ada3bbb9 entity \n",+ ".. ... ... \n",+ "967 4dbae5e4a3ee45bdbf9d55dec8921c2c entity \n",+ "968 4dbae5e4a3ee45bdbf9d55dec8921c2c entity \n",+ "969 4dbae5e4a3ee45bdbf9d55dec8921c2c entity \n",+ "970 4dbae5e4a3ee45bdbf9d55dec8921c2c entity \n",+ "971 2f3c4ce941c14624bfbd3da82ff8def7 entity \n",+ "\n",+ "[972 rows x 4 columns]"+ ]+ },+ "execution_count": 5,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "\n",+ "dataframe_dir = 'OrfPathHealth'\n",+ "df_concepts = pd.read_csv(f\"./data/output/{dataframe_dir}/concepts.csv\", sep=\"|\")\n",+ "\n",+ "dfc_split = dfText2DfNE(df_concepts)\n",+ "dfc_split"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": null,+ "metadata": {},+ "outputs": [],+ "source": []+ }+ ],+ "metadata": {+ "kernelspec": {+ "display_name": "OpenAI@3111",+ "language": "python",+ "name": "python3"+ },+ "language_info": {+ "codemirror_mode": {+ "name": "ipython",+ "version": 3+ },+ "file_extension": ".py",+ "mimetype": "text/x-python",+ "name": "python",+ "nbconvert_exporter": "python",+ "pygments_lexer": "ipython3",+ "version": "3.11.1"+ }+ },+ "nbformat": 4,+ "nbformat_minor": 2+}diff --git a/graph/nodes.html b/graph/nodes.htmlnew file mode 100644index 0000000..60e8bef--- /dev/null+++ b/graph/nodes.html@@ -0,0 +1,2308 @@+<html>+ <head>+ <meta charset="utf-8">++ <script>function neighbourhoodHighlight(params) {+ // console.log("in nieghbourhoodhighlight");+ allNodes = nodes.get({ returnType: "Object" });+ // originalNodes = JSON.parse(JSON.stringify(allNodes));+ // if something is selected:+ if (params.nodes.length > 0) {+ highlightActive = true;+ var i, j;+ var selectedNode = params.nodes[0];+ var degrees = 2;++ // mark all nodes as hard to read.+ for (let nodeId in allNodes) {+ // nodeColors[nodeId] = allNodes[nodeId].color;+ allNodes[nodeId].color = "rgba(200,200,200,0.5)";+ if (allNodes[nodeId].hiddenLabel === undefined) {+ allNodes[nodeId].hiddenLabel = allNodes[nodeId].label;+ allNodes[nodeId].label = undefined;+ }+ }+ var connectedNodes = network.getConnectedNodes(selectedNode);+ var allConnectedNodes = [];++ // get the second degree nodes+ for (i = 1; i < degrees; i++) {+ for (j = 0; j < connectedNodes.length; j++) {+ allConnectedNodes = allConnectedNodes.concat(+ network.getConnectedNodes(connectedNodes[j])+ );+ }+ }++ // all second degree nodes get a different color and their label back+ for (i = 0; i < allConnectedNodes.length; i++) {+ // allNodes[allConnectedNodes[i]].color = "pink";+ allNodes[allConnectedNodes[i]].color = "rgba(150,150,150,0.75)";+ if (allNodes[allConnectedNodes[i]].hiddenLabel !== undefined) {+ allNodes[allConnectedNodes[i]].label =+ allNodes[allConnectedNodes[i]].hiddenLabel;+ allNodes[allConnectedNodes[i]].hiddenLabel = undefined;+ }+ }++ // all first degree nodes get their own color and their label back+ for (i = 0; i < connectedNodes.length; i++) {+ // allNodes[connectedNodes[i]].color = undefined;+ allNodes[connectedNodes[i]].color = nodeColors[connectedNodes[i]];+ if (allNodes[connectedNodes[i]].hiddenLabel !== undefined) {+ allNodes[connectedNodes[i]].label =+ allNodes[connectedNodes[i]].hiddenLabel;+ allNodes[connectedNodes[i]].hiddenLabel = undefined;+ }+ }++ // the main node gets its own color and its label back.+ // allNodes[selectedNode].color = undefined;+ allNodes[selectedNode].color = nodeColors[selectedNode];+ if (allNodes[selectedNode].hiddenLabel !== undefined) {+ allNodes[selectedNode].label = allNodes[selectedNode].hiddenLabel;+ allNodes[selectedNode].hiddenLabel = undefined;+ }+ } else if (highlightActive === true) {+ // console.log("highlightActive was true");+ // reset all nodes+ for (let nodeId in allNodes) {+ // allNodes[nodeId].color = "purple";+ allNodes[nodeId].color = nodeColors[nodeId];+ // delete allNodes[nodeId].color;+ if (allNodes[nodeId].hiddenLabel !== undefined) {+ allNodes[nodeId].label = allNodes[nodeId].hiddenLabel;+ allNodes[nodeId].hiddenLabel = undefined;+ }+ }+ highlightActive = false;+ }++ // transform the object into an array+ var updateArray = [];+ if (params.nodes.length > 0) {+ for (let nodeId in allNodes) {+ if (allNodes.hasOwnProperty(nodeId)) {+ // console.log(allNodes[nodeId]);+ updateArray.push(allNodes[nodeId]);+ }+ }+ nodes.update(updateArray);+ } else {+ // console.log("Nothing was selected");+ for (let nodeId in allNodes) {+ if (allNodes.hasOwnProperty(nodeId)) {+ // console.log(allNodes[nodeId]);+ // allNodes[nodeId].color = {};+ updateArray.push(allNodes[nodeId]);+ }+ }+ nodes.update(updateArray);+ }+}++function filterHighlight(params) {+ allNodes = nodes.get({ returnType: "Object" });+ // if something is selected:+ if (params.nodes.length > 0) {+ filterActive = true;+ let selectedNodes = params.nodes;++ // hiding all nodes and saving the label+ for (let nodeId in allNodes) {+ allNodes[nodeId].hidden = true;+ if (allNodes[nodeId].savedLabel === undefined) {+ allNodes[nodeId].savedLabel = allNodes[nodeId].label;+ allNodes[nodeId].label = undefined;+ }+ }++ for (let i=0; i < selectedNodes.length; i++) {+ allNodes[selectedNodes[i]].hidden = false;+ if (allNodes[selectedNodes[i]].savedLabel !== undefined) {+ allNodes[selectedNodes[i]].label = allNodes[selectedNodes[i]].savedLabel;+ allNodes[selectedNodes[i]].savedLabel = undefined;+ }+ }++ } else if (filterActive === true) {+ // reset all nodes+ for (let nodeId in allNodes) {+ allNodes[nodeId].hidden = false;+ if (allNodes[nodeId].savedLabel !== undefined) {+ allNodes[nodeId].label = allNodes[nodeId].savedLabel;+ allNodes[nodeId].savedLabel = undefined;+ }+ }+ filterActive = false;+ }++ // transform the object into an array+ var updateArray = [];+ if (params.nodes.length > 0) {+ for (let nodeId in allNodes) {+ if (allNodes.hasOwnProperty(nodeId)) {+ updateArray.push(allNodes[nodeId]);+ }+ }+ nodes.update(updateArray);+ } else {+ for (let nodeId in allNodes) {+ if (allNodes.hasOwnProperty(nodeId)) {+ updateArray.push(allNodes[nodeId]);+ }+ }+ nodes.update(updateArray);+ }+}++function selectNode(nodes) {+ network.selectNodes(nodes);+ neighbourhoodHighlight({ nodes: nodes });+ return nodes;+}++function selectNodes(nodes) {+ network.selectNodes(nodes);+ filterHighlight({nodes: nodes});+ return nodes;+}++function highlightFilter(filter) {+ let selectedNodes = []+ let selectedProp = filter['property']+ if (filter['item'] === 'node') {+ let allNodes = nodes.get({ returnType: "Object" });+ for (let nodeId in allNodes) {+ if (allNodes[nodeId][selectedProp] && filter['value'].includes((allNodes[nodeId][selectedProp]).toString())) {+ selectedNodes.push(nodeId)+ }+ }+ }+ else if (filter['item'] === 'edge'){+ let allEdges = edges.get({returnType: 'object'});+ // check if the selected property exists for selected edge and select the nodes connected to the edge+ for (let edge in allEdges) {+ if (allEdges[edge][selectedProp] && filter['value'].includes((allEdges[edge][selectedProp]).toString())) {+ selectedNodes.push(allEdges[edge]['from'])+ selectedNodes.push(allEdges[edge]['to'])+ }+ }+ }+ selectNodes(selectedNodes)+}</script>+ <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />+ <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>+++++++ <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/tom-select/2.0.0-rc.4/css/tom-select.min.css" integrity="sha512-43fHB3GLgZfz8QXl1RPQ8O66oIgv3po9cJ5erMt1c4QISq9dYb195T3vr5ImnJPXuVroKcGBPXBFKETW8jrPNQ==" crossorigin="anonymous" referrerpolicy="no-referrer" />+ <script src="https://cdnjs.cloudflare.com/ajax/libs/tom-select/2.0.0-rc.4/js/tom-select.complete.js" integrity="sha512-jeF9CfnvzDiw9G9xiksVjxR2lib44Gnovvkv+3CgCG6NXCD4gqlA5nDAVW5WjpA+i+/zKsUWV5xNEbW1X/HH0Q==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>++++<center>+<h1></h1>+</center>++<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />+<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->+ <link+ href="https://cdn.jsdelivr.net/npm/[email protected]/dist/css/bootstrap.min.css"+ rel="stylesheet"+ integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"+ crossorigin="anonymous"+ />+ <script+ src="https://cdn.jsdelivr.net/npm/[email protected]/dist/js/bootstrap.bundle.min.js"+ integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"+ crossorigin="anonymous"+ ></script>+++ <center>+ <h1></h1>+ </center>+ <style type="text/css">++ #mynetwork {+ width: 100%;+ height: 900px;+ background-color: #111212;+ border: 1px solid lightgray;+ position: relative;+ float: left;+ }+++ #loadingBar {+ position:absolute;+ top:0px;+ left:0px;+ width: 100%;+ height: 900px;+ background-color:rgba(200,200,200,0.8);+ -webkit-transition: all 0.5s ease;+ -moz-transition: all 0.5s ease;+ -ms-transition: all 0.5s ease;+ -o-transition: all 0.5s ease;+ transition: all 0.5s ease;+ opacity:1;+ }++ #bar {+ position:absolute;+ top:0px;+ left:0px;+ width:20px;+ height:20px;+ margin:auto auto auto auto;+ border-radius:11px;+ border:2px solid rgba(30,30,30,0.05);+ background: rgb(0, 173, 246); /* Old browsers */+ box-shadow: 2px 0px 4px rgba(0,0,0,0.4);+ }++ #border {+ position:absolute;+ top:10px;+ left:10px;+ width:500px;+ height:23px;+ margin:auto auto auto auto;+ box-shadow: 0px 0px 4px rgba(0,0,0,0.2);+ border-radius:10px;+ }++ #text {+ position:absolute;+ top:8px;+ left:530px;+ width:30px;+ height:50px;+ margin:auto auto auto auto;+ font-size:22px;+ color: #000000;+ }++ div.outerBorder {+ position:relative;+ top:400px;+ width:600px;+ height:44px;+ margin:auto auto auto auto;+ border:8px solid rgba(0,0,0,0.1);+ background: rgb(252,252,252); /* Old browsers */+ background: -moz-linear-gradient(top, rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */+ background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */+ background: -webkit-linear-gradient(top, rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */+ background: -o-linear-gradient(top, rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */+ background: -ms-linear-gradient(top, rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */+ background: linear-gradient(to bottom, rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */+ filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */+ border-radius:72px;+ box-shadow: 0px 0px 10px rgba(0,0,0,0.2);+ }++++ #config {+ float: left;+ width: 400px;+ height: 600px;+ }++++ </style>+ </head>+++ <body>+ <div class="card" style="width: 100%">++ <div id="select-menu" class="card-header">+ <div class="row no-gutters">+ <div class="col-10 pb-2">+ <select+ class="form-select"+ aria-label="Default select example"+ onchange="selectNode([value]);"+ id="select-node"+ placeholder="Select node..."+ >+ <option selected>Select a Node by ID</option>++ <option value=" Member states"> Member states</option>++ <option value="access to vaccines, drugs, and other medical equipment">access to vaccines, drugs, and other medical equipment</option>++ <option value="10 million deaths">10 million deaths</option>++ <option value="Antimicrobial Resistance (AMR)">Antimicrobial Resistance (AMR)</option>++ <option value="100 Days Mission">100 Days Mission</option>++ <option value="One World Vaccine Library">One World Vaccine Library</option>++ <option value="150,000 Health and Wellness Centres (HWC)">150,000 Health and Wellness Centres (HWC)</option>++ <option value="Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)">Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)</option>++ <option value="191 countries">191 countries</option>++ <option value="vaccine nationalism">vaccine nationalism</option>++ <option value="COVAX Facility">COVAX Facility</option>++ <option value="vaccines">vaccines</option>++ <option value="COVID-19 vaccines">COVID-19 vaccines</option>++ <option value="2004 prices">2004 prices</option>++ <option value="Accelerating Global Health">Accelerating Global Health</option>++ <option value="generic medicine pricing policy">generic medicine pricing policy</option>++ <option value="2008 attempt to operationalise the OH approach for zoonotic disease control and prevention">2008 attempt to operationalise the OH approach for zoonotic disease control and prevention</option>++ <option value="One Health">One Health</option>++ <option value="2009">2009</option>++ <option value="Lower Out of Pocket Expenditure as a% of Current Health Expenditure">Lower Out of Pocket Expenditure as a% of Current Health Expenditure</option>++ <option value="2010 prices">2010 prices</option>++ <option value="2010 study">2010 study</option>++ <option value="2050">2050</option>++ <option value="27 July 2023">27 July 2023</option>++ <option value="consultations">consultations</option>++ <option value="420,000 die each year">420,000 die each year</option>++ <option value="Pathways to Health Equity for the G20">Pathways to Health Equity for the G20</option>++ <option value="600 million people are affected by food-borne diseases">600 million people are affected by food-borne diseases</option>++ <option value="ABDM ecosystem">ABDM ecosystem</option>++ <option value="Resilient Digital Health Ecosystem">Resilient Digital Health Ecosystem</option>++ <option value="ABHA numbers">ABHA numbers</option>++ <option value="AI assistant for frontline workers in 11 Indian languages">AI assistant for frontline workers in 11 Indian languages</option>++ <option value="impending disease outbreak">impending disease outbreak</option>++ <option value="AI in healthcare">AI in healthcare</option>++ <option value="AMR">AMR</option>++ <option value="Interventions">Interventions</option>++ <option value="Antimicrobials">Antimicrobials</option>++ <option value="Healthcare Systems">Healthcare Systems</option>++ <option value="Patient Outcomes">Patient Outcomes</option>++ <option value="Health Equity">Health Equity</option>++ <option value="Essay">Essay</option>++ <option value="Ranga Reddy Burri">Ranga Reddy Burri</option>++ <option value="Robert Skov">Robert Skov</option>++ <option value="Bulagonda Eswarappa Pradeep">Bulagonda Eswarappa Pradeep</option>++ <option value="Ralf Sudbrak">Ralf Sudbrak</option>++ <option value="LMICs">LMICs</option>++ <option value="vulnerable populations in HICs">vulnerable populations in HICs</option>++ <option value="antimicrobials pipeline">antimicrobials pipeline</option>++ <option value="industry leaving the field of antimicrobial drug discovery">industry leaving the field of antimicrobial drug discovery</option>++ <option value="AMR pandemic">AMR pandemic</option>++ <option value="consequences of AMR">consequences of AMR</option>++ <option value="need for increased action">need for increased action</option>++ <option value="multifaceted effort">multifaceted effort</option>++ <option value="reducing the circulation and spread of existing resistant microorganisms">reducing the circulation and spread of existing resistant microorganisms</option>++ <option value="increase of novel resistance mechanisms">increase of novel resistance mechanisms</option>++ <option value="lowering the overall use of antimicrobials">lowering the overall use of antimicrobials</option>++ <option value="antimicrobial stewardship">antimicrobial stewardship</option>++ <option value="accessibility of affordable and timely diagnostics">accessibility of affordable and timely diagnostics</option>++ <option value="strengthening IPC and biosecurity procedures">strengthening IPC and biosecurity procedures</option>++ <option value="AMR (Antimicrobial Resistance)">AMR (Antimicrobial Resistance)</option>++ <option value="Quadripartite">Quadripartite</option>++ <option value="One Health approach">One Health approach</option>++ <option value="National Action Plans (NAPs)">National Action Plans (NAPs)</option>++ <option value="ARG ARG">ARG ARG</option>++ <option value="ASHAs">ASHAs</option>++ <option value="OH approach">OH approach</option>++ <option value="AUSSPN">AUSSPN</option>++ <option value="Aadhaar">Aadhaar</option>++ <option value="technology">technology</option>++ <option value="Aadhaar-based e-KYC">Aadhaar-based e-KYC</option>++ <option value="India Stack">India Stack</option>++ <option value="Aadhaar-based eSign">Aadhaar-based eSign</option>++ <option value="Accelerating Efforts to Combat AMR">Accelerating Efforts to Combat AMR</option>++ <option value="Battle Against Antimicrobial Resistance">Battle Against Antimicrobial Resistance</option>++ <option value="Combating AMR">Combating AMR</option>++ <option value="Integrating Mental Health into General Healthcare">Integrating Mental Health into General Healthcare</option>++ <option value="Poverty">Poverty</option>++ <option value="Mental Health">Mental Health</option>++ <option value="Biological Determinants">Biological Determinants</option>++ <option value="Psychological Determinants">Psychological Determinants</option>++ <option value="Social Determinants">Social Determinants</option>++ <option value="Depression">Depression</option>++ <option value="Substance Use Disorders">Substance Use Disorders</option>++ <option value="Behavioural Addictions">Behavioural Addictions</option>++ <option value="Severe Mental Illness (SMI)">Severe Mental Illness (SMI)</option>++ <option value="Schizophrenia">Schizophrenia</option>++ <option value="Bipolar Mood Disorder">Bipolar Mood Disorder</option>++ <option value="Mental Health Care Act, 2017">Mental Health Care Act, 2017</option>++ <option value="reported violations">reported violations</option>++ <option value="rejections of claims for mental illness by insurance companies">rejections of claims for mental illness by insurance companies</option>++ <option value="discriminatory ceilings on the sum of reimbursement for mental illness">discriminatory ceilings on the sum of reimbursement for mental illness</option>++ <option value="people with serious mental illness (SMI)">people with serious mental illness (SMI)</option>++ <option value="shortened life expectancy">shortened life expectancy</option>++ <option value="multimorbidity">multimorbidity</option>++ <option value="non-communicable diseases (NCDs)">non-communicable diseases (NCDs)</option>++ <option value="tobacco and alcohol use">tobacco and alcohol use</option>++ <option value="physical inactivity">physical inactivity</option>++ <option value="poor diets">poor diets</option>++ <option value="national programs to address chronic conditions">national programs to address chronic conditions</option>++ <option value="chronic conditions">chronic conditions</option>++ <option value="poor horizontal integration across the programmes">poor horizontal integration across the programmes</option>++ <option value="homeless persons">homeless persons</option>++ <option value="women">women</option>++ <option value="persons with developmental disorders">persons with developmental disorders</option>++ <option value="Psychotropic medications">Psychotropic medications</option>++ <option value="Mental Health Policy (2014)">Mental Health Policy (2014)</option>++ <option value="digital academies at NIMHANS">digital academies at NIMHANS</option>++ <option value="m-Cessation">m-Cessation</option>++ <option value="tobacco quit-lines">tobacco quit-lines</option>++ <option value="National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)">National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)</option>++ <option value="Improvements in curative and preventive care domains">Improvements in curative and preventive care domains</option>++ <option value="Rehabilitative care">Rehabilitative care</option>++ <option value="National Mental Health Policy 2014">National Mental Health Policy 2014</option>++ <option value="Vulnerable populations">Vulnerable populations</option>++ <option value="Children">Children</option>++ <option value="Elderly">Elderly</option>++ <option value="Homeless">Homeless</option>++ <option value="Macro-environmental issues">Macro-environmental issues</option>++ <option value="Unemployment">Unemployment</option>++ <option value="Displacement">Displacement</option>++ <option value="Mental health impact of climate change">Mental health impact of climate change</option>++ <option value="Leadership and governance">Leadership and governance</option>++ <option value="one health">one health</option>++ <option value="zoonoses">zoonoses</option>++ <option value="wet markets">wet markets</option>++ <option value="Joint Plan of Action">Joint Plan of Action</option>++ <option value="equity">equity</option>++ <option value="procurement, distribution, administration of COVID-19 vaccines">procurement, distribution, administration of COVID-19 vaccines</option>++ <option value="COVID-19 pandemic">COVID-19 pandemic</option>++ <option value="novel paramyxovirus">novel paramyxovirus</option>++ <option value="Water-borne diseases">Water-borne diseases</option>++ <option value="Drinking or coming in contact with contaminated water">Drinking or coming in contact with contaminated water</option>++ <option value="Faecal-contaminated water">Faecal-contaminated water</option>++ <option value="Two billion people globally">Two billion people globally</option>++ <option value="Cholera, dysentery, typhoid and polio">Cholera, dysentery, typhoid and polio</option>++ <option value="Around 485,000 deaths every year">Around 485,000 deaths every year</option>++ <option value="Food-borne diseases">Food-borne diseases</option>++ <option value="Over 200 diseases">Over 200 diseases</option>++ <option value="Chemical substances such as unpasteurised (raw) milk">Chemical substances such as unpasteurised (raw) milk</option>++ <option value="Undercooked meat or eggs">Undercooked meat or eggs</option>++ <option value="Raw fruits and vegetables">Raw fruits and vegetables</option>++ <option value="Healthy life years lost">Healthy life years lost</option>++ <option value="Access to adequate safe and nutritious food">Access to adequate safe and nutritious food</option>++ <option value="One Health’">One Health’</option>++ <option value="Operationalising ‘One Health’">Operationalising ‘One Health’</option>++ <option value="Building a Resilient Digital Health Ecosystem in India">Building a Resilient Digital Health Ecosystem in India</option>++ <option value="Lav Agarwal">Lav Agarwal</option>++ <option value="communication">communication</option>++ <option value="transportation">transportation</option>++ <option value="healthcare">healthcare</option>++ <option value="electronic health records">electronic health records</option>++ <option value="artificial intelligence">artificial intelligence</option>++ <option value="wearable devices">wearable devices</option>++ <option value="health apps">health apps</option>++ <option value="CoWIN">CoWIN</option>++ <option value="COVID-19 'war rooms'">COVID-19 'war rooms'</option>++ <option value="digital health initiatives">digital health initiatives</option>++ <option value="COVID-19 India Portal">COVID-19 India Portal</option>++ <option value="marginalised communities">marginalised communities</option>++ <option value="India">India</option>++ <option value="digital inclusion">digital inclusion</option>++ <option value="urban telephone subscribers">urban telephone subscribers</option>++ <option value="gender gap in mobile ownership">gender gap in mobile ownership</option>++ <option value="India's digital infrastructure">India's digital infrastructure</option>++ <option value="intermediaries (digital media, e-commerce)">intermediaries (digital media, e-commerce)</option>++ <option value="connectivity to cause harm or commit crimes">connectivity to cause harm or commit crimes</option>++ <option value="comprehensive measures">comprehensive measures</option>++ <option value="potential DPI’s scalability">potential DPI’s scalability</option>++ <option value="India's DPI experience">India's DPI experience</option>++ <option value="Digital systems">Digital systems</option>++ <option value="Inclusive societies">Inclusive societies</option>++ <option value="Sustainable development in the 21st century">Sustainable development in the 21st century</option>++ <option value="Sameer Kanwar">Sameer Kanwar</option>++ <option value="Varun Kumar">Varun Kumar</option>++ <option value="Inadequate infection prevention and control">Inadequate infection prevention and control</option>++ <option value="Hand hygiene">Hand hygiene</option>++ <option value="Improper disinfection and sterilisation practices">Improper disinfection and sterilisation practices</option>++ <option value="Inadequate sanitation">Inadequate sanitation</option>++ <option value="Hospital-acquired infections">Hospital-acquired infections</option>++ <option value="Infection prevention and control measures">Infection prevention and control measures</option>++ <option value="Infection control practices">Infection control practices</option>++ <option value="Low- and middle-income countries (LMICs)">Low- and middle-income countries (LMICs)</option>++ <option value="World Health Organization">World Health Organization</option>++ <option value="Innovative financing mechanisms">Innovative financing mechanisms</option>++ <option value="G20">G20</option>++ <option value="Healthcare Spending">Healthcare Spending</option>++ <option value="G20 countries">G20 countries</option>++ <option value="Universal Health Coverage (UHC)">Universal Health Coverage (UHC)</option>++ <option value="Out-Of-Pocket Expenses (OOPE)">Out-Of-Pocket Expenses (OOPE)</option>++ <option value="Maximum Retail Price set by the MOH">Maximum Retail Price set by the MOH</option>++ <option value="public hospitals">public hospitals</option>++ <option value="private pharmacies">private pharmacies</option>++ <option value="NGO hospitals">NGO hospitals</option>++ <option value="Lowest Price Generic (LPG) medicines">Lowest Price Generic (LPG) medicines</option>++ <option value="Innovator Brand (IB) medicines">Innovator Brand (IB) medicines</option>++ <option value="declines ranging from 40 percent to 2200 percent">declines ranging from 40 percent to 2200 percent</option>++ <option value="generic medicine pricing policies have succeeded in lowering the price of medicines">generic medicine pricing policies have succeeded in lowering the price of medicines</option>++ <option value="variation in implementation">variation in implementation</option>++ <option value="excess paid by patients compared to MOH set prices">excess paid by patients compared to MOH set prices</option>++ <option value="narrow the differences">narrow the differences</option>++ <option value="more recently">more recently</option>++ <option value="UHC (Universal Health Coverage)">UHC (Universal Health Coverage)</option>++ <option value="National University of Singapore's Saw Swee Hock School of Public Health">National University of Singapore's Saw Swee Hock School of Public Health</option>++ <option value="Associate Professor Jeremy Lim">Associate Professor Jeremy Lim</option>++ <option value="Janice Tan">Janice Tan</option>++ <option value="Accelerating Global Health: Pathways to Health Equity for the G20">Accelerating Global Health: Pathways to Health Equity for the G20</option>++ <option value="cultural settings of LMICs">cultural settings of LMICs</option>++ <option value="brief psychological interventions">brief psychological interventions</option>++ <option value="lay counsellors">lay counsellors</option>++ <option value="moderate to severe depressive disorders and harmful drinking">moderate to severe depressive disorders and harmful drinking</option>++ <option value="health systems in HICs">health systems in HICs</option>++ <option value="long waiting periods for psychological intervention">long waiting periods for psychological intervention</option>++ <option value="low-intensity interventions">low-intensity interventions</option>++ <option value="Problem Management plus (PM+)">Problem Management plus (PM+)</option>++ <option value="adults in distress due to exposure to adversity">adults in distress due to exposure to adversity</option>++ <option value="family caregivers">family caregivers</option>++ <option value="mental health">mental health</option>++ <option value="indigenous interventions">indigenous interventions</option>++ <option value="Yoga">Yoga</option>++ <option value="alternative forms of medicine">alternative forms of medicine</option>++ <option value="COVID-19">COVID-19</option>++ <option value="Access to COVID-19 Tools Accelerator (ACT-A)">Access to COVID-19 Tools Accelerator (ACT-A)</option>++ <option value="pandemic">pandemic</option>++ <option value="Accord">Accord</option>++ <option value="Human Rights Protection">Human Rights Protection</option>++ <option value="Public Health and Healthcare Systems">Public Health and Healthcare Systems</option>++ <option value="Staff Protection">Staff Protection</option>++ <option value="Misinformation Management">Misinformation Management</option>++ <option value="Whole-of-Society Approach">Whole-of-Society Approach</option>++ <option value="Global Coordination">Global Coordination</option>++ <option value="Preparedness Plans">Preparedness Plans</option>++ <option value="Simulation Exercises">Simulation Exercises</option>++ <option value="Universal Health and Preparedness Review">Universal Health and Preparedness Review</option>++ <option value="Accurate and timely diagnostics">Accurate and timely diagnostics</option>++ <option value="Advance market commitment–type investments">Advance market commitment–type investments</option>++ <option value="Africa Center for Disease Control">Africa Center for Disease Control</option>++ <option value="African Union Commission">African Union Commission</option>++ <option value="African continent">African continent</option>++ <option value="Alternative treatments">Alternative treatments</option>++ <option value="Annual coverage of INR 500,000 per family">Annual coverage of INR 500,000 per family</option>++ <option value="Antibiotic Resistance Mechanisms">Antibiotic Resistance Mechanisms</option>++ <option value="Antimicrobial Resistance">Antimicrobial Resistance</option>++ <option value="Antibiotics">Antibiotics</option>++ <option value="Global Health Crisis">Global Health Crisis</option>++ <option value="Global Economy">Global Economy</option>++ <option value="Extreme Poverty">Extreme Poverty</option>++ <option value="Developing Nations">Developing Nations</option>++ <option value="Antimicrobial Drugs">Antimicrobial Drugs</option>++ <option value="Persistent Infectious Diseases">Persistent Infectious Diseases</option>++ <option value="Biological Evolution">Biological Evolution</option>++ <option value="Defense System of Microorganisms">Defense System of Microorganisms</option>++ <option value="Multisectoral inclusivity">Multisectoral inclusivity</option>++ <option value="OH concept">OH concept</option>++ <option value="WHO">WHO</option>++ <option value="Global Public Health Threats">Global Public Health Threats</option>++ <option value="US$11-444 million">US$11-444 million</option>++ <option value="Resistance">Resistance</option>++ <option value="Microorganisms">Microorganisms</option>++ <option value="Selection">Selection</option>++ <option value="Antimicrobial use">Antimicrobial use</option>++ <option value="Argentina">Argentina</option>++ <option value="health equity">health equity</option>++ <option value="Asian countries">Asian countries</option>++ <option value="mental health equity">mental health equity</option>++ <option value="National Program for Mental Health (NMHP)">National Program for Mental Health (NMHP)</option>++ <option value="Aurélia Nguyen">Aurélia Nguyen</option>++ <option value="COVAX">COVAX</option>++ <option value="Australia">Australia</option>++ <option value="Average Life Expectancy">Average Life Expectancy</option>++ <option value="G20 Countries">G20 Countries</option>++ <option value="Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)">Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)</option>++ <option value="Universal Health Care (UHC) in India">Universal Health Care (UHC) in India</option>++ <option value="Secondary and tertiary hospitalisations">Secondary and tertiary hospitalisations</option>++ <option value="Generic medicines">Generic medicines</option>++ <option value="Jan Aushadhi Kendras">Jan Aushadhi Kendras</option>++ <option value="Economic burden">Economic burden</option>++ <option value="Poor and marginalised">Poor and marginalised</option>++ <option value="Comprehensive services">Comprehensive services</option>++ <option value="Screening and essential mental health">Screening and essential mental health</option>++ <option value="Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)">Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)</option>++ <option value="Universal Health Coverage">Universal Health Coverage</option>++ <option value="Health and Wellness Centres">Health and Wellness Centres</option>++ <option value="National Tele Mental Health Programme (Tele MANAS)">National Tele Mental Health Programme (Tele MANAS)</option>++ <option value="National Mental Health Policy (2014)">National Mental Health Policy (2014)</option>++ <option value="National Health Policy (2017)">National Health Policy (2017)</option>++ <option value="Rights of Persons with Disability Act, 2016">Rights of Persons with Disability Act, 2016</option>++ <option value="BPJS">BPJS</option>++ <option value="UHC">UHC</option>++ <option value="BRABRAKOR">BRABRAKOR</option>++ <option value="Bacteriophages">Bacteriophages</option>++ <option value="Barbara Stocking">Barbara Stocking</option>++ <option value="bird and animal viruses">bird and animal viruses</option>++ <option value="chemistry and artificial intelligence (AI)">chemistry and artificial intelligence (AI)</option>++ <option value="antimicrobials">antimicrobials</option>++ <option value="in vitro and in vivo trials">in vitro and in vivo trials</option>++ <option value="bacteria">bacteria</option>++ <option value="antibiotics">antibiotics</option>++ <option value="quicker and more efficient antibiotic testing and approval pipelines">quicker and more efficient antibiotic testing and approval pipelines</option>++ <option value="antimicrobial discovery">antimicrobial discovery</option>++ <option value="existing drugs">existing drugs</option>++ <option value="natural products">natural products</option>++ <option value="alternate treatment strategies">alternate treatment strategies</option>++ <option value="computational approaches for drug design">computational approaches for drug design</option>++ <option value="interdisciplinary collaborations">interdisciplinary collaborations</option>++ <option value="new technologies">new technologies</option>++ <option value="clinical antibacterial pipeline">clinical antibacterial pipeline</option>++ <option value="Policy">Policy</option>++ <option value="Implementation">Implementation</option>++ <option value="New antibiotics">New antibiotics</option>++ <option value="Infection prevention and control practices">Infection prevention and control practices</option>++ <option value="Surveillance and data collection">Surveillance and data collection</option>++ <option value="National and global health plans">National and global health plans</option>++ <option value="Stakeholders">Stakeholders</option>++ <option value="Political will">Political will</option>++ <option value="Best Practices">Best Practices</option>++ <option value="Health Finance">Health Finance</option>++ <option value="Best practice examples">Best practice examples</option>++ <option value="Box 2. Technological Initiatives in India for Mental Health">Box 2. Technological Initiatives in India for Mental Health</option>++ <option value="Tele-MANAS initiative">Tele-MANAS initiative</option>++ <option value="Brazil">Brazil</option>++ <option value="CAN">CAN</option>++ <option value="CEPI (Coalition for Epidemic Preparedness Innovations)">CEPI (Coalition for Epidemic Preparedness Innovations)</option>++ <option value="CEPI's 100 Days Mission">CEPI's 100 Days Mission</option>++ <option value="CHI">CHI</option>++ <option value="CHIRUS">CHIRUS</option>++ <option value="vaccine candidates">vaccine candidates</option>++ <option value="Gavi-implementing countries">Gavi-implementing countries</option>++ <option value="routine immunisation">routine immunisation</option>++ <option value="COVID-19 vaccine coverage">COVID-19 vaccine coverage</option>++ <option value="pandemic preparedness">pandemic preparedness</option>++ <option value="most vulnerable people">most vulnerable people</option>++ <option value="equitable supply of vaccines">equitable supply of vaccines</option>++ <option value="finite supply of vaccine doses">finite supply of vaccine doses</option>++ <option value="H1N1 vaccine">H1N1 vaccine</option>++ <option value="Gavi, the Vaccine Alliance">Gavi, the Vaccine Alliance</option>++ <option value="COVAX AMC">COVAX AMC</option>++ <option value="hoarding">hoarding</option>++ <option value="export bans">export bans</option>++ <option value="H1N1 pandemic">H1N1 pandemic</option>++ <option value="lower-income economies">lower-income economies</option>++ <option value="wealthier nations">wealthier nations</option>++ <option value="vaccine-candidates">vaccine-candidates</option>++ <option value="technology platforms">technology platforms</option>++ <option value="regulatory approval">regulatory approval</option>++ <option value="large-scale investments">large-scale investments</option>++ <option value="COVAX portfolio">COVAX portfolio</option>++ <option value="Healthcare systems">Healthcare systems</option>++ <option value="Simulation exercises">Simulation exercises</option>++ <option value="Public health system">Public health system</option>++ <option value="Lockdown">Lockdown</option>++ <option value="Livelihoods and economy">Livelihoods and economy</option>++ <option value="Trade">Trade</option>++ <option value="Social services (education)">Social services (education)</option>++ <option value="Health system strengthening investments">Health system strengthening investments</option>++ <option value="Primary healthcare services">Primary healthcare services</option>++ <option value="Cold chain">Cold chain</option>++ <option value="Vaccine track-and-trace">Vaccine track-and-trace</option>++ <option value="Human resources">Human resources</option>++ <option value="Data monitoring systems">Data monitoring systems</option>++ <option value="COVID-19 vaccine Delivery Support (CDS)">COVID-19 vaccine Delivery Support (CDS)</option>++ <option value="Gavi">Gavi</option>++ <option value="health workforce">health workforce</option>++ <option value="COVID-19 infections and deaths among health workers">COVID-19 infections and deaths among health workers</option>++ <option value="limited availability of the health workforce">limited availability of the health workforce</option>++ <option value="lockdown">lockdown</option>++ <option value="global economy">global economy</option>++ <option value="novel coronavirus">novel coronavirus</option>++ <option value="disease">disease</option>++ <option value="zoonotic virus">zoonotic virus</option>++ <option value="Public Health Emergency of International Concern">Public Health Emergency of International Concern</option>++ <option value="low-income countries">low-income countries</option>++ <option value="vaccines and drugs">vaccines and drugs</option>++ <option value="vaccine manufacturing">vaccine manufacturing</option>++ <option value="Memorandum of Understanding">Memorandum of Understanding</option>++ <option value="Public Health Workforce">Public Health Workforce</option>++ <option value="regional, and global bodies">regional, and global bodies</option>++ <option value="COVID-19 vaccinations">COVID-19 vaccinations</option>++ <option value="Canada">Canada</option>++ <option value="Carbis Bay Health Declaration">Carbis Bay Health Declaration</option>++ <option value="Central and State Mental Health Authorities">Central and State Mental Health Authorities</option>++ <option value="mental health services">mental health services</option>++ <option value="mental illness">mental illness</option>++ <option value="Centres of Excellence for AI">Centres of Excellence for AI</option>++ <option value="China">China</option>++ <option value="Climate Change">Climate Change</option>++ <option value="India's G20 Leadership">India's G20 Leadership</option>++ <option value="Clinical decision support system">Clinical decision support system</option>++ <option value="Coalition for Epidemic Preparedness Innovations (CEPI)">Coalition for Epidemic Preparedness Innovations (CEPI)</option>++ <option value="pandemics">pandemics</option>++ <option value="Dr. Richard Hatchett">Dr. Richard Hatchett</option>++ <option value="Kate Kelland">Kate Kelland</option>++ <option value="DBT">DBT</option>++ <option value="DEPA">DEPA</option>++ <option value="DEU">DEU</option>++ <option value="DNDi (Drugs for Neglected Diseases Initiative)">DNDi (Drugs for Neglected Diseases Initiative)</option>++ <option value="DPI">DPI</option>++ <option value="digital literacy">digital literacy</option>++ <option value="digital divide">digital divide</option>++ <option value="India's digital transformation">India's digital transformation</option>++ <option value="inclusivity">inclusivity</option>++ <option value="scalability">scalability</option>++ <option value="regulation">regulation</option>++ <option value="collaboration">collaboration</option>++ <option value="Dame Barbara Stocking">Dame Barbara Stocking</option>++ <option value="Global Public Health Convention">Global Public Health Convention</option>++ <option value="Data Empowerment and Protection Architecture (DEPA)">Data Empowerment and Protection Architecture (DEPA)</option>++ <option value="India Enterprise Architecture">India Enterprise Architecture</option>++ <option value="Databases and knowledge-sharing resources">Databases and knowledge-sharing resources</option>++ <option value="Department for Digital Health and Innovation">Department for Digital Health and Innovation</option>++ <option value="World Health Organization (WHO)">World Health Organization (WHO)</option>++ <option value="Developing countries">Developing countries</option>++ <option value="Digital Health">Digital Health</option>++ <option value="India's G20 presidency">India's G20 presidency</option>++ <option value="Global Initiative on Digital Health (GIDH)">Global Initiative on Digital Health (GIDH)</option>++ <option value="Digital India">Digital India</option>++ <option value="transparency">transparency</option>++ <option value="Digital India programme">Digital India programme</option>++ <option value="India's Digital Public Infrastructure Transformation">India's Digital Public Infrastructure Transformation</option>++ <option value="Digital Personal Data Protection Bill 2022">Digital Personal Data Protection Bill 2022</option>++ <option value="Digital healthcare">Digital healthcare</option>++ <option value="Digital infrastructure">Digital infrastructure</option>++ <option value="Direct Benefit Transfer (DBT) programme">Direct Benefit Transfer (DBT) programme</option>++ <option value="Disability-Adjusted-Life-Years (DALYs)">Disability-Adjusted-Life-Years (DALYs)</option>++ <option value="mental disorders">mental disorders</option>++ <option value="treatment gap for mental and substance abuse disorders">treatment gap for mental and substance abuse disorders</option>++ <option value="out-of-pocket (OOP) spending">out-of-pocket (OOP) spending</option>++ <option value="medicines">medicines</option>++ <option value="Disease X pandemic virus">Disease X pandemic virus</option>++ <option value="Disease outbreaks">Disease outbreaks</option>++ <option value="Disparity Interventions">Disparity Interventions</option>++ <option value="District Mental Health Program (DMHP)">District Mental Health Program (DMHP)</option>++ <option value="Doha Trade Round">Doha Trade Round</option>++ <option value="Pandemic Accord">Pandemic Accord</option>++ <option value="Dr Priyadarshini Rajamani">Dr Priyadarshini Rajamani</option>++ <option value="Global Health">Global Health</option>++ <option value="Dr Soumya Swaminathan">Dr Soumya Swaminathan</option>++ <option value="EPHFs">EPHFs</option>++ <option value="national public health workforce capacity">national public health workforce capacity</option>++ <option value="EPHFs (Emergency Public Health Functions)">EPHFs (Emergency Public Health Functions)</option>++ <option value="Ebola">Ebola</option>++ <option value="zoonotic disease">zoonotic disease</option>++ <option value="Economic efficiency">Economic efficiency</option>++ <option value="Mental Health as a Pathway to Health Equity">Mental Health as a Pathway to Health Equity</option>++ <option value="Economic productivity gains">Economic productivity gains</option>++ <option value="Effective treatments for all">Effective treatments for all</option>++ <option value="Equitable pricing and access">Equitable pricing and access</option>++ <option value="Equity in access to drugs and vaccines">Equity in access to drugs and vaccines</option>++ <option value="Essential Public Health Functiona (EPHF)">Essential Public Health Functiona (EPHF)</option>++ <option value="Investing in the Public Health Workforce">Investing in the Public Health Workforce</option>++ <option value="Global investment">Global investment</option>++ <option value="G7 and G20 intergovernmental processes">G7 and G20 intergovernmental processes</option>++ <option value="Essential health services">Essential health services</option>++ <option value="Event-based disease surveillance">Event-based disease surveillance</option>++ <option value="FRA">FRA</option>++ <option value="FY 2021-22">FY 2021-22</option>++ <option value="Fight against AMR">Fight against AMR</option>++ <option value="Financial incentives">Financial incentives</option>++ <option value="Five-Year Forward View for Mental Health">Five-Year Forward View for Mental Health</option>++ <option value="Food Insecurity">Food Insecurity</option>++ <option value="Food and Agriculture Organisation (FAO)">Food and Agriculture Organisation (FAO)</option>++ <option value="Quadripartite Collaboration for One Health">Quadripartite Collaboration for One Health</option>++ <option value="Food and Agriculture Organization">Food and Agriculture Organization</option>++ <option value="France">France</option>++ <option value="One Health approach in India">One Health approach in India</option>++ <option value="Office of the Principal Scientific Adviser (PSA)">Office of the Principal Scientific Adviser (PSA)</option>++ <option value="Public Health Outcomes">Public Health Outcomes</option>++ <option value="Life Expectancy">Life Expectancy</option>++ <option value="GDP">GDP</option>++ <option value="Global Average of Life Expectancy">Global Average of Life Expectancy</option>++ <option value="Role of Health Finance in G20 Countries">Role of Health Finance in G20 Countries</option>++ <option value="G20 Independent High-Level Panel">G20 Independent High-Level Panel</option>++ <option value="G20 Italia Declaration of Health Ministers">G20 Italia Declaration of Health Ministers</option>++ <option value="Global Health Summit">Global Health Summit</option>++ <option value="OH workforce">OH workforce</option>++ <option value="Integrated OH surveillance system">Integrated OH surveillance system</option>++ <option value="Routine and emergency coordination mechanisms">Routine and emergency coordination mechanisms</option>++ <option value="Standardised framework for addressing zoonotic spillover risks">Standardised framework for addressing zoonotic spillover risks</option>++ <option value="Urbanisation and habitat fragmentation">Urbanisation and habitat fragmentation</option>++ <option value="Spillover risks and disease spread">Spillover risks and disease spread</option>++ <option value="G20 support to invest in preparedness and national capacity">G20 support to invest in preparedness and national capacity</option>++ <option value="workforce capacity and readiness">workforce capacity and readiness</option>++ <option value="national assessments and benchmarking">national assessments and benchmarking</option>++ <option value="World Bank’s Pandemic Fund">World Bank’s Pandemic Fund</option>++ <option value="strengthening human resources">strengthening human resources</option>++ <option value="countries prevent, prepare for, and respond to health emergencies">countries prevent, prepare for, and respond to health emergencies</option>++ <option value="sustainable public health workforce capacity in LMICs">sustainable public health workforce capacity in LMICs</option>++ <option value="alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord">alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord</option>++ <option value="Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)">Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)</option>++ <option value="G7">G7</option>++ <option value="G7 Germany">G7 Germany</option>++ <option value="G7 Summit">G7 Summit</option>++ <option value="G7 and the G20">G7 and the G20</option>++ <option value="GP/family physician">GP/family physician</option>++ <option value="Gavi (Global Alliance for Vaccines and Immunization)">Gavi (Global Alliance for Vaccines and Immunization)</option>++ <option value="Gavi and WHO">Gavi and WHO</option>++ <option value="in-country delivery requirements">in-country delivery requirements</option>++ <option value="Imperial College London">Imperial College London</option>++ <option value="conditions">conditions</option>++ <option value="Gender Inequality">Gender Inequality</option>++ <option value="Germany">Germany</option>++ <option value="Global">Global</option>++ <option value="Global DPI Summit21">Global DPI Summit21</option>++ <option value="India's Digital Public Infrastructure Transformation Ecosystem">India's Digital Public Infrastructure Transformation Ecosystem</option>++ <option value="Global Digital Health Partnership (GDHP)">Global Digital Health Partnership (GDHP)</option>++ <option value="Global Early Warning and Response System for Major Animal Diseases">Global Early Warning and Response System for Major Animal Diseases</option>++ <option value="ecological connectivity">ecological connectivity</option>++ <option value="Pathways to Health Equity">Pathways to Health Equity</option>++ <option value="Infectious diseases">Infectious diseases</option>++ <option value="Surveillance systems">Surveillance systems</option>++ <option value="Global collaboration and solidarity">Global collaboration and solidarity</option>++ <option value="Nature">Nature</option>++ <option value="Health and well-being for all people everywhere">Health and well-being for all people everywhere</option>++ <option value="MS Swaminathan Research Foundation">MS Swaminathan Research Foundation</option>++ <option value="Global Health Initiatives">Global Health Initiatives</option>++ <option value="Rome Declaration">Rome Declaration</option>++ <option value="countries across the world">countries across the world</option>++ <option value="resources to deliver">resources to deliver</option>++ <option value="Panel for a Global Public Health Convention">Panel for a Global Public Health Convention</option>++ <option value="Global Strategy on Digital Health 2020-2025">Global Strategy on Digital Health 2020-2025</option>++ <option value="Global Vaccine Library">Global Vaccine Library</option>++ <option value="coronavirus">coronavirus</option>++ <option value="Global Vector Control Response (GVCR) 2017–2030">Global Vector Control Response (GVCR) 2017–2030</option>++ <option value="Global average">Global average</option>++ <option value="Global economic loss due to mental disorders">Global economic loss due to mental disorders</option>++ <option value="Global partners">Global partners</option>++ <option value="Governments pool funding">Governments pool funding</option>++ <option value="Green Highlighted Countries">Green Highlighted Countries</option>++ <option value="HIV infections">HIV infections</option>++ <option value="global health system">global health system</option>++ <option value="Health Equity Assessment Toolkit (HEAT and HEAT Plus)">Health Equity Assessment Toolkit (HEAT and HEAT Plus)</option>++ <option value="Out-of-Pocket Expenditure (OOPE)">Out-of-Pocket Expenditure (OOPE)</option>++ <option value="Indonesia">Indonesia</option>++ <option value="JKN National Health Insurance">JKN National Health Insurance</option>++ <option value="hospital-centric healthcare system">hospital-centric healthcare system</option>++ <option value="preventive model">preventive model</option>++ <option value="universal health care">universal health care</option>++ <option value="Singapore">Singapore</option>++ <option value="primary care">primary care</option>++ <option value="judicious purchasing and effective procurement">judicious purchasing and effective procurement</option>++ <option value="Health Management Information System">Health Management Information System</option>++ <option value="Health Sector">Health Sector</option>++ <option value="Healthcare Spending and Health Outcomes">Healthcare Spending and Health Outcomes</option>++ <option value="Healthcare providers">Healthcare providers</option>++ <option value="JKN program">JKN program</option>++ <option value="High-Income Countries">High-Income Countries</option>++ <option value="Higher % GDP Spending in Healthcare">Higher % GDP Spending in Healthcare</option>++ <option value="Hospital Management Information System">Hospital Management Information System</option>++ <option value="Human rights">Human rights</option>++ <option value="IDN">IDN</option>++ <option value="IDNIND">IDNIND</option>++ <option value="IHR">IHR</option>++ <option value="WGIHR">WGIHR</option>++ <option value="INDKOR">INDKOR</option>++ <option value="ITA">ITA</option>++ <option value="Improving population health">Improving population health</option>++ <option value="social inequality">social inequality</option>++ <option value="gender issues">gender issues</option>++ <option value="community participation">community participation</option>++ <option value="National Mental Health Programme – District Mental Health Programme (>700 districts)">National Mental Health Programme – District Mental Health Programme (>700 districts)</option>++ <option value="Online Registration System">Online Registration System</option>++ <option value="National tuberculosis elimination (Ni-kshay)">National tuberculosis elimination (Ni-kshay)</option>++ <option value="Mother and Child Tracking System">Mother and Child Tracking System</option>++ <option value="Mera Aspataal (My Hospital)">Mera Aspataal (My Hospital)</option>++ <option value="Integrated Health Information Platform">Integrated Health Information Platform</option>++ <option value="Non-Communicable Diseases screening application">Non-Communicable Diseases screening application</option>++ <option value="Ministry of Electronics and Information Technology (MeitY)">Ministry of Electronics and Information Technology (MeitY)</option>++ <option value="One Government">One Government</option>++ <option value="Unified Payments Interface (UPI)">Unified Payments Interface (UPI)</option>++ <option value="Open Credit Enablement Network">Open Credit Enablement Network</option>++ <option value="Private sector service delivery">Private sector service delivery</option>++ <option value="India's DPI">India's DPI</option>++ <option value="MeitY study">MeitY study</option>++ <option value="US$500 billion by 2025">US$500 billion by 2025</option>++ <option value="India's digital economy potential to US$1 trillion">India's digital economy potential to US$1 trillion</option>++ <option value="business as usual scenario">business as usual scenario</option>++ <option value="real-time payments in India, China, Brazil">real-time payments in India, China, Brazil</option>++ <option value="physical delivery of financial benefits">physical delivery of financial benefits</option>++ <option value="digital payment systems">digital payment systems</option>++ <option value="beneficiaries' bank accounts">beneficiaries' bank accounts</option>++ <option value="corruption, eliminating middlemen">corruption, eliminating middlemen</option>++ <option value="forums and platforms for stakeholders">forums and platforms for stakeholders</option>++ <option value="policy discussions and regulatory consultations">policy discussions and regulatory consultations</option>++ <option value="balanced regulatory policies">balanced regulatory policies</option>++ <option value="Indian regulators">Indian regulators</option>++ <option value="presentation of the Digital India Act 2023">presentation of the Digital India Act 2023</option>++ <option value="consumer needs, emerging technologies, and market trends">consumer needs, emerging technologies, and market trends</option>++ <option value="challenges">challenges</option>++ <option value="government agencies">government agencies</option>++ <option value="industry leaders">industry leaders</option>++ <option value="startups">startups</option>++ <option value="academia">academia</option>++ <option value="civil society organisations">civil society organisations</option>++ <option value="India’s G20 presidency">India’s G20 presidency</option>++ <option value="Indian Rupees (INR)">Indian Rupees (INR)</option>++ <option value="healthcare expenditure">healthcare expenditure</option>++ <option value="OOP payments">OOP payments</option>++ <option value="drug pricing and procurement">drug pricing and procurement</option>++ <option value="Indonesian citizens">Indonesian citizens</option>++ <option value="Inequality">Inequality</option>++ <option value="Innovative Financing Mechanisms">Innovative Financing Mechanisms</option>++ <option value="Manufacturers and the private sector">Manufacturers and the private sector</option>++ <option value="Poor diagnostic capacity">Poor diagnostic capacity</option>++ <option value="Intergovernmental Negotiating Body (INB)">Intergovernmental Negotiating Body (INB)</option>++ <option value="International Health Regulations (IHR)">International Health Regulations (IHR)</option>++ <option value="Investing in mental health">Investing in mental health</option>++ <option value="Investment in treatment of mental illness">Investment in treatment of mental illness</option>++ <option value="JKN">JKN</option>++ <option value="Social Security Agency for Health (B P J S)">Social Security Agency for Health (B P J S)</option>++ <option value="medical benefit package">medical benefit package</option>++ <option value="Out-of-pocket expenditure (OOP)">Out-of-pocket expenditure (OOP)</option>++ <option value="Low and medium-income countries (LMICs)">Low and medium-income countries (LMICs)</option>++ <option value="JPNDEU">JPNDEU</option>++ <option value="Jan Dhan-Aadhaar-Mobile Yojana">Jan Dhan-Aadhaar-Mobile Yojana</option>++ <option value="Japan">Japan</option>++ <option value="KSA KSAFRA">KSA KSAFRA</option>++ <option value="infectious diseases">infectious diseases</option>++ <option value="ZAFTURTUR">ZAFTURTUR</option>++ <option value="USAUSAJPN">USAUSAJPN</option>++ <option value="SPNITA">SPNITA</option>++ <option value="RUSMEX">RUSMEX</option>++ <option value="MEX">MEX</option>++ <option value="SGP">SGP</option>++ <option value="SGPCAN">SGPCAN</option>++ <option value="UKUK">UKUK</option>++ <option value="ZAF">ZAF</option>++ <option value="MERS">MERS</option>++ <option value="MHCA 2017">MHCA 2017</option>++ <option value="MediShield Life">MediShield Life</option>++ <option value="Widening coverage">Widening coverage</option>++ <option value="pre-existing conditions">pre-existing conditions</option>++ <option value="older individuals">older individuals</option>++ <option value="Memorandum of Understanding (MOU)">Memorandum of Understanding (MOU)</option>++ <option value="United Nations (UN)">United Nations (UN)</option>++ <option value="Sustainable Development Goals (SDGs)">Sustainable Development Goals (SDGs)</option>++ <option value="United Kingdom (UK)">United Kingdom (UK)</option>++ <option value="National Health Service (NHS)">National Health Service (NHS)</option>++ <option value="Public Health Domain">Public Health Domain</option>++ <option value="Mental Health Review Boards">Mental Health Review Boards</option>++ <option value="Social inequality">Social inequality</option>++ <option value="The Burden of Mental Health, Substance Use Disorders and Multimorbidity">The Burden of Mental Health, Substance Use Disorders and Multimorbidity</option>++ <option value="Mental and substance-abuse disorders">Mental and substance-abuse disorders</option>++ <option value="Premature morbidity and mortality globally">Premature morbidity and mortality globally</option>++ <option value="National Mental Health Survey (NMHS), 2015-16">National Mental Health Survey (NMHS), 2015-16</option>++ <option value="Mexico">Mexico</option>++ <option value="MyGov platform">MyGov platform</option>++ <option value="digital governance">digital governance</option>++ <option value="citizen-centricity">citizen-centricity</option>++ <option value="government interactions">government interactions</option>++ <option value="citizen-government gap">citizen-government gap</option>++ <option value="enhance government services">enhance government services</option>++ <option value="democratic participation">democratic participation</option>++ <option value="NGOs">NGOs</option>++ <option value="Netherlands">Netherlands</option>++ <option value="New legislation">New legislation</option>++ <option value="antibiotic">antibiotic</option>++ <option value="Nipah">Nipah</option>++ <option value="interpersonal relationships">interpersonal relationships</option>++ <option value="veterinary workforce">veterinary workforce</option>++ <option value="academic institutions">academic institutions</option>++ <option value="local population">local population</option>++ <option value="Tamil Nadu Veterinary and Animal Sciences University">Tamil Nadu Veterinary and Animal Sciences University</option>++ <option value="Tamil Nadu Dr MGR Medical University">Tamil Nadu Dr MGR Medical University</option>++ <option value="Punjab">Punjab</option>++ <option value="SARS-CoV2 vaccine trial">SARS-CoV2 vaccine trial</option>++ <option value="outbreak investigation">outbreak investigation</option>++ <option value="vaccine hesitancy">vaccine hesitancy</option>++ <option value="OTC sale of antimicrobials">OTC sale of antimicrobials</option>++ <option value="United Nations Environment Programme">United Nations Environment Programme</option>++ <option value="World Organisation for Animal Health">World Organisation for Animal Health</option>++ <option value="pandemic prevention, preparedness, and response">pandemic prevention, preparedness, and response</option>++ <option value="domestic health systems">domestic health systems</option>++ <option value="One Health High-Level Expert Panel">One Health High-Level Expert Panel</option>++ <option value="One Health Joint Plan of Action (2022-2026)">One Health Joint Plan of Action (2022-2026)</option>++ <option value="World Health Organisation (WHO)">World Health Organisation (WHO)</option>++ <option value="United Nations Environment Programme (UNEP)">United Nations Environment Programme (UNEP)</option>++ <option value="World Organisation for Animal Health (OIE)">World Organisation for Animal Health (OIE)</option>++ <option value="pandemic prevention and preparedness">pandemic prevention and preparedness</option>++ <option value="World Bank's US$10-billion fund">World Bank's US$10-billion fund</option>++ <option value="UN’s high-level meeting on pandemic prevention, preparedness, and response (September 2023)">UN’s high-level meeting on pandemic prevention, preparedness, and response (September 2023)</option>++ <option value="zoonoses and transboundary animal diseases">zoonoses and transboundary animal diseases</option>++ <option value="zonotic policy documents">zonotic policy documents</option>++ <option value="lack of supportive policies">lack of supportive policies</option>++ <option value="conflicting departmental priorities">conflicting departmental priorities</option>++ <option value="limited institutional capacities">limited institutional capacities</option>++ <option value="cross-sectoral collaboration on disease control">cross-sectoral collaboration on disease control</option>++ <option value="contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts">contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts</option>++ <option value="new vaccines">new vaccines</option>++ <option value="improved surveillance">improved surveillance</option>++ <option value="non-pharmaceutical interventions">non-pharmaceutical interventions</option>++ <option value="virus families">virus families</option>++ <option value="Out-of-Pocket Expenses">Out-of-Pocket Expenses</option>++ <option value="PPR">PPR</option>++ <option value="WHO's 194 member states">WHO's 194 member states</option>++ <option value="World Health Assembly (WHA)">World Health Assembly (WHA)</option>++ <option value="Working Group on amendments to the IHR (WGIHR)">Working Group on amendments to the IHR (WGIHR)</option>++ <option value="World Trade Organization">World Trade Organization</option>++ <option value="TRIPS waiver">TRIPS waiver</option>++ <option value="equity of access">equity of access</option>++ <option value="Pandemic Accord and the IHR">Pandemic Accord and the IHR</option>++ <option value="financing">financing</option>++ <option value="annual financing need for future preparedness and response to pandemics">annual financing need for future preparedness and response to pandemics</option>++ <option value="Pradhan Mantri Jan-Dhan Yojana">Pradhan Mantri Jan-Dhan Yojana</option>++ <option value="Public Health System">Public Health System</option>++ <option value="Routine immunisation">Routine immunisation</option>++ <option value="occupations outside of the health sector">occupations outside of the health sector</option>++ <option value="roadmap and action plan">roadmap and action plan</option>++ <option value="standard EPHF">standard EPHF</option>++ <option value="whole-of-government and whole-of-society approach">whole-of-government and whole-of-society approach</option>++ <option value="national stakeholders">national stakeholders</option>++ <option value="existing national and global networks of partners">existing national and global networks of partners</option>++ <option value="country-based assessment">country-based assessment</option>++ <option value="policy improvement">policy improvement</option>++ <option value="Public health and emergency workforce roadmap">Public health and emergency workforce roadmap</option>++ <option value="R&D">R&D</option>++ <option value="recommendations">recommendations</option>++ <option value="supply">supply</option>++ <option value="demand">demand</option>++ <option value="manufacturing">manufacturing</option>++ <option value="country-level challenges">country-level challenges</option>++ <option value="other factors">other factors</option>++ <option value="at-risk investments">at-risk investments</option>++ <option value="funding">funding</option>++ <option value="R&D stage">R&D stage</option>++ <option value="RSV">RSV</option>++ <option value="healthcare structure">healthcare structure</option>++ <option value="Universal Health Care Coverage">Universal Health Care Coverage</option>++ <option value="WHO Data">WHO Data</option>++ <option value="Russia">Russia</option>++ <option value="SARS">SARS</option>++ <option value="South Africa">South Africa</option>++ <option value="South Korea">South Korea</option>++ <option value="Spain">Spain</option>++ <option value="Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal">Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal</option>++ <option value="Success in getting mRNA vaccine manufacturing underway in South Africa">Success in getting mRNA vaccine manufacturing underway in South Africa</option>++ <option value="World Mental Health Day">World Mental Health Day</option>++ <option value="tele-mental health services">tele-mental health services</option>++ <option value="remote and underserved areas">remote and underserved areas</option>++ <option value="Telephone/mobile based initiatives">Telephone/mobile based initiatives</option>++ <option value="eSanjeevani">eSanjeevani</option>++ <option value="e-Manas Karnataka">e-Manas Karnataka</option>++ <option value="Tele-MANAS programme">Tele-MANAS programme</option>++ <option value="evidence-based integration">evidence-based integration</option>++ <option value="Tele-education in medical education for remote areas">Tele-education in medical education for remote areas</option>++ <option value="The Urgent Need for a Pandemic Accord">The Urgent Need for a Pandemic Accord</option>++ <option value="Turkiye">Turkiye</option>++ <option value="national policies">national policies</option>++ <option value="healthcare providers">healthcare providers</option>++ <option value="public and private hospitals">public and private hospitals</option>++ <option value="clinics and facilities">clinics and facilities</option>++ <option value="healthcare infrastructure">healthcare infrastructure</option>++ <option value="disparities in healthcare infrastructure">disparities in healthcare infrastructure</option>++ <option value="UK">UK</option>++ <option value="UPI">UPI</option>++ <option value="United Nations Children’s Fund (UNICEF)">United Nations Children’s Fund (UNICEF)</option>++ <option value="United States">United States</option>++ <option value="WHO norms, standards, and">WHO norms, standards, and</option>++ <option value="digital public goods">digital public goods</option>++ <option value="World Federation of Public Health Associations (WFPHA), International">World Federation of Public Health Associations (WFPHA), International</option>++ <option value="healthcare service delivery">healthcare service delivery</option>++ <option value="World Mental Health Report, 2022">World Mental Health Report, 2022</option>++ <option value="interrelated services">interrelated services</option>++ <option value="life cycle">life cycle</option>++ <option value="maternal and child mental health">maternal and child mental health</option>++ <option value="elderly">elderly</option>++ <option value="abdm.gov.in">abdm.gov.in</option>++ <option value="access to healthcare services">access to healthcare services</option>++ <option value="differences among them">differences among them</option>++ <option value="wider spread of manufacturing">wider spread of manufacturing</option>++ <option value="manufacturing for the whole continent and globally">manufacturing for the whole continent and globally</option>++ <option value="financial investment">financial investment</option>++ <option value="technology transfer">technology transfer</option>++ <option value="pharmaceutical industry">pharmaceutical industry</option>++ <option value="technology transfer and the associated question of intellectual property rights">technology transfer and the associated question of intellectual property rights</option>++ <option value="wealthier governments funding R&D">wealthier governments funding R&D</option>++ <option value="companies earmark a percentage of vaccines for the poorer countries or sell to them at cost">companies earmark a percentage of vaccines for the poorer countries or sell to them at cost</option>++ <option value="addressing social and economic inequalities">addressing social and economic inequalities</option>++ <option value="advancements in computational">advancements in computational</option>++ <option value="agriculture sector">agriculture sector</option>++ <option value="ancillary supplies">ancillary supplies</option>++ <option value="life-saving equipment">life-saving equipment</option>++ <option value="animals">animals</option>++ <option value="patients">patients</option>++ <option value="stricter antibiotic prescription and consumption measures">stricter antibiotic prescription and consumption measures</option>++ <option value="antimicrobial drug development process">antimicrobial drug development process</option>++ <option value="antibiotic market">antibiotic market</option>++ <option value="development of new antibacterial treatments">development of new antibacterial treatments</option>++ <option value="antileprotic drug resistance">antileprotic drug resistance</option>++ <option value="antimicrobial resistance">antimicrobial resistance</option>++ <option value="artemisinin-based combination therapy-resistance">artemisinin-based combination therapy-resistance</option>++ <option value="avian influenza">avian influenza</option>++ <option value="big pharmaceutical companies">big pharmaceutical companies</option>++ <option value="bilateral customers">bilateral customers</option>++ <option value="biodiversity">biodiversity</option>++ <option value="infectious disease">infectious disease</option>++ <option value="epidemic">epidemic</option>++ <option value="prevent">prevent</option>++ <option value="checks and balances">checks and balances</option>++ <option value="cold chain">cold chain</option>++ <option value="consistent policy guidance">consistent policy guidance</option>++ <option value="record time">record time</option>++ <option value="esanjeevani.mohfw.gov.in">esanjeevani.mohfw.gov.in</option>++ <option value="spike protein">spike protein</option>++ <option value="neutralising antibodies">neutralising antibodies</option>++ <option value="countries lacking infrastructure">countries lacking infrastructure</option>++ <option value="cultural acceptance">cultural acceptance</option>++ <option value="dairy products">dairy products</option>++ <option value="dangerous and deadly outbreaks">dangerous and deadly outbreaks</option>++ <option value="global community">global community</option>++ <option value="delivery of mental healthcare">delivery of mental healthcare</option>++ <option value="destruction of natural habitats">destruction of natural habitats</option>++ <option value="developing countries">developing countries</option>++ <option value="emerging threat of AMR">emerging threat of AMR</option>++ <option value="return on investment for new antibiotics">return on investment for new antibiotics</option>++ <option value="small or micro biotech firms">small or micro biotech firms</option>++ <option value="novel reimbursement models">novel reimbursement models</option>++ <option value="diagnostic capacity">diagnostic capacity</option>++ <option value="digital health infrastructure">digital health infrastructure</option>++ <option value="direct benefit transfer (DBT) in India">direct benefit transfer (DBT) in India</option>++ <option value="disadvantaged populations">disadvantaged populations</option>++ <option value="drug procurement">drug procurement</option>++ <option value="state-owned enterprises">state-owned enterprises</option>++ <option value="generic medications">generic medications</option>++ <option value="drug-resistant Tuberculosis">drug-resistant Tuberculosis</option>++ <option value="e-governance">e-governance</option>++ <option value="e-governance platforms">e-governance platforms</option>++ <option value="early R&D">early R&D</option>++ <option value="vector-borne diseases">vector-borne diseases</option>++ <option value="eggs">eggs</option>++ <option value="emergency preparedness and response">emergency preparedness and response</option>++ <option value="ethnicity">ethnicity</option>++ <option value="public health system">public health system</option>++ <option value="primary healthcare">primary healthcare</option>++ <option value="referral pathways">referral pathways</option>++ <option value="mental care">mental care</option>++ <option value="physical care">physical care</option>++ <option value="robust information systems">robust information systems</option>++ <option value="mental and physical care integration">mental and physical care integration</option>++ <option value="exemptions and waivers">exemptions and waivers</option>++ <option value="family members">family members</option>++ <option value="financial incentives">financial incentives</option>++ <option value="gender">gender</option>++ <option value="general health services">general health services</option>++ <option value="public awareness campaigns">public awareness campaigns</option>++ <option value="geographic location">geographic location</option>++ <option value="health security">health security</option>++ <option value="pandemic threats">pandemic threats</option>++ <option value="incipient pandemic">incipient pandemic</option>++ <option value="potential opponents">potential opponents</option>++ <option value="viruses from around 25 viral families">viruses from around 25 viral families</option>++ <option value="global health agencies">global health agencies</option>++ <option value="zoonotic diseases">zoonotic diseases</option>++ <option value="pathogens">pathogens</option>++ <option value="urbanisation">urbanisation</option>++ <option value="illegal trade in wildlife">illegal trade in wildlife</option>++ <option value="global increase in climate-related and humanitarian disasters">global increase in climate-related and humanitarian disasters</option>++ <option value="government unified and dedicated online learning and training platform SAKSHAM">government unified and dedicated online learning and training platform SAKSHAM</option>++ <option value="health disparities">health disparities</option>++ <option value="health emergencies">health emergencies</option>++ <option value="health emergency">health emergency</option>++ <option value="socioeconomic status">socioeconomic status</option>++ <option value="race">race</option>++ <option value="redistributing resources">redistributing resources</option>++ <option value="targeted healthcare programs">targeted healthcare programs</option>++ <option value="improving access to quality healthcare services">improving access to quality healthcare services</option>++ <option value="promoting health education and prevention">promoting health education and prevention</option>++ <option value="health insurance">health insurance</option>++ <option value="health systems">health systems</option>++ <option value="healthcare resources">healthcare resources</option>++ <option value="high-income countries">high-income countries</option>++ <option value="humanitarian situations">humanitarian situations</option>++ <option value="inclusive capacity building of health professionals">inclusive capacity building of health professionals</option>++ <option value="online platforms, video conferencing, pre-recorded lectures">online platforms, video conferencing, pre-recorded lectures</option>++ <option value="personal protective equipment for healthcare workers">personal protective equipment for healthcare workers</option>++ <option value="vulnerable populations">vulnerable populations</option>++ <option value="quality and efficiency">quality and efficiency</option>++ <option value="integration of healthcare programmes">integration of healthcare programmes</option>++ <option value="overall healthcare service delivery">overall healthcare service delivery</option>++ <option value="transformation of the healthcare situation in the country">transformation of the healthcare situation in the country</option>++ <option value="international cooperation">international cooperation</option>++ <option value="international freight and logistics">international freight and logistics</option>++ <option value="trade barriers">trade barriers</option>++ <option value="life-saving medical countermeasures and materials">life-saving medical countermeasures and materials</option>++ <option value="low- and middle-income countries">low- and middle-income countries</option>++ <option value="vaccinations">vaccinations</option>++ <option value="strong, reliable health systems">strong, reliable health systems</option>++ <option value="scaling-up manufacturing">scaling-up manufacturing</option>++ <option value="securing deals">securing deals</option>++ <option value="operational, logistical, regulatory, and legal frameworks">operational, logistical, regulatory, and legal frameworks</option>++ <option value="safe injection equipment">safe injection equipment</option>++ <option value="mental health issues, including burnout">mental health issues, including burnout</option>++ <option value="poor working conditions">poor working conditions</option>++ <option value="protracted conflicts">protracted conflicts</option>++ <option value="public health crisis">public health crisis</option>++ <option value="reversals in life expectancy and Sustainable Development Goals">reversals in life expectancy and Sustainable Development Goals</option>++ <option value="meat handling">meat handling</option>++ <option value="parity for mental illness">parity for mental illness</option>++ <option value="physical conditions">physical conditions</option>++ <option value="persons with mental illness">persons with mental illness</option>++ <option value="roadmap">roadmap</option>++ <option value="public health workforce">public health workforce</option>++ <option value="pharmaceutical sector">pharmaceutical sector</option>++ <option value="vaccines, therapeutics, diagnostics">vaccines, therapeutics, diagnostics</option>++ <option value="vaccine makers">vaccine makers</option>++ <option value="regulatory frameworks">regulatory frameworks</option>++ <option value="vegetables">vegetables</option>++ </select>+ </div>+ <div class="col-2 pb-2">+ <button type="button" class="btn btn-primary btn-block" onclick="neighbourhoodHighlight({nodes: []});">Reset Selection</button>+ </div>+ </div>+ </div>+++ <div id="mynetwork" class="card-body"></div>+ </div>+++ <div id="loadingBar">+ <div class="outerBorder">+ <div id="text">0%</div>+ <div id="border">+ <div id="bar"></div>+ </div>+ </div>+ </div>+++ <div id="config"></div>+++ <script type="text/javascript">++ // initialize global variables.+ var edges;+ var nodes;+ var allNodes;+ var allEdges;+ var nodeColors;+ var originalNodes;+ var network;+ var container;+ var options, data;+ var filter = {+ item : '',+ property : '',+ value : []+ };+++ new TomSelect("#select-node",{+ create: false,+ sortField: {+ field: "text",+ direction: "asc"+ }+ });+++++ // This method is responsible for drawing the graph, returns the drawn network+ function drawGraph() {+ var container = document.getElementById('mynetwork');++++ // parsing and collecting nodes and edges from the python+ nodes = new vis.DataSet([{"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": " Member states", "label": " Member states", "shape": "dot", "size": 32, "title": " Member states"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "access to vaccines, drugs, and other medical equipment", "label": "access to vaccines, drugs, and other medical equipment", "shape": "dot", "size": 40, "title": "access to vaccines, drugs, and other medical equipment"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "10 million deaths", "label": "10 million deaths", "shape": "dot", "size": 24, "title": "10 million deaths"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Antimicrobial Resistance (AMR)", "label": "Antimicrobial Resistance (AMR)", "shape": "dot", "size": 40, "title": "Antimicrobial Resistance (AMR)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "100 Days Mission", "label": "100 Days Mission", "shape": "dot", "size": 24, "title": "100 Days Mission"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "One World Vaccine Library", "label": "One World Vaccine Library", "shape": "dot", "size": 40, "title": "One World Vaccine Library"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "150,000 Health and Wellness Centres (HWC)", "label": "150,000 Health and Wellness Centres (HWC)", "shape": "dot", "size": 24, "title": "150,000 Health and Wellness Centres (HWC)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "label": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "shape": "dot", "size": 40, "title": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "191 countries", "label": "191 countries", "shape": "dot", "size": 16, "title": "191 countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccine nationalism", "label": "vaccine nationalism", "shape": "dot", "size": 40, "title": "vaccine nationalism"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVAX Facility", "label": "COVAX Facility", "shape": "dot", "size": 38, "title": "COVAX Facility"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccines", "label": "vaccines", "shape": "dot", "size": 39, "title": "vaccines"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVID-19 vaccines", "label": "COVID-19 vaccines", "shape": "dot", "size": 40, "title": "COVID-19 vaccines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "2004 prices", "label": "2004 prices", "shape": "dot", "size": 24, "title": "2004 prices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Accelerating Global Health", "label": "Accelerating Global Health", "shape": "dot", "size": 39, "title": "Accelerating Global Health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "generic medicine pricing policy", "label": "generic medicine pricing policy", "shape": "dot", "size": 40, "title": "generic medicine pricing policy"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "2008 attempt to operationalise the OH approach for zoonotic disease control and prevention", "label": "2008 attempt to operationalise the OH approach for zoonotic disease control and prevention", "shape": "dot", "size": 24, "title": "2008 attempt to operationalise the OH approach for zoonotic disease control and prevention"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "One Health", "label": "One Health", "shape": "dot", "size": 38, "title": "One Health"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "2009", "label": "2009", "shape": "dot", "size": 8, "title": "2009"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "label": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "shape": "dot", "size": 40, "title": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "2010 prices", "label": "2010 prices", "shape": "dot", "size": 24, "title": "2010 prices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "2010 study", "label": "2010 study", "shape": "dot", "size": 32, "title": "2010 study"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "2050", "label": "2050", "shape": "dot", "size": 32, "title": "2050"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "27 July 2023", "label": "27 July 2023", "shape": "dot", "size": 16, "title": "27 July 2023"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "consultations", "label": "consultations", "shape": "dot", "size": 40, "title": "consultations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "420,000 die each year", "label": "420,000 die each year", "shape": "dot", "size": 16, "title": "420,000 die each year"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Pathways to Health Equity for the G20", "label": "Pathways to Health Equity for the G20", "shape": "dot", "size": 38, "title": "Pathways to Health Equity for the G20"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "600 million people are affected by food-borne diseases", "label": "600 million people are affected by food-borne diseases", "shape": "dot", "size": 24, "title": "600 million people are affected by food-borne diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "ABDM ecosystem", "label": "ABDM ecosystem", "shape": "dot", "size": 32, "title": "ABDM ecosystem"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Resilient Digital Health Ecosystem", "label": "Resilient Digital Health Ecosystem", "shape": "dot", "size": 40, "title": "Resilient Digital Health Ecosystem"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "ABHA numbers", "label": "ABHA numbers", "shape": "dot", "size": 32, "title": "ABHA numbers"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "AI assistant for frontline workers in 11 Indian languages", "label": "AI assistant for frontline workers in 11 Indian languages", "shape": "dot", "size": 32, "title": "AI assistant for frontline workers in 11 Indian languages"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "impending disease outbreak", "label": "impending disease outbreak", "shape": "dot", "size": 40, "title": "impending disease outbreak"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "AI in healthcare", "label": "AI in healthcare", "shape": "dot", "size": 32, "title": "AI in healthcare"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "AMR", "label": "AMR", "shape": "dot", "size": 39, "title": "AMR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Interventions", "label": "Interventions", "shape": "dot", "size": 24, "title": "Interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Antimicrobials", "label": "Antimicrobials", "shape": "dot", "size": 32, "title": "Antimicrobials"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Healthcare Systems", "label": "Healthcare Systems", "shape": "dot", "size": 24, "title": "Healthcare Systems"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Patient Outcomes", "label": "Patient Outcomes", "shape": "dot", "size": 32, "title": "Patient Outcomes"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health Equity", "label": "Health Equity", "shape": "dot", "size": 28, "title": "Health Equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Essay", "label": "Essay", "shape": "dot", "size": 16, "title": "Essay"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Ranga Reddy Burri", "label": "Ranga Reddy Burri", "shape": "dot", "size": 8, "title": "Ranga Reddy Burri"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Robert Skov", "label": "Robert Skov", "shape": "dot", "size": 8, "title": "Robert Skov"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Bulagonda Eswarappa Pradeep", "label": "Bulagonda Eswarappa Pradeep", "shape": "dot", "size": 8, "title": "Bulagonda Eswarappa Pradeep"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Ralf Sudbrak", "label": "Ralf Sudbrak", "shape": "dot", "size": 8, "title": "Ralf Sudbrak"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "LMICs", "label": "LMICs", "shape": "dot", "size": 30, "title": "LMICs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vulnerable populations in HICs", "label": "vulnerable populations in HICs", "shape": "dot", "size": 32, "title": "vulnerable populations in HICs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antimicrobials pipeline", "label": "antimicrobials pipeline", "shape": "dot", "size": 24, "title": "antimicrobials pipeline"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "industry leaving the field of antimicrobial drug discovery", "label": "industry leaving the field of antimicrobial drug discovery", "shape": "dot", "size": 32, "title": "industry leaving the field of antimicrobial drug discovery"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "AMR pandemic", "label": "AMR pandemic", "shape": "dot", "size": 40, "title": "AMR pandemic"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "consequences of AMR", "label": "consequences of AMR", "shape": "dot", "size": 32, "title": "consequences of AMR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "need for increased action", "label": "need for increased action", "shape": "dot", "size": 40, "title": "need for increased action"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "multifaceted effort", "label": "multifaceted effort", "shape": "dot", "size": 32, "title": "multifaceted effort"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "reducing the circulation and spread of existing resistant microorganisms", "label": "reducing the circulation and spread of existing resistant microorganisms", "shape": "dot", "size": 24, "title": "reducing the circulation and spread of existing resistant microorganisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "increase of novel resistance mechanisms", "label": "increase of novel resistance mechanisms", "shape": "dot", "size": 32, "title": "increase of novel resistance mechanisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "lowering the overall use of antimicrobials", "label": "lowering the overall use of antimicrobials", "shape": "dot", "size": 24, "title": "lowering the overall use of antimicrobials"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antimicrobial stewardship", "label": "antimicrobial stewardship", "shape": "dot", "size": 32, "title": "antimicrobial stewardship"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "accessibility of affordable and timely diagnostics", "label": "accessibility of affordable and timely diagnostics", "shape": "dot", "size": 24, "title": "accessibility of affordable and timely diagnostics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "strengthening IPC and biosecurity procedures", "label": "strengthening IPC and biosecurity procedures", "shape": "dot", "size": 24, "title": "strengthening IPC and biosecurity procedures"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "AMR (Antimicrobial Resistance)", "label": "AMR (Antimicrobial Resistance)", "shape": "dot", "size": 40, "title": "AMR (Antimicrobial Resistance)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Quadripartite", "label": "Quadripartite", "shape": "dot", "size": 24, "title": "Quadripartite"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "One Health approach", "label": "One Health approach", "shape": "dot", "size": 24, "title": "One Health approach"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Action Plans (NAPs)", "label": "National Action Plans (NAPs)", "shape": "dot", "size": 24, "title": "National Action Plans (NAPs)"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "ARG ARG", "label": "ARG ARG", "shape": "dot", "size": 8, "title": "ARG ARG"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "ASHAs", "label": "ASHAs", "shape": "dot", "size": 16, "title": "ASHAs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "OH approach", "label": "OH approach", "shape": "dot", "size": 40, "title": "OH approach"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "AUSSPN", "label": "AUSSPN", "shape": "dot", "size": 16, "title": "AUSSPN"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Aadhaar", "label": "Aadhaar", "shape": "dot", "size": 24, "title": "Aadhaar"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "technology", "label": "technology", "shape": "dot", "size": 38, "title": "technology"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Aadhaar-based e-KYC", "label": "Aadhaar-based e-KYC", "shape": "dot", "size": 24, "title": "Aadhaar-based e-KYC"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "India Stack", "label": "India Stack", "shape": "dot", "size": 40, "title": "India Stack"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Aadhaar-based eSign", "label": "Aadhaar-based eSign", "shape": "dot", "size": 24, "title": "Aadhaar-based eSign"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Accelerating Efforts to Combat AMR", "label": "Accelerating Efforts to Combat AMR", "shape": "dot", "size": 24, "title": "Accelerating Efforts to Combat AMR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Battle Against Antimicrobial Resistance", "label": "Battle Against Antimicrobial Resistance", "shape": "dot", "size": 40, "title": "Battle Against Antimicrobial Resistance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Combating AMR", "label": "Combating AMR", "shape": "dot", "size": 40, "title": "Combating AMR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Integrating Mental Health into General Healthcare", "label": "Integrating Mental Health into General Healthcare", "shape": "dot", "size": 40, "title": "Integrating Mental Health into General Healthcare"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Poverty", "label": "Poverty", "shape": "dot", "size": 29, "title": "Poverty"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental Health", "label": "Mental Health", "shape": "dot", "size": 40, "title": "Mental Health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Biological Determinants", "label": "Biological Determinants", "shape": "dot", "size": 32, "title": "Biological Determinants"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Psychological Determinants", "label": "Psychological Determinants", "shape": "dot", "size": 32, "title": "Psychological Determinants"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Social Determinants", "label": "Social Determinants", "shape": "dot", "size": 32, "title": "Social Determinants"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Depression", "label": "Depression", "shape": "dot", "size": 24, "title": "Depression"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Substance Use Disorders", "label": "Substance Use Disorders", "shape": "dot", "size": 24, "title": "Substance Use Disorders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Behavioural Addictions", "label": "Behavioural Addictions", "shape": "dot", "size": 24, "title": "Behavioural Addictions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Severe Mental Illness (SMI)", "label": "Severe Mental Illness (SMI)", "shape": "dot", "size": 24, "title": "Severe Mental Illness (SMI)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Schizophrenia", "label": "Schizophrenia", "shape": "dot", "size": 16, "title": "Schizophrenia"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Bipolar Mood Disorder", "label": "Bipolar Mood Disorder", "shape": "dot", "size": 16, "title": "Bipolar Mood Disorder"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental Health Care Act, 2017", "label": "Mental Health Care Act, 2017", "shape": "dot", "size": 24, "title": "Mental Health Care Act, 2017"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "reported violations", "label": "reported violations", "shape": "dot", "size": 16, "title": "reported violations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "rejections of claims for mental illness by insurance companies", "label": "rejections of claims for mental illness by insurance companies", "shape": "dot", "size": 24, "title": "rejections of claims for mental illness by insurance companies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "discriminatory ceilings on the sum of reimbursement for mental illness", "label": "discriminatory ceilings on the sum of reimbursement for mental illness", "shape": "dot", "size": 16, "title": "discriminatory ceilings on the sum of reimbursement for mental illness"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "people with serious mental illness (SMI)", "label": "people with serious mental illness (SMI)", "shape": "dot", "size": 24, "title": "people with serious mental illness (SMI)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "shortened life expectancy", "label": "shortened life expectancy", "shape": "dot", "size": 16, "title": "shortened life expectancy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "multimorbidity", "label": "multimorbidity", "shape": "dot", "size": 28, "title": "multimorbidity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "non-communicable diseases (NCDs)", "label": "non-communicable diseases (NCDs)", "shape": "dot", "size": 16, "title": "non-communicable diseases (NCDs)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "tobacco and alcohol use", "label": "tobacco and alcohol use", "shape": "dot", "size": 16, "title": "tobacco and alcohol use"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "physical inactivity", "label": "physical inactivity", "shape": "dot", "size": 16, "title": "physical inactivity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "poor diets", "label": "poor diets", "shape": "dot", "size": 16, "title": "poor diets"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "national programs to address chronic conditions", "label": "national programs to address chronic conditions", "shape": "dot", "size": 24, "title": "national programs to address chronic conditions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "chronic conditions", "label": "chronic conditions", "shape": "dot", "size": 16, "title": "chronic conditions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "poor horizontal integration across the programmes", "label": "poor horizontal integration across the programmes", "shape": "dot", "size": 24, "title": "poor horizontal integration across the programmes"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "homeless persons", "label": "homeless persons", "shape": "dot", "size": 16, "title": "homeless persons"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "women", "label": "women", "shape": "dot", "size": 16, "title": "women"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "persons with developmental disorders", "label": "persons with developmental disorders", "shape": "dot", "size": 16, "title": "persons with developmental disorders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Psychotropic medications", "label": "Psychotropic medications", "shape": "dot", "size": 24, "title": "Psychotropic medications"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental Health Policy (2014)", "label": "Mental Health Policy (2014)", "shape": "dot", "size": 32, "title": "Mental Health Policy (2014)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "digital academies at NIMHANS", "label": "digital academies at NIMHANS", "shape": "dot", "size": 24, "title": "digital academies at NIMHANS"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "m-Cessation", "label": "m-Cessation", "shape": "dot", "size": 16, "title": "m-Cessation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "tobacco quit-lines", "label": "tobacco quit-lines", "shape": "dot", "size": 16, "title": "tobacco quit-lines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)", "label": "National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)", "shape": "dot", "size": 32, "title": "National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Improvements in curative and preventive care domains", "label": "Improvements in curative and preventive care domains", "shape": "dot", "size": 32, "title": "Improvements in curative and preventive care domains"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Rehabilitative care", "label": "Rehabilitative care", "shape": "dot", "size": 24, "title": "Rehabilitative care"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Mental Health Policy 2014", "label": "National Mental Health Policy 2014", "shape": "dot", "size": 32, "title": "National Mental Health Policy 2014"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Vulnerable populations", "label": "Vulnerable populations", "shape": "dot", "size": 24, "title": "Vulnerable populations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Children", "label": "Children", "shape": "dot", "size": 16, "title": "Children"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Elderly", "label": "Elderly", "shape": "dot", "size": 16, "title": "Elderly"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Homeless", "label": "Homeless", "shape": "dot", "size": 16, "title": "Homeless"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Macro-environmental issues", "label": "Macro-environmental issues", "shape": "dot", "size": 32, "title": "Macro-environmental issues"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Unemployment", "label": "Unemployment", "shape": "dot", "size": 24, "title": "Unemployment"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Displacement", "label": "Displacement", "shape": "dot", "size": 16, "title": "Displacement"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental health impact of climate change", "label": "Mental health impact of climate change", "shape": "dot", "size": 24, "title": "Mental health impact of climate change"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Leadership and governance", "label": "Leadership and governance", "shape": "dot", "size": 24, "title": "Leadership and governance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "one health", "label": "one health", "shape": "dot", "size": 32, "title": "one health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "zoonoses", "label": "zoonoses", "shape": "dot", "size": 24, "title": "zoonoses"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "wet markets", "label": "wet markets", "shape": "dot", "size": 18, "title": "wet markets"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Joint Plan of Action", "label": "Joint Plan of Action", "shape": "dot", "size": 24, "title": "Joint Plan of Action"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "equity", "label": "equity", "shape": "dot", "size": 32, "title": "equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "procurement, distribution, administration of COVID-19 vaccines", "label": "procurement, distribution, administration of COVID-19 vaccines", "shape": "dot", "size": 40, "title": "procurement, distribution, administration of COVID-19 vaccines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "COVID-19 pandemic", "label": "COVID-19 pandemic", "shape": "dot", "size": 37, "title": "COVID-19 pandemic"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "novel paramyxovirus", "label": "novel paramyxovirus", "shape": "dot", "size": 24, "title": "novel paramyxovirus"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Water-borne diseases", "label": "Water-borne diseases", "shape": "dot", "size": 24, "title": "Water-borne diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Drinking or coming in contact with contaminated water", "label": "Drinking or coming in contact with contaminated water", "shape": "dot", "size": 16, "title": "Drinking or coming in contact with contaminated water"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Faecal-contaminated water", "label": "Faecal-contaminated water", "shape": "dot", "size": 16, "title": "Faecal-contaminated water"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Two billion people globally", "label": "Two billion people globally", "shape": "dot", "size": 24, "title": "Two billion people globally"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Cholera, dysentery, typhoid and polio", "label": "Cholera, dysentery, typhoid and polio", "shape": "dot", "size": 16, "title": "Cholera, dysentery, typhoid and polio"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Around 485,000 deaths every year", "label": "Around 485,000 deaths every year", "shape": "dot", "size": 24, "title": "Around 485,000 deaths every year"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Food-borne diseases", "label": "Food-borne diseases", "shape": "dot", "size": 16, "title": "Food-borne diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Over 200 diseases", "label": "Over 200 diseases", "shape": "dot", "size": 8, "title": "Over 200 diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Chemical substances such as unpasteurised (raw) milk", "label": "Chemical substances such as unpasteurised (raw) milk", "shape": "dot", "size": 8, "title": "Chemical substances such as unpasteurised (raw) milk"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Undercooked meat or eggs", "label": "Undercooked meat or eggs", "shape": "dot", "size": 8, "title": "Undercooked meat or eggs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Raw fruits and vegetables", "label": "Raw fruits and vegetables", "shape": "dot", "size": 8, "title": "Raw fruits and vegetables"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Healthy life years lost", "label": "Healthy life years lost", "shape": "dot", "size": 8, "title": "Healthy life years lost"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Access to adequate safe and nutritious food", "label": "Access to adequate safe and nutritious food", "shape": "dot", "size": 16, "title": "Access to adequate safe and nutritious food"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "One Health\u2019", "label": "One Health\u2019", "shape": "dot", "size": 24, "title": "One Health\u2019"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Operationalising \u2018One Health\u2019", "label": "Operationalising \u2018One Health\u2019", "shape": "dot", "size": 24, "title": "Operationalising \u2018One Health\u2019"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Building a Resilient Digital Health Ecosystem in India", "label": "Building a Resilient Digital Health Ecosystem in India", "shape": "dot", "size": 24, "title": "Building a Resilient Digital Health Ecosystem in India"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Lav Agarwal", "label": "Lav Agarwal", "shape": "dot", "size": 16, "title": "Lav Agarwal"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "communication", "label": "communication", "shape": "dot", "size": 32, "title": "communication"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "transportation", "label": "transportation", "shape": "dot", "size": 24, "title": "transportation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "healthcare", "label": "healthcare", "shape": "dot", "size": 40, "title": "healthcare"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "electronic health records", "label": "electronic health records", "shape": "dot", "size": 24, "title": "electronic health records"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "artificial intelligence", "label": "artificial intelligence", "shape": "dot", "size": 32, "title": "artificial intelligence"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "wearable devices", "label": "wearable devices", "shape": "dot", "size": 24, "title": "wearable devices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "health apps", "label": "health apps", "shape": "dot", "size": 16, "title": "health apps"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "CoWIN", "label": "CoWIN", "shape": "dot", "size": 32, "title": "CoWIN"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "COVID-19 \u0027war rooms\u0027", "label": "COVID-19 \u0027war rooms\u0027", "shape": "dot", "size": 24, "title": "COVID-19 \u0027war rooms\u0027"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "digital health initiatives", "label": "digital health initiatives", "shape": "dot", "size": 32, "title": "digital health initiatives"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "COVID-19 India Portal", "label": "COVID-19 India Portal", "shape": "dot", "size": 24, "title": "COVID-19 India Portal"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "marginalised communities", "label": "marginalised communities", "shape": "dot", "size": 32, "title": "marginalised communities"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "India", "label": "India", "shape": "dot", "size": 38, "title": "India"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "digital inclusion", "label": "digital inclusion", "shape": "dot", "size": 24, "title": "digital inclusion"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "urban telephone subscribers", "label": "urban telephone subscribers", "shape": "dot", "size": 16, "title": "urban telephone subscribers"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "gender gap in mobile ownership", "label": "gender gap in mobile ownership", "shape": "dot", "size": 24, "title": "gender gap in mobile ownership"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "India\u0027s digital infrastructure", "label": "India\u0027s digital infrastructure", "shape": "dot", "size": 32, "title": "India\u0027s digital infrastructure"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "intermediaries (digital media, e-commerce)", "label": "intermediaries (digital media, e-commerce)", "shape": "dot", "size": 16, "title": "intermediaries (digital media, e-commerce)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "connectivity to cause harm or commit crimes", "label": "connectivity to cause harm or commit crimes", "shape": "dot", "size": 24, "title": "connectivity to cause harm or commit crimes"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "comprehensive measures", "label": "comprehensive measures", "shape": "dot", "size": 32, "title": "comprehensive measures"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "potential DPI\u2019s scalability", "label": "potential DPI\u2019s scalability", "shape": "dot", "size": 16, "title": "potential DPI\u2019s scalability"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "India\u0027s DPI experience", "label": "India\u0027s DPI experience", "shape": "dot", "size": 24, "title": "India\u0027s DPI experience"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Digital systems", "label": "Digital systems", "shape": "dot", "size": 24, "title": "Digital systems"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Inclusive societies", "label": "Inclusive societies", "shape": "dot", "size": 16, "title": "Inclusive societies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Sustainable development in the 21st century", "label": "Sustainable development in the 21st century", "shape": "dot", "size": 16, "title": "Sustainable development in the 21st century"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Sameer Kanwar", "label": "Sameer Kanwar", "shape": "dot", "size": 24, "title": "Sameer Kanwar"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Varun Kumar", "label": "Varun Kumar", "shape": "dot", "size": 16, "title": "Varun Kumar"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Inadequate infection prevention and control", "label": "Inadequate infection prevention and control", "shape": "dot", "size": 32, "title": "Inadequate infection prevention and control"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Hand hygiene", "label": "Hand hygiene", "shape": "dot", "size": 16, "title": "Hand hygiene"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Improper disinfection and sterilisation practices", "label": "Improper disinfection and sterilisation practices", "shape": "dot", "size": 16, "title": "Improper disinfection and sterilisation practices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Inadequate sanitation", "label": "Inadequate sanitation", "shape": "dot", "size": 16, "title": "Inadequate sanitation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Hospital-acquired infections", "label": "Hospital-acquired infections", "shape": "dot", "size": 16, "title": "Hospital-acquired infections"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Infection prevention and control measures", "label": "Infection prevention and control measures", "shape": "dot", "size": 24, "title": "Infection prevention and control measures"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Infection control practices", "label": "Infection control practices", "shape": "dot", "size": 16, "title": "Infection control practices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Low- and middle-income countries (LMICs)", "label": "Low- and middle-income countries (LMICs)", "shape": "dot", "size": 24, "title": "Low- and middle-income countries (LMICs)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "World Health Organization", "label": "World Health Organization", "shape": "dot", "size": 24, "title": "World Health Organization"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Innovative financing mechanisms", "label": "Innovative financing mechanisms", "shape": "dot", "size": 40, "title": "Innovative financing mechanisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G20", "label": "G20", "shape": "dot", "size": 37, "title": "G20"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Healthcare Spending", "label": "Healthcare Spending", "shape": "dot", "size": 40, "title": "Healthcare Spending"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G20 countries", "label": "G20 countries", "shape": "dot", "size": 39, "title": "G20 countries"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Universal Health Coverage (UHC)", "label": "Universal Health Coverage (UHC)", "shape": "dot", "size": 36, "title": "Universal Health Coverage (UHC)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Out-Of-Pocket Expenses (OOPE)", "label": "Out-Of-Pocket Expenses (OOPE)", "shape": "dot", "size": 24, "title": "Out-Of-Pocket Expenses (OOPE)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Maximum Retail Price set by the MOH", "label": "Maximum Retail Price set by the MOH", "shape": "dot", "size": 24, "title": "Maximum Retail Price set by the MOH"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "public hospitals", "label": "public hospitals", "shape": "dot", "size": 24, "title": "public hospitals"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "private pharmacies", "label": "private pharmacies", "shape": "dot", "size": 16, "title": "private pharmacies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "NGO hospitals", "label": "NGO hospitals", "shape": "dot", "size": 24, "title": "NGO hospitals"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Lowest Price Generic (LPG) medicines", "label": "Lowest Price Generic (LPG) medicines", "shape": "dot", "size": 32, "title": "Lowest Price Generic (LPG) medicines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Innovator Brand (IB) medicines", "label": "Innovator Brand (IB) medicines", "shape": "dot", "size": 32, "title": "Innovator Brand (IB) medicines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "declines ranging from 40 percent to 2200 percent", "label": "declines ranging from 40 percent to 2200 percent", "shape": "dot", "size": 24, "title": "declines ranging from 40 percent to 2200 percent"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "generic medicine pricing policies have succeeded in lowering the price of medicines", "label": "generic medicine pricing policies have succeeded in lowering the price of medicines", "shape": "dot", "size": 32, "title": "generic medicine pricing policies have succeeded in lowering the price of medicines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "variation in implementation", "label": "variation in implementation", "shape": "dot", "size": 24, "title": "variation in implementation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "excess paid by patients compared to MOH set prices", "label": "excess paid by patients compared to MOH set prices", "shape": "dot", "size": 32, "title": "excess paid by patients compared to MOH set prices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "narrow the differences", "label": "narrow the differences", "shape": "dot", "size": 24, "title": "narrow the differences"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "more recently", "label": "more recently", "shape": "dot", "size": 16, "title": "more recently"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "UHC (Universal Health Coverage)", "label": "UHC (Universal Health Coverage)", "shape": "dot", "size": 32, "title": "UHC (Universal Health Coverage)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National University of Singapore\u0027s Saw Swee Hock School of Public Health", "label": "National University of Singapore\u0027s Saw Swee Hock School of Public Health", "shape": "dot", "size": 24, "title": "National University of Singapore\u0027s Saw Swee Hock School of Public Health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Associate Professor Jeremy Lim", "label": "Associate Professor Jeremy Lim", "shape": "dot", "size": 16, "title": "Associate Professor Jeremy Lim"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Janice Tan", "label": "Janice Tan", "shape": "dot", "size": 8, "title": "Janice Tan"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Accelerating Global Health: Pathways to Health Equity for the G20", "label": "Accelerating Global Health: Pathways to Health Equity for the G20", "shape": "dot", "size": 39, "title": "Accelerating Global Health: Pathways to Health Equity for the G20"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "cultural settings of LMICs", "label": "cultural settings of LMICs", "shape": "dot", "size": 32, "title": "cultural settings of LMICs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "brief psychological interventions", "label": "brief psychological interventions", "shape": "dot", "size": 24, "title": "brief psychological interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "lay counsellors", "label": "lay counsellors", "shape": "dot", "size": 32, "title": "lay counsellors"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "moderate to severe depressive disorders and harmful drinking", "label": "moderate to severe depressive disorders and harmful drinking", "shape": "dot", "size": 24, "title": "moderate to severe depressive disorders and harmful drinking"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "health systems in HICs", "label": "health systems in HICs", "shape": "dot", "size": 32, "title": "health systems in HICs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "long waiting periods for psychological intervention", "label": "long waiting periods for psychological intervention", "shape": "dot", "size": 24, "title": "long waiting periods for psychological intervention"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "low-intensity interventions", "label": "low-intensity interventions", "shape": "dot", "size": 32, "title": "low-intensity interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Problem Management plus (PM+)", "label": "Problem Management plus (PM+)", "shape": "dot", "size": 24, "title": "Problem Management plus (PM+)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "adults in distress due to exposure to adversity", "label": "adults in distress due to exposure to adversity", "shape": "dot", "size": 32, "title": "adults in distress due to exposure to adversity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "family caregivers", "label": "family caregivers", "shape": "dot", "size": 24, "title": "family caregivers"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "mental health", "label": "mental health", "shape": "dot", "size": 32, "title": "mental health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "indigenous interventions", "label": "indigenous interventions", "shape": "dot", "size": 24, "title": "indigenous interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Yoga", "label": "Yoga", "shape": "dot", "size": 32, "title": "Yoga"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "alternative forms of medicine", "label": "alternative forms of medicine", "shape": "dot", "size": 24, "title": "alternative forms of medicine"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "COVID-19", "label": "COVID-19", "shape": "dot", "size": 39, "title": "COVID-19"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Access to COVID-19 Tools Accelerator (ACT-A)", "label": "Access to COVID-19 Tools Accelerator (ACT-A)", "shape": "dot", "size": 32, "title": "Access to COVID-19 Tools Accelerator (ACT-A)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemic", "label": "pandemic", "shape": "dot", "size": 38, "title": "pandemic"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Accord", "label": "Accord", "shape": "dot", "size": 40, "title": "Accord"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Human Rights Protection", "label": "Human Rights Protection", "shape": "dot", "size": 32, "title": "Human Rights Protection"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Public Health and Healthcare Systems", "label": "Public Health and Healthcare Systems", "shape": "dot", "size": 24, "title": "Public Health and Healthcare Systems"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Staff Protection", "label": "Staff Protection", "shape": "dot", "size": 32, "title": "Staff Protection"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Misinformation Management", "label": "Misinformation Management", "shape": "dot", "size": 24, "title": "Misinformation Management"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Whole-of-Society Approach", "label": "Whole-of-Society Approach", "shape": "dot", "size": 32, "title": "Whole-of-Society Approach"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Global Coordination", "label": "Global Coordination", "shape": "dot", "size": 24, "title": "Global Coordination"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Preparedness Plans", "label": "Preparedness Plans", "shape": "dot", "size": 32, "title": "Preparedness Plans"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Simulation Exercises", "label": "Simulation Exercises", "shape": "dot", "size": 24, "title": "Simulation Exercises"}, {"color": "#9457db", "font": {"color": "#dbdbdb"}, "id": "Universal Health and Preparedness Review", "label": "Universal Health and Preparedness Review", "shape": "dot", "size": 32, "title": "Universal Health and Preparedness Review"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Accurate and timely diagnostics", "label": "Accurate and timely diagnostics", "shape": "dot", "size": 32, "title": "Accurate and timely diagnostics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Advance market commitment\u2013type investments", "label": "Advance market commitment\u2013type investments", "shape": "dot", "size": 24, "title": "Advance market commitment\u2013type investments"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Africa Center for Disease Control", "label": "Africa Center for Disease Control", "shape": "dot", "size": 16, "title": "Africa Center for Disease Control"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "African Union Commission", "label": "African Union Commission", "shape": "dot", "size": 16, "title": "African Union Commission"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "African continent", "label": "African continent", "shape": "dot", "size": 16, "title": "African continent"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Alternative treatments", "label": "Alternative treatments", "shape": "dot", "size": 24, "title": "Alternative treatments"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Annual coverage of INR 500,000 per family", "label": "Annual coverage of INR 500,000 per family", "shape": "dot", "size": 16, "title": "Annual coverage of INR 500,000 per family"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Antibiotic Resistance Mechanisms", "label": "Antibiotic Resistance Mechanisms", "shape": "dot", "size": 32, "title": "Antibiotic Resistance Mechanisms"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Antimicrobial Resistance", "label": "Antimicrobial Resistance", "shape": "dot", "size": 40, "title": "Antimicrobial Resistance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Antibiotics", "label": "Antibiotics", "shape": "dot", "size": 37, "title": "Antibiotics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Health Crisis", "label": "Global Health Crisis", "shape": "dot", "size": 32, "title": "Global Health Crisis"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Economy", "label": "Global Economy", "shape": "dot", "size": 16, "title": "Global Economy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Extreme Poverty", "label": "Extreme Poverty", "shape": "dot", "size": 8, "title": "Extreme Poverty"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Developing Nations", "label": "Developing Nations", "shape": "dot", "size": 16, "title": "Developing Nations"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Antimicrobial Drugs", "label": "Antimicrobial Drugs", "shape": "dot", "size": 24, "title": "Antimicrobial Drugs"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Persistent Infectious Diseases", "label": "Persistent Infectious Diseases", "shape": "dot", "size": 32, "title": "Persistent Infectious Diseases"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Biological Evolution", "label": "Biological Evolution", "shape": "dot", "size": 32, "title": "Biological Evolution"}, {"color": "#7957db", "font": {"color": "#dbdbdb"}, "id": "Defense System of Microorganisms", "label": "Defense System of Microorganisms", "shape": "dot", "size": 24, "title": "Defense System of Microorganisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Multisectoral inclusivity", "label": "Multisectoral inclusivity", "shape": "dot", "size": 24, "title": "Multisectoral inclusivity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "OH concept", "label": "OH concept", "shape": "dot", "size": 32, "title": "OH concept"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "WHO", "label": "WHO", "shape": "dot", "size": 32, "title": "WHO"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Public Health Threats", "label": "Global Public Health Threats", "shape": "dot", "size": 24, "title": "Global Public Health Threats"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "US$11-444 million", "label": "US$11-444 million", "shape": "dot", "size": 24, "title": "US$11-444 million"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Resistance", "label": "Resistance", "shape": "dot", "size": 32, "title": "Resistance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Microorganisms", "label": "Microorganisms", "shape": "dot", "size": 16, "title": "Microorganisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Selection", "label": "Selection", "shape": "dot", "size": 32, "title": "Selection"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Antimicrobial use", "label": "Antimicrobial use", "shape": "dot", "size": 16, "title": "Antimicrobial use"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Argentina", "label": "Argentina", "shape": "dot", "size": 16, "title": "Argentina"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "health equity", "label": "health equity", "shape": "dot", "size": 40, "title": "health equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Asian countries", "label": "Asian countries", "shape": "dot", "size": 24, "title": "Asian countries"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "mental health equity", "label": "mental health equity", "shape": "dot", "size": 40, "title": "mental health equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Program for Mental Health (NMHP)", "label": "National Program for Mental Health (NMHP)", "shape": "dot", "size": 40, "title": "National Program for Mental Health (NMHP)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Aur\u00e9lia Nguyen", "label": "Aur\u00e9lia Nguyen", "shape": "dot", "size": 24, "title": "Aur\u00e9lia Nguyen"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVAX", "label": "COVAX", "shape": "dot", "size": 36, "title": "COVAX"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Australia", "label": "Australia", "shape": "dot", "size": 16, "title": "Australia"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Average Life Expectancy", "label": "Average Life Expectancy", "shape": "dot", "size": 32, "title": "Average Life Expectancy"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "G20 Countries", "label": "G20 Countries", "shape": "dot", "size": 34, "title": "G20 Countries"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)", "label": "Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)", "shape": "dot", "size": 32, "title": "Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Universal Health Care (UHC) in India", "label": "Universal Health Care (UHC) in India", "shape": "dot", "size": 32, "title": "Universal Health Care (UHC) in India"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Secondary and tertiary hospitalisations", "label": "Secondary and tertiary hospitalisations", "shape": "dot", "size": 24, "title": "Secondary and tertiary hospitalisations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Generic medicines", "label": "Generic medicines", "shape": "dot", "size": 24, "title": "Generic medicines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Jan Aushadhi Kendras", "label": "Jan Aushadhi Kendras", "shape": "dot", "size": 24, "title": "Jan Aushadhi Kendras"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Economic burden", "label": "Economic burden", "shape": "dot", "size": 24, "title": "Economic burden"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Poor and marginalised", "label": "Poor and marginalised", "shape": "dot", "size": 16, "title": "Poor and marginalised"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Comprehensive services", "label": "Comprehensive services", "shape": "dot", "size": 16, "title": "Comprehensive services"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Screening and essential mental health", "label": "Screening and essential mental health", "shape": "dot", "size": 16, "title": "Screening and essential mental health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "label": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "shape": "dot", "size": 40, "title": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Universal Health Coverage", "label": "Universal Health Coverage", "shape": "dot", "size": 32, "title": "Universal Health Coverage"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health and Wellness Centres", "label": "Health and Wellness Centres", "shape": "dot", "size": 32, "title": "Health and Wellness Centres"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Tele Mental Health Programme (Tele MANAS)", "label": "National Tele Mental Health Programme (Tele MANAS)", "shape": "dot", "size": 24, "title": "National Tele Mental Health Programme (Tele MANAS)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Mental Health Policy (2014)", "label": "National Mental Health Policy (2014)", "shape": "dot", "size": 24, "title": "National Mental Health Policy (2014)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Health Policy (2017)", "label": "National Health Policy (2017)", "shape": "dot", "size": 24, "title": "National Health Policy (2017)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Rights of Persons with Disability Act, 2016", "label": "Rights of Persons with Disability Act, 2016", "shape": "dot", "size": 32, "title": "Rights of Persons with Disability Act, 2016"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "BPJS", "label": "BPJS", "shape": "dot", "size": 32, "title": "BPJS"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "UHC", "label": "UHC", "shape": "dot", "size": 40, "title": "UHC"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "BRABRAKOR", "label": "BRABRAKOR", "shape": "dot", "size": 8, "title": "BRABRAKOR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Bacteriophages", "label": "Bacteriophages", "shape": "dot", "size": 16, "title": "Bacteriophages"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Barbara Stocking", "label": "Barbara Stocking", "shape": "dot", "size": 8, "title": "Barbara Stocking"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "bird and animal viruses", "label": "bird and animal viruses", "shape": "dot", "size": 40, "title": "bird and animal viruses"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "chemistry and artificial intelligence (AI)", "label": "chemistry and artificial intelligence (AI)", "shape": "dot", "size": 32, "title": "chemistry and artificial intelligence (AI)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antimicrobials", "label": "antimicrobials", "shape": "dot", "size": 24, "title": "antimicrobials"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "in vitro and in vivo trials", "label": "in vitro and in vivo trials", "shape": "dot", "size": 16, "title": "in vitro and in vivo trials"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "bacteria", "label": "bacteria", "shape": "dot", "size": 24, "title": "bacteria"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antibiotics", "label": "antibiotics", "shape": "dot", "size": 32, "title": "antibiotics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "quicker and more efficient antibiotic testing and approval pipelines", "label": "quicker and more efficient antibiotic testing and approval pipelines", "shape": "dot", "size": 24, "title": "quicker and more efficient antibiotic testing and approval pipelines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antimicrobial discovery", "label": "antimicrobial discovery", "shape": "dot", "size": 32, "title": "antimicrobial discovery"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "existing drugs", "label": "existing drugs", "shape": "dot", "size": 24, "title": "existing drugs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "natural products", "label": "natural products", "shape": "dot", "size": 16, "title": "natural products"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "alternate treatment strategies", "label": "alternate treatment strategies", "shape": "dot", "size": 16, "title": "alternate treatment strategies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "computational approaches for drug design", "label": "computational approaches for drug design", "shape": "dot", "size": 24, "title": "computational approaches for drug design"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "interdisciplinary collaborations", "label": "interdisciplinary collaborations", "shape": "dot", "size": 16, "title": "interdisciplinary collaborations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "new technologies", "label": "new technologies", "shape": "dot", "size": 16, "title": "new technologies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "clinical antibacterial pipeline", "label": "clinical antibacterial pipeline", "shape": "dot", "size": 24, "title": "clinical antibacterial pipeline"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Policy", "label": "Policy", "shape": "dot", "size": 24, "title": "Policy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Implementation", "label": "Implementation", "shape": "dot", "size": 24, "title": "Implementation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "New antibiotics", "label": "New antibiotics", "shape": "dot", "size": 32, "title": "New antibiotics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Infection prevention and control practices", "label": "Infection prevention and control practices", "shape": "dot", "size": 24, "title": "Infection prevention and control practices"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Surveillance and data collection", "label": "Surveillance and data collection", "shape": "dot", "size": 24, "title": "Surveillance and data collection"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National and global health plans", "label": "National and global health plans", "shape": "dot", "size": 24, "title": "National and global health plans"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Stakeholders", "label": "Stakeholders", "shape": "dot", "size": 16, "title": "Stakeholders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Political will", "label": "Political will", "shape": "dot", "size": 16, "title": "Political will"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Best Practices", "label": "Best Practices", "shape": "dot", "size": 32, "title": "Best Practices"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Health Finance", "label": "Health Finance", "shape": "dot", "size": 40, "title": "Health Finance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Best practice examples", "label": "Best practice examples", "shape": "dot", "size": 24, "title": "Best practice examples"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "Box 2. Technological Initiatives in India for Mental Health", "label": "Box 2. Technological Initiatives in India for Mental Health", "shape": "dot", "size": 32, "title": "Box 2. Technological Initiatives in India for Mental Health"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "Tele-MANAS initiative", "label": "Tele-MANAS initiative", "shape": "dot", "size": 40, "title": "Tele-MANAS initiative"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Brazil", "label": "Brazil", "shape": "dot", "size": 16, "title": "Brazil"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "CAN", "label": "CAN", "shape": "dot", "size": 16, "title": "CAN"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "CEPI (Coalition for Epidemic Preparedness Innovations)", "label": "CEPI (Coalition for Epidemic Preparedness Innovations)", "shape": "dot", "size": 24, "title": "CEPI (Coalition for Epidemic Preparedness Innovations)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "CEPI\u0027s 100 Days Mission", "label": "CEPI\u0027s 100 Days Mission", "shape": "dot", "size": 24, "title": "CEPI\u0027s 100 Days Mission"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "CHI", "label": "CHI", "shape": "dot", "size": 16, "title": "CHI"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "CHIRUS", "label": "CHIRUS", "shape": "dot", "size": 8, "title": "CHIRUS"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccine candidates", "label": "vaccine candidates", "shape": "dot", "size": 40, "title": "vaccine candidates"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Gavi-implementing countries", "label": "Gavi-implementing countries", "shape": "dot", "size": 32, "title": "Gavi-implementing countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "routine immunisation", "label": "routine immunisation", "shape": "dot", "size": 24, "title": "routine immunisation"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVID-19 vaccine coverage", "label": "COVID-19 vaccine coverage", "shape": "dot", "size": 32, "title": "COVID-19 vaccine coverage"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemic preparedness", "label": "pandemic preparedness", "shape": "dot", "size": 24, "title": "pandemic preparedness"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "most vulnerable people", "label": "most vulnerable people", "shape": "dot", "size": 32, "title": "most vulnerable people"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "equitable supply of vaccines", "label": "equitable supply of vaccines", "shape": "dot", "size": 24, "title": "equitable supply of vaccines"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "finite supply of vaccine doses", "label": "finite supply of vaccine doses", "shape": "dot", "size": 24, "title": "finite supply of vaccine doses"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "H1N1 vaccine", "label": "H1N1 vaccine", "shape": "dot", "size": 16, "title": "H1N1 vaccine"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Gavi, the Vaccine Alliance", "label": "Gavi, the Vaccine Alliance", "shape": "dot", "size": 38, "title": "Gavi, the Vaccine Alliance"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVAX AMC", "label": "COVAX AMC", "shape": "dot", "size": 32, "title": "COVAX AMC"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "hoarding", "label": "hoarding", "shape": "dot", "size": 32, "title": "hoarding"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "export bans", "label": "export bans", "shape": "dot", "size": 24, "title": "export bans"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "H1N1 pandemic", "label": "H1N1 pandemic", "shape": "dot", "size": 32, "title": "H1N1 pandemic"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "lower-income economies", "label": "lower-income economies", "shape": "dot", "size": 24, "title": "lower-income economies"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "wealthier nations", "label": "wealthier nations", "shape": "dot", "size": 32, "title": "wealthier nations"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccine-candidates", "label": "vaccine-candidates", "shape": "dot", "size": 32, "title": "vaccine-candidates"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "technology platforms", "label": "technology platforms", "shape": "dot", "size": 24, "title": "technology platforms"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "regulatory approval", "label": "regulatory approval", "shape": "dot", "size": 24, "title": "regulatory approval"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "large-scale investments", "label": "large-scale investments", "shape": "dot", "size": 32, "title": "large-scale investments"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVAX portfolio", "label": "COVAX portfolio", "shape": "dot", "size": 32, "title": "COVAX portfolio"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Healthcare systems", "label": "Healthcare systems", "shape": "dot", "size": 24, "title": "Healthcare systems"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Simulation exercises", "label": "Simulation exercises", "shape": "dot", "size": 16, "title": "Simulation exercises"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public health system", "label": "Public health system", "shape": "dot", "size": 24, "title": "Public health system"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Lockdown", "label": "Lockdown", "shape": "dot", "size": 32, "title": "Lockdown"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Livelihoods and economy", "label": "Livelihoods and economy", "shape": "dot", "size": 24, "title": "Livelihoods and economy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Trade", "label": "Trade", "shape": "dot", "size": 16, "title": "Trade"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Social services (education)", "label": "Social services (education)", "shape": "dot", "size": 16, "title": "Social services (education)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health system strengthening investments", "label": "Health system strengthening investments", "shape": "dot", "size": 32, "title": "Health system strengthening investments"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Primary healthcare services", "label": "Primary healthcare services", "shape": "dot", "size": 24, "title": "Primary healthcare services"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Cold chain", "label": "Cold chain", "shape": "dot", "size": 16, "title": "Cold chain"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Vaccine track-and-trace", "label": "Vaccine track-and-trace", "shape": "dot", "size": 24, "title": "Vaccine track-and-trace"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Human resources", "label": "Human resources", "shape": "dot", "size": 16, "title": "Human resources"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Data monitoring systems", "label": "Data monitoring systems", "shape": "dot", "size": 24, "title": "Data monitoring systems"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "COVID-19 vaccine Delivery Support (CDS)", "label": "COVID-19 vaccine Delivery Support (CDS)", "shape": "dot", "size": 32, "title": "COVID-19 vaccine Delivery Support (CDS)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Gavi", "label": "Gavi", "shape": "dot", "size": 20, "title": "Gavi"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "health workforce", "label": "health workforce", "shape": "dot", "size": 40, "title": "health workforce"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "COVID-19 infections and deaths among health workers", "label": "COVID-19 infections and deaths among health workers", "shape": "dot", "size": 32, "title": "COVID-19 infections and deaths among health workers"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "limited availability of the health workforce", "label": "limited availability of the health workforce", "shape": "dot", "size": 40, "title": "limited availability of the health workforce"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "lockdown", "label": "lockdown", "shape": "dot", "size": 32, "title": "lockdown"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "global economy", "label": "global economy", "shape": "dot", "size": 24, "title": "global economy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "novel coronavirus", "label": "novel coronavirus", "shape": "dot", "size": 32, "title": "novel coronavirus"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "disease", "label": "disease", "shape": "dot", "size": 24, "title": "disease"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "zoonotic virus", "label": "zoonotic virus", "shape": "dot", "size": 16, "title": "zoonotic virus"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public Health Emergency of International Concern", "label": "Public Health Emergency of International Concern", "shape": "dot", "size": 24, "title": "Public Health Emergency of International Concern"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "low-income countries", "label": "low-income countries", "shape": "dot", "size": 16, "title": "low-income countries"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vaccines and drugs", "label": "vaccines and drugs", "shape": "dot", "size": 24, "title": "vaccines and drugs"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vaccine manufacturing", "label": "vaccine manufacturing", "shape": "dot", "size": 32, "title": "vaccine manufacturing"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Memorandum of Understanding", "label": "Memorandum of Understanding", "shape": "dot", "size": 24, "title": "Memorandum of Understanding"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public Health Workforce", "label": "Public Health Workforce", "shape": "dot", "size": 40, "title": "Public Health Workforce"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "regional, and global bodies", "label": "regional, and global bodies", "shape": "dot", "size": 40, "title": "regional, and global bodies"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "COVID-19 vaccinations", "label": "COVID-19 vaccinations", "shape": "dot", "size": 32, "title": "COVID-19 vaccinations"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Canada", "label": "Canada", "shape": "dot", "size": 16, "title": "Canada"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Carbis Bay Health Declaration", "label": "Carbis Bay Health Declaration", "shape": "dot", "size": 24, "title": "Carbis Bay Health Declaration"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Central and State Mental Health Authorities", "label": "Central and State Mental Health Authorities", "shape": "dot", "size": 32, "title": "Central and State Mental Health Authorities"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "mental health services", "label": "mental health services", "shape": "dot", "size": 40, "title": "mental health services"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "mental illness", "label": "mental illness", "shape": "dot", "size": 39, "title": "mental illness"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Centres of Excellence for AI", "label": "Centres of Excellence for AI", "shape": "dot", "size": 24, "title": "Centres of Excellence for AI"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "China", "label": "China", "shape": "dot", "size": 16, "title": "China"}, {"color": "#57b9db", "font": {"color": "#dbdbdb"}, "id": "Climate Change", "label": "Climate Change", "shape": "dot", "size": 24, "title": "Climate Change"}, {"color": "#57b9db", "font": {"color": "#dbdbdb"}, "id": "India\u0027s G20 Leadership", "label": "India\u0027s G20 Leadership", "shape": "dot", "size": 40, "title": "India\u0027s G20 Leadership"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Clinical decision support system", "label": "Clinical decision support system", "shape": "dot", "size": 16, "title": "Clinical decision support system"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Coalition for Epidemic Preparedness Innovations (CEPI)", "label": "Coalition for Epidemic Preparedness Innovations (CEPI)", "shape": "dot", "size": 34, "title": "Coalition for Epidemic Preparedness Innovations (CEPI)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemics", "label": "pandemics", "shape": "dot", "size": 36, "title": "pandemics"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Dr. Richard Hatchett", "label": "Dr. Richard Hatchett", "shape": "dot", "size": 32, "title": "Dr. Richard Hatchett"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Kate Kelland", "label": "Kate Kelland", "shape": "dot", "size": 24, "title": "Kate Kelland"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "DBT", "label": "DBT", "shape": "dot", "size": 24, "title": "DBT"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "DEPA", "label": "DEPA", "shape": "dot", "size": 32, "title": "DEPA"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "DEU", "label": "DEU", "shape": "dot", "size": 16, "title": "DEU"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "DNDi (Drugs for Neglected Diseases Initiative)", "label": "DNDi (Drugs for Neglected Diseases Initiative)", "shape": "dot", "size": 32, "title": "DNDi (Drugs for Neglected Diseases Initiative)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "DPI", "label": "DPI", "shape": "dot", "size": 40, "title": "DPI"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "digital literacy", "label": "digital literacy", "shape": "dot", "size": 38, "title": "digital literacy"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "digital divide", "label": "digital divide", "shape": "dot", "size": 32, "title": "digital divide"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "India\u0027s digital transformation", "label": "India\u0027s digital transformation", "shape": "dot", "size": 32, "title": "India\u0027s digital transformation"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "inclusivity", "label": "inclusivity", "shape": "dot", "size": 32, "title": "inclusivity"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "scalability", "label": "scalability", "shape": "dot", "size": 24, "title": "scalability"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "regulation", "label": "regulation", "shape": "dot", "size": 24, "title": "regulation"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "collaboration", "label": "collaboration", "shape": "dot", "size": 24, "title": "collaboration"}, {"color": "#57d3db", "font": {"color": "#dbdbdb"}, "id": "Dame Barbara Stocking", "label": "Dame Barbara Stocking", "shape": "dot", "size": 32, "title": "Dame Barbara Stocking"}, {"color": "#57d3db", "font": {"color": "#dbdbdb"}, "id": "Global Public Health Convention", "label": "Global Public Health Convention", "shape": "dot", "size": 40, "title": "Global Public Health Convention"}, {"color": "#57dbc9", "font": {"color": "#dbdbdb"}, "id": "Data Empowerment and Protection Architecture (DEPA)", "label": "Data Empowerment and Protection Architecture (DEPA)", "shape": "dot", "size": 16, "title": "Data Empowerment and Protection Architecture (DEPA)"}, {"color": "#57dbc9", "font": {"color": "#dbdbdb"}, "id": "India Enterprise Architecture", "label": "India Enterprise Architecture", "shape": "dot", "size": 40, "title": "India Enterprise Architecture"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Databases and knowledge-sharing resources", "label": "Databases and knowledge-sharing resources", "shape": "dot", "size": 32, "title": "Databases and knowledge-sharing resources"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Department for Digital Health and Innovation", "label": "Department for Digital Health and Innovation", "shape": "dot", "size": 24, "title": "Department for Digital Health and Innovation"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Health Organization (WHO)", "label": "World Health Organization (WHO)", "shape": "dot", "size": 34, "title": "World Health Organization (WHO)"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "Developing countries", "label": "Developing countries", "shape": "dot", "size": 32, "title": "Developing countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Digital Health", "label": "Digital Health", "shape": "dot", "size": 40, "title": "Digital Health"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "India\u0027s G20 presidency", "label": "India\u0027s G20 presidency", "shape": "dot", "size": 32, "title": "India\u0027s G20 presidency"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Global Initiative on Digital Health (GIDH)", "label": "Global Initiative on Digital Health (GIDH)", "shape": "dot", "size": 24, "title": "Global Initiative on Digital Health (GIDH)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Digital India", "label": "Digital India", "shape": "dot", "size": 32, "title": "Digital India"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "transparency", "label": "transparency", "shape": "dot", "size": 38, "title": "transparency"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "Digital India programme", "label": "Digital India programme", "shape": "dot", "size": 32, "title": "Digital India programme"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "India\u0027s Digital Public Infrastructure Transformation", "label": "India\u0027s Digital Public Infrastructure Transformation", "shape": "dot", "size": 40, "title": "India\u0027s Digital Public Infrastructure Transformation"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "Digital Personal Data Protection Bill 2022", "label": "Digital Personal Data Protection Bill 2022", "shape": "dot", "size": 24, "title": "Digital Personal Data Protection Bill 2022"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Digital healthcare", "label": "Digital healthcare", "shape": "dot", "size": 32, "title": "Digital healthcare"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Digital infrastructure", "label": "Digital infrastructure", "shape": "dot", "size": 32, "title": "Digital infrastructure"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "Direct Benefit Transfer (DBT) programme", "label": "Direct Benefit Transfer (DBT) programme", "shape": "dot", "size": 32, "title": "Direct Benefit Transfer (DBT) programme"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Disability-Adjusted-Life-Years (DALYs)", "label": "Disability-Adjusted-Life-Years (DALYs)", "shape": "dot", "size": 40, "title": "Disability-Adjusted-Life-Years (DALYs)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "mental disorders", "label": "mental disorders", "shape": "dot", "size": 32, "title": "mental disorders"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "treatment gap for mental and substance abuse disorders", "label": "treatment gap for mental and substance abuse disorders", "shape": "dot", "size": 24, "title": "treatment gap for mental and substance abuse disorders"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "out-of-pocket (OOP) spending", "label": "out-of-pocket (OOP) spending", "shape": "dot", "size": 16, "title": "out-of-pocket (OOP) spending"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "medicines", "label": "medicines", "shape": "dot", "size": 28, "title": "medicines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Disease X pandemic virus", "label": "Disease X pandemic virus", "shape": "dot", "size": 32, "title": "Disease X pandemic virus"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Disease outbreaks", "label": "Disease outbreaks", "shape": "dot", "size": 16, "title": "Disease outbreaks"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Disparity Interventions", "label": "Disparity Interventions", "shape": "dot", "size": 16, "title": "Disparity Interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "District Mental Health Program (DMHP)", "label": "District Mental Health Program (DMHP)", "shape": "dot", "size": 32, "title": "District Mental Health Program (DMHP)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Doha Trade Round", "label": "Doha Trade Round", "shape": "dot", "size": 24, "title": "Doha Trade Round"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Pandemic Accord", "label": "Pandemic Accord", "shape": "dot", "size": 39, "title": "Pandemic Accord"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Dr Priyadarshini Rajamani", "label": "Dr Priyadarshini Rajamani", "shape": "dot", "size": 16, "title": "Dr Priyadarshini Rajamani"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Health", "label": "Global Health", "shape": "dot", "size": 40, "title": "Global Health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Dr Soumya Swaminathan", "label": "Dr Soumya Swaminathan", "shape": "dot", "size": 32, "title": "Dr Soumya Swaminathan"}, {"color": "#57db94", "font": {"color": "#dbdbdb"}, "id": "EPHFs", "label": "EPHFs", "shape": "dot", "size": 32, "title": "EPHFs"}, {"color": "#57db94", "font": {"color": "#dbdbdb"}, "id": "national public health workforce capacity", "label": "national public health workforce capacity", "shape": "dot", "size": 40, "title": "national public health workforce capacity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "EPHFs (Emergency Public Health Functions)", "label": "EPHFs (Emergency Public Health Functions)", "shape": "dot", "size": 16, "title": "EPHFs (Emergency Public Health Functions)"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "Ebola", "label": "Ebola", "shape": "dot", "size": 24, "title": "Ebola"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "zoonotic disease", "label": "zoonotic disease", "shape": "dot", "size": 40, "title": "zoonotic disease"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Economic efficiency", "label": "Economic efficiency", "shape": "dot", "size": 24, "title": "Economic efficiency"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental Health as a Pathway to Health Equity", "label": "Mental Health as a Pathway to Health Equity", "shape": "dot", "size": 40, "title": "Mental Health as a Pathway to Health Equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Economic productivity gains", "label": "Economic productivity gains", "shape": "dot", "size": 16, "title": "Economic productivity gains"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Effective treatments for all", "label": "Effective treatments for all", "shape": "dot", "size": 32, "title": "Effective treatments for all"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Equitable pricing and access", "label": "Equitable pricing and access", "shape": "dot", "size": 32, "title": "Equitable pricing and access"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Equity in access to drugs and vaccines", "label": "Equity in access to drugs and vaccines", "shape": "dot", "size": 24, "title": "Equity in access to drugs and vaccines"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Essential Public Health Functiona (EPHF)", "label": "Essential Public Health Functiona (EPHF)", "shape": "dot", "size": 40, "title": "Essential Public Health Functiona (EPHF)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Investing in the Public Health Workforce", "label": "Investing in the Public Health Workforce", "shape": "dot", "size": 40, "title": "Investing in the Public Health Workforce"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Global investment", "label": "Global investment", "shape": "dot", "size": 40, "title": "Global investment"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "G7 and G20 intergovernmental processes", "label": "G7 and G20 intergovernmental processes", "shape": "dot", "size": 32, "title": "G7 and G20 intergovernmental processes"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Essential health services", "label": "Essential health services", "shape": "dot", "size": 16, "title": "Essential health services"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Event-based disease surveillance", "label": "Event-based disease surveillance", "shape": "dot", "size": 16, "title": "Event-based disease surveillance"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "FRA", "label": "FRA", "shape": "dot", "size": 16, "title": "FRA"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "FY 2021-22", "label": "FY 2021-22", "shape": "dot", "size": 24, "title": "FY 2021-22"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Fight against AMR", "label": "Fight against AMR", "shape": "dot", "size": 24, "title": "Fight against AMR"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Financial incentives", "label": "Financial incentives", "shape": "dot", "size": 24, "title": "Financial incentives"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Five-Year Forward View for Mental Health", "label": "Five-Year Forward View for Mental Health", "shape": "dot", "size": 24, "title": "Five-Year Forward View for Mental Health"}, {"color": "#57b9db", "font": {"color": "#dbdbdb"}, "id": "Food Insecurity", "label": "Food Insecurity", "shape": "dot", "size": 16, "title": "Food Insecurity"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Food and Agriculture Organisation (FAO)", "label": "Food and Agriculture Organisation (FAO)", "shape": "dot", "size": 32, "title": "Food and Agriculture Organisation (FAO)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Quadripartite Collaboration for One Health", "label": "Quadripartite Collaboration for One Health", "shape": "dot", "size": 40, "title": "Quadripartite Collaboration for One Health"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Food and Agriculture Organization", "label": "Food and Agriculture Organization", "shape": "dot", "size": 16, "title": "Food and Agriculture Organization"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "France", "label": "France", "shape": "dot", "size": 16, "title": "France"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "One Health approach in India", "label": "One Health approach in India", "shape": "dot", "size": 32, "title": "One Health approach in India"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Office of the Principal Scientific Adviser (PSA)", "label": "Office of the Principal Scientific Adviser (PSA)", "shape": "dot", "size": 24, "title": "Office of the Principal Scientific Adviser (PSA)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public Health Outcomes", "label": "Public Health Outcomes", "shape": "dot", "size": 32, "title": "Public Health Outcomes"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Life Expectancy", "label": "Life Expectancy", "shape": "dot", "size": 32, "title": "Life Expectancy"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "GDP", "label": "GDP", "shape": "dot", "size": 24, "title": "GDP"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Global Average of Life Expectancy", "label": "Global Average of Life Expectancy", "shape": "dot", "size": 24, "title": "Global Average of Life Expectancy"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Role of Health Finance in G20 Countries", "label": "Role of Health Finance in G20 Countries", "shape": "dot", "size": 40, "title": "Role of Health Finance in G20 Countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "G20 Independent High-Level Panel", "label": "G20 Independent High-Level Panel", "shape": "dot", "size": 24, "title": "G20 Independent High-Level Panel"}, {"color": "#57db5f", "font": {"color": "#dbdbdb"}, "id": "G20 Italia Declaration of Health Ministers", "label": "G20 Italia Declaration of Health Ministers", "shape": "dot", "size": 24, "title": "G20 Italia Declaration of Health Ministers"}, {"color": "#57db5f", "font": {"color": "#dbdbdb"}, "id": "Global Health Summit", "label": "Global Health Summit", "shape": "dot", "size": 40, "title": "Global Health Summit"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "OH workforce", "label": "OH workforce", "shape": "dot", "size": 32, "title": "OH workforce"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Integrated OH surveillance system", "label": "Integrated OH surveillance system", "shape": "dot", "size": 24, "title": "Integrated OH surveillance system"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Routine and emergency coordination mechanisms", "label": "Routine and emergency coordination mechanisms", "shape": "dot", "size": 32, "title": "Routine and emergency coordination mechanisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Standardised framework for addressing zoonotic spillover risks", "label": "Standardised framework for addressing zoonotic spillover risks", "shape": "dot", "size": 24, "title": "Standardised framework for addressing zoonotic spillover risks"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Urbanisation and habitat fragmentation", "label": "Urbanisation and habitat fragmentation", "shape": "dot", "size": 24, "title": "Urbanisation and habitat fragmentation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Spillover risks and disease spread", "label": "Spillover risks and disease spread", "shape": "dot", "size": 32, "title": "Spillover risks and disease spread"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "G20 support to invest in preparedness and national capacity", "label": "G20 support to invest in preparedness and national capacity", "shape": "dot", "size": 40, "title": "G20 support to invest in preparedness and national capacity"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "workforce capacity and readiness", "label": "workforce capacity and readiness", "shape": "dot", "size": 40, "title": "workforce capacity and readiness"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "national assessments and benchmarking", "label": "national assessments and benchmarking", "shape": "dot", "size": 32, "title": "national assessments and benchmarking"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "World Bank\u2019s Pandemic Fund", "label": "World Bank\u2019s Pandemic Fund", "shape": "dot", "size": 32, "title": "World Bank\u2019s Pandemic Fund"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "strengthening human resources", "label": "strengthening human resources", "shape": "dot", "size": 40, "title": "strengthening human resources"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "countries prevent, prepare for, and respond to health emergencies", "label": "countries prevent, prepare for, and respond to health emergencies", "shape": "dot", "size": 32, "title": "countries prevent, prepare for, and respond to health emergencies"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "sustainable public health workforce capacity in LMICs", "label": "sustainable public health workforce capacity in LMICs", "shape": "dot", "size": 40, "title": "sustainable public health workforce capacity in LMICs"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "label": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "shape": "dot", "size": 32, "title": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord"}, {"color": "#69db57", "font": {"color": "#dbdbdb"}, "id": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "label": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "shape": "dot", "size": 24, "title": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G7", "label": "G7", "shape": "dot", "size": 32, "title": "G7"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G7 Germany", "label": "G7 Germany", "shape": "dot", "size": 16, "title": "G7 Germany"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G7 Summit", "label": "G7 Summit", "shape": "dot", "size": 32, "title": "G7 Summit"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "G7 and the G20", "label": "G7 and the G20", "shape": "dot", "size": 24, "title": "G7 and the G20"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "GP/family physician", "label": "GP/family physician", "shape": "dot", "size": 24, "title": "GP/family physician"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Gavi (Global Alliance for Vaccines and Immunization)", "label": "Gavi (Global Alliance for Vaccines and Immunization)", "shape": "dot", "size": 24, "title": "Gavi (Global Alliance for Vaccines and Immunization)"}, {"color": "#84db57", "font": {"color": "#dbdbdb"}, "id": "Gavi and WHO", "label": "Gavi and WHO", "shape": "dot", "size": 32, "title": "Gavi and WHO"}, {"color": "#84db57", "font": {"color": "#dbdbdb"}, "id": "in-country delivery requirements", "label": "in-country delivery requirements", "shape": "dot", "size": 40, "title": "in-country delivery requirements"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Imperial College London", "label": "Imperial College London", "shape": "dot", "size": 24, "title": "Imperial College London"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "conditions", "label": "conditions", "shape": "dot", "size": 24, "title": "conditions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Gender Inequality", "label": "Gender Inequality", "shape": "dot", "size": 32, "title": "Gender Inequality"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Germany", "label": "Germany", "shape": "dot", "size": 16, "title": "Germany"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Global", "label": "Global", "shape": "dot", "size": 16, "title": "Global"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "Global DPI Summit21", "label": "Global DPI Summit21", "shape": "dot", "size": 24, "title": "Global DPI Summit21"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "label": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "shape": "dot", "size": 40, "title": "India\u0027s Digital Public Infrastructure Transformation Ecosystem"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Global Digital Health Partnership (GDHP)", "label": "Global Digital Health Partnership (GDHP)", "shape": "dot", "size": 32, "title": "Global Digital Health Partnership (GDHP)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Early Warning and Response System for Major Animal Diseases", "label": "Global Early Warning and Response System for Major Animal Diseases", "shape": "dot", "size": 32, "title": "Global Early Warning and Response System for Major Animal Diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "ecological connectivity", "label": "ecological connectivity", "shape": "dot", "size": 40, "title": "ecological connectivity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Pathways to Health Equity", "label": "Pathways to Health Equity", "shape": "dot", "size": 32, "title": "Pathways to Health Equity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Infectious diseases", "label": "Infectious diseases", "shape": "dot", "size": 32, "title": "Infectious diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Surveillance systems", "label": "Surveillance systems", "shape": "dot", "size": 24, "title": "Surveillance systems"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global collaboration and solidarity", "label": "Global collaboration and solidarity", "shape": "dot", "size": 32, "title": "Global collaboration and solidarity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Nature", "label": "Nature", "shape": "dot", "size": 16, "title": "Nature"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health and well-being for all people everywhere", "label": "Health and well-being for all people everywhere", "shape": "dot", "size": 32, "title": "Health and well-being for all people everywhere"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "MS Swaminathan Research Foundation", "label": "MS Swaminathan Research Foundation", "shape": "dot", "size": 16, "title": "MS Swaminathan Research Foundation"}, {"color": "#57b9db", "font": {"color": "#dbdbdb"}, "id": "Global Health Initiatives", "label": "Global Health Initiatives", "shape": "dot", "size": 32, "title": "Global Health Initiatives"}, {"color": "#57db5f", "font": {"color": "#dbdbdb"}, "id": "Rome Declaration", "label": "Rome Declaration", "shape": "dot", "size": 32, "title": "Rome Declaration"}, {"color": "#57d3db", "font": {"color": "#dbdbdb"}, "id": "countries across the world", "label": "countries across the world", "shape": "dot", "size": 32, "title": "countries across the world"}, {"color": "#57d3db", "font": {"color": "#dbdbdb"}, "id": "resources to deliver", "label": "resources to deliver", "shape": "dot", "size": 24, "title": "resources to deliver"}, {"color": "#57d3db", "font": {"color": "#dbdbdb"}, "id": "Panel for a Global Public Health Convention", "label": "Panel for a Global Public Health Convention", "shape": "dot", "size": 24, "title": "Panel for a Global Public Health Convention"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Global Strategy on Digital Health 2020-2025", "label": "Global Strategy on Digital Health 2020-2025", "shape": "dot", "size": 24, "title": "Global Strategy on Digital Health 2020-2025"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "Global Vaccine Library", "label": "Global Vaccine Library", "shape": "dot", "size": 32, "title": "Global Vaccine Library"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "coronavirus", "label": "coronavirus", "shape": "dot", "size": 40, "title": "coronavirus"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global Vector Control Response (GVCR) 2017\u20132030", "label": "Global Vector Control Response (GVCR) 2017\u20132030", "shape": "dot", "size": 32, "title": "Global Vector Control Response (GVCR) 2017\u20132030"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "Global average", "label": "Global average", "shape": "dot", "size": 24, "title": "Global average"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global economic loss due to mental disorders", "label": "Global economic loss due to mental disorders", "shape": "dot", "size": 16, "title": "Global economic loss due to mental disorders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Global partners", "label": "Global partners", "shape": "dot", "size": 24, "title": "Global partners"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Governments pool funding", "label": "Governments pool funding", "shape": "dot", "size": 24, "title": "Governments pool funding"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Green Highlighted Countries", "label": "Green Highlighted Countries", "shape": "dot", "size": 24, "title": "Green Highlighted Countries"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "HIV infections", "label": "HIV infections", "shape": "dot", "size": 32, "title": "HIV infections"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "global health system", "label": "global health system", "shape": "dot", "size": 40, "title": "global health system"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health Equity Assessment Toolkit (HEAT and HEAT Plus)", "label": "Health Equity Assessment Toolkit (HEAT and HEAT Plus)", "shape": "dot", "size": 24, "title": "Health Equity Assessment Toolkit (HEAT and HEAT Plus)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Out-of-Pocket Expenditure (OOPE)", "label": "Out-of-Pocket Expenditure (OOPE)", "shape": "dot", "size": 32, "title": "Out-of-Pocket Expenditure (OOPE)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Indonesia", "label": "Indonesia", "shape": "dot", "size": 30, "title": "Indonesia"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "JKN National Health Insurance", "label": "JKN National Health Insurance", "shape": "dot", "size": 16, "title": "JKN National Health Insurance"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "hospital-centric healthcare system", "label": "hospital-centric healthcare system", "shape": "dot", "size": 24, "title": "hospital-centric healthcare system"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "preventive model", "label": "preventive model", "shape": "dot", "size": 24, "title": "preventive model"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "universal health care", "label": "universal health care", "shape": "dot", "size": 32, "title": "universal health care"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Singapore", "label": "Singapore", "shape": "dot", "size": 16, "title": "Singapore"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "primary care", "label": "primary care", "shape": "dot", "size": 24, "title": "primary care"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "judicious purchasing and effective procurement", "label": "judicious purchasing and effective procurement", "shape": "dot", "size": 16, "title": "judicious purchasing and effective procurement"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health Management Information System", "label": "Health Management Information System", "shape": "dot", "size": 24, "title": "Health Management Information System"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Health Sector", "label": "Health Sector", "shape": "dot", "size": 24, "title": "Health Sector"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Healthcare Spending and Health Outcomes", "label": "Healthcare Spending and Health Outcomes", "shape": "dot", "size": 32, "title": "Healthcare Spending and Health Outcomes"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "Healthcare providers", "label": "Healthcare providers", "shape": "dot", "size": 16, "title": "Healthcare providers"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "JKN program", "label": "JKN program", "shape": "dot", "size": 40, "title": "JKN program"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "High-Income Countries", "label": "High-Income Countries", "shape": "dot", "size": 32, "title": "High-Income Countries"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Higher % GDP Spending in Healthcare", "label": "Higher % GDP Spending in Healthcare", "shape": "dot", "size": 24, "title": "Higher % GDP Spending in Healthcare"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Hospital Management Information System", "label": "Hospital Management Information System", "shape": "dot", "size": 24, "title": "Hospital Management Information System"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Human rights", "label": "Human rights", "shape": "dot", "size": 16, "title": "Human rights"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "IDN", "label": "IDN", "shape": "dot", "size": 8, "title": "IDN"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "IDNIND", "label": "IDNIND", "shape": "dot", "size": 8, "title": "IDNIND"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "IHR", "label": "IHR", "shape": "dot", "size": 40, "title": "IHR"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "WGIHR", "label": "WGIHR", "shape": "dot", "size": 32, "title": "WGIHR"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "INDKOR", "label": "INDKOR", "shape": "dot", "size": 8, "title": "INDKOR"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "ITA", "label": "ITA", "shape": "dot", "size": 16, "title": "ITA"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Improving population health", "label": "Improving population health", "shape": "dot", "size": 24, "title": "Improving population health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "social inequality", "label": "social inequality", "shape": "dot", "size": 32, "title": "social inequality"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "gender issues", "label": "gender issues", "shape": "dot", "size": 32, "title": "gender issues"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "community participation", "label": "community participation", "shape": "dot", "size": 24, "title": "community participation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)", "label": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)", "shape": "dot", "size": 32, "title": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Online Registration System", "label": "Online Registration System", "shape": "dot", "size": 16, "title": "Online Registration System"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National tuberculosis elimination (Ni-kshay)", "label": "National tuberculosis elimination (Ni-kshay)", "shape": "dot", "size": 24, "title": "National tuberculosis elimination (Ni-kshay)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mother and Child Tracking System", "label": "Mother and Child Tracking System", "shape": "dot", "size": 16, "title": "Mother and Child Tracking System"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mera Aspataal (My Hospital)", "label": "Mera Aspataal (My Hospital)", "shape": "dot", "size": 16, "title": "Mera Aspataal (My Hospital)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Integrated Health Information Platform", "label": "Integrated Health Information Platform", "shape": "dot", "size": 16, "title": "Integrated Health Information Platform"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Non-Communicable Diseases screening application", "label": "Non-Communicable Diseases screening application", "shape": "dot", "size": 16, "title": "Non-Communicable Diseases screening application"}, {"color": "#57dbc9", "font": {"color": "#dbdbdb"}, "id": "Ministry of Electronics and Information Technology (MeitY)", "label": "Ministry of Electronics and Information Technology (MeitY)", "shape": "dot", "size": 32, "title": "Ministry of Electronics and Information Technology (MeitY)"}, {"color": "#57dbc9", "font": {"color": "#dbdbdb"}, "id": "One Government", "label": "One Government", "shape": "dot", "size": 24, "title": "One Government"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Unified Payments Interface (UPI)", "label": "Unified Payments Interface (UPI)", "shape": "dot", "size": 32, "title": "Unified Payments Interface (UPI)"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Open Credit Enablement Network", "label": "Open Credit Enablement Network", "shape": "dot", "size": 16, "title": "Open Credit Enablement Network"}, {"color": "#ae57db", "font": {"color": "#dbdbdb"}, "id": "Private sector service delivery", "label": "Private sector service delivery", "shape": "dot", "size": 24, "title": "Private sector service delivery"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "India\u0027s DPI", "label": "India\u0027s DPI", "shape": "dot", "size": 32, "title": "India\u0027s DPI"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "MeitY study", "label": "MeitY study", "shape": "dot", "size": 32, "title": "MeitY study"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "US$500 billion by 2025", "label": "US$500 billion by 2025", "shape": "dot", "size": 24, "title": "US$500 billion by 2025"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "India\u0027s digital economy potential to US$1 trillion", "label": "India\u0027s digital economy potential to US$1 trillion", "shape": "dot", "size": 32, "title": "India\u0027s digital economy potential to US$1 trillion"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "business as usual scenario", "label": "business as usual scenario", "shape": "dot", "size": 16, "title": "business as usual scenario"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "real-time payments in India, China, Brazil", "label": "real-time payments in India, China, Brazil", "shape": "dot", "size": 24, "title": "real-time payments in India, China, Brazil"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "physical delivery of financial benefits", "label": "physical delivery of financial benefits", "shape": "dot", "size": 16, "title": "physical delivery of financial benefits"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "digital payment systems", "label": "digital payment systems", "shape": "dot", "size": 24, "title": "digital payment systems"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "beneficiaries\u0027 bank accounts", "label": "beneficiaries\u0027 bank accounts", "shape": "dot", "size": 16, "title": "beneficiaries\u0027 bank accounts"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "corruption, eliminating middlemen", "label": "corruption, eliminating middlemen", "shape": "dot", "size": 24, "title": "corruption, eliminating middlemen"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "forums and platforms for stakeholders", "label": "forums and platforms for stakeholders", "shape": "dot", "size": 32, "title": "forums and platforms for stakeholders"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "policy discussions and regulatory consultations", "label": "policy discussions and regulatory consultations", "shape": "dot", "size": 32, "title": "policy discussions and regulatory consultations"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "balanced regulatory policies", "label": "balanced regulatory policies", "shape": "dot", "size": 24, "title": "balanced regulatory policies"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "Indian regulators", "label": "Indian regulators", "shape": "dot", "size": 32, "title": "Indian regulators"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "presentation of the Digital India Act 2023", "label": "presentation of the Digital India Act 2023", "shape": "dot", "size": 24, "title": "presentation of the Digital India Act 2023"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "consumer needs, emerging technologies, and market trends", "label": "consumer needs, emerging technologies, and market trends", "shape": "dot", "size": 32, "title": "consumer needs, emerging technologies, and market trends"}, {"color": "#57dbae", "font": {"color": "#dbdbdb"}, "id": "challenges", "label": "challenges", "shape": "dot", "size": 16, "title": "challenges"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "government agencies", "label": "government agencies", "shape": "dot", "size": 32, "title": "government agencies"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "industry leaders", "label": "industry leaders", "shape": "dot", "size": 32, "title": "industry leaders"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "startups", "label": "startups", "shape": "dot", "size": 24, "title": "startups"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "academia", "label": "academia", "shape": "dot", "size": 16, "title": "academia"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "civil society organisations", "label": "civil society organisations", "shape": "dot", "size": 24, "title": "civil society organisations"}, {"color": "#9edb57", "font": {"color": "#dbdbdb"}, "id": "India\u2019s G20 presidency", "label": "India\u2019s G20 presidency", "shape": "dot", "size": 32, "title": "India\u2019s G20 presidency"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Indian Rupees (INR)", "label": "Indian Rupees (INR)", "shape": "dot", "size": 16, "title": "Indian Rupees (INR)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "healthcare expenditure", "label": "healthcare expenditure", "shape": "dot", "size": 24, "title": "healthcare expenditure"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "OOP payments", "label": "OOP payments", "shape": "dot", "size": 16, "title": "OOP payments"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "drug pricing and procurement", "label": "drug pricing and procurement", "shape": "dot", "size": 32, "title": "drug pricing and procurement"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "Indonesian citizens", "label": "Indonesian citizens", "shape": "dot", "size": 32, "title": "Indonesian citizens"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Inequality", "label": "Inequality", "shape": "dot", "size": 32, "title": "Inequality"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Innovative Financing Mechanisms", "label": "Innovative Financing Mechanisms", "shape": "dot", "size": 24, "title": "Innovative Financing Mechanisms"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Manufacturers and the private sector", "label": "Manufacturers and the private sector", "shape": "dot", "size": 32, "title": "Manufacturers and the private sector"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Poor diagnostic capacity", "label": "Poor diagnostic capacity", "shape": "dot", "size": 24, "title": "Poor diagnostic capacity"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Intergovernmental Negotiating Body (INB)", "label": "Intergovernmental Negotiating Body (INB)", "shape": "dot", "size": 16, "title": "Intergovernmental Negotiating Body (INB)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "International Health Regulations (IHR)", "label": "International Health Regulations (IHR)", "shape": "dot", "size": 32, "title": "International Health Regulations (IHR)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Investing in mental health", "label": "Investing in mental health", "shape": "dot", "size": 32, "title": "Investing in mental health"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Investment in treatment of mental illness", "label": "Investment in treatment of mental illness", "shape": "dot", "size": 24, "title": "Investment in treatment of mental illness"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "JKN", "label": "JKN", "shape": "dot", "size": 24, "title": "JKN"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "Social Security Agency for Health (B P J S)", "label": "Social Security Agency for Health (B P J S)", "shape": "dot", "size": 24, "title": "Social Security Agency for Health (B P J S)"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "medical benefit package", "label": "medical benefit package", "shape": "dot", "size": 24, "title": "medical benefit package"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "Out-of-pocket expenditure (OOP)", "label": "Out-of-pocket expenditure (OOP)", "shape": "dot", "size": 16, "title": "Out-of-pocket expenditure (OOP)"}, {"color": "#b9db57", "font": {"color": "#dbdbdb"}, "id": "Low and medium-income countries (LMICs)", "label": "Low and medium-income countries (LMICs)", "shape": "dot", "size": 8, "title": "Low and medium-income countries (LMICs)"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "JPNDEU", "label": "JPNDEU", "shape": "dot", "size": 8, "title": "JPNDEU"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Jan Dhan-Aadhaar-Mobile Yojana", "label": "Jan Dhan-Aadhaar-Mobile Yojana", "shape": "dot", "size": 32, "title": "Jan Dhan-Aadhaar-Mobile Yojana"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Japan", "label": "Japan", "shape": "dot", "size": 16, "title": "Japan"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "KSA KSAFRA", "label": "KSA KSAFRA", "shape": "dot", "size": 8, "title": "KSA KSAFRA"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "infectious diseases", "label": "infectious diseases", "shape": "dot", "size": 40, "title": "infectious diseases"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "ZAFTURTUR", "label": "ZAFTURTUR", "shape": "dot", "size": 8, "title": "ZAFTURTUR"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "USAUSAJPN", "label": "USAUSAJPN", "shape": "dot", "size": 16, "title": "USAUSAJPN"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "SPNITA", "label": "SPNITA", "shape": "dot", "size": 8, "title": "SPNITA"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "RUSMEX", "label": "RUSMEX", "shape": "dot", "size": 8, "title": "RUSMEX"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "MEX", "label": "MEX", "shape": "dot", "size": 16, "title": "MEX"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "SGP", "label": "SGP", "shape": "dot", "size": 16, "title": "SGP"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "SGPCAN", "label": "SGPCAN", "shape": "dot", "size": 8, "title": "SGPCAN"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "UKUK", "label": "UKUK", "shape": "dot", "size": 16, "title": "UKUK"}, {"color": "#db57b9", "font": {"color": "#dbdbdb"}, "id": "ZAF", "label": "ZAF", "shape": "dot", "size": 16, "title": "ZAF"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "MERS", "label": "MERS", "shape": "dot", "size": 28, "title": "MERS"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "MHCA 2017", "label": "MHCA 2017", "shape": "dot", "size": 32, "title": "MHCA 2017"}, {"color": "#d3db57", "font": {"color": "#dbdbdb"}, "id": "MediShield Life", "label": "MediShield Life", "shape": "dot", "size": 40, "title": "MediShield Life"}, {"color": "#d3db57", "font": {"color": "#dbdbdb"}, "id": "Widening coverage", "label": "Widening coverage", "shape": "dot", "size": 32, "title": "Widening coverage"}, {"color": "#d3db57", "font": {"color": "#dbdbdb"}, "id": "pre-existing conditions", "label": "pre-existing conditions", "shape": "dot", "size": 32, "title": "pre-existing conditions"}, {"color": "#d3db57", "font": {"color": "#dbdbdb"}, "id": "older individuals", "label": "older individuals", "shape": "dot", "size": 24, "title": "older individuals"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Memorandum of Understanding (MOU)", "label": "Memorandum of Understanding (MOU)", "shape": "dot", "size": 32, "title": "Memorandum of Understanding (MOU)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "United Nations (UN)", "label": "United Nations (UN)", "shape": "dot", "size": 24, "title": "United Nations (UN)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Sustainable Development Goals (SDGs)", "label": "Sustainable Development Goals (SDGs)", "shape": "dot", "size": 32, "title": "Sustainable Development Goals (SDGs)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "United Kingdom (UK)", "label": "United Kingdom (UK)", "shape": "dot", "size": 24, "title": "United Kingdom (UK)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Health Service (NHS)", "label": "National Health Service (NHS)", "shape": "dot", "size": 16, "title": "National Health Service (NHS)"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public Health Domain", "label": "Public Health Domain", "shape": "dot", "size": 24, "title": "Public Health Domain"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Mental Health Review Boards", "label": "Mental Health Review Boards", "shape": "dot", "size": 24, "title": "Mental Health Review Boards"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Social inequality", "label": "Social inequality", "shape": "dot", "size": 24, "title": "Social inequality"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "The Burden of Mental Health, Substance Use Disorders and Multimorbidity", "label": "The Burden of Mental Health, Substance Use Disorders and Multimorbidity", "shape": "dot", "size": 24, "title": "The Burden of Mental Health, Substance Use Disorders and Multimorbidity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Mental and substance-abuse disorders", "label": "Mental and substance-abuse disorders", "shape": "dot", "size": 16, "title": "Mental and substance-abuse disorders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Premature morbidity and mortality globally", "label": "Premature morbidity and mortality globally", "shape": "dot", "size": 8, "title": "Premature morbidity and mortality globally"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "National Mental Health Survey (NMHS), 2015-16", "label": "National Mental Health Survey (NMHS), 2015-16", "shape": "dot", "size": 8, "title": "National Mental Health Survey (NMHS), 2015-16"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Mexico", "label": "Mexico", "shape": "dot", "size": 16, "title": "Mexico"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "MyGov platform", "label": "MyGov platform", "shape": "dot", "size": 40, "title": "MyGov platform"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "digital governance", "label": "digital governance", "shape": "dot", "size": 32, "title": "digital governance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "citizen-centricity", "label": "citizen-centricity", "shape": "dot", "size": 32, "title": "citizen-centricity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "government interactions", "label": "government interactions", "shape": "dot", "size": 24, "title": "government interactions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "citizen-government gap", "label": "citizen-government gap", "shape": "dot", "size": 24, "title": "citizen-government gap"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "enhance government services", "label": "enhance government services", "shape": "dot", "size": 24, "title": "enhance government services"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "democratic participation", "label": "democratic participation", "shape": "dot", "size": 24, "title": "democratic participation"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "NGOs", "label": "NGOs", "shape": "dot", "size": 32, "title": "NGOs"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Netherlands", "label": "Netherlands", "shape": "dot", "size": 16, "title": "Netherlands"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "New legislation", "label": "New legislation", "shape": "dot", "size": 24, "title": "New legislation"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "antibiotic", "label": "antibiotic", "shape": "dot", "size": 40, "title": "antibiotic"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "Nipah", "label": "Nipah", "shape": "dot", "size": 24, "title": "Nipah"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "interpersonal relationships", "label": "interpersonal relationships", "shape": "dot", "size": 32, "title": "interpersonal relationships"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "veterinary workforce", "label": "veterinary workforce", "shape": "dot", "size": 24, "title": "veterinary workforce"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "academic institutions", "label": "academic institutions", "shape": "dot", "size": 32, "title": "academic institutions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "local population", "label": "local population", "shape": "dot", "size": 24, "title": "local population"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Tamil Nadu Veterinary and Animal Sciences University", "label": "Tamil Nadu Veterinary and Animal Sciences University", "shape": "dot", "size": 24, "title": "Tamil Nadu Veterinary and Animal Sciences University"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Tamil Nadu Dr MGR Medical University", "label": "Tamil Nadu Dr MGR Medical University", "shape": "dot", "size": 32, "title": "Tamil Nadu Dr MGR Medical University"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Punjab", "label": "Punjab", "shape": "dot", "size": 16, "title": "Punjab"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "SARS-CoV2 vaccine trial", "label": "SARS-CoV2 vaccine trial", "shape": "dot", "size": 32, "title": "SARS-CoV2 vaccine trial"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "outbreak investigation", "label": "outbreak investigation", "shape": "dot", "size": 24, "title": "outbreak investigation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vaccine hesitancy", "label": "vaccine hesitancy", "shape": "dot", "size": 32, "title": "vaccine hesitancy"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "OTC sale of antimicrobials", "label": "OTC sale of antimicrobials", "shape": "dot", "size": 32, "title": "OTC sale of antimicrobials"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "United Nations Environment Programme", "label": "United Nations Environment Programme", "shape": "dot", "size": 16, "title": "United Nations Environment Programme"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Organisation for Animal Health", "label": "World Organisation for Animal Health", "shape": "dot", "size": 16, "title": "World Organisation for Animal Health"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemic prevention, preparedness, and response", "label": "pandemic prevention, preparedness, and response", "shape": "dot", "size": 32, "title": "pandemic prevention, preparedness, and response"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "domestic health systems", "label": "domestic health systems", "shape": "dot", "size": 24, "title": "domestic health systems"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "One Health High-Level Expert Panel", "label": "One Health High-Level Expert Panel", "shape": "dot", "size": 32, "title": "One Health High-Level Expert Panel"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "One Health Joint Plan of Action (2022-2026)", "label": "One Health Joint Plan of Action (2022-2026)", "shape": "dot", "size": 24, "title": "One Health Joint Plan of Action (2022-2026)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Health Organisation (WHO)", "label": "World Health Organisation (WHO)", "shape": "dot", "size": 32, "title": "World Health Organisation (WHO)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "United Nations Environment Programme (UNEP)", "label": "United Nations Environment Programme (UNEP)", "shape": "dot", "size": 24, "title": "United Nations Environment Programme (UNEP)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Organisation for Animal Health (OIE)", "label": "World Organisation for Animal Health (OIE)", "shape": "dot", "size": 16, "title": "World Organisation for Animal Health (OIE)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemic prevention and preparedness", "label": "pandemic prevention and preparedness", "shape": "dot", "size": 32, "title": "pandemic prevention and preparedness"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Bank\u0027s US$10-billion fund", "label": "World Bank\u0027s US$10-billion fund", "shape": "dot", "size": 24, "title": "World Bank\u0027s US$10-billion fund"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "UN\u2019s high-level meeting on pandemic prevention, preparedness, and response (September 2023)", "label": "UN\u2019s high-level meeting on pandemic prevention, preparedness, and response (September 2023)", "shape": "dot", "size": 32, "title": "UN\u2019s high-level meeting on pandemic prevention, preparedness, and response (September 2023)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "zoonoses and transboundary animal diseases", "label": "zoonoses and transboundary animal diseases", "shape": "dot", "size": 32, "title": "zoonoses and transboundary animal diseases"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "zonotic policy documents", "label": "zonotic policy documents", "shape": "dot", "size": 32, "title": "zonotic policy documents"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "lack of supportive policies", "label": "lack of supportive policies", "shape": "dot", "size": 24, "title": "lack of supportive policies"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "conflicting departmental priorities", "label": "conflicting departmental priorities", "shape": "dot", "size": 24, "title": "conflicting departmental priorities"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "limited institutional capacities", "label": "limited institutional capacities", "shape": "dot", "size": 24, "title": "limited institutional capacities"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "cross-sectoral collaboration on disease control", "label": "cross-sectoral collaboration on disease control", "shape": "dot", "size": 16, "title": "cross-sectoral collaboration on disease control"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts", "label": "contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts", "shape": "dot", "size": 24, "title": "contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "new vaccines", "label": "new vaccines", "shape": "dot", "size": 24, "title": "new vaccines"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "improved surveillance", "label": "improved surveillance", "shape": "dot", "size": 16, "title": "improved surveillance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "non-pharmaceutical interventions", "label": "non-pharmaceutical interventions", "shape": "dot", "size": 24, "title": "non-pharmaceutical interventions"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "virus families", "label": "virus families", "shape": "dot", "size": 32, "title": "virus families"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Out-of-Pocket Expenses", "label": "Out-of-Pocket Expenses", "shape": "dot", "size": 24, "title": "Out-of-Pocket Expenses"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "PPR", "label": "PPR", "shape": "dot", "size": 16, "title": "PPR"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "WHO\u0027s 194 member states", "label": "WHO\u0027s 194 member states", "shape": "dot", "size": 24, "title": "WHO\u0027s 194 member states"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Health Assembly (WHA)", "label": "World Health Assembly (WHA)", "shape": "dot", "size": 32, "title": "World Health Assembly (WHA)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Working Group on amendments to the IHR (WGIHR)", "label": "Working Group on amendments to the IHR (WGIHR)", "shape": "dot", "size": 24, "title": "Working Group on amendments to the IHR (WGIHR)"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "World Trade Organization", "label": "World Trade Organization", "shape": "dot", "size": 24, "title": "World Trade Organization"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "TRIPS waiver", "label": "TRIPS waiver", "shape": "dot", "size": 32, "title": "TRIPS waiver"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "equity of access", "label": "equity of access", "shape": "dot", "size": 32, "title": "equity of access"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "Pandemic Accord and the IHR", "label": "Pandemic Accord and the IHR", "shape": "dot", "size": 24, "title": "Pandemic Accord and the IHR"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "financing", "label": "financing", "shape": "dot", "size": 32, "title": "financing"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "annual financing need for future preparedness and response to pandemics", "label": "annual financing need for future preparedness and response to pandemics", "shape": "dot", "size": 32, "title": "annual financing need for future preparedness and response to pandemics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Pradhan Mantri Jan-Dhan Yojana", "label": "Pradhan Mantri Jan-Dhan Yojana", "shape": "dot", "size": 24, "title": "Pradhan Mantri Jan-Dhan Yojana"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public Health System", "label": "Public Health System", "shape": "dot", "size": 24, "title": "Public Health System"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Routine immunisation", "label": "Routine immunisation", "shape": "dot", "size": 8, "title": "Routine immunisation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "occupations outside of the health sector", "label": "occupations outside of the health sector", "shape": "dot", "size": 32, "title": "occupations outside of the health sector"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "roadmap and action plan", "label": "roadmap and action plan", "shape": "dot", "size": 32, "title": "roadmap and action plan"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "standard EPHF", "label": "standard EPHF", "shape": "dot", "size": 24, "title": "standard EPHF"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "whole-of-government and whole-of-society approach", "label": "whole-of-government and whole-of-society approach", "shape": "dot", "size": 32, "title": "whole-of-government and whole-of-society approach"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "national stakeholders", "label": "national stakeholders", "shape": "dot", "size": 24, "title": "national stakeholders"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "existing national and global networks of partners", "label": "existing national and global networks of partners", "shape": "dot", "size": 32, "title": "existing national and global networks of partners"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "country-based assessment", "label": "country-based assessment", "shape": "dot", "size": 24, "title": "country-based assessment"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "policy improvement", "label": "policy improvement", "shape": "dot", "size": 32, "title": "policy improvement"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "Public health and emergency workforce roadmap", "label": "Public health and emergency workforce roadmap", "shape": "dot", "size": 24, "title": "Public health and emergency workforce roadmap"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "R\u0026D", "label": "R\u0026D", "shape": "dot", "size": 40, "title": "R\u0026D"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "recommendations", "label": "recommendations", "shape": "dot", "size": 32, "title": "recommendations"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "supply", "label": "supply", "shape": "dot", "size": 32, "title": "supply"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "demand", "label": "demand", "shape": "dot", "size": 32, "title": "demand"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "manufacturing", "label": "manufacturing", "shape": "dot", "size": 32, "title": "manufacturing"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "country-level challenges", "label": "country-level challenges", "shape": "dot", "size": 40, "title": "country-level challenges"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "other factors", "label": "other factors", "shape": "dot", "size": 32, "title": "other factors"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "at-risk investments", "label": "at-risk investments", "shape": "dot", "size": 40, "title": "at-risk investments"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "funding", "label": "funding", "shape": "dot", "size": 32, "title": "funding"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "R\u0026D stage", "label": "R\u0026D stage", "shape": "dot", "size": 32, "title": "R\u0026D stage"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "RSV", "label": "RSV", "shape": "dot", "size": 32, "title": "RSV"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "healthcare structure", "label": "healthcare structure", "shape": "dot", "size": 24, "title": "healthcare structure"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Universal Health Care Coverage", "label": "Universal Health Care Coverage", "shape": "dot", "size": 32, "title": "Universal Health Care Coverage"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "WHO Data", "label": "WHO Data", "shape": "dot", "size": 16, "title": "WHO Data"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Russia", "label": "Russia", "shape": "dot", "size": 16, "title": "Russia"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "SARS", "label": "SARS", "shape": "dot", "size": 28, "title": "SARS"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "South Africa", "label": "South Africa", "shape": "dot", "size": 16, "title": "South Africa"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "South Korea", "label": "South Korea", "shape": "dot", "size": 16, "title": "South Korea"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Spain", "label": "Spain", "shape": "dot", "size": 16, "title": "Spain"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal", "label": "Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal", "shape": "dot", "size": 32, "title": "Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "Success in getting mRNA vaccine manufacturing underway in South Africa", "label": "Success in getting mRNA vaccine manufacturing underway in South Africa", "shape": "dot", "size": 32, "title": "Success in getting mRNA vaccine manufacturing underway in South Africa"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "World Mental Health Day", "label": "World Mental Health Day", "shape": "dot", "size": 24, "title": "World Mental Health Day"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "tele-mental health services", "label": "tele-mental health services", "shape": "dot", "size": 32, "title": "tele-mental health services"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "remote and underserved areas", "label": "remote and underserved areas", "shape": "dot", "size": 24, "title": "remote and underserved areas"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "Telephone/mobile based initiatives", "label": "Telephone/mobile based initiatives", "shape": "dot", "size": 24, "title": "Telephone/mobile based initiatives"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "eSanjeevani", "label": "eSanjeevani", "shape": "dot", "size": 32, "title": "eSanjeevani"}, {"color": "#5784db", "font": {"color": "#dbdbdb"}, "id": "e-Manas Karnataka", "label": "e-Manas Karnataka", "shape": "dot", "size": 24, "title": "e-Manas Karnataka"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Tele-MANAS programme", "label": "Tele-MANAS programme", "shape": "dot", "size": 32, "title": "Tele-MANAS programme"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "evidence-based integration", "label": "evidence-based integration", "shape": "dot", "size": 40, "title": "evidence-based integration"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "Tele-education in medical education for remote areas", "label": "Tele-education in medical education for remote areas", "shape": "dot", "size": 32, "title": "Tele-education in medical education for remote areas"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "The Urgent Need for a Pandemic Accord", "label": "The Urgent Need for a Pandemic Accord", "shape": "dot", "size": 16, "title": "The Urgent Need for a Pandemic Accord"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "Turkiye", "label": "Turkiye", "shape": "dot", "size": 16, "title": "Turkiye"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "national policies", "label": "national policies", "shape": "dot", "size": 32, "title": "national policies"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "healthcare providers", "label": "healthcare providers", "shape": "dot", "size": 32, "title": "healthcare providers"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "public and private hospitals", "label": "public and private hospitals", "shape": "dot", "size": 24, "title": "public and private hospitals"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "clinics and facilities", "label": "clinics and facilities", "shape": "dot", "size": 24, "title": "clinics and facilities"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "healthcare infrastructure", "label": "healthcare infrastructure", "shape": "dot", "size": 32, "title": "healthcare infrastructure"}, {"color": "#5769db", "font": {"color": "#dbdbdb"}, "id": "disparities in healthcare infrastructure", "label": "disparities in healthcare infrastructure", "shape": "dot", "size": 24, "title": "disparities in healthcare infrastructure"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "UK", "label": "UK", "shape": "dot", "size": 16, "title": "UK"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "UPI", "label": "UPI", "shape": "dot", "size": 24, "title": "UPI"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "United Nations Children\u2019s Fund (UNICEF)", "label": "United Nations Children\u2019s Fund (UNICEF)", "shape": "dot", "size": 24, "title": "United Nations Children\u2019s Fund (UNICEF)"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "United States", "label": "United States", "shape": "dot", "size": 16, "title": "United States"}, {"color": "#dbc957", "font": {"color": "#dbdbdb"}, "id": "WHO norms, standards, and", "label": "WHO norms, standards, and", "shape": "dot", "size": 32, "title": "WHO norms, standards, and"}, {"color": "#dbc957", "font": {"color": "#dbdbdb"}, "id": "digital public goods", "label": "digital public goods", "shape": "dot", "size": 40, "title": "digital public goods"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "World Federation of Public Health Associations (WFPHA), International", "label": "World Federation of Public Health Associations (WFPHA), International", "shape": "dot", "size": 16, "title": "World Federation of Public Health Associations (WFPHA), International"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "healthcare service delivery", "label": "healthcare service delivery", "shape": "dot", "size": 40, "title": "healthcare service delivery"}, {"color": "#dbae57", "font": {"color": "#dbdbdb"}, "id": "World Mental Health Report, 2022", "label": "World Mental Health Report, 2022", "shape": "dot", "size": 40, "title": "World Mental Health Report, 2022"}, {"color": "#dbae57", "font": {"color": "#dbdbdb"}, "id": "interrelated services", "label": "interrelated services", "shape": "dot", "size": 32, "title": "interrelated services"}, {"color": "#dbae57", "font": {"color": "#dbdbdb"}, "id": "life cycle", "label": "life cycle", "shape": "dot", "size": 24, "title": "life cycle"}, {"color": "#dbae57", "font": {"color": "#dbdbdb"}, "id": "maternal and child mental health", "label": "maternal and child mental health", "shape": "dot", "size": 16, "title": "maternal and child mental health"}, {"color": "#dbae57", "font": {"color": "#dbdbdb"}, "id": "elderly", "label": "elderly", "shape": "dot", "size": 16, "title": "elderly"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "abdm.gov.in", "label": "abdm.gov.in", "shape": "dot", "size": 8, "title": "abdm.gov.in"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "access to healthcare services", "label": "access to healthcare services", "shape": "dot", "size": 32, "title": "access to healthcare services"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "differences among them", "label": "differences among them", "shape": "dot", "size": 24, "title": "differences among them"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "wider spread of manufacturing", "label": "wider spread of manufacturing", "shape": "dot", "size": 24, "title": "wider spread of manufacturing"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "manufacturing for the whole continent and globally", "label": "manufacturing for the whole continent and globally", "shape": "dot", "size": 24, "title": "manufacturing for the whole continent and globally"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "financial investment", "label": "financial investment", "shape": "dot", "size": 32, "title": "financial investment"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "technology transfer", "label": "technology transfer", "shape": "dot", "size": 24, "title": "technology transfer"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "pharmaceutical industry", "label": "pharmaceutical industry", "shape": "dot", "size": 32, "title": "pharmaceutical industry"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "technology transfer and the associated question of intellectual property rights", "label": "technology transfer and the associated question of intellectual property rights", "shape": "dot", "size": 24, "title": "technology transfer and the associated question of intellectual property rights"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "wealthier governments funding R\u0026D", "label": "wealthier governments funding R\u0026D", "shape": "dot", "size": 32, "title": "wealthier governments funding R\u0026D"}, {"color": "#db5769", "font": {"color": "#dbdbdb"}, "id": "companies earmark a percentage of vaccines for the poorer countries or sell to them at cost", "label": "companies earmark a percentage of vaccines for the poorer countries or sell to them at cost", "shape": "dot", "size": 24, "title": "companies earmark a percentage of vaccines for the poorer countries or sell to them at cost"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "addressing social and economic inequalities", "label": "addressing social and economic inequalities", "shape": "dot", "size": 24, "title": "addressing social and economic inequalities"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "advancements in computational", "label": "advancements in computational", "shape": "dot", "size": 16, "title": "advancements in computational"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "agriculture sector", "label": "agriculture sector", "shape": "dot", "size": 32, "title": "agriculture sector"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "ancillary supplies", "label": "ancillary supplies", "shape": "dot", "size": 24, "title": "ancillary supplies"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "life-saving equipment", "label": "life-saving equipment", "shape": "dot", "size": 40, "title": "life-saving equipment"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "animals", "label": "animals", "shape": "dot", "size": 32, "title": "animals"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "patients", "label": "patients", "shape": "dot", "size": 24, "title": "patients"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "stricter antibiotic prescription and consumption measures", "label": "stricter antibiotic prescription and consumption measures", "shape": "dot", "size": 32, "title": "stricter antibiotic prescription and consumption measures"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "antimicrobial drug development process", "label": "antimicrobial drug development process", "shape": "dot", "size": 24, "title": "antimicrobial drug development process"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "antibiotic market", "label": "antibiotic market", "shape": "dot", "size": 24, "title": "antibiotic market"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "development of new antibacterial treatments", "label": "development of new antibacterial treatments", "shape": "dot", "size": 40, "title": "development of new antibacterial treatments"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "antileprotic drug resistance", "label": "antileprotic drug resistance", "shape": "dot", "size": 24, "title": "antileprotic drug resistance"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "antimicrobial resistance", "label": "antimicrobial resistance", "shape": "dot", "size": 24, "title": "antimicrobial resistance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "artemisinin-based combination therapy-resistance", "label": "artemisinin-based combination therapy-resistance", "shape": "dot", "size": 24, "title": "artemisinin-based combination therapy-resistance"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "avian influenza", "label": "avian influenza", "shape": "dot", "size": 24, "title": "avian influenza"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "big pharmaceutical companies", "label": "big pharmaceutical companies", "shape": "dot", "size": 16, "title": "big pharmaceutical companies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "bilateral customers", "label": "bilateral customers", "shape": "dot", "size": 24, "title": "bilateral customers"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "biodiversity", "label": "biodiversity", "shape": "dot", "size": 32, "title": "biodiversity"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "infectious disease", "label": "infectious disease", "shape": "dot", "size": 32, "title": "infectious disease"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "epidemic", "label": "epidemic", "shape": "dot", "size": 24, "title": "epidemic"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "prevent", "label": "prevent", "shape": "dot", "size": 16, "title": "prevent"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "checks and balances", "label": "checks and balances", "shape": "dot", "size": 24, "title": "checks and balances"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "cold chain", "label": "cold chain", "shape": "dot", "size": 24, "title": "cold chain"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "consistent policy guidance", "label": "consistent policy guidance", "shape": "dot", "size": 24, "title": "consistent policy guidance"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "record time", "label": "record time", "shape": "dot", "size": 32, "title": "record time"}, {"color": "#db57d3", "font": {"color": "#dbdbdb"}, "id": "esanjeevani.mohfw.gov.in", "label": "esanjeevani.mohfw.gov.in", "shape": "dot", "size": 8, "title": "esanjeevani.mohfw.gov.in"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "spike protein", "label": "spike protein", "shape": "dot", "size": 32, "title": "spike protein"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "neutralising antibodies", "label": "neutralising antibodies", "shape": "dot", "size": 24, "title": "neutralising antibodies"}, {"color": "#84db57", "font": {"color": "#dbdbdb"}, "id": "countries lacking infrastructure", "label": "countries lacking infrastructure", "shape": "dot", "size": 24, "title": "countries lacking infrastructure"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "cultural acceptance", "label": "cultural acceptance", "shape": "dot", "size": 24, "title": "cultural acceptance"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "dairy products", "label": "dairy products", "shape": "dot", "size": 16, "title": "dairy products"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "dangerous and deadly outbreaks", "label": "dangerous and deadly outbreaks", "shape": "dot", "size": 16, "title": "dangerous and deadly outbreaks"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "global community", "label": "global community", "shape": "dot", "size": 40, "title": "global community"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "delivery of mental healthcare", "label": "delivery of mental healthcare", "shape": "dot", "size": 32, "title": "delivery of mental healthcare"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "destruction of natural habitats", "label": "destruction of natural habitats", "shape": "dot", "size": 24, "title": "destruction of natural habitats"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "developing countries", "label": "developing countries", "shape": "dot", "size": 24, "title": "developing countries"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "emerging threat of AMR", "label": "emerging threat of AMR", "shape": "dot", "size": 32, "title": "emerging threat of AMR"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "return on investment for new antibiotics", "label": "return on investment for new antibiotics", "shape": "dot", "size": 24, "title": "return on investment for new antibiotics"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "small or micro biotech firms", "label": "small or micro biotech firms", "shape": "dot", "size": 16, "title": "small or micro biotech firms"}, {"color": "#db9457", "font": {"color": "#dbdbdb"}, "id": "novel reimbursement models", "label": "novel reimbursement models", "shape": "dot", "size": 24, "title": "novel reimbursement models"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "diagnostic capacity", "label": "diagnostic capacity", "shape": "dot", "size": 32, "title": "diagnostic capacity"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "digital health infrastructure", "label": "digital health infrastructure", "shape": "dot", "size": 24, "title": "digital health infrastructure"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "direct benefit transfer (DBT) in India", "label": "direct benefit transfer (DBT) in India", "shape": "dot", "size": 32, "title": "direct benefit transfer (DBT) in India"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "disadvantaged populations", "label": "disadvantaged populations", "shape": "dot", "size": 24, "title": "disadvantaged populations"}, {"color": "#db7957", "font": {"color": "#dbdbdb"}, "id": "drug procurement", "label": "drug procurement", "shape": "dot", "size": 32, "title": "drug procurement"}, {"color": "#db7957", "font": {"color": "#dbdbdb"}, "id": "state-owned enterprises", "label": "state-owned enterprises", "shape": "dot", "size": 40, "title": "state-owned enterprises"}, {"color": "#db7957", "font": {"color": "#dbdbdb"}, "id": "generic medications", "label": "generic medications", "shape": "dot", "size": 40, "title": "generic medications"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "drug-resistant Tuberculosis", "label": "drug-resistant Tuberculosis", "shape": "dot", "size": 32, "title": "drug-resistant Tuberculosis"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "e-governance", "label": "e-governance", "shape": "dot", "size": 24, "title": "e-governance"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "e-governance platforms", "label": "e-governance platforms", "shape": "dot", "size": 24, "title": "e-governance platforms"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "early R\u0026D", "label": "early R\u0026D", "shape": "dot", "size": 24, "title": "early R\u0026D"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vector-borne diseases", "label": "vector-borne diseases", "shape": "dot", "size": 24, "title": "vector-borne diseases"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "eggs", "label": "eggs", "shape": "dot", "size": 16, "title": "eggs"}, {"color": "#57db94", "font": {"color": "#dbdbdb"}, "id": "emergency preparedness and response", "label": "emergency preparedness and response", "shape": "dot", "size": 24, "title": "emergency preparedness and response"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "ethnicity", "label": "ethnicity", "shape": "dot", "size": 24, "title": "ethnicity"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "public health system", "label": "public health system", "shape": "dot", "size": 32, "title": "public health system"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "primary healthcare", "label": "primary healthcare", "shape": "dot", "size": 32, "title": "primary healthcare"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "referral pathways", "label": "referral pathways", "shape": "dot", "size": 16, "title": "referral pathways"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "mental care", "label": "mental care", "shape": "dot", "size": 24, "title": "mental care"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "physical care", "label": "physical care", "shape": "dot", "size": 16, "title": "physical care"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "robust information systems", "label": "robust information systems", "shape": "dot", "size": 24, "title": "robust information systems"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "mental and physical care integration", "label": "mental and physical care integration", "shape": "dot", "size": 16, "title": "mental and physical care integration"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "exemptions and waivers", "label": "exemptions and waivers", "shape": "dot", "size": 24, "title": "exemptions and waivers"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "family members", "label": "family members", "shape": "dot", "size": 24, "title": "family members"}, {"color": "#db7957", "font": {"color": "#dbdbdb"}, "id": "financial incentives", "label": "financial incentives", "shape": "dot", "size": 24, "title": "financial incentives"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "gender", "label": "gender", "shape": "dot", "size": 24, "title": "gender"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "general health services", "label": "general health services", "shape": "dot", "size": 24, "title": "general health services"}, {"color": "#db7957", "font": {"color": "#dbdbdb"}, "id": "public awareness campaigns", "label": "public awareness campaigns", "shape": "dot", "size": 32, "title": "public awareness campaigns"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "geographic location", "label": "geographic location", "shape": "dot", "size": 24, "title": "geographic location"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "health security", "label": "health security", "shape": "dot", "size": 32, "title": "health security"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pandemic threats", "label": "pandemic threats", "shape": "dot", "size": 24, "title": "pandemic threats"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "incipient pandemic", "label": "incipient pandemic", "shape": "dot", "size": 24, "title": "incipient pandemic"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "potential opponents", "label": "potential opponents", "shape": "dot", "size": 16, "title": "potential opponents"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "viruses from around 25 viral families", "label": "viruses from around 25 viral families", "shape": "dot", "size": 24, "title": "viruses from around 25 viral families"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "global health agencies", "label": "global health agencies", "shape": "dot", "size": 32, "title": "global health agencies"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "zoonotic diseases", "label": "zoonotic diseases", "shape": "dot", "size": 32, "title": "zoonotic diseases"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "pathogens", "label": "pathogens", "shape": "dot", "size": 24, "title": "pathogens"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "urbanisation", "label": "urbanisation", "shape": "dot", "size": 24, "title": "urbanisation"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "illegal trade in wildlife", "label": "illegal trade in wildlife", "shape": "dot", "size": 24, "title": "illegal trade in wildlife"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "global increase in climate-related and humanitarian disasters", "label": "global increase in climate-related and humanitarian disasters", "shape": "dot", "size": 16, "title": "global increase in climate-related and humanitarian disasters"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "government unified and dedicated online learning and training platform SAKSHAM", "label": "government unified and dedicated online learning and training platform SAKSHAM", "shape": "dot", "size": 32, "title": "government unified and dedicated online learning and training platform SAKSHAM"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "health disparities", "label": "health disparities", "shape": "dot", "size": 32, "title": "health disparities"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "health emergencies", "label": "health emergencies", "shape": "dot", "size": 32, "title": "health emergencies"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "health emergency", "label": "health emergency", "shape": "dot", "size": 32, "title": "health emergency"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "socioeconomic status", "label": "socioeconomic status", "shape": "dot", "size": 24, "title": "socioeconomic status"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "race", "label": "race", "shape": "dot", "size": 24, "title": "race"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "redistributing resources", "label": "redistributing resources", "shape": "dot", "size": 24, "title": "redistributing resources"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "targeted healthcare programs", "label": "targeted healthcare programs", "shape": "dot", "size": 24, "title": "targeted healthcare programs"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "improving access to quality healthcare services", "label": "improving access to quality healthcare services", "shape": "dot", "size": 32, "title": "improving access to quality healthcare services"}, {"color": "#5f57db", "font": {"color": "#dbdbdb"}, "id": "promoting health education and prevention", "label": "promoting health education and prevention", "shape": "dot", "size": 24, "title": "promoting health education and prevention"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "health insurance", "label": "health insurance", "shape": "dot", "size": 32, "title": "health insurance"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "health systems", "label": "health systems", "shape": "dot", "size": 32, "title": "health systems"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "healthcare resources", "label": "healthcare resources", "shape": "dot", "size": 32, "title": "healthcare resources"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "high-income countries", "label": "high-income countries", "shape": "dot", "size": 16, "title": "high-income countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "humanitarian situations", "label": "humanitarian situations", "shape": "dot", "size": 32, "title": "humanitarian situations"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "inclusive capacity building of health professionals", "label": "inclusive capacity building of health professionals", "shape": "dot", "size": 24, "title": "inclusive capacity building of health professionals"}, {"color": "#c957db", "font": {"color": "#dbdbdb"}, "id": "online platforms, video conferencing, pre-recorded lectures", "label": "online platforms, video conferencing, pre-recorded lectures", "shape": "dot", "size": 24, "title": "online platforms, video conferencing, pre-recorded lectures"}, {"color": "#84db57", "font": {"color": "#dbdbdb"}, "id": "personal protective equipment for healthcare workers", "label": "personal protective equipment for healthcare workers", "shape": "dot", "size": 32, "title": "personal protective equipment for healthcare workers"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vulnerable populations", "label": "vulnerable populations", "shape": "dot", "size": 24, "title": "vulnerable populations"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "quality and efficiency", "label": "quality and efficiency", "shape": "dot", "size": 16, "title": "quality and efficiency"}, {"color": "#db5f57", "font": {"color": "#dbdbdb"}, "id": "integration of healthcare programmes", "label": "integration of healthcare programmes", "shape": "dot", "size": 32, "title": "integration of healthcare programmes"}, {"color": "#db5f57", "font": {"color": "#dbdbdb"}, "id": "overall healthcare service delivery", "label": "overall healthcare service delivery", "shape": "dot", "size": 40, "title": "overall healthcare service delivery"}, {"color": "#db5f57", "font": {"color": "#dbdbdb"}, "id": "transformation of the healthcare situation in the country", "label": "transformation of the healthcare situation in the country", "shape": "dot", "size": 40, "title": "transformation of the healthcare situation in the country"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "international cooperation", "label": "international cooperation", "shape": "dot", "size": 32, "title": "international cooperation"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "international freight and logistics", "label": "international freight and logistics", "shape": "dot", "size": 24, "title": "international freight and logistics"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "trade barriers", "label": "trade barriers", "shape": "dot", "size": 24, "title": "trade barriers"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "life-saving medical countermeasures and materials", "label": "life-saving medical countermeasures and materials", "shape": "dot", "size": 32, "title": "life-saving medical countermeasures and materials"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "low- and middle-income countries", "label": "low- and middle-income countries", "shape": "dot", "size": 24, "title": "low- and middle-income countries"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccinations", "label": "vaccinations", "shape": "dot", "size": 32, "title": "vaccinations"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "strong, reliable health systems", "label": "strong, reliable health systems", "shape": "dot", "size": 32, "title": "strong, reliable health systems"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "scaling-up manufacturing", "label": "scaling-up manufacturing", "shape": "dot", "size": 32, "title": "scaling-up manufacturing"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "securing deals", "label": "securing deals", "shape": "dot", "size": 24, "title": "securing deals"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "operational, logistical, regulatory, and legal frameworks", "label": "operational, logistical, regulatory, and legal frameworks", "shape": "dot", "size": 32, "title": "operational, logistical, regulatory, and legal frameworks"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "safe injection equipment", "label": "safe injection equipment", "shape": "dot", "size": 24, "title": "safe injection equipment"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "mental health issues, including burnout", "label": "mental health issues, including burnout", "shape": "dot", "size": 24, "title": "mental health issues, including burnout"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "poor working conditions", "label": "poor working conditions", "shape": "dot", "size": 24, "title": "poor working conditions"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "protracted conflicts", "label": "protracted conflicts", "shape": "dot", "size": 16, "title": "protracted conflicts"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "public health crisis", "label": "public health crisis", "shape": "dot", "size": 24, "title": "public health crisis"}, {"color": "#579edb", "font": {"color": "#dbdbdb"}, "id": "reversals in life expectancy and Sustainable Development Goals", "label": "reversals in life expectancy and Sustainable Development Goals", "shape": "dot", "size": 16, "title": "reversals in life expectancy and Sustainable Development Goals"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "meat handling", "label": "meat handling", "shape": "dot", "size": 24, "title": "meat handling"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "parity for mental illness", "label": "parity for mental illness", "shape": "dot", "size": 24, "title": "parity for mental illness"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "physical conditions", "label": "physical conditions", "shape": "dot", "size": 24, "title": "physical conditions"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "persons with mental illness", "label": "persons with mental illness", "shape": "dot", "size": 32, "title": "persons with mental illness"}, {"color": "#57db94", "font": {"color": "#dbdbdb"}, "id": "roadmap", "label": "roadmap", "shape": "dot", "size": 32, "title": "roadmap"}, {"color": "#57db94", "font": {"color": "#dbdbdb"}, "id": "public health workforce", "label": "public health workforce", "shape": "dot", "size": 32, "title": "public health workforce"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "pharmaceutical sector", "label": "pharmaceutical sector", "shape": "dot", "size": 24, "title": "pharmaceutical sector"}, {"color": "#db579e", "font": {"color": "#dbdbdb"}, "id": "vaccines, therapeutics, diagnostics", "label": "vaccines, therapeutics, diagnostics", "shape": "dot", "size": 16, "title": "vaccines, therapeutics, diagnostics"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "vaccine makers", "label": "vaccine makers", "shape": "dot", "size": 32, "title": "vaccine makers"}, {"color": "#db5784", "font": {"color": "#dbdbdb"}, "id": "regulatory frameworks", "label": "regulatory frameworks", "shape": "dot", "size": 32, "title": "regulatory frameworks"}, {"color": "#57db79", "font": {"color": "#dbdbdb"}, "id": "vegetables", "label": "vegetables", "shape": "dot", "size": 16, "title": "vegetables"}]);+ edges = new vis.DataSet([{"from": " Member states", "to": "access to vaccines, drugs, and other medical equipment", "width": 4.5}, {"from": "10 million deaths", "to": "Antimicrobial Resistance (AMR)", "width": 4.0}, {"from": "100 Days Mission", "to": "One World Vaccine Library", "width": 3.5}, {"from": "150,000 Health and Wellness Centres (HWC)", "to": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "width": 4.0}, {"from": "191 countries", "to": "vaccine nationalism", "width": 3.5}, {"from": "191 countries", "to": "COVAX Facility", "width": 3.5}, {"from": "191 countries", "to": "vaccines", "width": 3.5}, {"from": "191 countries", "to": "COVID-19 vaccines", "width": 3.5}, {"from": "2004 prices", "to": "Accelerating Global Health", "width": 4.0}, {"from": "2004 prices", "to": "generic medicine pricing policy", "width": 4.0}, {"from": "2008 attempt to operationalise the OH approach for zoonotic disease control and prevention", "to": "One Health", "width": 4.0}, {"from": "2009", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "2010 prices", "to": "Accelerating Global Health", "width": 4.0}, {"from": "2010 prices", "to": "generic medicine pricing policy", "width": 4.0}, {"from": "2010 study", "to": "Accelerating Global Health", "width": 4.5}, {"from": "2010 study", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "2050", "to": "Antimicrobial Resistance (AMR)", "width": 4.5}, {"from": "27 July 2023", "to": "consultations", "width": 3.5}, {"from": "420,000 die each year", "to": "Accelerating Global Health", "width": 3.5}, {"from": "420,000 die each year", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "600 million people are affected by food-borne diseases", "to": "Accelerating Global Health", "width": 4.0}, {"from": "600 million people are affected by food-borne diseases", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "ABDM ecosystem", "to": "Resilient Digital Health Ecosystem", "width": 4.5}, {"from": "ABHA numbers", "to": "Resilient Digital Health Ecosystem", "width": 4.5}, {"from": "AI assistant for frontline workers in 11 Indian languages", "to": "impending disease outbreak", "width": 4.5}, {"from": "AI in healthcare", "to": "Resilient Digital Health Ecosystem", "width": 4.5}, {"from": "AMR", "to": "Interventions", "width": 4.0}, {"from": "AMR", "to": "Antimicrobials", "width": 4.5}, {"from": "AMR", "to": "Healthcare Systems", "width": 4.0}, {"from": "AMR", "to": "Patient Outcomes", "width": 4.5}, {"from": "AMR", "to": "Health Equity", "width": 4.0}, {"from": "AMR", "to": "Essay", "width": 3.5}, {"from": "AMR", "to": "Ranga Reddy Burri", "width": 3.0}, {"from": "AMR", "to": "Robert Skov", "width": 3.0}, {"from": "AMR", "to": "Bulagonda Eswarappa Pradeep", "width": 3.0}, {"from": "AMR", "to": "Ralf Sudbrak", "width": 3.0}, {"from": "AMR", "to": "Accelerating Global Health", "width": 5.0}, {"from": "AMR", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "AMR", "to": "LMICs", "width": 4.5}, {"from": "AMR", "to": "vulnerable populations in HICs", "width": 4.5}, {"from": "AMR", "to": "antimicrobials pipeline", "width": 4.0}, {"from": "AMR", "to": "industry leaving the field of antimicrobial drug discovery", "width": 4.5}, {"from": "AMR", "to": "AMR pandemic", "width": 5.0}, {"from": "AMR", "to": "consequences of AMR", "width": 4.5}, {"from": "AMR", "to": "need for increased action", "width": 5.0}, {"from": "AMR", "to": "multifaceted effort", "width": 4.5}, {"from": "AMR", "to": "reducing the circulation and spread of existing resistant microorganisms", "width": 4.0}, {"from": "AMR", "to": "increase of novel resistance mechanisms", "width": 4.5}, {"from": "AMR", "to": "lowering the overall use of antimicrobials", "width": 4.0}, {"from": "AMR", "to": "antimicrobial stewardship", "width": 4.5}, {"from": "AMR", "to": "accessibility of affordable and timely diagnostics", "width": 4.0}, {"from": "AMR", "to": "strengthening IPC and biosecurity procedures", "width": 4.0}, {"from": "AMR (Antimicrobial Resistance)", "to": "Accelerating Global Health", "width": 5.0}, {"from": "AMR (Antimicrobial Resistance)", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "AMR (Antimicrobial Resistance)", "to": "Quadripartite", "width": 4.0}, {"from": "AMR (Antimicrobial Resistance)", "to": "One Health approach", "width": 4.5}, {"from": "AMR (Antimicrobial Resistance)", "to": "National Action Plans (NAPs)", "width": 4.0}, {"from": "AMR pandemic", "to": "Accelerating Global Health", "width": 5.0}, {"from": "AMR pandemic", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "AMR pandemic", "to": "LMICs", "width": 4.5}, {"from": "AMR pandemic", "to": "vulnerable populations in HICs", "width": 4.5}, {"from": "AMR pandemic", "to": "antimicrobials pipeline", "width": 4.0}, {"from": "AMR pandemic", "to": "industry leaving the field of antimicrobial drug discovery", "width": 4.5}, {"from": "AMR pandemic", "to": "consequences of AMR", "width": 4.5}, {"from": "AMR pandemic", "to": "need for increased action", "width": 5.0}, {"from": "AMR pandemic", "to": "multifaceted effort", "width": 4.5}, {"from": "AMR pandemic", "to": "reducing the circulation and spread of existing resistant microorganisms", "width": 4.0}, {"from": "AMR pandemic", "to": "increase of novel resistance mechanisms", "width": 4.5}, {"from": "AMR pandemic", "to": "lowering the overall use of antimicrobials", "width": 4.0}, {"from": "AMR pandemic", "to": "antimicrobial stewardship", "width": 4.5}, {"from": "AMR pandemic", "to": "accessibility of affordable and timely diagnostics", "width": 4.0}, {"from": "AMR pandemic", "to": "strengthening IPC and biosecurity procedures", "width": 4.0}, {"from": "ARG ARG", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "ASHAs", "to": "OH approach", "width": 3.5}, {"from": "AUSSPN", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "Aadhaar", "to": "technology", "width": 4.0}, {"from": "Aadhaar-based e-KYC", "to": "India Stack", "width": 4.0}, {"from": "Aadhaar-based eSign", "to": "India Stack", "width": 4.0}, {"from": "Accelerating Efforts to Combat AMR", "to": "Battle Against Antimicrobial Resistance", "width": 4.0}, {"from": "Accelerating Efforts to Combat AMR", "to": "Combating AMR", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "Accelerating Global Health", "to": "Integrating Mental Health into General Healthcare", "width": 5.0}, {"from": "Accelerating Global Health", "to": "Poverty", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Mental Health", "width": 5.0}, {"from": "Accelerating Global Health", "to": "Biological Determinants", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Psychological Determinants", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Social Determinants", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Depression", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Substance Use Disorders", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Behavioural Addictions", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Severe Mental Illness (SMI)", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Schizophrenia", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Bipolar Mood Disorder", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Mental Health Care Act, 2017", "width": 4.0}, {"from": "Accelerating Global Health", "to": "reported violations", "width": 3.5}, {"from": "Accelerating Global Health", "to": "rejections of claims for mental illness by insurance companies", "width": 4.0}, {"from": "Accelerating Global Health", "to": "discriminatory ceilings on the sum of reimbursement for mental illness", "width": 3.5}, {"from": "Accelerating Global Health", "to": "people with serious mental illness (SMI)", "width": 4.0}, {"from": "Accelerating Global Health", "to": "shortened life expectancy", "width": 3.5}, {"from": "Accelerating Global Health", "to": "multimorbidity", "width": 4.0}, {"from": "Accelerating Global Health", "to": "non-communicable diseases (NCDs)", "width": 3.5}, {"from": "Accelerating Global Health", "to": "tobacco and alcohol use", "width": 3.5}, {"from": "Accelerating Global Health", "to": "physical inactivity", "width": 3.5}, {"from": "Accelerating Global Health", "to": "poor diets", "width": 3.5}, {"from": "Accelerating Global Health", "to": "national programs to address chronic conditions", "width": 4.0}, {"from": "Accelerating Global Health", "to": "chronic conditions", "width": 3.5}, {"from": "Accelerating Global Health", "to": "poor horizontal integration across the programmes", "width": 4.0}, {"from": "Accelerating Global Health", "to": "homeless persons", "width": 3.5}, {"from": "Accelerating Global Health", "to": "women", "width": 3.5}, {"from": "Accelerating Global Health", "to": "persons with developmental disorders", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Psychotropic medications", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Mental Health Policy (2014)", "width": 4.5}, {"from": "Accelerating Global Health", "to": "digital academies at NIMHANS", "width": 4.0}, {"from": "Accelerating Global Health", "to": "m-Cessation", "width": 3.5}, {"from": "Accelerating Global Health", "to": "tobacco quit-lines", "width": 3.5}, {"from": "Accelerating Global Health", "to": "National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Improvements in curative and preventive care domains", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Rehabilitative care", "width": 4.0}, {"from": "Accelerating Global Health", "to": "National Mental Health Policy 2014", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Vulnerable populations", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Children", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Elderly", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Homeless", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Macro-environmental issues", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Unemployment", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Displacement", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Mental health impact of climate change", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Leadership and governance", "width": 4.0}, {"from": "Accelerating Global Health", "to": "one health", "width": 4.5}, {"from": "Accelerating Global Health", "to": "zoonoses", "width": 4.0}, {"from": "Accelerating Global Health", "to": "wet markets", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Joint Plan of Action", "width": 4.0}, {"from": "Accelerating Global Health", "to": "equity", "width": 4.5}, {"from": "Accelerating Global Health", "to": "procurement, distribution, administration of COVID-19 vaccines", "width": 4.0}, {"from": "Accelerating Global Health", "to": "COVID-19 pandemic", "width": 4.5}, {"from": "Accelerating Global Health", "to": "novel paramyxovirus", "width": 4.0}, {"from": "Accelerating Global Health", "to": "One World Vaccine Library", "width": 5.0}, {"from": "Accelerating Global Health", "to": "Water-borne diseases", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Drinking or coming in contact with contaminated water", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Faecal-contaminated water", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Two billion people globally", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Cholera, dysentery, typhoid and polio", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Around 485,000 deaths every year", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Food-borne diseases", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Over 200 diseases", "width": 3.0}, {"from": "Accelerating Global Health", "to": "Chemical substances such as unpasteurised (raw) milk", "width": 3.0}, {"from": "Accelerating Global Health", "to": "Undercooked meat or eggs", "width": 3.0}, {"from": "Accelerating Global Health", "to": "Raw fruits and vegetables", "width": 3.0}, {"from": "Accelerating Global Health", "to": "Healthy life years lost", "width": 3.0}, {"from": "Accelerating Global Health", "to": "Access to adequate safe and nutritious food", "width": 3.5}, {"from": "Accelerating Global Health", "to": "One Health\u2019", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Operationalising \u2018One Health\u2019", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Building a Resilient Digital Health Ecosystem in India", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Lav Agarwal", "width": 3.5}, {"from": "Accelerating Global Health", "to": "technology", "width": 5.0}, {"from": "Accelerating Global Health", "to": "communication", "width": 4.5}, {"from": "Accelerating Global Health", "to": "transportation", "width": 4.0}, {"from": "Accelerating Global Health", "to": "healthcare", "width": 5.0}, {"from": "Accelerating Global Health", "to": "electronic health records", "width": 4.0}, {"from": "Accelerating Global Health", "to": "artificial intelligence", "width": 4.5}, {"from": "Accelerating Global Health", "to": "wearable devices", "width": 4.0}, {"from": "Accelerating Global Health", "to": "health apps", "width": 3.5}, {"from": "Accelerating Global Health", "to": "CoWIN", "width": 4.5}, {"from": "Accelerating Global Health", "to": "COVID-19 \u0027war rooms\u0027", "width": 4.0}, {"from": "Accelerating Global Health", "to": "digital health initiatives", "width": 4.5}, {"from": "Accelerating Global Health", "to": "COVID-19 India Portal", "width": 4.0}, {"from": "Accelerating Global Health", "to": "marginalised communities", "width": 4.5}, {"from": "Accelerating Global Health", "to": "India", "width": 5.0}, {"from": "Accelerating Global Health", "to": "digital inclusion", "width": 4.0}, {"from": "Accelerating Global Health", "to": "urban telephone subscribers", "width": 3.5}, {"from": "Accelerating Global Health", "to": "gender gap in mobile ownership", "width": 4.0}, {"from": "Accelerating Global Health", "to": "India\u0027s digital infrastructure", "width": 4.5}, {"from": "Accelerating Global Health", "to": "intermediaries (digital media, e-commerce)", "width": 3.5}, {"from": "Accelerating Global Health", "to": "connectivity to cause harm or commit crimes", "width": 4.0}, {"from": "Accelerating Global Health", "to": "comprehensive measures", "width": 4.5}, {"from": "Accelerating Global Health", "to": "potential DPI\u2019s scalability", "width": 3.5}, {"from": "Accelerating Global Health", "to": "India\u0027s DPI experience", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Digital systems", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Inclusive societies", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Sustainable development in the 21st century", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Sameer Kanwar", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Varun Kumar", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Inadequate infection prevention and control", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Hand hygiene", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Improper disinfection and sterilisation practices", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Inadequate sanitation", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Hospital-acquired infections", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Infection prevention and control measures", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Infection control practices", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Low- and middle-income countries (LMICs)", "width": 4.0}, {"from": "Accelerating Global Health", "to": "World Health Organization", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Quadripartite", "width": 4.0}, {"from": "Accelerating Global Health", "to": "One Health approach", "width": 4.5}, {"from": "Accelerating Global Health", "to": "National Action Plans (NAPs)", "width": 4.0}, {"from": "Accelerating Global Health", "to": "LMICs", "width": 4.5}, {"from": "Accelerating Global Health", "to": "vulnerable populations in HICs", "width": 4.5}, {"from": "Accelerating Global Health", "to": "antimicrobials pipeline", "width": 4.0}, {"from": "Accelerating Global Health", "to": "industry leaving the field of antimicrobial drug discovery", "width": 4.5}, {"from": "Accelerating Global Health", "to": "consequences of AMR", "width": 4.5}, {"from": "Accelerating Global Health", "to": "need for increased action", "width": 5.0}, {"from": "Accelerating Global Health", "to": "multifaceted effort", "width": 4.5}, {"from": "Accelerating Global Health", "to": "reducing the circulation and spread of existing resistant microorganisms", "width": 4.0}, {"from": "Accelerating Global Health", "to": "increase of novel resistance mechanisms", "width": 4.5}, {"from": "Accelerating Global Health", "to": "lowering the overall use of antimicrobials", "width": 4.0}, {"from": "Accelerating Global Health", "to": "antimicrobial stewardship", "width": 4.5}, {"from": "Accelerating Global Health", "to": "accessibility of affordable and timely diagnostics", "width": 4.0}, {"from": "Accelerating Global Health", "to": "strengthening IPC and biosecurity procedures", "width": 4.0}, {"from": "Accelerating Global Health", "to": "G20", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Healthcare Spending", "width": 4.5}, {"from": "Accelerating Global Health", "to": "G20 countries", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Out-Of-Pocket Expenses (OOPE)", "width": 4.0}, {"from": "Accelerating Global Health", "to": "generic medicine pricing policy", "width": 5.0}, {"from": "Accelerating Global Health", "to": "Maximum Retail Price set by the MOH", "width": 4.0}, {"from": "Accelerating Global Health", "to": "public hospitals", "width": 4.0}, {"from": "Accelerating Global Health", "to": "private pharmacies", "width": 3.5}, {"from": "Accelerating Global Health", "to": "NGO hospitals", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Lowest Price Generic (LPG) medicines", "width": 4.5}, {"from": "Accelerating Global Health", "to": "Innovator Brand (IB) medicines", "width": 4.5}, {"from": "Accelerating Global Health", "to": "declines ranging from 40 percent to 2200 percent", "width": 4.0}, {"from": "Accelerating Global Health", "to": "generic medicine pricing policies have succeeded in lowering the price of medicines", "width": 4.5}, {"from": "Accelerating Global Health", "to": "variation in implementation", "width": 4.0}, {"from": "Accelerating Global Health", "to": "excess paid by patients compared to MOH set prices", "width": 4.5}, {"from": "Accelerating Global Health", "to": "narrow the differences", "width": 4.0}, {"from": "Accelerating Global Health", "to": "more recently", "width": 3.5}, {"from": "Accelerating Global Health", "to": "UHC (Universal Health Coverage)", "width": 4.5}, {"from": "Accelerating Global Health", "to": "National University of Singapore\u0027s Saw Swee Hock School of Public Health", "width": 4.0}, {"from": "Accelerating Global Health", "to": "Associate Professor Jeremy Lim", "width": 3.5}, {"from": "Accelerating Global Health", "to": "Janice Tan", "width": 3.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "cultural settings of LMICs", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "brief psychological interventions", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "lay counsellors", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "moderate to severe depressive disorders and harmful drinking", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "health systems in HICs", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "long waiting periods for psychological intervention", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "low-intensity interventions", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "Problem Management plus (PM+)", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "adults in distress due to exposure to adversity", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "family caregivers", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "mental health", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "indigenous interventions", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "Yoga", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "alternative forms of medicine", "width": 4.0}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "multimorbidity", "width": 4.5}, {"from": "Accelerating Global Health: Pathways to Health Equity for the G20", "to": "COVID-19", "width": 4.5}, {"from": "Access to COVID-19 Tools Accelerator (ACT-A)", "to": "pandemic", "width": 4.5}, {"from": "Access to adequate safe and nutritious food", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Accord", "to": "Human Rights Protection", "width": 4.5}, {"from": "Accord", "to": "Public Health and Healthcare Systems", "width": 4.0}, {"from": "Accord", "to": "Staff Protection", "width": 4.5}, {"from": "Accord", "to": "Misinformation Management", "width": 4.0}, {"from": "Accord", "to": "Whole-of-Society Approach", "width": 4.5}, {"from": "Accord", "to": "Global Coordination", "width": 4.0}, {"from": "Accord", "to": "Preparedness Plans", "width": 4.5}, {"from": "Accord", "to": "Simulation Exercises", "width": 4.0}, {"from": "Accord", "to": "Universal Health and Preparedness Review", "width": 4.5}, {"from": "Accurate and timely diagnostics", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Advance market commitment\u2013type investments", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "Africa Center for Disease Control", "to": "COVID-19 pandemic", "width": 3.5}, {"from": "African Union Commission", "to": "COVID-19 pandemic", "width": 3.5}, {"from": "African continent", "to": "COVID-19 pandemic", "width": 3.5}, {"from": "Alternative treatments", "to": "Battle Against Antimicrobial Resistance", "width": 4.0}, {"from": "Alternative treatments", "to": "Combating AMR", "width": 4.0}, {"from": "Annual coverage of INR 500,000 per family", "to": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "width": 3.5}, {"from": "Antibiotic Resistance Mechanisms", "to": "Antimicrobial Resistance", "width": 4.5}, {"from": "Antibiotics", "to": "Antimicrobial Resistance (AMR)", "width": 4.0}, {"from": "Antibiotics", "to": "Global Health Crisis", "width": 4.5}, {"from": "Antibiotics", "to": "Health Equity", "width": 4.0}, {"from": "Antibiotics", "to": "Global Economy", "width": 3.5}, {"from": "Antibiotics", "to": "Extreme Poverty", "width": 3.0}, {"from": "Antibiotics", "to": "Developing Nations", "width": 3.5}, {"from": "Antibiotics", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Antimicrobial Drugs", "to": "Antimicrobial Resistance", "width": 4.0}, {"from": "Antimicrobial Resistance", "to": "Persistent Infectious Diseases", "width": 4.5}, {"from": "Antimicrobial Resistance", "to": "Biological Evolution", "width": 4.5}, {"from": "Antimicrobial Resistance", "to": "Defense System of Microorganisms", "width": 4.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "Multisectoral inclusivity", "width": 4.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "OH concept", "width": 4.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "WHO", "width": 4.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "Global Public Health Threats", "width": 4.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "Global Economy", "width": 3.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "US$11-444 million", "width": 4.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "Global Health Crisis", "width": 4.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "Health Equity", "width": 4.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "Extreme Poverty", "width": 3.0}, {"from": "Antimicrobial Resistance (AMR)", "to": "Developing Nations", "width": 3.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "Resistance", "width": 4.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "Microorganisms", "width": 3.5}, {"from": "Antimicrobial Resistance (AMR)", "to": "Selection", "width": 4.5}, {"from": "Antimicrobial use", "to": "Battle Against Antimicrobial Resistance", "width": 3.5}, {"from": "Antimicrobial use", "to": "Combating AMR", "width": 3.5}, {"from": "Antimicrobials", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Argentina", "to": "health equity", "width": 3.5}, {"from": "Around 485,000 deaths every year", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Asian countries", "to": "mental health equity", "width": 4.0}, {"from": "Asian countries", "to": "National Program for Mental Health (NMHP)", "width": 4.0}, {"from": "Asian countries", "to": "India", "width": 4.0}, {"from": "Associate Professor Jeremy Lim", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Aur\u00e9lia Nguyen", "to": "COVAX", "width": 4.0}, {"from": "Australia", "to": "health equity", "width": 3.5}, {"from": "Average Life Expectancy", "to": "G20 Countries", "width": 4.5}, {"from": "Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)", "to": "India", "width": 4.5}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Universal Health Care (UHC) in India", "width": 4.5}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Secondary and tertiary hospitalisations", "width": 4.0}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Generic medicines", "width": 4.0}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Jan Aushadhi Kendras", "width": 3.5}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Economic burden", "width": 4.0}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Poor and marginalised", "width": 3.5}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Comprehensive services", "width": 3.5}, {"from": "Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Screening and essential mental health", "width": 3.5}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Universal Health Coverage", "width": 4.5}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Health and Wellness Centres", "width": 4.5}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "National Tele Mental Health Programme (Tele MANAS)", "width": 4.0}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Jan Aushadhi Kendras", "width": 4.5}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "National Mental Health Policy (2014)", "width": 4.0}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "National Health Policy (2017)", "width": 4.0}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Rights of Persons with Disability Act, 2016", "width": 4.5}, {"from": "Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)", "to": "Mental Health Care Act, 2017", "width": 4.0}, {"from": "BPJS", "to": "UHC", "width": 4.5}, {"from": "BRABRAKOR", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "Bacteriophages", "to": "Battle Against Antimicrobial Resistance", "width": 3.5}, {"from": "Bacteriophages", "to": "Combating AMR", "width": 3.5}, {"from": "Barbara Stocking", "to": "bird and animal viruses", "width": 3.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "chemistry and artificial intelligence (AI)", "width": 4.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "antimicrobials", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "in vitro and in vivo trials", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "bacteria", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "antibiotics", "width": 4.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "quicker and more efficient antibiotic testing and approval pipelines", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "antimicrobial discovery", "width": 4.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "existing drugs", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "natural products", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "alternate treatment strategies", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "computational approaches for drug design", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "interdisciplinary collaborations", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "new technologies", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "clinical antibacterial pipeline", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "Combating AMR", "width": 5.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "Policy", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "Implementation", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "New antibiotics", "width": 4.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "Infection prevention and control practices", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "Surveillance and data collection", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "One Health approach", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "National and global health plans", "width": 4.0}, {"from": "Battle Against Antimicrobial Resistance", "to": "Stakeholders", "width": 3.5}, {"from": "Battle Against Antimicrobial Resistance", "to": "Political will", "width": 3.5}, {"from": "Behavioural Addictions", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Behavioural Addictions", "to": "Integrating Mental Health into General Healthcare", "width": 4.0}, {"from": "Behavioural Addictions", "to": "Mental Health", "width": 4.0}, {"from": "Best Practices", "to": "Health Finance", "width": 4.5}, {"from": "Best Practices", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "Best practice examples", "to": "OH approach", "width": 4.0}, {"from": "Best practice examples", "to": "G20 countries", "width": 4.0}, {"from": "Biological Determinants", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "Biological Determinants", "to": "Integrating Mental Health into General Healthcare", "width": 4.5}, {"from": "Biological Determinants", "to": "Mental Health", "width": 4.5}, {"from": "Bipolar Mood Disorder", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Bipolar Mood Disorder", "to": "Integrating Mental Health into General Healthcare", "width": 3.5}, {"from": "Bipolar Mood Disorder", "to": "Mental Health", "width": 3.5}, {"from": "Box 2. Technological Initiatives in India for Mental Health", "to": "Tele-MANAS initiative", "width": 4.5}, {"from": "Brazil", "to": "health equity", "width": 3.5}, {"from": "Building a Resilient Digital Health Ecosystem in India", "to": "technology", "width": 4.0}, {"from": "Building a Resilient Digital Health Ecosystem in India", "to": "healthcare", "width": 4.0}, {"from": "CAN", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "CEPI (Coalition for Epidemic Preparedness Innovations)", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "CEPI\u0027s 100 Days Mission", "to": "One World Vaccine Library", "width": 4.0}, {"from": "CHI", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "CHIRUS", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "COVAX", "to": "pandemic", "width": 4.0}, {"from": "COVAX", "to": "procurement, distribution, administration of COVID-19 vaccines", "width": 4.0}, {"from": "COVAX", "to": "vaccine candidates", "width": 4.5}, {"from": "COVAX", "to": "Gavi-implementing countries", "width": 4.5}, {"from": "COVAX", "to": "routine immunisation", "width": 4.0}, {"from": "COVAX", "to": "COVID-19 vaccine coverage", "width": 4.5}, {"from": "COVAX", "to": "pandemic preparedness", "width": 4.0}, {"from": "COVAX", "to": "most vulnerable people", "width": 4.5}, {"from": "COVAX", "to": "equitable supply of vaccines", "width": 4.0}, {"from": "COVAX", "to": "finite supply of vaccine doses", "width": 4.0}, {"from": "COVAX", "to": "H1N1 vaccine", "width": 3.5}, {"from": "COVAX", "to": "Gavi, the Vaccine Alliance", "width": 4.5}, {"from": "COVAX AMC", "to": "Gavi, the Vaccine Alliance", "width": 4.5}, {"from": "COVAX Facility", "to": "pandemic", "width": 4.0}, {"from": "COVAX Facility", "to": "vaccine candidates", "width": 4.0}, {"from": "COVAX Facility", "to": "vaccine nationalism", "width": 5.0}, {"from": "COVAX Facility", "to": "hoarding", "width": 4.5}, {"from": "COVAX Facility", "to": "export bans", "width": 4.0}, {"from": "COVAX Facility", "to": "H1N1 pandemic", "width": 4.5}, {"from": "COVAX Facility", "to": "vaccines", "width": 5.0}, {"from": "COVAX Facility", "to": "lower-income economies", "width": 4.0}, {"from": "COVAX Facility", "to": "wealthier nations", "width": 4.5}, {"from": "COVAX Facility", "to": "COVID-19 vaccines", "width": 5.0}, {"from": "COVAX Facility", "to": "vaccine-candidates", "width": 4.5}, {"from": "COVAX Facility", "to": "technology platforms", "width": 4.0}, {"from": "COVAX Facility", "to": "regulatory approval", "width": 4.0}, {"from": "COVAX Facility", "to": "large-scale investments", "width": 4.5}, {"from": "COVAX Facility", "to": "COVAX portfolio", "width": 4.5}, {"from": "COVAX portfolio", "to": "vaccine nationalism", "width": 4.5}, {"from": "COVAX portfolio", "to": "vaccines", "width": 4.5}, {"from": "COVAX portfolio", "to": "COVID-19 vaccines", "width": 4.5}, {"from": "COVID-19", "to": "Healthcare systems", "width": 4.0}, {"from": "COVID-19", "to": "Simulation exercises", "width": 3.5}, {"from": "COVID-19", "to": "Public health system", "width": 4.0}, {"from": "COVID-19", "to": "Lockdown", "width": 4.5}, {"from": "COVID-19", "to": "Livelihoods and economy", "width": 4.0}, {"from": "COVID-19", "to": "Trade", "width": 3.5}, {"from": "COVID-19", "to": "Social services (education)", "width": 3.5}, {"from": "COVID-19", "to": "procurement, distribution, administration of COVID-19 vaccines", "width": 4.5}, {"from": "COVID-19", "to": "Health system strengthening investments", "width": 4.5}, {"from": "COVID-19", "to": "Primary healthcare services", "width": 4.0}, {"from": "COVID-19", "to": "Cold chain", "width": 3.5}, {"from": "COVID-19", "to": "Vaccine track-and-trace", "width": 4.0}, {"from": "COVID-19", "to": "Human resources", "width": 3.5}, {"from": "COVID-19", "to": "Data monitoring systems", "width": 4.0}, {"from": "COVID-19", "to": "COVID-19 vaccine Delivery Support (CDS)", "width": 4.5}, {"from": "COVID-19", "to": "Gavi", "width": 4.0}, {"from": "COVID-19", "to": "health workforce", "width": 4.5}, {"from": "COVID-19 infections and deaths among health workers", "to": "limited availability of the health workforce", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "lockdown", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "global economy", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "novel coronavirus", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "disease", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "zoonotic virus", "width": 3.5}, {"from": "COVID-19 pandemic", "to": "Public Health Emergency of International Concern", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "low-income countries", "width": 3.5}, {"from": "COVID-19 pandemic", "to": "vaccines and drugs", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "vaccine manufacturing", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "Memorandum of Understanding", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "Gavi", "width": 3.5}, {"from": "COVID-19 pandemic", "to": "Public Health Workforce", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "regional, and global bodies", "width": 4.0}, {"from": "COVID-19 pandemic", "to": "Resilient Digital Health Ecosystem", "width": 4.5}, {"from": "COVID-19 pandemic", "to": "G20 countries", "width": 4.5}, {"from": "COVID-19 vaccinations", "to": "Gavi, the Vaccine Alliance", "width": 4.5}, {"from": "COVID-19 vaccines", "to": "vaccine nationalism", "width": 5.0}, {"from": "COVID-19 vaccines", "to": "hoarding", "width": 4.5}, {"from": "COVID-19 vaccines", "to": "export bans", "width": 4.0}, {"from": "COVID-19 vaccines", "to": "H1N1 pandemic", "width": 4.5}, {"from": "COVID-19 vaccines", "to": "vaccines", "width": 5.0}, {"from": "COVID-19 vaccines", "to": "lower-income economies", "width": 4.0}, {"from": "COVID-19 vaccines", "to": "wealthier nations", "width": 4.5}, {"from": "COVID-19 vaccines", "to": "vaccine-candidates", "width": 4.5}, {"from": "COVID-19 vaccines", "to": "technology platforms", "width": 4.0}, {"from": "COVID-19 vaccines", "to": "regulatory approval", "width": 4.0}, {"from": "COVID-19 vaccines", "to": "large-scale investments", "width": 4.5}, {"from": "Canada", "to": "health equity", "width": 3.5}, {"from": "Carbis Bay Health Declaration", "to": "health workforce", "width": 4.0}, {"from": "Central and State Mental Health Authorities", "to": "mental health services", "width": 4.5}, {"from": "Central and State Mental Health Authorities", "to": "mental illness", "width": 4.5}, {"from": "Centres of Excellence for AI", "to": "Resilient Digital Health Ecosystem", "width": 4.0}, {"from": "Chemical substances such as unpasteurised (raw) milk", "to": "Pathways to Health Equity for the G20", "width": 3.0}, {"from": "Children", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "China", "to": "health equity", "width": 3.5}, {"from": "Cholera, dysentery, typhoid and polio", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Climate Change", "to": "India\u0027s G20 Leadership", "width": 4.0}, {"from": "Clinical decision support system", "to": "Resilient Digital Health Ecosystem", "width": 3.5}, {"from": "Coalition for Epidemic Preparedness Innovations (CEPI)", "to": "pandemic", "width": 3.5}, {"from": "Coalition for Epidemic Preparedness Innovations (CEPI)", "to": "pandemics", "width": 5.0}, {"from": "Coalition for Epidemic Preparedness Innovations (CEPI)", "to": "Dr. Richard Hatchett", "width": 4.5}, {"from": "Coalition for Epidemic Preparedness Innovations (CEPI)", "to": "Kate Kelland", "width": 4.0}, {"from": "Combating AMR", "to": "Policy", "width": 4.0}, {"from": "Combating AMR", "to": "Implementation", "width": 4.0}, {"from": "Combating AMR", "to": "New antibiotics", "width": 4.5}, {"from": "Combating AMR", "to": "Infection prevention and control practices", "width": 4.0}, {"from": "Combating AMR", "to": "Surveillance and data collection", "width": 4.0}, {"from": "Combating AMR", "to": "One Health approach", "width": 3.5}, {"from": "Combating AMR", "to": "National and global health plans", "width": 4.0}, {"from": "Combating AMR", "to": "Stakeholders", "width": 3.5}, {"from": "Combating AMR", "to": "Political will", "width": 3.5}, {"from": "DBT", "to": "technology", "width": 4.0}, {"from": "DEPA", "to": "India Stack", "width": 4.5}, {"from": "DEU", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "DNDi (Drugs for Neglected Diseases Initiative)", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "DPI", "to": "digital literacy", "width": 5.0}, {"from": "DPI", "to": "digital divide", "width": 4.5}, {"from": "DPI", "to": "India\u0027s digital transformation", "width": 4.5}, {"from": "DPI", "to": "technology", "width": 4.0}, {"from": "DPI", "to": "inclusivity", "width": 4.5}, {"from": "DPI", "to": "scalability", "width": 4.0}, {"from": "DPI", "to": "regulation", "width": 4.0}, {"from": "DPI", "to": "collaboration", "width": 4.0}, {"from": "Dame Barbara Stocking", "to": "Global Public Health Convention", "width": 4.5}, {"from": "Data Empowerment and Protection Architecture (DEPA)", "to": "India Enterprise Architecture", "width": 3.5}, {"from": "Databases and knowledge-sharing resources", "to": "OH approach", "width": 4.5}, {"from": "Databases and knowledge-sharing resources", "to": "G20 countries", "width": 4.5}, {"from": "Department for Digital Health and Innovation", "to": "World Health Organization (WHO)", "width": 4.0}, {"from": "Depression", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Depression", "to": "Integrating Mental Health into General Healthcare", "width": 4.0}, {"from": "Depression", "to": "Mental Health", "width": 4.0}, {"from": "Developing countries", "to": "access to vaccines, drugs, and other medical equipment", "width": 4.5}, {"from": "Digital Health", "to": "India\u0027s G20 presidency", "width": 4.5}, {"from": "Digital Health", "to": "Global Initiative on Digital Health (GIDH)", "width": 4.0}, {"from": "Digital Health", "to": "World Health Organization (WHO)", "width": 3.5}, {"from": "Digital India", "to": "transparency", "width": 4.5}, {"from": "Digital India programme", "to": "India\u0027s Digital Public Infrastructure Transformation", "width": 4.5}, {"from": "Digital Personal Data Protection Bill 2022", "to": "India\u0027s Digital Public Infrastructure Transformation", "width": 4.0}, {"from": "Digital healthcare", "to": "India", "width": 4.5}, {"from": "Digital infrastructure", "to": "India Stack", "width": 4.5}, {"from": "Direct Benefit Transfer (DBT) programme", "to": "India\u0027s Digital Public Infrastructure Transformation", "width": 4.5}, {"from": "Disability-Adjusted-Life-Years (DALYs)", "to": "mental disorders", "width": 4.5}, {"from": "Disability-Adjusted-Life-Years (DALYs)", "to": "treatment gap for mental and substance abuse disorders", "width": 4.0}, {"from": "Disability-Adjusted-Life-Years (DALYs)", "to": "out-of-pocket (OOP) spending", "width": 3.5}, {"from": "Disability-Adjusted-Life-Years (DALYs)", "to": "medicines", "width": 4.0}, {"from": "Disease X pandemic virus", "to": "One World Vaccine Library", "width": 4.5}, {"from": "Disease outbreaks", "to": "Public Health Workforce", "width": 3.5}, {"from": "Disparity Interventions", "to": "Mental Health", "width": 3.5}, {"from": "Displacement", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "District Mental Health Program (DMHP)", "to": "mental health equity", "width": 4.5}, {"from": "District Mental Health Program (DMHP)", "to": "National Program for Mental Health (NMHP)", "width": 4.5}, {"from": "District Mental Health Program (DMHP)", "to": "India", "width": 4.5}, {"from": "Doha Trade Round", "to": "Pandemic Accord", "width": 4.0}, {"from": "Dr Priyadarshini Rajamani", "to": "Global Health", "width": 3.5}, {"from": "Dr Soumya Swaminathan", "to": "Global Health", "width": 4.5}, {"from": "Dr. Richard Hatchett", "to": "pandemics", "width": 4.5}, {"from": "Drinking or coming in contact with contaminated water", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "EPHFs", "to": "national public health workforce capacity", "width": 4.5}, {"from": "EPHFs (Emergency Public Health Functions)", "to": "regional, and global bodies", "width": 3.5}, {"from": "Ebola", "to": "zoonotic disease", "width": 4.0}, {"from": "Economic efficiency", "to": "Mental Health as a Pathway to Health Equity", "width": 4.0}, {"from": "Economic productivity gains", "to": "Mental Health as a Pathway to Health Equity", "width": 3.5}, {"from": "Effective treatments for all", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Elderly", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Equitable pricing and access", "to": "Innovative financing mechanisms", "width": 4.5}, {"from": "Equity in access to drugs and vaccines", "to": "Pandemic Accord", "width": 4.0}, {"from": "Essential Public Health Functiona (EPHF)", "to": "Investing in the Public Health Workforce", "width": 5.0}, {"from": "Essential Public Health Functiona (EPHF)", "to": "Global investment", "width": 5.0}, {"from": "Essential Public Health Functiona (EPHF)", "to": "G7 and G20 intergovernmental processes", "width": 4.5}, {"from": "Essential Public Health Functiona (EPHF)", "to": "World Health Organization (WHO)", "width": 5.0}, {"from": "Essential health services", "to": "Public Health Workforce", "width": 3.5}, {"from": "Event-based disease surveillance", "to": "Resilient Digital Health Ecosystem", "width": 3.5}, {"from": "FRA", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "FY 2021-22", "to": "transparency", "width": 4.0}, {"from": "Faecal-contaminated water", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Fight against AMR", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "Financial incentives", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "Five-Year Forward View for Mental Health", "to": "Mental Health", "width": 4.0}, {"from": "Food Insecurity", "to": "India\u0027s G20 Leadership", "width": 3.5}, {"from": "Food and Agriculture Organisation (FAO)", "to": "One Health", "width": 4.5}, {"from": "Food and Agriculture Organisation (FAO)", "to": "Quadripartite Collaboration for One Health", "width": 4.5}, {"from": "Food and Agriculture Organization", "to": "One Health", "width": 3.5}, {"from": "Food-borne diseases", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "France", "to": "health equity", "width": 3.5}, {"from": "G20", "to": "regional, and global bodies", "width": 4.5}, {"from": "G20", "to": "One Health approach in India", "width": 4.5}, {"from": "G20", "to": "Office of the Principal Scientific Adviser (PSA)", "width": 4.0}, {"from": "G20", "to": "Global Health", "width": 4.0}, {"from": "G20", "to": "Public Health Outcomes", "width": 4.5}, {"from": "G20", "to": "Health Equity", "width": 4.5}, {"from": "G20", "to": "Life Expectancy", "width": 4.5}, {"from": "G20", "to": "Healthcare Spending", "width": 5.0}, {"from": "G20", "to": "GDP", "width": 4.0}, {"from": "G20 Countries", "to": "Global Average of Life Expectancy", "width": 4.0}, {"from": "G20 Countries", "to": "Role of Health Finance in G20 Countries", "width": 4.5}, {"from": "G20 Countries", "to": "Health Finance", "width": 4.5}, {"from": "G20 Countries", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "G20 Independent High-Level Panel", "to": "Pandemic Accord", "width": 4.0}, {"from": "G20 Italia Declaration of Health Ministers", "to": "Global Health Summit", "width": 4.0}, {"from": "G20 countries", "to": "OH approach", "width": 5.0}, {"from": "G20 countries", "to": "OH workforce", "width": 4.5}, {"from": "G20 countries", "to": "Integrated OH surveillance system", "width": 4.0}, {"from": "G20 countries", "to": "Routine and emergency coordination mechanisms", "width": 4.5}, {"from": "G20 countries", "to": "Standardised framework for addressing zoonotic spillover risks", "width": 4.0}, {"from": "G20 countries", "to": "Urbanisation and habitat fragmentation", "width": 4.0}, {"from": "G20 countries", "to": "Spillover risks and disease spread", "width": 4.5}, {"from": "G20 countries", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "G20 countries", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "G20 countries", "to": "Out-Of-Pocket Expenses (OOPE)", "width": 4.0}, {"from": "G20 support to invest in preparedness and national capacity", "to": "workforce capacity and readiness", "width": 5.0}, {"from": "G20 support to invest in preparedness and national capacity", "to": "national assessments and benchmarking", "width": 4.5}, {"from": "G20 support to invest in preparedness and national capacity", "to": "World Bank\u2019s Pandemic Fund", "width": 4.5}, {"from": "G20 support to invest in preparedness and national capacity", "to": "strengthening human resources", "width": 5.0}, {"from": "G20 support to invest in preparedness and national capacity", "to": "countries prevent, prepare for, and respond to health emergencies", "width": 4.5}, {"from": "G20 support to invest in preparedness and national capacity", "to": "sustainable public health workforce capacity in LMICs", "width": 5.0}, {"from": "G20 support to invest in preparedness and national capacity", "to": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "width": 4.5}, {"from": "G20 support to invest in preparedness and national capacity", "to": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "width": 4.0}, {"from": "G7", "to": "regional, and global bodies", "width": 4.5}, {"from": "G7 Germany", "to": "health workforce", "width": 3.5}, {"from": "G7 Summit", "to": "health workforce", "width": 4.5}, {"from": "G7 and G20 intergovernmental processes", "to": "Investing in the Public Health Workforce", "width": 4.5}, {"from": "G7 and G20 intergovernmental processes", "to": "Global investment", "width": 4.5}, {"from": "G7 and G20 intergovernmental processes", "to": "World Health Organization (WHO)", "width": 4.5}, {"from": "G7 and the G20", "to": "One World Vaccine Library", "width": 4.0}, {"from": "GDP", "to": "Healthcare Spending", "width": 4.0}, {"from": "GP/family physician", "to": "Health Finance", "width": 4.0}, {"from": "Gavi (Global Alliance for Vaccines and Immunization)", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "Gavi and WHO", "to": "in-country delivery requirements", "width": 4.5}, {"from": "Gavi, the Vaccine Alliance", "to": "Imperial College London", "width": 4.0}, {"from": "Gavi, the Vaccine Alliance", "to": "conditions", "width": 4.0}, {"from": "Gavi, the Vaccine Alliance", "to": "pandemic", "width": 4.5}, {"from": "Gender Inequality", "to": "Public Health Workforce", "width": 4.5}, {"from": "Germany", "to": "health equity", "width": 3.5}, {"from": "Global", "to": "health equity", "width": 3.5}, {"from": "Global DPI Summit21", "to": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "width": 4.0}, {"from": "Global Digital Health Partnership (GDHP)", "to": "World Health Organization (WHO)", "width": 4.5}, {"from": "Global Early Warning and Response System for Major Animal Diseases", "to": "ecological connectivity", "width": 4.5}, {"from": "Global Health", "to": "Pathways to Health Equity", "width": 4.5}, {"from": "Global Health", "to": "Infectious diseases", "width": 4.5}, {"from": "Global Health", "to": "Surveillance systems", "width": 4.0}, {"from": "Global Health", "to": "Global collaboration and solidarity", "width": 4.5}, {"from": "Global Health", "to": "Nature", "width": 3.5}, {"from": "Global Health", "to": "Health and well-being for all people everywhere", "width": 4.5}, {"from": "Global Health", "to": "MS Swaminathan Research Foundation", "width": 3.5}, {"from": "Global Health", "to": "World Health Organization", "width": 4.0}, {"from": "Global Health Initiatives", "to": "India\u0027s G20 Leadership", "width": 4.5}, {"from": "Global Health Summit", "to": "Rome Declaration", "width": 4.5}, {"from": "Global Public Health Convention", "to": "countries across the world", "width": 4.5}, {"from": "Global Public Health Convention", "to": "resources to deliver", "width": 4.0}, {"from": "Global Public Health Convention", "to": "Panel for a Global Public Health Convention", "width": 4.0}, {"from": "Global Strategy on Digital Health 2020-2025", "to": "World Health Organization (WHO)", "width": 4.0}, {"from": "Global Vaccine Library", "to": "coronavirus", "width": 4.5}, {"from": "Global Vector Control Response (GVCR) 2017\u20132030", "to": "ecological connectivity", "width": 4.5}, {"from": "Global average", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 4.0}, {"from": "Global economic loss due to mental disorders", "to": "Mental Health as a Pathway to Health Equity", "width": 3.5}, {"from": "Global investment", "to": "Investing in the Public Health Workforce", "width": 5.0}, {"from": "Global investment", "to": "World Health Organization (WHO)", "width": 5.0}, {"from": "Global partners", "to": "Public Health Workforce", "width": 4.0}, {"from": "Governments pool funding", "to": "Innovative financing mechanisms", "width": 4.0}, {"from": "Green Highlighted Countries", "to": "Health Finance", "width": 4.0}, {"from": "Green Highlighted Countries", "to": "Universal Health Coverage (UHC)", "width": 4.0}, {"from": "H1N1 pandemic", "to": "vaccine nationalism", "width": 4.5}, {"from": "H1N1 pandemic", "to": "vaccines", "width": 4.5}, {"from": "HIV infections", "to": "global health system", "width": 4.5}, {"from": "Health Equity", "to": "Mental Health", "width": 4.5}, {"from": "Health Equity", "to": "Healthcare Spending", "width": 4.5}, {"from": "Health Equity Assessment Toolkit (HEAT and HEAT Plus)", "to": "Mental Health", "width": 4.0}, {"from": "Health Finance", "to": "Universal Health Coverage (UHC)", "width": 5.0}, {"from": "Health Finance", "to": "Out-of-Pocket Expenditure (OOPE)", "width": 4.5}, {"from": "Health Finance", "to": "Indonesia", "width": 3.5}, {"from": "Health Finance", "to": "JKN National Health Insurance", "width": 3.5}, {"from": "Health Finance", "to": "hospital-centric healthcare system", "width": 4.0}, {"from": "Health Finance", "to": "preventive model", "width": 4.0}, {"from": "Health Finance", "to": "universal health care", "width": 4.5}, {"from": "Health Finance", "to": "Singapore", "width": 3.5}, {"from": "Health Finance", "to": "primary care", "width": 4.0}, {"from": "Health Finance", "to": "judicious purchasing and effective procurement", "width": 3.5}, {"from": "Health Management Information System", "to": "India", "width": 4.0}, {"from": "Health Sector", "to": "Public Health Workforce", "width": 4.0}, {"from": "Healthcare Spending", "to": "Public Health Outcomes", "width": 4.5}, {"from": "Healthcare Spending", "to": "Life Expectancy", "width": 4.5}, {"from": "Healthcare Spending and Health Outcomes", "to": "Role of Health Finance in G20 Countries", "width": 4.5}, {"from": "Healthcare providers", "to": "JKN program", "width": 3.5}, {"from": "Healthy life years lost", "to": "Pathways to Health Equity for the G20", "width": 3.0}, {"from": "High-Income Countries", "to": "Mental Health", "width": 4.5}, {"from": "Higher % GDP Spending in Healthcare", "to": "Role of Health Finance in G20 Countries", "width": 4.0}, {"from": "Homeless", "to": "Pathways to Health Equity for the G20", "width": 3.5}, {"from": "Hospital Management Information System", "to": "India", "width": 4.0}, {"from": "Human rights", "to": "Mental Health as a Pathway to Health Equity", "width": 3.5}, {"from": "IDN", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "IDNIND", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "IHR", "to": "WGIHR", "width": 4.5}, {"from": "IHR", "to": "Pandemic Accord", "width": 4.5}, {"from": "IHR", "to": "One Health", "width": 4.0}, {"from": "INDKOR", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "ITA", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.5}, {"from": "Improvements in curative and preventive care domains", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "Improving population health", "to": "Mental Health as a Pathway to Health Equity", "width": 4.0}, {"from": "India", "to": "Mental Health as a Pathway to Health Equity", "width": 3.5}, {"from": "India", "to": "mental health equity", "width": 5.0}, {"from": "India", "to": "social inequality", "width": 4.5}, {"from": "India", "to": "gender issues", "width": 4.5}, {"from": "India", "to": "community participation", "width": 4.0}, {"from": "India", "to": "National Program for Mental Health (NMHP)", "width": 5.0}, {"from": "India", "to": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)", "width": 4.5}, {"from": "India", "to": "One Health", "width": 4.5}, {"from": "India", "to": "Online Registration System", "width": 3.5}, {"from": "India", "to": "National tuberculosis elimination (Ni-kshay)", "width": 4.0}, {"from": "India", "to": "Mother and Child Tracking System", "width": 3.5}, {"from": "India", "to": "Mera Aspataal (My Hospital)", "width": 3.5}, {"from": "India", "to": "Integrated Health Information Platform", "width": 3.5}, {"from": "India", "to": "Non-Communicable Diseases screening application", "width": 3.5}, {"from": "India", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "India", "to": "marginalised communities", "width": 4.5}, {"from": "India", "to": "digital inclusion", "width": 4.0}, {"from": "India", "to": "urban telephone subscribers", "width": 3.5}, {"from": "India", "to": "gender gap in mobile ownership", "width": 4.0}, {"from": "India", "to": "India\u0027s digital infrastructure", "width": 4.5}, {"from": "India", "to": "intermediaries (digital media, e-commerce)", "width": 3.5}, {"from": "India", "to": "connectivity to cause harm or commit crimes", "width": 4.0}, {"from": "India", "to": "comprehensive measures", "width": 4.5}, {"from": "India", "to": "potential DPI\u2019s scalability", "width": 3.5}, {"from": "India", "to": "health equity", "width": 3.5}, {"from": "India Enterprise Architecture", "to": "Ministry of Electronics and Information Technology (MeitY)", "width": 4.5}, {"from": "India Enterprise Architecture", "to": "One Government", "width": 4.0}, {"from": "India Stack", "to": "Unified Payments Interface (UPI)", "width": 4.5}, {"from": "India Stack", "to": "Open Credit Enablement Network", "width": 3.5}, {"from": "India Stack", "to": "Private sector service delivery", "width": 4.0}, {"from": "India\u0027s DPI", "to": "technology", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "MeitY study", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "US$500 billion by 2025", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "India\u0027s digital economy potential to US$1 trillion", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "business as usual scenario", "width": 3.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "real-time payments in India, China, Brazil", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "physical delivery of financial benefits", "width": 3.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "digital payment systems", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "beneficiaries\u0027 bank accounts", "width": 3.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "corruption, eliminating middlemen", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "forums and platforms for stakeholders", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "policy discussions and regulatory consultations", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "balanced regulatory policies", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "Indian regulators", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "presentation of the Digital India Act 2023", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "consumer needs, emerging technologies, and market trends", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation", "to": "challenges", "width": 3.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "government agencies", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "industry leaders", "width": 4.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "startups", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "academia", "width": 3.5}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "civil society organisations", "width": 4.0}, {"from": "India\u0027s Digital Public Infrastructure Transformation Ecosystem", "to": "India\u2019s G20 presidency", "width": 4.5}, {"from": "India\u0027s digital infrastructure", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "India\u0027s digital transformation", "to": "digital literacy", "width": 4.5}, {"from": "Indian Rupees (INR)", "to": "transparency", "width": 3.5}, {"from": "Indonesia", "to": "health equity", "width": 3.5}, {"from": "Indonesia", "to": "Universal Health Coverage (UHC)", "width": 4.0}, {"from": "Indonesia", "to": "medicines", "width": 4.5}, {"from": "Indonesia", "to": "healthcare expenditure", "width": 4.0}, {"from": "Indonesia", "to": "OOP payments", "width": 3.5}, {"from": "Indonesia", "to": "drug pricing and procurement", "width": 4.5}, {"from": "Indonesian citizens", "to": "JKN program", "width": 4.5}, {"from": "Inequality", "to": "Mental Health", "width": 4.5}, {"from": "Innovative Financing Mechanisms", "to": "Role of Health Finance in G20 Countries", "width": 4.0}, {"from": "Innovative financing mechanisms", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Innovative financing mechanisms", "to": "Manufacturers and the private sector", "width": 4.5}, {"from": "Innovative financing mechanisms", "to": "Poor diagnostic capacity", "width": 4.0}, {"from": "Innovator Brand (IB) medicines", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "Integrated OH surveillance system", "to": "OH approach", "width": 4.0}, {"from": "Integrating Mental Health into General Healthcare", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "Integrating Mental Health into General Healthcare", "to": "Poverty", "width": 4.5}, {"from": "Integrating Mental Health into General Healthcare", "to": "Mental Health", "width": 5.0}, {"from": "Integrating Mental Health into General Healthcare", "to": "Psychological Determinants", "width": 4.5}, {"from": "Integrating Mental Health into General Healthcare", "to": "Social Determinants", "width": 4.5}, {"from": "Integrating Mental Health into General Healthcare", "to": "Substance Use Disorders", "width": 4.0}, {"from": "Integrating Mental Health into General Healthcare", "to": "Severe Mental Illness (SMI)", "width": 4.0}, {"from": "Integrating Mental Health into General Healthcare", "to": "Schizophrenia", "width": 3.5}, {"from": "Intergovernmental Negotiating Body (INB)", "to": "Pandemic Accord", "width": 3.5}, {"from": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "to": "workforce capacity and readiness", "width": 4.0}, {"from": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "to": "strengthening human resources", "width": 4.0}, {"from": "Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)", "to": "sustainable public health workforce capacity in LMICs", "width": 4.0}, {"from": "International Health Regulations (IHR)", "to": "Pandemic Accord", "width": 4.5}, {"from": "Investing in mental health", "to": "Mental Health as a Pathway to Health Equity", "width": 4.5}, {"from": "Investing in the Public Health Workforce", "to": "World Health Organization (WHO)", "width": 5.0}, {"from": "Investment in treatment of mental illness", "to": "Mental Health as a Pathway to Health Equity", "width": 4.0}, {"from": "JKN", "to": "UHC", "width": 4.0}, {"from": "JKN National Health Insurance", "to": "Universal Health Coverage (UHC)", "width": 3.5}, {"from": "JKN program", "to": "Social Security Agency for Health (B P J S)", "width": 4.0}, {"from": "JKN program", "to": "medical benefit package", "width": 4.0}, {"from": "JKN program", "to": "Out-of-pocket expenditure (OOP)", "width": 3.5}, {"from": "JKN program", "to": "Low and medium-income countries (LMICs)", "width": 3.0}, {"from": "JPNDEU", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "Jan Dhan-Aadhaar-Mobile Yojana", "to": "transparency", "width": 4.5}, {"from": "Janice Tan", "to": "Pathways to Health Equity for the G20", "width": 3.0}, {"from": "Japan", "to": "health equity", "width": 3.5}, {"from": "Joint Plan of Action", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "KSA KSAFRA", "to": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "width": 3.0}, {"from": "Kate Kelland", "to": "pandemics", "width": 4.0}, {"from": "LMICs", "to": "Mental Health", "width": 4.5}, {"from": "LMICs", "to": "infectious diseases", "width": 4.0}, {"from": "LMICs", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "LMICs", "to": "need for increased action", "width": 4.5}, {"from": "Lav Agarwal", "to": "technology", "width": 3.5}, {"from": "Lav Agarwal", "to": "healthcare", "width": 3.5}, {"from": "Leadership and governance", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "ZAFTURTUR", "width": 3.0}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "USAUSAJPN", "width": 3.5}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "SPNITA", "width": 3.0}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "RUSMEX", "width": 3.0}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "MEX", "width": 3.5}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "SGP", "width": 3.5}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "SGPCAN", "width": 3.0}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "UKUK", "width": 3.5}, {"from": "Lower Out of Pocket Expenditure as a% of Current Health Expenditure", "to": "ZAF", "width": 3.5}, {"from": "Lowest Price Generic (LPG) medicines", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "MERS", "to": "coronavirus", "width": 4.5}, {"from": "MERS", "to": "zoonotic disease", "width": 4.0}, {"from": "MHCA 2017", "to": "mental health services", "width": 4.5}, {"from": "MHCA 2017", "to": "mental illness", "width": 4.5}, {"from": "Macro-environmental issues", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "Maximum Retail Price set by the MOH", "to": "generic medicine pricing policy", "width": 4.0}, {"from": "MediShield Life", "to": "Widening coverage", "width": 4.5}, {"from": "MediShield Life", "to": "pre-existing conditions", "width": 4.5}, {"from": "MediShield Life", "to": "older individuals", "width": 4.0}, {"from": "Memorandum of Understanding (MOU)", "to": "One Health", "width": 4.5}, {"from": "Memorandum of Understanding (MOU)", "to": "Quadripartite Collaboration for One Health", "width": 4.5}, {"from": "Mental Health", "to": "World Health Organization (WHO)", "width": 4.0}, {"from": "Mental Health", "to": "United Nations (UN)", "width": 4.0}, {"from": "Mental Health", "to": "Sustainable Development Goals (SDGs)", "width": 4.5}, {"from": "Mental Health", "to": "Pathways to Health Equity for the G20", "width": 5.0}, {"from": "Mental Health", "to": "Poverty", "width": 4.5}, {"from": "Mental Health", "to": "Psychological Determinants", "width": 4.5}, {"from": "Mental Health", "to": "Social Determinants", "width": 4.5}, {"from": "Mental Health", "to": "Substance Use Disorders", "width": 4.0}, {"from": "Mental Health", "to": "Severe Mental Illness (SMI)", "width": 4.0}, {"from": "Mental Health", "to": "Schizophrenia", "width": 3.5}, {"from": "Mental Health", "to": "United Kingdom (UK)", "width": 4.0}, {"from": "Mental Health", "to": "National Health Service (NHS)", "width": 3.5}, {"from": "Mental Health", "to": "Public Health Domain", "width": 4.0}, {"from": "Mental Health Policy (2014)", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "Mental Health Review Boards", "to": "mental health services", "width": 4.0}, {"from": "Mental Health Review Boards", "to": "mental illness", "width": 4.0}, {"from": "Mental Health as a Pathway to Health Equity", "to": "Social inequality", "width": 4.0}, {"from": "Mental Health as a Pathway to Health Equity", "to": "The Burden of Mental Health, Substance Use Disorders and Multimorbidity", "width": 4.0}, {"from": "Mental Health as a Pathway to Health Equity", "to": "Mental and substance-abuse disorders", "width": 3.5}, {"from": "Mental Health as a Pathway to Health Equity", "to": "Premature morbidity and mortality globally", "width": 3.0}, {"from": "Mental Health as a Pathway to Health Equity", "to": "National Mental Health Survey (NMHS), 2015-16", "width": 3.0}, {"from": "Mental health impact of climate change", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Mexico", "to": "health equity", "width": 3.5}, {"from": "MyGov platform", "to": "digital governance", "width": 4.5}, {"from": "MyGov platform", "to": "citizen-centricity", "width": 4.5}, {"from": "MyGov platform", "to": "technology", "width": 4.5}, {"from": "MyGov platform", "to": "government interactions", "width": 4.0}, {"from": "MyGov platform", "to": "citizen-government gap", "width": 4.0}, {"from": "MyGov platform", "to": "enhance government services", "width": 4.0}, {"from": "MyGov platform", "to": "transparency", "width": 4.0}, {"from": "MyGov platform", "to": "democratic participation", "width": 4.0}, {"from": "NGO hospitals", "to": "generic medicine pricing policy", "width": 4.0}, {"from": "NGOs", "to": "mental health services", "width": 4.5}, {"from": "NGOs", "to": "mental illness", "width": 4.5}, {"from": "National Mental Health Policy 2014", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)", "to": "mental health equity", "width": 4.5}, {"from": "National Mental Health Programme \u2013 District Mental Health Programme (\u003e700 districts)", "to": "National Program for Mental Health (NMHP)", "width": 4.5}, {"from": "National Program for Mental Health (NMHP)", "to": "mental health equity", "width": 5.0}, {"from": "National Program for Mental Health (NMHP)", "to": "social inequality", "width": 4.5}, {"from": "National Program for Mental Health (NMHP)", "to": "gender issues", "width": 4.5}, {"from": "National Program for Mental Health (NMHP)", "to": "community participation", "width": 4.0}, {"from": "National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "National University of Singapore\u0027s Saw Swee Hock School of Public Health", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Netherlands", "to": "health equity", "width": 3.5}, {"from": "New legislation", "to": "antibiotic", "width": 4.0}, {"from": "Nipah", "to": "zoonotic disease", "width": 4.0}, {"from": "OH approach", "to": "OH workforce", "width": 4.5}, {"from": "OH approach", "to": "Routine and emergency coordination mechanisms", "width": 4.5}, {"from": "OH approach", "to": "Standardised framework for addressing zoonotic spillover risks", "width": 4.0}, {"from": "OH approach", "to": "Urbanisation and habitat fragmentation", "width": 4.0}, {"from": "OH approach", "to": "Spillover risks and disease spread", "width": 4.5}, {"from": "OH approach", "to": "interpersonal relationships", "width": 4.5}, {"from": "OH approach", "to": "veterinary workforce", "width": 4.0}, {"from": "OH approach", "to": "academic institutions", "width": 4.5}, {"from": "OH approach", "to": "local population", "width": 4.0}, {"from": "OH approach", "to": "Tamil Nadu Veterinary and Animal Sciences University", "width": 4.0}, {"from": "OH approach", "to": "Tamil Nadu Dr MGR Medical University", "width": 4.5}, {"from": "OH approach", "to": "Punjab", "width": 3.5}, {"from": "OH approach", "to": "SARS-CoV2 vaccine trial", "width": 4.5}, {"from": "OH approach", "to": "outbreak investigation", "width": 4.0}, {"from": "OH approach", "to": "vaccine hesitancy", "width": 4.5}, {"from": "OTC sale of antimicrobials", "to": "antibiotic", "width": 4.5}, {"from": "One Health", "to": "Pandemic Accord", "width": 3.5}, {"from": "One Health", "to": "World Health Organization", "width": 4.0}, {"from": "One Health", "to": "United Nations Environment Programme", "width": 3.5}, {"from": "One Health", "to": "World Organisation for Animal Health", "width": 3.5}, {"from": "One Health", "to": "pandemic prevention, preparedness, and response", "width": 4.5}, {"from": "One Health", "to": "domestic health systems", "width": 4.0}, {"from": "One Health", "to": "Quadripartite Collaboration for One Health", "width": 5.0}, {"from": "One Health", "to": "One Health High-Level Expert Panel", "width": 4.5}, {"from": "One Health", "to": "One Health Joint Plan of Action (2022-2026)", "width": 4.0}, {"from": "One Health", "to": "World Health Organisation (WHO)", "width": 4.5}, {"from": "One Health", "to": "United Nations Environment Programme (UNEP)", "width": 4.0}, {"from": "One Health", "to": "World Organisation for Animal Health (OIE)", "width": 3.5}, {"from": "One Health", "to": "pandemic prevention and preparedness", "width": 4.5}, {"from": "One Health", "to": "World Bank\u0027s US$10-billion fund", "width": 4.0}, {"from": "One Health", "to": "UN\u2019s high-level meeting on pandemic prevention, preparedness, and response (September 2023)", "width": 4.5}, {"from": "One Health", "to": "WHO", "width": 4.5}, {"from": "One Health", "to": "zoonoses and transboundary animal diseases", "width": 4.5}, {"from": "One Health", "to": "zonotic policy documents", "width": 4.5}, {"from": "One Health", "to": "lack of supportive policies", "width": 4.0}, {"from": "One Health", "to": "conflicting departmental priorities", "width": 4.0}, {"from": "One Health", "to": "limited institutional capacities", "width": 4.0}, {"from": "One Health", "to": "cross-sectoral collaboration on disease control", "width": 3.5}, {"from": "One Health", "to": "contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts", "width": 4.0}, {"from": "One Health", "to": "pandemic", "width": 4.0}, {"from": "One Health High-Level Expert Panel", "to": "Quadripartite Collaboration for One Health", "width": 4.5}, {"from": "One Health Joint Plan of Action (2022-2026)", "to": "Quadripartite Collaboration for One Health", "width": 4.0}, {"from": "One Health\u2019", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "One World Vaccine Library", "to": "Pathways to Health Equity for the G20", "width": 4.5}, {"from": "One World Vaccine Library", "to": "novel paramyxovirus", "width": 4.0}, {"from": "One World Vaccine Library", "to": "new vaccines", "width": 4.0}, {"from": "One World Vaccine Library", "to": "improved surveillance", "width": 3.5}, {"from": "One World Vaccine Library", "to": "non-pharmaceutical interventions", "width": 4.0}, {"from": "One World Vaccine Library", "to": "virus families", "width": 4.5}, {"from": "One World Vaccine Library", "to": "pandemics", "width": 4.0}, {"from": "Operationalising \u2018One Health\u2019", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Out-Of-Pocket Expenses (OOPE)", "to": "Pathways to Health Equity for the G20", "width": 4.0}, {"from": "Out-of-Pocket Expenditure (OOPE)", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "Out-of-Pocket Expenses", "to": "Role of Health Finance in G20 Countries", "width": 4.0}, {"from": "Over 200 diseases", "to": "Pathways to Health Equity for the G20", "width": 3.0}, {"from": "PPR", "to": "Pandemic Accord", "width": 3.5}, {"from": "Pandemic Accord", "to": "WHO\u0027s 194 member states", "width": 4.0}, {"from": "Pandemic Accord", "to": "World Health Assembly (WHA)", "width": 4.5}, {"from": "Pandemic Accord", "to": "Working Group on amendments to the IHR (WGIHR)", "width": 4.0}, {"from": "Pandemic Accord", "to": "World Trade Organization", "width": 4.0}, {"from": "Pandemic Accord", "to": "TRIPS waiver", "width": 4.5}, {"from": "Pandemic Accord", "to": "equity of access", "width": 4.5}, {"from": "Pandemic Accord", "to": "Pandemic Accord and the IHR", "width": 4.0}, {"from": "Pandemic Accord", "to": "financing", "width": 4.5}, {"from": "Pandemic Accord", "to": "annual financing need for future preparedness and response to pandemics", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "Poverty", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Psychological Determinants", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "Social Determinants", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "Substance Use Disorders", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Severe Mental Illness (SMI)", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Schizophrenia", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "Psychotropic medications", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "digital academies at NIMHANS", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "m-Cessation", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "tobacco quit-lines", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "Rehabilitative care", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Vulnerable populations", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Unemployment", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "one health", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "zoonoses", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "wet markets", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "equity", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "procurement, distribution, administration of COVID-19 vaccines", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "Water-borne diseases", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Two billion people globally", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Undercooked meat or eggs", "width": 3.0}, {"from": "Pathways to Health Equity for the G20", "to": "Raw fruits and vegetables", "width": 3.0}, {"from": "Pathways to Health Equity for the G20", "to": "technology", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "healthcare", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "marginalised communities", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "digital inclusion", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "urban telephone subscribers", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "gender gap in mobile ownership", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "intermediaries (digital media, e-commerce)", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "connectivity to cause harm or commit crimes", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "comprehensive measures", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "potential DPI\u2019s scalability", "width": 3.5}, {"from": "Pathways to Health Equity for the G20", "to": "vulnerable populations in HICs", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "antimicrobials pipeline", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "industry leaving the field of antimicrobial drug discovery", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "consequences of AMR", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "need for increased action", "width": 5.0}, {"from": "Pathways to Health Equity for the G20", "to": "multifaceted effort", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "reducing the circulation and spread of existing resistant microorganisms", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "increase of novel resistance mechanisms", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "lowering the overall use of antimicrobials", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "antimicrobial stewardship", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "accessibility of affordable and timely diagnostics", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "strengthening IPC and biosecurity procedures", "width": 4.0}, {"from": "Pathways to Health Equity for the G20", "to": "Universal Health Coverage (UHC)", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "Pathways to Health Equity for the G20", "to": "UHC (Universal Health Coverage)", "width": 4.5}, {"from": "Pradhan Mantri Jan-Dhan Yojana", "to": "transparency", "width": 4.0}, {"from": "Public Health System", "to": "Public Health Workforce", "width": 4.0}, {"from": "Public Health Workforce", "to": "Routine immunisation", "width": 3.0}, {"from": "Public Health Workforce", "to": "occupations outside of the health sector", "width": 4.5}, {"from": "Public Health Workforce", "to": "roadmap and action plan", "width": 4.5}, {"from": "Public Health Workforce", "to": "standard EPHF", "width": 4.0}, {"from": "Public Health Workforce", "to": "whole-of-government and whole-of-society approach", "width": 4.5}, {"from": "Public Health Workforce", "to": "national stakeholders", "width": 4.0}, {"from": "Public Health Workforce", "to": "existing national and global networks of partners", "width": 4.5}, {"from": "Public Health Workforce", "to": "country-based assessment", "width": 4.0}, {"from": "Public Health Workforce", "to": "policy improvement", "width": 4.5}, {"from": "Public Health Workforce", "to": "World Health Organization", "width": 4.5}, {"from": "Public Health Workforce", "to": "Public health and emergency workforce roadmap", "width": 4.0}, {"from": "Quadripartite Collaboration for One Health", "to": "World Health Organisation (WHO)", "width": 4.5}, {"from": "Quadripartite Collaboration for One Health", "to": "United Nations Environment Programme (UNEP)", "width": 4.0}, {"from": "Quadripartite Collaboration for One Health", "to": "World Organisation for Animal Health (OIE)", "width": 3.5}, {"from": "R\u0026D", "to": "recommendations", "width": 4.5}, {"from": "R\u0026D", "to": "supply", "width": 4.5}, {"from": "R\u0026D", "to": "demand", "width": 4.5}, {"from": "R\u0026D", "to": "manufacturing", "width": 4.5}, {"from": "R\u0026D", "to": "country-level challenges", "width": 5.0}, {"from": "R\u0026D", "to": "other factors", "width": 4.5}, {"from": "R\u0026D", "to": "at-risk investments", "width": 5.0}, {"from": "R\u0026D", "to": "funding", "width": 4.5}, {"from": "R\u0026D", "to": "vaccines", "width": 5.0}, {"from": "R\u0026D", "to": "R\u0026D stage", "width": 4.5}, {"from": "R\u0026D stage", "to": "country-level challenges", "width": 4.5}, {"from": "R\u0026D stage", "to": "at-risk investments", "width": 4.5}, {"from": "R\u0026D stage", "to": "vaccines", "width": 4.5}, {"from": "RSV", "to": "coronavirus", "width": 4.5}, {"from": "Resilient Digital Health Ecosystem", "to": "healthcare structure", "width": 4.0}, {"from": "Role of Health Finance in G20 Countries", "to": "Universal Health Care Coverage", "width": 4.5}, {"from": "Role of Health Finance in G20 Countries", "to": "WHO Data", "width": 3.5}, {"from": "Russia", "to": "health equity", "width": 3.5}, {"from": "SARS", "to": "coronavirus", "width": 4.5}, {"from": "SARS", "to": "zoonotic disease", "width": 4.0}, {"from": "Singapore", "to": "health equity", "width": 3.5}, {"from": "South Africa", "to": "health equity", "width": 3.5}, {"from": "South Korea", "to": "health equity", "width": 3.5}, {"from": "Spain", "to": "health equity", "width": 3.5}, {"from": "Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal", "to": "impending disease outbreak", "width": 4.5}, {"from": "Success in getting mRNA vaccine manufacturing underway in South Africa", "to": "access to vaccines, drugs, and other medical equipment", "width": 4.5}, {"from": "Tele-MANAS initiative", "to": "World Mental Health Day", "width": 4.0}, {"from": "Tele-MANAS initiative", "to": "tele-mental health services", "width": 4.5}, {"from": "Tele-MANAS initiative", "to": "remote and underserved areas", "width": 4.0}, {"from": "Tele-MANAS initiative", "to": "Telephone/mobile based initiatives", "width": 4.0}, {"from": "Tele-MANAS initiative", "to": "eSanjeevani", "width": 4.5}, {"from": "Tele-MANAS initiative", "to": "e-Manas Karnataka", "width": 4.0}, {"from": "Tele-MANAS programme", "to": "evidence-based integration", "width": 4.5}, {"from": "Tele-education in medical education for remote areas", "to": "impending disease outbreak", "width": 4.5}, {"from": "The Urgent Need for a Pandemic Accord", "to": "bird and animal viruses", "width": 3.5}, {"from": "Turkiye", "to": "health equity", "width": 3.5}, {"from": "UHC", "to": "national policies", "width": 4.5}, {"from": "UHC", "to": "healthcare providers", "width": 4.5}, {"from": "UHC", "to": "public and private hospitals", "width": 4.0}, {"from": "UHC", "to": "clinics and facilities", "width": 4.0}, {"from": "UHC", "to": "healthcare infrastructure", "width": 4.5}, {"from": "UHC", "to": "disparities in healthcare infrastructure", "width": 4.0}, {"from": "UK", "to": "health equity", "width": 3.5}, {"from": "UPI", "to": "technology", "width": 4.0}, {"from": "United Nations Children\u2019s Fund (UNICEF)", "to": "pandemic", "width": 4.0}, {"from": "United States", "to": "health equity", "width": 3.5}, {"from": "Universal Health Coverage (UHC)", "to": "evidence-based integration", "width": 4.0}, {"from": "Universal Health Coverage (UHC)", "to": "health equity", "width": 4.5}, {"from": "WHO norms, standards, and", "to": "digital public goods", "width": 4.5}, {"from": "World Bank\u2019s Pandemic Fund", "to": "workforce capacity and readiness", "width": 4.5}, {"from": "World Bank\u2019s Pandemic Fund", "to": "strengthening human resources", "width": 4.5}, {"from": "World Bank\u2019s Pandemic Fund", "to": "sustainable public health workforce capacity in LMICs", "width": 4.5}, {"from": "World Federation of Public Health Associations (WFPHA), International", "to": "regional, and global bodies", "width": 3.5}, {"from": "World Health Organization (WHO)", "to": "healthcare service delivery", "width": 4.5}, {"from": "World Health Organization (WHO)", "to": "pandemic", "width": 4.5}, {"from": "World Mental Health Report, 2022", "to": "interrelated services", "width": 4.5}, {"from": "World Mental Health Report, 2022", "to": "life cycle", "width": 4.0}, {"from": "World Mental Health Report, 2022", "to": "maternal and child mental health", "width": 3.5}, {"from": "World Mental Health Report, 2022", "to": "elderly", "width": 3.5}, {"from": "abdm.gov.in", "to": "consultations", "width": 3.0}, {"from": "access to healthcare services", "to": "health equity", "width": 4.5}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "differences among them", "width": 4.0}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "wider spread of manufacturing", "width": 4.0}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "manufacturing for the whole continent and globally", "width": 4.0}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "financial investment", "width": 4.5}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "technology transfer", "width": 4.0}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "pharmaceutical industry", "width": 4.5}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "technology transfer and the associated question of intellectual property rights", "width": 4.0}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "wealthier governments funding R\u0026D", "width": 4.5}, {"from": "access to vaccines, drugs, and other medical equipment", "to": "companies earmark a percentage of vaccines for the poorer countries or sell to them at cost", "width": 4.0}, {"from": "accessibility of affordable and timely diagnostics", "to": "need for increased action", "width": 4.0}, {"from": "addressing social and economic inequalities", "to": "health equity", "width": 4.0}, {"from": "advancements in computational", "to": "antibiotic", "width": 3.5}, {"from": "agriculture sector", "to": "zoonotic disease", "width": 4.5}, {"from": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "to": "workforce capacity and readiness", "width": 4.5}, {"from": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "to": "strengthening human resources", "width": 4.5}, {"from": "alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord", "to": "sustainable public health workforce capacity in LMICs", "width": 4.5}, {"from": "ancillary supplies", "to": "life-saving equipment", "width": 4.0}, {"from": "ancillary supplies", "to": "vaccines", "width": 4.0}, {"from": "animals", "to": "global health system", "width": 4.5}, {"from": "antibiotic", "to": "patients", "width": 4.0}, {"from": "antibiotic", "to": "stricter antibiotic prescription and consumption measures", "width": 4.5}, {"from": "antibiotic", "to": "antimicrobial drug development process", "width": 4.0}, {"from": "antibiotic market", "to": "development of new antibacterial treatments", "width": 4.0}, {"from": "antileprotic drug resistance", "to": "global health system", "width": 4.0}, {"from": "antimicrobial resistance", "to": "pandemic", "width": 4.0}, {"from": "antimicrobial stewardship", "to": "need for increased action", "width": 4.5}, {"from": "antimicrobials pipeline", "to": "need for increased action", "width": 4.0}, {"from": "artemisinin-based combination therapy-resistance", "to": "global health system", "width": 4.0}, {"from": "artificial intelligence", "to": "technology", "width": 4.5}, {"from": "artificial intelligence", "to": "healthcare", "width": 4.5}, {"from": "at-risk investments", "to": "recommendations", "width": 4.5}, {"from": "at-risk investments", "to": "supply", "width": 4.5}, {"from": "at-risk investments", "to": "demand", "width": 4.5}, {"from": "at-risk investments", "to": "manufacturing", "width": 4.5}, {"from": "at-risk investments", "to": "country-level challenges", "width": 5.0}, {"from": "at-risk investments", "to": "other factors", "width": 4.5}, {"from": "at-risk investments", "to": "funding", "width": 4.5}, {"from": "at-risk investments", "to": "vaccines", "width": 5.0}, {"from": "avian influenza", "to": "zoonotic disease", "width": 4.0}, {"from": "big pharmaceutical companies", "to": "development of new antibacterial treatments", "width": 3.5}, {"from": "bilateral customers", "to": "procurement, distribution, administration of COVID-19 vaccines", "width": 4.0}, {"from": "biodiversity", "to": "ecological connectivity", "width": 4.5}, {"from": "bird and animal viruses", "to": "infectious disease", "width": 4.5}, {"from": "bird and animal viruses", "to": "epidemic", "width": 4.0}, {"from": "bird and animal viruses", "to": "pandemic", "width": 4.0}, {"from": "bird and animal viruses", "to": "prevent", "width": 3.5}, {"from": "checks and balances", "to": "mental health services", "width": 4.0}, {"from": "checks and balances", "to": "mental illness", "width": 4.0}, {"from": "cold chain", "to": "life-saving equipment", "width": 4.0}, {"from": "cold chain", "to": "vaccines", "width": 4.0}, {"from": "collaboration", "to": "digital literacy", "width": 4.0}, {"from": "communication", "to": "technology", "width": 4.5}, {"from": "communication", "to": "healthcare", "width": 4.5}, {"from": "community participation", "to": "mental health equity", "width": 4.0}, {"from": "consequences of AMR", "to": "need for increased action", "width": 4.5}, {"from": "consistent policy guidance", "to": "life-saving equipment", "width": 4.0}, {"from": "consistent policy guidance", "to": "vaccines", "width": 4.0}, {"from": "consultations", "to": "record time", "width": 4.5}, {"from": "consultations", "to": "patients", "width": 4.0}, {"from": "consultations", "to": "esanjeevani.mohfw.gov.in", "width": 3.0}, {"from": "coronavirus", "to": "spike protein", "width": 4.5}, {"from": "coronavirus", "to": "neutralising antibodies", "width": 4.0}, {"from": "countries lacking infrastructure", "to": "in-country delivery requirements", "width": 4.0}, {"from": "countries prevent, prepare for, and respond to health emergencies", "to": "workforce capacity and readiness", "width": 4.5}, {"from": "countries prevent, prepare for, and respond to health emergencies", "to": "strengthening human resources", "width": 4.5}, {"from": "countries prevent, prepare for, and respond to health emergencies", "to": "sustainable public health workforce capacity in LMICs", "width": 4.5}, {"from": "country-level challenges", "to": "recommendations", "width": 4.5}, {"from": "country-level challenges", "to": "supply", "width": 4.5}, {"from": "country-level challenges", "to": "demand", "width": 4.5}, {"from": "country-level challenges", "to": "manufacturing", "width": 4.5}, {"from": "country-level challenges", "to": "other factors", "width": 4.5}, {"from": "country-level challenges", "to": "funding", "width": 4.5}, {"from": "country-level challenges", "to": "vaccines", "width": 5.0}, {"from": "cultural acceptance", "to": "evidence-based integration", "width": 4.0}, {"from": "dairy products", "to": "zoonotic disease", "width": 3.5}, {"from": "dangerous and deadly outbreaks", "to": "global community", "width": 3.5}, {"from": "declines ranging from 40 percent to 2200 percent", "to": "generic medicine pricing policy", "width": 4.0}, {"from": "delivery of mental healthcare", "to": "mental health services", "width": 4.5}, {"from": "delivery of mental healthcare", "to": "mental illness", "width": 4.5}, {"from": "demand", "to": "vaccines", "width": 4.5}, {"from": "destruction of natural habitats", "to": "global health system", "width": 4.0}, {"from": "developing countries", "to": "infectious diseases", "width": 4.0}, {"from": "development of new antibacterial treatments", "to": "emerging threat of AMR", "width": 4.5}, {"from": "development of new antibacterial treatments", "to": "return on investment for new antibiotics", "width": 4.0}, {"from": "development of new antibacterial treatments", "to": "small or micro biotech firms", "width": 3.5}, {"from": "development of new antibacterial treatments", "to": "novel reimbursement models", "width": 4.0}, {"from": "diagnostic capacity", "to": "infectious diseases", "width": 4.5}, {"from": "digital divide", "to": "digital literacy", "width": 4.5}, {"from": "digital health infrastructure", "to": "technology", "width": 4.0}, {"from": "digital literacy", "to": "evidence-based integration", "width": 4.0}, {"from": "digital literacy", "to": "technology", "width": 4.0}, {"from": "digital literacy", "to": "inclusivity", "width": 4.5}, {"from": "digital literacy", "to": "scalability", "width": 4.0}, {"from": "digital literacy", "to": "regulation", "width": 4.0}, {"from": "direct benefit transfer (DBT) in India", "to": "transparency", "width": 4.5}, {"from": "disadvantaged populations", "to": "healthcare service delivery", "width": 4.0}, {"from": "drug procurement", "to": "state-owned enterprises", "width": 4.5}, {"from": "drug procurement", "to": "generic medications", "width": 4.5}, {"from": "drug-resistant Tuberculosis", "to": "global health system", "width": 4.5}, {"from": "e-governance", "to": "technology", "width": 4.0}, {"from": "e-governance platforms", "to": "transparency", "width": 4.0}, {"from": "early R\u0026D", "to": "life-saving equipment", "width": 4.0}, {"from": "early R\u0026D", "to": "vaccines", "width": 4.0}, {"from": "ecological connectivity", "to": "zoonoses", "width": 4.0}, {"from": "ecological connectivity", "to": "vector-borne diseases", "width": 4.0}, {"from": "eggs", "to": "zoonotic disease", "width": 3.5}, {"from": "electronic health records", "to": "technology", "width": 4.0}, {"from": "electronic health records", "to": "healthcare", "width": 4.0}, {"from": "emergency preparedness and response", "to": "national public health workforce capacity", "width": 4.0}, {"from": "ethnicity", "to": "health equity", "width": 4.0}, {"from": "evidence-based integration", "to": "public health system", "width": 4.5}, {"from": "evidence-based integration", "to": "primary healthcare", "width": 4.5}, {"from": "evidence-based integration", "to": "referral pathways", "width": 3.5}, {"from": "evidence-based integration", "to": "mental care", "width": 4.0}, {"from": "evidence-based integration", "to": "physical care", "width": 3.5}, {"from": "evidence-based integration", "to": "robust information systems", "width": 4.0}, {"from": "evidence-based integration", "to": "mental and physical care integration", "width": 3.5}, {"from": "excess paid by patients compared to MOH set prices", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "exemptions and waivers", "to": "life-saving equipment", "width": 4.0}, {"from": "exemptions and waivers", "to": "vaccines", "width": 4.0}, {"from": "export bans", "to": "vaccine candidates", "width": 4.0}, {"from": "export bans", "to": "vaccine nationalism", "width": 4.0}, {"from": "export bans", "to": "vaccines", "width": 4.0}, {"from": "family members", "to": "mental health services", "width": 4.0}, {"from": "family members", "to": "mental illness", "width": 4.0}, {"from": "financial incentives", "to": "state-owned enterprises", "width": 4.0}, {"from": "financial incentives", "to": "generic medications", "width": 4.0}, {"from": "funding", "to": "vaccines", "width": 4.5}, {"from": "gender", "to": "health equity", "width": 4.0}, {"from": "gender issues", "to": "mental health equity", "width": 4.5}, {"from": "general health services", "to": "mental health services", "width": 4.0}, {"from": "general health services", "to": "mental illness", "width": 4.0}, {"from": "generic medications", "to": "state-owned enterprises", "width": 5.0}, {"from": "generic medications", "to": "public awareness campaigns", "width": 4.5}, {"from": "generic medicine pricing policies have succeeded in lowering the price of medicines", "to": "generic medicine pricing policy", "width": 4.5}, {"from": "generic medicine pricing policy", "to": "public hospitals", "width": 4.0}, {"from": "generic medicine pricing policy", "to": "private pharmacies", "width": 3.5}, {"from": "generic medicine pricing policy", "to": "variation in implementation", "width": 4.0}, {"from": "generic medicine pricing policy", "to": "narrow the differences", "width": 4.0}, {"from": "generic medicine pricing policy", "to": "more recently", "width": 3.5}, {"from": "geographic location", "to": "health equity", "width": 4.0}, {"from": "global community", "to": "health security", "width": 4.5}, {"from": "global community", "to": "pandemic threats", "width": 4.0}, {"from": "global community", "to": "vaccines", "width": 4.5}, {"from": "global community", "to": "incipient pandemic", "width": 4.0}, {"from": "global community", "to": "potential opponents", "width": 3.5}, {"from": "global community", "to": "viruses from around 25 viral families", "width": 4.0}, {"from": "global health agencies", "to": "vaccine candidates", "width": 4.5}, {"from": "global health system", "to": "zoonotic diseases", "width": 4.5}, {"from": "global health system", "to": "pathogens", "width": 4.0}, {"from": "global health system", "to": "urbanisation", "width": 4.0}, {"from": "global health system", "to": "illegal trade in wildlife", "width": 4.0}, {"from": "global health system", "to": "wet markets", "width": 4.0}, {"from": "global increase in climate-related and humanitarian disasters", "to": "limited availability of the health workforce", "width": 3.5}, {"from": "government unified and dedicated online learning and training platform SAKSHAM", "to": "impending disease outbreak", "width": 4.5}, {"from": "health apps", "to": "technology", "width": 3.5}, {"from": "health apps", "to": "healthcare", "width": 3.5}, {"from": "health disparities", "to": "health equity", "width": 4.5}, {"from": "health emergencies", "to": "life-saving equipment", "width": 4.5}, {"from": "health emergencies", "to": "vaccines", "width": 4.5}, {"from": "health emergency", "to": "pandemic", "width": 4.5}, {"from": "health equity", "to": "socioeconomic status", "width": 4.0}, {"from": "health equity", "to": "race", "width": 4.0}, {"from": "health equity", "to": "redistributing resources", "width": 4.0}, {"from": "health equity", "to": "targeted healthcare programs", "width": 4.0}, {"from": "health equity", "to": "improving access to quality healthcare services", "width": 4.5}, {"from": "health equity", "to": "promoting health education and prevention", "width": 4.0}, {"from": "health insurance", "to": "mental health services", "width": 4.5}, {"from": "health insurance", "to": "mental illness", "width": 4.5}, {"from": "health systems", "to": "pandemic", "width": 4.5}, {"from": "healthcare", "to": "technology", "width": 5.0}, {"from": "healthcare", "to": "transportation", "width": 4.0}, {"from": "healthcare", "to": "wearable devices", "width": 4.0}, {"from": "healthcare resources", "to": "healthcare service delivery", "width": 4.5}, {"from": "healthcare service delivery", "to": "mental illness", "width": 4.5}, {"from": "high-income countries", "to": "infectious diseases", "width": 3.5}, {"from": "hoarding", "to": "vaccine nationalism", "width": 4.5}, {"from": "hoarding", "to": "vaccines", "width": 4.5}, {"from": "humanitarian situations", "to": "life-saving equipment", "width": 4.5}, {"from": "humanitarian situations", "to": "vaccines", "width": 4.5}, {"from": "impending disease outbreak", "to": "inclusive capacity building of health professionals", "width": 4.0}, {"from": "impending disease outbreak", "to": "online platforms, video conferencing, pre-recorded lectures", "width": 4.0}, {"from": "in-country delivery requirements", "to": "personal protective equipment for healthcare workers", "width": 4.5}, {"from": "increase of novel resistance mechanisms", "to": "need for increased action", "width": 4.5}, {"from": "industry leaving the field of antimicrobial drug discovery", "to": "need for increased action", "width": 4.5}, {"from": "infectious diseases", "to": "vulnerable populations", "width": 4.0}, {"from": "infectious diseases", "to": "quality and efficiency", "width": 3.5}, {"from": "integration of healthcare programmes", "to": "overall healthcare service delivery", "width": 4.5}, {"from": "integration of healthcare programmes", "to": "transformation of the healthcare situation in the country", "width": 4.5}, {"from": "international cooperation", "to": "pandemic", "width": 4.5}, {"from": "international freight and logistics", "to": "life-saving equipment", "width": 4.0}, {"from": "international freight and logistics", "to": "vaccines", "width": 4.0}, {"from": "large-scale investments", "to": "vaccine nationalism", "width": 4.5}, {"from": "large-scale investments", "to": "vaccines", "width": 4.5}, {"from": "life-saving equipment", "to": "trade barriers", "width": 4.0}, {"from": "life-saving equipment", "to": "life-saving medical countermeasures and materials", "width": 4.5}, {"from": "life-saving equipment", "to": "low- and middle-income countries", "width": 4.0}, {"from": "life-saving equipment", "to": "vaccines", "width": 5.0}, {"from": "life-saving equipment", "to": "vaccinations", "width": 4.5}, {"from": "life-saving equipment", "to": "strong, reliable health systems", "width": 4.5}, {"from": "life-saving equipment", "to": "scaling-up manufacturing", "width": 4.5}, {"from": "life-saving equipment", "to": "securing deals", "width": 4.0}, {"from": "life-saving equipment", "to": "operational, logistical, regulatory, and legal frameworks", "width": 4.5}, {"from": "life-saving equipment", "to": "safe injection equipment", "width": 4.0}, {"from": "life-saving medical countermeasures and materials", "to": "vaccines", "width": 4.5}, {"from": "limited availability of the health workforce", "to": "mental health issues, including burnout", "width": 4.0}, {"from": "limited availability of the health workforce", "to": "poor working conditions", "width": 4.0}, {"from": "limited availability of the health workforce", "to": "protracted conflicts", "width": 3.5}, {"from": "limited availability of the health workforce", "to": "public health crisis", "width": 4.0}, {"from": "limited availability of the health workforce", "to": "reversals in life expectancy and Sustainable Development Goals", "width": 3.5}, {"from": "low- and middle-income countries", "to": "vaccines", "width": 4.0}, {"from": "lower-income economies", "to": "vaccine nationalism", "width": 4.0}, {"from": "lower-income economies", "to": "vaccines", "width": 4.0}, {"from": "lowering the overall use of antimicrobials", "to": "need for increased action", "width": 4.0}, {"from": "manufacturing", "to": "vaccines", "width": 4.5}, {"from": "meat handling", "to": "zoonotic disease", "width": 4.0}, {"from": "mental health equity", "to": "social inequality", "width": 4.5}, {"from": "mental health services", "to": "parity for mental illness", "width": 4.0}, {"from": "mental health services", "to": "physical conditions", "width": 4.0}, {"from": "mental health services", "to": "persons with mental illness", "width": 4.5}, {"from": "mental health services", "to": "mental illness", "width": 5.0}, {"from": "mental illness", "to": "parity for mental illness", "width": 4.0}, {"from": "mental illness", "to": "physical conditions", "width": 4.0}, {"from": "mental illness", "to": "persons with mental illness", "width": 4.5}, {"from": "multifaceted effort", "to": "need for increased action", "width": 4.5}, {"from": "national assessments and benchmarking", "to": "workforce capacity and readiness", "width": 4.5}, {"from": "national assessments and benchmarking", "to": "strengthening human resources", "width": 4.5}, {"from": "national assessments and benchmarking", "to": "sustainable public health workforce capacity in LMICs", "width": 4.5}, {"from": "national public health workforce capacity", "to": "roadmap", "width": 4.5}, {"from": "national public health workforce capacity", "to": "public health workforce", "width": 4.5}, {"from": "need for increased action", "to": "vulnerable populations in HICs", "width": 4.5}, {"from": "need for increased action", "to": "reducing the circulation and spread of existing resistant microorganisms", "width": 4.0}, {"from": "need for increased action", "to": "strengthening IPC and biosecurity procedures", "width": 4.0}, {"from": "operational, logistical, regulatory, and legal frameworks", "to": "vaccines", "width": 4.5}, {"from": "other factors", "to": "vaccines", "width": 4.5}, {"from": "overall healthcare service delivery", "to": "transformation of the healthcare situation in the country", "width": 5.0}, {"from": "pandemic", "to": "pharmaceutical sector", "width": 4.0}, {"from": "pandemic", "to": "vaccines, therapeutics, diagnostics", "width": 3.5}, {"from": "procurement, distribution, administration of COVID-19 vaccines", "to": "vaccine makers", "width": 4.5}, {"from": "public awareness campaigns", "to": "state-owned enterprises", "width": 4.5}, {"from": "recommendations", "to": "vaccines", "width": 4.5}, {"from": "regulatory approval", "to": "vaccine nationalism", "width": 4.0}, {"from": "regulatory approval", "to": "vaccines", "width": 4.0}, {"from": "regulatory frameworks", "to": "technology", "width": 4.5}, {"from": "safe injection equipment", "to": "vaccines", "width": 4.0}, {"from": "scaling-up manufacturing", "to": "vaccines", "width": 4.5}, {"from": "securing deals", "to": "vaccines", "width": 4.0}, {"from": "strengthening human resources", "to": "workforce capacity and readiness", "width": 5.0}, {"from": "strengthening human resources", "to": "sustainable public health workforce capacity in LMICs", "width": 5.0}, {"from": "strong, reliable health systems", "to": "vaccines", "width": 4.5}, {"from": "supply", "to": "vaccines", "width": 4.5}, {"from": "sustainable public health workforce capacity in LMICs", "to": "workforce capacity and readiness", "width": 5.0}, {"from": "technology", "to": "transportation", "width": 4.0}, {"from": "technology", "to": "wearable devices", "width": 4.0}, {"from": "technology platforms", "to": "vaccine nationalism", "width": 4.0}, {"from": "technology platforms", "to": "vaccines", "width": 4.0}, {"from": "trade barriers", "to": "vaccines", "width": 4.0}, {"from": "vaccinations", "to": "vaccines", "width": 4.5}, {"from": "vaccine nationalism", "to": "vaccines", "width": 5.0}, {"from": "vaccine nationalism", "to": "wealthier nations", "width": 4.5}, {"from": "vaccine nationalism", "to": "vaccine-candidates", "width": 4.5}, {"from": "vaccine-candidates", "to": "vaccines", "width": 4.5}, {"from": "vaccines", "to": "wealthier nations", "width": 4.5}, {"from": "vegetables", "to": "zoonotic disease", "width": 3.5}]);++ nodeColors = {};+ allNodes = nodes.get({ returnType: "Object" });+ for (nodeId in allNodes) {+ nodeColors[nodeId] = allNodes[nodeId].color;+ }+ allEdges = edges.get({ returnType: "Object" });+ // adding nodes and edges to the graph+ data = {nodes: nodes, edges: edges};++ var options = {+ "configure": {+ "enabled": true,+ "filter": "physics"+ },+ "edges": {+ "color": {+ "inherit": true+ },+ "smooth": {+ "enabled": true,+ "type": "dynamic"+ }+ },+ "interaction": {+ "dragNodes": true,+ "hideEdgesOnDrag": false,+ "hideNodesOnDrag": false+ },+ "physics": {+ "enabled": true,+ "repulsion": {+ "centralGravity": 0.2,+ "damping": 0.09,+ "nodeDistance": 150,+ "springConstant": 0.05,+ "springLength": 400+ },+ "solver": "repulsion",+ "stabilization": {+ "enabled": true,+ "fit": true,+ "iterations": 1000,+ "onlyDynamicEdges": false,+ "updateInterval": 50+ }+ }+};++++++ // if this network requires displaying the configure window,+ // put it in its div+ options.configure["container"] = document.getElementById("config");+++ network = new vis.Network(container, data, options);+++++ network.on("selectNode", neighbourhoodHighlight);+++++++ network.on("stabilizationProgress", function(params) {+ document.getElementById('loadingBar').removeAttribute("style");+ var maxWidth = 496;+ var minWidth = 20;+ var widthFactor = params.iterations/params.total;+ var width = Math.max(minWidth,maxWidth * widthFactor);+ document.getElementById('bar').style.width = width + 'px';+ document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';+ });+ network.once("stabilizationIterationsDone", function() {+ document.getElementById('text').innerHTML = '100%';+ document.getElementById('bar').style.width = '496px';+ document.getElementById('loadingBar').style.opacity = 0;+ // really clean the dom element+ setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);+ });+++ return network;++ }+ drawGraph();+ </script>+ </body>+</html>\ No newline at end of filediff --git a/helpers/__init__ b/helpers/__init__new file mode 100644index 0000000..e69de29diff --git a/helpers/df_helpers.py b/helpers/df_helpers.pynew file mode 100644index 0000000..2772424--- /dev/null+++ b/helpers/df_helpers.py@@ -0,0 +1,37 @@+import uuid+import pandas as pd+import numpy as np+from .prompts import extractConcepts++def documents2Dataframe(documents) -> pd.DataFrame:+ rows = []+ for chunk in documents:+ row = {+ "text": chunk.page_content,+ **chunk.metadata,+ "chunk_id": uuid.uuid4().hex,+ }+ rows = rows + [row]++ df = pd.DataFrame(rows)+ return df++def df2ConceptsList(dataframe: pd.DataFrame) -> list:+ # dataframe.reset_index(inplace=True)+ results = dataframe.apply(+ lambda row: extractConcepts(row.text, {"chunk_id": row.chunk_id, "type": "concept"}), axis=1+ )+ # invalid json results in NaN+ results = results.dropna()+ results = results.reset_index(drop=True)++ ## Flatten the list of lists to one single list of entities.+ concept_list = np.concatenate(results).ravel().tolist()+ return concept_list++def concepts2Df(concepts_list) -> pd.DataFrame:+ ## Remove all NaN entities+ concepts_dataframe = pd.DataFrame(concepts_list).replace(" ", np.nan)+ concepts_dataframe = concepts_dataframe.dropna(subset=["entity"])++ return concepts_dataframe\ No newline at end of filediff --git a/helpers/prompts.py b/helpers/prompts.pynew file mode 100644index 0000000..1e39a15--- /dev/null+++ b/helpers/prompts.py@@ -0,0 +1,32 @@+import sys+sys.path.append('..')++import json+import ollama.client as client++def extractConcepts(prompt: str, metadata = {}, model="mistral-openorca:latest"):+ SYS_PROMPT = (+ "Your task is extract the key concepts (and non personal entities) mentioned in the given text. "+ "Extract only the most important and atomistic concepts, if needed break the concepts down to the simpler concepts."+ "Categorize the concepts in one of the following categories: "+ "[event, concept, place, object, document, organisation, condition, misc]\n"+ "Format your output as a list of json with the following format:\n"+ "[\n"+ " {\n"+ ' "entity": The Concept,\n'+ ' "importance": The contextual importance of the concept on a scale of 1 to 5 (5 being the highest),\n'+ ' "category": The Type of Concept,\n'+ " }, \n"+ "{ }, \n"+ "]\n"+ )+ response, _ = client.generate(+ model_name=model, system=SYS_PROMPT, prompt=prompt+ )+ try:+ result = json.loads(response)+ result = [dict(item, **metadata) for item in result]+ except:+ print("\n\nERROR ### Here is the buggy response: ", response, "\n\n")+ result = None+ return result\ No newline at end of filediff --git a/ner.ipynb b/ner.ipynbnew file mode 100644index 0000000..bcba397--- /dev/null+++ b/ner.ipynb@@ -0,0 +1,480 @@+{+ "cells": [+ {+ "cell_type": "code",+ "execution_count": 158,+ "metadata": {},+ "outputs": [],+ "source": [+ "import pandas as pd\n",+ "import numpy as np\n",+ "from langchain.document_loaders import PyPDFLoader\n",+ "from langchain.document_loaders import PyPDFDirectoryLoader\n",+ "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",+ "import uuid\n",+ "import json\n",+ "import ollama.client as client\n",+ "\n",+ "\n",+ "\n",+ "splitter = RecursiveCharacterTextSplitter(\n",+ " chunk_size = 800,\n",+ " chunk_overlap = 100,\n",+ " length_function = len,\n",+ " is_separator_regex = False,\n",+ ")"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 111,+ "metadata": {},+ "outputs": [+ {+ "name": "stderr",+ "output_type": "stream",+ "text": [+ "Some weights of the model checkpoint at dslim/bert-large-NER were not used when initializing BertForTokenClassification: ['bert.pooler.dense.weight', 'bert.pooler.dense.bias']\n",+ "- This IS expected if you are initializing BertForTokenClassification from the checkpoint of a model trained on another task or with another architecture (e.g. initializing a BertForSequenceClassification model from a BertForPreTraining model).\n",+ "- This IS NOT expected if you are initializing BertForTokenClassification from the checkpoint of a model that you expect to be exactly identical (initializing a BertForSequenceClassification model from a BertForSequenceClassification model).\n"+ ]+ },+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ "Number of parameters -> 332.538889 Mn\n"+ ]+ }+ ],+ "source": [+ "from transformers import pipeline\n",+ "\n",+ "## Roberta based NER\n",+ "# ner = pipeline(\"token-classification\", model=\"2rtl3/mn-xlm-roberta-base-named-entity\", aggregation_strategy=\"simple\")\n",+ "ner = pipeline(\"token-classification\", model=\"dslim/bert-large-NER\", aggregation_strategy=\"simple\")\n",+ "\n",+ "\n",+ "print(\"Number of parameters ->\", ner.model.num_parameters()/1000000, \"Mn\")\n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 112,+ "metadata": {},+ "outputs": [],+ "source": [+ "def row2NamedEntities(row):\n",+ " # print(row)\n",+ " ner_results = ner(row['text'])\n",+ " metadata = {'chunk_id': row['chunk_id']}\n",+ " entities = []\n",+ " for result in ner_results:\n",+ " entities = entities + [{'name': result['word'], 'entity': result['entity_group'], **metadata}]\n",+ " \n",+ " return entities\n",+ "\n",+ "def dfText2DfNE(dataframe):\n",+ " ## Takes a dataframe from the parsed data and returns dataframe with named entities. \n",+ " ## The input dataframe must have a text and a chunk_id column. \n",+ "\n",+ " ## Using swifter for parallelism\n",+ " ## 1. Calculate named entities for each row of the dataframe. \n",+ " results = dataframe.apply(row2NamedEntities, axis=1)\n",+ "\n",+ " ## Flatten the list of lists to one single list of entities. \n",+ " entities_list = np.concatenate(results).ravel().tolist()\n",+ "\n",+ " ## Remove all NaN entities\n",+ " entities_dataframe = pd.DataFrame(entities_list).replace(' ', np.nan)\n",+ " entities_dataframe = entities_dataframe.dropna(subset=['entity'])\n",+ "\n",+ " ## Count the number of occurances per chunk id\n",+ " entities_dataframe = entities_dataframe.groupby(['name', 'entity', 'chunk_id']).size().reset_index(name='count')\n",+ "\n",+ " return entities_dataframe"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 134,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/plain": [+ "167"+ ]+ },+ "execution_count": 134,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "loader = PyPDFLoader(\"./data/GlobalPublicHealth2022.pdf\")\n",+ "# loader = PyPDFDirectoryLoader(\"./data/kesy1dd\")\n",+ "\n",+ "pages = loader.load_and_split(text_splitter=splitter)\n",+ "len(pages)\n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 135,+ "metadata": {},+ "outputs": [],+ "source": [+ "\n",+ "rows = []\n",+ "for page in pages:\n",+ " row = {'text': page.page_content, **page.metadata, 'chunk_id': uuid.uuid4().hex}\n",+ " rows += [row]\n",+ "\n",+ "df = pd.DataFrame(rows)\n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 136,+ "metadata": {},+ "outputs": [],+ "source": [+ "dfne = dfText2DfNE(df)\n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 137,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/html": [+ "<div>\n",+ "<style scoped>\n",+ " .dataframe tbody tr th:only-of-type {\n",+ " vertical-align: middle;\n",+ " }\n",+ "\n",+ " .dataframe tbody tr th {\n",+ " vertical-align: top;\n",+ " }\n",+ "\n",+ " .dataframe thead th {\n",+ " text-align: right;\n",+ " }\n",+ "</style>\n",+ "<table border=\"1\" class=\"dataframe\">\n",+ " <thead>\n",+ " <tr style=\"text-align: right;\">\n",+ " <th></th>\n",+ " <th>index</th>\n",+ " <th>name</th>\n",+ " <th>entity</th>\n",+ " <th>count</th>\n",+ " <th>chunk_id</th>\n",+ " </tr>\n",+ " </thead>\n",+ " <tbody>\n",+ " <tr>\n",+ " <th>0</th>\n",+ " <td>486</td>\n",+ " <td>WHO</td>\n",+ " <td>ORG</td>\n",+ " <td>228</td>\n",+ " <td>02db3a55557341d8ba3851dedd6223ed,077b1c4c99064...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>1</th>\n",+ " <td>390</td>\n",+ " <td>Region</td>\n",+ " <td>MISC</td>\n",+ " <td>72</td>\n",+ " <td>07a0744df31b4bfeaa18460091a48c6f,082f7b2fd6794...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>2</th>\n",+ " <td>384</td>\n",+ " <td>R</td>\n",+ " <td>MISC</td>\n",+ " <td>57</td>\n",+ " <td>088ecaeee2804c10bb2a8eb885930949,1a1455b89c444...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>3</th>\n",+ " <td>160</td>\n",+ " <td>E</td>\n",+ " <td>MISC</td>\n",+ " <td>37</td>\n",+ " <td>045bd2ce17da4b839e1198a6603c3b34,0a342463219b4...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>4</th>\n",+ " <td>161</td>\n",+ " <td>E</td>\n",+ " <td>ORG</td>\n",+ " <td>36</td>\n",+ " <td>02db3a55557341d8ba3851dedd6223ed,0848d9f456f04...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>...</th>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " <td>...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>95</th>\n",+ " <td>195</td>\n",+ " <td>Event Management System</td>\n",+ " <td>MISC</td>\n",+ " <td>3</td>\n",+ " <td>15113bcf8e2f4018a589268bf2e67852,650b458e34044...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>96</th>\n",+ " <td>124</td>\n",+ " <td>China</td>\n",+ " <td>LOC</td>\n",+ " <td>3</td>\n",+ " <td>7a56d66c7a9a4b249c4b5e7a9ad1bcd0</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>97</th>\n",+ " <td>131</td>\n",+ " <td>Congo</td>\n",+ " <td>LOC</td>\n",+ " <td>3</td>\n",+ " <td>045bd2ce17da4b839e1198a6603c3b34,d510aaa685194...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>98</th>\n",+ " <td>440</td>\n",+ " <td>South -</td>\n",+ " <td>MISC</td>\n",+ " <td>3</td>\n",+ " <td>66faf6d1a4334bf69bd0300b7653096c,fb187a00ea554...</td>\n",+ " </tr>\n",+ " <tr>\n",+ " <th>99</th>\n",+ " <td>121</td>\n",+ " <td>Chiku</td>\n",+ " <td>MISC</td>\n",+ " <td>3</td>\n",+ " <td>5b9a455f599e4608a50da16e71a71a31,616c2f5978124...</td>\n",+ " </tr>\n",+ " </tbody>\n",+ "</table>\n",+ "<p>100 rows × 5 columns</p>\n",+ "</div>"+ ],+ "text/plain": [+ " index name entity count \\\n",+ "0 486 WHO ORG 228 \n",+ "1 390 Region MISC 72 \n",+ "2 384 R MISC 57 \n",+ "3 160 E MISC 37 \n",+ "4 161 E ORG 36 \n",+ ".. ... ... ... ... \n",+ "95 195 Event Management System MISC 3 \n",+ "96 124 China LOC 3 \n",+ "97 131 Congo LOC 3 \n",+ "98 440 South - MISC 3 \n",+ "99 121 Chiku MISC 3 \n",+ "\n",+ " chunk_id \n",+ "0 02db3a55557341d8ba3851dedd6223ed,077b1c4c99064... \n",+ "1 07a0744df31b4bfeaa18460091a48c6f,082f7b2fd6794... \n",+ "2 088ecaeee2804c10bb2a8eb885930949,1a1455b89c444... \n",+ "3 045bd2ce17da4b839e1198a6603c3b34,0a342463219b4... \n",+ "4 02db3a55557341d8ba3851dedd6223ed,0848d9f456f04... \n",+ ".. ... \n",+ "95 15113bcf8e2f4018a589268bf2e67852,650b458e34044... \n",+ "96 7a56d66c7a9a4b249c4b5e7a9ad1bcd0 \n",+ "97 045bd2ce17da4b839e1198a6603c3b34,d510aaa685194... \n",+ "98 66faf6d1a4334bf69bd0300b7653096c,fb187a00ea554... \n",+ "99 5b9a455f599e4608a50da16e71a71a31,616c2f5978124... \n",+ "\n",+ "[100 rows x 5 columns]"+ ]+ },+ "execution_count": 137,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "df_ne = dfne.groupby(['name', 'entity']).agg({'count': 'sum', 'chunk_id': ','.join}).reset_index()\n",+ "df_ne.sort_values(by='count', ascending=False).head(100).reset_index()"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 140,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/plain": [+ "'assesses the likelihood and consequences of an acute public health threat due to exposure \\nto an identified hazard. RRA involves a joint assessment by the WHO Country and Regional \\nOffices and headquarters. It is conducted for events with serious public health implications \\nfollowing pre-defined criteria within WHO. The RRA process provides a forum for the \\ntimely assessment of available data, which takes into account the contextual and hazard-\\nspecific knowledge and feedback of key experts across WHO. It supports a collaborative \\nexpert prioritization of immediate actions in a time-sensitive manner. The finalized RRA \\nreport may be shared with key stakeholders that could contribute to the response. RRA \\nreports have become well accepted documents of high practical value both within WHO'"+ ]+ },+ "execution_count": 140,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "pages[12].page_content"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 184,+ "metadata": {},+ "outputs": [],+ "source": [+ "\n",+ "\n",+ "def extractConcepts(prompt: str, model='mistral-openorca:latest'):\n",+ " SYS_PROMPT = (\n",+ " \"Your task is to extract the key entities mentioned in the users input.\\n\"\n",+ " \"Entities may include - event, concept, person, place, object, document, organisation, artifact, misc, etc.\\n\"\n",+ " \"Format your output as a list of json with the following structure.\\n\"\n",+ " \"[{\\n\"\n",+ " \" \\\"entity\\\": The Entity string\\n\"\n",+ " \" \\\"importance\\\": How important is the entity given the context on a scale of 1 to 5, 5 being the highest.\\n\"\n",+ " \" \\\"type\\\": Type of entity\\n\"\n",+ " \"}, { }]\"\n",+ " )\n",+ " response, context = client.generate(model_name=model, system=SYS_PROMPT, prompt=prompt)\n",+ " return json.loads(response)\n"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 185,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ " [\n",+ " {\n",+ " \"entity\": \"acute public health events\",\n",+ " \"importance\": 4,\n",+ " \"type\": \"event\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"infectious diseases\",\n",+ " \"importance\": 3,\n",+ " \"type\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"disasters\",\n",+ " \"importance\": 2,\n",+ " \"type\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"EMS\",\n",+ " \"importance\": 3,\n",+ " \"type\": \"document\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"RRA reports\",\n",+ " \"importance\": 2,\n",+ " \"type\": \"document\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"EIS bulletins\",\n",+ " \"importance\": 2,\n",+ " \"type\": \"document\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"DON reports\",\n",+ " \"importance\": 2,\n",+ " \"type\": \"document\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"WHO Regions\",\n",+ " \"importance\": 3,\n",+ " \"type\": \"organization\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"IHR (2005) framework\",\n",+ " \"importance\": 4,\n",+ " \"type\": \"concept\"\n",+ " },\n",+ " {\n",+ " \"entity\": \"WHO\",\n",+ " \"importance\": 4,\n",+ " \"type\": \"organization\"\n",+ " }\n",+ "]"+ ]+ }+ ],+ "source": [+ "res = extractConcepts(prompt = pages[22].page_content)"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 168,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/plain": [+ "[{'entity': 'infectious diseases', 'importance': 4},\n",+ " {'entity': 'disasters', 'importance': 3},\n",+ " {'entity': 'EMS', 'importance': 3},\n",+ " {'entity': 'RRA reports', 'importance': 2},\n",+ " {'entity': 'EIS bulletins', 'importance': 1.5},\n",+ " {'entity': 'DON reports', 'importance': 1},\n",+ " {'entity': 'WHO Regions', 'importance': 2},\n",+ " {'entity': 'IHR (2005) framework', 'importance': 3}]"+ ]+ },+ "execution_count": 168,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "res"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": null,+ "metadata": {},+ "outputs": [],+ "source": []+ }+ ],+ "metadata": {+ "kernelspec": {+ "display_name": "OpenAI@3111",+ "language": "python",+ "name": "python3"+ },+ "language_info": {+ "codemirror_mode": {+ "name": "ipython",+ "version": 3+ },+ "file_extension": ".py",+ "mimetype": "text/x-python",+ "name": "python",+ "nbconvert_exporter": "python",+ "pygments_lexer": "ipython3",+ "version": "3.11.1"+ }+ },+ "nbformat": 4,+ "nbformat_minor": 2+}diff --git a/ollama/__init__.py b/ollama/__init__.pynew file mode 100644index 0000000..e69de29diff --git a/ollama/client.py b/ollama/client.pynew file mode 100644index 0000000..9f4e336--- /dev/null+++ b/ollama/client.py@@ -0,0 +1,224 @@+import os+import json+import requests++BASE_URL = os.environ.get('OLLAMA_HOST', 'http://localhost:11434')++# Generate a response for a given prompt with a provided model. This is a streaming endpoint, so will be a series of responses.+# The final response object will include statistics and additional data from the request. Use the callback function to override+# the default handler.+def generate(model_name, prompt, system=None, template=None, context=None, options=None, callback=None):+ try:+ url = f"{BASE_URL}/api/generate"+ payload = {+ "model": model_name,+ "prompt": prompt,+ "system": system,+ "template": template,+ "context": context,+ "options": options+ }++ # Remove keys with None values+ payload = {k: v for k, v in payload.items() if v is not None}++ with requests.post(url, json=payload, stream=True) as response:+ response.raise_for_status()++ # Creating a variable to hold the context history of the final chunk+ final_context = None++ # Variable to hold concatenated response strings if no callback is provided+ full_response = ""++ # Iterating over the response line by line and displaying the details+ for line in response.iter_lines():+ if line:+ # Parsing each line (JSON chunk) and extracting the details+ chunk = json.loads(line)++ # If a callback function is provided, call it with the chunk+ if callback:+ callback(chunk)+ else:+ # If this is not the last chunk, add the "response" field value to full_response and print it+ if not chunk.get("done"):+ response_piece = chunk.get("response", "")+ full_response += response_piece+ print(response_piece, end="", flush=True)++ # Check if it's the last chunk (done is true)+ if chunk.get("done"):+ final_context = chunk.get("context")++ # Return the full response and the final context+ return full_response, final_context+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return None, None++# Create a model from a Modelfile. Use the callback function to override the default handler.+def create(model_name, model_path, callback=None):+ try:+ url = f"{BASE_URL}/api/create"+ payload = {"name": model_name, "path": model_path}++ # Making a POST request with the stream parameter set to True to handle streaming responses+ with requests.post(url, json=payload, stream=True) as response:+ response.raise_for_status()++ # Iterating over the response line by line and displaying the status+ for line in response.iter_lines():+ if line:+ # Parsing each line (JSON chunk) and extracting the status+ chunk = json.loads(line)++ if callback:+ callback(chunk)+ else:+ print(f"Status: {chunk.get('status')}")+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")++# Pull a model from a the model registry. Cancelled pulls are resumed from where they left off, and multiple+# calls to will share the same download progress. Use the callback function to override the default handler.+def pull(model_name, insecure=False, callback=None):+ try:+ url = f"{BASE_URL}/api/pull"+ payload = {+ "name": model_name,+ "insecure": insecure+ }++ # Making a POST request with the stream parameter set to True to handle streaming responses+ with requests.post(url, json=payload, stream=True) as response:+ response.raise_for_status()++ # Iterating over the response line by line and displaying the details+ for line in response.iter_lines():+ if line:+ # Parsing each line (JSON chunk) and extracting the details+ chunk = json.loads(line)++ # If a callback function is provided, call it with the chunk+ if callback:+ callback(chunk)+ else:+ # Print the status message directly to the console+ print(chunk.get('status', ''), end='', flush=True)++ # If there's layer data, you might also want to print that (adjust as necessary)+ if 'digest' in chunk:+ print(f" - Digest: {chunk['digest']}", end='', flush=True)+ print(f" - Total: {chunk['total']}", end='', flush=True)+ print(f" - Completed: {chunk['completed']}", end='\n', flush=True)+ else:+ print()+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")++# Push a model to the model registry. Use the callback function to override the default handler.+def push(model_name, insecure=False, callback=None):+ try:+ url = f"{BASE_URL}/api/push"+ payload = {+ "name": model_name,+ "insecure": insecure+ }++ # Making a POST request with the stream parameter set to True to handle streaming responses+ with requests.post(url, json=payload, stream=True) as response:+ response.raise_for_status()++ # Iterating over the response line by line and displaying the details+ for line in response.iter_lines():+ if line:+ # Parsing each line (JSON chunk) and extracting the details+ chunk = json.loads(line)++ # If a callback function is provided, call it with the chunk+ if callback:+ callback(chunk)+ else:+ # Print the status message directly to the console+ print(chunk.get('status', ''), end='', flush=True)++ # If there's layer data, you might also want to print that (adjust as necessary)+ if 'digest' in chunk:+ print(f" - Digest: {chunk['digest']}", end='', flush=True)+ print(f" - Total: {chunk['total']}", end='', flush=True)+ print(f" - Completed: {chunk['completed']}", end='\n', flush=True)+ else:+ print()+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")++# List models that are available locally.+def list():+ try:+ response = requests.get(f"{BASE_URL}/api/tags")+ response.raise_for_status()+ data = response.json()+ models = data.get('models', [])+ return models++ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return None++# Copy a model. Creates a model with another name from an existing model.+def copy(source, destination):+ try:+ # Create the JSON payload+ payload = {+ "source": source,+ "destination": destination+ }++ response = requests.post(f"{BASE_URL}/api/copy", json=payload)+ response.raise_for_status()++ # If the request was successful, return a message indicating that the copy was successful+ return "Copy successful"++ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return None++# Delete a model and its data.+def delete(model_name):+ try:+ url = f"{BASE_URL}/api/delete"+ payload = {"name": model_name}+ response = requests.delete(url, json=payload)+ response.raise_for_status()+ return "Delete successful"+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return None++# Show info about a model.+def show(model_name):+ try:+ url = f"{BASE_URL}/api/show"+ payload = {"name": model_name}+ response = requests.post(url, json=payload)+ response.raise_for_status()++ # Parse the JSON response and return it+ data = response.json()+ return data+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return None++def heartbeat():+ try:+ url = f"{BASE_URL}/"+ response = requests.head(url)+ response.raise_for_status()+ return "Ollama is running"+ except requests.exceptions.RequestException as e:+ print(f"An error occurred: {e}")+ return "Ollama is not running"+diff --git a/relationships.ipynb b/relationships.ipynbnew file mode 100644index 0000000..b5843d1--- /dev/null+++ b/relationships.ipynb@@ -0,0 +1,155 @@+{+ "cells": [+ {+ "cell_type": "markdown",+ "metadata": {},+ "source": [+ "# Extract relationshipts between concepts\n",+ "Currently not using this"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 2,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/plain": [+ "[{'name': 'mistral:instruct',\n",+ " 'modified_at': '2023-10-14T11:39:58.684144971+05:30',\n",+ " 'size': 4108916688,\n",+ " 'digest': '8aa307f73b2622af521e8f22d46e4b777123c4df91898dcb2e4079dc8fdf579e'},\n",+ " {'name': 'mistral-openorca:latest',\n",+ " 'modified_at': '2023-10-14T14:27:09.318837452+05:30',\n",+ " 'size': 4108928254,\n",+ " 'digest': '12dc6acc14d0c4d3309e035cac6ff83e64c023aa774b21c41e342982699f436c'}]"+ ]+ },+ "execution_count": 2,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "import ollama.client as client\n",+ "client.list()"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 87,+ "metadata": {},+ "outputs": [+ {+ "data": {+ "text/plain": [+ "'{{- if .System }}\\n<|im_start|>system {{ .System }}<|im_end|>\\n{{- end }}\\n<|im_start|>user\\n{{ .Prompt }}<|im_end|>\\n<|im_start|>assistant\\n'"+ ]+ },+ "execution_count": 87,+ "metadata": {},+ "output_type": "execute_result"+ }+ ],+ "source": [+ "mistral_instruct = 'mistral:instruct'\n",+ "mistral_openorca = 'mistral-openorca:latest'\n",+ "mcard = client.show(mistral_openorca)\n",+ "mcard['template']"+ ]+ },+ {+ "cell_type": "code",+ "execution_count": 86,+ "metadata": {},+ "outputs": [+ {+ "name": "stdout",+ "output_type": "stream",+ "text": [+ " {\n",+ " \"Entity 1\": Cryosurgery,\n",+ " \"Entity 2\": non-narcotic pain,\n",+ " \"Relationship\": Cryosurgery uses liquid nitrogen to freeze and kill cancer cells, which is a part of the minimally invasive surgical techniques. Non-narcotic pain is one of the methods used in post-surgical care for pain management as per ASURE protocols.\n",+ " \"Related\": 'Yes'\n",+ "}"+ ]+ }+ ],+ "source": [+ "system_prompt = \"\"\"\n",+ "Your task is to find find a relationships between the entities given as a python list.\\n\n",+ "You can use the provided context (delimited between ```) and no other prior knowledge. \\n\n",+ "Follow this chain of thought\n",+ "Thought 1: What are the two entities as per the context. \n",+ "Thought 2: What is the relationship between the given entities as per the given context?. \n",+ "Thought 3: Is this a direct relationship as per the context.\n",+ "Format your response as JSON with the following structure:\\n\n",+ "{ \n",+ " \"Entity 1\": First Entity,\n",+ " \"Entity 2\": Second Entity,\n",+ " \"Relationship\": Explain the Relationship,\n",+ " \"Related\": 'Yes' only if a direct relation can be infered, otherwise 'No'\n",+ "}\n",+ "\"\"\"\n",+ "prompt = \"\"\"\n",+ "Entites: ['Cryosurgery', 'non-narcotic pain'].\n",+ "\n",+ "Context: ``` \n",+ "The two primary types of cancer surgery are open surgery and minimally invasive surgery.\n",+ "\n",+ "In open surgery, the surgical oncologist makes a large incision, usually to remove all or part of a tumor and some of the surrounding healthy tissue (margins).\n",+ "\n",+ "Minimally invasive surgical techniques may involve the techniques listed below.\n",+ "\n",+ "Laparoscopy: A surgical oncologist makes a few small incisions and inserts a laparoscope —a thin tube with a tiny camera attached to it—into one of the incisions to capture an interior image, while inserting surgical tools into the other incisions to excise malignancies and surrounding tissue.\n",+ "\n",+ "Laser surgery: The surgeon uses a narrow beam of high-intensity light to remove a tumor.\n",+ "\n",+ "Cryosurgery: The surgeon uses liquid nitrogen to freeze and kill cancer cells.\n",+ "\n",+ "Robotic surgery: This surgery is similar to a laparoscopic surgery. However, instead of manipulating surgical tools by hand, the surgeon uses a computer console to operate the robotic tools.\n",+ "\n",+ "Other procedures, such as endoscopies, embolization, Mohs micrographic surgery and pleuroscopies, may be performed by non-surgeons, including dermatologists, radiation oncologists and interventional pulmonologists, depending on the procedure.\n",+ "\n",+ "Non-surgical treatments may take place before surgery (neoadjuvant therapy) or after surgery (adjuvant therapy) to help prevent cancer growth, metastasis or recurrence. The treatments may include chemotherapy, radiation therapy or hormone therapy.\n",+ "\n",+ "The Advanced Surgical Recovery Program (ASURE) at City of Hope is designed to help patients recover from surgery more quickly and with fewer complications. ASURE is intended to improve surgical outcomes and enhance the patient experience before, during and after surgery, while also reducing the length of a patient’s hospital stay.\n",+ "\n",+ "The program is delivered by City of Hope multidisciplinary teams, which include surgeons, anesthesiologists, nutritionists, behavioral health therapists, nurses and other clinicians. They work collaboratively to implement evidenced-informed protocols, all under one roof. ASURE combines post-surgical rehabilitation with pre-habilitation, by preparing patients before surgery.\n",+ "\n",+ "Typically, ASURE protocols involve nutrition, pain management with non-narcotic pain relievers and physical activity within 24 hours after surgery. The use of enhanced recovery methods like those used in ASURE has been shown to reduce fatigue, post-surgery complications and the amount of narcotics used in post-surgical care, while helping patients resume their everyday activities more quickly.\n",+ "```\n",+ "\"\"\"\n",+ "\n",+ "combined_prompt = system_prompt + \"\\n\" + prompt\n",+ "response, context = client.generate(\n",+ " model_name=mistral_openorca, prompt=prompt, system=system_prompt\n",+ ")"+ ]+ }+ ],+ "metadata": {+ "kernelspec": {+ "display_name": "OpenAI@3111",+ "language": "python",+ "name": "python3"+ },+ "language_info": {+ "codemirror_mode": {+ "name": "ipython",+ "version": 3+ },+ "file_extension": ".py",+ "mimetype": "text/x-python",+ "name": "python",+ "nbconvert_exporter": "python",+ "pygments_lexer": "ipython3",+ "version": "3.11.1"+ },+ "orig_nbformat": 4+ },+ "nbformat": 4,+ "nbformat_minor": 2+}diff --git a/requirements.txt b/requirements.txtnew file mode 100644index 0000000..d85b9ad--- /dev/null+++ b/requirements.txt@@ -0,0 +1,238 @@+accelerate==0.21.0+aiohttp==3.8.6+aiosignal==1.3.1+annotated-types==0.6.0+anyio==3.7.1+appnope==0.1.3+argon2-cffi==21.3.0+argon2-cffi-bindings==21.2.0+arrow==1.2.3+asttokens==2.2.1+async-lru==2.0.4+async-timeout==4.0.3+attrs==23.1.0+Babel==2.12.1+backcall==0.2.0+backoff==2.2.1+beautifulsoup4==4.12.2+bleach==6.0.0+build==0.10.0+CacheControl==0.13.1+cachetools==5.3.1+certifi==2023.7.22+cffi==1.15.1+chardet==4.0.0+charset-normalizer==3.3.0+cleo==2.0.1+click==8.1.6+cloudpickle==2.2.1+comm==0.1.4+contourpy==1.1.1+crashtest==0.4.1+cycler==0.12.1+dask==2023.8.0+dataclasses==0.6+dataclasses-json==0.6.1+debugpy==1.6.7+decorator==5.1.1+defusedxml==0.7.1+deprecation==2.1.0+distlib==0.3.7+docopt==0.6.2+dulwich==0.21.6+einops==0.6.1+emoji==2.8.0+executing==1.2.0+fastjsonschema==2.18.0+filelock==3.12.2+filetype==1.2.0+fonttools==4.43.1+fqdn==1.5.1+frozenlist==1.4.0+fsspec==2023.6.0+google-api-core==2.11.1+google-api-python-client==2.96.0+google-auth==2.22.0+google-auth-httplib2==0.1.0+google-auth-oauthlib==1.0.0+googleapis-common-protos==1.60.0+gotrue==1.0.3+graphviz==0.20.1+gspread==5.10.0+gspread-pandas==3.2.2+h11==0.14.0+httpcore==0.17.3+httplib2==0.22.0+httpx==0.24.1+huggingface-hub==0.16.4+idna==3.4+importlib-metadata==6.8.0+importlib-resources==6.1.0+iniconfig==2.0.0+installer==0.7.0+ipykernel==6.25.0+ipython==8.14.0+isoduration==20.11.0+jaraco.classes==3.3.0+jedi==0.19.0+Jinja2==3.1.2+joblib==1.3.2+json5==0.9.14+jsonpatch==1.33+jsonpickle==3.0.2+jsonpointer==2.4+jsonschema==4.19.0+jsonschema-specifications==2023.7.1+jupyter-events==0.7.0+jupyter-lsp==2.2.0+jupyter_client==8.3.0+jupyter_core==5.3.1+jupyter_server==2.7.0+jupyter_server_terminals==0.4.4+jupyterlab==4.0.4+jupyterlab-pygments==0.2.2+jupyterlab_server==2.24.0+keyring==24.2.0+kiwisolver==1.4.5+langchain==0.0.314+langdetect==1.0.9+langsmith==0.0.43+locket==1.0.0+lxml==4.9.3+MarkupSafe==2.1.3+marshmallow==3.20.1+marshmallow-enum==1.5.1+matplotlib==3.8.0+matplotlib-inline==0.1.6+mistune==3.0.1+more-itertools==10.1.0+mpmath==1.3.0+msgpack==1.0.7+multidict==6.0.4+mypy-extensions==1.0.0+nbclient==0.8.0+nbconvert==7.7.3+nbformat==5.9.2+nest-asyncio==1.5.7+networkx==3.1+nltk==3.8.1+notebook_shim==0.2.3+numexpr==2.8.5+numpy==1.25.2+oauthlib==3.2.2+openai==0.27.8+openapi-schema-pydantic==1.2.4+overrides==7.4.0+packaging==23.2+pandas==2.0.3+pandocfilters==1.5.0+parso==0.8.3+partd==1.4.0+pathlib==1.0.1+pdf2image==1.16.3+pexpect==4.8.0+pgvector==0.2.1+pickleshare==0.7.5+Pillow==10.0.1+pipreqs==0.4.13+pkginfo==1.9.6+platformdirs==3.10.0+pluggy==1.2.0+poetry==1.6.1+poetry-core==1.7.0+poetry-plugin-export==1.5.0+postgrest==0.10.8+postgrest-py==0.4.0+prometheus-client==0.17.1+prompt-toolkit==3.0.39+protobuf==4.24.0+psutil==5.9.5+psycopg2==2.9.7+ptyprocess==0.7.0+pure-eval==0.2.2+py==1.11.0+pyasn1==0.5.0+pyasn1-modules==0.3.0+pycparser==2.21+pydantic==2.4.2+pydantic_core==2.10.1+Pygments==2.16.1+pyparsing==3.1.1+pypdf==3.16.1+pypdfium2==4.21.0+pyproject_hooks==1.0.0+pyrsistent==0.19.3+pytest==6.2.5+python-dateutil==2.8.2+python-dotenv==1.0.0+python-iso639==2023.6.15+python-json-logger==2.0.7+python-magic==0.4.27+pytz==2023.3+pyvis==0.3.2+PyYAML==6.0.1+pyzmq==25.1.0+rapidfuzz==2.15.1+realtime==1.0.0+realtime-py==0.1.3+referencing==0.30.2+regex==2023.6.3+requests==2.31.0+requests-oauthlib==1.3.1+requests-toolbelt==1.0.0+rfc3339-validator==0.1.4+rfc3986==1.5.0+rfc3986-validator==0.1.1+rpds-py==0.9.2+rsa==4.9+safetensors==0.3.1+seaborn==0.13.0+Send2Trash==1.8.2+shellingham==1.5.3+six==1.16.0+sniffio==1.3.0+soupsieve==2.4.1+SQLAlchemy==2.0.22+stack-data==0.6.2+storage3==0.5.4+StrEnum==0.4.15+supabase==1.0.4+supabase-py==0.0.2+supafunc==0.2.3+swifter==1.4.0+sympy==1.12+tabulate==0.9.0+tenacity==8.2.3+terminado==0.17.1+tiktoken==0.4.0+tinycss2==1.2.1+tokenizers==0.14.1+toml==0.10.2+tomlkit==0.12.1+toolz==0.12.0+torch==2.1.0+torchvision==0.16.0+tornado==6.3.2+tqdm==4.65.0+traitlets==5.9.0+transformers==4.34.0+trove-classifiers==2023.9.19+typing-inspect==0.9.0+typing_extensions==4.8.0+tzdata==2023.3+unstructured==0.10.24+uri-template==1.3.0+uritemplate==4.1.1+urllib3==2.0.6+virtualenv==20.24.5+wcwidth==0.2.6+webcolors==1.13+webencodings==0.5.1+websocket-client==1.6.1+websockets==10.4+wikipedia==1.4.0+xattr==0.10.1+yachalk==0.1.5+yarg==0.1.9+yarl==1.9.2+zipp==3.16.2